{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "40afbf8a",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "b780a84f",
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "4a963d3f",
   "metadata": {},
   "outputs": [],
   "source": [
    "KEY = \"38517ce28e0b3edf338f9065494b19034408\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "c5a1842f",
   "metadata": {},
   "outputs": [],
   "source": [
    "BASE_URL = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&usehistory=y\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "67e1dbc6",
   "metadata": {},
   "outputs": [],
   "source": [
    "TERM = \"ME/CFS\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "1752d2d8",
   "metadata": {},
   "outputs": [],
   "source": [
    "response = requests.get(f\"{BASE_URL}&term={TERM}&retmax=1000&api_key={KEY}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "1498f716",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "200"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response.status_code"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "0c68357a",
   "metadata": {},
   "outputs": [],
   "source": [
    "search = response.text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "cfd1a400",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['37328077',\n",
       " '37303862',\n",
       " '37297899',\n",
       " '37291581',\n",
       " '37252045',\n",
       " '37243973',\n",
       " '37241210',\n",
       " '37240059',\n",
       " '37234076',\n",
       " '37231733',\n",
       " '37230457',\n",
       " '37226227',\n",
       " '37219607',\n",
       " '37205352',\n",
       " '37193573',\n",
       " '37182295',\n",
       " '37179299',\n",
       " '37177559',\n",
       " '37170956',\n",
       " '37155451',\n",
       " '37131449',\n",
       " '37129123',\n",
       " '37128534',\n",
       " '37109676',\n",
       " '37064029',\n",
       " '37054777',\n",
       " '37046994',\n",
       " '37046554',\n",
       " '37013608',\n",
       " '37012343',\n",
       " '36984572',\n",
       " '36982194',\n",
       " '36981522',\n",
       " '36977713',\n",
       " '36963989',\n",
       " '36948138',\n",
       " '36938769',\n",
       " '36937672',\n",
       " '36923151',\n",
       " '36911963',\n",
       " '36911962',\n",
       " '36911961',\n",
       " '36911960',\n",
       " '36908615',\n",
       " '36902264',\n",
       " '36890852',\n",
       " '36855180',\n",
       " '36852237',\n",
       " '36851614',\n",
       " '36836022',\n",
       " '36835097',\n",
       " '36830795',\n",
       " '36789311',\n",
       " '36774379',\n",
       " '36769022',\n",
       " '36768336',\n",
       " '36767803',\n",
       " '36766636',\n",
       " '36765375',\n",
       " '36758522',\n",
       " '36758521',\n",
       " '36750846',\n",
       " '36737407',\n",
       " '36732593',\n",
       " '36730360',\n",
       " '36728717',\n",
       " '36713904',\n",
       " '36698810',\n",
       " '36696833',\n",
       " '36695893',\n",
       " '36672687',\n",
       " '36657309',\n",
       " '36653846',\n",
       " '36648965',\n",
       " '36648876',\n",
       " '36632532',\n",
       " '36611357',\n",
       " '36589231',\n",
       " '36560525',\n",
       " '36557009',\n",
       " '36553962',\n",
       " '36552153',\n",
       " '36540020',\n",
       " '36517845',\n",
       " '36510244',\n",
       " '36494693',\n",
       " '36494667',\n",
       " '36474290',\n",
       " '36456114',\n",
       " '36431185',\n",
       " '36412084',\n",
       " '36387947',\n",
       " '36367977',\n",
       " '36358996',\n",
       " '36356549',\n",
       " '36352819',\n",
       " '36341457',\n",
       " '36310761',\n",
       " '36300129',\n",
       " '36294186',\n",
       " '36292504',\n",
       " '36292229',\n",
       " '36284352',\n",
       " '36259126',\n",
       " '36240287',\n",
       " '36238301',\n",
       " '36233152',\n",
       " '36229036',\n",
       " '36222215',\n",
       " '36213251',\n",
       " '36204816',\n",
       " '36189286',\n",
       " '36188362',\n",
       " '36170726',\n",
       " '36166227',\n",
       " '36153556',\n",
       " '36153118',\n",
       " '36149952',\n",
       " '36121803',\n",
       " '36112069',\n",
       " '36100326',\n",
       " '36066495',\n",
       " '36065103',\n",
       " '36061488',\n",
       " '36045606',\n",
       " '36043493',\n",
       " '36015078',\n",
       " '36012469',\n",
       " '35996850',\n",
       " '35991464',\n",
       " '35986236',\n",
       " '35954219',\n",
       " '35945527',\n",
       " '35943990',\n",
       " '35925074',\n",
       " '35910083',\n",
       " '35896905',\n",
       " '35888568',\n",
       " '35887252',\n",
       " '35885805',\n",
       " '35875815',\n",
       " '35854226',\n",
       " '35847821',\n",
       " '35835467',\n",
       " '35832182',\n",
       " '35821534',\n",
       " '35821115',\n",
       " '35816681',\n",
       " '35814774',\n",
       " '35768680',\n",
       " '35764955',\n",
       " '35742069',\n",
       " '35736801',\n",
       " '35736359',\n",
       " '35720699',\n",
       " '35693009',\n",
       " '35656619',\n",
       " '35656104',\n",
       " '35640165',\n",
       " '35637934',\n",
       " '35632649',\n",
       " '35632408',\n",
       " '35628033',\n",
       " '35626248',\n",
       " '35623634',\n",
       " '35614970',\n",
       " '35606640',\n",
       " '35589661',\n",
       " '35589660',\n",
       " '35585196',\n",
       " '35577360',\n",
       " '35576832',\n",
       " '35570777',\n",
       " '35527811',\n",
       " '35526605',\n",
       " '35501074',\n",
       " '35493814',\n",
       " '35487443',\n",
       " '35482424',\n",
       " '35465246',\n",
       " '35457093',\n",
       " '35454374',\n",
       " '35433768',\n",
       " '35432363',\n",
       " '35421511',\n",
       " '35407562',\n",
       " '35404768',\n",
       " '35359819',\n",
       " '35358096',\n",
       " '35355311',\n",
       " '35350440',\n",
       " '35345768',\n",
       " '35341334',\n",
       " '35334595',\n",
       " '35320297',\n",
       " '35318112',\n",
       " '35317812',\n",
       " '35309313',\n",
       " '35290404',\n",
       " '35287333',\n",
       " '35280890',\n",
       " '35264003',\n",
       " '35262958',\n",
       " '35236205',\n",
       " '35229657',\n",
       " '35207003',\n",
       " '35206241',\n",
       " '35203896',\n",
       " '35195253',\n",
       " '35194336',\n",
       " '35186443',\n",
       " '35172863',\n",
       " '35172836',\n",
       " '35155455',\n",
       " '35140252',\n",
       " '35102619',\n",
       " '35074481',\n",
       " '35073915',\n",
       " '35056406',\n",
       " '35056360',\n",
       " '35056336',\n",
       " '35053821',\n",
       " '35046929',\n",
       " '35043127',\n",
       " '35011914',\n",
       " '35011770',\n",
       " '34975729',\n",
       " '34975370',\n",
       " '34970156',\n",
       " '34966354',\n",
       " '34922127',\n",
       " '34906823',\n",
       " '34888989',\n",
       " '34880053',\n",
       " '34876158',\n",
       " '34867935',\n",
       " '34857177',\n",
       " '34842817',\n",
       " '34831634',\n",
       " '34829952',\n",
       " '34828592',\n",
       " '34828583',\n",
       " '34809664',\n",
       " '34768601',\n",
       " '34749736',\n",
       " '34716184',\n",
       " '34716175',\n",
       " '35438859',\n",
       " '34707521',\n",
       " '34684066',\n",
       " '34684049',\n",
       " '34683011',\n",
       " '34682970',\n",
       " '34682909',\n",
       " '34682454',\n",
       " '34682360',\n",
       " '34668532',\n",
       " '34667909',\n",
       " '34662673',\n",
       " '34640544',\n",
       " '34638540',\n",
       " '37043585',\n",
       " '36996267',\n",
       " '35467812',\n",
       " '35442597',\n",
       " '35438861',\n",
       " '35438860',\n",
       " '35438858',\n",
       " '35438857',\n",
       " '35438856',\n",
       " '35438855',\n",
       " '34577881',\n",
       " '34577808',\n",
       " '34575280',\n",
       " '34572574',\n",
       " '34567431',\n",
       " '34541918',\n",
       " '34540633',\n",
       " '34539356',\n",
       " '34537220',\n",
       " '34484973',\n",
       " '34474739',\n",
       " '34459918',\n",
       " '34454716',\n",
       " '34454515',\n",
       " '34444817',\n",
       " '34442121',\n",
       " '34441971',\n",
       " '34441898',\n",
       " '34439855',\n",
       " '34423789',\n",
       " '34422848',\n",
       " '34408721',\n",
       " '34404633',\n",
       " '34403736',\n",
       " '34400495',\n",
       " '34388151',\n",
       " '34385257',\n",
       " '34368926',\n",
       " '34362944',\n",
       " '34361987',\n",
       " '34356297',\n",
       " '34355438',\n",
       " '34352259',\n",
       " '34351274',\n",
       " '34344688',\n",
       " '34341960',\n",
       " '34341773',\n",
       " '34326841',\n",
       " '34321254',\n",
       " '34315375',\n",
       " '34300271',\n",
       " '34300183',\n",
       " '34291062',\n",
       " '34266470',\n",
       " '34263741',\n",
       " '34262415',\n",
       " '34254637',\n",
       " '34248921',\n",
       " '34240650',\n",
       " '34222292',\n",
       " '34209852',\n",
       " '34202826',\n",
       " '34201825',\n",
       " '34201806',\n",
       " '34201087',\n",
       " '34200126',\n",
       " '34198946',\n",
       " '34198913',\n",
       " '34191221',\n",
       " '34175230',\n",
       " '34172152',\n",
       " '34137042',\n",
       " '34113066',\n",
       " '34072494',\n",
       " '34071326',\n",
       " '34071264',\n",
       " '34070367',\n",
       " '34070286',\n",
       " '34069603',\n",
       " '34065069',\n",
       " '34065013',\n",
       " '34026797',\n",
       " '34020666',\n",
       " '34011981',\n",
       " '33998565',\n",
       " '33996867',\n",
       " '33959278',\n",
       " '33952227',\n",
       " '33947430',\n",
       " '33930983',\n",
       " '33925784',\n",
       " '33925566',\n",
       " '33923830',\n",
       " '33919671',\n",
       " '33889154',\n",
       " '33882940',\n",
       " '33874961',\n",
       " '33847020',\n",
       " '33840241',\n",
       " '33829023',\n",
       " '33825299',\n",
       " '33819446',\n",
       " '33810365',\n",
       " '33806902',\n",
       " '33800953',\n",
       " '33794313',\n",
       " '33791744',\n",
       " '33671082',\n",
       " '33669532',\n",
       " '33669438',\n",
       " '33659857',\n",
       " '33652747',\n",
       " '33652622',\n",
       " '33633136',\n",
       " '33596913',\n",
       " '33585528',\n",
       " '33585505',\n",
       " '33577778',\n",
       " '33572894',\n",
       " '33572802',\n",
       " '33562474',\n",
       " '33556867',\n",
       " '33536023',\n",
       " '33529750',\n",
       " '33528911',\n",
       " '33506707',\n",
       " '33498629',\n",
       " '33498489',\n",
       " '33479068',\n",
       " '33440400',\n",
       " '33430175',\n",
       " '33397399',\n",
       " '33397331',\n",
       " '36507470',\n",
       " '33375343',\n",
       " '33374291',\n",
       " '33367564',\n",
       " '33353469',\n",
       " '33329554',\n",
       " '33327624',\n",
       " '33326582',\n",
       " '33322316',\n",
       " '33317538',\n",
       " '33274349',\n",
       " '33199820',\n",
       " '33184353',\n",
       " '33173222',\n",
       " '33168001',\n",
       " '33148325',\n",
       " '33142896',\n",
       " '33119613',\n",
       " '33114704',\n",
       " '33114612',\n",
       " '33092097',\n",
       " '33081294',\n",
       " '33059588',\n",
       " '33050553',\n",
       " '33046133',\n",
       " '33041960',\n",
       " '32982905',\n",
       " '32974259',\n",
       " '32972442',\n",
       " '32940215',\n",
       " '32899468',\n",
       " '32889791',\n",
       " '32873297',\n",
       " '32849252',\n",
       " '32823979',\n",
       " '32799889',\n",
       " '32793195',\n",
       " '32777701',\n",
       " '32772569',\n",
       " '32751659',\n",
       " '32744306',\n",
       " '32727489',\n",
       " '32727475',\n",
       " '32692761',\n",
       " '34589868',\n",
       " '32674263',\n",
       " '32670016',\n",
       " '32635535',\n",
       " '32629923',\n",
       " '32623426',\n",
       " '32609410',\n",
       " '32601171',\n",
       " '32571354',\n",
       " '32568154',\n",
       " '32568153',\n",
       " '32568152',\n",
       " '32568151',\n",
       " '32568149',\n",
       " '32568148',\n",
       " '32568146',\n",
       " '32568145',\n",
       " '32568144',\n",
       " '32568143',\n",
       " '32555018',\n",
       " '32545797',\n",
       " '32527207',\n",
       " '32513266',\n",
       " '32488281',\n",
       " '32482748',\n",
       " '32470498',\n",
       " '32466160',\n",
       " '32455633',\n",
       " '32432991',\n",
       " '32426159',\n",
       " '32411717',\n",
       " '32353033',\n",
       " '32328064',\n",
       " '32327453',\n",
       " '32306967',\n",
       " '32296708',\n",
       " '32291908',\n",
       " '32275686',\n",
       " '32273857',\n",
       " '32272608',\n",
       " '32257068',\n",
       " '32247028',\n",
       " '32210306',\n",
       " '32154656',\n",
       " '32140630',\n",
       " '32129496',\n",
       " '32093722',\n",
       " '32085571',\n",
       " '32062027',\n",
       " '32046358',\n",
       " '32046336',\n",
       " '32041178',\n",
       " '32039912',\n",
       " '32034172',\n",
       " '34589837',\n",
       " '31970624',\n",
       " '31947545',\n",
       " '31906988',\n",
       " '31901625',\n",
       " '36313239',\n",
       " '33777500',\n",
       " '31890263',\n",
       " '31871540',\n",
       " '31861543',\n",
       " '31854020',\n",
       " '31840339',\n",
       " '31830003',\n",
       " '31827600',\n",
       " '31827223',\n",
       " '31824487',\n",
       " '31814961',\n",
       " '31805176',\n",
       " '31801546',\n",
       " '31796045',\n",
       " '31759091',\n",
       " '31736966',\n",
       " '31727160',\n",
       " '31699051',\n",
       " '31671321',\n",
       " '31669858',\n",
       " '31651868',\n",
       " '31620406',\n",
       " '31616305',\n",
       " '31610852',\n",
       " '31534083',\n",
       " '31509764',\n",
       " '31506915',\n",
       " '31475007',\n",
       " '31465778',\n",
       " '31431446',\n",
       " '31394725',\n",
       " '31373106',\n",
       " '31357483',\n",
       " '31348786',\n",
       " '31334205',\n",
       " '31331036',\n",
       " '31330791',\n",
       " '31295930',\n",
       " '31277442',\n",
       " '31267953',\n",
       " '31257290',\n",
       " '31234662',\n",
       " '31233110',\n",
       " '31179255',\n",
       " '31161646',\n",
       " '31139604',\n",
       " '31059838',\n",
       " '31058116',\n",
       " '31057538',\n",
       " '31053295',\n",
       " '31040055',\n",
       " '31036648',\n",
       " '31001499',\n",
       " '31001197',\n",
       " '30974900',\n",
       " '30968005',\n",
       " '30948154',\n",
       " '30934066',\n",
       " '30929860',\n",
       " '30914065',\n",
       " '30910331',\n",
       " '30897114',\n",
       " '30889846',\n",
       " '30871727',\n",
       " '30871578',\n",
       " '30851951',\n",
       " '30847333',\n",
       " '30828572',\n",
       " '30814539',\n",
       " '30805319',\n",
       " '30795933',\n",
       " '30791746',\n",
       " '30741357',\n",
       " '30740389',\n",
       " '30734339',\n",
       " '30719431',\n",
       " '30687207',\n",
       " '30671425',\n",
       " '30665828',\n",
       " '30632248',\n",
       " '30617782',\n",
       " '33014628',\n",
       " '30594919',\n",
       " '34043303',\n",
       " '30564562',\n",
       " '30564186',\n",
       " '30563204',\n",
       " '30525014',\n",
       " '30538664',\n",
       " '30505831',\n",
       " '30502905',\n",
       " '30516085',\n",
       " '30478703',\n",
       " '30463572',\n",
       " '30451113',\n",
       " '30430664',\n",
       " '30416112',\n",
       " '30405620',\n",
       " '30340599',\n",
       " '30325738',\n",
       " '30325737',\n",
       " '30303941',\n",
       " '30298340',\n",
       " '30285773',\n",
       " '30234078',\n",
       " '30222036',\n",
       " '30220343',\n",
       " '30181183',\n",
       " '30174633',\n",
       " '30167477',\n",
       " '30119681',\n",
       " '30076265',\n",
       " '30036399',\n",
       " '30018122',\n",
       " '30008263',\n",
       " '29971693',\n",
       " '29968805',\n",
       " '29938127',\n",
       " '29929450',\n",
       " '29867995',\n",
       " '29856774',\n",
       " '29772739',\n",
       " '29738079',\n",
       " '29707427',\n",
       " '29692205',\n",
       " '29654166',\n",
       " '29650052',\n",
       " '29635081',\n",
       " '29602463',\n",
       " '29600930',\n",
       " '29562932',\n",
       " '29536371',\n",
       " '29523751',\n",
       " '29497420',\n",
       " '29486769',\n",
       " '29426834',\n",
       " '29409505',\n",
       " '29391028',\n",
       " '29382635',\n",
       " '29375937',\n",
       " '29348374',\n",
       " '29348373',\n",
       " '29348371',\n",
       " '29348370',\n",
       " '29348369',\n",
       " '31435490',\n",
       " '28877941',\n",
       " '28805528',\n",
       " '28805516',\n",
       " '28805512',\n",
       " '28800089',\n",
       " '28765100',\n",
       " '28760971',\n",
       " '28752613',\n",
       " '28747192',\n",
       " '28709432',\n",
       " '28694809',\n",
       " '28674681',\n",
       " '28654136',\n",
       " '28649428',\n",
       " '28633629',\n",
       " '28632291',\n",
       " '28592308',\n",
       " '28589117',\n",
       " '28478837',\n",
       " '28441964',\n",
       " '28410877',\n",
       " '28375204',\n",
       " '28339438',\n",
       " '28338983',\n",
       " '28303641',\n",
       " '28261110',\n",
       " '28239872',\n",
       " '28231836',\n",
       " '28116577',\n",
       " '28104625',\n",
       " '28087544',\n",
       " '28059425',\n",
       " '30984868',\n",
       " '28033311',\n",
       " '28018972',\n",
       " '27998272',\n",
       " '27808584',\n",
       " '27806082',\n",
       " '27766535',\n",
       " '27737819',\n",
       " '27729349',\n",
       " '27721367',\n",
       " '27655658',\n",
       " '27600520',\n",
       " '27580693',\n",
       " '27573827',\n",
       " '27536947',\n",
       " '27359321',\n",
       " '27338587',\n",
       " '27275835',\n",
       " '27118537',\n",
       " '27099524',\n",
       " '26965484',\n",
       " '26859813',\n",
       " '26843550',\n",
       " '26804593',\n",
       " '26791940',\n",
       " '26757840',\n",
       " '26708036',\n",
       " '26707044',\n",
       " '26683192',\n",
       " '26646713',\n",
       " '26615570',\n",
       " '26613325',\n",
       " '26604026',\n",
       " '26562880',\n",
       " '26454487',\n",
       " '26449441',\n",
       " '26345409',\n",
       " '26147503',\n",
       " '26147001',\n",
       " '26132314',\n",
       " '26079000',\n",
       " '26075755',\n",
       " '26075754',\n",
       " '26045439',\n",
       " '26035692',\n",
       " '26029488',\n",
       " '25990639',\n",
       " '25912615',\n",
       " '25866194',\n",
       " '25789592',\n",
       " '25685246',\n",
       " '25695122',\n",
       " '25617880',\n",
       " '25584527',\n",
       " '25584526',\n",
       " '25584525',\n",
       " '25584524',\n",
       " '25584523',\n",
       " '26973799',\n",
       " '30313001',\n",
       " '25433843',\n",
       " '25308475',\n",
       " '25239244',\n",
       " '25214803',\n",
       " '25136940',\n",
       " '24938650',\n",
       " '24755065',\n",
       " '24734022',\n",
       " '26977374',\n",
       " '24669210',\n",
       " '24596470',\n",
       " '24557875',\n",
       " '24531167',\n",
       " '27213118',\n",
       " '24278791',\n",
       " '24229326',\n",
       " '24068715',\n",
       " '24068616',\n",
       " '23952563',\n",
       " '23918092',\n",
       " '23914329',\n",
       " '23850395',\n",
       " '23791918',\n",
       " '23689679',\n",
       " '23685416',\n",
       " '23664637',\n",
       " '23561675',\n",
       " '23504301',\n",
       " '23497361',\n",
       " '23445264',\n",
       " '25224898',\n",
       " '23236553',\n",
       " '23166120',\n",
       " '23160704',\n",
       " '22963543',\n",
       " '22951418',\n",
       " '22927850',\n",
       " '22837795',\n",
       " '22832503',\n",
       " '22795611',\n",
       " '22787191',\n",
       " '22718491',\n",
       " '22614823',\n",
       " '22521895',\n",
       " '22445460',\n",
       " '22315600',\n",
       " '24340168',\n",
       " '22181560',\n",
       " '22170145',\n",
       " '22158691',\n",
       " '22022360',\n",
       " '21975140',\n",
       " '21967891',\n",
       " '21966179',\n",
       " '21892413',\n",
       " '21823124',\n",
       " '21794183',\n",
       " '21767035',\n",
       " '21619607',\n",
       " '21571484',\n",
       " '21554673',\n",
       " '21552194',\n",
       " '21455120',\n",
       " '21254053',\n",
       " '21244747',\n",
       " '20924033',\n",
       " '20872086',\n",
       " '20647985',\n",
       " '20609377',\n",
       " '20579119',\n",
       " '20550693',\n",
       " '20433584',\n",
       " '20412374',\n",
       " '20380780',\n",
       " '20348363',\n",
       " '20303231',\n",
       " '20192908',\n",
       " '20185398',\n",
       " '20046396',\n",
       " '20038921',\n",
       " '20035260',\n",
       " '20035251',\n",
       " '20010505',\n",
       " '19855351',\n",
       " '19855350',\n",
       " '19828908',\n",
       " '19697479',\n",
       " '19696083',\n",
       " '19513826',\n",
       " '19356884',\n",
       " '21253446',\n",
       " '18578185',\n",
       " '18397528',\n",
       " '18269338']"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "[x[4:12] for x in search.split('\\n')[5:835]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "80433d9d",
   "metadata": {},
   "outputs": [],
   "source": [
    "id_list = [x[4:12] for x in search.split('\\n')[5:837]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "45c28043",
   "metadata": {},
   "outputs": [],
   "source": [
    "id_list = [int(x) for x in id_list]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "ad882dc9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "832"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(id_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "e060d0e8",
   "metadata": {},
   "outputs": [],
   "source": [
    "from bs4 import BeautifulSoup"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "3f197472",
   "metadata": {},
   "outputs": [],
   "source": [
    "import time"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "2edc4b2a",
   "metadata": {},
   "outputs": [],
   "source": [
    "RET = \"&retmode=text&rettype=abstract\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "cbc4e54a",
   "metadata": {},
   "outputs": [],
   "source": [
    "FETCH_URL = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed\"\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "6df055fe",
   "metadata": {},
   "outputs": [],
   "source": [
    "d = \"\"\n",
    "d = d.join(RET)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "48294d62",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'&retmode=text&rettype=abstract'"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "d"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "f2678902",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "832"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(id_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "42f231c1",
   "metadata": {},
   "outputs": [],
   "source": [
    "data = []"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "46591cc2",
   "metadata": {},
   "outputs": [],
   "source": [
    "req_data = requests.get(f\"{FETCH_URL}&id={id_list[0:52]}&retmode=xml&retstart=0&retmax=52&api_key={KEY}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "91d2a7c8",
   "metadata": {},
   "outputs": [],
   "source": [
    "response = req_data.text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "b074e527",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "str"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "type(response)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "332b0179",
   "metadata": {
    "scrolled": false
   },
   "outputs": [],
   "source": [
    "data.append(response)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "d239d11c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['<?xml version=\"1.0\" ?>\\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2023//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd\">\\n<PubmedArticleSet>\\n<PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37328077</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1879-0038</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>877</Volume><PubDate><Year>2023</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>Gene</Title><ISOAbbreviation>Gene</ISOAbbreviation></Journal><ArticleTitle>A unique circular RNA expression pattern in the peripheral blood of myalgic encephalomyelitis/chronic fatigue syndrome patients.</ArticleTitle><Pagination><StartPage>147568</StartPage><MedlinePgn>147568</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.gene.2023.147568</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0378-1119(23)00409-2</ELocationID><Abstract><AbstractText>Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease with obscure aetiology. The underdiagnosis rate of ME/CFS is high due to the lack of diagnostic criteria based on objective markers. In recent years, circRNAs have emerged as potential genetic biomarkers for neurological diseases, including Parkinson\\'s disease and Alzheimer\\'s disease, making them likely to have the same prospect of being biomarkers in ME/CFS. However, despite the extensive amount of research that has been performed on the transcriptomes of ME/CFS patients, all of them are solely focused on linear RNAs, and the profiling of circRNAs in ME/CFS has been completely omitted. In this study, we investigated the expression profiles of circRNAs, comparing ME/CFS patients and controls before and after two sessions of cardiopulmonary exercise longitudinally. In patients with ME/CFS, the number of detected circRNAs was higher compared to healthy controls, indicating potential differences in circRNA expression associated with the disease. Additionally, healthy controls showed an increase in the number of circRNAs following exercise testing, while no similar pattern was evident in ME/CFS patients, further highlighting physiological differences between the two groups. A lack of correlation was observed between differentially expressed circRNAs and their corresponding coding genes in terms of expression and function, suggesting the potential of circRNAs as independent biomarkers in ME/CFS. Specifically, 14 circRNAs were highly expressed in ME/CFS patients but absent in controls throughout the exercise study, indicating a unique molecular signature specific to ME/CFS patients and providing potential diagnostic biomarkers for the disease. Significant enrichment of protein and gene regulative pathways were detected in relation to five of these 14 circRNAs based on their predicted miRNA target genes. Overall, this is the first study to describe the circRNA expression profile in peripheral blood of ME/CFS patients, providing valuable insights into the molecular mechanisms underlying the disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Cheng</LastName><ForeName>Yuning</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xu</LastName><ForeName>Si-Mei</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Takenaka</LastName><ForeName>Konii</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lindner</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Curry-Hyde</LastName><ForeName>Ashton</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Janitz</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia; Paul Flechsig Institute of Brain Research, University of Leipzig, 04103 Leipzig, Germany. Electronic address: m.janitz@unsw.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Gene</MedlineTA><NlmUniqueID>7706761</NlmUniqueID><ISSNLinking>0378-1119</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">Circular transcriptome profiling</Keyword><Keyword MajorTopicYN=\"N\">Differential expression</Keyword><Keyword MajorTopicYN=\"N\">Myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN=\"N\">circular RNAs</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>6</Month><Day>17</Day><Hour>5</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>6</Month><Day>17</Day><Hour>5</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>19</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37328077</ArticleId><ArticleId IdType=\"doi\">10.1016/j.gene.2023.147568</ArticleId><ArticleId IdType=\"pii\">S0378-1119(23)00409-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37303862</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">2667-2421</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>15</Volume><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>IBRO neuroscience reports</Title><ISOAbbreviation>IBRO Neurosci Rep</ISOAbbreviation></Journal><ArticleTitle>Orthostatic chronotropic incompetence in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>10</EndPage><MedlinePgn>1-10</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.ibneur.2023.04.005</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">Orthostatic intolerance (OI) is a core diagnostic criterion in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The majority of ME/CFS patients have no evidence of hypotension or postural orthostatic tachycardia syndrome (POTS) during head-up tilt, but do show a significantly larger reduction in stroke volume index (SVI) when upright compared to controls. Theoretically a reduction in SVI should be accompanied by a compensatory increase in heart rate (HR). When there is an incomplete compensatory increase in HR, this is considered chronotropic incompetence. This study explored the relationship between HR and SVI to determine whether chronotropic incompetence was present during tilt testing in ME/CFS patients.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">From a database of individuals who had undergone tilt testing with Doppler measurements for SVI both supine and end-tilt, we selected ME/CFS patients and healthy controls (HC) who had no evidence of POTS or hypotension during the test. To determine the relation between the HR increase and SVI decrease during the tilt test in patients, we calculated the 95% prediction intervals of this relation in HC. Chronotropic incompetence in patients was defined as a HR increase below the lower limit of the 95th % prediction interval of the HR increase in HC.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">We compared 362 ME/CFS patients with 52 HC. At end-tilt, tilt lasting for 15 (4) min, ME/CFS patients had a significantly lower SVI (22 (4) vs. 27 (4) ml/m<sup>2</sup>; p&#xa0;&lt;&#xa0;0.0001) and a higher HR (87 (11) vs. 78 (15) bpm; p&#xa0;&lt;&#xa0;0.0001) compared to HC. There was a similar relationship between HR and SVI between ME/CFS patients and HC in the supine position. During tilt ME/CFS patients had a lower HR for a given SVI; 37% had an inadequate HR increase. Chronotropic incompetence was more common in more severely affected ME/CFS patients.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"UNASSIGNED\">These novel findings represent the first description of orthostatic chronotropic incompetence during tilt testing in ME/CFS patients.</AbstractText><CopyrightInformation>&#xa9; 2023 Published by Elsevier Ltd on behalf of International Brain Research Organization.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>van Campen</LastName><ForeName>C Linda M C</ForeName><Initials>CLMC</Initials><AffiliationInfo><Affiliation>Stichting CardioZorg, Planetenweg 5, 2132 HN Hoofddorp, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Verheugt</LastName><ForeName>Freek W A</ForeName><Initials>FWA</Initials><AffiliationInfo><Affiliation>Radboud UMC, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rowe</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Visser</LastName><ForeName>Frans C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Stichting CardioZorg, Planetenweg 5, 2132 HN Hoofddorp, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>IBRO Neurosci Rep</MedlineTA><NlmUniqueID>101775148</NlmUniqueID><ISSNLinking>2667-2421</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Cardiac index</Keyword><Keyword MajorTopicYN=\"N\">Chronotropic incompetence</Keyword><Keyword MajorTopicYN=\"N\">ME/CFS</Keyword><Keyword MajorTopicYN=\"N\">Orthostatic intolerance</Keyword><Keyword MajorTopicYN=\"N\">Stroke volume index</Keyword><Keyword MajorTopicYN=\"N\">Tilt table testing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>3</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37303862</ArticleId><ArticleId IdType=\"pmc\">PMC10250802</ArticleId><ArticleId IdType=\"doi\">10.1016/j.ibneur.2023.04.005</ArticleId><ArticleId IdType=\"pii\">S2667-2421(23)00037-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Camm A.J., Fei L. Chronotropic incompetence--Part I: Normal regulation of the heart rate. Clin. Cardiol. 1996;19:424&#x2013;428.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8723604</ArticleId></ArticleIdList></Reference><Reference><Citation>Camm A.J., Fei L. Chronotropic incompetence--Part II: Clinical implications. Clin. Cardiol. 1996;19:503&#x2013;508.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8790957</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., Van De Sande M.I., De Meirleir K.L., Klimas N.G., Broderick G., Mitchell T., Staines D., Powles A.C., Speight N., Vallings R., Bateman L., Baumgarten-Austrheim B., Bell D.S., Carlo-Stella N., Chia J., Darragh A., Jo D., Lewis D., Light A.R., Marshall-Gradisbik S., Mena I., Mikovits J.A., Miwa K., Murovska M., Pall M.L., Stevens S. Myalgic encephalomyelitis: International Consensus Criteria. J. Intern Med. 2011;270:327&#x2013;338.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3427890</ArticleId><ArticleId IdType=\"pubmed\">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhari S.A., Sacerdote A., Bahtiyar G. 1-alpha hydroxylation defect in postural orthostatic tachycardia syndrome: remission with calcitriol supplementation. BMJ Case Rep. 2012;2012 bcr0220125730.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3433525</ArticleId><ArticleId IdType=\"pubmed\">22891006</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D.B., Vanriper S., Dougherty R.J., Lindheimer J.B., Falvo M.J., Chen Y., Lin J.S., Unger E.R., Group M.S. Cardiopulmonary, metabolic, and perceptual responses during exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Multi-site Clinical Assessment of ME/CFS (MCAM) sub-study. PLoS One. 2022;17</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8923458</ArticleId><ArticleId IdType=\"pubmed\">35290404</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport T.E., Lehnen M., Stevens S.R., Vanness J.M., Stevens J., Snell C.R. Chronotropic intolerance: an overlooked determinant of symptoms and activity limitation in myalgic encephalomyelitis/chronic fatigue syndrome? Front Pedia. 2019;7:82.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6439478</ArticleId><ArticleId IdType=\"pubmed\">30968005</ArticleId></ArticleIdList></Reference><Reference><Citation>Duprez D.A., De Buyzere M.L., Drieghe B., Vanhaverbeke F., Taes Y., Michielsen W., Clement D.L. Long- and short-term blood pressure and RR-interval variability and psychosomatic distress in chronic fatigue syndrome. Clin. Sci. (Lond. ) 1998;94:57&#x2013;63.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9505867</ArticleId></ArticleIdList></Reference><Reference><Citation>Eeftinck Schattenkerk D.W., Van Lieshout J.J., Van Den Meiracker A.H., Wesseling K.R., Blanc S., Wieling W., Van Montfrans G.A., Settels J.J., Wesseling K.H., Westerhof B.E. Nexfin noninvasive continuous blood pressure validated against Riva-Rocci/Korotkoff. Am. J. Hypertens. 2009;22:378&#x2013;383.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19180062</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A., Burri P., Melander O. Orthostatic hypotension in genetically related hypertensive and normotensive individuals. J. Hypertens. 2009;27:976&#x2013;982.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19402222</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman R., Wieling W., Axelrod F.B., Benditt D.G., Benarroch E., Biaggioni I., Cheshire W.P., Chelimsky T., Cortelli P., Gibbons C.H., Goldstein D.S., Hainsworth R., Hilz M.J., Jacob G., Kaufmann H., Jordan J., Lipsitz L.A., Levine B.D., Low P.A., Mathias C., Raj S.R., Robertson D., Sandroni P., Schatz I.J., Schondorf R., Stewart J.M., Van Dijk J.G. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton. Neurosci. 2011;161:46&#x2013;48.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21393070</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas J., Santos R., Azevedo E., Carvalho M., Boomsma F., Meiracker A., Falcao De Freitas A., Abreu-Lima C. Hemodynamic, autonomic and neurohormonal behaviour of familial amyloidotic polyneuropathy and neurally mediated syncope patients during supine and orthostatic stress. Int J. Cardiol. 2007;116:242&#x2013;248.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16843544</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern Med. 1994;121:953&#x2013;959.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerrity T.R., Bates J., Bell D.S., Chrousos G., Furst G., Hedrick T., Hurwitz B., Kula R.W., Levine S.M., Moore R.C., Schondorf R. Chronic fatigue syndrome: what role does the autonomic nervous system play in the pathophysiology of this complex illness? Neuroimmunomodulation. 2002;10:134&#x2013;141.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12481153</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollingsworth K.G., Hodgson T., Macgowan G.A., Blamire A.M., Newton J.L. Impaired cardiac function in chronic fatigue syndrome measured using magnetic resonance cardiac tagging. J. Intern Med. 2012;271:264&#x2013;270.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3627316</ArticleId><ArticleId IdType=\"pubmed\">21793948</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurwitz B.E., Coryell V.T., Parker M., Martin P., Laperriere A., Klimas N.G., Sfakianakis G.N., Bilsker M.S. Chronic fatigue syndrome: illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function. Clin. Sci. (Lond. ) 2010;118:125&#x2013;135.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19469714</ArticleId></ArticleIdList></Reference><Reference><Citation>Inbar O., Dlin R., Rotstein A., Whipp B.J. Physiological responses to incremental exercise in patients with chronic fatigue syndrome. Med Sci. Sports Exerc. 2001;33:1463&#x2013;1470.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11528333</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine (Iom) The National Academies Press,; Washington DC: 2015. Beyond Mayalgic Encephalomyelitis/chronic Fatigue Syndrome: Redefining an Illness.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almazan A., Pallares J.G., Buendia-Romero A., Martinez-Cava A., Courel-Ibanez J. Chronotropic Incompetence in Non-Hospitalized Patients with Post-COVID-19 Syndrome. J. Clin. Med. 2021:10.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8617992</ArticleId><ArticleId IdType=\"pubmed\">34830716</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P., Arevalo C., Oliveira R.K.F., Faria-Urbina M., Felsenstein D., Oaklander A.L., Systrom D.M. Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest. 2021;160:642&#x2013;651.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8727854</ArticleId><ArticleId IdType=\"pubmed\">33577778</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimas N.G., Koneru A.O. Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions. Curr. Rheuma Rep. 2007;9:482&#x2013;487.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18177602</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamanca J.J., Peckerman A., Walker J., Kesil W., Cook S., Taylor A., Natelson B.H. Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin. Physiol. 1999;19:111&#x2013;120.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10200892</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes F., Pierard S., De Meester C., Boulif J., Amzulescu M., Vancraeynest D., Pouleur A.-C., Pasquet A., Gerber B., Vanoverschelde J.-L. Impact of left ventricular outflow tract ellipticity on the grading of aortic stenosis in patients with normal ejection fraction. J. Cardiovasc. Magn. Reson. 2017;19:37.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5351048</ArticleId><ArticleId IdType=\"pubmed\">28292302</ArticleId></ArticleIdList></Reference><Reference><Citation>Martina J.R., Westerhof B.E., Van Goudoever J., De Beaumont E.M., Truijen J., Kim Y.S., Immink R.V., Jobsis D.A., Hollmann M.W., Lahpor J.R., De Mol B.A., Van Lieshout J.J. Noninvasive continuous arterial blood pressure monitoring with Nexfin(R) Anesthesiology. 2012;116:1092&#x2013;1103.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22415387</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L., Hou W., Chui J., Han R., Gelb A.W. Cardiac output and cerebral blood flow: the integrated regulation of brain perfusion in adult humans. Anesthesiology. 2015;123:1198&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26402848</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa K., Fujita M. Cardiovascular dysfunction with low cardiac output due to a small heart in patients with chronic fatigue syndrome. Intern Med. 2009;48:1849&#x2013;1854.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19881233</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa K., Fujita M. Small heart with low cardiac output for orthostatic intolerance in patients with chronic fatigue syndrome. Clin. Cardiol. 2011;34:782&#x2013;786.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6652296</ArticleId><ArticleId IdType=\"pubmed\">22120591</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton J.L., Sheth A., Shin J., Pairman J., Wilton K., Burt J.A., Jones D.E. Lower ambulatory blood pressure in chronic fatigue syndrome. Psychosom. Med. 2009;71:361&#x2013;365.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19297309</ArticleId></ArticleIdList></Reference><Reference><Citation>Nwosu E.A., Rahko P.S., Hanson P., Grogan E.W., Jr. Hemodynamic and volumetric response of the normal left ventricle to upright tilt testing. Am. Heart J. 1994;128:106&#x2013;113.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7912470</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross J., Jr., Linhart J.W., Brauwald E. Effects of changing heart rate in man by electrical stimulation of the right atrium. studies at rest, during exercise, and with isoproterenol. Circulation. 1965;32:549&#x2013;558.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">5825546</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon R.S., Grubb B.P., 2nd, Olshansky B., Shen W.K., Calkins H., Brignole M., Raj S.R., Krahn A.D., Morillo C.A., Stewart J.M., Sutton R., Sandroni P., Friday K.J., Hachul D.T., Cohen M.I., Lau D.H., Mayuga K.A., Moak J.P., Sandhu R.K., Kanjwal K. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12:e41&#x2013;e63.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5267948</ArticleId><ArticleId IdType=\"pubmed\">25980576</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen W.K., Sheldon R.S., Benditt D.G., Cohen M.I., Forman D.E., Goldberger Z.D., Grubb B.P., Hamdan M.H., Krahn A.D., Link M.S., Olshansky B., Raj S.R., Sandhu R.K., Sorajja D., Sun B.C., Yancy C.W. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol. 2017;70:620&#x2013;663.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28286222</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemaker J.K., Hogeman C.S., Khan M., Kimmerly D.S., Sinoway L.I. Gender affects sympathetic and hemodynamic response to postural stress. Am. J. Physiol. Heart Circ. Physiol. 2001;281:H2028&#x2013;H2035.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11668064</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahvanainen A., Koskela J., Tikkakoski A., Lahtela J., Leskinen M., Kahonen M., Nieminen T., Koobi T., Mustonen J., Porsti I. Analysis of cardiovascular responses to passive head-up tilt using continuous pulse wave analysis and impedance cardiography. Scand. J. Clin. Lab Invest. 2009;69:128&#x2013;137.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18850486</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahvanainen A., Leskinen M., Koskela J., Ilveskoski E., Nordhausen K., Oja H., Kahonen M., Koobi T., Mustonen J., Porsti I. Ageing and cardiovascular responses to head-up tilt in healthy subjects. Atherosclerosis. 2009;207:445&#x2013;451.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19580971</ArticleId></ArticleIdList></Reference><Reference><Citation>Timmers H.J., Wieling W., Soetekouw P.M., Bleijenberg G., Van Der Meer J.W., Lenders J.W. Hemodynamic and neurohumoral responses to head-up tilt in patients with chronic fatigue syndrome. Clin. Auton. Res. 2002;12:273&#x2013;280.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12357281</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C.(L.)M.C., Rowe P.C., Visser F.C. Blood Volume Status in ME/CFS Correlates With the Presence or Absence of Orthostatic Symptoms: Preliminary Results. Front Pedia. 2018;6:4.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6262290</ArticleId><ArticleId IdType=\"pubmed\">30525014</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C.(L.)M.C., Rowe P.C., Visser F.C. Validation of the Severity of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by Other Measures than History: Activity Bracelet, Cardiopulmonary Exercise Testing and a Validated Activity Questionnaire: SF-36. Healthcare. 2020;8:16.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7551321</ArticleId><ArticleId IdType=\"pubmed\">32823979</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C.(L.)M.C., Rowe P.C., Visser F.C. The Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Joint Hypermobility Show Larger Cerebral Blood Flow Reductions during Orthostatic Stress Testing Than Patients without Hypermobility: A Case Control Study. Med. Res. Arch. 2021:9.</Citation></Reference><Reference><Citation>van Campen C.L.M.C., Rowe P.C., Visser F.C. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Med. (Kaunas. ) 2021:58.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8778312</ArticleId><ArticleId IdType=\"pubmed\">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C.(L.)M.C., Verheugt F.W.A., Rowe P.C., Visser F.C. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography. Clin. Neurophysiol. Pr. 2020;5:50&#x2013;58.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7044650</ArticleId><ArticleId IdType=\"pubmed\">32140630</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C.(L.)M.C., Verheugt F.W.A., Visser F.C. Cerebral blood flow changes during tilt table testing in healthy volunteers, as assessed by Doppler imaging of the carotid and vertebral arteries. Clin. Neurophysiol. Pr. 2018;3:91&#x2013;95.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6133915</ArticleId><ArticleId IdType=\"pubmed\">30215015</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C.(L.)M.C., Visser F.C. The abnormal Cardiac Index and Stroke Volume Index changes during a normal Tilt Table Test in ME/CFS patients compared to healthy volunteers, are not related to deconditioning. J. Thromb. Circ. 2018:1&#x2013;8.</Citation></Reference><Reference><Citation>van Campen C.(L.)M.C., Visser F.C. Blood volume status in patients with chronic fatigue syndrome: relation to complaints. Int. J. Clin. Med. 2018;9:809&#x2013;819.</Citation></Reference><Reference><Citation>van Campen C.(L.)M.C., Visser F.C. The higher resting heart rate in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients compared to healthy controls: relation with stroke volumes. Med. Res. Arch. 2022:10.</Citation></Reference><Reference><Citation>van de Luit L., van der Meulen J., Cleophas T.J., Zwinderman A.H. Amplified amplitudes of circadian rhythms and nighttime hypotension in patients with chronic fatigue syndrome: improvement by inopamil but not by melatonin. Angiology. 1998;49:903&#x2013;908.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9822046</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanness J.M., Snell C.R., Strayer D.R., Dempsey L., Stevens S.R. Subclassifying chronic fatigue syndrome through exercise testing. Med Sci. Sports Exerc. 2003;35:908&#x2013;913.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12783037</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyller V.B., Saul J.P., Amlie J.P., Thaulow E. Sympathetic predominance of cardiovascular regulation during mild orthostatic stress in adolescents with chronic fatigue. Clin. Physiol. Funct. Imaging. 2007;27:231&#x2013;238.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17564672</ArticleId></ArticleIdList></Reference><Reference><Citation>Youde J., Panerai R., Gillies C., Potter J. Reproducibility of circulatory changes to head-up tilt in healthy elderly subjects. Age Ageing. 2003;32:375&#x2013;381.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12851179</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidi A., Benitez D., Gaydecki P.A., Vohra A., Fitzpatrick A.P. Haemodynamic effects of increasing angle of head up tilt. Heart. 2000;83:181&#x2013;184.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC1729297</ArticleId><ArticleId IdType=\"pubmed\">10648492</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37297899</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Print\">2077-0383</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>12</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">3704</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/jcm12113704</ELocationID><Abstract><AbstractText>We characterized the fatty acid profiles in the erythrocyte membrane of pediatric patients with cystic fibrosis (CF) receiving highly concentrated docosahexaenoic acid (DHA) supplementation (Tridocosahexanoin-AOX<sup>&#xae;</sup> 70%) at 50 mg/kg/day (<i>n</i> = 11) or matching placebo (<i>n</i> = 11) for 12 months. The mean age was 11.7 years. The DHA group showed a statistically significant improvement in n-3 polyunsaturated fatty acids (PUFAs), which was observed as early as 6 months and further increased at 12 months. Among the n-3 PUFAs, there was a significant increase in DHA and eicosapentaenoic acid (EPA). Additionally, a statistically significant decrease in n-6 PUFAs was found, primarily due to a decrease in arachidonic acid (AA) levels and elongase 5 activity. However, we did not observe any changes in linoleic acid levels. The long-term administration of DHA over one year was safe and well tolerated. In summary, the administration of a high-rich DHA supplement at a dose of 50 mg/kg/day for one year can correct erythrocyte AA/DHA imbalance and reduce fatty acid inflammatory markers. However, it is important to note that essential fatty acid alterations cannot be fully normalized with this treatment. These data provide timely information of essential fatty acid profile for future comparative research.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Ayats-Vidal</LastName><ForeName>Roser</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Pediatric Allergies, Immunology and Pneumology Unit, Pediatric Medicine Service, Institut d\\'Investigaci&#xf3; i Innovaci&#xf3; Parc Taul&#xed; (I3PT-CERCA), Parc Taul&#xed; Hospital Universitari, Universitat Aut&#xf2;noma de Barcelona, Parc Taul&#xed; 1, E-08208 Sabadell, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bosque-Garc&#xed;a</LastName><ForeName>Montserrat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Allergies, Immunology and Pneumology Unit, Pediatric Medicine Service, Institut d\\'Investigaci&#xf3; i Innovaci&#xf3; Parc Taul&#xed; (I3PT-CERCA), Parc Taul&#xed; Hospital Universitari, Universitat Aut&#xf2;noma de Barcelona, Parc Taul&#xed; 1, E-08208 Sabadell, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cordobilla</LastName><ForeName>Bego&#xf1;a</ForeName><Initials>B</Initials><Identifier Source=\"ORCID\">0000-0002-0418-9387</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, E-08028 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Asensio-De la Cruz</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Pediatric Allergies, Immunology and Pneumology Unit, Pediatric Medicine Service, Institut d\\'Investigaci&#xf3; i Innovaci&#xf3; Parc Taul&#xed; (I3PT-CERCA), Parc Taul&#xed; Hospital Universitari, Universitat Aut&#xf2;noma de Barcelona, Parc Taul&#xed; 1, E-08208 Sabadell, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Garc&#xed;a-Gonz&#xe1;lez</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Allergies, Immunology and Pneumology Unit, Pediatric Medicine Service, Institut d\\'Investigaci&#xf3; i Innovaci&#xf3; Parc Taul&#xed; (I3PT-CERCA), Parc Taul&#xed; Hospital Universitari, Universitat Aut&#xf2;noma de Barcelona, Parc Taul&#xed; 1, E-08208 Sabadell, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Castro-Marrero</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0002-2481-3052</Identifier><AffiliationInfo><Affiliation>ME/CFS Research Unit, Division of Rheumatology, Vall d\\'Hebron Research Institute, Universitat Aut&#xf2;noma de Barcelona, E-08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>L&#xf3;pez-Rico</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Pharmacy Department, Institut d\\'Investigaci&#xf3; I Innovaci&#xf3; Parc Taul&#xed; (I3PT-CERCA), Parc Taul&#xed; Hospital Universitari, Universitat Aut&#xf2;noma de Barcelona, E-08208 Sabadell, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Domingo</LastName><ForeName>Joan Carles</ForeName><Initials>JC</Initials><Identifier Source=\"ORCID\">0000-0002-6356-0836</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, E-08028 Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">cystic fibrosis</Keyword><Keyword MajorTopicYN=\"N\">docosahexaenoic acid</Keyword><Keyword MajorTopicYN=\"N\">eicosapentaenoic acid</Keyword><Keyword MajorTopicYN=\"N\">fatty acids</Keyword><Keyword MajorTopicYN=\"N\">omega-3</Keyword><Keyword MajorTopicYN=\"N\">pancreatic insufficiency</Keyword><Keyword MajorTopicYN=\"N\">randomized controlled study</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>15</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>15</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37297899</ArticleId><ArticleId IdType=\"pmc\">PMC10253750</ArticleId><ArticleId IdType=\"doi\">10.3390/jcm12113704</ArticleId><ArticleId IdType=\"pii\">jcm12113704</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shteinberg M., Haq I.J., Polineni D., Davies J.C. Cystic fibrosis. Lancet. 2021;397:2195&#x2013;2211. doi: 10.1016/S0140-6736(20)32542-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(20)32542-3</ArticleId><ArticleId IdType=\"pubmed\">34090606</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanssens L.S., Duchateau J., Casimir G.J. CFTR Protein: Not just a chloride channel? Cells. 2021;10:2844. doi: 10.3390/cells10112844.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells10112844</ArticleId><ArticleId IdType=\"pmc\">PMC8616376</ArticleId><ArticleId IdType=\"pubmed\">34831067</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia L.d.C.e., Petry L.M., Germani P.A.V.D.S., Xavier L.F., de Barros P.B., Meneses A.D.S., Prestes L.M., Bittencourt L.B., Pieta M.P., Friedrich F., et al. Translational research in cystic fibrosis: From bench to beside. Front. Pediatr. 2022;10:881470. doi: 10.3389/fped.2022.881470.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2022.881470</ArticleId><ArticleId IdType=\"pmc\">PMC9149599</ArticleId><ArticleId IdType=\"pubmed\">35652053</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrell P.M., Mischler E.H., Engle M.J., Brown D.J., Lau S.M. Fatty acid abnormalities in cystic fibrosis. Pediatr. Res. 1985;19:104&#x2013;109. doi: 10.1203/00006450-198501000-00028.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1203/00006450-198501000-00028</ArticleId><ArticleId IdType=\"pubmed\">3918287</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumpsen J.A., Brown N.E., Thomson A.B., Man S.P., Goh Y.K., Ma D., Clandinin M. Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis. J. Cyst. Fibros. 2006;5:77&#x2013;84. doi: 10.1016/j.jcf.2006.01.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jcf.2006.01.004</ArticleId><ArticleId IdType=\"pubmed\">16507353</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman S.D., Blanco P.G., Zaman M.M., Shea J.C., Ollero M., Hopper I.K., Weed D.A., Gelrud A., Regan M.M., Laposata M., et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N. Engl. J. Med. 2004;350:560&#x2013;569. doi: 10.1056/NEJMoa021218.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa021218</ArticleId><ArticleId IdType=\"pubmed\">14762183</ArticleId></ArticleIdList></Reference><Reference><Citation>Roulet M., Frascarolo P., Rappaz I., Pilet M. Essential fatty acid deficiency in well nourished young cystic fibrosis patients. Eur. J. Pediatr. 1997;156:952&#x2013;956. doi: 10.1007/s004310050750.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s004310050750</ArticleId><ArticleId IdType=\"pubmed\">9453380</ArticleId></ArticleIdList></Reference><Reference><Citation>Strandvik B. Fatty acid metabolism in cystic fibrosis. Prostaglandins Leukot. Essent. Fatty Acids. 2010;83:121&#x2013;129. doi: 10.1016/j.plefa.2010.07.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.plefa.2010.07.002</ArticleId><ArticleId IdType=\"pubmed\">20673710</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Biervliet S., Van Biervliet J.P., Vande Velde S., Robberecht E. Serum zinc concentrations in cystic fibrosis patients aged above 4 years: A cross-sectional evaluation. Biol. Trace Elem. Res. 2007;119:19&#x2013;26. doi: 10.1007/s12011-007-0041-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12011-007-0041-9</ArticleId><ArticleId IdType=\"pubmed\">17914215</ArticleId></ArticleIdList></Reference><Reference><Citation>Galabert C., Filliat M., Chazalette J.P. Fatty-acid composition of serum-lecithins in cystic-fibrosis patients without steatorrhoea. Lancet. 1978;2:903. doi: 10.1016/S0140-6736(78)91620-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(78)91620-3</ArticleId><ArticleId IdType=\"pubmed\">81456</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubbard V.S., Dunn G.D., di Sant&#x2019;Agnese P.A. Abnormal fatty-acid composition of plasma-lipids in cystic fibrosis. A primary or a secondary defect? Lancet. 1977;2:1302&#x2013;1304. doi: 10.1016/S0140-6736(77)90359-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(77)90359-2</ArticleId><ArticleId IdType=\"pubmed\">74723</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogiers V., Dab I., Crokaert R., Vis H.L. Long chain non-esterified fatty acid pattern in plasma of cystic fibrosis patients and their parents. Pediatr. Res. 1980;14:1088&#x2013;1091. doi: 10.1203/00006450-198009000-00015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1203/00006450-198009000-00015</ArticleId><ArticleId IdType=\"pubmed\">7454450</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha N., McCarron A., Rout-Pitt N., Donnelley M., Parsons D.W., Hryciw D.H. Essential fatty acid deficiency in cystic fibrosis disease progression: Role of genotype and sex. Nutrients. 2022;14:4666. doi: 10.3390/nu14214666.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu14214666</ArticleId><ArticleId IdType=\"pmc\">PMC9657825</ArticleId><ArticleId IdType=\"pubmed\">36364928</ArticleId></ArticleIdList></Reference><Reference><Citation>Seegmiller A.C. Abnormal unsaturated fatty acid metabolism in cystic fibrosis: Biochemical mechanisms and clinical implications. Int. J. Mol. Sci. 2014;15:16083&#x2013;16099. doi: 10.3390/ijms150916083.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms150916083</ArticleId><ArticleId IdType=\"pmc\">PMC4200767</ArticleId><ArticleId IdType=\"pubmed\">25216340</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson C. Al-Turkmani MR, Savaille JE, Alturkmani R, Katrangi W, Cluette-Brown JE; et al. Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism. J. Lipid. Res. 2008;49:1692&#x2013;1700. doi: 10.1194/jlr.M700388-JLR200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1194/jlr.M700388-JLR200</ArticleId><ArticleId IdType=\"pmc\">PMC2444007</ArticleId><ArticleId IdType=\"pubmed\">18441018</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogiers V., Dab I., Michotte Y., Vercruysse A., Crokaert R., Vis H.L. Abnormal fatty acid turnover in the phospholipids of the red blood cell membranes of cystic fibrosis patients (in vitro study) Pediatr. Res. 1984;18:704&#x2013;709. doi: 10.1203/00006450-198408000-00005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1203/00006450-198408000-00005</ArticleId><ArticleId IdType=\"pubmed\">6472942</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd-Still J.D., Johnson S.B., Holman R.T. Essential fatty acid status and fluidity of plasma phospholipids in cystic fibrosis infants. Am. J. Clin. Nutr. 1991;54:1029&#x2013;1035. doi: 10.1093/ajcn/54.6.1029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ajcn/54.6.1029</ArticleId><ArticleId IdType=\"pubmed\">1957818</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogiers V., Crokaert R., Vis H.L. Altered phospholipid composition and changed fatty acid pattern of the various phospholipid fractions of red cell membranes of cystic fibrosis children with pancreatic insufficiency. Clin. Chim. Acta. 1980;105:105&#x2013;115. doi: 10.1016/0009-8981(80)90098-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0009-8981(80)90098-4</ArticleId><ArticleId IdType=\"pubmed\">7398080</ArticleId></ArticleIdList></Reference><Reference><Citation>Strandvik B. Relation between essential fatty acid metabolism and gastrointestinal symptoms in cystic fibrosis. Acta Paediatr. Scand. Suppl. 1989;363:58&#x2013;63. doi: 10.1111/apa.1989.78.s363.58.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/apa.1989.78.s363.58</ArticleId><ArticleId IdType=\"pubmed\">2701926</ArticleId></ArticleIdList></Reference><Reference><Citation>Strandvik B., Br&#xf6;nneg&#xe5;rd M., Gilljam H., Carlstedt-Duke J. Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis. Scand. J. Gastroenterol. 1988;143:1&#x2013;4. doi: 10.3109/00365528809090205.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/00365528809090205</ArticleId><ArticleId IdType=\"pubmed\">2455328</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman S.D., Katz M.H., Parker E.M., Laposata M., Urman M.Y., Alvarez J.G. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice. Proc. Natl. Acad. Sci. USA. 1999;96:13995&#x2013;14000. doi: 10.1073/pnas.96.24.13995.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.96.24.13995</ArticleId><ArticleId IdType=\"pmc\">PMC24179</ArticleId><ArticleId IdType=\"pubmed\">10570187</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilbault C., Wojewodka G., Saeed Z., Hajduch M., Matouk E., De Sanctis J.B., Radzioch D. Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide. Am. J. Respir. Cell. Mol. Biol. 2009;41:100&#x2013;106. doi: 10.1165/rcmb.2008-0279OC.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1165/rcmb.2008-0279OC</ArticleId><ArticleId IdType=\"pubmed\">19059886</ArticleId></ArticleIdList></Reference><Reference><Citation>Njoroge S.W., Laposata M., Boyd K.L., Seegmiller A.C. Polyunsaturated fatty acid supplementation reverses cystic fibrosis-related fatty acid abnormalities in CFTR-/- mice by suppressing fatty acid desaturases. J. Nutr. Biochem. 2015;26:36&#x2013;43. doi: 10.1016/j.jnutbio.2014.09.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jnutbio.2014.09.001</ArticleId><ArticleId IdType=\"pubmed\">25448610</ArticleId></ArticleIdList></Reference><Reference><Citation>Christophe A., Robberecht E., De Baets F., Franckx H. Increase of long chain omega-3 fatty acids in the major serum lipid classes of patients with cystic fibrosis. Ann. Nutr. Metab. 1992;36:304&#x2013;312. doi: 10.1159/000177734.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000177734</ArticleId><ArticleId IdType=\"pubmed\">1492758</ArticleId></ArticleIdList></Reference><Reference><Citation>Clandinin M.T., Zuberbuhler P., Brown N.E., Kielo E.S., Goh Y.K. Fatty acid pool size in plasma lipoprotein fractions of cystic fibrosis patients. Am. J. Clin. Nutr. 1995;62:1268&#x2013;1275. doi: 10.1093/ajcn/62.6.1268.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ajcn/62.6.1268</ArticleId><ArticleId IdType=\"pubmed\">7491891</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastor &#xd3;., Guzm&#xe1;n-Lafuente P., Serna J., Mu&#xf1;oz-Hern&#xe1;ndez M., L&#xf3;pez Neyra A., Garc&#xed;a-Rozas P., Garc&#xed;a-Seisdedos D., Alc&#xe1;zar A., Lasunci&#xf3;n M.A., Busto R., et al. A comprehensive evaluation of omega-3 fatty acid supplementation in cystic fibrosis patients using lipidomics. J. Nutr. Biochem. 2019;63:197&#x2013;205. doi: 10.1016/j.jnutbio.2018.09.026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jnutbio.2018.09.026</ArticleId><ArticleId IdType=\"pubmed\">30414540</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd-Still J.D., Powers C.A., Hoffman D.R., Boyd-Trull K., Lester L.A., Benisek D.C., Arterburn L.M. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: A randomized, controlled study. Nutrition. 2006;22:36&#x2013;46. doi: 10.1016/j.nut.2005.05.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nut.2005.05.006</ArticleId><ArticleId IdType=\"pubmed\">16226012</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Neyra A., Su&#xe1;rez L., Mu&#xf1;oz M., de Blas A., de Valbuena M.R., Garriga M., Calvo J., Ribes C., Moreno R.G., M&#xe1;iz L., et al. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: A randomized, multi-center, double-blind, placebo-controlled trial. Prostaglandins Leukot. Essent. Fatty Acids. 2020;162:102186. doi: 10.1016/j.plefa.2020.102186.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.plefa.2020.102186</ArticleId><ArticleId IdType=\"pubmed\">33038833</ArticleId></ArticleIdList></Reference><Reference><Citation>Alicandro G., Faelli N., Gagliardini R., Santini B., Magazz&#xf9; G., Biffi A., Ris&#xe9; P., Galli C., Tirelli A., Loi S., et al. A randomized placebo-controlled study on high-dose oral algal docosahexaenoic acid supplementation in children with cystic fibrosis. Prostaglandins Leukot. Essent. Fatty Acids. 2013;88:163&#x2013;169. doi: 10.1016/j.plefa.2012.10.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.plefa.2012.10.002</ArticleId><ArticleId IdType=\"pubmed\">23266209</ArticleId></ArticleIdList></Reference><Reference><Citation>Teopompi E., Ris&#xe9; P., Pisi R., Buccellati C., Aiello M., Pisi G., Tripodi C., Fainardi V., Clini E., Chetta A., et al. Arachidonic acid and docosahexaenoic acid metabolites in the airways of adults with cystic fibrosis: Effect of docosahexaenoic acid supplementation. Front. Pharmacol. 2019;23:10:938. doi: 10.3389/fphar.2019.00938.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2019.00938</ArticleId><ArticleId IdType=\"pmc\">PMC6716427</ArticleId><ArticleId IdType=\"pubmed\">31507425</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Biervliet S., Van Biervliet J.P., Robberecht E., Christophe A. Docosahexaenoic acid trials in cystic fibrosis: A review of the rationale behind the clinical trials. J. Cyst. Fibros. 2005;4:27&#x2013;34. doi: 10.1016/j.jcf.2004.11.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jcf.2004.11.001</ArticleId><ArticleId IdType=\"pubmed\">15752678</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson H., Stackhouse C. Omega-3 fatty acid supplementation for cystic fibrosis. Cochrane Database Syst. Rev. 2020;4:CD002201. doi: 10.1002/14651858.CD002201.pub6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/14651858.CD002201.pub6</ArticleId><ArticleId IdType=\"pmc\">PMC7147930</ArticleId><ArticleId IdType=\"pubmed\">32275788</ArticleId></ArticleIdList></Reference><Reference><Citation>Brudy Technology SL. Use of DHA for Treating a Pathology Associated with Cellular Oxidative Damage. EP 1962825 B1. European Patent. 2014 April 02;</Citation></Reference><Reference><Citation>Gasso F., Bogdanov P., Domingo J.C. Docosahexaenoic acid improves endogenous antioxidant defense in ARPE-19 cells. Investig. Ophthalmol. Vis. Sci. 2008;49:5932.</Citation></Reference><Reference><Citation>Lepage G., Roy C.C. Direct transesterification of all classes of lipids in a one-step reaction. J. Lipid. Res. 1986;27:114&#x2013;120. doi: 10.1016/S0022-2275(20)38861-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0022-2275(20)38861-1</ArticleId><ArticleId IdType=\"pubmed\">3958609</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsons H.G., O&#x2019;Loughlin E.V., Forbes D., Cooper D., Gall D.G. Supplemental calories improve essential fatty acid deficiency in cystic fibrosis patients. Pediatr. Res. 1988;24:353&#x2013;356. doi: 10.1203/00006450-198809000-00016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1203/00006450-198809000-00016</ArticleId><ArticleId IdType=\"pubmed\">3211621</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandebrouck C., Ferreira T. Glued in lipids: Lipointoxication in cystic fibrosis. EBioMedicine. 2020;61:103038. doi: 10.1016/j.ebiom.2020.103038.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ebiom.2020.103038</ArticleId><ArticleId IdType=\"pmc\">PMC7648119</ArticleId><ArticleId IdType=\"pubmed\">33038767</ArticleId></ArticleIdList></Reference><Reference><Citation>Arterburn L.M., Hall E.B., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 2006;83((Suppl. 6)):1467S&#x2013;1476S. doi: 10.1093/ajcn/83.6.1467S.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ajcn/83.6.1467S</ArticleId><ArticleId IdType=\"pubmed\">16841856</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Biervliet S., Devos M., Delhaye T., Van Biervliet J.P., Robberecht E., Christophe A. Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients. Prostaglandins Leukot. Essent. Fatty Acids. 2008;78:109&#x2013;115. doi: 10.1016/j.plefa.2007.12.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.plefa.2007.12.005</ArticleId><ArticleId IdType=\"pubmed\">18276127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ris&#xe9; P., Eligini S., Ghezzi S., Colli S., Galli C. Fatty acid composition of plasma, blood cells and whole blood: Relevance for the assessment of the fatty acid status in humans. Prostaglandins Leukot. Essent. Fatty Acids. 2007;76:363&#x2013;369. doi: 10.1016/j.plefa.2007.05.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.plefa.2007.05.003</ArticleId><ArticleId IdType=\"pubmed\">17588731</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q., Ma J., Campos H., Hankinson S.E., Hu F.B. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am. J. Clin. Nutr. 2007;86:74&#x2013;81. doi: 10.1093/ajcn/86.1.74.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ajcn/86.1.74</ArticleId><ArticleId IdType=\"pubmed\">17616765</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunes O., Tascilar E., Sertoglu E., Tas A., Serdar M.A., Kaya G., Kayadibi H., Ozcan O. Associations between erythrocyte membrane fatty acid compositions and insulin resistance in obese adolescents. Chem. Phys. Lipids. 2014;184:69&#x2013;75. doi: 10.1016/j.chemphyslip.2014.09.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.chemphyslip.2014.09.006</ArticleId><ArticleId IdType=\"pubmed\">25262585</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" VersionID=\"2\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"2\">37291581</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1479-5876</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>The relevance of pacing strategies in managing symptoms of post-COVID-19 syndrome.</ArticleTitle><Pagination><StartPage>375</StartPage><MedlinePgn>375</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">375</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1186/s12967-023-04229-w</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Post-COVID-19 syndrome (PCS) shares many features with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). PCS represents a major health issue worldwide because it severely impacts patients\\' work activities and their quality of life. In the absence of treatment for both conditions and given the beneficial effect of pacing strategies in ME/CFS, we conducted this study to assess the effectiveness of pacing in PCS patients.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">We retrospectively included patients meeting the World Health Organization definition of PCS who attended the Internal Medicine Department of Angers University Hospital, France between June 2020 and June 2022, and were followed up until December 2022. Pacing strategies were systematically proposed for all patients. Their medical records were reviewed and data related to baseline and follow-up assessments were collected. This included epidemiological characteristics, COVID-19 symptoms and associated conditions, fatigue features, perceived health status, employment activity, and the degree of pacing adherence assessed by the engagement in pacing subscale (EPS). Recovery was defined as the ability to return to work, and improvement was regarded as the reduction of the number and severity of symptoms.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">A total of 86 patients were included and followed-up for a median time of 10 [6-13] months. Recovery and improvement rates were 33.7% and 23.3%, respectively. The EPS score was the only variable significantly associated with recovery on multivariate analysis (OR 40.43 [95% CI 6.22-262.6], p&#x2009;&lt;&#x2009;0.001). Patients who better adhered to pacing (high EPS scores) experienced significantly higher recovery and improvement rates (60-33.3% respectively) than those with low (5.5-5.5% respectively), or moderate (4.3-17.4% respectively) scores.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"CONCLUSIONS\">Our findings demonstrated that pacing is effective in the management of patients with PCS, and that high levels of adherence to pacing are associated with better outcomes.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Ghali</LastName><ForeName>Alaa</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0003-2040-3387</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Clinical Immunology, Angers University Hospital, 4 Rue Larrey, 49000, Angers, France. alghali@chu-angers.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lacombe</LastName><ForeName>Valentin</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Clinical Immunology, Angers University Hospital, 4 Rue Larrey, 49000, Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ravaiau</LastName><ForeName>Camille</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Clinical Immunology, Angers University Hospital, 4 Rue Larrey, 49000, Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Delattre</LastName><ForeName>Estelle</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Clinical Immunology, Angers University Hospital, 4 Rue Larrey, 49000, Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ghali</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Faculty of Medicine of Angers, Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Urbanski</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Clinical Immunology, Angers University Hospital, 4 Rue Larrey, 49000, Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lavigne</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Clinical Immunology, Angers University Hospital, 4 Rue Larrey, 49000, Angers, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011788\" MajorTopicYN=\"N\">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000094024\" MajorTopicYN=\"N\">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012189\" MajorTopicYN=\"N\">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086382\" MajorTopicYN=\"Y\">COVID-19</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Adherence</Keyword><Keyword MajorTopicYN=\"N\">Myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">Outcomes</Keyword><Keyword MajorTopicYN=\"N\">Pacing strategies</Keyword><Keyword MajorTopicYN=\"N\">Post-COVID syndrome</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37291581</ArticleId><ArticleId IdType=\"pmc\">PMC10248991</ArticleId><ArticleId IdType=\"doi\">10.1186/s12967-023-04229-w</ArticleId><ArticleId IdType=\"pii\">10.1186/s12967-023-04229-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2021 doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType=\"pmc\">PMC8691845</ArticleId><ArticleId IdType=\"pubmed\">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020 doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.m3026</ArticleId><ArticleId IdType=\"pubmed\">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March&#x2013;June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType=\"pmc\">PMC7392393</ArticleId><ArticleId IdType=\"pubmed\">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, Mangsbo SM, Nilsson P, Hober S, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325:2015. doi: 10.1001/jama.2021.5612.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2021.5612</ArticleId><ArticleId IdType=\"pmc\">PMC8027932</ArticleId><ArticleId IdType=\"pubmed\">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333:575. doi: 10.1136/bmj.38933.585764.AE.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType=\"pmc\">PMC1569956</ArticleId><ArticleId IdType=\"pubmed\">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokolevich ZM, Crowe M, Mendez D, Biros E, Reznik JE. Most common long COVID physical symptoms in working age adults who experienced mild COVID-19 infection: a scoping review. Healthcare. 2022;10:2577. doi: 10.3390/healthcare10122577.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare10122577</ArticleId><ArticleId IdType=\"pmc\">PMC9778298</ArticleId><ArticleId IdType=\"pubmed\">36554098</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType=\"pmc\">PMC8280690</ArticleId><ArticleId IdType=\"pubmed\">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Lunz Trujillo K, Safarpour A, Santillana M, Ognyanova K, Druckman J, et al. Association of post&#x2013;COVID-19 condition symptoms and employment status. JAMA Netw Open. 2023;6:e2256152. doi: 10.1001/jamanetworkopen.2022.56152.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamanetworkopen.2022.56152</ArticleId><ArticleId IdType=\"pmc\">PMC9932847</ArticleId><ArticleId IdType=\"pubmed\">36790806</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO. Evidence for active epstein-barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med. 1985;102:1&#x2013;7. doi: 10.7326/0003-4819-102-1-.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-102-1-</ArticleId><ArticleId IdType=\"pubmed\">2578266</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther Adv Infect Dis. 2021;8:204993612110093.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8060761</ArticleId><ArticleId IdType=\"pubmed\">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)&#x2014;a systemic review and comparison of clinical presentation and symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57050418</ArticleId><ArticleId IdType=\"pmc\">PMC8145228</ArticleId><ArticleId IdType=\"pubmed\">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. 2011;270:327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType=\"pmc\">PMC3427890</ArticleId><ArticleId IdType=\"pubmed\">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoad A, Spickett G, Elliott J, Newton J. Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome. QJM Mon J Assoc Physicians. 2008;101:961&#x2013;965. doi: 10.1093/qjmed/hcn123.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/qjmed/hcn123</ArticleId><ArticleId IdType=\"pubmed\">18805903</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M, St&#xe5;hlberg M, Runold M, Nygren-Bonnier M, Nilsson J, Olshansky B, et al. Long-Haul post&#x2013;COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome. JACC Case Rep. 2021;3:573&#x2013;580. doi: 10.1016/j.jaccas.2021.01.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaccas.2021.01.009</ArticleId><ArticleId IdType=\"pmc\">PMC7946344</ArticleId><ArticleId IdType=\"pubmed\">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe5;hlberg M, Reistam U, Fedorowski A, Villacorta H, Horiuchi Y, Bax J, et al. Post-COVID-19 tachycardia syndrome: a distinct phenotype of post-acute COVID-19 syndrome. Am J Med. 2021;134:1451&#x2013;1456. doi: 10.1016/j.amjmed.2021.07.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.amjmed.2021.07.004</ArticleId><ArticleId IdType=\"pmc\">PMC8356730</ArticleId><ArticleId IdType=\"pubmed\">34390682</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021 doi: 10.1007/s12026-021-09185-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12026-021-09185-5</ArticleId><ArticleId IdType=\"pmc\">PMC8009458</ArticleId><ArticleId IdType=\"pubmed\">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatziagelaki E, Adamaki M, Tsilioni I, Dimitriadis G, Theoharides TC. Myalgic encephalomyelitis/chronic fatigue syndrome&#x2014;metabolic disease or disturbed homeostasis due to focal inflammation in the hypothalamus? J Pharmacol Exp Ther. 2018;367:155&#x2013;167. doi: 10.1124/jpet.118.250845.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1124/jpet.118.250845</ArticleId><ArticleId IdType=\"pubmed\">30076265</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Tsilioni I, Ren H. Recent advances in our understanding of mast cell activation&#x2014;or should it be mast cell mediator disorders? Expert Rev Clin Immunol. 2019;15:639&#x2013;656. doi: 10.1080/1744666X.2019.1596800.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/1744666X.2019.1596800</ArticleId><ArticleId IdType=\"pmc\">PMC7003574</ArticleId><ArticleId IdType=\"pubmed\">30884251</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType=\"pmc\">PMC7529115</ArticleId><ArticleId IdType=\"pubmed\">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Mast cell activation symptoms are prevalent in Long-COVID. Int J Infect Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType=\"pmc\">PMC8459548</ArticleId><ArticleId IdType=\"pubmed\">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, Board on the Health of Select Populations, Institute of Medicine . Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington: National Academies Press (US); 2015.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Petracek LS, Suskauer SJ, Vickers RF, Patel NR, Violand RL, Swope RL, et al. Adolescent and young adult ME/CFS after confirmed or probable COVID-19. Front Med. 2021;8:668944. doi: 10.3389/fmed.2021.668944.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmed.2021.668944</ArticleId><ArticleId IdType=\"pmc\">PMC8116546</ArticleId><ArticleId IdType=\"pubmed\">33996867</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci U S A. 2021;118:e2024358118. doi: 10.1073/pnas.2024358118.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2024358118</ArticleId><ArticleId IdType=\"pmc\">PMC8403932</ArticleId><ArticleId IdType=\"pubmed\">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L, Muldowney K, Torres-Harding S. The energy envelope theory and myalgic encephalomyelitis/chronic fatigue syndrome. AAOHN J Off J Am Assoc Occup Health Nurses. 2008;56:189&#x2013;195.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18578185</ArticleId></ArticleIdList></Reference><Reference><Citation>Abonie US, Sandercock GRH, Heesterbeek M, Hettinga FJ. Effects of activity pacing in patients with chronic conditions associated with fatigue complaints: a meta-analysis. Disabil Rehabil. 2020;42:613&#x2013;622. doi: 10.1080/09638288.2018.1504994.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/09638288.2018.1504994</ArticleId><ArticleId IdType=\"pubmed\">30449204</ArticleId></ArticleIdList></Reference><Reference><Citation>Furst GP, Gerber LH, Smith CC, Fisher S, Shulman B. A program for improving energy conservation behaviors in adults with rheumatoid arthritis. Am J Occup Ther Off Publ Am Occup Ther Assoc. 1987;41:102&#x2013;111. doi: 10.5014/ajot.41.2.102.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5014/ajot.41.2.102</ArticleId><ArticleId IdType=\"pubmed\">3565525</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SL, Lyden AK, Smith DM, Dong Q, Koliba JF. Effects of a tailored activity pacing intervention on pain and fatigue for adults with osteoarthritis. Am J Occup Ther Off Publ Am Occup Ther Assoc. 2010;64:869&#x2013;876. doi: 10.5014/ajot.2010.09198.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5014/ajot.2010.09198</ArticleId><ArticleId IdType=\"pmc\">PMC3655423</ArticleId><ArticleId IdType=\"pubmed\">21218677</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudsmit EM, Nijs J, Jason LA, Wallman KE. Pacing as a strategy to improve energy management in myalgic encephalomyelitis/chronic fatigue syndrome: a consensus document. Disabil Rehabil. 2012;34:1140&#x2013;1147. doi: 10.3109/09638288.2011.635746.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/09638288.2011.635746</ArticleId><ArticleId IdType=\"pubmed\">22181560</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Melrose H, Lerman A, Burroughs V, Lewis K, King CP, et al. Managing chronic fatigue syndrome: overview and case study. AAOHN J Off J Am Assoc Occup Health Nurses. 1999;47:17&#x2013;21.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10205371</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor RR. Quality of life and symptom severity for individuals with chronic fatigue syndrome: findings from a randomized clinical trial. Am J Occup Ther Off Publ Am Occup Ther Assoc. 2004;58:35&#x2013;43. doi: 10.5014/ajot.58.1.35.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5014/ajot.58.1.35</ArticleId><ArticleId IdType=\"pubmed\">14763634</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. COVID-19 and Your Health. Cent. Dis. Control Prev. 2020 https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html Accessed from 3Feb 2022</Citation></Reference><Reference><Citation>Long COVID Fatigue - Your COVID Recovery. 2022 https://www.yourcovidrecovery.nhs.uk/i-think-i-have-long-covid/effects-on-your-body/fatigue-feeling-tired-all-the-time/ Accessed from 13 Feb 2023.</Citation></Reference><Reference><Citation>Ghali A, Lacout C, Ghali M, Gury A, Delattre E, Lavigne C, et al. Warning signals of post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: a retrospective analysis of 197 patients. J Clin Med. 2021;10:2517. doi: 10.3390/jcm10112517.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm10112517</ArticleId><ArticleId IdType=\"pmc\">PMC8201170</ArticleId><ArticleId IdType=\"pubmed\">34200126</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121&#x2013;1123. doi: 10.1001/archneur.1989.00520460115022.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archneur.1989.00520460115022</ArticleId><ArticleId IdType=\"pubmed\">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehead L. The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. J Pain Symptom Manage. 2009;37:107&#x2013;128. doi: 10.1016/j.jpainsymman.2007.08.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jpainsymman.2007.08.019</ArticleId><ArticleId IdType=\"pubmed\">19111779</ArticleId></ArticleIdList></Reference><Reference><Citation>Smedal T, Beiske AG, Glad SB, Myhr K-M, Aarseth JH, Svensson E, et al. Fatigue in multiple sclerosis: associations with health-related quality of life and physical performance. Eur J Neurol. 2011;18:114&#x2013;120. doi: 10.1111/j.1468-1331.2010.03090.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1468-1331.2010.03090.x</ArticleId><ArticleId IdType=\"pubmed\">20491899</ArticleId></ArticleIdList></Reference><Reference><Citation>Alingh RA, Hoekstra F, van der Schans CP, Hettinga FJ, Dekker R, van der Woude LHV. Protocol of a longitudinal cohort study on physical activity behaviour in physically disabled patients participating in a rehabilitation counselling programme: ReSpAct. BMJ Open. 2015;5:e007591&#x2013;e007591. doi: 10.1136/bmjopen-2015-007591.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmjopen-2015-007591</ArticleId><ArticleId IdType=\"pmc\">PMC4316554</ArticleId><ArticleId IdType=\"pubmed\">25633288</ArticleId></ArticleIdList></Reference><Reference><Citation>Abonie US, Hoekstra F, Seves BL, van der Woude LHV, Dekker R, Hettinga FJ. Associations between activity pacing, fatigue, and physical activity in adults with multiple sclerosis: a cross sectional study. J Funct Morphol Kinesiol. 2020;5:43. doi: 10.3390/jfmk5020043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jfmk5020043</ArticleId><ArticleId IdType=\"pmc\">PMC7739300</ArticleId><ArticleId IdType=\"pubmed\">33467259</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathiowetz VG, Finlayson ML, Matuska KM, Chen HY, Luo P. Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Mult Scler Houndmills Basingstoke Engl. 2005;11:592&#x2013;601. doi: 10.1191/1352458505ms1198oa.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1191/1352458505ms1198oa</ArticleId><ArticleId IdType=\"pubmed\">16193899</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielson WR, Jensen MP, Karsdorp PA, Vlaeyen JWS. Activity pacing in chronic pain: concepts, evidence, and future directions. Clin J Pain. 2013;29:461&#x2013;468. doi: 10.1097/AJP.0b013e3182608561.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/AJP.0b013e3182608561</ArticleId><ArticleId IdType=\"pubmed\">23247005</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards A, Abonie U, Hettinga F, Pyne D, Oh T, Polman R. Practical and clinical approaches using pacing to improve self-regulation in special populations such as children and people with mental health or learning disabilities. J Rehabil Med Clin Commun. 2021 doi: 10.2340/20030711-1000058.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2340/20030711-1000058</ArticleId><ArticleId IdType=\"pmc\">PMC8101060</ArticleId><ArticleId IdType=\"pubmed\">33968335</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType=\"pmc\">PMC9388369</ArticleId><ArticleId IdType=\"pubmed\">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes S-S, et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType=\"pmc\">PMC9214726</ArticleId><ArticleId IdType=\"pubmed\">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType=\"pubmed\">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz MA, Neves PF, Lima SS, Lopes JD, Torres MK, Vallinoto IM, Bichara CD, Santos EF, de Brito MT, Da Silva AL, Leite MD, et al. Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front Cell Infect Microbiol. 2022 doi: 10.3389/fcimb.2022.922422.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType=\"pmc\">PMC9279918</ArticleId><ArticleId IdType=\"pubmed\">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>White AT, Light AR, Hughen RW, Bateman L, Martins TB, Hill HR, et al. Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology. 2010 doi: 10.1111/j.1469-8986.2010.00978.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1469-8986.2010.00978.x</ArticleId><ArticleId IdType=\"pmc\">PMC4378647</ArticleId><ArticleId IdType=\"pubmed\">20230500</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes Rivera M, Mastronardi C, Silva-Aldana C, Arcos-Burgos M, Lidbury B. Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review. Diagnostics. 2019;9:91. doi: 10.3390/diagnostics9030091.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics9030091</ArticleId><ArticleId IdType=\"pmc\">PMC6787585</ArticleId><ArticleId IdType=\"pubmed\">31394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Grygiel-G&#xf3;rniak B, Puszczewicz M. Fatigue and interleukin-6&#x2014;a multi-faceted relationship. Reumatologia/Rheumatology. 2015;4:207&#x2013;212. doi: 10.5114/reum.2015.53998.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5114/reum.2015.53998</ArticleId><ArticleId IdType=\"pmc\">PMC4847294</ArticleId><ArticleId IdType=\"pubmed\">27407249</ArticleId></ArticleIdList></Reference><Reference><Citation>Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Pedersen BK. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol. 2000;529:237&#x2013;242. doi: 10.1111/j.1469-7793.2000.00237.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1469-7793.2000.00237.x</ArticleId><ArticleId IdType=\"pmc\">PMC2270169</ArticleId><ArticleId IdType=\"pubmed\">11080265</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty S, Harley R, McAuley JJ, Crowe LAN, Pedret C, Kirwan PD, et al. The effect of exercise on cytokines: implications for musculoskeletal health: a narrative review. BMC Sports Sci Med Rehabil. 2022;14:5. doi: 10.1186/s13102-022-00397-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13102-022-00397-2</ArticleId><ArticleId IdType=\"pmc\">PMC8740100</ArticleId><ArticleId IdType=\"pubmed\">34991697</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry RW, Morton AR, Keast D. Overtraining in athletes: an update. Sports Med. 1991;12:32&#x2013;65. doi: 10.2165/00007256-199112010-00004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2165/00007256-199112010-00004</ArticleId><ArticleId IdType=\"pubmed\">1925188</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng AJ, Jude B, Lanner JT. Intramuscular mechanisms of overtraining. Redox Biol. 2020;35:101480. doi: 10.1016/j.redox.2020.101480.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.redox.2020.101480</ArticleId><ArticleId IdType=\"pmc\">PMC7284919</ArticleId><ArticleId IdType=\"pubmed\">32179050</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelley J, Hudson J, Mackintosh KA, Saynor ZL, Duckers J, Lewis KE, et al. &#x2018;I Live a Kind of Shadow Life&#x2019;: individual experiences of COVID-19 recovery and the impact on physical activity levels. Int J Environ Res Public Health. 2021;18:11417. doi: 10.3390/ijerph182111417.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijerph182111417</ArticleId><ArticleId IdType=\"pmc\">PMC8583577</ArticleId><ArticleId IdType=\"pubmed\">34769934</ArticleId></ArticleIdList></Reference><Reference><Citation>Filler K, Lyon D, Bennett J, McCain N, Elswick R, Lukkahatai N, et al. Association of mitochondrial dysfunction and fatigue: a review of the literature. BBA Clin. 2014;1:12&#x2013;23. doi: 10.1016/j.bbacli.2014.04.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbacli.2014.04.001</ArticleId><ArticleId IdType=\"pmc\">PMC4136529</ArticleId><ArticleId IdType=\"pubmed\">25147756</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibellini L, De Biasi S, Paolini A, Borella R, Boraldi F, Mattioli M, et al. Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol Med. 2020 doi: 10.15252/emmm.202013001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/emmm.202013001</ArticleId><ArticleId IdType=\"pmc\">PMC7645870</ArticleId><ArticleId IdType=\"pubmed\">33078545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajaz S, McPhail MJ, Singh KK, Mujib S, Trovato FM, Napoli S, et al. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Physiol-Cell Physiol. 2021;320:C57&#x2013;65. doi: 10.1152/ajpcell.00426.2020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpcell.00426.2020</ArticleId><ArticleId IdType=\"pmc\">PMC7816428</ArticleId><ArticleId IdType=\"pubmed\">33151090</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc. 2021;96:2861&#x2013;2878. doi: 10.1016/j.mayocp.2021.07.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType=\"pubmed\">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo F. Chronic fatigue syndrome: physical and cardiovascular deconditioning. QJM. 1998;91:475&#x2013;481. doi: 10.1093/qjmed/91.7.475.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/qjmed/91.7.475</ArticleId><ArticleId IdType=\"pubmed\">9797930</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulcher K, White P. Strength and physiological response to exercise in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry. 2000;69:302&#x2013;307. doi: 10.1136/jnnp.69.3.302.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jnnp.69.3.302</ArticleId><ArticleId IdType=\"pmc\">PMC1737090</ArticleId><ArticleId IdType=\"pubmed\">10945803</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazelmans E, Bleijenberg G, Voeten MJM, van der Meer JWM, Folgering H. Impact of a maximal exercise test on symptoms and activity in chronic fatigue syndrome. J Psychosom Res. 2005;59:201&#x2013;208. doi: 10.1016/j.jpsychores.2005.04.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jpsychores.2005.04.003</ArticleId><ArticleId IdType=\"pubmed\">16223622</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen CL, Rowe PC, Visser FC. Deconditioning does not explain orthostatic intolerance in ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) J Transl Med. 2021 doi: 10.1186/s12967-021-02819-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-021-02819-0</ArticleId><ArticleId IdType=\"pmc\">PMC8097965</ArticleId><ArticleId IdType=\"pubmed\">33947430</ArticleId></ArticleIdList></Reference><Reference><Citation>Geraghty K, Hann M, Kurtev S. Myalgic encephalomyelitis/chronic fatigue syndrome patients&#x2019; reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: analysis of a primary survey compared with secondary surveys. J Health Psychol. 2017 doi: 10.1177/1359105317726152.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1359105317726152</ArticleId><ArticleId IdType=\"pubmed\">28847166</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilshire CE, Kindlon T, Courtney R, Matthees A, Tuller D, Geraghty K, et al. Rethinking the treatment of chronic fatigue syndrome&#x2014;a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT. BMC Psychol. 2018;6:6. doi: 10.1186/s40359-018-0218-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40359-018-0218-3</ArticleId><ArticleId IdType=\"pmc\">PMC5863477</ArticleId><ArticleId IdType=\"pubmed\">29562932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujawski S, Cossington J, S&#x142;omko J, Zawadka-Kunikowska M, Tafil-Klawe M, Klawe J, et al. Relationship between cardiopulmonary, mitochondrial and autonomic nervous system function improvement after an individualised activity programme upon chronic fatigue syndrome patients. J Clin Med. 2021;10:1542. doi: 10.3390/jcm10071542.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm10071542</ArticleId><ArticleId IdType=\"pmc\">PMC8038762</ArticleId><ArticleId IdType=\"pubmed\">33917586</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink M, Vink-Niese F. is it useful to question the recovery behaviour of patients with ME/CFS or long COVID? Healthcare. 2022;10:392. doi: 10.3390/healthcare10020392.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare10020392</ArticleId><ArticleId IdType=\"pmc\">PMC8872229</ArticleId><ArticleId IdType=\"pubmed\">35207003</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview|Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management|Guidance|NICE. NICE; https://www.nice.org.uk/guidance/ng206 Accessed from 27 Feb 2022.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35438859</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37252045</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">2296-2360</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in pediatrics</Title><ISOAbbreviation>Front Pediatr</ISOAbbreviation></Journal><ArticleTitle>Comparison of a 20 degree and 70 degree tilt test in adolescent myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients.</ArticleTitle><Pagination><StartPage>1169447</StartPage><MedlinePgn>1169447</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">1169447</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3389/fped.2023.1169447</ELocationID><Abstract><AbstractText Label=\"INTRODUCTION\" NlmCategory=\"UNASSIGNED\">During a standard 70-degree head-up tilt test, 90% of adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) develop an abnormal reduction in cerebral blood flow (CBF). A 70-degree test might not be tolerated by young ME/CFS patients because of the high incidence of syncopal spells. This study examined whether a test at 20 degrees would be sufficient to provoke important reductions in CBF in young ME/CFS patients.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">We analyzed 83 studies of adolescent ME/CFS patients. We assessed CBF using extracranial Doppler measurements of the internal carotid and vertebral arteries supine and during the tilt. We studied 42 adolescents during a 20 degree and 41 during a 70 degree test.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">At 20 degrees, no patients developed postural orthostatic tachycardia (POTS), compared to 32% at 70 degrees (<i>p</i>&#x2009;=&#x2009;0.0002). The CBF reduction during the 20 degree tilt of -27(6)% was slightly less than during the reduction during a 70 degree test [-31(7)%; <i>p</i>&#x2009;=&#x2009;0.003]. Seventeen adolescents had CBF measurements at both 20 and 70 degrees. The CBF reduction in these patients with both a 20 and 70 degrees test was significantly larger at 70 degrees than at 20 degrees (<i>p</i>&#x2009;&lt;&#x2009;0.0001).</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"UNASSIGNED\">A 20 degree tilt in young ME/CFS patients resulted in a CBF reduction comparable to that in adult patients during a 70 degree test. The lower tilt angle provoked less POTS, emphasizing the importance of using the 70 degree angle for that diagnosis. Further study is needed to explore whether CBF measurements during tilt provide an improved standard for classifying orthostatic intolerance.</AbstractText><CopyrightInformation>&#xa9; 2023 Van Campen, Rowe and Visser.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>van Campen</LastName><ForeName>C Linda M C</ForeName><Initials>CLMC</Initials><AffiliationInfo><Affiliation>Stichting CardioZorg, Hoofddorp, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rowe</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Visser</LastName><ForeName>Frans C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Stichting CardioZorg, Hoofddorp, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pediatr</MedlineTA><NlmUniqueID>101615492</NlmUniqueID><ISSNLinking>2296-2360</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">20 degree</Keyword><Keyword MajorTopicYN=\"N\">70 degree</Keyword><Keyword MajorTopicYN=\"N\">adolescents</Keyword><Keyword MajorTopicYN=\"N\">cerebral blood flow</Keyword><Keyword MajorTopicYN=\"N\">myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN=\"N\">orthostatic intolerance</Keyword><Keyword MajorTopicYN=\"N\">tilt-table testing</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor ZN declared a shared affiliation with the author PCR at the time of review.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>30</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>30</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>30</Day><Hour>11</Hour><Minute>48</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37252045</ArticleId><ArticleId IdType=\"pmc\">PMC10213432</ArticleId><ArticleId IdType=\"doi\">10.3389/fped.2023.1169447</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bou-Holaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA. (1995) 274:961&#x2013;7. 10.1001/jama.1995.03530120053041</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.1995.03530120053041</ArticleId><ArticleId IdType=\"pubmed\">7674527</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe PC, Calkins H. Neurally mediated hypotension and chronic fatigue syndrome. Am J Med. (1998) 105:15S&#x2013;21S. 10.1016/S0002-9343(98)00167-3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0002-9343(98)00167-3</ArticleId><ArticleId IdType=\"pubmed\">9790477</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart JM, Gewitz MH, Weldon A, Arlievsky N, Li K, Munoz J. Orthostatic intolerance in adolescent chronic fatigue syndrome. Pediatrics. (1999) 103:116&#x2013;21. 10.1542/peds.103.1.116</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1542/peds.103.1.116</ArticleId><ArticleId IdType=\"pubmed\">9917448</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine (Iom). Beyond mayalgic encephalomyelitis/chronic fatigue syndrome: Redefining an illness. Washington DC: The National Academies Press; (2015).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen CLMC, Verheugt FWA, Rowe PC, Visser FC. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: a quantitative, controlled study using Doppler echography. Clin Neurophysiol Pract. (2020b) 5:50&#x2013;8. 10.1016/j.cnp.2020.01.003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cnp.2020.01.003</ArticleId><ArticleId IdType=\"pmc\">PMC7044650</ArticleId><ArticleId IdType=\"pubmed\">32140630</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieling W, Ganzeboom KS, Saul JP. Reflex syncope in children and adolescents. Heart. (2004) 90:1094. 10.1136/hrt.2003.022996</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/hrt.2003.022996</ArticleId><ArticleId IdType=\"pmc\">PMC1768435</ArticleId><ArticleId IdType=\"pubmed\">15310717</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyller VB, Due R, Saul JP, Amlie JP, Thaulow E. Usefulness of an abnormal cardiovascular response during low-grade head-up tilt-test for discriminating adolescents with chronic fatigue from healthy controls. Am J Cardiol. (2007) 99:997&#x2013;1001. 10.1016/j.amjcard.2006.10.067</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.amjcard.2006.10.067</ArticleId><ArticleId IdType=\"pubmed\">17398200</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen CLMC, Rowe PC, Visser FC. Cerebral blood flow is reduced in severe myalgic encephalomyelitis/chronic fatigue syndrome patients during mild orthostatic stress testing: an exploratory study at 20 degrees of head-up tilt testing. Healthcare. (2020a) 8:169. 10.3390/healthcare8020169</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare8020169</ArticleId><ArticleId IdType=\"pmc\">PMC7349207</ArticleId><ArticleId IdType=\"pubmed\">32545797</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue syndrome study group. Ann Intern Med. (1994) 121:953&#x2013;9. 10.7326/0003-4819-121-12-199412150-00009</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType=\"pubmed\">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, Van De Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. (2011) 270:327&#x2013;38. 10.1111/j.1365-2796.2011.02428.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType=\"pmc\">PMC3427890</ArticleId><ArticleId IdType=\"pubmed\">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen CLMC, Verheugt FWA, Visser FC. Cerebral blood flow changes during tilt table testing in healthy volunteers, as assessed by Doppler imaging of the carotid and vertebral arteries. Clin Neurophysiol Pract. (2018b) 3:91&#x2013;5. 10.1016/j.cnp.2018.02.004</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cnp.2018.02.004</ArticleId><ArticleId IdType=\"pmc\">PMC6133915</ArticleId><ArticleId IdType=\"pubmed\">30215015</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci. (2011) 161:46&#x2013;8. 10.1016/j.autneu.2011.02.004</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autneu.2011.02.004</ArticleId><ArticleId IdType=\"pubmed\">21393070</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon RS, Grubb BP, 2nd, Olshansky B, Shen WK, Calkins H, Brignole M, et al. 2015 Heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. (2015) 12:e41&#x2013;63. 10.1016/j.hrthm.2015.03.029</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.hrthm.2015.03.029</ArticleId><ArticleId IdType=\"pmc\">PMC5267948</ArticleId><ArticleId IdType=\"pubmed\">25980576</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen CLMC, Visser FC, De Cock CC, Vos HS, Kamp O, Visser CA. Comparison of the haemodynamics of different pacing sites in patients undergoing resynchronisation treatment: need for individualisation of lead localisation. Heart. (2006) 92:1795&#x2013;800. 10.1136/hrt.2004.050435</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/hrt.2004.050435</ArticleId><ArticleId IdType=\"pmc\">PMC1861309</ArticleId><ArticleId IdType=\"pubmed\">16803940</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes F, Pierard S, De Meester C, Boulif J, Amzulescu M, Vancraeynest D, et al. Impact of left ventricular outflow tract ellipticity on the grading of aortic stenosis in patients with normal ejection fraction. J Cardiovasc Magn Reson. (2017) 19:37. 10.1186/s12968-017-0344-8</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12968-017-0344-8</ArticleId><ArticleId IdType=\"pmc\">PMC5351048</ArticleId><ArticleId IdType=\"pubmed\">28292302</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoiland RL, Fisher JA, Ainslie PN. Regulation of the cerebral circulation by arterial carbon dioxide. Compr Physiol. (2019) 9:1101&#x2013;54. 10.1002/cphy.c180021</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cphy.c180021</ArticleId><ArticleId IdType=\"pubmed\">31187899</ArticleId></ArticleIdList></Reference><Reference><Citation>Timmers HJ, Wieling W, Soetekouw PM, Bleijenberg G, Van Der Meer JW, Lenders JW. Hemodynamic and neurohumoral responses to head-up tilt in patients with chronic fatigue syndrome. Clin Auton Res. (2002) 12:273&#x2013;80. 10.1007/s10286-002-0014-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10286-002-0014-1</ArticleId><ArticleId IdType=\"pubmed\">12357281</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen CLMC, Visser FC. The abnormal cardiac Index and stroke volume Index changes during a normal tilt table test in ME/CFS patients compared to healthy volunteers, are not related to deconditioning. J Thromb Cir. (2018):1&#x2013;18. 10.29011/JTC-107.000007</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.29011/JTC-107.000007</ArticleId></ArticleIdList></Reference><Reference><Citation>Streeten DH, Thomas D, Bell DS. The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci. (2000) 320:1&#x2013;8. 10.1016/S0002-9629(15)40790-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0002-9629(15)40790-6</ArticleId><ArticleId IdType=\"pubmed\">10910366</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen CLMC, Rowe PC, Visser FC. Blood volume Status in ME/CFS correlates with the presence or absence of orthostatic symptoms: preliminary results. Front Pediatr. (2018a) 6:4. 10.3389/fped.2018.00352</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2018.00352</ArticleId><ArticleId IdType=\"pmc\">PMC6262290</ArticleId><ArticleId IdType=\"pubmed\">30525014</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT. Orthostatic intolerance and chronic fatigue syndrome associated with ehlers-danlos syndrome. J Pediatr. (1999) 135:494&#x2013;9. 10.1016/S0022-3476(99)70173-3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0022-3476(99)70173-3</ArticleId><ArticleId IdType=\"pubmed\">10518084</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen CLMC, Rowe PC, Visser FC. The myalgic encephalomyelitis/chronic fatigue syndrome patients with joint hypermobility show larger cerebral blood flow reductions during orthostatic stress testing than patients without hypermobility: a case control study. Med Res Arch. (2021c) 9. 10.18103/mra.v9i6.2494</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18103/mra.v9i6.2494</ArticleId></ArticleIdList></Reference><Reference><Citation>Keskin K, &#xc7;ift&#xe7;i S, &#xd6;nc&#xfc; J, Melike Do&#x11f;an G, &#xc7;etinkal G, Sezai Y&#x131;ld&#x131;z S, et al. Orthostatic hypotension and age-related sarcopenia. Turk J Phys Med Rehabil. (2021) 67:25&#x2013;31. 10.5606/tftrd.2021.5461</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5606/tftrd.2021.5461</ArticleId><ArticleId IdType=\"pmc\">PMC8088799</ArticleId><ArticleId IdType=\"pubmed\">33948540</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q, Vangundy TB, Galbreath MM, Shibata S, Jain M, Hastings JL, et al. Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol. (2010) 55:2858&#x2013;68. 10.1016/j.jacc.2010.02.043</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jacc.2010.02.043</ArticleId><ArticleId IdType=\"pmc\">PMC2914315</ArticleId><ArticleId IdType=\"pubmed\">20579544</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyller VB, Vitelli V, Sulheim D, Fagermoen E, Winger A, Godang K, et al. Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: a cross-sectional study. J Transl Med. (2016) 14:121. 10.1186/s12967-016-0873-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-016-0873-1</ArticleId><ArticleId IdType=\"pmc\">PMC4858924</ArticleId><ArticleId IdType=\"pubmed\">27149955</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport TE, Lehnen M, Stevens SR, Vanness JM, Stevens J, Snell CR. Chronotropic intolerance: an overlooked determinant of symptoms and activity limitation in myalgic encephalomyelitis/chronic fatigue syndrome? Front Pediatr. (2019) 7:82. 10.3389/fped.2019.00082</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2019.00082</ArticleId><ArticleId IdType=\"pmc\">PMC6439478</ArticleId><ArticleId IdType=\"pubmed\">30968005</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, et al. Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an 11C-(R)-PK11195 PET study. J Nucl Med. (2014) 55:945&#x2013;50. 10.2967/jnumed.113.131045</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2967/jnumed.113.131045</ArticleId><ArticleId IdType=\"pubmed\">24665088</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XL, Ling TY, Charlesworth MC, Figueroa JJ, Low P, Shen WK, et al. Autoimmunoreactive IgGs against cardiac lipid raft-associated proteins in patients with postural orthostatic tachycardia syndrome. Transl Res. (2013) 162:34&#x2013;44. 10.1016/j.trsl.2013.03.002</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.trsl.2013.03.002</ArticleId><ArticleId IdType=\"pmc\">PMC3691285</ArticleId><ArticleId IdType=\"pubmed\">23562385</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherbakov N, Szklarski M, Hartwig J, Sotzny F, Lorenz S, Meyer A, et al. Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome. ESC Heart Fail. (2020) 7:1064&#x2013;71. 10.1002/ehf2.12633</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ehf2.12633</ArticleId><ArticleId IdType=\"pmc\">PMC7261521</ArticleId><ArticleId IdType=\"pubmed\">32154656</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen CLMC, Rowe PC, Visser FC. Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients. Clin Neurophysiol Pract. (2021b) 6:245&#x2013;55. 10.1016/j.cnp.2021.09.001</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cnp.2021.09.001</ArticleId><ArticleId IdType=\"pmc\">PMC8505270</ArticleId><ArticleId IdType=\"pubmed\">34667909</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes JM, Kruger A, Proal A, Kell DB, Pretorius E. The occurrence of hyperactivated platelets and fibrinaloid microclots in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Pharmaceuticals [Online]. (2022) 15:931&#x2013;47. 10.3390/ph15080931</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ph15080931</ArticleId><ArticleId IdType=\"pmc\">PMC9413879</ArticleId><ArticleId IdType=\"pubmed\">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidi A, Benitez D, Gaydecki PA, Vohra A, Fitzpatrick AP. Haemodynamic effects of increasing angle of head up tilt. Heart. (2000) 83:181&#x2013;4. 10.1136/heart.83.2.181</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/heart.83.2.181</ArticleId><ArticleId IdType=\"pmc\">PMC1729297</ArticleId><ArticleId IdType=\"pubmed\">10648492</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Hou W, Chui J, Han R, Gelb AW. Cardiac output and cerebral blood flow: the integrated regulation of brain perfusion in adult humans. Anesthesiology. (2015) 123:1198&#x2013;208. 10.1097/ALN.0000000000000872</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/ALN.0000000000000872</ArticleId><ArticleId IdType=\"pubmed\">26402848</ArticleId></ArticleIdList></Reference><Reference><Citation>Youde J, Panerai R, Gillies C, Potter J. Reproducibility of circulatory changes to head-up tilt in healthy elderly subjects. Age Ageing. (2003) 32:375&#x2013;81. 10.1093/ageing/32.4.375</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ageing/32.4.375</ArticleId><ArticleId IdType=\"pubmed\">12851179</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemaker JK, Hogeman CS, Khan M, Kimmerly DS, Sinoway LI. Gender affects sympathetic and hemodynamic response to postural stress. Am J Physiol Heart Circ Physiol. (2001) 281:H2028&#x2013;2035. 10.1152/ajpheart.2001.281.5.H2028</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpheart.2001.281.5.H2028</ArticleId><ArticleId IdType=\"pubmed\">11668064</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart JM, Medow MS, Messer ZR, Baugham IL, Terilli C, Ocon AJ. Postural neurocognitive and neuronal activated cerebral blood flow deficits in young chronic fatigue syndrome patients with postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. (2012) 302:H1185&#x2013;94. 10.1152/ajpheart.00994.2011</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpheart.00994.2011</ArticleId><ArticleId IdType=\"pmc\">PMC3311460</ArticleId><ArticleId IdType=\"pubmed\">22180650</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S, Bourne KM, Stiles LE, Grubb BP, Fedorowski A, Stewart JM, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 national institutes of health expert consensus meeting&#x2014;part 1. Autonomic Neurosci. (2021) 235:102828. 10.1016/j.autneu.2021.102828</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autneu.2021.102828</ArticleId><ArticleId IdType=\"pmc\">PMC8455420</ArticleId><ArticleId IdType=\"pubmed\">34144933</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin KJ, Kim SE, Park KM, Park J, Ha SY, Kim SE, et al. Cerebral hemodynamics in orthostatic intolerance with normal head-up tilt test. Acta Neurol Scand. (2015) 134:108&#x2013;15. 10.1111/ane.12516</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/ane.12516</ArticleId><ArticleId IdType=\"pubmed\">26427910</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Kim HT, Park KM, Ha SY, Kim SE, Shin KJ, et al. Orthostatic dizziness in Parkinson\\'s disease is attributed to cerebral hypoperfusion: a transcranial Doppler study. J Clin Ultrasound. (2017) 45:337&#x2013;42. 10.1002/jcu.22452</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jcu.22452</ArticleId><ArticleId IdType=\"pubmed\">28401995</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P. Hypocapnic cerebral hypoperfusion: a biomarker of orthostatic intolerance. PLoS One. (2018) 13:e0204419. 10.1371/journal.pone.0204419</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0204419</ArticleId><ArticleId IdType=\"pmc\">PMC6157889</ArticleId><ArticleId IdType=\"pubmed\">30256820</ArticleId></ArticleIdList></Reference><Reference><Citation>Medow MS, Sood S, Messer Z, Dzogbeta S, Terilli C, Stewart JM. Phenylephrine alteration of cerebral blood flow during orthostasis: effect on n-back performance in chronic fatigue syndrome. J Appl Physiol. (2014) 117:1157&#x2013;64. 10.1152/japplphysiol.00527.2014</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/japplphysiol.00527.2014</ArticleId><ArticleId IdType=\"pmc\">PMC4233252</ArticleId><ArticleId IdType=\"pubmed\">25277740</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen CLMC, Rowe PC, Verheugt FWA, Visser FC. Numeric rating scales show prolonged post-exertional symptoms after orthostatic testing of adults with myalgic encephalomyelitis/chronic fatigue syndrome. Front Med. (2021a) 7:10. 10.3389/fmed.2020.602894</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmed.2020.602894</ArticleId><ArticleId IdType=\"pmc\">PMC7874746</ArticleId><ArticleId IdType=\"pubmed\">33585505</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37243973</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>27</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1552-6569</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2023</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>Journal of neuroimaging : official journal of the American Society of Neuroimaging</Title><ISOAbbreviation>J Neuroimaging</ISOAbbreviation></Journal><ArticleTitle>Free-water-corrected diffusion and adrenergic/muscarinic antibodies in myalgic encephalomyelitis/chronic fatigue syndrome.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1111/jon.13128</ELocationID><Abstract><AbstractText Label=\"BACKGROUND AND PURPOSE\" NlmCategory=\"OBJECTIVE\">Free-water-corrected diffusion tensor imaging (FW-DTI), a new analysis method for diffusion MRI, can indicate neuroinflammation and degeneration. There is increasing evidence of autoimmune etiology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). We used FW-DTI and conventional DTI to investigate microstructural brain changes related to autoantibody titers in patients with ME/CFS.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">We prospectively examined 58 consecutive right-handed ME/CFS patients who underwent both brain MRI including FW-DTI and a blood analysis of autoantibody titers against &#x3b2;1 adrenergic receptor (&#x3b2;1 AdR-Ab), &#x3b2;2 AdR-Ab, M3 acetylcholine receptor (M3 AchR-Ab), and M4 AchR-Ab. We investigated the correlations between these four autoantibody titers and three FW-DTI indices-free water (FW), FW-corrected fractional anisotropy (FAt), and FW-corrected mean diffusivity-as well as two conventional DTI indices-fractional anisotropy (FA) and mean diffusivity. The patients\\' age and gender were considered as nuisance covariates. We also evaluated the correlations between the FW-DTI indices and the performance status and disease duration.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Significant negative correlations between the serum levels of several autoantibody titers and DTI indices were identified, mainly in the right frontal operculum. The disease duration showed significant negative correlations with both FAt and FA in the right frontal operculum. The changes in the FW-corrected DTI indices were observed over a wider extent compared to the conventional DTI indices.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">These results demonstrate the value of using DTI to assess the microstructure of ME/CFS. The abnormalities of right frontal operculum may be a diagnostic marker for ME/CFS.</AbstractText><CopyrightInformation>&#xa9; 2023 American Society of Neuroimaging.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Kimura</LastName><ForeName>Yukio</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Radiology, National Center Hospital of Neurology and Psychiatry, Kodaira, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sato</LastName><ForeName>Wakiro</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Maikusa</LastName><ForeName>Norihide</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Radiology, National Center Hospital of Neurology and Psychiatry, Kodaira, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Diversity Adaptation of Human Mind, University of Tokyo, Komaba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ota</LastName><ForeName>Miho</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuropsychiatry, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shigemoto</LastName><ForeName>Yoko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Radiology, National Center Hospital of Neurology and Psychiatry, Kodaira, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chiba</LastName><ForeName>Emiko</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Radiology, National Center Hospital of Neurology and Psychiatry, Kodaira, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Arizono</LastName><ForeName>Elly</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Radiology, National Center Hospital of Neurology and Psychiatry, Kodaira, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Maki</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Radiology, National Center Hospital of Neurology and Psychiatry, Kodaira, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shin</LastName><ForeName>Isu</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sekimachi Medical Clinic, Nerima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Amano</LastName><ForeName>Keiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Seifuso Hospital, Niiza, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Matsuda</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><Identifier Source=\"ORCID\">0000-0002-6297-9897</Identifier><AffiliationInfo><Affiliation>Department of Radiology, National Center Hospital of Neurology and Psychiatry, Kodaira, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Drug Discovery and Cyclotron Research Center, Southern TOHOKU Research Institute for Neuroscience, Koriyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yamamura</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sato</LastName><ForeName>Noriko</ForeName><Initials>N</Initials><Identifier Source=\"ORCID\">0000-0002-9305-7131</Identifier><AffiliationInfo><Affiliation>Department of Radiology, National Center Hospital of Neurology and Psychiatry, Kodaira, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><Agency>Intramural Research Grant (3-10) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neuroimaging</MedlineTA><NlmUniqueID>9102705</NlmUniqueID><ISSNLinking>1051-2284</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">adrenergic/muscarinic receptors</Keyword><Keyword MajorTopicYN=\"N\">diffusion tensor imaging</Keyword><Keyword MajorTopicYN=\"N\">free-water imaging</Keyword><Keyword MajorTopicYN=\"N\">myalgic encephalomyelitis/chronic fatigue syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>15</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37243973</ArticleId><ArticleId IdType=\"doi\">10.1111/jon.13128</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Fukuda K, Straus SE, Hickie I, et&#xa0;al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121:953-9.</Citation></Reference><Reference><Citation>Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am J Psychiatry. 2003;160:221-36.</Citation></Reference><Reference><Citation>Faulkner S, Smith A. A longitudinal study of the relationship between psychological distress and recurrence of upper respiratory tract infections in chronic fatigue syndrome. Br J Health Psychol. 2008;13:177-86.</Citation></Reference><Reference><Citation>Sato W, Ono H, Matsutani T, et&#xa0;al. Skewing of the B cell receptor repertoire in myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav Immun. 2021;95:245-55.</Citation></Reference><Reference><Citation>Loebel M, Grabowski P, Heidecke H, et&#xa0;al. Antibodies to &#x3b2; adrenergic and muscarinic cholinergic receptors in patients with chronic fatigue syndrome. Brain Behav Immun. 2016;52:32-9.</Citation></Reference><Reference><Citation>Fujii H, Sato W, Kimura Y, et&#xa0;al. Altered structural brain networks related to adrenergic/muscarinic receptor autoantibodies in chronic fatigue syndrome. J Neuroimaging. 2020;30:822-7</Citation></Reference><Reference><Citation>Zeineh MM, Kang J, Atlas SW, et&#xa0;al. Right arcuate fasciculus abnormality in chronic fatigue syndrome. Radiology. 2015;274:517-26</Citation></Reference><Reference><Citation>Thapaliya K, Marshall-Gradisnik S, Staines D, et&#xa0;al. Diffusion tensor imaging reveals neuronal microstructural changes in myalgic encephalomyelitis/chronic fatigue syndrome. Eur J Neurosci. 2021;54:6214-28.</Citation></Reference><Reference><Citation>Alexander AL, Lee JE, Lazar M, et&#xa0;al. Diffusion tensor imaging of the brain. Neurotherapeutics. 2007;4:316-29.</Citation></Reference><Reference><Citation>Kamagata K, Andica C, Hatano T, et&#xa0;al. Advanced diffusion magnetic resonance imaging in patients with Alzheimer\\'s and Parkinson\\'s diseases. Neural Regen Res. 2020;15:1590-600.</Citation></Reference><Reference><Citation>Pasternak O, Sochen N, Gur Y, et&#xa0;al. Free water elimination and mapping from diffusion MRI. Magn Reson Med. 2009;62:717-30.</Citation></Reference><Reference><Citation>Bergamino M, Walsh RR, Stokes AM. Free-water diffusion tensor imaging improves the accuracy and sensitivity of white matter analysis in Alzheimer\\'s disease. Sci Rep. 2021;11:6990.</Citation></Reference><Reference><Citation>Uddin MN, Faiyaz A, Wang L, et&#xa0;al. A longitudinal analysis of brain extracellular free water in HIV infected individuals. Sci Rep 2021;11:8273.</Citation></Reference><Reference><Citation>Andica C, Kamagata K, Hatano T, et&#xa0;al. Free-water imaging in white and gray matter in Parkinson\\'s disease. Cells. 2019;8:839.</Citation></Reference><Reference><Citation>Saito A, Kamagata K, Ueda R, et&#xa0;al. Ventricular volumetry and free-water corrected diffusion tensor imaging of the anterior thalamic radiation in idiopathic normal pressure hydrocephalus. J Neuroradiol. 2020;47:312-7.</Citation></Reference><Reference><Citation>Oestreich LKL, Lyall AE, Pasternak O, et&#xa0;al. Characterizing white matter changes in chronic schizophrenia: a free-water imaging multi-site study. Schizophr Res. 2017;189:153-61.</Citation></Reference><Reference><Citation>Carruthers B, Jain A, De Meirleir K, et&#xa0;al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr 2003;11:7-115.</Citation></Reference><Reference><Citation>Carruthers B, van de Sande M, De Meirleir K, et&#xa0;al. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med. 2011;270:327-38.</Citation></Reference><Reference><Citation>Matsuda Y, Matsui T, Kataoka K, et&#xa0;al. A two-year follow-up study of chronic fatigue syndrome comorbid with psychiatric disorders. Psychiat Clin Neuros. 2009;63:365-73.</Citation></Reference><Reference><Citation>Hoy AR, Koay CG, Kecskemeti SR, et&#xa0;al. Optimization of a free water elimination two-compartmental model for diffusion tensor imaging. Neuroimage. 2014;103:323-33.</Citation></Reference><Reference><Citation>Henriques RN, Rokem A, Garyfallidis E, et&#xa0;al. Optimization of a free water elimination two-compartment model for diffusion tensor imaging. ReScience. 2017;3:2.</Citation></Reference><Reference><Citation>Veraart J, Fieremans E, Novikov DS. Diffusion MRI noise mapping using random matrix theory. Magn Reson Med. 2016;76:1582-93.</Citation></Reference><Reference><Citation>Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007;38:95-113.</Citation></Reference><Reference><Citation>Oestreich LKL, O\\'Sullivan MJ. Transdiagnostic in vivo magnetic resonance imaging markers of neuroinflammation. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022;7:638-58.</Citation></Reference><Reference><Citation>Barz&#xf3; P, Marmarou A, Fatouros P, et&#xa0;al. Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging. J Neurosurg. 1997;87:900e7.</Citation></Reference><Reference><Citation>Lipton P. Ischemic cell death in brain neurons. Physiol Rev. 1999;79:1431-568.</Citation></Reference><Reference><Citation>Fukuda S, Nojima J, Motoki Y, et&#xa0;al. A potential biomarker for fatigue: oxidative stress and anti-oxidative activity. Biol Psychol. 2016;118:88-93.</Citation></Reference><Reference><Citation>Lee JS, Kim HG, Lee DS, et&#xa0;al. Oxidative stress is a convincing contributor to idiopathic chronic fatigue. Sci Rep. 2018;8:12890.</Citation></Reference><Reference><Citation>Kimelberg HK. Current concepts of brain edema. Review of laboratory investigations. J Neurosurg. 1995;83:1051-9</Citation></Reference><Reference><Citation>Edde M, Theaud G, Rheault F, et&#xa0;al. Free water: a marker of age-related modifications of the cingulum white matter and its association with cognitive decline. PLoS One. 2020;15:e0242696.</Citation></Reference><Reference><Citation>Sutoko S, Atsumori H, Obata A, et&#xa0;al. Lesions in the right Rolandic operculum are associated with self-rating affective and apathetic depressive symptoms for post-stroke patients. Sci Rep 2020;10:20264.</Citation></Reference><Reference><Citation>Schmahmann JD, Smith EE, Eichler FS, et&#xa0;al. Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates. Ann N Y Acad Sci. 2008;1142:266-309.</Citation></Reference><Reference><Citation>Kinoshita M, Nakajima R, Shinohara H, et&#xa0;al. Chronic spatial working memory deficit associated with the superior longitudinal fasciculus: a study using voxel-based lesion-symptom mapping and intraoperative direct stimulation in right prefrontal glioma surgery. J Neurosurg. 2016;125:1024-32.</Citation></Reference><Reference><Citation>Karlsgodt KH, van Erp TG, Poldrack RA, et&#xa0;al. Diffusion tensor imaging of the superior longitudinal fasciculus and working memory in recent-onset schizophrenia. Biol Psychiatry. 2008;63:512-8.</Citation></Reference><Reference><Citation>Deluca J, Christodoulou C, Diamond BJ, et&#xa0;al. Working memory deficits in chronic fatigue syndrome: differentiating between speed and accuracy of information processing. J Int Neuropsychol Soc. 2004;10:101-9.</Citation></Reference><Reference><Citation>Marshall PS, Forstot M, Callies A, et&#xa0;al. Cognitive slowing and working memory difficulties in chronic fatigue syndrome. Psychosom Med. 1997;59:58-66.</Citation></Reference><Reference><Citation>Kimura Y, Sato N, Ota M, et&#xa0;al. Brain abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: evaluation by diffusional kurtosis imaging and neurite orientation dispersion and density imaging. J Magn Reson Imaging. 2019;49:818-24.</Citation></Reference><Reference><Citation>Rayhan RU, Stevens BW, Timbol CR, et&#xa0;al. Increased brain white matter axial diffusivity associated with fatigue, pain and hyperalgesia in Gulf War illness. PLoS One. 2013;8:e58493.</Citation></Reference><Reference><Citation>Liang W, Yu Q, Wang W, et&#xa0;al. A comparative study of the superior longitudinal fasciculus subdivisions between neonates and young adults. Brain Struct Funct. 2022;227:2713-30.</Citation></Reference><Reference><Citation>Makris N, Kennedy DN, McInerney S, et&#xa0;al. Segmentation of subcomponents within the superior longitudinal fascicle in humans: a quantitative, in vivo, DT-MRI study. Cereb Cortex. 2005;15:854-69.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37241210</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1648-9144</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>59</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Comorbidities: Linked by Vascular Pathomechanisms and Vasoactive Mediators?</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">978</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/medicina59050978</ELocationID><Abstract><AbstractText>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is often associated with various other syndromes or conditions including mast cell activation (MCA), dysmenorrhea and endometriosis, postural tachycardia (POTS) and small fiber neuropathy (SFN). The causes of these syndromes and the reason for their frequent association are not yet fully understood. We previously published a comprehensive hypothesis of the ME/CFS pathophysiology that explains the majority of symptoms, findings and chronicity of the disease. We wondered whether some of the identified key pathomechanisms in ME/CFS are also operative in MCA, endometriosis and dysmenorrhea, POTS, decreased cerebral blood flow and SFN, and possibly may provide clues on their causes and frequent co-occurrence. Our analysis indeed provides strong arguments in favor of this assumption, and we conclude that the main pathomechanisms responsible for this association are excessive generation and spillover into the systemic circulation of inflammatory and vasoactive tissue mediators, dysfunctional &#x3b2;2AdR, and the mutual triggering of symptomatology and disease initiation. Overall, vascular dysfunction appears to be a strong common denominator in these linkages.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wirth</LastName><ForeName>Klaus J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Institute of General Pharmacology and Toxicology, University Hospital Frankfurt am Main, Goethe-University, Theodor-Stern Kai 7, D-60590 Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>L&#xf6;hn</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of General Pharmacology and Toxicology, University Hospital Frankfurt am Main, Goethe-University, Theodor-Stern Kai 7, D-60590 Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI=\"Q000150\" MajorTopicYN=\"N\">complications</QualifierName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D004412\" MajorTopicYN=\"N\">Dysmenorrhea</DescriptorName><QualifierName UI=\"Q000150\" MajorTopicYN=\"N\">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D004715\" MajorTopicYN=\"Y\">Endometriosis</DescriptorName><QualifierName UI=\"Q000150\" MajorTopicYN=\"N\">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015897\" MajorTopicYN=\"N\">Comorbidity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">MCA</Keyword><Keyword MajorTopicYN=\"N\">ME/CFS</Keyword><Keyword MajorTopicYN=\"N\">brain fog</Keyword><Keyword MajorTopicYN=\"N\">cerebral blood flow</Keyword><Keyword MajorTopicYN=\"N\">dysmenorrhea</Keyword><Keyword MajorTopicYN=\"N\">endometriosis</Keyword><Keyword MajorTopicYN=\"N\">long COVID</Keyword><Keyword MajorTopicYN=\"N\">orthostatic intolerance</Keyword><Keyword MajorTopicYN=\"N\">small fiber neuropathy</Keyword><Keyword MajorTopicYN=\"N\">&#x3b2;2-adrenergic receptors</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>1</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37241210</ArticleId><ArticleId IdType=\"pmc\">PMC10224216</ArticleId><ArticleId IdType=\"doi\">10.3390/medicina59050978</ArticleId><ArticleId IdType=\"pii\">medicina59050978</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carruthers B.M., Van De Sande M.I., De Meirleir K.L., Klimas N.G., Broderick G., Mitchell T., Staines D., Powles A.C., Speight N., Vallings R., et al. Myalgic encephalomyelitis: International Consensus Criteria. J. Intern. Med. 2011;270:327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType=\"pmc\">PMC3427890</ArticleId><ArticleId IdType=\"pubmed\">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Holtzman C.S., Sunnquist M., Cotler J. The development of an instrument to assess post-exertional malaise in patients with myalgic encephalomyelitis and chronic fatigue syndrome. J. Health Psychol. 2021;26:238&#x2013;248. doi: 10.1177/1359105318805819.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1359105318805819</ArticleId><ArticleId IdType=\"pmc\">PMC7988339</ArticleId><ArticleId IdType=\"pubmed\">30354489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)&#x2014;A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57050418</ArticleId><ArticleId IdType=\"pmc\">PMC8145228</ArticleId><ArticleId IdType=\"pubmed\">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Cholevas C., Polyzoidis K., Politis A. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Biofactors. 2021;47:232&#x2013;241. doi: 10.1002/biof.1726.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/biof.1726</ArticleId><ArticleId IdType=\"pmc\">PMC8250989</ArticleId><ArticleId IdType=\"pubmed\">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K., Scheibenbogen C. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against &#x3b2;2-adrenergic receptors. Autoimmun. Rev. 2020;19:102527. doi: 10.1016/j.autrev.2020.102527.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2020.102527</ArticleId><ArticleId IdType=\"pubmed\">32247028</ArticleId></ArticleIdList></Reference><Reference><Citation>Boneva R.S., Lin J.-M.S., Wieser F., Nater U.M., Ditzen B., Taylor R.N., Unger E.R. Endometriosis as a Comorbid Condition in Chronic Fatigue Syndrome (CFS): Secondary Analysis of Data From a CFS Case-Control Study. Front. Pediatr. 2019;7:195. doi: 10.3389/fped.2019.00195.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2019.00195</ArticleId><ArticleId IdType=\"pmc\">PMC6537603</ArticleId><ArticleId IdType=\"pubmed\">31179251</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho Y.J., Lee S.H., Park J.W., Han M., Park M.J., Han S.J. Dysfunctional signaling underlying endometriosis: Current state of knowledge. J. Mol. Endocrinol. 2018;60:R97&#x2013;R113. doi: 10.1530/JME-17-0227.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1530/JME-17-0227</ArticleId><ArticleId IdType=\"pubmed\">29330150</ArticleId></ArticleIdList></Reference><Reference><Citation>Signorile P.G., Cassano M., Viceconte R., Marcattilj V., Baldi A. Endometriosis: A Retrospective Analysis of Clinical Data from a Cohort of 4083 Patients, with Focus on Symptoms. In Vivo. 2022;36:874&#x2013;883. doi: 10.21873/invivo.12776.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.21873/invivo.12776</ArticleId><ArticleId IdType=\"pmc\">PMC8931881</ArticleId><ArticleId IdType=\"pubmed\">35241545</ArticleId></ArticleIdList></Reference><Reference><Citation>DiBenedetti D., Soliman A.M., Gupta C., Surrey E.S. Patients&#x2019; perspectives of endometriosis-related fatigue: Qualitative interviews. J. Patient-Rep. Outcomes. 2020;4:33. doi: 10.1186/s41687-020-00200-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s41687-020-00200-1</ArticleId><ArticleId IdType=\"pmc\">PMC7203274</ArticleId><ArticleId IdType=\"pubmed\">32377820</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe P.C., Underhill R.A., Friedman K.J., Gurwitt A., Medow M.S., Schwartz M.S., Speight N., Stewart J.M., Vallings R., Rowe K.S. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Front. Pediatr. 2017;5:121. doi: 10.3389/fped.2017.00121.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2017.00121</ArticleId><ArticleId IdType=\"pmc\">PMC5474682</ArticleId><ArticleId IdType=\"pubmed\">28674681</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev. Med. Virol. 2022;32:e2315. doi: 10.1002/rmv.2315.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/rmv.2315</ArticleId><ArticleId IdType=\"pubmed\">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit N.M., Churchill A., Nsair A., Hsu J.J. Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known? Am. Heart J. Plus Cardiol. Res. Pract. 2021;5:100025. doi: 10.1016/j.ahjo.2021.100025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ahjo.2021.100025</ArticleId><ArticleId IdType=\"pmc\">PMC8223036</ArticleId><ArticleId IdType=\"pubmed\">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., L&#xf6;hn M. Orthostatic Intolerance after COVID-19 Infection: Is Disturbed Microcirculation of the Vasa Vasorum of Capacitance Vessels the Primary Defect? Medicina. 2022;58:1807. doi: 10.3390/medicina58121807.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina58121807</ArticleId><ArticleId IdType=\"pmc\">PMC9788017</ArticleId><ArticleId IdType=\"pubmed\">36557009</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Brinth L., Hendrickson J.E., Martinez-Lavin M. Autonomic dysfunction and HPV immunization: An overview. Immunol. Res. 2018;66:744&#x2013;754. doi: 10.1007/s12026-018-9036-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12026-018-9036-1</ArticleId><ArticleId IdType=\"pubmed\">30478703</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttgereit T., Gu S., Carneiro-Le&#xe3;o L., Gutsche A., Maurer M., Siebenhaar F. Idiopathic mast cell activation syndrome is more often suspected than diagnosed&#x2014;A prospective real-life study. Allergy. 2022;77:2794&#x2013;2802. doi: 10.1111/all.15304.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/all.15304</ArticleId><ArticleId IdType=\"pubmed\">35364617</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihistamines. J. Investig. Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jim-2021-002051</ArticleId><ArticleId IdType=\"pmc\">PMC8494538</ArticleId><ArticleId IdType=\"pubmed\">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashauri H.L. COVID-19 Histamine theory: Why antihistamines should be incorporated as the basic component in COVID-19 management? Health Sci. Rep. 2023;6:e1109. doi: 10.1002/hsr2.1109.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/hsr2.1109</ArticleId><ArticleId IdType=\"pmc\">PMC9903129</ArticleId><ArticleId IdType=\"pubmed\">36778771</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu C., Fuhler G.M., Pan Y. Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19? Int. J. Mol. Sci. 2021;22:5672. doi: 10.3390/ijms22115672.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22115672</ArticleId><ArticleId IdType=\"pmc\">PMC8199351</ArticleId><ArticleId IdType=\"pubmed\">34073529</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto M.D., Lambert N., Downs C.A., Abrahim H., Hughes T.D., Rahmani A.M., Burton C.W., Chakraborty R. Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection. J. Nurse Pract. 2022;18:335&#x2013;338. doi: 10.1016/j.nurpra.2021.12.016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nurpra.2021.12.016</ArticleId><ArticleId IdType=\"pmc\">PMC8820139</ArticleId><ArticleId IdType=\"pubmed\">35153633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M.J. Nonclonal Mast Cell Activation Syndrome: A Growing Body of Evidence. Immunol. Allergy Clin. N. Am. 2018;38:469&#x2013;481. doi: 10.1016/j.iac.2018.04.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.iac.2018.04.002</ArticleId><ArticleId IdType=\"pmc\">PMC6049091</ArticleId><ArticleId IdType=\"pubmed\">30007464</ArticleId></ArticleIdList></Reference><Reference><Citation>Arun S., Storan A., Myers B. Mast cell activation syndrome and the link with long COVID. Br. J. Hosp. Med. 2022;83:1&#x2013;10. doi: 10.12968/hmed.2022.0123.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.12968/hmed.2022.0123</ArticleId><ArticleId IdType=\"pubmed\">35938771</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock L.B., Brook J.B., Walters A.S., Goris A., Afrin L.B., Molderings G.J. Mast cell activation symptoms are prevalent in Long-COVID. Int. J. Infect. Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType=\"pmc\">PMC8459548</ArticleId><ArticleId IdType=\"pubmed\">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolarz B., Szy&#x142;&#x142;o K., Romanowicz H. Endometriosis: Epidemiology, Classification, Pathogenesis, Treatment and Genetics (Review of Literature) Int. J. Mol. Sci. 2021;22:10554. doi: 10.3390/ijms221910554.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms221910554</ArticleId><ArticleId IdType=\"pmc\">PMC8508982</ArticleId><ArticleId IdType=\"pubmed\">34638893</ArticleId></ArticleIdList></Reference><Reference><Citation>Knific T., Fishman D., Vogler A., Gst&#xf6;ttner M., Wenzl R., Peterson H., Ri&#x17e;ner T.L. Multiplex analysis of 40 cytokines do not allow separation between endometriosis patients and controls. Sci. Rep. 2019;9:16738. doi: 10.1038/s41598-019-52899-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-52899-8</ArticleId><ArticleId IdType=\"pmc\">PMC6853932</ArticleId><ArticleId IdType=\"pubmed\">31723213</ArticleId></ArticleIdList></Reference><Reference><Citation>Ylikorkala O., Dawood M.Y. New concepts in dysmenorrhea. Am. J. Obstet. Gynecol. 1978;130:833&#x2013;847. doi: 10.1016/0002-9378(78)90019-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0002-9378(78)90019-4</ArticleId><ArticleId IdType=\"pubmed\">25021</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcikowska Z., Rajkowska-Labon E., Grzybowska M.E., Hansdorfer-Korzon R., Zorena K. Inflammatory Markers in Dysmenorrhea and Therapeutic Options. Int. J. Environ. Res. Public Health. 2020;17:1191. doi: 10.3390/ijerph17041191.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijerph17041191</ArticleId><ArticleId IdType=\"pmc\">PMC7068519</ArticleId><ArticleId IdType=\"pubmed\">32069859</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimar&#xe3;es I., P&#xf3;voa A.M. Primary Dysmenorrhea: Assessment and Treatment. Rev. Bras. Ginecol. Obstet. 2020;42:501&#x2013;507. doi: 10.1055/s-0040-1712131.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1055/s-0040-1712131</ArticleId><ArticleId IdType=\"pubmed\">32559803</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacovides S., Avidon I., Baker F.C. What we know about primary dysmenorrhea today: A critical review. Hum. Reprod. Update. 2015;21:762&#x2013;778. doi: 10.1093/humupd/dmv039.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/humupd/dmv039</ArticleId><ArticleId IdType=\"pubmed\">26346058</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K., Hirose M., Furukawa S., Hayakawa H., Kimura E. Changes in Hemodynamics and Bradykinin Concentration in Coronary Sinus Blood in Experimental Coronary Artery Occlusion. Jpn. Heart J. 1977;18:679&#x2013;689. doi: 10.1536/ihj.18.679.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1536/ihj.18.679</ArticleId><ArticleId IdType=\"pubmed\">303709</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch M., Wendorf M., Dendorfer A., Wolfrum S., Schulze K., Spillmann F., Schultheiss H.-P., Tsch&#xf6;pe C. Cardiac kinin level in experimental diabetes mellitus: Role of kininases. Am. J. Physiol. Circ. Physiol. 2003;285:H418&#x2013;H423. doi: 10.1152/ajpheart.00677.2002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpheart.00677.2002</ArticleId><ArticleId IdType=\"pubmed\">12637359</ArticleId></ArticleIdList></Reference><Reference><Citation>Linz W., Wiemer G., Sch&#xf6;lkens B.A. Role of Kinins in the Pathophysiology of Myocardial Ischemia: In Vitro and In Vivo Studies. Diabetes. 1996;45:S51&#x2013;S58. doi: 10.2337/diab.45.1.S51.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2337/diab.45.1.S51</ArticleId><ArticleId IdType=\"pubmed\">8529801</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan H.-L., Chen S.-R., Scicli G.M., Carretero O.A. Cardiac interstitial bradykinin release during ischemia is enhanced by ischemic preconditioning. Am. J. Physiol. Circ. Physiol. 2000;279:H116&#x2013;H121. doi: 10.1152/ajpheart.2000.279.1.H116.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpheart.2000.279.1.H116</ArticleId><ArticleId IdType=\"pubmed\">10899048</ArticleId></ArticleIdList></Reference><Reference><Citation>Staszewska-Barczak J., Ferreira S.H., Vane J.R. An excitatory nociceptive cardiac reflex elicited by bradykinin and potentiated by prostaglandins and myocardial ischaemia. Cardiovasc. Res. 1976;10:314&#x2013;327. doi: 10.1093/cvr/10.3.314.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cvr/10.3.314</ArticleId><ArticleId IdType=\"pubmed\">954016</ArticleId></ArticleIdList></Reference><Reference><Citation>Stebbins C.L., Carretero O.A., Mindroiu T., Longhurst J.C. Bradykinin release from contracting skeletal muscle of the cat. J. Appl. Physiol. 1990;69:1225&#x2013;1230. doi: 10.1152/jappl.1990.69.4.1225.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/jappl.1990.69.4.1225</ArticleId><ArticleId IdType=\"pubmed\">2124582</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) J. Transl. Med. 2021;19:162. doi: 10.1186/s12967-021-02833-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-021-02833-2</ArticleId><ArticleId IdType=\"pmc\">PMC8058748</ArticleId><ArticleId IdType=\"pubmed\">33882940</ArticleId></ArticleIdList></Reference><Reference><Citation>Bynke A., Julin P., Gottfries C.-G., Heidecke H., Scheibenbogen C., Bergquist J. Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients&#x2014;A validation study in plasma and cerebrospinal fluid from two Swedish cohorts. Brain Behav. Immun. Health. 2020;7:100107. doi: 10.1016/j.bbih.2020.100107.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbih.2020.100107</ArticleId><ArticleId IdType=\"pmc\">PMC8474431</ArticleId><ArticleId IdType=\"pubmed\">34589868</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A., Shoenfeld Y. Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic tachycardia syndrome, autoimmune diseases and autoimmune/inflammatory syndrome induced by adjuvants. Autoimmun. Rev. 2023;22:103230. doi: 10.1016/j.autrev.2022.103230.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2022.103230</ArticleId><ArticleId IdType=\"pubmed\">36347462</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C. Dyspnea in Post-COVID Syndrome following Mild Acute COVID-19 Infections: Potential Causes and Consequences for a Therapeutic Approach. Medicina. 2022;58:419. doi: 10.3390/medicina58030419.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina58030419</ArticleId><ArticleId IdType=\"pmc\">PMC8951558</ArticleId><ArticleId IdType=\"pubmed\">35334595</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C., Paul F. An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Transl. Med. 2021;19:471. doi: 10.1186/s12967-021-03143-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-021-03143-3</ArticleId><ArticleId IdType=\"pmc\">PMC8607226</ArticleId><ArticleId IdType=\"pubmed\">34809664</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M., Grabowski P., Heidecke H., Bauer S., Hanitsch L.G., Wittke K., Meisel C., Reinke P., Volk H.-D., Fluge &#xd8;., et al. Antibodies to &#x3b2; adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain Behav. Immun. 2016;52:32&#x2013;39. doi: 10.1016/j.bbi.2015.09.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2015.09.013</ArticleId><ArticleId IdType=\"pubmed\">26399744</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe N., Toyama H., Ejima Y., Saito K., Tamada T., Yamauchi M., Kazama I. &#x3b1;1-Adrenergic Receptor Blockade by Prazosin Synergistically Stabilizes Rat Peritoneal Mast Cells. BioMed Res. Int. 2020;2020:3214186. doi: 10.1155/2020/3214186.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2020/3214186</ArticleId><ArticleId IdType=\"pmc\">PMC7243011</ArticleId><ArticleId IdType=\"pubmed\">32461978</ArticleId></ArticleIdList></Reference><Reference><Citation>MC van Campen C., Rowe P.C., Visser F.C. Reductions in Cerebral Blood Flow Can Be Provoked by Sitting in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Healthcare. 2020;8:394. doi: 10.3390/healthcare8040394.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare8040394</ArticleId><ArticleId IdType=\"pmc\">PMC7712289</ArticleId><ArticleId IdType=\"pubmed\">33050553</ArticleId></ArticleIdList></Reference><Reference><Citation>Petra A.I., Panagiotidou S., Stewart J.M., Conti P., Theoharides T.C. Spectrum of mast cell activation disorders. Expert Rev. Clin. Immunol. 2014;10:729&#x2013;739. doi: 10.1586/1744666X.2014.906302.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1586/1744666X.2014.906302</ArticleId><ArticleId IdType=\"pubmed\">24784142</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Tsilioni I., Ren H. Recent advances in our understanding of mast cell activation&#x2014;Or should it be mast cell mediator disorders? Expert Rev. Clin. Immunol. 2019;15:639&#x2013;656. doi: 10.1080/1744666X.2019.1596800.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/1744666X.2019.1596800</ArticleId><ArticleId IdType=\"pmc\">PMC7003574</ArticleId><ArticleId IdType=\"pubmed\">30884251</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueff A., Dray A. Sensitization of peripheral afferent fibres in the in vitro neonatal rat spinal cord-tail by bradykinin and prostaglandins. Neuroscience. 1993;54:527&#x2013;535. doi: 10.1016/0306-4522(93)90272-H.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0306-4522(93)90272-H</ArticleId><ArticleId IdType=\"pubmed\">8336834</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.-J., Ahn Y.-C., Jang E.-S., Lee S.-W., Lee S.-H., Son C.-G. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) J. Transl. Med. 2020;18:100. doi: 10.1186/s12967-020-02269-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType=\"pmc\">PMC7038594</ArticleId><ArticleId IdType=\"pubmed\">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo L., Zhang Y., Huang T., Zhou F., Xiong C., Liu Y., Zhai P., Wang G., Tan J., Jiao C., et al. A description of the current status of chronic fatigue syndrome and associated factors among university students in Wuhan, China. Front. Psychiatry. 2022;13:1047014. doi: 10.3389/fpsyt.2022.1047014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fpsyt.2022.1047014</ArticleId><ArticleId IdType=\"pmc\">PMC9877457</ArticleId><ArticleId IdType=\"pubmed\">36713904</ArticleId></ArticleIdList></Reference><Reference><Citation>Deumer U.-S., Varesi A., Floris V., Savioli G., Mantovani E., L&#xf3;pez-Carrasco P., Rosati G.M., Prasad S., Ricevuti G. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview. J. Clin. Med. 2021;10:4786. doi: 10.3390/jcm10204786.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm10204786</ArticleId><ArticleId IdType=\"pmc\">PMC8538807</ArticleId><ArticleId IdType=\"pubmed\">34682909</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P., Giannetti M.P., Weller E., Hamilton M.J., Castells M. Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy. Ann. Allergy Asthma Immunol. 2021;128:299&#x2013;306.e1. doi: 10.1016/j.anai.2021.10.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.anai.2021.10.006</ArticleId><ArticleId IdType=\"pubmed\">34648976</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitag H., Szklarski M., Lorenz S., Sotzny F., Bauer S., Philippe A., Kedor C., Grabowski P., Lange T., Riemekasten G., et al. Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Clin. Med. 2021;10:3675. doi: 10.3390/jcm10163675.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm10163675</ArticleId><ArticleId IdType=\"pmc\">PMC8397061</ArticleId><ArticleId IdType=\"pubmed\">34441971</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., F&#xfc;rst J., Schulze-Rothe S., Wallukat A., H&#xf6;nicke A.-S., M&#xfc;ller J. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J. Transl. Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType=\"pmc\">PMC8049853</ArticleId><ArticleId IdType=\"pubmed\">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., David P., Arnheim D., Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun. Rev. 2022;21:103071. doi: 10.1016/j.autrev.2022.103071.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2022.103071</ArticleId><ArticleId IdType=\"pmc\">PMC8848724</ArticleId><ArticleId IdType=\"pubmed\">35182777</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczykowski C., Mardin C., Lucio M., Wallukat G., Hoffmanns J., Schr&#xf6;der T., Raith F., Rogge L., Heltmann F., Moritz M., et al. Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation. Int. J. Mol. Sci. 2022;23:7209. doi: 10.3390/ijms23137209.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23137209</ArticleId><ArticleId IdType=\"pmc\">PMC9266742</ArticleId><ArticleId IdType=\"pubmed\">35806214</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikkelsen E., Sakr A.M., Jespersen L.T. Studies on the Effect of Histamine in Isolated Human Pulmonary Arteries and Veins. Acta Pharmacol. Toxicol. 2009;54:86&#x2013;93. doi: 10.1111/j.1600-0773.1984.tb01900.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1600-0773.1984.tb01900.x</ArticleId><ArticleId IdType=\"pubmed\">6231804</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoeffter P., Godfraind T. Histamine Receptors in the Smooth Muscle of Human Internal Mammary Artery and Saphenous Vein. Basic Clin. Pharmacol. Toxicol. 1989;64:64&#x2013;71. doi: 10.1111/j.1600-0773.1989.tb00603.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1600-0773.1989.tb00603.x</ArticleId><ArticleId IdType=\"pubmed\">2755913</ArticleId></ArticleIdList></Reference><Reference><Citation>Diana J., Schwinghamer J., Young S. Direct effect of histamine on arterial and venous resistance in isolated dog hindlimb. Am. J. Physiol. Content. 1968;214:494&#x2013;505. doi: 10.1152/ajplegacy.1968.214.3.494.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajplegacy.1968.214.3.494</ArticleId><ArticleId IdType=\"pubmed\">5638981</ArticleId></ArticleIdList></Reference><Reference><Citation>Dachman W.D., Bedarida G., Blaschke T.F., Hoffman B.B. Histamine-induced venodilation in human beings involves both H1 and H2 receptor subtypes. J. Allergy Clin. Immunol. 1994;93:606&#x2013;614. doi: 10.1016/S0091-6749(94)70072-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0091-6749(94)70072-9</ArticleId><ArticleId IdType=\"pubmed\">8151062</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller-Schweinitzer E. On the pharmacology of venous smooth muscle from dog and man. Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. 1979;106:690&#x2013;704.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">94863</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuru H., Kohno S., Iwata M., Shigei T. Characterization of histamine receptors in isolated rabbit veins. Experiment. 1987;243:696&#x2013;702.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2960796</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergner M., Gr&#xe4;ser T., Handschuk L., Tiedt N. Vasomotor tone of isolated porcine coronary veins in response to acetylcholine, noradrenaline, and histamine. Biomed. Biochim. Acta. 1988;47:775&#x2013;779.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3240307</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshiuchi K., Farkas J., Natelson B.H. Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Clin. Physiol. Funct. Imaging. 2006;26:83&#x2013;86. doi: 10.1111/j.1475-097X.2006.00649.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1475-097X.2006.00649.x</ArticleId><ArticleId IdType=\"pubmed\">16494597</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen C.M.C., Rowe P.C., Visser F.C. Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients. Clin. Neurophysiol. Pract. 2021;6:245&#x2013;255. doi: 10.1016/j.cnp.2021.09.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cnp.2021.09.001</ArticleId><ArticleId IdType=\"pmc\">PMC8505270</ArticleId><ArticleId IdType=\"pubmed\">34667909</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan Z.Y., Barnden L.R., Kwiatek R.A., Bhuta S., Hermens D.F., Lagopoulos J. Neuroimaging characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A systematic review. J. Transl. Med. 2020;18:335. doi: 10.1186/s12967-020-02506-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-020-02506-6</ArticleId><ArticleId IdType=\"pmc\">PMC7466519</ArticleId><ArticleId IdType=\"pubmed\">32873297</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan Z.Y., Finegan K., Bhuta S., Ireland T., Staines D.R., Marshall-Gradisnik S.M., Barnden L.R. Brain function characteristics of chronic fatigue syndrome: A task fMRI study. NeuroImage Clin. 2018;19:279&#x2013;286. doi: 10.1016/j.nicl.2018.04.025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nicl.2018.04.025</ArticleId><ArticleId IdType=\"pmc\">PMC6051500</ArticleId><ArticleId IdType=\"pubmed\">30035022</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M., Sadato N., Okada T., Mizuno K., Sasabe T., Tanabe H.C., Saito D.N., Onoe H., Kuratsune H., Watanabe Y. Reduced responsiveness is an essential feature of chronic fatigue syndrome: A fMRI study. BMC Neurol. 2006;6:9. doi: 10.1186/1471-2377-6-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2377-6-9</ArticleId><ArticleId IdType=\"pmc\">PMC1397862</ArticleId><ArticleId IdType=\"pubmed\">16504053</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanasila L., Diviani D. Protein-Protein Interactions at the Adrenergic Receptors. Curr. Drug Targets. 2012;13:15&#x2013;27. doi: 10.2174/138945012798868489.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/138945012798868489</ArticleId><ArticleId IdType=\"pmc\">PMC3290771</ArticleId><ArticleId IdType=\"pubmed\">21777184</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoeijmakers J.G., Merkies I.S., Faber C.G. Small fiber neuropathies: Expanding their etiologies. Curr. Opin. Neurol. 2022;35:545&#x2013;552. doi: 10.1097/WCO.0000000000001103.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/WCO.0000000000001103</ArticleId><ArticleId IdType=\"pubmed\">35950732</ArticleId></ArticleIdList></Reference><Reference><Citation>Brag&#xe9;e B., Michos A., Drum B., Fahlgren M., Szulkin R., Bertilson B.C. Signs of Intracranial Hypertension, Hypermobility, and Craniocervical Obstructions in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front. Neurol. 2020;11:828. doi: 10.3389/fneur.2020.00828.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2020.00828</ArticleId><ArticleId IdType=\"pmc\">PMC7485557</ArticleId><ArticleId IdType=\"pubmed\">32982905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulens M., Bruyninckx F., Dankaerts W., Rasschaert R., De Mulder P., Stalmans I., Vansant G., Bervoets C. High Prevalence of Perineural Cysts in Patients with Fibromyalgia and Chronic Fatigue Syndrome. Pain Med. 2021;22:883&#x2013;890. doi: 10.1093/pm/pnaa410.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/pm/pnaa410</ArticleId><ArticleId IdType=\"pubmed\">33260218</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37240059</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>24</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>13</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Detection of Elevated Level of Tetrahydrobiopterin in Serum Samples of ME/CFS Patients with Orthostatic Intolerance: A Pilot Study.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">8713</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms24108713</ELocationID><Abstract><AbstractText>Myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) is a multisystem chronic illness characterized by severe muscle fatigue, pain, dizziness, and brain fog. Many patients with ME/CFS experience orthostatic intolerance (OI), which is characterized by frequent dizziness, light-headedness, and feeling faint while maintaining an upright posture. Despite intense investigation, the molecular mechanism of this debilitating condition is still unknown. OI is often manifested by cardiovascular alterations, such as reduced cerebral blood flow, reduced blood pressure, and diminished heart rate. The bioavailability of tetrahydrobiopterin (BH4), an essential cofactor of endothelial nitric oxide synthase (eNOS) enzyme, is tightly coupled with cardiovascular health and circulation. To explore the role of BH4 in ME/CFS, serum samples of CFS patients (<i>n</i> = 32), CFS patients with OI only (<i>n</i> = 10; CFS + OI), and CFS patients with both OI and small fiber polyneuropathy (<i>n</i> = 12; CFS + OI + SFN) were subjected to BH4 ELISA. Interestingly, our results revealed that the BH4 expression is significantly high in CFS, CFS + OI, and CFS + OI + SFN patients compared to age-/gender-matched controls. Finally, a ROS production assay in cultured microglial cells followed by Pearson correlation statistics indicated that the elevated BH4 in serum samples of CFS + OI patients might be associated with the oxidative stress response. These findings suggest that the regulation of BH4 metabolism could be a promising target for understanding the molecular mechanism of CFS and CFS with OI.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Gottschalk</LastName><ForeName>Carl Gunnar</ForeName><Initials>CG</Initials><Identifier Source=\"ORCID\">0000-0003-4229-2542</Identifier><AffiliationInfo><Affiliation>Simmaron Research Institute, 948 Incline Way, Incline Village, NV 89451, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Simmaron Research and Development Laboratory, Chemistry Building, University of Wisconsin-Milwaukee, 3210 N Cramer Street, Suite # 214, Milwaukee, WI 53211, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Whelan</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Simmaron Research Institute, 948 Incline Way, Incline Village, NV 89451, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Peterson</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Simmaron Research Institute, 948 Incline Way, Incline Village, NV 89451, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sierra Internal Medicine, 920 Incline Way, Incline Village, NV 89451, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Roy</LastName><ForeName>Avik</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Simmaron Research Institute, 948 Incline Way, Incline Village, NV 89451, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Simmaron Research and Development Laboratory, Chemistry Building, University of Wisconsin-Milwaukee, 3210 N Cramer Street, Suite # 214, Milwaukee, WI 53211, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>NA</GrantID><Agency>Fondation de Sibylla Hesse</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EGX657432I</RegistryNumber><NameOfSubstance UI=\"C003402\">sapropterin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D054971\" MajorTopicYN=\"Y\">Orthostatic Intolerance</DescriptorName><QualifierName UI=\"Q000150\" MajorTopicYN=\"N\">complications</QualifierName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D010865\" MajorTopicYN=\"N\">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D004244\" MajorTopicYN=\"N\">Dizziness</DescriptorName><QualifierName UI=\"Q000150\" MajorTopicYN=\"N\">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">ME/CFS</Keyword><Keyword MajorTopicYN=\"N\">endothelial NOS</Keyword><Keyword MajorTopicYN=\"N\">orthostatic intolerance</Keyword><Keyword MajorTopicYN=\"N\">reactive oxygen species</Keyword><Keyword MajorTopicYN=\"N\">small fiber polyneuropathy</Keyword><Keyword MajorTopicYN=\"N\">tetrahydrobiopterin</Keyword></KeywordList><CoiStatement>A.R., C.G.G., R.W. and D.P. are employees of Simmaron Research INC, a 501C non-profit research organization. The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37240059</ArticleId><ArticleId IdType=\"pmc\">PMC10218672</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms24108713</ArticleId><ArticleId IdType=\"pii\">ijms24108713</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lim E.J., Ahn Y.C., Jang E.S., Lee S.W., Lee S.H., Son C.G. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) J. Transl. Med. 2020;18:100. doi: 10.1186/s12967-020-02269-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType=\"pmc\">PMC7038594</ArticleId><ArticleId IdType=\"pubmed\">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Son C.-G. Review of the prevalence of chronic fatigue worldwide. J. Korean Med. 2012;33:25&#x2013;33.</Citation></Reference><Reference><Citation>Natelson B.H., Lin J.-M.S., Blate M., Khan S., Chen Y., Unger E.R. Physiological assessment of orthostatic intolerance in chronic fatigue syndrome. J. Transl. Med. 2022;20:95. doi: 10.1186/s12967-022-03289-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-022-03289-8</ArticleId><ArticleId IdType=\"pmc\">PMC8849016</ArticleId><ArticleId IdType=\"pubmed\">35172863</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L., Bested A.C., Bonilla H.F., Chheda B.V., Chu L., Curtin J.M., Dempsey T.T., Dimmock M.E., Dowell T.G., Felsenstein D. Mayo Clinic Proceedings. Elsevier; Amsterdam, The Netherlands: 2021. Myalgic encephalomyelitis/chronic fatigue syndrome: Essentials of diagnosis and management; pp. 2861&#x2013;2878.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Basantsova N.Y., Starshinova A.A., Dori A., Zinchenko Y.S., Yablonskiy P.K., Shoenfeld Y. Small-fiber neuropathy definition, diagnosis, and treatment. Neurol. Sci. 2019;40:1343&#x2013;1350. doi: 10.1007/s10072-019-03871-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10072-019-03871-x</ArticleId><ArticleId IdType=\"pubmed\">30968230</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoenfeld Y., Ryabkova V.A., Scheibenbogen C., Brinth L., Martinez-Lavin M., Ikeda S., Heidecke H., Watad A., Bragazzi N.L., Chapman J. Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy. Clin. Immunol. 2020;214:108384. doi: 10.1016/j.clim.2020.108384.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.clim.2020.108384</ArticleId><ArticleId IdType=\"pubmed\">32171889</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi L., Adam C., Beaudonnet G., Beauvais D., Cauquil C., Not A., Morassi O., Benmalek A., Trassard O., Echaniz-Laguna A., et al. Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis. Eur. J. Neurol. 2022;29:1477&#x2013;1487. doi: 10.1111/ene.15268.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/ene.15268</ArticleId><ArticleId IdType=\"pubmed\">35100482</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinose H., Nomura T., Sumi-Ichinose C. Metabolism of tetrahydrobiopterin: Its relevance in monoaminergic neurons and neurological disorders. Chem. Rec. 2008;8:378&#x2013;385. doi: 10.1002/tcr.20166.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/tcr.20166</ArticleId><ArticleId IdType=\"pubmed\">19107867</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia T., Gray D.W., Shiman R. Regulation of rat liver phenylalanine hydroxylase. III. Control of catalysis by (6R)-tetrahydrobiopterin and phenylalanine. J. Biol. Chem. 1994;269:24657&#x2013;24665. doi: 10.1016/S0021-9258(17)31441-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0021-9258(17)31441-2</ArticleId><ArticleId IdType=\"pubmed\">7929137</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagatsu T., Nagatsu I. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson&#x2019;s disease (PD): Historical overview and future prospects. J. Neural Transm. 2016;123:1255&#x2013;1278. doi: 10.1007/s00702-016-1596-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00702-016-1596-4</ArticleId><ArticleId IdType=\"pubmed\">27491309</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada M., Sugimoto T., Matsuura S., Nagatsu T. (6R)-Tetrahydrobiopterin increases the activity of tryptophan hydroxylase in rat raphe slices. J. Neurochem. 1986;47:1544&#x2013;1547. doi: 10.1111/j.1471-4159.1986.tb00792.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1471-4159.1986.tb00792.x</ArticleId><ArticleId IdType=\"pubmed\">3489816</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D.-D., Chen L.-Y., Xie J.-B., Shu C., Yang T., Zhou S., Yuan H., Chen A.F. Tetrahydrobiopterin regulation of eNOS redox function. Curr. Pharm. Des. 2014;20:3554&#x2013;3562. doi: 10.2174/13816128113196660747.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/13816128113196660747</ArticleId><ArticleId IdType=\"pubmed\">24180387</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashi Y., Sasaki S., Nakagawa K., Kimura M., Noma K., Hara K., Jitsuiki D., Goto C., Oshima T., Chayama K. Tetrahydrobiopterin improves aging-related impairment of endothelium-dependent vasodilation through increase in nitric oxide production. Atherosclerosis. 2006;186:390&#x2013;395. doi: 10.1016/j.atherosclerosis.2005.07.025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.atherosclerosis.2005.07.025</ArticleId><ArticleId IdType=\"pubmed\">16129443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W.Z., Fang X.H., Stephenson L.L., Khiabani K.T., Zamboni W.A. Effects of supplementation of BH4 after prolonged ischemia in skeletal muscle. Microsurgery. 2007;27:200&#x2013;205. doi: 10.1002/micr.20331.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/micr.20331</ArticleId><ArticleId IdType=\"pubmed\">17326224</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.-M., Huang A., Kaley G., Sun D. eNOS uncoupling and endothelial dysfunction in aged vessels. Am. J. Physiol.-Heart Circ. Physiol. 2009;297:H1829&#x2013;H1836. doi: 10.1152/ajpheart.00230.2009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpheart.00230.2009</ArticleId><ArticleId IdType=\"pmc\">PMC2781386</ArticleId><ArticleId IdType=\"pubmed\">19767531</ArticleId></ArticleIdList></Reference><Reference><Citation>Karbach S., Wenzel P., Waisman A., Munzel T., Daiber A. eNOS uncoupling in cardiovascular diseases-the role of oxidative stress and inflammation. Curr. Pharm. Des. 2014;20:3579&#x2013;3594. doi: 10.2174/13816128113196660748.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/13816128113196660748</ArticleId><ArticleId IdType=\"pubmed\">24180381</ArticleId></ArticleIdList></Reference><Reference><Citation>Sindler A.L., Delp M.D., Reyes R., Wu G., Muller-Delp J.M. Effects of ageing and exercise training on eNOS uncoupling in skeletal muscle resistance arterioles. J. Physiol. 2009;587:3885&#x2013;3897. doi: 10.1113/jphysiol.2009.172221.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1113/jphysiol.2009.172221</ArticleId><ArticleId IdType=\"pmc\">PMC2746616</ArticleId><ArticleId IdType=\"pubmed\">19528246</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottschalk G., Peterson D., Knox K., Maynard M., Whelan R.J., Roy A. Elevated ATG13 in serum of patients with ME/CFS stimulates oxidative stress response in microglial cells via activation of receptor for advanced glycation end products (RAGE) Mol. Cell. Neurosci. 2022;120:103731. doi: 10.1016/j.mcn.2022.103731.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mcn.2022.103731</ArticleId><ArticleId IdType=\"pubmed\">35487443</ArticleId></ArticleIdList></Reference><Reference><Citation>Blau N., Thony B., Spada M., Ponzone A. Tetrahydrobiopterin and inherited hyperphenylalaninemias. Turk. J. Pediatr. 1996;38:19&#x2013;35.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8819618</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnbacher R., Scheibenreiter S., Blau N., Bieglmayer C., Frisch H., Waldhauser F. Hyperprolactinemia, a tool in treatment control of tetrahydrobiopterin deficiency: Endocrine studies in an affected girl. Pediatr. Res. 1998;43:472&#x2013;477. doi: 10.1203/00006450-199804000-00006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1203/00006450-199804000-00006</ArticleId><ArticleId IdType=\"pubmed\">9545000</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyland K., Kasim S., Egami K., Arnold L., Jinnah H. Tetrahydrobiopterin deficiency and dopamine loss in a genetic mouse model of Lesch-Nyhan disease. J. Inherit. Metab. Dis. 2004;27:165&#x2013;178. doi: 10.1023/B:BOLI.0000028728.93113.4d.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1023/B:BOLI.0000028728.93113.4d</ArticleId><ArticleId IdType=\"pubmed\">15159647</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Chen W., Rezvan A., Jo H., Harrison D.G. Tetrahydrobiopterin deficiency and nitric oxide synthase uncoupling contribute to atherosclerosis induced by disturbed flow. Arterioscler. Thromb. Vasc. Biol. 2011;31:1547&#x2013;1554. doi: 10.1161/ATVBAHA.111.226456.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/ATVBAHA.111.226456</ArticleId><ArticleId IdType=\"pmc\">PMC3117114</ArticleId><ArticleId IdType=\"pubmed\">21512164</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuaiphichai S., Starr A., Nandi M., Channon K.M., McNeill E. Endothelial cell tetrahydrobiopterin deficiency attenuates LPS-induced vascular dysfunction and hypotension. Vasc. Pharmacol. 2016;77:69&#x2013;79. doi: 10.1016/j.vph.2015.08.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.vph.2015.08.009</ArticleId><ArticleId IdType=\"pmc\">PMC4746318</ArticleId><ArticleId IdType=\"pubmed\">26276526</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H.J., Lee S.Y., Cho Y., No H., Kim S.W., Hwang O. Tetrahydrobiopterin causes mitochondrial dysfunction in dopaminergic cells: Implications for Parkinson&#x2019;s disease. Neurochem. Int. 2006;48:255&#x2013;262. doi: 10.1016/j.neuint.2005.10.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuint.2005.10.011</ArticleId><ArticleId IdType=\"pubmed\">16343695</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.Y., Moon Y., Hee Choi D., Jin Choi H., Hwang O. Particular vulnerability of rat mesencephalic dopaminergic neurons to tetrahydrobiopterin: Relevance to Parkinson&#x2019;s disease. Neurobiol. Dis. 2007;25:112&#x2013;120. doi: 10.1016/j.nbd.2006.08.024.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2006.08.024</ArticleId><ArticleId IdType=\"pubmed\">17049260</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak S.S., Suk J., Choi J.H., Yang S., Kim J.W., Sohn S., Chung J.H., Hong Y.H., Lee D.H., Ahn J.K., et al. Autophagy induction by tetrahydrobiopterin deficiency. Autophagy. 2011;7:1323&#x2013;1334. doi: 10.4161/auto.7.11.16627.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4161/auto.7.11.16627</ArticleId><ArticleId IdType=\"pmc\">PMC3242797</ArticleId><ArticleId IdType=\"pubmed\">21795851</ArticleId></ArticleIdList></Reference><Reference><Citation>Porkert M., Sher S., Reddy U., Cheema F., Niessner C., Kolm P., Jones D.P., Hooper C., Taylor W.R., Harrison D., et al. Tetrahydrobiopterin: A novel antihypertensive therapy. J. Hum. Hypertens. 2008;22:401&#x2013;407. doi: 10.1038/sj.jhh.1002329.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sj.jhh.1002329</ArticleId><ArticleId IdType=\"pubmed\">18322548</ArticleId></ArticleIdList></Reference><Reference><Citation>Channon K. Tetrahydrobiopterin: Regulator of Endothelial Nitric Oxide Synthase in Vascular Disease. Trends Cardiovasc. Med. 2004;14:323&#x2013;327. doi: 10.1016/j.tcm.2004.10.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tcm.2004.10.003</ArticleId><ArticleId IdType=\"pubmed\">15596110</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y., Feng Y., Gu L., Liu P., Cao J., Zhang S. The Critical Role of Tetrahydrobiopterin (BH4) Metabolism in Modulating Radiosensitivity: BH4/NOS Axis as an Angel or a Devil. Front. Oncol. 2021;11:720632. doi: 10.3389/fonc.2021.720632.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fonc.2021.720632</ArticleId><ArticleId IdType=\"pmc\">PMC8429800</ArticleId><ArticleId IdType=\"pubmed\">34513700</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano A.H., Maya J., Giloteaux L., Peterson D.L., Maynard M., Gottschalk C.G., Hanson M.R. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J. Clin. Investig. 2020;130:1491&#x2013;1505. doi: 10.1172/JCI132185.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI132185</ArticleId><ArticleId IdType=\"pmc\">PMC7269566</ArticleId><ArticleId IdType=\"pubmed\">31830003</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37234076</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>28</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">2673-6861</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>4</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in rehabilitation sciences</Title><ISOAbbreviation>Front Rehabil Sci</ISOAbbreviation></Journal><ArticleTitle>Female reproductive health impacts of Long COVID and associated illnesses including ME/CFS, POTS, and connective tissue disorders: a literature review.</ArticleTitle><Pagination><StartPage>1122673</StartPage><MedlinePgn>1122673</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">1122673</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3389/fresc.2023.1122673</ELocationID><Abstract><AbstractText>Long COVID disproportionately affects premenopausal women, but relatively few studies have examined Long COVID\\'s impact on female reproductive health. We conduct a review of the literature documenting the female reproductive health impacts of Long COVID which may include disruptions to the menstrual cycle, gonadal function, ovarian sufficiency, menopause, and fertility, as well as symptom exacerbation around menstruation. Given limited research, we also review the reproductive health impacts of overlapping and associated illnesses including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS), connective tissue disorders like Ehlers-Danlos syndrome (EDS), and endometriosis, as these illnesses may help to elucidate reproductive health conditions in Long COVID. These associated illnesses, whose patients are 70%-80% women, have increased rates of dysmenorrhea, amenorrhea, oligomenorrhea, dyspareunia, endometriosis, infertility, vulvodynia, intermenstrual bleeding, ovarian cysts, uterine fibroids and bleeding, pelvic congestion syndrome, gynecological surgeries, and adverse pregnancy complications such as preeclampsia, maternal mortality, and premature birth. Additionally, in Long COVID and associated illnesses, symptoms can be impacted by the menstrual cycle, pregnancy, and menopause. We propose priorities for future research and reproductive healthcare in Long COVID based on a review of the literature. These include screening Long COVID patients for comorbid and associated conditions; studying the impacts of the menstrual cycle, pregnancy, and menopause on symptoms and illness progression; uncovering the role of sex differences and sex hormones in Long COVID and associated illnesses; and addressing historical research and healthcare inequities that have contributed to detrimental knowledge gaps for this patient population.</AbstractText><CopyrightInformation>&#xa9; 2023 Pollack, von Saltza, McCorkell, Santos, Hultman, Cohen and Soares.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Pollack</LastName><ForeName>Beth</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>von Saltza</LastName><ForeName>Emelia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative, Washington, DC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>McCorkell</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative, Washington, DC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Santos</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative, Washington, DC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hultman</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative, Washington, DC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cohen</LastName><ForeName>Alison K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative, Washington, DC, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology &amp; Biostatistics, School of Medicine, University of California, San Francisco, San Francisco, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Soares</LastName><ForeName>Let&#xed;cia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative, Washington, DC, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Rehabil Sci</MedlineTA><NlmUniqueID>9918227358906676</NlmUniqueID><ISSNLinking>2673-6861</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Ehlers-Danlos sydrome</Keyword><Keyword MajorTopicYN=\"N\">Long COVID</Keyword><Keyword MajorTopicYN=\"N\">endometriosis</Keyword><Keyword MajorTopicYN=\"N\">female</Keyword><Keyword MajorTopicYN=\"N\">myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN=\"N\">post-acute sequalae of SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN=\"N\">postural orthostatic tachycardia syndrome</Keyword><Keyword MajorTopicYN=\"N\">reproductive health</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>26</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>26</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>26</Day><Hour>12</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37234076</ArticleId><ArticleId IdType=\"pmc\">PMC10208411</ArticleId><ArticleId IdType=\"doi\">10.3389/fresc.2023.1122673</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a delphi consensus. Lancet Infect Dis. (2022) 22:e102&#x2013;7. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType=\"pmc\">PMC8691845</ArticleId><ArticleId IdType=\"pubmed\">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType=\"pmc\">PMC8280690</ArticleId><ArticleId IdType=\"pubmed\">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType=\"pmc\">PMC9839201</ArticleId><ArticleId IdType=\"pubmed\">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Campen CM, Rowe PC, Visser FC. Orthostatic symptoms and reductions in cerebral blood flow in long-haul COVID-19 patients: similarities with myalgic encephalomyelitis/chronic fatigue syndrome. Medicina (Mex). (2022) 58:28. 10.3390/medicina58010028</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina58010028</ArticleId><ArticleId IdType=\"pmc\">PMC8778312</ArticleId><ArticleId IdType=\"pubmed\">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. (2022) 28:911&#x2013;23. 10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType=\"pubmed\">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. (2021) 12:698169. Available at:\\nhttps://www.frontiersin.org/articles/10.3389/fmicb.2021.698169\\n(Accessed November 18, 2022). 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType=\"doi\">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType=\"pmc\">PMC8260991</ArticleId><ArticleId IdType=\"pubmed\">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. (2021) 20:172. 10.1186/s12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType=\"pmc\">PMC8381139</ArticleId><ArticleId IdType=\"pubmed\">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, et al. Long COVID in adults discharged from UK hospitals after COVID-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health&#x2014;Eur. (2021) 8:100186. 10.1016/j.lanepe.2021.100186</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType=\"pmc\">PMC8343377</ArticleId><ArticleId IdType=\"pubmed\">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID&#x2014;Household Pulse Survey&#x2014;COVID-19. (2022). Available at:\\nhttps://www.cdc.gov/nchs/covid19/pulse/long-covid.htm\\n(Accessed December 2, 2022).</Citation></Reference><Reference><Citation>Stewart S, Newson L, Briggs TA, Grammatopoulos D, Young L, Gill P. Long COVID risk&#x2014;a signal to address sex hormones and women\\'s Health. Lancet Reg Health Eur. (2021) 11:100242. 10.1016/j.lanepe.2021.100242</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.lanepe.2021.100242</ArticleId><ArticleId IdType=\"pmc\">PMC8561426</ArticleId><ArticleId IdType=\"pubmed\">34746909</ArticleId></ArticleIdList></Reference><Reference><Citation>Low PA, Sandroni P, Joyner M, Shen W-K. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol. (2009) 20:352&#x2013;8. 10.1111/j.1540-8167.2008.01407.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1540-8167.2008.01407.x</ArticleId><ArticleId IdType=\"pmc\">PMC3904426</ArticleId><ArticleId IdType=\"pubmed\">19207771</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, et al. A community-based study of chronic fatigue syndrome. Arch Intern Med. (1999) 159:2129&#x2013;37. 10.1001/archinte.159.18.2129</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archinte.159.18.2129</ArticleId><ArticleId IdType=\"pubmed\">10527290</ArticleId></ArticleIdList></Reference><Reference><Citation>Demmler JC, Atkinson MD, Reinhold EJ, Choy E, Lyons RA, Brophy ST. Diagnosed prevalence of ehlers-danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case&#x2013;control comparison. BMJ Open. (2019) 9:e031365. 10.1136/bmjopen-2019-031365</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmjopen-2019-031365</ArticleId><ArticleId IdType=\"pmc\">PMC6858200</ArticleId><ArticleId IdType=\"pubmed\">31685485</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlow SD, Campbell OMR. Epidemiology of menstrual disorders in developing countries: a systematic review. BJOG Int J Obstet Gynaecol. (2004) 111:6&#x2013;16. 10.1111/j.1471-0528.2004.00012.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1471-0528.2004.00012.x</ArticleId><ArticleId IdType=\"pubmed\">14687045</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirin AA. Gender disparity in the funding of diseases by the U.S. National institutes of health. J Womens Health. (2021) 30:956&#x2013;63. 10.1089/jwh.2020.8682</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/jwh.2020.8682</ArticleId><ArticleId IdType=\"pmc\">PMC8290307</ArticleId><ArticleId IdType=\"pubmed\">33232627</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisman CS, Cassard SD. Health consequences of exclusion or underrepresentation of women in clinical studies (I). Washington (DC): National Academies Press (US) (1999. Available at:\\nhttps://www.ncbi.nlm.nih.gov/books/NBK236583/\\n(Accessed December 12, 2022).</Citation></Reference><Reference><Citation>Newson L, Lewis R, O&#x2019;Hara M. Long COVID and menopause&#x2014;the important role of hormones in long COVID must be considered. Maturitas. (2021) 152:74. 10.1016/j.maturitas.2021.08.026</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.maturitas.2021.08.026</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina-Perucha L, L&#xf3;pez-Jim&#xe9;nez T, Holst AS, Jacques-Avi&#xf1;&#xf3; C, Munr&#xf3;s-Feliu J, Mart&#xed;nez-Bueno C, et al. Self-reported menstrual alterations during the COVID-19 syndemic in Spain: a cross-sectional study. Int J Womens Health. (2022) 14:529&#x2013;44. 10.2147/IJWH.S354655</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/IJWH.S354655</ArticleId><ArticleId IdType=\"pmc\">PMC9013667</ArticleId><ArticleId IdType=\"pubmed\">35444473</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan SM, Shilen A, Heslin KM, Ishimwe P, Allen AM, Jacobs ET, et al. SARS-CoV-2 infection and subsequent changes in the menstrual cycle among participants in the Arizona CoVHORT study. Am J Obstet Gynecol. (2022) 226:270&#x2013;3. 10.1016/j.ajog.2021.09.016</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajog.2021.09.016</ArticleId><ArticleId IdType=\"pmc\">PMC8452349</ArticleId><ArticleId IdType=\"pubmed\">34555320</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvergne A, Kountourides G, Argentieri MA, Agyen L, Rogers N, Knight D, et al. A retrospective case-control study on menstrual cycle changes following COVID-19 vaccination and disease. iScience. (2023) 26:106401. 10.1016/j.isci.2023.106401</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.isci.2023.106401</ArticleId><ArticleId IdType=\"pmc\">PMC10015085</ArticleId><ArticleId IdType=\"pubmed\">36987520</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KMN, Junkins EJ, Luo C, Fatima UA, Cox ML, Clancy KBH. Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination. Sci Adv. (2022) 8:eabm7201. 10.1126/sciadv.abm7201</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/sciadv.abm7201</ArticleId><ArticleId IdType=\"pmc\">PMC9286513</ArticleId><ArticleId IdType=\"pubmed\">35857495</ArticleId></ArticleIdList></Reference><Reference><Citation>Madaan S, Talwar D, Jaiswal A, Kumar S, Acharya N, Acharya S, et al. Post-COVID-19 menstrual abnormalities and infertility: repercussions of the pandemic. J Educ Health Promot. (2022) 11:170. 10.4103/jehp.jehp_1200_21</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/jehp.jehp_1200_21</ArticleId><ArticleId IdType=\"pmc\">PMC9277727</ArticleId><ArticleId IdType=\"pubmed\">35847136</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins J, Al-Inizi S. Premature ovarian insufficiency secondary to COVID-19 infection: an original case report. Int J Gynecol Obstet. (2021) 154:179&#x2013;80. 10.1002/ijgo.13719</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ijgo.13719</ArticleId><ArticleId IdType=\"pmc\">PMC9087667</ArticleId><ArticleId IdType=\"pubmed\">33896002</ArticleId></ArticleIdList></Reference><Reference><Citation>Puca E, Puca E. Premature ovarian failure related to SARS-CoV-2 infection. J Med Cases. (2022) 13:155&#x2013;8. 10.14740/jmc3791</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14740/jmc3791</ArticleId><ArticleId IdType=\"pmc\">PMC8993449</ArticleId><ArticleId IdType=\"pubmed\">35464328</ArticleId></ArticleIdList></Reference><Reference><Citation>Revelli A, Piane LD, Casano S, Molinari E, Massobrio M, Rinaudo P. Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol. (2009) 7:40. 10.1186/1477-7827-7-40</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1477-7827-7-40</ArticleId><ArticleId IdType=\"pmc\">PMC2685803</ArticleId><ArticleId IdType=\"pubmed\">19413899</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero Y, Pascuali N, Vel&#xe1;zquez C, Oubi&#xf1;a G, Hauk V, de Z&#xfa;&#xf1;iga I, et al. SARS-CoV-2 infection negatively affects ovarian function in ART patients. Biochim Biophys Acta &#x2014;Mol Basis Dis. (2022) 1868:166295. 10.1016/j.bbadis.2021.166295</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2021.166295</ArticleId><ArticleId IdType=\"pmc\">PMC8550892</ArticleId><ArticleId IdType=\"pubmed\">34718118</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas. (2010) 65:161&#x2013;6. 10.1016/j.maturitas.2009.08.003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.maturitas.2009.08.003</ArticleId><ArticleId IdType=\"pmc\">PMC2815011</ArticleId><ArticleId IdType=\"pubmed\">19733988</ArticleId></ArticleIdList></Reference><Reference><Citation>Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition*. Hum Reprod. (2003) 18:199&#x2013;206. 10.1093/humrep/deg005</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/humrep/deg005</ArticleId><ArticleId IdType=\"pubmed\">12525467</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe1;sconez-Gonz&#xe1;lez J, Fernandez-Naranjo R, Izquierdo-Condoy JS, Delgado-Moreira K, Cordovez S, Tello-De-la-Torre A, et al. Comparative analysis of long-term self-reported COVID-19 symptoms among pregnant women. J Infect Public Health. (2023) 16:430&#x2013;40. 10.1016/j.jiph.2023.01.012</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jiph.2023.01.012</ArticleId><ArticleId IdType=\"pmc\">PMC9851727</ArticleId><ArticleId IdType=\"pubmed\">36736066</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshar Y, Gaw SL, Flaherman VJ, Chambers BD, Krakow D, Berghella V, et al. Clinical presentation of coronavirus disease 2019 (COVID-19) in pregnant and recently pregnant people. Obstet Gynecol. (2020) 136:1117&#x2013;25. 10.1097/AOG.0000000000004178</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/AOG.0000000000004178</ArticleId><ArticleId IdType=\"pmc\">PMC7673633</ArticleId><ArticleId IdType=\"pubmed\">33027186</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos CAD, Fonseca Filho GG, Alves MM, Macedo EYL, Pontes MdA, Paula AP, et al. Maternal and neonatal outcomes associated with mild COVID-19 infection in an obstetric cohort in Brazil. Am J Trop Med Hyg. (2022) 107:1060&#x2013;5. 10.4269/ajtmh.22-0421</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4269/ajtmh.22-0421</ArticleId><ArticleId IdType=\"pmc\">PMC9709018</ArticleId><ArticleId IdType=\"pubmed\">36252801</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Funk S, Bateman L, Stoddard GJ, Hammer S, Sullivan K, et al. Orthostatic challenge causes distinctive symptomatic, hemodynamic and cognitive responses in long COVID and myalgic encephalomyelitis/chronic fatigue syndrome. Front Med. (2022) 9:917019. 10.3389/fmed.2022.917019</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmed.2022.917019</ArticleId><ArticleId IdType=\"pmc\">PMC9285104</ArticleId><ArticleId IdType=\"pubmed\">35847821</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. (2022) 13:5104. 10.1038/s41467-022-32507-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType=\"pmc\">PMC9426365</ArticleId><ArticleId IdType=\"pubmed\">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini DM, Brunjes DL, Lala A, Trivieri MG, Contreras JP, Natelson BH. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post&#x2013;coronavirus disease. JACC Heart Fail. (2021) 9:927&#x2013;37. 10.1016/j.jchf.2021.10.002</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType=\"pmc\">PMC8629098</ArticleId><ArticleId IdType=\"pubmed\">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw BH, Stiles LE, Bourne K, Green EA, Shibao CA, Okamoto LE, et al. The face of postural tachycardia syndrome&#x2014;insights from a large cross-sectional online community-based survey. J Intern Med. (2019) 286:438&#x2013;48. 10.1111/joim.12895</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/joim.12895</ArticleId><ArticleId IdType=\"pmc\">PMC6790699</ArticleId><ArticleId IdType=\"pubmed\">30861229</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. (2011) 270:327&#x2013;38. 10.1111/j.1365-2796.2011.02428.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType=\"pmc\">PMC3427890</ArticleId><ArticleId IdType=\"pubmed\">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L, Valencia IJ, Garvert DW, Montoya JG. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. (2019) 7:12. 10.3389/fped.2019.00012</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2019.00012</ArticleId><ArticleId IdType=\"pmc\">PMC6370741</ArticleId><ArticleId IdType=\"pubmed\">30805319</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas N, Gurvich C, Huang K, Gooley PR, Armstrong CW. The underlying sex differences in neuroendocrine adaptations relevant to myalgic encephalomyelitis chronic fatigue syndrome. Front Neuroendocrinol. (2022) 66:100995. 10.1016/j.yfrne.2022.100995</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.yfrne.2022.100995</ArticleId><ArticleId IdType=\"pubmed\">35421511</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlow BL, Signorello LB, Hall JE, Dailey C, Komaroff AL. Reproductive correlates of chronic fatigue syndrome. Am J Med. (1998) 105:94S&#x2013;9S. 10.1016/s0002-9343(98)00173-9</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s0002-9343(98)00173-9</ArticleId><ArticleId IdType=\"pubmed\">9790489</ArticleId></ArticleIdList></Reference><Reference><Citation>Boneva RS, Maloney EM, Lin J-M, Jones JF, Wieser F, Nater UM, et al. Gynecological history in chronic fatigue syndrome: a population-based case-control study | journal of Women\\'s health. J Womens Health. (2011) 20:21&#x2013;8. 10.1089/jwh.2009.1900</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/jwh.2009.1900</ArticleId><ArticleId IdType=\"pmc\">PMC3017420</ArticleId><ArticleId IdType=\"pubmed\">21091051</ArticleId></ArticleIdList></Reference><Reference><Citation>Boneva RS, Lin J-MS, Unger ER. Early menopause and other gynecologic risk indicators for chronic fatigue syndrome in women. Menopause. (2015) 22:826&#x2013;34. 10.1097/GME.0000000000000411</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/GME.0000000000000411</ArticleId><ArticleId IdType=\"pmc\">PMC5745581</ArticleId><ArticleId IdType=\"pubmed\">25647777</ArticleId></ArticleIdList></Reference><Reference><Citation>Boneva RS, Lin J-MS, Wieser F, Nater UM, Ditzen B, Taylor RN, et al. Endometriosis as a comorbid condition in chronic fatigue syndrome (CFS): secondary analysis of data from a CFS case-control study. Front Pediatr. (2019) 7:195. 10.3389/fped.2019.00195</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2019.00195</ArticleId><ArticleId IdType=\"pmc\">PMC6537603</ArticleId><ArticleId IdType=\"pubmed\">31179251</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark K, Del Fante P, Beilby J. Myalgic Encephalopathy/Chronic Fatigue Syndrome Longitudinal Outcomes Pilot Study Report. (2006)\\nhttp://sacfs.asn.au/download/me_cfs_pilot_study_report.pdf</Citation></Reference><Reference><Citation>Gimeno Pi I, Guitard Sein-Echaluce ML, Rossell&#xf3; Aubach L, Torres Puig-Gros J, Fern&#xe1;ndez Sol&#xe0; J. Stressful events in the onset of chronic fatigue syndrome. Rev Esp Salud Publica. (2016) 90:e1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27535808</ArticleId></ArticleIdList></Reference><Reference><Citation>Hira R, Baker JR, Siddiqui T, Ranada SI, Soroush A, Karalasingham K, et al. Objective hemodynamic cardiovascular autonomic abnormalities in post-acute sequelae of COVID-19. Can J Cardiol. (2022) 0. 10.1016/j.cjca.2022.12.002. (In press)</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cjca.2022.12.002</ArticleId><ArticleId IdType=\"pmc\">PMC9733966</ArticleId><ArticleId IdType=\"pubmed\">36509178</ArticleId></ArticleIdList></Reference><Reference><Citation>Federowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J Intern Med. (2018) 285:352&#x2013;66. 10.1111/joim.12852</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/joim.12852</ArticleId><ArticleId IdType=\"pubmed\">30372565</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q, VanGundy TB, Shibata S, Auchus RJ, Williams GH, Levine BD. Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome. Hypertension. (2010) 56:82&#x2013;90. 10.1161/HYPERTENSIONAHA.110.151787</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/HYPERTENSIONAHA.110.151787</ArticleId><ArticleId IdType=\"pmc\">PMC2894615</ArticleId><ArticleId IdType=\"pubmed\">20479333</ArticleId></ArticleIdList></Reference><Reference><Citation>Peggs KJ, Nguyen H, Enayat D, Keller NR, Al-Hendy A, Raj SR. Gynecologic disorders and menstrual cycle lightheadedness in postural tachycardia syndrome. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. (2012) 118:242&#x2013;6. 10.1016/j.ijgo.2012.04.014</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijgo.2012.04.014</ArticleId><ArticleId IdType=\"pmc\">PMC3413773</ArticleId><ArticleId IdType=\"pubmed\">22721633</ArticleId></ArticleIdList></Reference><Reference><Citation>Knuttinen M-G, Zurcher KS, Khurana N, Patel I, Foxx-Orenstein A, Harris LA, et al. Imaging findings of pelvic venous insufficiency in patients with postural orthostatic tachycardia syndrome. Phlebology. (2021) 36:32&#x2013;7. 10.1177/0268355520947610</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0268355520947610</ArticleId><ArticleId IdType=\"pubmed\">32757696</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourne KM, Nerenberg KA, Stiles LE, Shibao CA, Okamoto LE, Garland EM, et al. Symptoms of postural orthostatic tachycardia syndrome in pregnancy: a cross-sectional, community-based survey. BJOG Int J Obstet Gynaecol. (2023). 10.1111/1471-0528.17437. (In press)</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/1471-0528.17437</ArticleId><ArticleId IdType=\"pubmed\">36908200</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S, Poya H, Bett GCL. Pregnancy in postural tachycardia syndrome: clinical course and maternal and fetal outcomes. J Matern Fetal Neonatal Med. (2012) 25:1631&#x2013;4. 10.3109/14767058.2011.648671</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/14767058.2011.648671</ArticleId><ArticleId IdType=\"pubmed\">22185354</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Outcomes of pregnancy in patients with preexisting postural tachycardia syndrome. Pacing Clin Electrophysiol. (2009) 32:1000&#x2013;3. 10.1111/j.1540-8159.2009.02430.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1540-8159.2009.02430.x</ArticleId><ArticleId IdType=\"pubmed\">19659618</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zang C, Xu Z, Zhang Y, Xu J, Bian J, et al. Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat Med. (2023) 29:226&#x2013;35. 10.1038/s41591-022-02116-3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-022-02116-3</ArticleId><ArticleId IdType=\"pmc\">PMC9873564</ArticleId><ArticleId IdType=\"pubmed\">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. New ICD-10CM code for the 2019 Novel Coronavirus (COVID-19), December 3, 2020. (2021)\\nhttps://www.cdc.gov/nchs/data/icd/Announcement-New-ICD-code-for-coronavirus-19-508.pdf</Citation></Reference><Reference><Citation>Gavrilova N, Soprun L, Lukashenko M, Ryabkova V, Fedotkina TV, Churilov LP, et al. New clinical phenotype of the post-COVID syndrome: fibromyalgia and joint hypermobility condition. Pathophysiology. (2022) 29:24&#x2013;9. 10.3390/pathophysiology29010003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pathophysiology29010003</ArticleId><ArticleId IdType=\"pmc\">PMC8954589</ArticleId><ArticleId IdType=\"pubmed\">35366287</ArticleId></ArticleIdList></Reference><Reference><Citation>Gensemer C, Burks R, Kautz S, Judge DP, Lavallee M, Norris RA. Hypermobile ehlers-danlos syndromes: complex phenotypes, challenging diagnoses, and poorly understood causes. Dev Dyn Off Publ Am Assoc Anat. (2021) 250:318&#x2013;44. 10.1002/dvdy.220</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/dvdy.220</ArticleId><ArticleId IdType=\"pmc\">PMC7785693</ArticleId><ArticleId IdType=\"pubmed\">32629534</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AJ, Stiles LE, Sheehan T, Bascom R, Levy HP, Francomano CA, et al. Prevalence of hypermobile ehlers-danlos syndrome in postural orthostatic tachycardia syndrome. Auton Neurosci. (2020) 224:102637. 10.1016/j.autneu.2020.102637.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autneu.2020.102637.</ArticleId><ArticleId IdType=\"pmc\">PMC7282488</ArticleId><ArticleId IdType=\"pubmed\">31954224</ArticleId></ArticleIdList></Reference><Reference><Citation>Brag&#xe9;e B, Michos A, Drum B, Fahlgren M, Szulkin R, Bertilson BC. Signs of intracranial hypertension, hypermobility, and craniocervical obstructions in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol. (2020) 11:828. Available at:\\nhttps://www.frontiersin.org/articles/10.3389/fneur.2020.00828\\n(Accessed November 29, 2022). 10.3389/fneur.2020.00828</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2020.00828</ArticleId><ArticleId IdType=\"doi\">10.3389/fneur.2020.00828</ArticleId><ArticleId IdType=\"pmc\">PMC7485557</ArticleId><ArticleId IdType=\"pubmed\">32982905</ArticleId></ArticleIdList></Reference><Reference><Citation>Eccles JA, Thompson B, Themelis K, Amato ML, Stocks R, Pound A, et al. Beyond bones: the relevance of variants of connective tissue (hypermobility) to fibromyalgia, ME/CFS and controversies surrounding diagnostic classification: an observational study. Clin Med. (2021) 21:53&#x2013;8. 10.7861/clinmed.2020-0743</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7861/clinmed.2020-0743</ArticleId><ArticleId IdType=\"pmc\">PMC7850199</ArticleId><ArticleId IdType=\"pubmed\">33479068</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaco A, Choi D, Uzun S, Maitland A, Riley B. Association of mast-cell-related conditions with hypermobile syndromes: a review of the literature. Immunol Res. (2022) 70:419&#x2013;31. 10.1007/s12026-022-09280-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12026-022-09280-1</ArticleId><ArticleId IdType=\"pmc\">PMC9022617</ArticleId><ArticleId IdType=\"pubmed\">35449490</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajardo I, Pejler G. Human mast cell &#x3b2;-tryptase is a gelatinase 1. J Immunol. (2003) 171:1493&#x2013;9. 10.4049/jimmunol.171.3.1493</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/jimmunol.171.3.1493</ArticleId><ArticleId IdType=\"pubmed\">12874242</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Mast cell activation symptoms are prevalent in long-COVID. Int J Infect Dis. (2021) 112:217&#x2013;26. 10.1016/j.ijid.2021.09.043</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType=\"pmc\">PMC8459548</ArticleId><ArticleId IdType=\"pubmed\">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Brock I, Chopra P, Maitland A, Francomano C. Ep305&#x2014;frequency and co-occurrence of comorbidities in the ehlers-danlos syndromes. Mol Genet Metab. (2021) 132:S194. 10.1016/S1096-7192(21)00387-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1096-7192(21)00387-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P, Arevalo C, Oliveira RKF, Faria-Urbina M, Felsenstein D, Oaklander AL, et al. Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. CHEST. (2021) 160:642&#x2013;51. 10.1016/j.chest.2021.01.082</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.chest.2021.01.082</ArticleId><ArticleId IdType=\"pmc\">PMC8727854</ArticleId><ArticleId IdType=\"pubmed\">33577778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohno R, Cannom DS, Olshansky B, Xi SC, Krishnappa D, Adkisson WO, et al. Mast cell activation disorder and postural orthostatic tachycardia syndrome: a clinical association. J Am Heart Assoc. (2021) 10:e021002. 10.1161/JAHA.121.021002</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/JAHA.121.021002</ArticleId><ArticleId IdType=\"pmc\">PMC8649306</ArticleId><ArticleId IdType=\"pubmed\">34398691</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez AMC, Dietrich JE. Gynecologic management of pediatric and adolescent patients with ehlers-danlos syndrome. J Pediatr Adolesc Gynecol. (2020) 33:291&#x2013;5. 10.1016/j.jpag.2019.12.011</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jpag.2019.12.011</ArticleId><ArticleId IdType=\"pubmed\">31883462</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon-Rodin J, Leb&#xe8;gue G, Becourt S, Hamonet C, Gompel A. Gynecologic symptoms and the influence on reproductive life in 386 women with hypermobility type ehlers-danlos syndrome: a cohort study. Orphanet J Rare Dis. (2016) 11:124. 10.1186/s13023-016-0511-2</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13023-016-0511-2</ArticleId><ArticleId IdType=\"pmc\">PMC5020453</ArticleId><ArticleId IdType=\"pubmed\">27619482</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst BS, Lang MB, Kullstam SM, Usadi RS, Matthews ML, Marshburn PB. Reproductive challenges in women with ehlers-danlos syndrome: survey results from over 1350 respondents from the ehlers-danlos national foundation. Fertil Steril. (2012) 98:S112. 10.1016/j.fertnstert.2012.07.411</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.fertnstert.2012.07.411</ArticleId></ArticleIdList></Reference><Reference><Citation>Glayzer JE, McFarlin BL, Castori M, Suarez ML, Meinel MC, Kobak WH, et al. High rate of dyspareunia and probable vulvodynia in ehlers-danlos syndromes and hypermobility spectrum disorders: an online survey. Am J Med Genet C Semin Med Genet. (2021) 187:599&#x2013;608. 10.1002/ajmg.c.31939</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ajmg.c.31939</ArticleId><ArticleId IdType=\"pmc\">PMC8665058</ArticleId><ArticleId IdType=\"pubmed\">34747110</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiegel E, Nicholls-Dempsey L, Czuzoj-Shulman N, Abenhaim HA. Pregnancy outcomes in women with ehlers-danlos syndrome. J Matern Fetal Neonatal Med. (2020) 35:1683&#x2013;9. 10.1080/14767058.2020.1767574</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/14767058.2020.1767574</ArticleId><ArticleId IdType=\"pubmed\">32654548</ArticleId></ArticleIdList></Reference><Reference><Citation>Underhill LA, Barbarita C, Collis S, Tucker R, Lechner BE. Association of maternal versus fetal ehlers-danlos syndrome Status with poor pregnancy outcomes. Reprod Sci. (2022) 29:3459&#x2013;64. 10.1007/s43032-022-00992-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s43032-022-00992-1</ArticleId><ArticleId IdType=\"pmc\">PMC9734202</ArticleId><ArticleId IdType=\"pubmed\">35676499</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. (2022) 28:1706&#x2013;14. 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType=\"pmc\">PMC9388369</ArticleId><ArticleId IdType=\"pubmed\">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. International Classification of Diseases, 11th Revision (ICD-11). (2018).</Citation></Reference><Reference><Citation>Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. (2021) 397:839&#x2013;52. 10.1016/S0140-6736(21)00389-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(21)00389-5</ArticleId><ArticleId IdType=\"pubmed\">33640070</ArticleId></ArticleIdList></Reference><Reference><Citation>Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. (2020) 382:1244&#x2013;56. 10.1056/NEJMra1810764</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMra1810764</ArticleId><ArticleId IdType=\"pubmed\">32212520</ArticleId></ArticleIdList></Reference><Reference><Citation>Laufer MR, Sanfilippo J, Rose G. Adolescent endometriosis: diagnosis and treatment approaches. J Pediatr Adolesc Gynecol. (2003) 16:S3&#x2013;11. 10.1016/s1083-3188(03)00066-4</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s1083-3188(03)00066-4</ArticleId><ArticleId IdType=\"pubmed\">12742180</ArticleId></ArticleIdList></Reference><Reference><Citation>Secosan C, Balulescu L, Brasoveanu S, Balint O, Pirtea P, Dorin G, et al. Endometriosis in menopause-renewed attention on a controversial disease. Diagn Basel Switz. (2020) 10:134. 10.3390/diagnostics10030134</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics10030134</ArticleId><ArticleId IdType=\"pmc\">PMC7151055</ArticleId><ArticleId IdType=\"pubmed\">32121424</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez RS, Vnencak-Jones CL, Shi C, Fadare O. Endomyometriosis (&#x201c;uterus-like mass&#x201d;) in an XY male: case report with molecular confirmation and literature review. Int J Surg Pathol. (2014) 22:421&#x2013;6. 10.1177/1066896913501385</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1066896913501385</ArticleId><ArticleId IdType=\"pubmed\">24651910</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukunaga M. Paratesticular endometriosis in a man with a prolonged hormonal therapy for prostatic carcinoma. Pathol Res Pract. (2012) 208:59&#x2013;61. 10.1016/j.prp.2011.10.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.prp.2011.10.007</ArticleId><ArticleId IdType=\"pubmed\">22104297</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabr FI, Mani V. An unusual cause of abdominal pain in a male patient: endometriosis. Avicenna J Med. (2014) 4:99&#x2013;101. 10.4103/2231-0770.140660</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/2231-0770.140660</ArticleId><ArticleId IdType=\"pmc\">PMC4183904</ArticleId><ArticleId IdType=\"pubmed\">25298953</ArticleId></ArticleIdList></Reference><Reference><Citation>Breintoft K, Pinnerup R, Henriksen TB, Rytter D, Uldbjerg N, Forman A, et al. Endometriosis and risk of adverse pregnancy outcome: a systematic review and meta-analysis. J Clin Med. (2021) 10:667. 10.3390/jcm10040667</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm10040667</ArticleId><ArticleId IdType=\"pmc\">PMC7916165</ArticleId><ArticleId IdType=\"pubmed\">33572322</ArticleId></ArticleIdList></Reference><Reference><Citation>Farland LV, Prescott J, Sasamoto N, Tobias DK, Gaskins AJ, Stuart JJ, et al. Endometriosis and risk of adverse pregnancy outcomes. Obstet Gynecol. (2019) 134:527&#x2013;36. 10.1097/AOG.0000000000003410</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/AOG.0000000000003410</ArticleId><ArticleId IdType=\"pmc\">PMC6922084</ArticleId><ArticleId IdType=\"pubmed\">31403584</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D&#x2019;Hooghe T, De Bie B, et al. ESHRE Guideline: management of women with endometriosis &#x2020;. Hum Reprod. (2014) 29:400&#x2013;12. 10.1093/humrep/det457</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/humrep/det457</ArticleId><ArticleId IdType=\"pubmed\">24435778</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudelist G, Fritzer N, Thomas A, Niehues C, Oppelt P, Haas D, et al. Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod Oxf Engl. (2012) 27:3412&#x2013;6. 10.1093/humrep/des316</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/humrep/des316</ArticleId><ArticleId IdType=\"pubmed\">22990516</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradi M, Parker M, Sneddon A, Lopez V, Ellwood D. Impact of endometriosis on women\\'s lives: a qualitative study. BMC Womens Health. (2014) 14:123. 10.1186/1472-6874-14-123</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1472-6874-14-123</ArticleId><ArticleId IdType=\"pmc\">PMC4287196</ArticleId><ArticleId IdType=\"pubmed\">25280500</ArticleId></ArticleIdList></Reference><Reference><Citation>Nnoaham KE, Hummelshoj L, Webster P, d&#x2019;Hooghe T, de Cicco Nardone F, de Cicco Nardone C, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. (2011) 96:366&#x2013;373.e8. 10.1016/j.fertnstert.2011.05.090</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.fertnstert.2011.05.090</ArticleId><ArticleId IdType=\"pmc\">PMC3679489</ArticleId><ArticleId IdType=\"pubmed\">21718982</ArticleId></ArticleIdList></Reference><Reference><Citation>Pino I, Belloni GM, Barbera V, Solima E, Radice D, Angioni S, et al. &#x201c;Better late than never but never late is better&#x201d;, especially in young women. A multicenter Italian study on diagnostic delay for symptomatic endometriosis. Eur J Contracept Reprod. (2022) 28:1&#x2013;7. 10.1080/13625187.2022.2128644</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/13625187.2022.2128644</ArticleId><ArticleId IdType=\"pubmed\">36287190</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod Oxf Engl. (2002) 17:2715&#x2013;24. 10.1093/humrep/17.10.2715</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/humrep/17.10.2715</ArticleId><ArticleId IdType=\"pubmed\">12351553</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiruchelvam U, Wingfield M, O&#x2019;Farrelly C. Natural killer cells: key players in endometriosis. Am J Reprod Immunol. (2015) 74:291&#x2013;301. 10.1111/aji.12408</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/aji.12408</ArticleId><ArticleId IdType=\"pubmed\">26104509</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogg C, Horne AW, Greaves E. Endometriosis-associated macrophages: origin, phenotype, and function. Front Endocrinol. (2020) 11:7. 10.3389/fendo.2020.00007</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2020.00007</ArticleId><ArticleId IdType=\"pmc\">PMC6989423</ArticleId><ArticleId IdType=\"pubmed\">32038499</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrelluzzi KFS, Garcia MC, Petta CA, Grassi-Kassisse DM, Spadari-Bratfisch RC. Salivary cortisol concentrations, stress and quality of life in women with endometriosis and chronic pelvic pain. Stress Amst Neth. (2008) 11:390&#x2013;7. 10.1080/10253890701840610</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/10253890701840610</ArticleId><ArticleId IdType=\"pubmed\">18800310</ArticleId></ArticleIdList></Reference><Reference><Citation>Scutiero G, Iannone P, Bernardi G, Bonaccorsi G, Spadaro S, Volta CA, et al. Oxidative stress and endometriosis: a systematic review of the literature. Oxid Med Cell Longev. (2017) 2017:7265238. 10.1155/2017/7265238.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2017/7265238</ArticleId><ArticleId IdType=\"pmc\">PMC5625949</ArticleId><ArticleId IdType=\"pubmed\">29057034</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchhoff D, Kaulfuss S, Fuhrmann U, Maurer M, Zollner TM. Mast cells in endometriosis: guilty or innocent bystanders? Expert Opin Ther Targets. (2012) 16:237&#x2013;41. 10.1517/14728222.2012.661415</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1517/14728222.2012.661415</ArticleId><ArticleId IdType=\"pubmed\">22332753</ArticleId></ArticleIdList></Reference><Reference><Citation>Roerink ME, Roerink SHPP, Skoluda N, van der Schaaf ME, Hermus ARMM, van der Meer JWM, et al. Hair and salivary cortisol in a cohort of women with chronic fatigue syndrome. Horm Behav. (2018) 103:1&#x2013;6. 10.1016/j.yhbeh.2018.05.016</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.yhbeh.2018.05.016</ArticleId><ArticleId IdType=\"pubmed\">29807037</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton-Fitch N, du Preez S, Cabanas H, Staines D, Marshall-Gradisnik S. A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome. Syst Rev. (2019) 8:279. 10.1186/s13643-019-1202-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13643-019-1202-6</ArticleId><ArticleId IdType=\"pmc\">PMC6857215</ArticleId><ArticleId IdType=\"pubmed\">31727160</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottschalk G, Peterson D, Knox K, Maynard M, Whelan RJ, Roy A. Elevated ATG13 in serum of patients with ME/CFS stimulates oxidative stress response in microglial cells via activation of receptor for advanced glycation end products (RAGE). Mol Cell Neurosci. (2022) 120:103731. 10.1016/j.mcn.2022.103731</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mcn.2022.103731</ArticleId><ArticleId IdType=\"pubmed\">35487443</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasso EM, Muraki K, Eaton-Fitch N, Smith P, Lesslar OL, Deed G, et al. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients. Mol Med Camb Mass. (2022) 28:98. 10.1186/s10020-022-00528-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s10020-022-00528-y</ArticleId><ArticleId IdType=\"pmc\">PMC9388968</ArticleId><ArticleId IdType=\"pubmed\">35986236</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, et al. Distinguishing features of long COVID identified through immune profiling. MedRxiv Prepr Serv Health Sci. (2022) 2022.08.09:22278592. 10.1101/2022.08.09.22278592</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2022.08.09.22278592</ArticleId></ArticleIdList></Reference><Reference><Citation>Villaume WA. Marginal BH4 deficiencies, iNOS, and self-perpetuating oxidative stress in post-acute sequelae of COVID-19. Med Hypotheses. (2022) 163:110842. 10.1016/j.mehy.2022.110842</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mehy.2022.110842</ArticleId><ArticleId IdType=\"pmc\">PMC9006446</ArticleId><ArticleId IdType=\"pubmed\">35431403</ArticleId></ArticleIdList></Reference><Reference><Citation>Sourial S, Tempest N, Hapangama DK. Theories on the pathogenesis of endometriosis. Int J Reprod Med. (2014) 2014:179515. 10.1155/2014/179515</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2014/179515</ArticleId><ArticleId IdType=\"pmc\">PMC4334056</ArticleId><ArticleId IdType=\"pubmed\">25763392</ArticleId></ArticleIdList></Reference><Reference><Citation>Cousins FL, McKinnon BD, Mortlock S, Fitzgerald HC, Zhang C, Montgomery GW, et al. New concepts on the etiology of endometriosis. J Obstet Gynaecol Res. (2023) 49:1090&#x2013;105. 10.1111/jog.15549</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jog.15549</ArticleId><ArticleId IdType=\"pubmed\">36746607</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan KN, Fujishita A, Hiraki K, Kitajima M, Nakashima M, Fushiki S, et al. Bacterial contamination hypothesis: a new concept in endometriosis. Reprod Med Biol. (2018) 17:125&#x2013;33. 10.1002/rmb2.12083</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/rmb2.12083</ArticleId><ArticleId IdType=\"pmc\">PMC5902457</ArticleId><ArticleId IdType=\"pubmed\">29692669</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan KN, Kitajima M, Hiraki K, Yamaguchi N, Katamine S, Matsuyama T, et al. Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis. Fertil Steril. (2010) 94:2860&#x2013;2863.e1&#x2013;3. 10.1016/j.fertnstert.2010.04.053</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.fertnstert.2010.04.053</ArticleId><ArticleId IdType=\"pubmed\">20627244</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan W, Wu Y, Chai X, Wu X. The colonized microbiota composition in the peritoneal fluid in women with endometriosis. Arch Gynecol Obstet. (2022) 305:1573&#x2013;80. 10.1007/s00404-021-06338-7</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00404-021-06338-7</ArticleId><ArticleId IdType=\"pubmed\">34988659</ArticleId></ArticleIdList></Reference><Reference><Citation>Noh EJ, Kim DJ, Lee JY, Park JH, Kim J-S, Han JW, et al. Ureaplasma urealyticum infection contributes to the development of pelvic endometriosis through toll-like receptor 2. Front Immunol. (2019) 10:2373. 10.3389/fimmu.2019.02373</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2019.02373</ArticleId><ArticleId IdType=\"pmc\">PMC6788432</ArticleId><ArticleId IdType=\"pubmed\">31636643</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, Lindseth IA, Marshall TG. Microbe-microbe and host-microbe interactions drive microbiome dysbiosis and inflammatory processes. Discov Med. (2017) 23:51&#x2013;60.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28245427</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A, Marshall T. Myalgic encephalomyelitis/chronic fatigue syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity. Front Pediatr. (2018) 6:373. 10.3389/fped.2018.00373</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2018.00373</ArticleId><ArticleId IdType=\"pmc\">PMC6288442</ArticleId><ArticleId IdType=\"pubmed\">30564562</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, Albert PJ, Marshall TG. The human microbiome and autoimmunity. Curr Opin Rheumatol. (2013) 25:234&#x2013;40. 10.1097/BOR.0b013e32835cedbf</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/BOR.0b013e32835cedbf</ArticleId><ArticleId IdType=\"pubmed\">23370376</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. (2022) 3:371&#x2013;387.e9. 10.1016/j.medj.2022.04.001</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType=\"pmc\">PMC9005383</ArticleId><ArticleId IdType=\"pubmed\">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, Pfister A, Meyer M, R&#xf6;ssler A, et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. (2022) 163:495&#x2013;506.e8. 10.1053/j.gastro.2022.04.037</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType=\"pmc\">PMC9057012</ArticleId><ArticleId IdType=\"pubmed\">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC-Y, Ng SSS, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. (2022) 71:544&#x2013;52. 10.1136/gutjnl-2021-325989</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType=\"pmc\">PMC8814432</ArticleId><ArticleId IdType=\"pubmed\">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran JP, Bradley E, Zeamer AL, Cincotta L, Salive M-C, Dutta P, et al. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID. JCI Insight. (2021) 6:e152346. 10.1172/jci.insight.152346</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/jci.insight.152346</ArticleId><ArticleId IdType=\"pmc\">PMC8564890</ArticleId><ArticleId IdType=\"pubmed\">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirin AA, Dimmock ME, Jason LA. Research update: the relation between ME/CFS disease burden and research funding in the USA. Work. (2020) 66:277&#x2013;82. 10.3233/WOR-203173</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/WOR-203173</ArticleId><ArticleId IdType=\"pubmed\">32568148</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher G, Kotze M, Moremi K, Oladejo S, et al. Combined triple treatment of fibrin amyloid microclots and platelet pathology in individuals with long COVID/ post-acute sequelae of COVID-19 (PASC) can resolve their persistent symptoms. (2021). 10.21203/rs.3.rs-1205453/v1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.21203/rs.3.rs-1205453/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes JM, Kruger A, Proal A, Kell DB, Pretorius E. The occurrence of hyperactivated platelets and fibrinaloid microclots in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Pharmaceuticals. (2022) 15:931. 10.3390/ph15080931</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ph15080931</ArticleId><ArticleId IdType=\"pmc\">PMC9413879</ArticleId><ArticleId IdType=\"pubmed\">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanepoel AC, Visagie A, de Lange Z, Emmerson O, Nielsen VG, Pretorius E. The clinical relevance of altered fibrinogen packaging in the presence of 17&#x3b2;-estradiol and progesterone. Thromb Res. (2016) 146:23&#x2013;34. 10.1016/j.thromres.2016.08.022</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.thromres.2016.08.022</ArticleId><ArticleId IdType=\"pubmed\">27566845</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing Y, Run-Qian L, Hao-Ran W, Hao-Ran C, Ya-Bin L, Yang G, et al. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod. (2020) 26:367&#x2013;73. 10.1093/molehr/gaaa030</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/molehr/gaaa030</ArticleId><ArticleId IdType=\"pmc\">PMC7239105</ArticleId><ArticleId IdType=\"pubmed\">32365180</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Piazza M, Boner AL, Bellanti JA. Long COVID: a proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome. Allergy Asthma Proc. (2022) 43:187&#x2013;93. 10.2500/aap.2022.43.220018</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2500/aap.2022.43.220018</ArticleId><ArticleId IdType=\"pmc\">PMC9106095</ArticleId><ArticleId IdType=\"pubmed\">35524358</ArticleId></ArticleIdList></Reference><Reference><Citation>Shultz SJ, Sander TC, Kirk SE, Perrin DH. Sex differences in knee joint laxity change across the female menstrual cycle. J Sports Med Phys Fitness. (2005) 45:594&#x2013;603.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC1890029</ArticleId><ArticleId IdType=\"pubmed\">16446695</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeziorska M, Salamonsen LA, Woolley DE. Mast cell and eosinophil distribution and activation in human endometrium throughout the menstrual cycle. Biol Reprod. (1995) 53:312&#x2013;20. 10.1095/biolreprod53.2.312</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1095/biolreprod53.2.312</ArticleId><ArticleId IdType=\"pubmed\">7492683</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugamata M, Ihara T, Uchiide I. Increase of activated mast cells in human endometriosis. Am J Reprod Immunol. (2005) 53:120&#x2013;5. 10.1111/j.1600-0897.2005.00254.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1600-0897.2005.00254.x</ArticleId><ArticleId IdType=\"pubmed\">15727565</ArticleId></ArticleIdList></Reference><Reference><Citation>Binda MM, Donnez J, Dolmans M-M. Targeting mast cells: a new way to treat endometriosis. Expert Opin Ther Targets. (2017) 21:67&#x2013;75. 10.1080/14728222.2017.1260548</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/14728222.2017.1260548</ArticleId><ArticleId IdType=\"pubmed\">27841046</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczyk G, Pyzlak M, Klimkiewicz J, Smiertka W, Miedzi&#x144;ska-Maciejewska M, Szukiewicz D. Mast cells and histamine: do they influence placental vascular network and development in preeclampsia? Mediators Inflamm. (2012) 2012:307189. 10.1155/2012/307189</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2012/307189</ArticleId><ArticleId IdType=\"pmc\">PMC3388381</ArticleId><ArticleId IdType=\"pubmed\">22778495</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi M, Hicks C, El-Assaad F, El-Omar E, Condous G. Endometriosis and the microbiome: a systematic review. BJOG Int J Obstet Gynaecol. (2020) 127:239&#x2013;49. 10.1111/1471-0528.15916</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/1471-0528.15916</ArticleId><ArticleId IdType=\"pubmed\">31454452</ArticleId></ArticleIdList></Reference><Reference><Citation>Ata B, Yildiz S, Turkgeldi E, Brocal VP, Dinleyici EC, Moya A, et al. The endobiota study: comparison of vaginal, cervical and gut Microbiota between women with stage 3/4 endometriosis and healthy controls. Sci Rep. (2019) 9:2204. 10.1038/s41598-019-39700-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-39700-6</ArticleId><ArticleId IdType=\"pmc\">PMC6379373</ArticleId><ArticleId IdType=\"pubmed\">30778155</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasundhara D, Raju VN, Hemalatha R, Nagpal R, Kumar M. Vaginal &amp; gut microbiota diversity in pregnant women with bacterial vaginosis &amp; effect of oral probiotics: an exploratory study. Indian J Med Res. (2021) 153:492&#x2013;502. 10.4103/ijmr.IJMR_350_19</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/ijmr.IJMR_350_19</ArticleId><ArticleId IdType=\"pmc\">PMC8354056</ArticleId><ArticleId IdType=\"pubmed\">34380796</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne EH, Farcasanu M, Bloom SM, Xulu N, Xu J, Hykes BL, et al. Antigen presenting cells link the female genital tract microbiome to mucosal inflammation, with hormonal contraception as an additional modulator of inflammatory signatures. Front Cell Infect Microbiol. (2021) 11:733619. 10.3389/fcimb.2021.733619</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcimb.2021.733619</ArticleId><ArticleId IdType=\"pmc\">PMC8482842</ArticleId><ArticleId IdType=\"pubmed\">34604114</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrotta AR, Borrelli GM, Martins CO, Kallas EG, Sanabani SS, Griffith LG, et al. The vaginal microbiome as a tool to predict rASRM stage of disease in endometriosis: a pilot study. Reprod Sci. (2020) 27:1064&#x2013;73. 10.1007/s43032-019-00113-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s43032-019-00113-5</ArticleId><ArticleId IdType=\"pmc\">PMC7539818</ArticleId><ArticleId IdType=\"pubmed\">32046455</ArticleId></ArticleIdList></Reference><Reference><Citation>Power ML, Quaglieri C, Schulkin J. Reproductive microbiomes: a new thread in the microbial network. Reprod Sci Thousand Oaks Calif. (2017) 24:1482&#x2013;92. 10.1177/1933719117698577</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1933719117698577</ArticleId><ArticleId IdType=\"pubmed\">28322134</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh T-C, Edwards NC, Bhattacharyya SK, Nitschelm KD, Burnett AL. The epidemic of COVID-19-related erectile dysfunction: a scoping review and health care perspective. Sex Med Rev. (2022) 10:286&#x2013;310. 10.1016/j.sxmr.2021.09.002</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.sxmr.2021.09.002</ArticleId><ArticleId IdType=\"pmc\">PMC8450276</ArticleId><ArticleId IdType=\"pubmed\">34732316</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini G, Aneja R. Cancer as a prospective sequela of long COVID-19. Bioessays. (2021) 43:2000331. 10.1002/bies.202000331</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/bies.202000331</ArticleId><ArticleId IdType=\"pmc\">PMC8206711</ArticleId><ArticleId IdType=\"pubmed\">33914346</ArticleId></ArticleIdList></Reference><Reference><Citation>Mecha EO, Njagi JN, Makunja RN, Omwandho COA, Saunders PTK, Horne AW. Endometriosis among African women. Reprod Fertil. (2022) 3:C40&#x2013;3. 10.1530/RAF-22-0040</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1530/RAF-22-0040</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayliss K, Riste L, Fisher L, Wearden A, Peters S, Lovell K, et al. Diagnosis and management of chronic fatigue syndrome/myalgic encephalitis in black and minority ethnic people: a qualitative study. Prim Health Care Res Dev. (2014) 15:143&#x2013;55. 10.1017/S1463423613000145</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S1463423613000145</ArticleId><ArticleId IdType=\"pubmed\">23702254</ArticleId></ArticleIdList></Reference><Reference><Citation>Varma T, Jones CP, Oladele C, Miller J. Diversity in clinical research: public health and social justice imperatives. J Med Ethics. (2022) 49:200&#x2013;3. 10.1136/medethics-2021-108068</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/medethics-2021-108068</ArticleId><ArticleId IdType=\"pubmed\">35428737</ArticleId></ArticleIdList></Reference><Reference><Citation>Plesons M, Patkar A, Babb J, Balapitiya A, Carson F, Caruso BA, et al. The state of adolescent menstrual health in low- and middle-income countries and suggestions for future action and research. Reprod Health. (2021) 18:31. 10.1186/s12978-021-01082-2</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12978-021-01082-2</ArticleId><ArticleId IdType=\"pmc\">PMC7869499</ArticleId><ArticleId IdType=\"pubmed\">33557877</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson EJ, Becker A, Baluran DA. Gendered racism on the body: an intersectional approach to maternal mortality in the United States. Popul Res Policy Rev. (2022) 51:1261&#x2013;94. 10.1007/s11113-021-09691-2</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11113-021-09691-2</ArticleId></ArticleIdList></Reference><Reference><Citation>National Academies of Sciences E, Division H and M, Practice B on PH and PH, States C on C-BS to PHE in the U, Baciu A, Negussie Y, Geller A, Weinstein JN.\\nThe state of health disparities in the United States. Washington (DC): National Academies Press (US) (2017. Available at:\\nhttps://www.ncbi.nlm.nih.gov/books/NBK425844/\\n(Accessed December 2, 2022).</Citation></Reference><Reference><Citation>Zhang L, Losin EAR, Ashar YK, Koban L, Wager TD. Gender biases in estimation of Others&#x2019; pain. J Pain. (2021) 22:1048&#x2013;59. 10.1016/j.jpain.2021.03.001</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jpain.2021.03.001</ArticleId><ArticleId IdType=\"pmc\">PMC8827218</ArticleId><ArticleId IdType=\"pubmed\">33684539</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EH, Shofer FS, Dean AJ, Hollander JE, Baxt WG, Robey JL, et al. Gender disparity in analgesic treatment of emergency department patients with acute abdominal pain. Acad Emerg Med. (2008) 15:414&#x2013;8. 10.1111/j.1553-2712.2008.00100.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1553-2712.2008.00100.x</ArticleId><ArticleId IdType=\"pubmed\">18439195</ArticleId></ArticleIdList></Reference><Reference><Citation>As-Sanie S, Black R, Giudice LC, Gray Valbrun T, Gupta J, Jones B, et al. Assessing research gaps and unmet needs in endometriosis. Am J Obstet Gynecol. (2019) 221:86&#x2013;94. 10.1016/j.ajog.2019.02.033</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajog.2019.02.033</ArticleId><ArticleId IdType=\"pubmed\">30790565</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims OT, Gupta J, Missmer SA, Aninye IO. Stigma and endometriosis: a brief overview and recommendations to improve psychosocial well-being and diagnostic delay. Int J Environ Res Public Health. (2021) 18:8210. 10.3390/ijerph18158210</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijerph18158210</ArticleId><ArticleId IdType=\"pmc\">PMC8346066</ArticleId><ArticleId IdType=\"pubmed\">34360501</ArticleId></ArticleIdList></Reference><Reference><Citation>Avnoon N. Time for women-centred gynaecology. Nat Rev Urol. (2022) 19:689&#x2013;90. 10.1038/s41585-022-00656-4</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41585-022-00656-4</ArticleId><ArticleId IdType=\"pubmed\">36085514</ArticleId></ArticleIdList></Reference><Reference><Citation>Au L, Capotescu C, Eyal G, Finestone G. Long COVID and medical gaslighting: dismissal, delayed diagnosis, and deferred treatment. Ssm Qual Res Health. (2022) 2:100167. 10.1016/j.ssmqr.2022.100167</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ssmqr.2022.100167</ArticleId><ArticleId IdType=\"pmc\">PMC9448633</ArticleId><ArticleId IdType=\"pubmed\">36092770</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. (2019) 220:354.e1&#x2013;354.e12. 10.1016/j.ajog.2018.12.039</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajog.2018.12.039</ArticleId><ArticleId IdType=\"pubmed\">30625295</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L, Authier FJ, Scheibenbogen C, Lorusso L, Helland IB, Martin JA, et al. European Network on myalgic encephalomyelitis/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in Europe. Med Kaunas Lith. (2021) 57:510. 10.3390/medicina57050510</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57050510</ArticleId><ArticleId IdType=\"pmc\">PMC8161074</ArticleId><ArticleId IdType=\"pubmed\">34069603</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37231733</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1745-9206</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2023</Year><Month>May</Month><Day>25</Day></PubDate></JournalIssue><Title>Chronic illness</Title><ISOAbbreviation>Chronic Illn</ISOAbbreviation></Journal><ArticleTitle>Service users\\' and parents/carers\\' experiences of a paediatric chronic fatigue service: A service evaluation.</ArticleTitle><Pagination><StartPage>17423953231178185</StartPage><MedlinePgn>17423953231178185</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1177/17423953231178185</ELocationID><Abstract><AbstractText Label=\"OBJECTIVES\" NlmCategory=\"OBJECTIVE\">This service evaluation explored the experiences of families receiving care in a paediatric chronic fatigue service. The evaluation aimed to improve service provision across paediatric chronic fatigue services more widely.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">Children and young people aged 7-18 years (<i>n</i>&#x2009;&#x2009;=&#x2009;&#x2009;25) and parents/carers (<i>n</i>&#x2009;&#x2009;=&#x2009;&#x2009;25) completed a postal survey exploring experiences of a paediatric chronic fatigue service. Quantitative data were analysed descriptively, and qualitative data were analysed using thematic analysis.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Most service usersand parents/carers (88%) agreed that the service met their needs, that they felt supported by staff, and most notably, a large portion (74%) reported the team increased their activity levels. A small number disagreed (7%) with statements relating to positive links with other services, ease of talking to staff and suitability of appointment type. The thematic analysis revealed three themes: help managing chronic fatigue syndrome, experience of professional support and accessibility of service. Families reported benefiting from increased understanding of chronic fatigue syndrome, learning new strategies, the team linking with schools, feeling validated and mental health support. Accessibility was a particular problem including the service location, setup of appointments and difficulty contacting the team.</AbstractText><AbstractText Label=\"DISCUSSION\" NlmCategory=\"CONCLUSIONS\">The evaluation presents recommendations for paediatric Chronic Fatigue services to improve service user experiences.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Hartley</LastName><ForeName>Gemma</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neurodevelopmental Assessment Pathway, Child and Adolescent Mental Health Service, Rotherham Doncaster and South Humber NHS Foundation Trust, Rotherham, UK.</Affiliation><Identifier Source=\"RINGGOLD\">9514</Identifier></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Purrington</LastName><ForeName>Jack</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0001-5678-8763</Identifier><AffiliationInfo><Affiliation>Clinical Psychology Team, Chrysalis Associates, Sheffield and York, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chronic Illn</MedlineTA><NlmUniqueID>101253019</NlmUniqueID><ISSNLinking>1742-3953</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">ME/CFS</Keyword><Keyword MajorTopicYN=\"N\">chronic fatigue</Keyword><Keyword MajorTopicYN=\"N\">myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN=\"N\">service evaluation</Keyword><Keyword MajorTopicYN=\"N\">service user feedback</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>26</Day><Hour>3</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37231733</ArticleId><ArticleId IdType=\"doi\">10.1177/17423953231178185</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37230457</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1090-2392</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>112</Volume><PubDate><Year>2023</Year><Month>May</Month><Day>23</Day></PubDate></JournalIssue><Title>Cryobiology</Title><ISOAbbreviation>Cryobiology</ISOAbbreviation></Journal><ArticleTitle>Effects of whole-body cryotherapy and static stretching are maintained 4 weeks after treatment in most patients with chronic fatigue syndrome.</ArticleTitle><Pagination><StartPage>104546</StartPage><MedlinePgn>104546</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.cryobiol.2023.05.003</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0011-2240(23)00035-4</ELocationID><Abstract><AbstractText>In the previous study, whole-body cryotherapy (WBC)+static stretching (SS) has been shown to reduce the severity of some symptoms in Chronic Fatigue Syndrome (CFS) noted just after the therapy. Here we consider the effects of treatment and explore the sustainability of symptom improvements at four weeks (one-month) follow-up. Twenty-two CFS patients were assessed one month after WBC&#xa0;+&#xa0;SS programme. Parameters related to fatigue (Chalder Fatigue Questionnaire (CFQ), Fatigue Impact Scale (FIS), Fatigue Severity Scale (FSS)), cognitive function (Trial Making test part A and B (TMT A and TMT B and its difference (TMT B-A)), Coding) hemodynamic, aortic stiffness (aortic systolic blood pressure (sBP aortic)) and autonomic nervous system functioning were measured. TMT A, TMT B, TMT B-A and Coding improved at one month after the WBC&#xa0;+&#xa0;SS programme. WBC&#xa0;+&#xa0;SS had a significant effect on the increase in sympathetic nervous system activity in rest. WBC&#xa0;+&#xa0;SS had a significant, positive chronotropic effect on the cardiac muscle. Peripheral and aortic systolic blood pressure decreased one month after WBC&#xa0;+&#xa0;SS in comparison to before. Effects of WBC&#xa0;+&#xa0;SS on reduction of fatigue, indicators of aortic stiffness and symptoms severity related to autonomic nervous system disturbance and improvement in cognitive function were maintained at one month. However, improvement in all three fatigue scales (CFQ, FIS and FSS) was noted in 17 of 22 patients. In addition, ten patients were treated initially but they were not assessed at 4 weeks, and are thus not included in the 22 patients who were examined on follow-up. The overall effects of WBC&#xa0;+&#xa0;SS noted at one month post-treatment should be interpreted with caution.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Kujawski</LastName><ForeName>S&#x142;awomir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, &#x15a;wi&#x119;toja&#x144;ska 20, 85-077, Bydgoszcz, Poland. Electronic address: skujawski@cm.umk.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zalewski</LastName><ForeName>Pawe&#x142;</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, &#x15a;wi&#x119;toja&#x144;ska 20, 85-077, Bydgoszcz, Poland; Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Warsaw Medical University, 1b Banacha Street, 02-097, Warsaw, Poland. Electronic address: p.zalewski@cm.umk.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Godlewska</LastName><ForeName>Beata R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, United Kingdom. Electronic address: beata.godlewska@psych.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cudnoch-J&#x119;drzejewska</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Warsaw Medical University, 1b Banacha Street, 02-097, Warsaw, Poland. Electronic address: agnieszka.cudnoch@wum.edu.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Murovska</LastName><ForeName>Modra</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Microbiology and Virology, Riga Stradin&#x161; University, LV-1067, Riga, Latvia. Electronic address: modra.murovska@rsu.lv.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Newton</LastName><ForeName>Julia L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Population Health Sciences Institute, The Medical School, Newcastle University, Framlington Place, Newcastle-upon-Tyne, NE2 4HH, UK. Electronic address: julia.newton@newcastle.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Soko&#x142;owski</LastName><ForeName>&#x141;ukasz</ForeName><Initials>&#x141;</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, &#x15a;wi&#x119;toja&#x144;ska 20, 85-077, Bydgoszcz, Poland. Electronic address: lukasz.sokolowski@cm.umk.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>S&#x142;omko</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, &#x15a;wi&#x119;toja&#x144;ska 20, 85-077, Bydgoszcz, Poland. Electronic address: jslomko@cm.umk.pl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Cryobiology</MedlineTA><NlmUniqueID>0006252</NlmUniqueID><ISSNLinking>0011-2240</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Autonomic nervous system</Keyword><Keyword MajorTopicYN=\"N\">CFS</Keyword><Keyword MajorTopicYN=\"N\">Chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">Cognitive function</Keyword><Keyword MajorTopicYN=\"N\">Cold therapy</Keyword><Keyword MajorTopicYN=\"N\">Cryotherapy</Keyword><Keyword MajorTopicYN=\"N\">ME/CFS</Keyword><Keyword MajorTopicYN=\"N\">Myalgic encephalomyelitis</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>26</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>26</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>25</Day><Hour>19</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37230457</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cryobiol.2023.05.003</ArticleId><ArticleId IdType=\"pii\">S0011-2240(23)00035-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" VersionID=\"2\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"2\">37226227</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>28</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1741-7015</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>24</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review.</ArticleTitle><Pagination><StartPage>189</StartPage><MedlinePgn>189</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">189</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1186/s12916-023-02893-9</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\">Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multifaceted condition that affects most body systems. There is currently no known diagnostic biomarker; instead, diagnosis is dependent on application of symptom-based case criteria following exclusion of any other potential medical conditions. While there are some studies that report potential biomarkers for ME/CFS, their efficacy has not been validated. The aim of this systematic review is to collate and appraise literature pertaining to a potential biomarker(s) which may effectively differentiate ME/CFS patients from healthy controls.</AbstractText><AbstractText Label=\"METHODS\">This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Cochrane review guidelines. PubMed, Embase and Scopus were systematically searched for articles containing \"biomarker\" and \"ME/CFS\" keywords in the abstract or title and if they included the following criteria: (1) were observational studies published between December 1994 and April 2022; (2) involved adult human participants; (3) full text is available in English (4) original research; (5) diagnosis of ME/CFS patients made according to the Fukuda criteria (1994), Canadian Consensus Criteria (2003), International Consensus Criteria (2011) or Institute of Medicine Criteria (2015); (6) study investigated potential biomarkers of ME/CFS compared to healthy controls. Quality and Bias were assessed using the Joanna Briggs Institute Critical Appraisal Checklist for Case Control Studies.</AbstractText><AbstractText Label=\"RESULTS\">A total of 101 publications were included in this systematic review. Potential biomarkers ranged from genetic/epigenetic (19.8%), immunological (29.7%), metabolomics/mitochondrial/microbiome (14.85%), endovascular/circulatory (17.82%), neurological (7.92%), ion channel (8.91%) and physical dysfunction biomarkers (8.91%). Most of the potential biomarkers reported were blood-based (79.2%). Use of lymphocytes as a model to investigate ME/CFS pathology was prominent among immune-based biomarkers. Most biomarkers had secondary (43.56%) or tertiary (54.47%) selectivity, which is the ability for the biomarker to identify a disease-causing agent, and a moderate (59.40%) to complex (39.60%) ease-of-detection, including the requirement of specialised equipment.</AbstractText><AbstractText Label=\"CONCLUSIONS\">All potential ME/CFS biomarkers differed in efficiency, quality, and translatability as a diagnostic marker. Reproducibility of findings between the included publications were limited, however, several studies validated the involvement of immune dysfunction in the pathology of ME/CFS and the use of lymphocytes as a model to investigate the pathomechanism of illness. The heterogeneity shown across many of the included studies highlights the need for multidisciplinary research and uniform protocols in ME/CFS biomarker research.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Maksoud</LastName><ForeName>Rebekah</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>National Centre for Neuroimmunology and Emerging Diseases (NCNED), Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia. r.maksoud@griffith.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium Health International for Myalgic Encephalomyelitis, Griffith University, Gold Coast, Australia. r.maksoud@griffith.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmacy and Medical Science, Griffith University, Gold Coast, Australia. r.maksoud@griffith.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Magawa</LastName><ForeName>Chandi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Centre for Neuroimmunology and Emerging Diseases (NCNED), Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium Health International for Myalgic Encephalomyelitis, Griffith University, Gold Coast, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmacy and Medical Science, Griffith University, Gold Coast, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Eaton-Fitch</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Centre for Neuroimmunology and Emerging Diseases (NCNED), Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium Health International for Myalgic Encephalomyelitis, Griffith University, Gold Coast, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Thapaliya</LastName><ForeName>Kiran</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Centre for Neuroimmunology and Emerging Diseases (NCNED), Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium Health International for Myalgic Encephalomyelitis, Griffith University, Gold Coast, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Marshall-Gradisnik</LastName><ForeName>Sonya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Centre for Neuroimmunology and Emerging Diseases (NCNED), Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium Health International for Myalgic Encephalomyelitis, Griffith University, Gold Coast, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D000078182\">Systematic Review</PublicationType><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\\'t</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015415\">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D014481\" MajorTopicYN=\"N\" Type=\"Geographic\">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002170\" MajorTopicYN=\"N\" Type=\"Geographic\">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015203\" MajorTopicYN=\"N\">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000047\" MajorTopicYN=\"N\">Academies and Institutes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015415\" MajorTopicYN=\"N\">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Biomarker</Keyword><Keyword MajorTopicYN=\"N\">Chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">Diagnostic test</Keyword><Keyword MajorTopicYN=\"N\">Myalgic encephalomyelitis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest. The authors disclose Patent Cooperation Treaty application number WO2016176726A1 and Australian provisional application 2022902253.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>25</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>23</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37226227</ArticleId><ArticleId IdType=\"pmc\">PMC10206551</ArticleId><ArticleId IdType=\"doi\">10.1186/s12916-023-02893-9</ArticleId><ArticleId IdType=\"pii\">10.1186/s12916-023-02893-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) J Transl Med. 2020;18(1):100. doi: 10.1186/s12967-020-02269-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType=\"pmc\">PMC7038594</ArticleId><ArticleId IdType=\"pubmed\">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med. 2011;270(4):327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType=\"pmc\">PMC3427890</ArticleId><ArticleId IdType=\"pubmed\">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Brurberg KG, F&#xf8;nhus MS, Larun L, Flottorp S, Malterud K. Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review. BMJ Open. 2014;4(2):e003973. doi: 10.1136/bmjopen-2013-003973.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmjopen-2013-003973</ArticleId><ArticleId IdType=\"pmc\">PMC3918975</ArticleId><ArticleId IdType=\"pubmed\">24508851</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121(12):953&#x2013;9. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType=\"pubmed\">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, et al. Myalgic encephalomyelitis/chronic fatigue syndrome. J Chronic Fatigue Syndrome. 2003;11(1):7&#x2013;115. doi: 10.1300/J092v11n01_02.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Board on the Health of Select Populations, Institute of Medicine. The National Academies Collection: Reports funded by National Institutes of Health. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. Washington (DC): National Academies Press (US) Copyright 2015 by the National Academy of Sciences. All rights reserved; 2015.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Close S, Marshall-Gradisnik S, Byrnes J, Smith P, Nghiem S, Staines D. The economic impacts of myalgic encephalomyelitis/chronic fatigue syndrome in an Australian cohort. Front Public Health. 2020;8:420. doi: 10.3389/fpubh.2020.00420.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fpubh.2020.00420</ArticleId><ArticleId IdType=\"pmc\">PMC7472917</ArticleId><ArticleId IdType=\"pubmed\">32974259</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeux R. Biomarkers: potential uses and limitations. NeuroRx. 2004;1(2):182&#x2013;188. doi: 10.1602/neurorx.1.2.182.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1602/neurorx.1.2.182</ArticleId><ArticleId IdType=\"pmc\">PMC534923</ArticleId><ArticleId IdType=\"pubmed\">15717018</ArticleId></ArticleIdList></Reference><Reference><Citation>Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2010;5(6):463&#x2013;466. doi: 10.1097/COH.0b013e32833ed177.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/COH.0b013e32833ed177</ArticleId><ArticleId IdType=\"pmc\">PMC3078627</ArticleId><ArticleId IdType=\"pubmed\">20978388</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrnes SA, Weigl BH. Selecting analytical biomarkers for diagnostic applications: a first principles approach. Expert Rev Mol Diagn. 2018;18(1):19&#x2013;26. doi: 10.1080/14737159.2018.1412258.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/14737159.2018.1412258</ArticleId><ArticleId IdType=\"pubmed\">29200322</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.n71</ArticleId><ArticleId IdType=\"pmc\">PMC8005924</ArticleId><ArticleId IdType=\"pubmed\">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 Cochrane; 2022.</Citation></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan&#x2014;a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi: 10.1186/s13643-016-0384-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType=\"pmc\">PMC5139140</ArticleId><ArticleId IdType=\"pubmed\">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker TH, Stone JC, Sears K, Klugar M, Leonardi-Bee J, Tufanaru C, et al. Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process. JBI Evidence Synthesis. 2023;21(3):478&#x2013;493. doi: 10.11124/JBIES-22-00125.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.11124/JBIES-22-00125</ArticleId><ArticleId IdType=\"pubmed\">36121230</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen J, Murray A, Di Maria C, Newton JL. Chronic fatigue syndrome and impaired peripheral pulse characteristics on orthostasis&#x2013;a new potential diagnostic biomarker. Physiol Meas. 2012;33(2):231&#x2013;241. doi: 10.1088/0967-3334/33/2/231.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1088/0967-3334/33/2/231</ArticleId><ArticleId IdType=\"pubmed\">22273713</ArticleId></ArticleIdList></Reference><Reference><Citation>Almenar-P&#xe9;rez E, Sarr&#xed;a L, Nathanson L, Oltra E. Assessing diagnostic value of microRNAs from peripheral blood mononuclear cells and extracellular vesicles in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Sci Rep. 2020;10(1):2064. doi: 10.1038/s41598-020-58506-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-020-58506-5</ArticleId><ArticleId IdType=\"pmc\">PMC7005890</ArticleId><ArticleId IdType=\"pubmed\">32034172</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong CW, McGregor NR, Sheedy JR, Buttfield I, Butt HL, Gooley PR. NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome. Clin Chim Acta. 2012;413(19):1525&#x2013;1531. doi: 10.1016/j.cca.2012.06.022.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cca.2012.06.022</ArticleId><ArticleId IdType=\"pubmed\">22728138</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauensteiner J, Bertinat R, Le&#xf3;n LE, Riederer M, Sep&#xfa;lveda N, Westermeier F. Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients. Sci Rep. 2021;11(1):10604. doi: 10.1038/s41598-021-89834-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-021-89834-9</ArticleId><ArticleId IdType=\"pmc\">PMC8134566</ArticleId><ArticleId IdType=\"pubmed\">34011981</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Hampton D, Marques de Menezes EG, Deng X, Montoya JG, Anderson J, et al. Comparative Analysis of Extracellular Vesicles in Patients with Severe and Mild Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Immunol. 2022;13:841910. doi: 10.3389/fimmu.2022.841910.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2022.841910</ArticleId><ArticleId IdType=\"pmc\">PMC8931328</ArticleId><ArticleId IdType=\"pubmed\">35309313</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, Ashton KJ, Batovska J, Staines DR, Marshall-Gradisnik SM. High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis. PLoS One. 2014;9(9):e102783. doi: 10.1371/journal.pone.0102783.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0102783</ArticleId><ArticleId IdType=\"pmc\">PMC4169517</ArticleId><ArticleId IdType=\"pubmed\">25238588</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, Ashton KJ, van Driel M, Staines DR, Peterson D, Atkinson GM, et al. Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Affect Disord. 2012;141(2):261&#x2013;269. doi: 10.1016/j.jad.2012.03.037.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jad.2012.03.037</ArticleId><ArticleId IdType=\"pubmed\">22572093</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, et al. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Transl Med. 2011;9:81. doi: 10.1186/1479-5876-9-81.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-9-81</ArticleId><ArticleId IdType=\"pmc\">PMC3120691</ArticleId><ArticleId IdType=\"pubmed\">21619669</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabanas H, Muraki K, Eaton N, Balinas C, Staines D, Marshall-Gradisnik S. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. Mol Med. 2018;24(1):44. doi: 10.1186/s10020-018-0046-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s10020-018-0046-1</ArticleId><ArticleId IdType=\"pmc\">PMC6092868</ArticleId><ArticleId IdType=\"pubmed\">30134818</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Serrano-Pertierra E, Oliveira-Rodr&#xed;guez M, Zaragoz&#xe1; MC, Mart&#xed;nez-Mart&#xed;nez A, Blanco-L&#xf3;pez MDC, et al. Circulating extracellular vesicles as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis: an exploratory pilot study. J Extracell Vesicles. 2018;7(1):1453730. doi: 10.1080/20013078.2018.1453730.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/20013078.2018.1453730</ArticleId><ArticleId IdType=\"pmc\">PMC5912186</ArticleId><ArticleId IdType=\"pubmed\">29696075</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacko A, Staines DR, Johnston SC, Marshall-Gradisnik SM. Dysregulation of protein kinase gene expression in NK cells from chronic fatigue syndrome/myalgic encephalomyelitis patients. Gene Regul Syst Biol. 2016;10:85&#x2013;93.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5003121</ArticleId><ArticleId IdType=\"pubmed\">27594784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cliff JM, King EC, Lee JS, Sep&#xfa;lveda N, Wolf AS, Kingdon C, et al. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Front Immunol. 2019;10:796. doi: 10.3389/fimmu.2019.00796.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2019.00796</ArticleId><ArticleId IdType=\"pmc\">PMC6477089</ArticleId><ArticleId IdType=\"pubmed\">31057538</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vega WC, Herrera S, Vernon SD, McGowan PO. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) BMC Med Genomics. 2017;10(1):11. doi: 10.1186/s12920-017-0248-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12920-017-0248-3</ArticleId><ArticleId IdType=\"pmc\">PMC5324230</ArticleId><ArticleId IdType=\"pubmed\">28231836</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo JC, Cordobilla B, Ferrer R, Giralt M, Alegre-Mart&#xed;n J, Castro-Marrero J. Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Antioxid Redox Signal. 2021;34(18):1420&#x2013;1427. doi: 10.1089/ars.2020.8230.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/ars.2020.8230</ArticleId><ArticleId IdType=\"pubmed\">33353469</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton-Fitch N, Du Preez S, Cabanas H, Muraki K, Staines D, Marshall-Gradisnik S. Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients. J Transl Med. 2022;20(1):94. doi: 10.1186/s12967-022-03297-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-022-03297-8</ArticleId><ArticleId IdType=\"pmc\">PMC8848670</ArticleId><ArticleId IdType=\"pubmed\">35172836</ArticleId></ArticleIdList></Reference><Reference><Citation>Eguchi A, Fukuda S, Kuratsune H, Nojima J, Nakatomi Y, Watanabe Y, et al. Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav Immun. 2020;84:106&#x2013;114. doi: 10.1016/j.bbi.2019.11.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2019.11.015</ArticleId><ArticleId IdType=\"pmc\">PMC7010541</ArticleId><ArticleId IdType=\"pubmed\">31759091</ArticleId></ArticleIdList></Reference><Reference><Citation>Escorihuela RM, Capdevila L, Castro JR, Zaragoz&#xe0; MC, Maurel S, Alegre J, et al. Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med. 2020;18(1):4. doi: 10.1186/s12967-019-02184-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-019-02184-z</ArticleId><ArticleId IdType=\"pmc\">PMC6943898</ArticleId><ArticleId IdType=\"pubmed\">31906988</ArticleId></ArticleIdList></Reference><Reference><Citation>Esfandyarpour R, Kashi A, Nemat-Gorgani M, Wilhelmy J, Davis RW. A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Proc Natl Acad Sci U S A. 2019;116(21):10250&#x2013;10257. doi: 10.1073/pnas.1901274116.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1901274116</ArticleId><ArticleId IdType=\"pmc\">PMC6535016</ArticleId><ArticleId IdType=\"pubmed\">31036648</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa P, Urra JM. Decreased Expression of the CD57 Molecule in T lymphocytes of patients with chronic fatigue syndrome. Mol Neurobiol. 2019;56(9):6581&#x2013;6585. doi: 10.1007/s12035-019-1549-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-019-1549-7</ArticleId><ArticleId IdType=\"pubmed\">30895436</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenouillet E, Vigouroux A, Steinberg JG, Chagvardieff A, Retornaz F, Guieu R, et al. Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients. J Transl Med. 2016;14(1):251. doi: 10.1186/s12967-016-1010-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-016-1010-x</ArticleId><ArticleId IdType=\"pmc\">PMC5006431</ArticleId><ArticleId IdType=\"pubmed\">27580693</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher MA, Rosenthal M, Antoni M, Ironson G, Zeng XR, Barnes Z, et al. Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome. Behav Brain Funct. 2010;6:76. doi: 10.1186/1744-9081-6-76.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1744-9081-6-76</ArticleId><ArticleId IdType=\"pmc\">PMC3024290</ArticleId><ArticleId IdType=\"pubmed\">21190576</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher MA, Zeng XR, Barnes Z, Levis S, Klimas NG. Plasma cytokines in women with chronic fatigue syndrome. J Transl Med. 2009;7:96. doi: 10.1186/1479-5876-7-96.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-7-96</ArticleId><ArticleId IdType=\"pmc\">PMC2779802</ArticleId><ArticleId IdType=\"pubmed\">19909538</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher MA, Zeng XR, Maher K, Levis S, Hurwitz B, Antoni M, et al. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. PLoS ONE. 2010;5(5):e10817. doi: 10.1371/journal.pone.0010817.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0010817</ArticleId><ArticleId IdType=\"pmc\">PMC2876037</ArticleId><ArticleId IdType=\"pubmed\">20520837</ArticleId></ArticleIdList></Reference><Reference><Citation>Frith J, Zalewski P, Klawe JJ, Pairman J, Bitner A, Tafil-Klawe M, et al. Impaired blood pressure variability in chronic fatigue syndrome&#x2013;a potential biomarker. QJM. 2012;105(9):831&#x2013;838. doi: 10.1093/qjmed/hcs085.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/qjmed/hcs085</ArticleId><ArticleId IdType=\"pubmed\">22670061</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda S, Nojima J, Motoki Y, Yamaguti K, Nakatomi Y, Okawa N, et al. A potential biomarker for fatigue: oxidative stress and anti-oxidative activity. Biol Psychol. 2016;118:88&#x2013;93. doi: 10.1016/j.biopsycho.2016.05.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopsycho.2016.05.005</ArticleId><ArticleId IdType=\"pubmed\">27224647</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, Gurbaxani BM, Hu J, Heilman KJ, Emanuele Ii VA, Lewis GF, et al. Multiscale analysis of heart rate variability in non-stationary environments. Front Physiol. 2013;4:119. doi: 10.3389/fphys.2013.00119.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2013.00119</ArticleId><ArticleId IdType=\"pmc\">PMC3667239</ArticleId><ArticleId IdType=\"pubmed\">23755016</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Ruppert D, Levine SM, Hanson MR. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism. Mol Biosyst. 2017;13(2):371&#x2013;379. doi: 10.1039/C6MB00600K.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C6MB00600K</ArticleId><ArticleId IdType=\"pmc\">PMC5365380</ArticleId><ArticleId IdType=\"pubmed\">28059425</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Ruppert D, Levine SM, Hanson MR. Prospective biomarkers from plasma metabolomics of myalgic encephalomyelitis/chronic fatigue syndrome implicate redox imbalance in disease symptomatology. Metabolites. 2018;8(4):90. doi: 10.3390/metabo8040090.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/metabo8040090</ArticleId><ArticleId IdType=\"pmc\">PMC6315598</ArticleId><ArticleId IdType=\"pubmed\">30563204</ArticleId></ArticleIdList></Reference><Reference><Citation>Gow JW, Hagan S, Herzyk P, Cannon C, Behan PO, Chaudhuri A. A gene signature for post-infectious chronic fatigue syndrome. BMC Med Genomics. 2009;2:38. doi: 10.1186/1755-8794-2-38.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1755-8794-2-38</ArticleId><ArticleId IdType=\"pmc\">PMC2716361</ArticleId><ArticleId IdType=\"pubmed\">19555476</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravelsina S, Nora-Krukle Z, Vilmane A, Svirskis S, Vecvagare K, Krumina A, et al. Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Biomolecules. 2021;11(8):1189. doi: 10.3390/biom11081189.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom11081189</ArticleId><ArticleId IdType=\"pmc\">PMC8394088</ArticleId><ArticleId IdType=\"pubmed\">34439855</ArticleId></ArticleIdList></Reference><Reference><Citation>Groven N, Fors EA, Stunes AK, Reitan SK. MCP-1 is increased in patients with CFS and FM, whilst several other immune markers are significantly lower than healthy controls. Brain Behav Immun Health. 2020;4:100067. doi: 10.1016/j.bbih.2020.100067.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbih.2020.100067</ArticleId><ArticleId IdType=\"pmc\">PMC8474618</ArticleId><ArticleId IdType=\"pubmed\">34589849</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nther OP, Gardy JL, Stafford P, Fluge &#xd8;, Mella O, Tang P, et al. Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Mol Neurobiol. 2019;56(6):4249&#x2013;4257. doi: 10.1007/s12035-018-1354-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-018-1354-8</ArticleId><ArticleId IdType=\"pmc\">PMC6505503</ArticleId><ArticleId IdType=\"pubmed\">30298340</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N, et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J Transl Med. 2022;20(1):138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType=\"pmc\">PMC8938726</ArticleId><ArticleId IdType=\"pubmed\">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin P, Williams MV, Klimas NG, Fletcher MA, Barnes Z, Ariza ME. Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology. J Med Virol. 2017;89(9):1636&#x2013;1645. doi: 10.1002/jmv.24810.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.24810</ArticleId><ArticleId IdType=\"pmc\">PMC5513753</ArticleId><ArticleId IdType=\"pubmed\">28303641</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanevik K, Kristoffersen EK, S&#xf8;rnes S, M&#xf8;rch K, N&#xe6;ss H, Rivenes AC, et al. Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome. BMC Infect Dis. 2012;12:258. doi: 10.1186/1471-2334-12-258.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2334-12-258</ArticleId><ArticleId IdType=\"pmc\">PMC3553045</ArticleId><ArticleId IdType=\"pubmed\">23061432</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Wong N, et al. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) BMC Immunol. 2015;16(1):35. doi: 10.1186/s12865-015-0101-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12865-015-0101-4</ArticleId><ArticleId IdType=\"pmc\">PMC4450981</ArticleId><ArticleId IdType=\"pubmed\">26032326</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Montoya JG, Klimas NG, Levine S, Felsenstein D, Bateman L, et al. Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci Adv. 2015;1(1):e1400121. doi: 10.1126/sciadv.1400121.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/sciadv.1400121</ArticleId><ArticleId IdType=\"pmc\">PMC4465185</ArticleId><ArticleId IdType=\"pubmed\">26079000</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacob E, Light AR, Donaldson GW, Okifuji A, Hughen RW, White AT, et al. Gene expression factor analysis to differentiate pathways linked to fibromyalgia, chronic fatigue syndrome, and depression in a diverse patient sample. Arthritis Care Res (Hoboken) 2016;68(1):132&#x2013;140. doi: 10.1002/acr.22639.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/acr.22639</ArticleId><ArticleId IdType=\"pmc\">PMC4684820</ArticleId><ArticleId IdType=\"pubmed\">26097208</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawad Kadhum MA. The possible role of interleukin-17a elevation in the development of chronic fatigue syndrome. Indian J Public Health Res Dev. 2018;9(11):1911&#x2013;1915. doi: 10.5958/0976-5506.2018.01728.X.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5958/0976-5506.2018.01728.X</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaiboullina SF, DeMeirleir KL, Rawat S, Berk GS, Gaynor-Berk RS, Mijatovic T, et al. Cytokine expression provides clues to the pathophysiology of Gulf War illness and myalgic encephalomyelitis. Cytokine. 2015;72(1):1&#x2013;8. doi: 10.1016/j.cyto.2014.11.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cyto.2014.11.019</ArticleId><ArticleId IdType=\"pmc\">PMC4410698</ArticleId><ArticleId IdType=\"pubmed\">25514671</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitami T, Fukuda S, Kato T, Yamaguti K, Nakatomi Y, Yamano E, et al. Deep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population. Sci Rep. 2020;10(1):19933. doi: 10.1038/s41598-020-77105-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-020-77105-y</ArticleId><ArticleId IdType=\"pmc\">PMC7669873</ArticleId><ArticleId IdType=\"pubmed\">33199820</ArticleId></ArticleIdList></Reference><Reference><Citation>Landi A, Broadhurst D, Vernon SD, Tyrrell DL, Houghton M. Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome. Cytokine. 2016;78:27&#x2013;36. doi: 10.1016/j.cyto.2015.11.018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cyto.2015.11.018</ArticleId><ArticleId IdType=\"pubmed\">26615570</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidbury BA, Kita B, Lewis DP, Hayward S, Ludlow H, Hedger MP, et al. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study. J Transl Med. 2017;15(1):60. doi: 10.1186/s12967-017-1161-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-017-1161-4</ArticleId><ArticleId IdType=\"pmc\">PMC5353946</ArticleId><ArticleId IdType=\"pubmed\">28302133</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidbury BA, Kita B, Richardson AM, Lewis DP, Privitera E, Hayward S, et al. Rethinking ME/CFS Diagnostic Reference Intervals via Machine Learning, and the Utility of Activin B for Defining Symptom Severity. Diagnostics (Basel) 2019;9(3):79. doi: 10.3390/diagnostics9030079.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics9030079</ArticleId><ArticleId IdType=\"pmc\">PMC6787626</ArticleId><ArticleId IdType=\"pubmed\">31331036</ArticleId></ArticleIdList></Reference><Reference><Citation>Light AR, Bateman L, Jo D, Hughen RW, Vanhaitsma TA, White AT, et al. Gene expression alterations at baseline and following moderate exercise in patients with chronic fatigue syndrome and fibromyalgia syndrome. J Intern Med. 2012;271(1):64&#x2013;81. doi: 10.1111/j.1365-2796.2011.02405.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2796.2011.02405.x</ArticleId><ArticleId IdType=\"pmc\">PMC3175315</ArticleId><ArticleId IdType=\"pubmed\">21615807</ArticleId></ArticleIdList></Reference><Reference><Citation>Light AR, White AT, Hughen RW, Light KC. Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. J Pain. 2009;10(10):1099&#x2013;1112. doi: 10.1016/j.jpain.2009.06.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jpain.2009.06.003</ArticleId><ArticleId IdType=\"pmc\">PMC2757484</ArticleId><ArticleId IdType=\"pubmed\">19647494</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Bosmans E, Kubera M. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers. Neuro Endocrinol Lett. 2015;36(5):439&#x2013;446.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26707044</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Med Sci Monit. 2011;17(4):Sc11&#x2013;5. doi: 10.12659/MSM.881699.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.12659/MSM.881699</ArticleId><ArticleId IdType=\"pmc\">PMC3539515</ArticleId><ArticleId IdType=\"pubmed\">21455120</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Mihaylova I, De Ruyter M. Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in chronic fatigue syndrome (CFS): relevance for the inflammatory response in CFS. Neuro Endocrinol Lett. 2005;26(5):487&#x2013;492.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16264414</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Twisk FN, Kubera M, Ringel K. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-&#x3b1;, PMN-elastase, lysozyme and neopterin. J Affect Disord. 2012;136(3):933&#x2013;939. doi: 10.1016/j.jad.2011.09.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jad.2011.09.004</ArticleId><ArticleId IdType=\"pubmed\">21975140</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher KJ, Klimas NG, Fletcher MA. Chronic fatigue syndrome is associated with diminished intracellular perforin. Clin Exp Immunol. 2005;142(3):505&#x2013;511. doi: 10.1111/j.1365-2249.2005.02935.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2249.2005.02935.x</ArticleId><ArticleId IdType=\"pmc\">PMC1440524</ArticleId><ArticleId IdType=\"pubmed\">16297163</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano AH, Giloteaux L, Keller BA, Levine SM, Hanson MR. Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome. PeerJ. 2018;6:e4282. doi: 10.7717/peerj.4282.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7717/peerj.4282</ArticleId><ArticleId IdType=\"pmc\">PMC5784577</ArticleId><ArticleId IdType=\"pubmed\">29375937</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall-Gradisnik S, Huth T, Chacko A, Johnston S, Smith P, Staines D. Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome. Appl Clin Gen. 2016;9:39&#x2013;47. doi: 10.2147/TACG.S99405.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/TACG.S99405</ArticleId><ArticleId IdType=\"pmc\">PMC4821384</ArticleId><ArticleId IdType=\"pubmed\">27099524</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall-Gradisnik S, Johnston S, Chacko A, Nguyen T, Smith P, Staines D. Single nucleotide polymorphisms and genotypes of transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in myalgic encephalomyelitis/chronic fatigue syndrome patients. J Int Med Res. 2016;44(6):1381&#x2013;1394. doi: 10.1177/0300060516671622.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0300060516671622</ArticleId><ArticleId IdType=\"pmc\">PMC5536760</ArticleId><ArticleId IdType=\"pubmed\">27834303</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew SJ, Mao X, Keegan KA, Levine SM, Smith EL, Heier LA, et al. Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (1)H MRS imaging study. NMR Biomed. 2009;22(3):251&#x2013;8. doi: 10.1002/nbm.1315.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/nbm.1315</ArticleId><ArticleId IdType=\"pubmed\">18942064</ArticleId></ArticleIdList></Reference><Reference><Citation>Melvin A, Lacerda E, Dockrell HM, O\\'Rahilly S, Nacul L. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. 2019;17(1):409. doi: 10.1186/s12967-019-02153-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-019-02153-6</ArticleId><ArticleId IdType=\"pmc\">PMC6892232</ArticleId><ArticleId IdType=\"pubmed\">31801546</ArticleId></ArticleIdList></Reference><Reference><Citation>Metselaar PI, Mendoza-Maldonado L, Li Yim AYF, Abarkan I, Henneman P, Te Velde AA, et al. Recursive ensemble feature selection provides a robust mRNA expression signature for myalgic encephalomyelitis/chronic fatigue syndrome. Sci Rep. 2021;11(1):4541. doi: 10.1038/s41598-021-83660-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-021-83660-9</ArticleId><ArticleId IdType=\"pmc\">PMC7907358</ArticleId><ArticleId IdType=\"pubmed\">33633136</ArticleId></ArticleIdList></Reference><Reference><Citation>Milivojevic M, Che X, Bateman L, Cheng A, Garcia BA, Hornig M, et al. Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS. PLoS One. 2020;15(7):e0236148. doi: 10.1371/journal.pone.0236148.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0236148</ArticleId><ArticleId IdType=\"pmc\">PMC7373296</ArticleId><ArticleId IdType=\"pubmed\">32692761</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, Sanislav O, Allan CY, Annesley SJ, Fisher PR. Cell-Based Blood Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Int J Mol Sci. 2020;21(3):1142. doi: 10.3390/ijms21031142.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21031142</ArticleId><ArticleId IdType=\"pmc\">PMC7037777</ArticleId><ArticleId IdType=\"pubmed\">32046336</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L, de Barros B, Kingdon CC, Cliff JM, Clark TG, Mudie K, et al. Evidence of clinical pathology abnormalities in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) from an analytic cross-sectional study. Diagnostics (Basel). 2019;9(2):41. doi: 10.3390/diagnostics9020041.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics9020041</ArticleId><ArticleId IdType=\"pmc\">PMC6627354</ArticleId><ArticleId IdType=\"pubmed\">30974900</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul LC, Mudie K, Kingdon CC, Clark TG, Lacerda EM. Hand grip strength as a clinical biomarker for ME/CFS and disease severity. Front Neurol. 2018;9:992. doi: 10.3389/fneur.2018.00992.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2018.00992</ArticleId><ArticleId IdType=\"pmc\">PMC6277492</ArticleId><ArticleId IdType=\"pubmed\">30538664</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy-Szakal D, Barupal DK, Lee B, Che X, Williams BL, Kahn EJR, et al. Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. Sci Rep. 2018;8(1):10056. doi: 10.1038/s41598-018-28477-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-018-28477-9</ArticleId><ArticleId IdType=\"pmc\">PMC6030047</ArticleId><ArticleId IdType=\"pubmed\">29968805</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy-Szakal D, Williams BL, Mishra N, Che X, Lee B, Bateman L, et al. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome. 2017;5(1):44. doi: 10.1186/s40168-017-0261-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40168-017-0261-y</ArticleId><ArticleId IdType=\"pmc\">PMC5405467</ArticleId><ArticleId IdType=\"pubmed\">28441964</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson BH, Intriligator R, Cherniack NS, Chandler HK, Stewart JM. Hypocapnia is a biological marker for orthostatic intolerance in some patients with chronic fatigue syndrome. Dyn Med. 2007;6:2. doi: 10.1186/1476-5918-6-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1476-5918-6-2</ArticleId><ArticleId IdType=\"pmc\">PMC1796865</ArticleId><ArticleId IdType=\"pubmed\">17263876</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson BH, Vu D, Coplan JD, Mao X, Blate M, Kang G, et al. Elevations of Ventricular Lactate Levels Occur in Both Chronic Fatigue Syndrome and Fibromyalgia. Fatigue. 2017;5(1):15&#x2013;20.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5754037</ArticleId><ArticleId IdType=\"pubmed\">29308330</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson MJ, Buckley JD, Thomson RL, Bellenger CR, Davison K. Markers of Cardiac Autonomic Function During Consecutive Day Peak Exercise Tests in People With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Physiol. 2021;12:771899. doi: 10.3389/fphys.2021.771899.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2021.771899</ArticleId><ArticleId IdType=\"pmc\">PMC8713453</ArticleId><ArticleId IdType=\"pubmed\">34970156</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson MJ, Buckley JD, Thomson RL, Clark D, Kwiatek R, Davison K. Diagnostic sensitivity of 2-day cardiopulmonary exercise testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Transl Med. 2019;17(1):80. doi: 10.1186/s12967-019-1836-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-019-1836-0</ArticleId><ArticleId IdType=\"pmc\">PMC6417168</ArticleId><ArticleId IdType=\"pubmed\">30871578</ArticleId></ArticleIdList></Reference><Reference><Citation>Nepotchatykh E, Elremaly W, Caraus I, Godbout C, Leveau C, Chalder L, et al. Profile of circulating microRNAs in myalgic encephalomyelitis and their relation to symptom severity, and disease pathophysiology. Sci Rep. 2020;10(1):19620. doi: 10.1038/s41598-020-76438-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-020-76438-y</ArticleId><ArticleId IdType=\"pmc\">PMC7665057</ArticleId><ArticleId IdType=\"pubmed\">33184353</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T, Johnston S, Clarke L, Smith P, Staines D, Marshall-Gradisnik S. Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels. Clin Exp Immunol. 2017;187(2):284&#x2013;293. doi: 10.1111/cei.12882.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/cei.12882</ArticleId><ArticleId IdType=\"pmc\">PMC5217865</ArticleId><ArticleId IdType=\"pubmed\">27727448</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J, Van Oosterwijck J, Meeus M, Lambrecht L, Metzger K, Fr&#xe9;mont M, et al. Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: the role of elastase, complement C4a and interleukin-1beta. J Intern Med. 2010;267(4):418&#x2013;435. doi: 10.1111/j.1365-2796.2009.02178.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2796.2009.02178.x</ArticleId><ArticleId IdType=\"pubmed\">20433584</ArticleId></ArticleIdList></Reference><Reference><Citation>Nkiliza A, Parks M, Cseresznye A, Oberlin S, Evans JE, Darcey T, et al. Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms. J Transl Med. 2021;19(1):370. doi: 10.1186/s12967-021-03035-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-021-03035-6</ArticleId><ArticleId IdType=\"pmc\">PMC8401202</ArticleId><ArticleId IdType=\"pubmed\">34454515</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada T, Tanaka M, Kuratsune H, Watanabe Y, Sadato N. Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol. 2004;4(1):14. doi: 10.1186/1471-2377-4-14.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2377-4-14</ArticleId><ArticleId IdType=\"pmc\">PMC524491</ArticleId><ArticleId IdType=\"pubmed\">15461817</ArticleId></ArticleIdList></Reference><Reference><Citation>Petty RD, McCarthy NE, Dieu RL, Kerr JR. MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential diagnostic biomarkers in natural killer (NK) cells of patients with Chronic Fatigue Syndrome (CFS)/myalgic encephalomyelitis (ME) PLoS One. 2016;11(3):e0150904. doi: 10.1371/journal.pone.0150904.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0150904</ArticleId><ArticleId IdType=\"pmc\">PMC4788442</ArticleId><ArticleId IdType=\"pubmed\">26967895</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell R, Ren J, Lewith G, Barclay W, Holgate S, Almond J. Identification of novel expressed sequences, up-regulated in the leucocytes of chronic fatigue syndrome patients. Clin Exp Allergy. 2003;33(10):1450&#x2013;1456. doi: 10.1046/j.1365-2222.2003.01745.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1046/j.1365-2222.2003.01745.x</ArticleId><ArticleId IdType=\"pubmed\">14519154</ArticleId></ArticleIdList></Reference><Reference><Citation>Provenzano D, Washington SD, Baraniuk JN. A machine learning approach to the differentiation of functional magnetic resonance imaging data of chronic fatigue syndrome (CFS) from a sedentary control. Front Comput Neurosci. 2020;14:2. doi: 10.3389/fncom.2020.00002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncom.2020.00002</ArticleId><ArticleId IdType=\"pmc\">PMC7000378</ArticleId><ArticleId IdType=\"pubmed\">32063839</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayhan RU, Baraniuk JN. Submaximal exercise provokes increased activation of the anterior default mode network during the resting state as a biomarker of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurosci. 2021;15:748426. doi: 10.3389/fnins.2021.748426.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2021.748426</ArticleId><ArticleId IdType=\"pmc\">PMC8714840</ArticleId><ArticleId IdType=\"pubmed\">34975370</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivas JL, Palencia T, Fern&#xe1;ndez G, Garc&#xed;a M. Association of T and NK cell phenotype with the diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Front Immunol. 2018;9:1028. doi: 10.3389/fimmu.2018.01028.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2018.01028</ArticleId><ArticleId IdType=\"pmc\">PMC5954087</ArticleId><ArticleId IdType=\"pubmed\">29867995</ArticleId></ArticleIdList></Reference><Reference><Citation>Saiki T, Kawai T, Morita K, Ohta M, Saito T, Rokutan K, et al. Identification of marker genes for differential diagnosis of chronic fatigue syndrome. Mol Med. 2008;14(9):599&#x2013;607. doi: 10.2119/2007-00059.Saiki.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2119/2007-00059.Saiki</ArticleId><ArticleId IdType=\"pmc\">PMC2442021</ArticleId><ArticleId IdType=\"pubmed\">18596870</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan ZY, Finegan K, Bhuta S, Ireland T, Staines DR, Marshall-Gradisnik SM, et al. Decreased connectivity and increased blood oxygenation level dependent complexity in the default mode network in individuals with chronic fatigue syndrome. Brain Connect. 2018;8(1):33&#x2013;39. doi: 10.1089/brain.2017.0549.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/brain.2017.0549</ArticleId><ArticleId IdType=\"pubmed\">29152994</ArticleId></ArticleIdList></Reference><Reference><Citation>Shishioh-Ikejima N, Ogawa T, Yamaguti K, Watanabe Y, Kuratsune H, Kiyama H. The increase of alpha-melanocyte-stimulating hormone in the plasma of chronic fatigue syndrome patients. BMC Neurol. 2010;10:73. doi: 10.1186/1471-2377-10-73.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2377-10-73</ArticleId><ArticleId IdType=\"pmc\">PMC2933583</ArticleId><ArticleId IdType=\"pubmed\">20731841</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla SK, Cook D, Meyer J, Vernon SD, Le T, Clevidence D, et al. Changes in gut and plasma microbiome following exercise challenge in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) PLoS One. 2015;10(12):e0145453. doi: 10.1371/journal.pone.0145453.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0145453</ArticleId><ArticleId IdType=\"pmc\">PMC4684203</ArticleId><ArticleId IdType=\"pubmed\">26683192</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonato M, Dall\\'Acqua S, Zilli C, Sut S, Tenconi R, Gallo N, et al. Tryptophan metabolites, cytokines, and fatty acid binding protein 2 in myalgic encephalomyelitis/chronic fatigue syndrome. Biomedicines. 2021;9(11):1724. doi: 10.3390/biomedicines9111724.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biomedicines9111724</ArticleId><ArticleId IdType=\"pmc\">PMC8615774</ArticleId><ArticleId IdType=\"pubmed\">34829952</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Stafford P, Schlauch KA, Tillett RR, Gollery M, Johnston SA, et al. Humoral immunity profiling of subjects with myalgic encephalomyelitis using a random peptide microarray differentiates cases from controls with high specificity and sensitivity. Mol Neurobiol. 2016;55(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5472503</ArticleId><ArticleId IdType=\"pubmed\">27981498</ArticleId></ArticleIdList></Reference><Reference><Citation>Snell CR, Stevens SR, Davenport TE, Van Ness JM JM. Discriminative validity of metabolic and workload measurements for identifying people with chronic fatigue syndrome. Physical Therapy. 2013;93(11):1484&#x2013;92. doi: 10.2522/ptj.20110368.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2522/ptj.20110368</ArticleId><ArticleId IdType=\"pubmed\">23813081</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorensen B, Streib JE, Strand M, Make B, Giclas PC, Fleshner M, et al. Complement activation in a model of chronic fatigue syndrome. J Allergy Clin Immunol. 2003;112(2):397&#x2013;403. doi: 10.1067/mai.2003.1615.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1067/mai.2003.1615</ArticleId><ArticleId IdType=\"pubmed\">12897748</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rland K, Sandvik MK, Rekeland IG, Ribu L, Sm&#xe5;stuen MC, Mella O, et al. Reduced endothelial function in myalgic encephalomyelitis/chronic fatigue syndrome&#x2013;results from open-label cyclophosphamide intervention study. Front Med. 2021;8:642710. doi: 10.3389/fmed.2021.642710.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmed.2021.642710</ArticleId><ArticleId IdType=\"pmc\">PMC8019750</ArticleId><ArticleId IdType=\"pubmed\">33829023</ArticleId></ArticleIdList></Reference><Reference><Citation>Stringer EA, Baker KS, Carroll IR, Montoya JG, Chu L, Maecker HT, et al. Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology. J Transl Med. 2013;11:93. doi: 10.1186/1479-5876-11-93.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-11-93</ArticleId><ArticleId IdType=\"pmc\">PMC3637529</ArticleId><ArticleId IdType=\"pubmed\">23570606</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung AP, Tang JJ, Guglielmo MJ, Smith-Gagen J, Bateman L, Navarrete-Galvan L, et al. Antibody-dependent cell-mediated cytotoxicity (ADCC) in familial myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Fatigue. 2020;8(4):226&#x2013;244.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7993113</ArticleId><ArticleId IdType=\"pubmed\">33777500</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E, Kleffmann T, Edgar C, de Lange M, Vallings R, Tate W. A SWATH-MS analysis of myalgic encephalomyelitis/chronic fatigue syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction. J Transl Med. 2020;18(1):365. doi: 10.1186/s12967-020-02533-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-020-02533-3</ArticleId><ArticleId IdType=\"pmc\">PMC7512220</ArticleId><ArticleId IdType=\"pubmed\">32972442</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarski M, Freitag H, Lorenz S, Becker SC, Sotzny F, Bauer S, et al. Delineating the association between soluble CD26 and autoantibodies against G-Protein coupled receptors, immunological and cardiovascular parameters identifies distinct patterns in post-infectious vs. non-infection-triggered myalgic encephalomyelitis/chronic fatigue syndrome. Front Immunol. 2021;12:644548. doi: 10.3389/fimmu.2021.644548.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2021.644548</ArticleId><ArticleId IdType=\"pmc\">PMC8056217</ArticleId><ArticleId IdType=\"pubmed\">33889154</ArticleId></ArticleIdList></Reference><Reference><Citation>Thambirajah AA, Sleigh K, Stiver HG, Chow AW. Differential heat shock protein responses to strenuous standardized exercise in chronic fatigue syndrome patients and matched healthy controls. Clin Invest Med. 2008;31(6):E319&#x2013;E327. doi: 10.25011/cim.v31i6.4917.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.25011/cim.v31i6.4917</ArticleId><ArticleId IdType=\"pubmed\">19032901</ArticleId></ArticleIdList></Reference><Reference><Citation>Thapaliya K, Marshall-Gradisnik S, Staines D, Barnden L. Diffusion tensor imaging reveals neuronal microstructural changes in myalgic encephalomyelitis/chronic fatigue syndrome. Eur J Neurosci. 2021;54:6214. doi: 10.1111/ejn.15413.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/ejn.15413</ArticleId><ArticleId IdType=\"pmc\">PMC9291819</ArticleId><ArticleId IdType=\"pubmed\">34355438</ArticleId></ArticleIdList></Reference><Reference><Citation>Theorell J, Bileviciute-Ljungar I, Tesi B, Schlums H, Johnsgaard MS, Asadi-Azarbaijani B, et al. Unperturbed cytotoxic lymphocyte phenotype and function in myalgic encephalomyelitis/chronic fatigue syndrome patients. Front Immunol. 2017;8:723. doi: 10.3389/fimmu.2017.00723.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2017.00723</ArticleId><ArticleId IdType=\"pmc\">PMC5483846</ArticleId><ArticleId IdType=\"pubmed\">28694809</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiev KP, Demettre E, Ercolano P, Bastide L, Lebleu B, Cabane J. RNase L levels in peripheral blood mononuclear cells: 37-kilodalton/83-kilodalton isoform ratio is a potential test for chronic fatigue syndrome. Clin Diagn Lab Immunol. 2003;10(2):315&#x2013;316.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC150526</ArticleId><ArticleId IdType=\"pubmed\">12626460</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokunaga K, Sung AP, Tang JJ, Guglielmo MJ, Smith-Gagen J, Bateman L, et al. Inclusion of family members without ME/CFS in research studies promotes discovery of biomarkers specific for ME/CFS. Work. 2020;66(2):327&#x2013;337. doi: 10.3233/WOR-203177.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/WOR-203177</ArticleId><ArticleId IdType=\"pubmed\">32568152</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Reeves WC. Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome. J Autoimmune Dis. 2005;2:5. doi: 10.1186/1740-2557-2-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1740-2557-2-5</ArticleId><ArticleId IdType=\"pmc\">PMC1177983</ArticleId><ArticleId IdType=\"pubmed\">15916704</ArticleId></ArticleIdList></Reference><Reference><Citation>White AT, Light AR, Hughen RW, Vanhaitsma TA, Light KC. Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls. Psychosom Med. 2012;74(1):46&#x2013;54. doi: 10.1097/PSY.0b013e31824152ed.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/PSY.0b013e31824152ed</ArticleId><ArticleId IdType=\"pmc\">PMC3256093</ArticleId><ArticleId IdType=\"pubmed\">22210239</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeineh MM, Kang J, Atlas SW, Raman MM, Reiss AL, Norris JL, et al. Right arcuate fasciculus abnormality in chronic fatigue syndrome. Radiology. 2015;274(2):517&#x2013;526. doi: 10.1148/radiol.14141079.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1148/radiol.14141079</ArticleId><ArticleId IdType=\"pubmed\">25353054</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciregia F, Kollipara L, Giusti L, Zahedi RP, Giacomelli C, Mazzoni MR, et al. Bottom-up proteomics suggests an association between differential expression of mitochondrial proteins and chronic fatigue syndrome. Transl Psychiatry. 2016;6(9):e904. doi: 10.1038/tp.2016.184.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/tp.2016.184</ArticleId><ArticleId IdType=\"pmc\">PMC5048217</ArticleId><ArticleId IdType=\"pubmed\">27676445</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, et al. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med. 2012;10:88. doi: 10.1186/1479-5876-10-88.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-10-88</ArticleId><ArticleId IdType=\"pmc\">PMC3464733</ArticleId><ArticleId IdType=\"pubmed\">22571715</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Ramos S, et al. Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. J Transl Med. 2015;13:299. doi: 10.1186/s12967-015-0653-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-015-0653-3</ArticleId><ArticleId IdType=\"pmc\">PMC4568602</ArticleId><ArticleId IdType=\"pubmed\">26370228</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyller VB. The chronic fatigue syndrome&#x2013;an update. Acta Neurol Scand Suppl. 2007;187:7&#x2013;14. doi: 10.1111/j.1600-0404.2007.00840.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1600-0404.2007.00840.x</ArticleId><ArticleId IdType=\"pubmed\">17419822</ArticleId></ArticleIdList></Reference><Reference><Citation>Buford TW, Manini TM. Sedentary individuals as \"controls\" in human studies: the correct approach? Proc Natl Acad Sci U S A. 2010;107(34):E134. doi: 10.1073/pnas.1008118107.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1008118107</ArticleId><ArticleId IdType=\"pmc\">PMC2930538</ArticleId><ArticleId IdType=\"pubmed\">20660311</ArticleId></ArticleIdList></Reference><Reference><Citation>Mata MM, Mahmood F, Sowell RT, Baum LL. Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays. J Immunol Methods. 2014;406:1&#x2013;9. doi: 10.1016/j.jim.2014.01.017.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jim.2014.01.017</ArticleId><ArticleId IdType=\"pmc\">PMC4029863</ArticleId><ArticleId IdType=\"pubmed\">24561308</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenike AE, Halushka MK. miR-21: a non-specific biomarker of all maladies. Biomark Res. 2021;9(1):18. doi: 10.1186/s40364-021-00272-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40364-021-00272-1</ArticleId><ArticleId IdType=\"pmc\">PMC7953557</ArticleId><ArticleId IdType=\"pubmed\">33712063</ArticleId></ArticleIdList></Reference><Reference><Citation>Krier JB, Kalia SS, Green RC. Genomic sequencing in clinical practice: applications, challenges, and opportunities. Dialogues Clin Neurosci. 2016;18(3):299&#x2013;312. doi: 10.31887/DCNS.2016.18.3/jkrier.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.31887/DCNS.2016.18.3/jkrier</ArticleId><ArticleId IdType=\"pmc\">PMC5067147</ArticleId><ArticleId IdType=\"pubmed\">27757064</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton-Fitch N, du Preez S, Cabanas H, Staines D, Marshall-Gradisnik S. A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome. Syst Rev. 2019;8(1):279. doi: 10.1186/s13643-019-1202-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13643-019-1202-6</ArticleId><ArticleId IdType=\"pmc\">PMC6857215</ArticleId><ArticleId IdType=\"pubmed\">31727160</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvao J, Davis B, Tilley M, Normando E, Duchen MR, Cordeiro MF. Unexpected low-dose toxicity of the universal solvent DMSO. Faseb j. 2014;28(3):1317&#x2013;1330. doi: 10.1096/fj.13-235440.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1096/fj.13-235440</ArticleId><ArticleId IdType=\"pubmed\">24327606</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eeden C, Khan L, Osman MS, Cohen Tervaert JW. Natural Killer Cell Dysfunction and Its Role in COVID-19. Int J Mol Sci. 2020;21(17):6351. doi: 10.3390/ijms21176351.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21176351</ArticleId><ArticleId IdType=\"pmc\">PMC7503862</ArticleId><ArticleId IdType=\"pubmed\">32883007</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi J. NK cell dysfunction in patients with COVID-19. Cell Mol Immunol. 2022;19(2):127&#x2013;129. doi: 10.1038/s41423-021-00825-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41423-021-00825-2</ArticleId><ArticleId IdType=\"pmc\">PMC8755515</ArticleId><ArticleId IdType=\"pubmed\">35022604</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L, Valencia IJ, Garvert DW, Montoya JG. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. 2019;7:12. doi: 10.3389/fped.2019.00012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2019.00012</ArticleId><ArticleId IdType=\"pmc\">PMC6370741</ArticleId><ArticleId IdType=\"pubmed\">30805319</ArticleId></ArticleIdList></Reference><Reference><Citation>Holden S, Maksoud R, Eaton-Fitch N, Cabanas H, Staines D, Marshall-Gradisnik S. A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease. J Transl Med. 2020;18(1):290. doi: 10.1186/s12967-020-02452-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-020-02452-3</ArticleId><ArticleId IdType=\"pmc\">PMC7392668</ArticleId><ArticleId IdType=\"pubmed\">32727475</ArticleId></ArticleIdList></Reference><Reference><Citation>Barends M, Verschuren L, Morava E, Nesbitt V, Turnbull D, McFarland R. Causes of death in adults with mitochondrial disease. JIMD Rep. 2016;26:103&#x2013;113. doi: 10.1007/8904_2015_449.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/8904_2015_449</ArticleId><ArticleId IdType=\"pmc\">PMC4864865</ArticleId><ArticleId IdType=\"pubmed\">26354038</ArticleId></ArticleIdList></Reference><Reference><Citation>Taube SE, Clark GM, Dancey JE, McShane LM, Sigman CC, Gutman SI. A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment. J Natl Cancer Inst. 2009;101(21):1453&#x2013;1463. doi: 10.1093/jnci/djp334.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jnci/djp334</ArticleId><ArticleId IdType=\"pmc\">PMC2773185</ArticleId><ArticleId IdType=\"pubmed\">19855077</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" VersionID=\"2\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"2\">37219607</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1432-1459</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>270</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>The association between the number of symptoms and the severity of Post-COVID-Fatigue after SARS-CoV-2 infection treated in an outpatient setting.</ArticleTitle><Pagination><StartPage>3294</StartPage><EndPage>3302</EndPage><MedlinePgn>3294-3302</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s00415-023-11752-9</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Post-COVID-Fatigue (PCF) is one of the most reported symptoms following SARS-CoV-2 infection. Currently, research on persistent symptoms focuses mainly on severe infections, while outpatients are rarely included in observations.</AbstractText><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"OBJECTIVE\">To investigate whether the severity of PCF is related to the number of acute and persistent symptoms due to mild-to-moderate COVID-19 and to compare the most common symptoms during acute infection with the persistent symptoms in PCF patients.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">A total of 425 participants were examined after COVID-19 treated as an outpatient (median 249&#xa0;days [IQR: 135; 322] after acute disease) at the site of University Hospital Augsburg, Germany. The Fatigue Assessment Scale (FAS) was used to quantify the severity of PCF. The number of symptoms (maximum 41) during acute infection and persistent symptoms (during the last 14&#xa0;days before examination) were added up to sum scores. Multivariable linear regression models were used to show the association between the number of symptoms and PCF.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Of the 425 participants, 37% (n&#x2009;=&#x2009;157) developed PCF; most were women (70%). The median number of symptoms was significantly higher in the PCF group than in the non-PCF group at both time points. In multivariable linear regression models, both sum scores were associated with PCF (acute symptoms: &#x3b2;-estimate per additional symptom [95%-CI]: 0.48 [0.39; 0.57], p&#x2009;&lt;&#x2009;0.0001); persistent symptoms: &#x3b2;-estimate per additional symptom [95%-CI]: 1.18 [1.02; 1.34], p&#x2009;&lt;&#x2009;0.0001). The acute symptoms strongest associated with PCF severity were difficulty concentrating, memory problems, dyspnea or shortness of breath on exertion, palpitations, and problems with movement coordination.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"CONCLUSIONS\">Each additional symptom that occurs in COVID-19 increases the likelihood of suffering a higher severity of PCF. Further research is needed to identify the aetiology of PCF.</AbstractText><AbstractText Label=\"TRIAL REGISTRATION\" NlmCategory=\"BACKGROUND\">Nr. NCT04615026. Date of registration: November 4, 2020.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Schmidbauer</LastName><ForeName>Lena</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">0000-0003-2606-8655</Identifier><AffiliationInfo><Affiliation>Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen, Marchioninistra&#xdf;e 15, 81377, Munich, Germany. Schmidbauer.lena@gmx.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pettenkofer School of Public Health, Munich, Germany. Schmidbauer.lena@gmx.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany. Schmidbauer.lena@gmx.de.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kirchberger</LastName><ForeName>Inge</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Epidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Go&#xdf;lau</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Vascular Surgery, Medical Faculty, University of Augsburg, Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Warm</LastName><ForeName>Tobias D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Vascular Surgery, Medical Faculty, University of Augsburg, Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hyhlik-D&#xfc;rr</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vascular Surgery, Medical Faculty, University of Augsburg, Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Linseisen</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Epidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Meisinger</LastName><ForeName>Christa</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Epidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN=\"Y\"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04615026</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086382\" MajorTopicYN=\"Y\">COVID-19</DescriptorName><QualifierName UI=\"Q000150\" MajorTopicYN=\"N\">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D010045\" MajorTopicYN=\"N\">Outpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086402\" MajorTopicYN=\"N\">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012307\" MajorTopicYN=\"N\">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005221\" MajorTopicYN=\"N\">Fatigue</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">FAS</Keyword><Keyword MajorTopicYN=\"N\">ME/CFS</Keyword><Keyword MajorTopicYN=\"N\">Outpatients</Keyword><Keyword MajorTopicYN=\"N\">Post-COVID-Fatigue</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>23</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>23</Day><Hour>11</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37219607</ArticleId><ArticleId IdType=\"pmc\">PMC10204671</ArticleId><ArticleId IdType=\"doi\">10.1007/s00415-023-11752-9</ArticleId><ArticleId IdType=\"pii\">10.1007/s00415-023-11752-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carruthers BM, van de Sande MI, de Meirleir KL, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. 2011;270:327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType=\"pmc\">PMC3427890</ArticleId><ArticleId IdType=\"pubmed\">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheibenbogen C, Volk H-D, Grabowski P et al (2014) Chronisches fatigue-Syndrom: Heutige Vorstellung zur pathogenese, diagnostik und therapie. https://immunologie.charite.de/fileadmin/user_upload/microsites/m_cc12/immunologie/Immundefekt-Ambulanz/Chronisches_Fatigue-Syndrom.pdf. Accessed 26 Jul 2022</Citation></Reference><Reference><Citation>Institut f&#xfc;r Qualit&#xe4;t und Wirtschaftlichkeit im Gesundheitswesen N21-01-ME/CFS: Aktueller Kenntnisstand&#x2014;Berichtsplan&#x2014;Version 1.0 (2022) https://www.iqwig.de/download/n21-01_me-cfs-aktueller-kenntnisstand_berichtsplan_v1-0.pdf. Accessed 26 Jul 2022</Citation></Reference><Reference><Citation>Kwon S, Jin C, Cho S-Y, et al. Analysis of factors affecting post-stroke fatigue: an observational, cross-sectional, retrospective chart review study. Healthcare (Basel) 2021;9:1586. doi: 10.3390/healthcare9111586.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare9111586</ArticleId><ArticleId IdType=\"pmc\">PMC8621383</ArticleId><ArticleId IdType=\"pubmed\">34828631</ArticleId></ArticleIdList></Reference><Reference><Citation>Musch S (2020) ME/CFS k&#xf6;nnte die deutsche Volkswirtschaft jedes Jahr 7,4 Milliarden Euro kosten. https://www.mecfs.de/me-cfs-koennte-die-deutsche-volkswirtschaft-jedes-jahr-74-milliarden-euro-kosten/. Accessed 29 May 2022</Citation></Reference><Reference><Citation>Townsden L, Dyer AH, Jones K, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType=\"pmc\">PMC7652254</ArticleId><ArticleId IdType=\"pubmed\">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;nig RS, Albrich WC, Kahlert CR, et al. The gut microbiome in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) Front Immunol. 2021;12:628741. doi: 10.3389/fimmu.2021.628741.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2021.628741</ArticleId><ArticleId IdType=\"pmc\">PMC8761622</ArticleId><ArticleId IdType=\"pubmed\">35046929</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType=\"pmc\">PMC7833295</ArticleId><ArticleId IdType=\"pubmed\">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType=\"pmc\">PMC8893149</ArticleId><ArticleId IdType=\"pubmed\">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Meisinger C, Go&#xdf;lau Y, Warm TD, et al. Post-COVID-19 fatigue and SARS-CoV-2 specific humoral and T-cell responses in male and female outpatients. Front Immunol. 2022;13:902140. doi: 10.3389/fimmu.2022.902140.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2022.902140</ArticleId><ArticleId IdType=\"pmc\">PMC9178094</ArticleId><ArticleId IdType=\"pubmed\">35693828</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, et al. Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: a population-based study. Int J Environ Res Public Health. 2021;18:256. doi: 10.3390/ijerph18042030.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijerph18042030</ArticleId><ArticleId IdType=\"pmc\">PMC7921928</ArticleId><ArticleId IdType=\"pubmed\">33669714</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth KJ, Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) J Transl Med. 2021;19:162. doi: 10.1186/s12967-021-02833-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-021-02833-2</ArticleId><ArticleId IdType=\"pmc\">PMC8058748</ArticleId><ArticleId IdType=\"pubmed\">33882940</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Nieters A, Kr&#xe4;usslich H-G, et al. Post-acute sequelae of covid-19 six to 12 months after infection: population based study. BMJ. 2022;379:e071050. doi: 10.1136/bmj-2022-071050.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj-2022-071050</ArticleId><ArticleId IdType=\"pmc\">PMC9557001</ArticleId><ArticleId IdType=\"pubmed\">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch B, Kern-Matschilles S, Haschka SJ et al (2021) COVID-19-related symptoms 6 months after the infection&#x2014;update on a prospective cohort study in Germany. https://www.medrxiv.org/content/10.1101/2021.02.12.21251619v1.full-text. Accessed 26 Jul 2022</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. 2021 doi: 10.1101/2021.01.27.21250617.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType=\"pmc\">PMC8352980</ArticleId><ArticleId IdType=\"pubmed\">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung TJ, Neumann C, Bahmer T, et al. Fatigue and cognitive impairment after COVID-19: A prospective multicentre study. EClinicalMedicine. 2022;53:101651. doi: 10.1016/j.eclinm.2022.101651.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.eclinm.2022.101651</ArticleId><ArticleId IdType=\"pmc\">PMC9482331</ArticleId><ArticleId IdType=\"pubmed\">36133318</ArticleId></ArticleIdList></Reference><Reference><Citation>Charti&#xe9;&#x2014;Universit&#xe4;tsmedizin Berlin Post-COVID-Fatigue: Infolge von COVID treten eine Reihe von Langzeitfolgen auf, bei denen Fatigue ein h&#xe4;ufiges Symptom ist (2022) https://cfc.charite.de/fuer_patienten/post_covid_fatigue/. Accessed 11 Jul 2022</Citation></Reference><Reference><Citation>World Health Organization (2022) Coronavirus (COVID-19) dashboard. https://covid19.who.int/. Accessed 26 Jul 2022</Citation></Reference><Reference><Citation>Blankenfeld H, Kaduszkiewicz H, Kochen MM et al (2022) SARS-CoV-2/Covid-19-Informationen &amp; Praxishilfen f&#xfc;r niedergelassene Haus&#xe4;rztinnen und Haus&#xe4;rzte: S2e-Leitlinie. https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S2-Leitlinien/053-054_S2e_SARS-CoV-2%20und%20COVID-19/V22/053-054l_S2e%20Coronavirus_V22_22-02-2022.pdf. Accessed 1 Jul 2022</Citation></Reference><Reference><Citation>Zaim S, Chong JH, Sankaranarayanan V, et al. COVID-19 and multiorgan response. Curr Probl Cardiol. 2020;45:100618. doi: 10.1016/j.cpcardiol.2020.100618.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cpcardiol.2020.100618</ArticleId><ArticleId IdType=\"pmc\">PMC7187881</ArticleId><ArticleId IdType=\"pubmed\">32439197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth KJ, Scheibenbogen C, Paul F. An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Transl Med. 2021;19:471. doi: 10.1186/s12967-021-03143-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-021-03143-3</ArticleId><ArticleId IdType=\"pmc\">PMC8607226</ArticleId><ArticleId IdType=\"pubmed\">34809664</ArticleId></ArticleIdList></Reference><Reference><Citation>ild care foundation (2022) How to use the Fatigue Assessment Scale (FAS)? https://www.ildcare.nl/index.php/how-to-use-the-fas-fatigue-assessment-scale/. Accessed 01 Jul 2022</Citation></Reference><Reference><Citation>Michielsen HJ, de Vries J, van Heck GL. Psychometric qualities of a brief self-rated fatigue measure. J Psychosom Res. 2003;54:345&#x2013;352. doi: 10.1016/s0022-3999(02)00392-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s0022-3999(02)00392-6</ArticleId><ArticleId IdType=\"pubmed\">12670612</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH-B, Wing Y-K, Yu MW-M, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169:2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType=\"pubmed\">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Joli J, Buck P, Zipfel S, et al. Post-COVID-19 fatigue: a systematic review. Front Psychiatry. 2022;13:947973. doi: 10.3389/fpsyt.2022.947973.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fpsyt.2022.947973</ArticleId><ArticleId IdType=\"pmc\">PMC9403611</ArticleId><ArticleId IdType=\"pubmed\">36032234</ArticleId></ArticleIdList></Reference><Reference><Citation>Cope H, David A, Pelosi A, et al. Predictors of chronic \"postviral\" fatigue. The Lancet. 1994;344:864&#x2013;868. doi: 10.1016/S0140-6736(94)92833-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(94)92833-9</ArticleId><ArticleId IdType=\"pubmed\">7916407</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari N, Hosseinian-Far A, Jalali R, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Glob Health. 2020;16:57. doi: 10.1186/s12992-020-00589-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12992-020-00589-w</ArticleId><ArticleId IdType=\"pmc\">PMC7338126</ArticleId><ArticleId IdType=\"pubmed\">32631403</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel A, Steer RA, Beck AT. Are there any gender differences in frequency of self-reported somatic symptoms of depression? J Affect Disord. 2005;89:177&#x2013;181. doi: 10.1016/j.jad.2005.06.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jad.2005.06.009</ArticleId><ArticleId IdType=\"pubmed\">16202455</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, Mc-Corkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType=\"pmc\">PMC8280690</ArticleId><ArticleId IdType=\"pubmed\">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, et al. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022;39:159&#x2013;167. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/fampra/cmab076</ArticleId><ArticleId IdType=\"pmc\">PMC8414057</ArticleId><ArticleId IdType=\"pubmed\">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType=\"pmc\">PMC8155823</ArticleId><ArticleId IdType=\"pubmed\">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27:1507&#x2013;1513. doi: 10.1016/j.cmi.2021.05.033.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType=\"pmc\">PMC8180450</ArticleId><ArticleId IdType=\"pubmed\">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahey GM, Marshall KE, McDonald E, et al. Symptom profiles and progression in hospitalized and nonhospitalized patients with coronavirus disease, Colorado, USA, 2020. Emerg Infect Dis. 2021;27:385&#x2013;395. doi: 10.3201/eid2702.203729.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3201/eid2702.203729</ArticleId><ArticleId IdType=\"pmc\">PMC7853576</ArticleId><ArticleId IdType=\"pubmed\">33496225</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13:1957. doi: 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType=\"pmc\">PMC9005552</ArticleId><ArticleId IdType=\"pubmed\">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. 2022;74:1191&#x2013;1198. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cid/ciab611</ArticleId><ArticleId IdType=\"pmc\">PMC8394862</ArticleId><ArticleId IdType=\"pubmed\">34223884</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37205352</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>25</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2023</Year><Month>Apr</Month><Day>26</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>A Mixed Methods System for the Assessment of Post Exertional Malaise in Encephalomyelitis/Chronic Fatigue Syndrome.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">2023.04.24.23288821</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1101/2023.04.24.23288821</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">A central feature of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is post exertional malaise (PEM), which is an acute worsening of symptoms after a physical, emotional and/or mental exertion. PEM is also a feature of Long COVID. Dynamic measures of PEM have historically included scaled questionnaires which have not been validated in ME/CFS. To enhance our understanding of PEM and how best to measure it, we conducted semi-structured qualitative interviews (QIs) at the same intervals as Visual Analog Scale (VAS) measures after a Cardiopulmonary Exercise Test (CPET).</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">Ten ME/CFS and nine healthy volunteers participated in a CPET. For each participant, PEM symptom VAS (7 symptoms) and semi-structured QIs were administered at six timepoints over 72 hours before and after a single CPET. QI data were used to plot the severity of PEM at each time point and identify the self-described most bothersome symptom for each patient. QI data were used to determine the symptom trajectory and peak of PEM. Performance of QI and VAS data were compared to each other using Spearman correlations.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">QIs documented that each ME/CFS volunteer had a unique PEM experience, with differences noted in the onset, severity, trajectory over time, and most bothersome symptom. No healthy volunteers experienced PEM. Scaled QI data were able to identify PEM peaks and trajectories, even when VAS scales were unable to do so due to known ceiling and floor effects. QI and VAS fatigue data corresponded well prior to exercise (baseline, r=0.7) but poorly at peak PEM (r=0.28) and with the change from baseline to peak (r=0.20). When the most bothersome symptom identified from QIs was used, these correlations improved (r=.0.77, 0.42. and 0.54 respectively) and reduced the observed VAS scale ceiling and floor effects.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"UNASSIGNED\">QIs were able to capture changes in PEM severity and symptom quality over time in all the ME/CFS volunteers, even when VAS scales failed to do so. Information collected from QIs also improved the performance of VAS. Measurement of PEM can be improved by using a quantitative-qualitative mixed model approach.</AbstractText><AbstractText Label=\"DISCLAIMER\" NlmCategory=\"UNASSIGNED\">This research/work/investigator was supported (in part) by the Division of Intramural Research of the National Institutes of Health, NINDS. The content is solely the responsibility of the author(s) and does not necessarily represent the official views of the National Institutes of Health.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Stussman</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Author><Author ValidYN=\"Y\"><LastName>Calco</LastName><ForeName>Brice</ForeName><Initials>B</Initials></Author><Author ValidYN=\"Y\"><LastName>Norato</LastName><ForeName>Gina</ForeName><Initials>G</Initials></Author><Author ValidYN=\"Y\"><LastName>Gavin</LastName><ForeName>Angelique</ForeName><Initials>A</Initials></Author><Author ValidYN=\"Y\"><LastName>Chigurupati</LastName><ForeName>Snigdha</ForeName><Initials>S</Initials></Author><Author ValidYN=\"Y\"><LastName>Nath</LastName><ForeName>Avindra</ForeName><Initials>A</Initials></Author><Author ValidYN=\"Y\"><LastName>Walitt</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D000076942\">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37205352</ArticleId><ArticleId IdType=\"pmc\">PMC10187342</ArticleId><ArticleId IdType=\"doi\">10.1101/2023.04.24.23288821</ArticleId><ArticleId IdType=\"pii\">2023.04.24.23288821</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Unger ER, Lin JS, Brimmer DJ, Lapp CW, Komaroff AL, Nath A, Laird S, Iskander J. CDC Grand Rounds: Chronic Fatigue Syndrome Advancing Research and Clinical Education. MMWR Morb Mortal Wkly Rep. 2016. Dec 30;65(5051):1434 1438.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28033311</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Hartle M, Sullivan K, Bell J, Abbaszadeh S, Unutmaz D, Bateman L. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Work. 2023. Mar 7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Dorri JA. ME/CFS and Post-Exertional Malaise among Patients with Long COVID. Neurol Int. 2022. Dec 20;15(1):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9844405</ArticleId><ArticleId IdType=\"pubmed\">36648965</ArticleId></ArticleIdList></Reference><Reference><Citation>Stussman B, Williams A, Snow J, Gavin A, Scott R, Nath A, Walitt B. Characterization of Post-exertional Malaise in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Neurol. 2020. Sep 18;11:1025.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7530890</ArticleId><ArticleId IdType=\"pubmed\">33071931</ArticleId></ArticleIdList></Reference><Reference><Citation>IOM Report: https://www.ncbi.nlm.nih.gov/books/NBK274235/.</Citation></Reference><Reference><Citation>Stevens S, Snell C, Stevens J, Keller B, VanNess JM. Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Pediatr. 2018. Sep 4;6:242.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6131594</ArticleId><ArticleId IdType=\"pubmed\">30234078</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams VS, Morlock RJ, Feltner D. Psychometric evaluation of a visual analog scale for the assessment of anxiety. Health Qual Life Outcomes. 2010. Jun 8;8:57.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2904728</ArticleId><ArticleId IdType=\"pubmed\">20529361</ArticleId></ArticleIdList></Reference><Reference><Citation>Averbuch M, Katzper M. Assessment of visual analog versus categorical scale for measurement of osteoarthritis pain. J Clin Pharmacol. 2004. Apr;44(4):368&#x2013;72.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15051743</ArticleId></ArticleIdList></Reference><Reference><Citation>Buisman ETIA, Grens H, Wang R, Bhattacharya S, Braat DDM, Huppelschoten AG, van der Steeg JW. Trends in research on pain relief during oocyte retrieval for IVF/ICSI: a systematic, methodological review. Hum Reprod Open. 2022. Feb 16;2022(1):hoac006.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8868119</ArticleId><ArticleId IdType=\"pubmed\">35224230</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen CLMC, Rowe PC, Verheugt FWA, Visser FC. Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Med (Lausanne). 2021. Jan 27;7:602894.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7874746</ArticleId><ArticleId IdType=\"pubmed\">33585505</ArticleId></ArticleIdList></Reference><Reference><Citation>VanNess JM, Stevens SR, Bateman L, Stiles TL, Snell CR. Postexertional malaise in women with chronic fatigue syndrome. J Womens Health (Larchmt). 2010. Feb;19(2):239&#x2013;44.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20095909</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Oosterwijck J, Nijs J, Meeus M, Lefever I, Huybrechts L, Lambrecht L, Paul L. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an experimental study. J Intern Med. 2010. Sep;268(3):265&#x2013;78.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20412374</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook DB, Light AR, Light KC, Broderick G, Shields MR, Dougherty RJ, Meyer JD, VanRiper S, Stegner AJ, Ellingson LD, Vernon SD. Neural consequences of post-exertion malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Brain Behav Immun. 2017. May;62:87&#x2013;99.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28216087</ArticleId></ArticleIdList></Reference><Reference><Citation>Learmonth YC, Paul L, McFadyen AK, Marshall-McKenna R, Mattison P, Miller L, McFarlane NG. Short-term effect of aerobic exercise on symptoms in multiple sclerosis and chronic fatigue syndrome: a pilot study. Int J MS Care. 2014. Summer;16(2):76&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4106394</ArticleId><ArticleId IdType=\"pubmed\">25061431</ArticleId></ArticleIdList></Reference><Reference><Citation>Polli A, Van Oosterwijck J, Nijs J, Marusic U, De Wandele I, Paul L, Meeus M, Moorkens G, Lambrecht L, Ickmans K. Relationship Between Exercise-induced Oxidative Stress Changes and Parasympathetic Activity in Chronic Fatigue Syndrome: An Observational Study in Patients and Healthy Subjects. Clin Ther. 2019. Apr;41(4):641&#x2013;655.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30665828</ArticleId></ArticleIdList></Reference><Reference><Citation>Light AR, Bateman L, Jo D, Hughen RW, Vanhaitsma TA, White AT, Light KC. Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome. J Intern Med. 2012. Jan;271(1):64&#x2013;81.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3175315</ArticleId><ArticleId IdType=\"pubmed\">21615807</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Holtzman CS, Sunnquist M, Cotler J. The development of an instrument to assess post-exertional malaise in patients with myalgic encephalomyelitis and chronic fatigue syndrome. J Health Psychol. 2021. Feb;26(2):238&#x2013;248.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7988339</ArticleId><ArticleId IdType=\"pubmed\">30354489</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Evans M, So S, Scott J, Brown A. Problems in defining post-exertional malaise. J Prev Interv Community. 2015;43(1):20&#x2013;31.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4295644</ArticleId><ArticleId IdType=\"pubmed\">25584525</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock KW, Wang XS, Shi Q, Cleeland CS, Fagundes CP, Vernon SD. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome. Qual Life Res. 2017. Apr;26(4):913&#x2013;921.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5336422</ArticleId><ArticleId IdType=\"pubmed\">27600520</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L, Valencia IJ, Garvert DW, Montoya JG. Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey. PLoS One. 2018. Jun 1;13(6):e0197811.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5983853</ArticleId><ArticleId IdType=\"pubmed\">29856774</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtzman CS, Bhatia S, Cotler J, Jason LA. Assessment of Post Exertional Malaise (PEM) in Patients with Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS): A Patient Driven Survey. Diagnostics (Basel). 2019. Mar 2;9(1).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6468435</ArticleId><ArticleId IdType=\"pubmed\">30832336</ArticleId></ArticleIdList></Reference><Reference><Citation>Boruch AE, Lindheimer JB, Klein-Adams JC, Stegner AJ, Wylie GR, Ninneman JV, Alexander T, Gretzon NP, Samy B, Van Riper SM, Falvo MJ, Cook DB. Predicting post-exertional malaise in Gulf War Illness based on acute exercise responses. Life Sci. 2021. Sep 1;280:119701.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34119538</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindheimer JB, Alexander T, Qian W, Klein-Adams JC, Lange G, Natelson H B, Cook DB, Hill HZ, Falvo MJ. An analysis of 2-day cardiopulmonary exercise testing to assess unexplained fatigue. Physiol Rep. 2020. Sep;8(17):e14564.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7507580</ArticleId><ArticleId IdType=\"pubmed\">32889791</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimek L, Bergmann KC, Biedermann T, et al. Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care. Allergo J Int. 2017;26(1):16&#x2013;24.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5288410</ArticleId><ArticleId IdType=\"pubmed\">28217433</ArticleId></ArticleIdList></Reference><Reference><Citation>Haefeli M, Elfering A. Pain assessment. Eur Spine J. 2006. Jan;15 Suppl 1(Suppl 1):S17&#x2013;24.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3454549</ArticleId><ArticleId IdType=\"pubmed\">16320034</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, Fainsinger R, Aass N, Kaasa; European Palliative Care Research Collaborative (EPCRC). Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage. 2011. Jun;41(6):1073&#x2013;93.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21621130</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotler J, Holtzman C, Dudun C, Jason LA. A Brief Questionnaire to Assess Post-Exertional Malaise. Diagnostics (Basel). 2018. Sep 11;8(3):66.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6165517</ArticleId><ArticleId IdType=\"pubmed\">30208578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujawski S, S&#x142;omko J, Hodges L, Pheby DFH, Murovska M, Newton JL, Zalewski P. Post-Exertional Malaise May Be Related to Central Blood Pressure, Sympathetic Activity and Mental Fatigue in Chronic Fatigue Syndrome Patients. J Clin Med. 2021. May 26;10(11):2327.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8198768</ArticleId><ArticleId IdType=\"pubmed\">34073494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujawski S, S&#x142;omko J, Newton JL, Eaton-Fitch N, Staines DR, Marshall-Gradisnik S, Zalewski P. Network Analysis of Symptoms Co-Occurrence in Chronic Fatigue Syndrome. Int J Environ Res Public Health. 2021. Oct 13;18(20):10736.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8535251</ArticleId><ArticleId IdType=\"pubmed\">34682478</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R, Yeung ST, Wrightson JG, Millet GY, Culos-Reed SN. Post-exertional Malaise in People With Chronic Cancer-Related Fatigue. J Pain Symptom Manage. 2020. Aug;60(2):407&#x2013;416.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32105793</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateo LJ, Chu L, Stevens S, Stevens J, Snell CR, Davenport T, VanNess JM. Post-exertional symptoms distinguish Myalgic Encephalomyelitis/Chronic Fatigue Syndrome subjects from healthy controls. Work. 2020;66(2):265&#x2013;275.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32568143</ArticleId></ArticleIdList></Reference><Reference><Citation>Creswell JW, Plano Clark VL. Designing and conducting mixed methods research, 2nd edition. Thousand Oaks, CA: Sage Publications; 2011.</Citation></Reference><Reference><Citation>Mezzani A. Cardiopulmonary Exercise Testing: Basics of Methodology and Measurements. Ann Am Thorac Soc. 2017. Jul;14(Supplement_1):S3&#x2013;S11. doi: 10.1513/AnnalsATS.201612-997FR.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1513/AnnalsATS.201612-997FR</ArticleId><ArticleId IdType=\"pubmed\">28510504</ArticleId></ArticleIdList></Reference><Reference><Citation>Broderick G, Ben-Hamo R, Vashishtha S, Efroni S, Nathanson L, Barnes Z, Fletcher MA, Klimas N. Altered immune pathway activity under exercise challenge in Gulf War Illness: an exploratory analysis. Brain Behav Immun. 2013. Feb;28:159&#x2013;69.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23201588</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team (2022). R: A language and environment for statistical computing.\\nR Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.</Citation></Reference><Reference><Citation>Taylor R. Interpretation of the Correlation Coefficient: A Basic Review. Journal of Diagnostic Medical Sonography 1990;6:35&#x2013;39.</Citation></Reference><Reference><Citation>Chang CJ, Hung LY, Kogelnik AM, Kaufman D, Aiyar RS, Chu AM, Wilhelmy J, Li P, Tannenbaum L, Xiao W, Davis RW. A Comprehensive Examination of Severely Ill ME/CFS Patients. Healthcare (Basel). 2021. Sep 29;9(10):1290.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8535418</ArticleId><ArticleId IdType=\"pubmed\">34682970</ArticleId></ArticleIdList></Reference><Reference><Citation>May M, Milrad SF, Perdomo DM, Czaja SJ, Fletcher MA, Jutagir DR, Hall DL, Klimas N, Antoni MH. Post-exertional malaise is associated with greater symptom burden and psychological distress in patients diagnosed with Chronic Fatigue Syndrome. J Psychosom Res. 2020. Feb;129:109893.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7007968</ArticleId><ArticleId IdType=\"pubmed\">31884303</ArticleId></ArticleIdList></Reference><Reference><Citation>Beletsky A, Nwachukwu BU, Gorodischer T, Chahla J, Forsythe B, Cole BJ, Verma NN. Psychometric properties of visual analog scale assessments for function, pain, and strength compared with disease-specific upper extremity outcome measures in rotator cuff repair. JSES Int. 2020. May 23;4(3):619&#x2013;624.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7479024</ArticleId><ArticleId IdType=\"pubmed\">32939496</ArticleId></ArticleIdList></Reference><Reference><Citation>Filocamo G, Dav&#xec; S, Pistorio A, Bertamino M, Ruperto N, Lattanzi B, Consolaro A, Magni-Manzoni S, Galasso R, Varnier GC, Martini A, Ravelli A. Evaluation of 21-numbered circle and 10-centimeter horizontal line visual analog scales for physician and parent subjective ratings in juvenile idiopathic arthritis. J Rheumatol. 2010. Jul;37(7):1534.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20551105</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37193573</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Print\">1433-6251</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>99</Volume><Issue>3</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>ZFA. Zeitschrift fur Allgemeinmedizin</Title><ISOAbbreviation>ZFA (Stuttgart)</ISOAbbreviation></Journal><ArticleTitle>[Tiredness/Fatigue-S3&#xa0;guideline update].</ArticleTitle><Pagination><StartPage>127</StartPage><EndPage>132</EndPage><MedlinePgn>127-132</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s44266-023-00045-z</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">Fatigue is one of the most common reasons for seeking medical counseling in the family medicine (FM), often entailing diagnostic uncertainty. Patients use terms describing emotional, cognitive, physical, and behavioral aspects. A&#xa0;number of biological, mental, and social causes may underlie the symptom of fatigue, often in combination. This guideline describes the procedures to be applied for primary undetermined symptomatology.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">The experts involved conducted a&#xa0;systematic search using the terms for fatigue in the context of FM in PubMed, Cochrane Library and via manual search. Concerning related guidelines, the National Institute for Health and Care Excellence (NICE) guideline was used for myalgic encephalitis/chronic fatigue syndrome (ME/CFS). In a&#xa0;structured consensus process, broad approval of the core recommendations/background text of the revised guideline was attained.</AbstractText><AbstractText Label=\"MOST IMPORTANT MESSAGES\" NlmCategory=\"UNASSIGNED\">1)&#xa0;Alongside gathering information concerning the symptom characteristics, the anamnesis aims to collect information about pre-existing health conditions, sleeping behavior, use of drugs and psychosocial factors. 2)&#xa0;Depression and anxiety as two common causes will be identified based on screening questions. The occurrence of post-exertional malaise (PEM) will be inquired. 3)&#xa0;The following basic diagnostics are recommended: physical examination, laboratory tests (blood glucose, full blood count, blood sedimentation/CRP, transaminases/&#x3b3;-GT, TSH). 4)&#xa0;Further examinations should be conducted only in case of specific indications. 5)&#xa0;A biopsychosocial approach is to be adopted. 6)&#xa0;Behavioral therapy and symptom-oriented activating measures can improve fatigue in underlying diseases and undetermined fatigue. 7)&#xa0;In case of PEM, further ME/CFS criteria should be collected and patients have to be supervised accordingly.</AbstractText><CopyrightInformation>&#xa9; The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Kornder</LastName><ForeName>Nele</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Karl-von-Frisch-Str.&#xa0;4, 35043 Marburg, Deutschland Institut f&#xfc;r Allgemeinmedizin, Philipps-Universit&#xe4;t Marburg.</Affiliation><Identifier Source=\"GRID\">grid.10253.35</Identifier><Identifier Source=\"ISNI\">0000 0004 1936 9756</Identifier></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Baum</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Karl-von-Frisch-Str.&#xa0;4, 35043 Marburg, Deutschland Institut f&#xfc;r Allgemeinmedizin, Philipps-Universit&#xe4;t Marburg.</Affiliation><Identifier Source=\"GRID\">grid.10253.35</Identifier><Identifier Source=\"ISNI\">0000 0004 1936 9756</Identifier></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Maisel</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>M&#xfc;nster, Deutschland Centrum f&#xfc;r Allgemeinmedizin, Westf&#xe4;lische Wilhelms-Universit&#xe4;t M&#xfc;nster.</Affiliation><Identifier Source=\"GRID\">grid.5949.1</Identifier><Identifier Source=\"ISNI\">0000 0001 2172 9288</Identifier></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lindner</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Karl-von-Frisch-Str.&#xa0;4, 35043 Marburg, Deutschland Institut f&#xfc;r Allgemeinmedizin, Philipps-Universit&#xe4;t Marburg.</Affiliation><Identifier Source=\"GRID\">grid.10253.35</Identifier><Identifier Source=\"ISNI\">0000 0004 1936 9756</Identifier></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI=\"D004740\">English Abstract</PublicationType><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><VernacularTitle>M&#xfc;digkeit&#xa0;&#x2013; Update der S3-Leitlinie.</VernacularTitle><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>ZFA (Stuttgart)</MedlineTA><NlmUniqueID>7613263</NlmUniqueID><ISSNLinking>1433-6251</ISSNLinking></MedlineJournalInfo><OtherAbstract Type=\"Publisher\" Language=\"ger\"><AbstractText Label=\"HINTERGRUND\">M&#xfc;digkeit ist ein h&#xe4;ufiges Symptom in der Hausarztpraxis, bei dem oft diagnostische Unsicherheit besteht. Betroffene verwenden Beschreibungen, die emotionale, kognitive, k&#xf6;rperliche oder Verhaltensaspekte beinhalten. Eine Vielzahl biologischer, seelischer und sozialer Ursachen ist denkbar, oft in Kombination. Die Leitlinie bezieht sich auf das Vorgehen bei prim&#xe4;r ungekl&#xe4;rter Symptomatik.</AbstractText><AbstractText Label=\"SUCHMETHODEN\">Die beteiligten Expert:innen f&#xfc;hrten eine systematische Recherche mit den Begriffen f&#xfc;r M&#xfc;digkeit im Kontext haus&#xe4;rztlicher Versorgung in PubMed, Cochrane Library und mit Handsuche durch. Bez&#xfc;glich verwandter Leitlinien konnte f&#xfc;r die myalgische Enzephalitis/chronisches Fatigue-Syndrom (ME/CFS) auf die Leitlinie des National Institute of Health and Care Excellence (NICE) zur&#xfc;ckgegriffen werden. In einem strukturierten Konsensprozess wurde weitgehende Zustimmung zu Kernempfehlungen/Hintergrundtext der &#xfc;berarbeiteten Leitlinie erreicht.</AbstractText><AbstractText Label=\"WICHTIGSTE BOTSCHAFTEN\">1)&#xa0;Neben den Charakteristika des Symptoms sollen u.&#x202f;a. Vorerkrankungen, Schlafverhalten, Zufuhr psychotroper Substanzen, psychosoziale und Umweltfaktoren erfragt werden. 2)&#xa0;Depression und Angst sollen als h&#xe4;ufige Ursache anhand von Screeningfragen erfasst, zudem das Auftreten einer postexertionellen Malaise (PEM) erfragt werden. 3)&#xa0;Als Basisdiagnostik wird empfohlen: k&#xf6;rperliche Untersuchung, Laboruntersuchungen (Blutglukose, gro&#xdf;es Blutbild, BSG/CRP, Transaminasen/&#x3b3;-GT, TSH). 4)&#xa0;Weitere Untersuchungen sind nur bei spezifischen Hinweisen indiziert. 5)&#xa0;Ein biopsychosozialer Ansatz ist anzustreben. 6)&#xa0;Verhaltenstherapie und symptomorientierte aktivierende Ma&#xdf;nahmen k&#xf6;nnen M&#xfc;digkeit bei zugrunde liegender Erkrankung sowie bei ungekl&#xe4;rter Ursache verbessern. 7)&#xa0;Bei PEM werden weitere ME/CFS-Kriterien erfasst und Betroffene dementsprechend betreut.</AbstractText><CopyrightInformation>&#xa9; The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2023.</CopyrightInformation></OtherAbstract><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Biopsychosocial approach</Keyword><Keyword MajorTopicYN=\"N\">Family medicine</Keyword><Keyword MajorTopicYN=\"N\">Fatigue</Keyword><Keyword MajorTopicYN=\"N\">General practice</Keyword><Keyword MajorTopicYN=\"N\">Leading symptom</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>21</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37193573</ArticleId><ArticleId IdType=\"pmc\">PMC10124695</ArticleId><ArticleId IdType=\"doi\">10.1007/s44266-023-00045-z</ArticleId><ArticleId IdType=\"pii\">45</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stadje R. M&#xfc;digkeit als Symptom in der Prim&#xe4;rversorgung: eine systematische &#xdc;bersichtsarbeit. Marburg: Philipps-Universit&#xe4;t; 2015.</Citation></Reference><Reference><Citation>W&#xfc;bken M, B&#xfc;hner M, Barth N, Schneider A. Welche Aspekte tragen in der t&#xe4;glichen Routine zur diagnostischen Unsicherheit bei?: Ergebnisse einer haus&#xe4;rztlichen Befragung. Z Allg Med. 2015;2015(92):392&#x2013;398. doi: 10.3238/zfa.2015.0392-0398.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3238/zfa.2015.0392-0398</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely JW, Kaldjian LC, D&#x2019;Alessandro DM. Diagnostic errors in primary care: lessons learned. J Am Board Fam Med. 2012;25(1):87&#x2013;97. doi: 10.3122/jabfm.2012.01.110174.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3122/jabfm.2012.01.110174</ArticleId><ArticleId IdType=\"pubmed\">22218629</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S, Henderson KM, Tapley A, et al. Investigation of fatigue by Australian general practice registrars: a&#xa0;cross-sectional study. J Prim Health Care. 2015;7(2):109&#x2013;116. doi: 10.1071/HC15109.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1071/HC15109</ArticleId><ArticleId IdType=\"pubmed\">26125056</ArticleId></ArticleIdList></Reference><Reference><Citation>Maisel P, Baum E, Donner-Banzhoff N. Fatigue as the chief complaint&#x2014;epidemiology, causes, diagnosis, and treatment. Dtsch Arztebl Int. 2021;118(33&#x2013;34):566&#x2013;576. doi: 10.3238/arztebl.m2021.0192.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3238/arztebl.m2021.0192</ArticleId><ArticleId IdType=\"pmc\">PMC8579431</ArticleId><ArticleId IdType=\"pubmed\">34196270</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum E, Lindner N, Andreas S et&#xa0;al (2022) S3 Leitlinie M&#xfc;digkeit der Deutschen Gesellschaft f&#xfc;r Allgemeinmedizin. https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S3-Leitlinien/053-002_Leitlinie%20Muedigkeit/Aktualisierung%20Dezember%202022/Langfassung%20Leitlinie%20Mu%CC%88digkeit.pdf. Zugegriffen: 10. Jan. 2023</Citation></Reference><Reference><Citation>Baum E, Lindner N, Andreas S et al Deutsche Gesellschaft f&#xfc;r Allgemeinmedizin und Familienmedizin. M&#xfc;digkeit S3-Leitlinie, Leitlinienreport, AWMF-Register-Nr.&#xa0;053-002, Stand Dezember 2022. https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S3-Leitlinien/053-002_Leitlinie%20Muedigkeit/Aktualisierung%20Dezember%202022/Leitlinienreport%20Leitlinie%20Mu%CC%88digkeit.pdf. Zugegriffen: 10. Jan. 2023</Citation></Reference><Reference><Citation>Nacul L, Authier FJ, Scheibenbogen C, et al. European network on myalgic encephalomyelitis/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in europe. Medicina. 2021;57(5):510. doi: 10.3390/medicina57050510.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57050510</ArticleId><ArticleId IdType=\"pmc\">PMC8161074</ArticleId><ArticleId IdType=\"pubmed\">34069603</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview | Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management | Guidance | NICE; 2023 [cited 2023 January 16] Available from: URL: https://www.nice.org.uk/guidance/ng206.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35438859</ArticleId></ArticleIdList></Reference><Reference><Citation> (2022) Homepage GIN. https://g-i-n.net/. Zugegriffen: 16. Jan. 2023</Citation></Reference><Reference><Citation> (2022) S3 Leitlinie M&#xfc;digkeit, Fragebogen zur Anamnese. https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S3-Leitlinien/053-002_Leitlinie%20Muedigkeit/Aktualisierung%20Dezember%202022/Fragebogen%20Leitlinie%20Mu%CC%88digkeit.pdf. Zugegriffen: 10. Jan. 2023</Citation></Reference><Reference><Citation>Baum E, Lindner N, Maisel P (2022) S3 Leitlinie M&#xfc;digkeit Kurzversion. https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S3-Leitlinien/053-002_Leitlinie%20Muedigkeit/Aktualisierung%20Dezember%202022/Kurzfassung%20Leitlinie%20Mu%CC%88digkeit.pdf. Zugegriffen: 10. Jan. 2023</Citation></Reference><Reference><Citation>Horton M, Perry AE. Screening for depression in primary care: a&#xa0;Rasch analysis of the PHQ-9. BJPsych Bull. 2016;40(5):237&#x2013;243. doi: 10.1192/pb.bp.114.050294.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1192/pb.bp.114.050294</ArticleId><ArticleId IdType=\"pmc\">PMC5046780</ArticleId><ArticleId IdType=\"pubmed\">27752340</ArticleId></ArticleIdList></Reference><Reference><Citation>Blank T (2018) Gesundheitsfragebogen f&#xfc;r Patienten (PHQ-9): Psychische Erkrankungen in der Hausarztpraxis:: Abteilung Allgemeinmedizin der Universit&#xe4;t Greifswald. https://kompetenzzentrum-allgemeinmedizin-mv.de/wp-content/uploads/2018/07/PHQ9-Depressionsfragebogen-2018.pdf. Zugegriffen: 10.&#xa0;Jan. 2023</Citation></Reference><Reference><Citation>Katon W, Kleinman A, Rosen G. Depression and somatization: a&#xa0;review. Am J Med. 1982;72(2):241&#x2013;247. doi: 10.1016/0002-9343(82)90816-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0002-9343(82)90816-6</ArticleId><ArticleId IdType=\"pubmed\">6460443</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37182295</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1873-5347</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>327</Volume><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Social science &amp; medicine (1982)</Title><ISOAbbreviation>Soc Sci Med</ISOAbbreviation></Journal><ArticleTitle>Contesting misrecognition online: Experiences of epistemic in/justice by vloggers with contested illnesses.</ArticleTitle><Pagination><StartPage>115951</StartPage><MedlinePgn>115951</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.socscimed.2023.115951</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0277-9536(23)00308-8</ELocationID><Abstract><AbstractText>Contested illnesses, such as fibromyalgia, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and chronic Lyme disease (CLD), are surrounded by polemic debates regarding their etiology, symptomology, treatment, and even their existence. People who suffer from these contested illnesses arguably also suffer from \"epistemic injustice.\" This concept, coined by the philosopher Miranda Fricker, captures how people\\'s knowledge may be discredited because of identity prejudices. In our paper, this concept is used to understand how seven Dutch women with contested illnesses experience the emancipatory potential of their vlogging practices. Our findings show how these women understood their vlogging as a means to break with epistemic smothering, understood as the propensity to cater ones testimony to one\\'s audience (Dotson, 2011), and as a means to attain and enhance epistemic justice. However, our findings also show how vlogging about contested illnesses did not seem to allow these women to fully break with their epistemic smothering practices, and that the ableist design and gendered norms of YouTube were experienced as obstacles to attaining epistemic justice. We conclude that, even though social media do seem to hold emancipatory potential for these women, the experiences of individual users are diverse and ambiguous.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Groenevelt</LastName><ForeName>I P Irene</ForeName><Initials>IPI</Initials><AffiliationInfo><Affiliation>Department of Culture Studies, Tilburg School of Humanities and Digital Sciences, Tilburg University, the Netherlands. Electronic address: I.P.Groenevelt@tilburguniversity.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>de Boer</LastName><ForeName>M L Marjolein</ForeName><Initials>MLM</Initials><AffiliationInfo><Affiliation>Department of Culture Studies, Tilburg School of Humanities and Digital Sciences, Tilburg University, the Netherlands. Electronic address: M.L.deBoer@tilburguniversity.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\\'t</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>05</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Soc Sci Med</MedlineTA><NlmUniqueID>8303205</NlmUniqueID><ISSNLinking>0277-9536</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012935\" MajorTopicYN=\"N\">Social Justice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005356\" MajorTopicYN=\"Y\">Fibromyalgia</DescriptorName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011287\" MajorTopicYN=\"N\">Prejudice</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Contested illness</Keyword><Keyword MajorTopicYN=\"N\">Epistemic injustice</Keyword><Keyword MajorTopicYN=\"N\">Illness experiences</Keyword><Keyword MajorTopicYN=\"N\">Recognition</Keyword><Keyword MajorTopicYN=\"N\">Vlogging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>18</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37182295</ArticleId><ArticleId IdType=\"doi\">10.1016/j.socscimed.2023.115951</ArticleId><ArticleId IdType=\"pii\">S0277-9536(23)00308-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" VersionID=\"2\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"2\">37179299</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1479-5876</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.</ArticleTitle><Pagination><StartPage>322</StartPage><MedlinePgn>322</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">322</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1186/s12967-023-04179-3</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\">Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, heterogenous disease characterized by unexplained persistent fatigue and other features including cognitive impairment, myalgias, post-exertional malaise, and immune system dysfunction. Cytokines are present in plasma and encapsulated in extracellular vesicles (EVs), but there have been only a few reports of EV characteristics and cargo in ME/CFS. Several small studies have previously described plasma proteins or protein pathways that are associated with ME/CFS.</AbstractText><AbstractText Label=\"METHODS\">We prepared extracellular vesicles (EVs) from frozen plasma samples from a cohort of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) cases and controls with prior published plasma cytokine and plasma proteomics data. The cytokine content of the plasma-derived extracellular vesicles was determined by a multiplex assay and differences between patients and controls were assessed. We then performed multi-omic statistical analyses that considered not only this new data, but extensive clinical data describing the health of the subjects.</AbstractText><AbstractText Label=\"RESULTS\">ME/CFS cases exhibited greater size and concentration of EVs in plasma. Assays of cytokine content in EVs revealed IL2 was significantly higher in cases. We observed numerous correlations among EV cytokines, among plasma cytokines, and among plasma proteins from mass spectrometry proteomics. Significant correlations between clinical data and protein levels suggest roles of particular proteins and pathways in the disease. For example, higher levels of the pro-inflammatory cytokines Granulocyte-Monocyte Colony-Stimulating Factor (CSF2) and Tumor Necrosis Factor (TNF&#x3b1;) were correlated with greater physical and fatigue symptoms in ME/CFS cases. Higher serine protease SERPINA5, which is involved in hemostasis, was correlated with higher SF-36 general health scores in ME/CFS. Machine learning classifiers were able to identify a list of 20 proteins that could discriminate between cases and controls, with XGBoost providing the best classification with 86.1% accuracy and a cross-validated AUROC value of 0.947. Random Forest distinguished cases from controls with 79.1% accuracy and an AUROC value of 0.891 using only 7 proteins.</AbstractText><AbstractText Label=\"CONCLUSIONS\">These findings add to the substantial number of objective differences in biomolecules that have been identified in individuals with ME/CFS. The observed correlations of proteins important in immune responses and hemostasis with clinical data further implicates a disturbance of these functions in ME/CFS.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Giloteaux</LastName><ForeName>Ludovic</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Genetics, Cornell University, 323 Biotechnology Building, 526 Campus Road, Ithaca, NY, 14853, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Li</LastName><ForeName>Jiayin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Statistics and Data Science, Cornell University, Ithaca, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hornig</LastName><ForeName>Mady</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lipkin</LastName><ForeName>W Ian</ForeName><Initials>WI</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Columbia University Mailman School of Public Health, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Neurology and Pathology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ruppert</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Statistics and Data Science, Cornell University, Ithaca, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Operations Research and Information Engineering, Cornell University, Ithaca, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hanson</LastName><ForeName>Maureen R</ForeName><Initials>MR</Initials><Identifier Source=\"ORCID\">0000-0001-8141-3058</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology and Genetics, Cornell University, 323 Biotechnology Building, 526 Campus Road, Ithaca, NY, 14853, USA. mrh5@cornell.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>U54NS105541</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI109761</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013486\">Research Support, U.S. Gov\\'t, Non-P.H.S.</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\\'t</PublicationType><PublicationType UI=\"D052061\">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016207\">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016207\" MajorTopicYN=\"Y\">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D040901\" MajorTopicYN=\"N\">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002450\" MajorTopicYN=\"N\">Cell Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016022\" MajorTopicYN=\"N\">Case-Control Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Cytokines</Keyword><Keyword MajorTopicYN=\"N\">Extracellular vesicles</Keyword><Keyword MajorTopicYN=\"N\">Myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">Plasma</Keyword><Keyword MajorTopicYN=\"N\">Proteomics</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37179299</ArticleId><ArticleId IdType=\"pmc\">PMC10182359</ArticleId><ArticleId IdType=\"doi\">10.1186/s12967-023-04179-3</ArticleId><ArticleId IdType=\"pii\">10.1186/s12967-023-04179-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>IoM C. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness . Washington: National Academies Press; 2015.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia JKS. The role of enterovirus in chronic fatigue syndrome. J Clin Pathol. 2005;11:1126. doi: 10.1136/jcp.2004.020255.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jcp.2004.020255</ArticleId><ArticleId IdType=\"pmc\">PMC1770761</ArticleId><ArticleId IdType=\"pubmed\">16254097</ArticleId></ArticleIdList></Reference><Reference><Citation>O\\'Neal AJ, Hanson MR. The enterovirus theory of disease etiology in myalgic encephalomyelitis/chronic fatigue syndrome: a critical review. Front Med. 2021;8:688486. doi: 10.3389/fmed.2021.688486.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmed.2021.688486</ArticleId><ArticleId IdType=\"pmc\">PMC8253308</ArticleId><ArticleId IdType=\"pubmed\">34222292</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson MR, Germain A. Letter to the editor of metabolites. Metabolites. 2020;10(5):216. doi: 10.3390/metabo10050216.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/metabo10050216</ArticleId><ArticleId IdType=\"pmc\">PMC7281557</ArticleId><ArticleId IdType=\"pubmed\">32466160</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re\\'em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType=\"pmc\">PMC8280690</ArticleId><ArticleId IdType=\"pubmed\">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva OA, Maksoud R, Beeraka NM, Madhunapantula SV, Sinelnikov M, Nikolenko VN, et al. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J Adv Res. 2022;40:179&#x2013;196. doi: 10.1016/j.jare.2021.11.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType=\"pmc\">PMC8619886</ArticleId><ArticleId IdType=\"pubmed\">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Gifford EJ, Vahey J, Hauser ER, Sims KJ, Efird JT, Dursa EK, et al. Gulf War illness in the Gulf War era cohort and biorepository: the Kansas and centers for disease control definitions. Life Sci. 2021;278:119454. doi: 10.1016/j.lfs.2021.119454.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.lfs.2021.119454</ArticleId><ArticleId IdType=\"pmc\">PMC10148241</ArticleId><ArticleId IdType=\"pubmed\">33811897</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraniuk JN. Review of the midbrain ascending arousal network nuclei and implications for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Gulf War Illness (GWI) and Postexertional Malaise (PEM) Brain Sci. 2022;12(2):132. doi: 10.3390/brainsci12020132.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/brainsci12020132</ArticleId><ArticleId IdType=\"pmc\">PMC8870178</ArticleId><ArticleId IdType=\"pubmed\">35203896</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraniuk JN, Casado B, Maibach H, Clauw DJ, Pannell LK, Hess SS. A chronic fatigue syndrome&#x2013;related proteome in human cerebrospinal fluid. BMC Neurol. 2005;5(1):1&#x2013;19. doi: 10.1186/1471-2377-5-22.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2377-5-22</ArticleId><ArticleId IdType=\"pmc\">PMC1326206</ArticleId><ArticleId IdType=\"pubmed\">16321154</ArticleId></ArticleIdList></Reference><Reference><Citation>Schutzer SE, Angel TE, Liu T, Schepmoes AA, Clauss TR, Adkins JN, et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS ONE. 2011;6(2):e17287. doi: 10.1371/journal.pone.0017287.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0017287</ArticleId><ArticleId IdType=\"pmc\">PMC3044169</ArticleId><ArticleId IdType=\"pubmed\">21383843</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Ruppert D, Levine SM, Hanson MR. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism. Mol BioSyst. 2017;13(2):371&#x2013;379. doi: 10.1039/C6MB00600K.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C6MB00600K</ArticleId><ArticleId IdType=\"pmc\">PMC5365380</ArticleId><ArticleId IdType=\"pubmed\">28059425</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Ruppert D, Levine SM, Hanson MR. Prospective biomarkers from plasma metabolomics of myalgic encephalomyelitis/chronic fatigue syndrome implicate redox imbalance in disease symptomatology. Metabolites. 2018;8(4):90. doi: 10.3390/metabo8040090.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/metabo8040090</ArticleId><ArticleId IdType=\"pmc\">PMC6315598</ArticleId><ArticleId IdType=\"pubmed\">30563204</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy-Szakal D, Barupal DK, Lee B, Che X, Williams BL, Kahn EJ, et al. Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. Sci Rep. 2018;8(1):10056. doi: 10.1038/s41598-018-28477-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-018-28477-9</ArticleId><ArticleId IdType=\"pmc\">PMC6030047</ArticleId><ArticleId IdType=\"pubmed\">29968805</ArticleId></ArticleIdList></Reference><Reference><Citation>Milivojevic M, Che X, Bateman L, Cheng A, Garcia BA, Hornig M, et al. Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS. PLoS ONE. 2020;15(7):e0236148. doi: 10.1371/journal.pone.0236148.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0236148</ArticleId><ArticleId IdType=\"pmc\">PMC7373296</ArticleId><ArticleId IdType=\"pubmed\">32692761</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleshner M, Crane CR. Exosomes, DAMPs and miRNA: features of stress physiology and immune homeostasis. Trends Immunol. 2017;38(10):768&#x2013;776. doi: 10.1016/j.it.2017.08.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.it.2017.08.002</ArticleId><ArticleId IdType=\"pmc\">PMC5624844</ArticleId><ArticleId IdType=\"pubmed\">28838855</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes BJ, Somerville CC. Modulating cytokine production via select packaging and secretion from extracellular vesicles. Front Immunol. 2020;11:1040. doi: 10.3389/fimmu.2020.01040.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2020.01040</ArticleId><ArticleId IdType=\"pmc\">PMC7272603</ArticleId><ArticleId IdType=\"pubmed\">32547552</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, et al. Alzheimer&#x2019;s disease &#x3b2;-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci. 2006;103(30):11172&#x2013;11177. doi: 10.1073/pnas.0603838103.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0603838103</ArticleId><ArticleId IdType=\"pmc\">PMC1544060</ArticleId><ArticleId IdType=\"pubmed\">16837572</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#x142;omka A, Urban SK, Lukacs-Kornek V, &#x17b;ekanowska E, Kornek M. Large extracellular vesicles: have we found the holy grail of inflammation? Front Immunol. 2018;9:2723. doi: 10.3389/fimmu.2018.02723.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2018.02723</ArticleId><ArticleId IdType=\"pmc\">PMC6300519</ArticleId><ArticleId IdType=\"pubmed\">30619239</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon YJ, Kim OY, Gho YS. Extracellular vesicles as emerging intercellular communicasomes. BMB Rep. 2014;47(10):531. doi: 10.5483/BMBRep.2014.47.10.164.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5483/BMBRep.2014.47.10.164</ArticleId><ArticleId IdType=\"pmc\">PMC4261509</ArticleId><ArticleId IdType=\"pubmed\">25104400</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung KH, Chu K, Lee ST, Park HK, Bahn JJ, Kim DH, et al. Circulating endothelial microparticles as a marker of cerebrovascular disease. Ann Neurol Off J Am Neurol Assoc Child Neurol Soc. 2009;66(2):191&#x2013;199.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19743467</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;nig L, Kasimir-Bauer S, Bittner A-K, Hoffmann O, Wagner B, Santos Manvailer LF, et al. Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy. Oncoimmunology. 2018;7(1):e1376153. doi: 10.1080/2162402X.2017.1376153.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/2162402X.2017.1376153</ArticleId><ArticleId IdType=\"pmc\">PMC5739576</ArticleId><ArticleId IdType=\"pubmed\">29296534</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C-H, Im E-J, Moon P-G, Baek M-C. Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles. BMC Cancer. 2018;18(1):1&#x2013;11. doi: 10.1186/s12885-018-4952-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12885-018-4952-y</ArticleId><ArticleId IdType=\"pmc\">PMC6211419</ArticleId><ArticleId IdType=\"pubmed\">30382917</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Serrano-Pertierra E, Oliveira-Rodr&#xed;guez M, Zaragoz&#xe1; MC, Mart&#xed;nez-Mart&#xed;nez A, Blanco-L&#xf3;pez MC, et al. Circulating extracellular vesicles as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis: an exploratory pilot study. J Extracell Vesicles. 2018;7(1):1453730. doi: 10.1080/20013078.2018.1453730.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/20013078.2018.1453730</ArticleId><ArticleId IdType=\"pmc\">PMC5912186</ArticleId><ArticleId IdType=\"pubmed\">29696075</ArticleId></ArticleIdList></Reference><Reference><Citation>Eguchi A, Fukuda S, Kuratsune H, Nojima J, Nakatomi Y, Watanabe Y, et al. Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav Immun. 2020;84:106&#x2013;114. doi: 10.1016/j.bbi.2019.11.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2019.11.015</ArticleId><ArticleId IdType=\"pmc\">PMC7010541</ArticleId><ArticleId IdType=\"pubmed\">31759091</ArticleId></ArticleIdList></Reference><Reference><Citation>Giloteaux L, O\\'Neal A, Castro-Marrero J, Levine SM, Hanson MR. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study. J Transl Med. 2020;18(1):387. doi: 10.1186/s12967-020-02560-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-020-02560-0</ArticleId><ArticleId IdType=\"pmc\">PMC7552484</ArticleId><ArticleId IdType=\"pubmed\">33046133</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy-Szakal D, Williams BL, Mishra N, Che X, Lee B, Bateman L, et al. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome. 2017;5(1):44. doi: 10.1186/s40168-017-0261-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40168-017-0261-y</ArticleId><ArticleId IdType=\"pmc\">PMC5405467</ArticleId><ArticleId IdType=\"pubmed\">28441964</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimas NG, Ironson G, Carter A, Balbin E, Bateman L, Felsenstein D, et al. Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome. Fatigue Biomed Health Behav. 2015;3:75&#x2013;96. doi: 10.1080/21641846.2015.1023652.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21641846.2015.1023652</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121(12):953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType=\"pubmed\">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndrome. 2003;11:7&#x2013;115. doi: 10.1300/J092v11n01_02.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30(6):473&#x2013;483. doi: 10.1097/00005650-199206000-00002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00005650-199206000-00002</ArticleId><ArticleId IdType=\"pubmed\">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Smets EM, Garssen B, Bonke B, De Haes JC. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315&#x2013;325. doi: 10.1016/0022-3999(94)00125-O.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0022-3999(94)00125-O</ArticleId><ArticleId IdType=\"pubmed\">7636775</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald W, Freeman ML, Lederman MM, Vasilieva E, Romero R, Margolis L. A System of cytokines encapsulated in extracellular vesicles. Sci Rep. 2018;8(1):8973. doi: 10.1038/s41598-018-27190-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-018-27190-x</ArticleId><ArticleId IdType=\"pmc\">PMC5997670</ArticleId><ArticleId IdType=\"pubmed\">29895824</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber PJ. Robust statistics. New York: John Wiley &amp; Sons; 1981.</Citation></Reference><Reference><Citation>Huber PJ. Robust estimation of a location parameter. Ann Math Stat. 1964;35:73&#x2013;101. doi: 10.1214/aoms/1177703732.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1214/aoms/1177703732</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg FH. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57(1):289&#x2013;300.</Citation></Reference><Reference><Citation>Benjamini Y, Krieger AM, Yekutieli D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika. 2006;3(3):491&#x2013;507. doi: 10.1093/biomet/93.3.491.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/biomet/93.3.491</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiman L. Random forests. Mach Learn. 2001;45:5&#x2013;32. doi: 10.1023/A:1010933404324.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1023/A:1010933404324</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Guestrin C, editors. XGBoost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining KDD 16; 2016.</Citation></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the lasso. J Roy Stat Soc Ser B. 1996;58:267&#x2013;288.</Citation></Reference><Reference><Citation>Yanez-Mo M, Siljander PR, Andreu Z, Zavec AB, Borras FE, Buzas EI, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066. doi: 10.3402/jev.v4.27066.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3402/jev.v4.27066</ArticleId><ArticleId IdType=\"pmc\">PMC4433489</ArticleId><ArticleId IdType=\"pubmed\">25979354</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Montoya JG, Klimas NG, Levine S, Felsenstein D, Bateman L, et al. Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci Adv. 2015;1(1):e1400121. doi: 10.1126/sciadv.1400121.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/sciadv.1400121</ArticleId><ArticleId IdType=\"pmc\">PMC4465185</ArticleId><ArticleId IdType=\"pubmed\">26079000</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Serrano-Pertierra E, Oliveira-Rodriguez M, Zaragoza MC, Martinez-Martinez A, Blanco-Lopez MDC, et al. Circulating extracellular vesicles as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis: an exploratory pilot study. J Extracell Vesicles. 2018;7(1):1453730. doi: 10.1080/20013078.2018.1453730.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/20013078.2018.1453730</ArticleId><ArticleId IdType=\"pmc\">PMC5912186</ArticleId><ArticleId IdType=\"pubmed\">29696075</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ, et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci USA. 2017;114(34):E7150&#x2013;E7158. doi: 10.1073/pnas.1710519114.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1710519114</ArticleId><ArticleId IdType=\"pmc\">PMC5576836</ArticleId><ArticleId IdType=\"pubmed\">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Gaglio CL, Furst J, Islam M, Sorenson M, Conroy KE, et al. Cytokine network analysis in a community-based pediatric sample of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chronic Illn. 2022 doi: 10.1177/17423953221101606.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/17423953221101606</ArticleId><ArticleId IdType=\"pmc\">PMC9666669</ArticleId><ArticleId IdType=\"pubmed\">35570777</ArticleId></ArticleIdList></Reference><Reference><Citation>Strawbridge R, Sartor ML, Scott F, Cleare AJ. Inflammatory proteins are altered in chronic fatigue syndrome&#x2014;a systematic review and meta-analysis. Neurosci Biobehav Rev. 2019;107:69&#x2013;83. doi: 10.1016/j.neubiorev.2019.08.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neubiorev.2019.08.011</ArticleId><ArticleId IdType=\"pubmed\">31465778</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Gottschalk G, Peterson D, Knox K, Schultz A, Eddy M, et al. Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. Mol Psychiatry. 2016;21(2):261&#x2013;269. doi: 10.1038/mp.2015.29.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/mp.2015.29</ArticleId><ArticleId IdType=\"pubmed\">25824300</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheney PR, Dorman SE, Bell DS. Interleukin-2 and the chronic fatigue syndrome. Ann Intern Med. 1989;110(4):321. doi: 10.7326/0003-4819-110-4-321_1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-110-4-321_1</ArticleId><ArticleId IdType=\"pubmed\">2783643</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Cotler J, Islam MF, Furst J, Sorenson M, Katz BZ. Cytokine networks analysis uncovers further differences between those who develop myalgic encephalomyelitis/chronic fatigue syndrome following infectious mononucleosis. Fatigue Biomed Health Behav. 2021;9(1):45&#x2013;57. doi: 10.1080/21641846.2021.1915131.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21641846.2021.1915131</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Dorling A. Critical roles for thrombin in acute and chronic inflammation. J Thromb Haemost. 2009;7(Suppl 1):122&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19630783</ArticleId></ArticleIdList></Reference><Reference><Citation>Hercus TR, Broughton SE, Ekert PG, Ramshaw HS, Perugini M, Grimbaldeston M, et al. The GM-CSF receptor family: mechanism of activation and implications for disease. Growth Factors. 2012;30(2):63&#x2013;75. doi: 10.3109/08977194.2011.649919.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/08977194.2011.649919</ArticleId><ArticleId IdType=\"pubmed\">22257375</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyette LB, Macedo C, Hadi K, Elinoff BD, Walters JT, Ramaswami B, et al. Phenotype, function, and differentiation potential of human monocyte subsets. PLoS ONE. 2017;12(4):e0176460. doi: 10.1371/journal.pone.0176460.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0176460</ArticleId><ArticleId IdType=\"pmc\">PMC5406034</ArticleId><ArticleId IdType=\"pubmed\">28445506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed F, Vu LT, Zhu H, Iu DSH, Fogarty EA, Kwak Y, et al. Single-cell transcriptomics of the immune system in ME/CFS at baseline and following symptom provocation. BioRXiv. 2022 doi: 10.1101/2022.10.13.512091.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2022.10.13.512091</ArticleId><ArticleId IdType=\"pubmed\">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29(6):313&#x2013;326. doi: 10.1089/jir.2008.0027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/jir.2008.0027</ArticleId><ArticleId IdType=\"pmc\">PMC2755091</ArticleId><ArticleId IdType=\"pubmed\">19441883</ArticleId></ArticleIdList></Reference><Reference><Citation>Stringer EA, Baker KS, Carroll IR, Montoya JG, Chu L, Maecker HT, et al. Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology. J Transl Med. 2013;11:93. doi: 10.1186/1479-5876-11-93.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-11-93</ArticleId><ArticleId IdType=\"pmc\">PMC3637529</ArticleId><ArticleId IdType=\"pubmed\">23570606</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazirinejad R, Ahmadi Z, Kazemi Arababadi M, Hassanshahi G, Kennedy D. The biological functions, structure and sources of CXCL10 and its outstanding part in the pathophysiology of multiple sclerosis. NeuroImmunoModulation. 2014;21(6):322&#x2013;330. doi: 10.1159/000357780.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000357780</ArticleId><ArticleId IdType=\"pubmed\">24642726</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011;477(7362):90&#x2013;94. doi: 10.1038/nature10357.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature10357</ArticleId><ArticleId IdType=\"pmc\">PMC3170097</ArticleId><ArticleId IdType=\"pubmed\">21886162</ArticleId></ArticleIdList></Reference><Reference><Citation>Patarca R, Klimas NG, Lugtendorf S, Antoni M, Fletcher MA. Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. Clin Infect Dis. 1994;18(Suppl 1):S147&#x2013;S153. doi: 10.1093/clinids/18.Supplement_1.S147.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/clinids/18.Supplement_1.S147</ArticleId><ArticleId IdType=\"pubmed\">8148443</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss RB, Mercandetti A, Vojdani A. TNF-alpha and chronic fatigue syndrome. J Clin Immunol. 1999;19(5):314&#x2013;316. doi: 10.1023/A:1020595709352.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1023/A:1020595709352</ArticleId><ArticleId IdType=\"pubmed\">10535608</ArticleId></ArticleIdList></Reference><Reference><Citation>Fruhbeck G, Catalan V, Ramirez B, Valenti V, Becerril S, Rodriguez A, et al. Serum levels of IL-1 RA increase with obesity and type 2 diabetes in relation to adipose tissue dysfunction and are reduced after bariatric surgery in parallel to adiposity. J Inflamm Res. 2022;15:1331&#x2013;1345. doi: 10.2147/JIR.S354095.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/JIR.S354095</ArticleId><ArticleId IdType=\"pmc\">PMC8884708</ArticleId><ArticleId IdType=\"pubmed\">35237063</ArticleId></ArticleIdList></Reference><Reference><Citation>Luotola K. IL-1 receptor antagonist (IL-1Ra) levels and management of metabolic disorders. Nutrients. 2022;14(16):3422. doi: 10.3390/nu14163422.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu14163422</ArticleId><ArticleId IdType=\"pmc\">PMC9415765</ArticleId><ArticleId IdType=\"pubmed\">36014927</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher MA, Zeng XR, Barnes Z, Levis S, Klimas NG. Plasma cytokines in women with chronic fatigue syndrome. J Transl Med. 2009;7:96. doi: 10.1186/1479-5876-7-96.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-7-96</ArticleId><ArticleId IdType=\"pmc\">PMC2779802</ArticleId><ArticleId IdType=\"pubmed\">19909538</ArticleId></ArticleIdList></Reference><Reference><Citation>Gierula M, Ahnstrom J. Anticoagulant protein S-New insights on interactions and functions. J Thromb Haemost. 2020;18(11):2801&#x2013;2811. doi: 10.1111/jth.15025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jth.15025</ArticleId><ArticleId IdType=\"pubmed\">32702208</ArticleId></ArticleIdList></Reference><Reference><Citation>Taheri H, Filion KB, Windle SB, Reynier P, Eisenberg MJ. Cholesteryl ester transfer protein inhibitors and cardiovascular outcomes: a systematic review and meta-analysis of randomized controlled trials. Cardiology. 2020;145(4):236&#x2013;250. doi: 10.1159/000505365.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000505365</ArticleId><ArticleId IdType=\"pubmed\">32172237</ArticleId></ArticleIdList></Reference><Reference><Citation>Maya J, Leddy S, Gottschalk C, Peterson D, Hanson MR. Altered fatty acid oxidation in lymphocyte populations of myalgic encephalomyelitis/chronic fatigue syndrome. Int J Mol Med. 2023;24(3):2010.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9916395</ArticleId><ArticleId IdType=\"pubmed\">36768336</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Geiger M. Cell penetrating SERPINA5 (ProteinC inhibitor, PCI): more questions than answers. Semin Cell Dev Biol. 2017;62:187&#x2013;193. doi: 10.1016/j.semcdb.2016.10.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.semcdb.2016.10.007</ArticleId><ArticleId IdType=\"pubmed\">27989561</ArticleId></ArticleIdList></Reference><Reference><Citation>Marlar RA, Griffin JH. Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J Clin Invest. 1980;66(5):1186&#x2013;1189. doi: 10.1172/JCI109952.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI109952</ArticleId><ArticleId IdType=\"pmc\">PMC371561</ArticleId><ArticleId IdType=\"pubmed\">6253526</ArticleId></ArticleIdList></Reference><Reference><Citation>Elisen MG, von dem Borne PA, Bouma BN, Meijers JC. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma. Blood. 1998;91(5):1542&#x2013;1547. doi: 10.1182/blood.V91.5.1542.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood.V91.5.1542</ArticleId><ArticleId IdType=\"pubmed\">9473218</ArticleId></ArticleIdList></Reference><Reference><Citation>Prendes MJ, Bielek E, Zechmeister-Machhart M, Vanyek-Zavadil E, Carroll VA, Breuss J, et al. Synthesis and ultrastructural localization of protein C inhibitor in human platelets and megakaryocytes. Blood. 1999;94(4):1300&#x2013;1312. doi: 10.1182/blood.V94.4.1300.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood.V94.4.1300</ArticleId><ArticleId IdType=\"pubmed\">10438718</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes JM, Kruger A, Proal A, Kell DB, Pretorius E. The occurrence of hyperactivated platelets and fibrinaloid microclots in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Pharmaceuticals. 2022;15(8):931. doi: 10.3390/ph15080931.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ph15080931</ArticleId><ArticleId IdType=\"pmc\">PMC9413879</ArticleId><ArticleId IdType=\"pubmed\">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajeevan MS, Dimulescu I, Murray J, Falkenberg VR, Unger ER. Pathway-focused genetic evaluation of immune and inflammation related genes with chronic fatigue syndrome. Hum Immunol. 2015;76(8):553&#x2013;560. doi: 10.1016/j.humimm.2015.06.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.humimm.2015.06.014</ArticleId><ArticleId IdType=\"pubmed\">26116897</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilli C, Hoeh AE, De Rossi G, Moss SE, Greenwood J. LRG1: an emerging player in disease pathogenesis. J Biomed Sci. 2022;29(1):6. doi: 10.1186/s12929-022-00790-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12929-022-00790-6</ArticleId><ArticleId IdType=\"pmc\">PMC8781713</ArticleId><ArticleId IdType=\"pubmed\">35062948</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 2002;110(6):771&#x2013;781. doi: 10.1172/JCI0215463.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI0215463</ArticleId><ArticleId IdType=\"pmc\">PMC151128</ArticleId><ArticleId IdType=\"pubmed\">12235108</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemmons DR. The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity. J Clin Invest. 2004;113(1):25&#x2013;27. doi: 10.1172/JCI20660.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI20660</ArticleId><ArticleId IdType=\"pmc\">PMC300772</ArticleId><ArticleId IdType=\"pubmed\">14702105</ArticleId></ArticleIdList></Reference><Reference><Citation>Bittermann E, Abdelhamed Z, Liegel RP, Menke C, Timms A, Beier DR, et al. Differential requirements of tubulin genes in mammalian forebrain development. PLoS Genet. 2019;15(8):e1008243. doi: 10.1371/journal.pgen.1008243.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pgen.1008243</ArticleId><ArticleId IdType=\"pmc\">PMC6697361</ArticleId><ArticleId IdType=\"pubmed\">31386652</ArticleId></ArticleIdList></Reference><Reference><Citation>Sordillo PP, Sordillo LA. The mystery of chemotherapy brain: kynurenines, tubulin and biophoton release. Anticancer Res. 2020;40(3):1189&#x2013;1200. doi: 10.21873/anticanres.14061.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.21873/anticanres.14061</ArticleId><ArticleId IdType=\"pubmed\">32132016</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez AR, Hancock EE, Adebayo S, Kiernicki DJ, Proskauer D, Attewell JR, et al. Estimating prevalence, demographics, and costs of ME/CFS using large scale medical claims data and machine learning. Front Pediatr. 2019;6:412. doi: 10.3389/fped.2018.00412.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2018.00412</ArticleId><ArticleId IdType=\"pmc\">PMC6331450</ArticleId><ArticleId IdType=\"pubmed\">30671425</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Giloteaux L, Moore GE, Levine SM, Chia JK, Keller BA, et al. Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 2022 doi: 10.1172/jci.insight.157621.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/jci.insight.157621</ArticleId><ArticleId IdType=\"pmc\">PMC9090259</ArticleId><ArticleId IdType=\"pubmed\">35358096</ArticleId></ArticleIdList></Reference><Reference><Citation>Nkiliza A, Parks M, Cseresznye A, Oberlin S, Evans JE, Darcey T, et al. Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms. J Transl Med. 2021;19(1):1&#x2013;15. doi: 10.1186/s12967-021-03035-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-021-03035-6</ArticleId><ArticleId IdType=\"pmc\">PMC8401202</ArticleId><ArticleId IdType=\"pubmed\">34454515</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson D, Brenu E, Gottschalk G, Ramos S, Nguyen T, Staines D, et al. Cytokines in the cerebrospinal fluids of patients with chronic fatigue syndrome/myalgic encephalomyelitis. Mediat Inflamm. 2015;2015:1&#x2013;4. doi: 10.1155/2015/929720.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2015/929720</ArticleId><ArticleId IdType=\"pmc\">PMC4365360</ArticleId><ArticleId IdType=\"pubmed\">25834308</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning PJ, Sutherland WH, McGrath MM, De Jong SA, Walker RJ, Williams MJ. Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity. 2008;16(9):2046&#x2013;2052. doi: 10.1038/oby.2008.334.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/oby.2008.334</ArticleId><ArticleId IdType=\"pubmed\">19186329</ArticleId></ArticleIdList></Reference><Reference><Citation>Netea SA, Janssen SA, Jaeger M, Jansen T, Jacobs L, Miller-Tomaszewska G, et al. Chocolate consumption modulates cytokine production in healthy individuals. Cytokine. 2013;62(1):40&#x2013;43. doi: 10.1016/j.cyto.2013.02.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cyto.2013.02.003</ArticleId><ArticleId IdType=\"pubmed\">23465690</ArticleId></ArticleIdList></Reference><Reference><Citation>Solis-Pereyra B, Aattouri N, Lemonnier D. Role of food in the stimulation of cytokine production. Am J Clin Nutr. 1997;66(2):521S&#x2013;S525. doi: 10.1093/ajcn/66.2.521S.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ajcn/66.2.521S</ArticleId><ArticleId IdType=\"pubmed\">9250142</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37177559</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1424-8220</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>23</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>Broadband Electrical Spectroscopy to Distinguish Single-Cell Ca<sup>2+</sup> Changes Due to Ionomycin Treatment in a Skeletal Muscle Cell Line.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">4358</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/s23094358</ELocationID><Abstract><AbstractText>Many skeletal muscle diseases such as muscular dystrophy, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and sarcopenia share the dysregulation of calcium (Ca<sup>2+</sup>) as a key mechanism of disease at a cellular level. Cytosolic concentrations of Ca<sup>2+</sup> can signal dysregulation in organelles including the mitochondria, nucleus, and sarcoplasmic reticulum in skeletal muscle. In this work, a treatment is applied to mimic the Ca<sup>2+</sup> increase associated with these atrophy-related disease states, and broadband impedance measurements are taken for single cells with and without this treatment using a microfluidic device. The resulting impedance measurements are fitted using a single-shell circuit simulation to show calculated electrical dielectric property contributions based on these Ca<sup>2+</sup> changes. From this, similar distributions were seen in the Ca<sup>2+</sup> from fluorescence measurements and the distribution of the S-parameter at a single frequency, identifying Ca<sup>2+</sup> as the main contributor to the electrical differences being identified. Extracted dielectric parameters also showed different distribution patterns between the untreated and ionomycin-treated groups; however, the overall electrical parameters suggest the impact of Ca<sup>2+</sup>-induced changes at a wider range of frequencies.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Ferguson</LastName><ForeName>Caroline A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, P.C. Rossin College of Engineering and Applied Sciences, Lehigh University, Bethlehem, PA 18015, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Santangelo</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Imaging and Clinical Sciences, University \"G. d\\'Annunzio\" Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Marramiero</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Imaging and Clinical Sciences, University \"G. d\\'Annunzio\" Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Farina</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Engineering of Information, University Politecnica delle Marche, 60131 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pietrangelo</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><Identifier Source=\"ORCID\">0000-0002-7507-1255</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Imaging and Clinical Sciences, University \"G. d\\'Annunzio\" Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cheng</LastName><ForeName>Xuanhong</ForeName><Initials>X</Initials><Identifier Source=\"ORCID\">0000-0002-6331-8572</Identifier><AffiliationInfo><Affiliation>Department of Bioengineering, P.C. Rossin College of Engineering and Applied Sciences, Lehigh University, Bethlehem, PA 18015, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Materials Science and Engineering, P.C. Rossin College of Engineering and Applied Sciences, Lehigh University, Bethlehem, PA 18015, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>1809623</GrantID><Agency>National Science Foundation, Division of Electrical, Communications &amp; Cyber Systems</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>56092-81-0</RegistryNumber><NameOfSubstance UI=\"D015759\">Ionomycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI=\"D002118\">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D015759\" MajorTopicYN=\"N\">Ionomycin</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D018485\" MajorTopicYN=\"Y\">Muscle Fibers, Skeletal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018482\" MajorTopicYN=\"Y\">Muscle, Skeletal</DescriptorName><QualifierName UI=\"Q000502\" MajorTopicYN=\"N\">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002460\" MajorTopicYN=\"N\">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D013057\" MajorTopicYN=\"N\">Spectrum Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002118\" MajorTopicYN=\"N\">Calcium</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">broadband impedance spectroscopy</Keyword><Keyword MajorTopicYN=\"N\">circuit modeling</Keyword><Keyword MajorTopicYN=\"N\">intracellular calcium</Keyword><Keyword MajorTopicYN=\"N\">single-cell characterization</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>1</Hour><Minute>39</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37177559</ArticleId><ArticleId IdType=\"pmc\">PMC10181519</ArticleId><ArticleId IdType=\"doi\">10.3390/s23094358</ArticleId><ArticleId IdType=\"pii\">s23094358</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beccafico S., Puglielli C., Pietrangelo T., Bellomo R., Fano G., Fulle S. Age-Dependent Effects on Functional Aspects in Human Satellite Cells. Ann. N. Y. Acad. Sci. 2007;1100:345&#x2013;352. doi: 10.1196/annals.1395.037.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1196/annals.1395.037</ArticleId><ArticleId IdType=\"pubmed\">17460197</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo-Sagua R., Parra V., Mu&#xf1;oz-Cordova F., Sanchez-Aguilera P., Garrido V., Contreras-Ferrat A., Chiong M., Lavandero S. Chapter Five&#x2014;Sarcoplasmic Reticulum and Calcium Signaling in Muscle Cells: Homeostasis and Disease. In: Kepp O., Galluzzi L., editors. International Review of Cell and Molecular Biology. Volume 350. Academic Press; Cambridge, MA, USA: 2020. pp. 197&#x2013;264. Biology of the Endoplasmic Reticulum.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32138900</ArticleId></ArticleIdList></Reference><Reference><Citation>Protasi F., Pietrangelo L., Boncompagni S. Calcium Entry Units (CEUs): Perspectives in Skeletal Muscle Function and Disease. J. Muscle Res. Cell Motil. 2021;42:233&#x2013;249. doi: 10.1007/s10974-020-09586-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10974-020-09586-3</ArticleId><ArticleId IdType=\"pmc\">PMC8332569</ArticleId><ArticleId IdType=\"pubmed\">32812118</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa A., Henr&#xed;quez-Olgu&#xed;n C., Jaimovich E. Reactive Oxygen Species and Calcium Signals in Skeletal Muscle: A Crosstalk Involved in Both Normal Signaling and Disease. Cell Calcium. 2016;60:172&#x2013;179. doi: 10.1016/j.ceca.2016.02.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ceca.2016.02.010</ArticleId><ArticleId IdType=\"pubmed\">26965208</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal A., Suryakumar G., Rathor R. Role of Defective Ca2+ Signaling in Skeletal Muscle Weakness: Pharmacological Implications. J. Cell Commun. Signal. 2018;12:645&#x2013;659. doi: 10.1007/s12079-018-0477-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12079-018-0477-z</ArticleId><ArticleId IdType=\"pmc\">PMC6235775</ArticleId><ArticleId IdType=\"pubmed\">29982883</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerwyn M., Maes M. Mechanisms Explaining Muscle Fatigue and Muscle Pain in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Review of Recent Findings. Curr. Rheumatol. Rep. 2017;19:1. doi: 10.1007/s11926-017-0628-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11926-017-0628-x</ArticleId><ArticleId IdType=\"pubmed\">28116577</ArticleId></ArticleIdList></Reference><Reference><Citation>Dargelos E., Brul&#xe9; C., Combaret L., Hadj-Sassi A., Dulong S., Poussard S., Cottin P. Involvement of the Calcium-Dependent Proteolytic System in Skeletal Muscle Aging. Exp. Gerontol. 2007;42:1088&#x2013;1098. doi: 10.1016/j.exger.2007.08.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.exger.2007.08.009</ArticleId><ArticleId IdType=\"pubmed\">17937979</ArticleId></ArticleIdList></Reference><Reference><Citation>Leijendekker W.J., Passaquin A.-C., Metzinger L., R&#xfc;egg U.T. Regulation of Cytosolic Calcium in Skeletal Muscle Cells of the Mdx Mouse under Conditions of Stress. Br. J. Pharmacol. 1996;118:611&#x2013;616. doi: 10.1111/j.1476-5381.1996.tb15445.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1476-5381.1996.tb15445.x</ArticleId><ArticleId IdType=\"pmc\">PMC1909736</ArticleId><ArticleId IdType=\"pubmed\">8762085</ArticleId></ArticleIdList></Reference><Reference><Citation>Berchtold M.W., Brinkmeier H., M&#xfc;ntener M. Calcium Ion in Skeletal Muscle: Its Crucial Role for Muscle Function, Plasticity, and Disease. Physiol. Rev. 2000;80:1215&#x2013;1265. doi: 10.1152/physrev.2000.80.3.1215.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/physrev.2000.80.3.1215</ArticleId><ArticleId IdType=\"pubmed\">10893434</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W., Tang D., Ni Z., Xiang N., Yi H. A Portable Single-Cell Analysis System Integrating Hydrodynamic Trapping with Broadband Impedance Spectroscopy. Sci. China Technol. Sci. 2017;60:1707&#x2013;1715. doi: 10.1007/s11431-017-9129-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11431-017-9129-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao X., Ocket I., Bao J., Doijen J., Zheng J., Kil D., Liu Z., Puers B., Schreurs D., Nauwelaers B. Broadband Dielectric Spectroscopy of Cell Cultures. IEEE Trans. Microw. Theory Tech. 2018;66:5750&#x2013;5759. doi: 10.1109/TMTT.2018.2873395.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1109/TMTT.2018.2873395</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning Y., Multari C., Luo X., Palego C., Cheng X., Hwang J.C.M., Denzi A., Merla C., Apollonio F., Liberti M. Broadband Electrical Detection of Individual Biological Cells. IEEE Trans. Microw. Theory Tech. 2014;62:1905&#x2013;1911. doi: 10.1109/TMTT.2014.2342660.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1109/TMTT.2014.2342660</ArticleId></ArticleIdList></Reference><Reference><Citation>Grenier K., Tamra A., Zedek A., Poiroux G., Artis F., Chen T., Chen W., Poupot M., Fournie J.-J., Dubuc D. Low Volume and Label-Free Molecules Characterization and Cell Monitoring with Microwave Dielectric Spectroscopy; Proceedings of the 2018 IEEE International Microwave Biomedical Conference (IMBioC); Philadelphia, PA, USA. 14&#x2013;15 June 2018; Piscataway, NJ, USA: IEEE; 2018. pp. 82&#x2013;84.</Citation></Reference><Reference><Citation>Foster K.R., Schwan H.P. Dielectric Properties of Tissues and Biological Materials: A Critical Review. Crit. Rev. Biomed. Eng. 1989;17:25&#x2013;104.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2651001</ArticleId></ArticleIdList></Reference><Reference><Citation>Markx G.H., Davey C.L. The Dielectric Properties of Biological Cells at Radiofrequencies: Applications in Biotechnology. Enzym. Microb. Technol. 1999;25:161&#x2013;171. doi: 10.1016/S0141-0229(99)00008-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0141-0229(99)00008-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasir N., Al Ahmad M. Cells Electrical Characterization: Dielectric Properties, Mixture, and Modeling Theories. J. Eng. 2020;2020:9475490. doi: 10.1155/2020/9475490.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2020/9475490</ArticleId></ArticleIdList></Reference><Reference><Citation>Grenier K., Dubuc D., Chen T., Artis F., Chretiennot T., Poupot M., Fournie J.-J. Recent Advances in Microwave-Based Dielectric Spectroscopy at the Cellular Level for Cancer Investigations. IEEE Trans. Microw. Theory Tech. 2013;61:2023&#x2013;2030. doi: 10.1109/TMTT.2013.2255885.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1109/TMTT.2013.2255885</ArticleId></ArticleIdList></Reference><Reference><Citation>ATCC  L6&#x2014;CRL-1458.  [(accessed on 24 October 2022)].  Available online:  https://www.atcc.org/products/crl-1458.</Citation></Reference><Reference><Citation>Fioretti B., Pietrangelo T., Catacuzzeno L., Franciolini F. Intermediate-Conductance Ca2+-Activated K+ Channel Is Expressed in C2C12 Myoblasts and Is Downregulated during Myogenesis. Am. J. Physiol. Cell Physiol. 2005;289:C89&#x2013;C96. doi: 10.1152/ajpcell.00369.2004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpcell.00369.2004</ArticleId><ArticleId IdType=\"pubmed\">15743891</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrangelo T., Mariggi&#xf2; M.A., Lorenzon P., Fulle S., Protasi F., Rathbone M., Werstiuk E., Fan&#xf2; G. Characterization of Specific GTP Binding Sites in C2C12 Mouse Skeletal Muscle Cells. J. Muscle Res. Cell Motil. 2002;23:107&#x2013;118. doi: 10.1023/A:1020288117082.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1023/A:1020288117082</ArticleId><ArticleId IdType=\"pubmed\">12416717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson C., Pini N., Du X., Farina M., Hwang J.M.C., Pietrangelo T., Cheng X. Broadband Electrical Impedance as a Novel Characterization of Oxidative Stress in Single L6 Skeletal Muscle Cells. Anal. Chim. Acta. 2021;1173:338678. doi: 10.1016/j.aca.2021.338678.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.aca.2021.338678</ArticleId><ArticleId IdType=\"pubmed\">34172152</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X., Ferguson C., Ma X., Cheng X., Hwang J.C.M. Ultra-Wideband Impedance Spectroscopy of the Nucleus in a Live Cell. IEEE J. Electromagn. RF Microw. Med. Biol. 2021;6:267&#x2013;272. doi: 10.1109/JERM.2021.3121258.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1109/JERM.2021.3121258</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X., Ladegard C., Ma X., Cheng X., Hwang J.C.M. Broadband Electrical Sensing of Nucleus Size in a Live Cell from 900 Hz to 40 GHz; Proceedings of the 2020 IEEE MTT-S International Microwave Biomedical Conference (IMBioC); Toulouse, France. 14&#x2013;17 December 2020; pp. 1&#x2013;4.</Citation></Reference><Reference><Citation>Caspers F. RF Engineering Basic Concepts: S-Parameters. arXiv. 20121201.2346v1</Citation></Reference><Reference><Citation>Kidokoro Y. Developmental Changes of Membrane Electrical Properties in a Rat Skeletal Muscle Cell Line. J. Physiol. 1975;244:129&#x2013;143. doi: 10.1113/jphysiol.1975.sp010787.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1113/jphysiol.1975.sp010787</ArticleId><ArticleId IdType=\"pmc\">PMC1330748</ArticleId><ArticleId IdType=\"pubmed\">1168256</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., Du X., Multari C.R., Ning Y., Luo X., Gholizadeh V., Palego C., Cheng X., Hwang J.C.M. Reproducible Broadband Measurement for Cytoplasm Capacitance of a Biological Cell; Proceedings of the 2016 IEEE MTT-S International Microwave Symposium (IMS); San Francisco, CA, USA. 22&#x2013;27 May 2016; Piscataway, NJ, USA: IEEE; 2016. pp. 1&#x2013;4.</Citation></Reference><Reference><Citation>Erdahl W.L., Chapman C.J., Taylor R.W., Pfeiffer D.R. Ca2+ Transport Properties of Ionophores A23187, Ionomycin, and 4-BrA23187 in a Well Defined Model System. Biophys. J. 1994;66:1678&#x2013;1693. doi: 10.1016/S0006-3495(94)80959-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0006-3495(94)80959-2</ArticleId><ArticleId IdType=\"pmc\">PMC1275887</ArticleId><ArticleId IdType=\"pubmed\">8061216</ArticleId></ArticleIdList></Reference><Reference><Citation>Caridha D., Yourick D., Cabezas M., Wolf L., Hudson T.H., Dow G.S. Mefloquine-Induced Disruption of Calcium Homeostasis in Mammalian Cells Is Similar to That Induced by Ionomycin. Antimicrob. Agents Chemother. 2008;52:684&#x2013;693. doi: 10.1128/AAC.00874-07.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/AAC.00874-07</ArticleId><ArticleId IdType=\"pmc\">PMC2224738</ArticleId><ArticleId IdType=\"pubmed\">17999964</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf6;zer E.B., Vernier P.T. Modulation of Biological Responses to 2 ns Electrical Stimuli by Field Reversal. Biochim. Biophys. Acta (BBA)&#x2014;Biomembr. 2019;1861:1228&#x2013;1239. doi: 10.1016/j.bbamem.2019.03.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamem.2019.03.019</ArticleId><ArticleId IdType=\"pubmed\">30981731</ArticleId></ArticleIdList></Reference><Reference><Citation>Pakhomova O.N., Gregory B., Semenov I., Pakhomov A.G. Calcium-Mediated Pore Expansion and Cell Death Following Nanoelectroporation. Biochim. Biophys. Acta. 2014;1838:2547&#x2013;2554. doi: 10.1016/j.bbamem.2014.06.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamem.2014.06.015</ArticleId><ArticleId IdType=\"pmc\">PMC4125538</ArticleId><ArticleId IdType=\"pubmed\">24978108</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke R.C., Bardet S.M., Carr L., Romanenko S., Arnaud-Cormos D., Leveque P., O&#x2019;Connor R.P. Nanosecond Pulsed Electric Fields Depolarize Transmembrane Potential via Voltage-Gated K+, Ca2+ and TRPM8 Channels in U87 Glioblastoma Cells. Biochim. Biophys. Acta Biomembr. 2017;1859:2040&#x2013;2050. doi: 10.1016/j.bbamem.2017.07.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamem.2017.07.004</ArticleId><ArticleId IdType=\"pubmed\">28693898</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Blackmore P.F., Hargrave B.Y., Xiao S., Beebe S.J., Schoenbach K.H. Nanosecond Pulse Electric Field (Nanopulse): A Novel Non-Ligand Agonist for Platelet Activation. Arch. Biochem. Biophys. 2008;471:240&#x2013;248. doi: 10.1016/j.abb.2007.12.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.abb.2007.12.009</ArticleId><ArticleId IdType=\"pubmed\">18177729</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller C., Hellsten Y., Steensberg A., Klarlund Pedersen B. Differential Regulation of IL-6 and TNF-&#x3b1; via Calcineurin in Human Skeletal Muscle Cells. Cytokine. 2006;36:141&#x2013;147. doi: 10.1016/j.cyto.2006.10.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cyto.2006.10.014</ArticleId><ArticleId IdType=\"pubmed\">17197194</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes A.G., Watt M.J., Carey A.L., Febbraio M.A. Ionomycin, but Not Physiologic Doses of Epinephrine, Stimulates Skeletal Muscle Interleukin-6 MRNA Expression and Protein Release. Metabolism. 2004;53:1492&#x2013;1495. doi: 10.1016/j.metabol.2004.05.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.metabol.2004.05.015</ArticleId><ArticleId IdType=\"pubmed\">15536607</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Zhao Y., Shang X., Ren H., Zhao Y., Liu X. CAIII Expression in Skeletal Muscle Is Regulated by Ca2+&#x2013;CaMKII&#x2013;MEF2C Signaling. Exp. Cell Res. 2019;385:111672. doi: 10.1016/j.yexcr.2019.111672.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.yexcr.2019.111672</ArticleId><ArticleId IdType=\"pubmed\">31614133</ArticleId></ArticleIdList></Reference><Reference><Citation>Roufa D., Wu F.S., Martonosi A.N. The Effect of Ca2+ Ionophores upon the Synthesis of Proteins in Cultured Skeletal Muscle. Biochim. Biophys. Acta (BBA)&#x2014;Gen. Subj. 1981;674:225&#x2013;237. doi: 10.1016/0304-4165(81)90380-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0304-4165(81)90380-9</ArticleId><ArticleId IdType=\"pubmed\">6786362</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrangelo T., Di Filippo E.S., Mancinelli R., Doria C., Rotini A., Fan&#xf2;-Illic G., Fulle S. Low Intensity Exercise Training Improves Skeletal Muscle Regeneration Potential. Front. Physiol. 2015;6:399. doi: 10.3389/fphys.2015.00399.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2015.00399</ArticleId><ArticleId IdType=\"pmc\">PMC4689811</ArticleId><ArticleId IdType=\"pubmed\">26733888</ArticleId></ArticleIdList></Reference><Reference><Citation>Petchakup C., Tay H.M., Li K.H.H., Hou H.W. Integrated Inertial-Impedance Cytometry for Rapid Label-Free Leukocyte Isolation and Profiling of Neutrophil Extracellular Traps (NETs) Lab Chip. 2019;19:1736&#x2013;1746. doi: 10.1039/C9LC00250B.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C9LC00250B</ArticleId><ArticleId IdType=\"pubmed\">31020286</ArticleId></ArticleIdList></Reference><Reference><Citation>Funkner S., Niehues G., Schmidt D.A., Heyden M., Schwaab G., Callahan K.M., Tobias D.J., Havenith M. Watching the Low-Frequency Motions in Aqueous Salt Solutions: The Terahertz Vibrational Signatures of Hydrated Ions. J. Am. Chem. Soc. 2012;134:1030&#x2013;1035. doi: 10.1021/ja207929u.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/ja207929u</ArticleId><ArticleId IdType=\"pubmed\">22124334</ArticleId></ArticleIdList></Reference><Reference><Citation>Balos V., Kaliannan N.K., Elgabarty H., Wolf M., K&#xfc;hne T.D., Sajadi M. Time-Resolved Terahertz&#x2013;Raman Spectroscopy Reveals That Cations and Anions Distinctly Modify Intermolecular Interactions of Water. Nat. Chem. 2022;14:1031&#x2013;1037. doi: 10.1038/s41557-022-00977-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41557-022-00977-2</ArticleId><ArticleId IdType=\"pmc\">PMC9417992</ArticleId><ArticleId IdType=\"pubmed\">35773490</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleichmann M., Mattson M.P. Neuronal Calcium Homeostasis and Dysregulation. Antioxid. Redox Signal. 2011;14:1261&#x2013;1273. doi: 10.1089/ars.2010.3386.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/ars.2010.3386</ArticleId><ArticleId IdType=\"pmc\">PMC3048837</ArticleId><ArticleId IdType=\"pubmed\">20626318</ArticleId></ArticleIdList></Reference><Reference><Citation>Brini M., Cal&#xec; T., Ottolini D., Carafoli E. Neuronal Calcium Signaling: Function and Dysfunction. Cell. Mol. Life Sci. 2014;71:2787&#x2013;2814. doi: 10.1007/s00018-013-1550-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00018-013-1550-7</ArticleId><ArticleId IdType=\"pubmed\">24442513</ArticleId></ArticleIdList></Reference><Reference><Citation>Mil&#xe1;n A.F., Rinc&#xf3;n O.A., Arango L.B., Reutovich A.A., Smith G.L., Giraldo M.A., Bou-Abdallah F., Calder&#xf3;n J.C. Calibration of Mammalian Skeletal Muscle Ca2+ Transients Recorded with the Fast Ca2+ Dye Mag-Fluo-4. Biochim. Biophys. Acta (BBA)&#x2014;Gen. Subj. 2021;1865:129939. doi: 10.1016/j.bbagen.2021.129939.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbagen.2021.129939</ArticleId><ArticleId IdType=\"pubmed\">34082059</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37170956</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Electronic\">1471-8391</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>146</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>21</Day></PubDate></JournalIssue><Title>British medical bulletin</Title><ISOAbbreviation>Br Med Bull</ISOAbbreviation></Journal><ArticleTitle>Whole-body cryotherapy as a treatment for chronic medical conditions?</ArticleTitle><Pagination><StartPage>43</StartPage><EndPage>72</EndPage><MedlinePgn>43-72</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1093/bmb/ldad007</ELocationID><Abstract><AbstractText Label=\"INTRODUCTION\" NlmCategory=\"BACKGROUND\">Whole-body cryotherapy (WBC) is a controlled exposure of the whole body to cold to gain health benefits. In recent years, data on potential applications of WBC in multiple clinical settings have emerged.</AbstractText><AbstractText Label=\"SOURCES OF DATA\" NlmCategory=\"METHODS\">PubMed, EBSCO and Clinical Key search using keywords including terms \\'whole body\\', \\'cryotherapy\\' and \\'cryostimulation\\'.</AbstractText><AbstractText Label=\"AREAS OF AGREEMENT\" NlmCategory=\"RESULTS\">WBC could be applied as adjuvant therapy in multiple conditions involving chronic inflammation because of its potent anti-inflammatory effects. Those might include systemic inflammation as in rheumatoid arthritis. In addition, WBC could serve as adjuvant therapy for chronic inflammation in some patients with obesity.</AbstractText><AbstractText Label=\"AREAS OF CONTROVERSY\" NlmCategory=\"RESULTS\">WBC probably might be applied as an adjuvant treatment in patients with chronic brain disorders including mild cognitive impairment and general anxiety disorder and in patients with depressive episodes and neuroinflammation reduction as in multiple sclerosis. WBC effects in metabolic disorder treatment are yet to be determined. WBC presumably exerts pleiotropic effects and therefore might serve as adjuvant therapy in multi-systemic disorders, including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).</AbstractText><AbstractText Label=\"GROWING POINTS\" NlmCategory=\"CONCLUSIONS\">The quality of studies on the effects of WBC in the clinical setting is in general low; hence, randomized controlled trials with adequate sample size and longer follow-up periods are needed.</AbstractText><AbstractText Label=\"AREAS ARE TIMELY FOR DEVELOPING RESEARCH\" NlmCategory=\"UNASSIGNED\">Further studies should examine the mechanism underlying the clinical efficacy of WBC. Multiple conditions might involve chronic inflammation, which in turn could be a potential target of WBC. Further research on the application of WBC in neurodegenerative disorders, neuropsychiatric disorders and ME/CFS should be conducted.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Tabisz</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, &#x15a;wi&#x119;toja&#x144;ska 20, Bydgoszcz 85-077, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Modlinska</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, &#x15a;wi&#x119;toja&#x144;ska 20, Bydgoszcz 85-077, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kujawski</LastName><ForeName>S&#x142;awomir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, &#x15a;wi&#x119;toja&#x144;ska 20, Bydgoszcz 85-077, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>S&#x142;omko</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, &#x15a;wi&#x119;toja&#x144;ska 20, Bydgoszcz 85-077, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zalewski</LastName><ForeName>Pawel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, &#x15a;wi&#x119;toja&#x144;ska 20, Bydgoszcz 85-077, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Warsaw Medical University, 1b Banacha Street, Warsaw 02-097, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br Med Bull</MedlineTA><NlmUniqueID>0376542</NlmUniqueID><ISSNLinking>0007-1420</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">chronic inflammation</Keyword><Keyword MajorTopicYN=\"N\">cognitive function</Keyword><Keyword MajorTopicYN=\"N\">cryotherapy</Keyword><Keyword MajorTopicYN=\"N\">metabolic disorders</Keyword><Keyword MajorTopicYN=\"N\">neurodegenerative disorders</Keyword><Keyword MajorTopicYN=\"N\">neuropsychiatric disorders</Keyword><Keyword MajorTopicYN=\"N\">obesity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37170956</ArticleId><ArticleId IdType=\"doi\">10.1093/bmb/ldad007</ArticleId><ArticleId IdType=\"pii\">7160593</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37155451</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">2168-8184</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Corona With Lyme: A Long COVID Case Study.</ArticleTitle><Pagination><StartPage>e36624</StartPage><MedlinePgn>e36624</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">e36624</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.7759/cureus.36624</ELocationID><Abstract><AbstractText>The longevity of the coronavirus disease 2019 (COVID-19) pandemic has necessitated continued discussion about the long-term impacts of SARS-CoV-2 infection. Many who develop an acute COVID-19 infection will later face a constellation of enduring symptoms of varying severity, otherwise known as long COVID. As the pandemic reaches its inevitable endemicity, the long COVID patient population will undoubtedly grow and require improved recognition and management. The case presented describes the three-year arc of a previously healthy 26-year-old female medical student from initial infection and induction of long COVID symptomology to near-total remission of the disease. In doing so, the course of this unique post-viral illness and the trials and errors of myriad treatment options will be chronologized, thereby contributing to the continued demand for understanding this mystifying disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Thor et al.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Thor</LastName><ForeName>Danielle C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Internal Medicine, Touro College of Osteopathic Medicine, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Suarez</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Osteopathic Medicine, Touro College of Osteopathic Medicine, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D002363\">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">covid long haul syndrome</Keyword><Keyword MajorTopicYN=\"N\">covid-19</Keyword><Keyword MajorTopicYN=\"N\">dysautonomia</Keyword><Keyword MajorTopicYN=\"N\">long covid</Keyword><Keyword MajorTopicYN=\"N\">lyme disease</Keyword><Keyword MajorTopicYN=\"N\">me/cfs</Keyword><Keyword MajorTopicYN=\"N\">pacs</Keyword><Keyword MajorTopicYN=\"N\">post-covid syndrome</Keyword><Keyword MajorTopicYN=\"N\">post-viral illness</Keyword><Keyword MajorTopicYN=\"N\">pots</Keyword></KeywordList><CoiStatement>A preliminary overview of this case study was previously presented as a virtual poster at the American Academy of Family Physicians\\' 2022 FMX Conference. The authorship of both the poster and case report are identical; the poster served as an introductory presentation to this far more extensive and up-to-date case report submitted here. The poster can be found here: https://www.researchgate.net/publication/364154743_Corona_with_Lyme_An_Overview_of_A_Long_COVID_Case_Study?channel=doi&amp;linkId=633ccaa2769781354ebc8723&amp;showFulltext=true#fullTextFileContent.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>13</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37155451</ArticleId><ArticleId IdType=\"pmc\">PMC10122830</ArticleId><ArticleId IdType=\"doi\">10.7759/cureus.36624</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. J Infect Dis. 2022;226:1593&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9047189</ArticleId><ArticleId IdType=\"pubmed\">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus.  [\\nMar;\\n2023 \\n];https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 World Health Organization. 2021 1</Citation></Reference><Reference><Citation>Multiple early factors anticipate post-acute COVID-19 sequelae. Su Y, Yuan D, Chen DG, et al. Cell. 2022;185:881&#x2013;895.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8786632</ArticleId><ArticleId IdType=\"pubmed\">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: major findings, mechanisms and recommendations. Davis HE, McCorkell L, Vogel JM, Topol EJ. Nat Rev Microbiol. 2023;21:133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9839201</ArticleId><ArticleId IdType=\"pubmed\">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID-19: challenges in the diagnosis and proposed diagnostic criteria. Raveendran AV. Diabetes Metab Syndr. 2021;15:145&#x2013;146.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7737559</ArticleId><ArticleId IdType=\"pubmed\">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>The relationship between physical activity and long COVID: a cross-sectional study. Wright J, Astill SL, Sivan M. Int J Environ Res Public Health. 2022;19:5093.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9105041</ArticleId><ArticleId IdType=\"pubmed\">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of COVID-19 vaccination on long COVID: systematic review. Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. BMJ Med. 2023;2:0.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9978692</ArticleId><ArticleId IdType=\"pubmed\">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Ormiston CK, &#x15a;wi&#x105;tkiewicz I, Taub PR. Heart Rhythm. 2022;19:1880&#x2013;1889.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9287587</ArticleId><ArticleId IdType=\"pubmed\">35853576</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: distinction between organ damage and deconditioning. Kersten J, Baumhardt M, Hartveg P, et al. J Clin Med. 2021;10:3782.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8432179</ArticleId><ArticleId IdType=\"pubmed\">34501230</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID and the risk of suicide. Sher L. Gen Hosp Psychiatry. 2023;80:66&#x2013;67.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9721155</ArticleId><ArticleId IdType=\"pubmed\">36494289</ArticleId></ArticleIdList></Reference><Reference><Citation>Could cognitive behavioural therapy be an effective treatment for long COVID and post COVID-19 fatigue syndrome? Lessons from the Qure study for Q-fever fatigue syndrome. Vink M, Vink-Niese A. Healthcare (Basel) 2020;8:552.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7764131</ArticleId><ArticleId IdType=\"pubmed\">33322316</ArticleId></ArticleIdList></Reference><Reference><Citation>Using crowdsourced medicine to manage uncertainty on Reddit: the case of COVID-19 long-haulers. Thompson CM, Rhidenour KB, Blackburn KG, Barrett AK, Babu S. Patient Educ Couns. 2022;105:322&#x2013;330.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8805953</ArticleId><ArticleId IdType=\"pubmed\">34281723</ArticleId></ArticleIdList></Reference><Reference><Citation>Outpatient treatment of COVID-19 with metformin, ivermectin, and fluvoxamine and the development of long COVID over 10-month follow-up. [PREPRINT] Bramante CT, Buse JB, Liebovitz D, et al. medRxiv. 2022</Citation></Reference><Reference><Citation>Estrogen hormone is an essential sex factor inhibiting inflammation and immune response in COVID-19. Li F, Boon AC, Michelson AP, Foraker RE, Zhan M, Payne PR. Sci Rep. 2022;12:9462.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9175532</ArticleId><ArticleId IdType=\"pubmed\">35676404</ArticleId></ArticleIdList></Reference><Reference><Citation>Lots of long COVID treatment leads, but few are proven. Shaffer L. Proc Natl Acad Sci U S A. 2022;119:0.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9456722</ArticleId><ArticleId IdType=\"pubmed\">36048910</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37131449</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">2405-8440</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>9</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A preliminary survey among patients in Switzerland.</ArticleTitle><Pagination><StartPage>e15595</StartPage><MedlinePgn>e15595</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">e15595</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.heliyon.2023.e15595</ELocationID><Abstract><AbstractText>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a multi-factorial systemic chronic debilitating disease of poorly understood etiology and limited systematic evidence. The questionnaire and interview-based survey included 169 ME/CFS patients from the Swiss ME/CFS association. The majority of patients were females (72.2%), single (55.7%) and without children (62.5%). Only one third were working (full/part-time). The mean onset of ME/CFS was 31.6 years of age with 15% of patients being symptomatic before their 18th birthday. In this cohort, patients had documented ME/CFS for a mean 13.7 years, whereby half (50.3%) stated their condition was progressively worsening. Triggering events and times of disease onset were recalled by 90% of the participants. An infectious disease was associated with a singular or part of multiple events by 72.9% and 80.6%, respectively. Prior to disease onset, a third of the patients reported respiratory infections; followed by gastro-intestinal infections (15.4%) and tick-borne diseases (16.2%). Viral infections were recalled by 77.8% of the respondents, with Epstein Barr Virus being the most commonly reported agent. Patients self-reported an average number of 13 different symptoms, all described specific triggers of symptoms exacerbation and 82.2% suffered from co-morbidities. This study collated clinically relevant information on ME/CFS patients in Switzerland, highlighting the extent of disease severity, the associated factors negatively affecting daily life activities and work status as well as potential socio-economic impact.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Tschopp</LastName><ForeName>Rea</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of University of Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Armauer Hansen Research Institute, Jimma Road, PO Box 1005, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>K&#xf6;nig</LastName><ForeName>Rahel S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Basel, Klingelbergstrasse 61, 4056 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rejmer</LastName><ForeName>Protazy</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Seegarten Clinic, Seestrasse 155A, 8802 Kilchberg ZH, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Paris</LastName><ForeName>Daniel H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of University of Basel, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Co-morbidity</Keyword><Keyword MajorTopicYN=\"N\">Demography</Keyword><Keyword MajorTopicYN=\"N\">Myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">Switzerland</Keyword><Keyword MajorTopicYN=\"N\">Symptoms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>1</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37131449</ArticleId><ArticleId IdType=\"pmc\">PMC10149204</ArticleId><ArticleId IdType=\"doi\">10.1016/j.heliyon.2023.e15595</ArticleId><ArticleId IdType=\"pii\">S2405-8440(23)02802-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Poenaru S., Abdallah S.J., Corrales-Medina V., Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther. Adv. Infect. Dis. 2021;8 doi: 10.1177/20499361211009385.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/20499361211009385</ArticleId><ArticleId IdType=\"pmc\">PMC8060761</ArticleId><ArticleId IdType=\"pubmed\">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. https://www.cdc.gov/me-cfs/index.html. Accessed 15 January 2022.</Citation></Reference><Reference><Citation>Hickie I., Davenport T., Wakefield D., Vollmer-Conna U., Cameron B., et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333:575&#x2013;577. doi: 10.1136/bmj.38933.585764.AE.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType=\"pmc\">PMC1569956</ArticleId><ArticleId IdType=\"pubmed\">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampton T. Researchers find genetic clues to chronic fatigue syndrome. JAMA. 2006;295(21):2466&#x2013;2467. doi: 10.1001/jama.295.21.2466.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.295.21.2466</ArticleId><ArticleId IdType=\"pubmed\">16757709</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhill S., Booth N., Mclaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int. J. Clin. Exp. Med. 2009;2:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2680051</ArticleId><ArticleId IdType=\"pubmed\">19436827</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Elzakker M. Chronic fatigue syndrome from vagus nerve infection: a psycho-neuro-immunological hypothesis. Med. Hypotheses. 2013;81:414&#x2013;423. doi: 10.1016/j.mehy.2013.05.034.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mehy.2013.05.034</ArticleId><ArticleId IdType=\"pubmed\">23790471</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassford J.A.G. The neuroinflammatory etiopathology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Front. Physiol. 2017;8:88. doi: 10.3389/fphys.2017.00088.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2017.00088</ArticleId><ArticleId IdType=\"pmc\">PMC5314655</ArticleId><ArticleId IdType=\"pubmed\">28261110</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S., Nora Krukle Z., Henning N., Eliassen E., Shikova E., et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2018;16:268. doi: 10.1186/s12967-018-1644-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType=\"pmc\">PMC6167797</ArticleId><ArticleId IdType=\"pubmed\">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E., Noble A., Edgar C., Mackay A., Helliwell A., Vallings R., Ryan M., Tate W. Current research provides insight into the biological basis and diagnostic potential for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Diagnostics. 2019;9:73. doi: 10.3390/diagnostics9030073.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics9030073</ArticleId><ArticleId IdType=\"pmc\">PMC6787691</ArticleId><ArticleId IdType=\"pubmed\">31295930</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E.W., Van Driel M.L., Staines D.R., Ashton K.J., Ramos S.B., et al. Immunological abnormalities as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis. J. Transl. Med. 2011;9:81. doi: 10.1186/1479-5876-9-81.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-9-81</ArticleId><ArticleId IdType=\"pmc\">PMC3120691</ArticleId><ArticleId IdType=\"pubmed\">21619669</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya J.G., Holmes T.H., Anderson J.N., Maecker H.T., Rosenberg-Hasson Y., et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc. Natl. Acad. Sci. USA. 2017;114(34):E7150&#x2013;E7158.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5576836</ArticleId><ArticleId IdType=\"pubmed\">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano A.H., Maya J., Giloteaux L., Peterson D.L., Maynard M., et al. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J. Clin. Invest. 2020 doi: 10.1172/JCI132185.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI132185</ArticleId><ArticleId IdType=\"pmc\">PMC7269566</ArticleId><ArticleId IdType=\"pubmed\">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K., Scheibenbogen C. A unifying hypothesis of the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): recognitions from the finding of autoantibodies against &#xdf;2-adrenergic receptors. Autoimmun. Rev. 2020;19(6) doi: 10.1016/j.autrev.2020.102527.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2020.102527</ArticleId><ArticleId IdType=\"pubmed\">32247028</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall-Gradisnik S.M., Smith P., Brenu E.W., Nilius B., Ramos S.B., et al. Examination of single nucleotide polymorphisms (SNPs) in transient receptor potential (TRP) ion channels in chronic fatigue syndrome patients. Immunol. Immunogenetics Insights. 2015;5:1&#x2013;6. doi: 10.4137/III.S25.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4137/III.S25</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T., Staines D., Nilius B., Smith P., Marshall-Gradisnik S. Novel identification and characterization of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signaling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients. Biol. Res. 2016;49:27. doi: 10.1186/s40659-016-0087-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40659-016-0087-2</ArticleId><ArticleId IdType=\"pmc\">PMC4888729</ArticleId><ArticleId IdType=\"pubmed\">27245705</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall-Gradisnik S., Huth T., Chacko Anu, Johnston S., Smith P., et al. Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in Myalgic Encephalomyelitis/chronic fatigue syndrome. Appl. Clin. Genet. 2016;9:39&#x2013;47. doi: 10.2147/TACG.S99405.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/TACG.S99405</ArticleId><ArticleId IdType=\"pmc\">PMC4821384</ArticleId><ArticleId IdType=\"pubmed\">27099524</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K., Straus S.E., Hickie I., et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med. 1994;121(12):953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType=\"pubmed\">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., Van de Sande M.I., De Meirleir K.L., Klimas N.G., Broderick G., et al. Myalgic encephalomyelitis: international consensus criteria. J. Intern. Med. 2011;270(4):327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType=\"pmc\">PMC3427890</ArticleId><ArticleId IdType=\"pubmed\">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine (IOM) National Academies Press (US); Washington (DC): 2015. 2015. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.17226/19012</ArticleId><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.J., Son C.G. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2020;18(1):289. doi: 10.1186/s12967-020-02455-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-020-02455-0</ArticleId><ArticleId IdType=\"pmc\">PMC7391812</ArticleId><ArticleId IdType=\"pubmed\">32727489</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Ness J., Stevens S., Bateman L., Stiles T.L., Snell C.R. Postexertional malaise in women with chronic fatigue syndrome. J. Womens Health. 2010;19:239&#x2013;244. doi: 10.1089/jwh.2009.1507.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/jwh.2009.1507</ArticleId><ArticleId IdType=\"pubmed\">20095909</ArticleId></ArticleIdList></Reference><Reference><Citation>Lengert N., Drossel B. In silico analysis of exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Biophys. Chem. 2015;202:21&#x2013;31. doi: 10.1016/j.bpc.2015.03.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bpc.2015.03.009</ArticleId><ArticleId IdType=\"pubmed\">25899994</ArticleId></ArticleIdList></Reference><Reference><Citation>Twisk F.N. A definition of recovery in myalgic encephalomyelitis and chronic fatigue syndrome should be based upon objective measures. Qual. Life Res. 2014;23(9):2417&#x2013;2418. doi: 10.1007/s11136-014-0737-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11136-014-0737-1</ArticleId><ArticleId IdType=\"pubmed\">24935018</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamowicz J.L., Caikauskaite I., Friedberg F. Defining recovery in chronic fatigue syndrome: a critical review. Qual. Life Res. 2014;23(9):2407&#x2013;2416. doi: 10.1007/s11136-014-0705-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11136-014-0705-9</ArticleId><ArticleId IdType=\"pubmed\">24791749</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe P., Fontaine K., Lauver M., Jasion S.E., Marden C.L., et al. Neuromuscular strain increases symptom intensity in chronic fatigue syndrome. PLoS One. 2016;11 doi: 10.1371/journal.pone.0159386.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0159386</ArticleId><ArticleId IdType=\"pmc\">PMC4948885</ArticleId><ArticleId IdType=\"pubmed\">27428358</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L., Authier F.J., Scheibenbogen C., Lorusso L., Helland I.B., et al. Network on myalgic encephalomyelitis/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in Europe. Medicina. 2021;57(5):510. doi: 10.3390/medicina57050510. 19.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57050510</ArticleId><ArticleId IdType=\"pmc\">PMC8161074</ArticleId><ArticleId IdType=\"pubmed\">34069603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C.H., Shin H.C., Won C.W. Prevalence of chronic fatigue and chronic fatigue syndrome in Korea: community-based primary care study. J. Kor. Med. Sci. 2005;20(4):529&#x2013;534. doi: 10.3346/jkms.2005.20.4.529.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3346/jkms.2005.20.4.529</ArticleId><ArticleId IdType=\"pmc\">PMC2782143</ArticleId><ArticleId IdType=\"pubmed\">16100439</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L.C., Lacerda E.M., Pheby D., Campion P., Molokhia M al. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care. BMC Med. 2011;9:91. doi: 10.1186/1741-7015-9-91.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1741-7015-9-91</ArticleId><ArticleId IdType=\"pmc\">PMC3170215</ArticleId><ArticleId IdType=\"pubmed\">21794183</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston S., Brenu E.W., Staines D., et al. The prevalence of chronic fatigue syndrome/myalgic encephalomyelitis: a meta-analysis. Clin. Epidemiol. 2013;5:105&#x2013;110.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3616604</ArticleId><ArticleId IdType=\"pubmed\">23576883</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez A.R., Hancock E.E., Adebayo S., Kiernicki D.J., Proskauer D., et al. Estimating prevalence, demographics, and costs of ME/CFS using large scale medical claims data and machine learning. Front. Pediatr. 2019;6:412. doi: 10.3389/fped.2018.00412.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2018.00412</ArticleId><ArticleId IdType=\"pmc\">PMC6331450</ArticleId><ArticleId IdType=\"pubmed\">30671425</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.J., Ahn Y.C., Jang E.S., Lee S.W., Lee S.H., Son C.G. Systematic review and meta&#x2010;analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) J. Transl. Med. 2020;18:100. doi: 10.1186/s12967&#x2010;020&#x2010;02269&#x2010;0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967&#x2010;020&#x2010;02269&#x2010;0</ArticleId><ArticleId IdType=\"pmc\">PMC7038594</ArticleId><ArticleId IdType=\"pubmed\">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Mirin A.A. Updating the National Academy of Medicine ME/CFS prevalence and economic impact figures to account for population growth and inflation. Fatigue: Biomed., Health Behav. 2021 doi: 10.1080/21641846.2021.1878716.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21641846.2021.1878716</ArticleId></ArticleIdList></Reference><Reference><Citation>Estevez-Lopez F., Mudie K., Wang-Steverding X., Bakken I.J., Ivanovs A., et al. Systematic review of the epidemiological burden of myalgic encephalomyelitis/chronic fatigue syndrome across Europe: current evidence and EUROMENE research recommendations for epidemiology. J. Clin. Med. 2020;9(5):1557. doi: 10.3390/jcm9051557.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm9051557</ArticleId><ArticleId IdType=\"pmc\">PMC7290765</ArticleId><ArticleId IdType=\"pubmed\">32455633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hvidberg F.M., Brinth L.S., Olesen A.V., Petersen K.D., Ehlers L. The health-related quality of life for patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) PLoS One. 2015;10(7) doi: 10.1371/journal.pone.0132421.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0132421</ArticleId><ArticleId IdType=\"pmc\">PMC4492975</ArticleId><ArticleId IdType=\"pubmed\">26147503</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesamt f&#xfc;r Statistik  Familien in der Schweiz. Statistischer Bericht 2021; Neuchatel. BSF Nr. 1010-2100 (in German) 2021. https://www.bfs.admin.ch/bfs/de/home/statistiken/bevoelkerung/familien.assetdetail.17084546.html Accessed 10 January 2022.</Citation></Reference><Reference><Citation>Buchwald D., Herrell R., Ashton S., Belcourt M., Schmaling K., et al. A twin study of chronic fatigue. Psychosom. Med. 2001;63(6):936&#x2013;943. doi: 10.1097/00006842-200111000-00012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00006842-200111000-00012</ArticleId><ArticleId IdType=\"pubmed\">11719632</ArticleId></ArticleIdList></Reference><Reference><Citation>Albright F., Light K., Light A., Bateman L., Cannon-Albright L.A. Evidence for a heritable predisposition to chronic fatigue syndrome. BMC Neurol. 2011;11(1):62. doi: 10.1186/1471-2377-11-62.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2377-11-62</ArticleId><ArticleId IdType=\"pmc\">PMC3128000</ArticleId><ArticleId IdType=\"pubmed\">21619629</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L., Valencia I.J., Garvert D.W., Montoya J.G. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front. Pediatrics. 2019;7:12. doi: 10.3389/fped.2019.00012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2019.00012</ArticleId><ArticleId IdType=\"pmc\">PMC6370741</ArticleId><ArticleId IdType=\"pubmed\">30805319</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C., Brown A., Strassheim V., Elson J., Newton J., et al. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS One. 2017;12 doi: 10.1371/journal.pone.0186802.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0186802</ArticleId><ArticleId IdType=\"pmc\">PMC5655451</ArticleId><ArticleId IdType=\"pubmed\">29065167</ArticleId></ArticleIdList></Reference><Reference><Citation>Esterhuizen K., van der Westhuizen F.H., Louw R. Metabolomics of mitochondrial disease. Mitochondrion. 2017:97&#x2013;110. doi: 10.1016/j.mito.2017.05.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mito.2017.05.012</ArticleId><ArticleId IdType=\"pubmed\">28576558</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C., Newton J. Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review. Biochem. Soc. Trans. 2018;46:547&#x2013;553. doi: 10.1042/BST20170503.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/BST20170503</ArticleId><ArticleId IdType=\"pubmed\">29666214</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorman G.S., Elson J.L., Newman J., Payne B., McFarland R., et al. Perceived fatigue is highly prevalent and debilitating in patients with mitochondrial disease. Neuromuscul. Disord. 2015;25:563&#x2013;566. doi: 10.1016/j.nmd.2015.1003.1001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nmd.2015.1003.1001</ArticleId><ArticleId IdType=\"pmc\">PMC4502433</ArticleId><ArticleId IdType=\"pubmed\">26031904</ArticleId></ArticleIdList></Reference><Reference><Citation>Venter M., Tomas C., Pienaar I.S., Strassheim V., Erasmus E., et al. MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants. Sci. Rep. 2019;9(1):2914. doi: 10.1038/s41598-019-39060-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-39060-1</ArticleId><ArticleId IdType=\"pmc\">PMC6393470</ArticleId><ArticleId IdType=\"pubmed\">30814539</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi I.G., Sein-Echaluce M.L.G., Aubach L.R., Puig-Gros J.T., Sol&#xe0; J.F. Stressful events in the onset of chronic fatigue syndrome. Rev. Esp. Salud Publica. 2016:e1&#x2013;e7. PMID: 27535808.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27535808</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel S., Chapman J., Shoenfeld Y. Infection and vaccination in chronic fatigue syndrome: myth or reality? Autoimmunity. 2007;40(1):48&#x2013;53. doi: 10.1080/08916930701197273.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/08916930701197273</ArticleId><ArticleId IdType=\"pubmed\">17364497</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus P., Brubakk O., Nyland H., Wold B.H., Gjessing H.K., et al. Vaccination as teenagers against meningococcal disease and the risk of the chronic fatigue syndrome. Vaccine. 2009;27(1):23&#x2013;27. doi: 10.1016/j.vaccine.2008.10.043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.vaccine.2008.10.043</ArticleId><ArticleId IdType=\"pubmed\">18984023</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus P., Gunnes N., Tveito K., Bakken I.J., Ghaderi S., et al. Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine. 2015;33(46):6173&#x2013;6177. doi: 10.1016/j.vaccine.2015.10.018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.vaccine.2015.10.018</ArticleId><ArticleId IdType=\"pubmed\">26475444</ArticleId></ArticleIdList></Reference><Reference><Citation>Principi N., Esposito S. Aluminum in vaccines: does it create a safety problem? Vaccine. 2018;36(39):5825&#x2013;5831. doi: 10.1016/j.vaccine.2018.08.036.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.vaccine.2018.08.036</ArticleId><ArticleId IdType=\"pubmed\">30139653</ArticleId></ArticleIdList></Reference><Reference><Citation>Exley C., Swarbrick L., Gherardi R.K., Authier F.J. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med. Hypotheses. 2009;72(2):135&#x2013;139. doi: 10.1016/j.mehy.2008.09.040.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mehy.2008.09.040</ArticleId><ArticleId IdType=\"pubmed\">19004564</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherardi R.K., Cr&#xe9;peaux G., Authier F.J. Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system. Autoimmun. Rev. 2019;18(7):691&#x2013;705. doi: 10.1016/j.autrev.2019.05.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2019.05.006</ArticleId><ArticleId IdType=\"pubmed\">31059838</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., van de Sande M.I., De Meirleir K.L., Klimas N.G. Myalgic Encephalomyelitis: Adult &amp; Paediatric: International Consensus Primer for Medical Practitioners. 2012. http://www.investinme.org/Documents/Guidelines/Myalgic%20Encephalomyelitis%20International%20Consensus%20Primer%20-2012-11-26.pdf</Citation></Reference><Reference><Citation>Wagner N., Assmus F., Arendt G., Baum E., Baumann U., et al. Impfen bei Immundefizienz. Bundesgesundheitlbl. 2019;62:494&#x2013;515. doi: 10.1007/s00103-019-02905-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00103-019-02905-1</ArticleId><ArticleId IdType=\"pubmed\">30899964</ArticleId></ArticleIdList></Reference><Reference><Citation>Karrer U., Nadal D. Epstein-Barr Virus und infekti&#xf6;se Mononukleose. Swiss Med. Forum. 2014;14(11):226&#x2013;232. doi: 10.5167/uzh-96029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5167/uzh-96029</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikova E., Reshkova V., Kumanova &#x410;., Raleva S., Alexandrova D., et al. Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic &#x435;ncephalomyelitis/chronic fatigue syndrome. J. Med. Virol. 2020;92(12):3682&#x2013;3688. doi: 10.1002/jmv.25744.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.25744</ArticleId><ArticleId IdType=\"pmc\">PMC7687071</ArticleId><ArticleId IdType=\"pubmed\">32129496</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M., Strohschein K., Giannini C., Koelsch U., Bauer S., et al. Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome. PLoS One. 2014;9 doi: 10.1371/journal.pone.0085387.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0085387</ArticleId><ArticleId IdType=\"pmc\">PMC3893202</ArticleId><ArticleId IdType=\"pubmed\">24454857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M., Paiva B., Montero-Mateo R., Garcia N., Zabaleta A. Epstein-barr virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.656797.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2021.656797</ArticleId><ArticleId IdType=\"pmc\">PMC8634673</ArticleId><ArticleId IdType=\"pubmed\">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza M.E. Myalgic encephalomyelitis/chronic fatigue syndrome: the human herpesviruses are back. Biomolecules. 2021;11(2):185. doi: 10.3390/biom11020185.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom11020185</ArticleId><ArticleId IdType=\"pmc\">PMC7912523</ArticleId><ArticleId IdType=\"pubmed\">33572802</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa-Dzelzkaleja S., Krumina A., Capenko S., Nora-Krukle Z., Gravelsina S., et al. The persistent viral infections in the development and severity of myalgic encephalomyelitis/chronic fatigue syndrome. J. Transl. Med. 2023;21:33. doi: 10.1186/s12967-023-03887-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-023-03887-0</ArticleId><ArticleId IdType=\"pmc\">PMC9847171</ArticleId><ArticleId IdType=\"pubmed\">36653846</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold J.E., Okyay R.A., Licht W.E., Hurley D.J. Investigation of long COVID prevalence and its relationship to epstein-barr virus reactivation. Pathogens. 2021;10(6):763. doi: 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pathogens10060763</ArticleId><ArticleId IdType=\"pmc\">PMC8233978</ArticleId><ArticleId IdType=\"pubmed\">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J., Faro M., Aliste L., S&#xe1;ez-Franc&#xe0;s N., Calvo N., et al. Comorbidity in chronic fatigue syndrome/myalgic encephalomyelitis: a nationwide population-based cohort study. Psychosomatics. 2017;58(5):533&#x2013;543. doi: 10.1016/j.psym.2017.04.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.psym.2017.04.010</ArticleId><ArticleId IdType=\"pubmed\">28596045</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L., Darakjy S., Klimas N., Peterson D., Levine S.M., et al. Chronic fatigue syndrome and Co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study. Fatigue: Biomed. Health Behav. 2014;31:1&#x2013;15. doi: 10.1080/21641846.2014.978109.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21641846.2014.978109</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken I.J., Tveito K., Gunnes N., Ghadori S., Stoltenberg C., et al. Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008-2012. BMC Med. 2014;12:167. doi: 10.1186/s12916-014-0167-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12916-014-0167-5</ArticleId><ArticleId IdType=\"pmc\">PMC4189623</ArticleId><ArticleId IdType=\"pubmed\">25274261</ArticleId></ArticleIdList></Reference><Reference><Citation>Capelli E., Lorusso L., Ghitti M., Venturini L., Cusa C., Ricevuti G. Chronic fatigue syndrome: features of a population of patients from northern Italy. Internl. J. Immunopath. Pharmacol. 2015;28(1):53&#x2013;59. doi: 10.1177/0394632015572074.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0394632015572074</ArticleId><ArticleId IdType=\"pubmed\">25816406</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns R., Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup. Med. (Oxf.) 2005;55(1):20&#x2013;31. doi: 10.1093/occmed/kqi013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/occmed/kqi013</ArticleId><ArticleId IdType=\"pubmed\">15699087</ArticleId></ArticleIdList></Reference><Reference><Citation>Pheby D.F.H., Araja D., Berkis U., Brenna E., Cullinan J., et al. Literature review of GP knowledge and understanding of ME/CFS: a report from the socioeconomic working group of the European Network on ME/CFS (EUROMENE) Medicina. 2020;57(1):7. doi: 10.3390/medicina57010007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57010007</ArticleId><ArticleId IdType=\"pmc\">PMC7823627</ArticleId><ArticleId IdType=\"pubmed\">33374291</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37129123</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Print\">1565-1088</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The Israel Medical Association journal : IMAJ</Title><ISOAbbreviation>Isr Med Assoc J</ISOAbbreviation></Journal><ArticleTitle>Modulation of Beta-Adrenergic Autoantibodies Over Time in Post-Viral ME/CFS is Related to Fatigue and Pain Symptoms.</ArticleTitle><Pagination><StartPage>259</StartPage><EndPage>264</EndPage><MedlinePgn>259-264</MedlinePgn></Pagination><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Myalgic encephalomyelits/chronic fatigue syndrome (ME/CFS) is an acquired disease with symptoms of fatigue and pain. In pathogenesis, the induction of autoantibodies (AAB) against G-protein coupled receptors (GPCR), such as &#x3b2;-adrenergic receptors (&#x3b2;-AdR), has been suspected. GPCR-AAB correlate with symptom severity and autonomic dysfunction in ME/CFS. Objectives: To describe symptoms and treatment of a patient presenting with infection-triggered ME/CFS demonstrating that levels of &#x3b2;-AdR-AAB underlie modulation over time, correlating with the severity of symptoms.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">At T1 and T2, GPCR-AAB were measured and questionnaires assessing symptom severity were completed. TSHDS-IgM-AAB were tested, and SF density was analyzed via skin probe.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">At T2, elevated levels of &#x3b2;-AdR-AAB were found, corresponding with an aggravation of fatigue and pain symptoms. Elevated TSHDS-IgM-AAB were found, which corresponded with reduced fiber density from the skin probe.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">The levels of &#x3b2;-AdR-AAB in post-infectious ME/CFS can be modulated. Future studies might target interventions to reduce these AAB.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Busch</LastName><ForeName>Lena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Academy for Diagnostics and Prevention M&#xfc;nster, M&#xfc;nster, Germany, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Schriek</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Academy for Diagnostics and Prevention M&#xfc;nster, M&#xfc;nster, Germany, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Paul</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academy for Diagnostics and Prevention M&#xfc;nster, M&#xfc;nster, Germany, Department of Cardiovascular Medicine, University Hospital M&#xfc;nster, Steinfurt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Heidecke</LastName><ForeName>Harald</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>CellTrend GmbH, Luckenwalde, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Israel</Country><MedlineTA>Isr Med Assoc J</MedlineTA><NlmUniqueID>100930740</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D001323\">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018663\">Adrenergic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011943\">Receptors, Adrenergic, beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D007075\">Immunoglobulin M</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001323\" MajorTopicYN=\"Y\">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018663\" MajorTopicYN=\"N\">Adrenergic Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D063806\" MajorTopicYN=\"N\">Myalgia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011943\" MajorTopicYN=\"N\">Receptors, Adrenergic, beta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007075\" MajorTopicYN=\"N\">Immunoglobulin M</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>7</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37129123</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37128534</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">2168-8184</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>COVID-19: Post-recovery Manifestations.</ArticleTitle><Pagination><StartPage>e36886</StartPage><MedlinePgn>e36886</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">e36886</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.7759/cureus.36886</ELocationID><Abstract><AbstractText>Background Post-COVID-19 syndrome, also known as long COVID, is a disorder that has many characteristics, one of which is chronic fatigue following acute infection with the SARS-CoV-2 virus. Methodology We distributed a web-based survey among patients diagnosed with COVID-19&#xa0;across the world and collected 190 responses regarding their demographics, histories, COVID-19 infection courses, and common symptoms. Results We found that about 85.3% of the patients experienced some form of symptom following recovery from the infection. Among the reported symptoms, 59% of patients experienced fatigue or lethargy, 48.9% reported decreased stamina, 32.6% reported&#xa0;shortness of breath, 16.8% had a persistent cough, and 23.7% experienced anxiety following recovery from COVID-19. Conclusions Reported symptoms closely resembled myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); however, a deeper biochemical understanding of ME/CFS is required to confirm causation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Shaikh et al.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Shaikh</LastName><ForeName>Safia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Research, Southwest Family Medicine Associates, Dallas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Siddiqi</LastName><ForeName>Zunaira</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>General Medicine, Dow University of Health Sciences, Civil Hospital Karachi, Karachi, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ukachukwu</LastName><ForeName>Crystal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>General Medicine, University College Hospital, Ibadan, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mehkari</LastName><ForeName>Zainab</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Khan</LastName><ForeName>Sadaf</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Approval, PPD Inc, Houston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pamurthy</LastName><ForeName>Ketan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Medical School, Brown University, Providence, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jahan</LastName><ForeName>Farhat</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Research, St. Michael Hospital Research Laboratory, Ontario, CAN.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Brown</LastName><ForeName>Amaiya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical School, University of Arlington, Arlington, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">covid-19</Keyword><Keyword MajorTopicYN=\"N\">covid-19 manifestation</Keyword><Keyword MajorTopicYN=\"N\">long covid</Keyword><Keyword MajorTopicYN=\"N\">post-covid-19 recovery symptoms</Keyword><Keyword MajorTopicYN=\"N\">post-covid-19 syndrome</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>1</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37128534</ArticleId><ArticleId IdType=\"pmc\">PMC10147564</ArticleId><ArticleId IdType=\"doi\">10.7759/cureus.36886</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johns Hopkins Coronavirus Resource Center. Covid-19 map.  [\\nOct;\\n2021 \\n];https://coronavirus.jhu.edu/map.html 2021 REFERENCES</Citation></Reference><Reference><Citation>Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Komaroff AL, Bateman L. https://www.frontiersin.org/articles/10.3389/fmed.2020.606824/full. Front Med (Lausanne) 2020;7:606824.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7848220</ArticleId><ArticleId IdType=\"pubmed\">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Redefining the chronic fatigue syndrome. Ganiats TG. https://www.acpjournals.org/doi/abs/10.7326/M15-0357. Ann Intern Med. 2015;162:653&#x2013;654.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25668185</ArticleId></ArticleIdList></Reference><Reference><Citation>Chronic fatigue syndrome/myalgic encephalomyelitis is a legitimate disease that needs proper diagnosis and treatment, says IOM; report identifies five symptoms to diagnose disease.  [\\nOct;\\n2021 \\n]. 2021. https://www.nationalacademies.org/news/2015/02/chronic-fatigue-syndrome-myalgic-encephalomyelitis-is-a-legitimate-disease-that-needs-proper-diagnosis-and-treatment-says-iom-report-identifies-five-symptoms-to-diagnose-disease https://www.nationalacademies.org/news/2015/02/chronic-fatigue-syndrome-myalgic-encephalomyelitis-is-a-legitimate-disease-that-needs-proper-diagnosis-and-treatment-says-iom-report-identifies-five-symptoms-to-diagnose-disease</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. (2021, September 8. Centers for Disease Control and Prevention. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)  [\\nOct;\\n2021 \\n]. 2021. https://www.cdc.gov/me-cfs/index.html https://www.cdc.gov/me-cfs/index.html</Citation></Reference><Reference><Citation>Sickness: from the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons. Poon DC, Ho YS, Chiu K, Wong HL, Chang RC. Neurosci Biobehav Rev. 2015;57:30&#x2013;45.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26363665</ArticleId></ArticleIdList></Reference><Reference><Citation>The neuroimmune basis of fatigue. Dantzer R, Heijnen CJ, Kavelaars A, Laye S, Capuron L. https://doi.org/10.1016/j.tins.2013.10.003. Trends Neurosci. 2014;37:39&#x2013;46.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3889707</ArticleId><ArticleId IdType=\"pubmed\">24239063</ArticleId></ArticleIdList></Reference><Reference><Citation>Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 \\'long-haulers\\'? Wood E, Hall KH, Tate W. https://doi.org/10.1016/j.cdtm.2020.11.002. Chronic Dis Transl Med. 2021;7:14&#x2013;26.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7680046</ArticleId><ArticleId IdType=\"pubmed\">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. Grasselli G, Zangrillo A, Zanella A, et al. JAMA. 2020;323:1574&#x2013;1581.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7136855</ArticleId><ArticleId IdType=\"pubmed\">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends in mortality of hospitalised COVID-19 patients: a single centre observational cohort study from Spain. Garcia-Vidal C, C&#xf3;zar-Llist&#xf3; A, Meira F, et al.  https://doi.org/10.1016/j.lanepe.2021.100041. Lancet Reg Health Eur. 2021;3:100041.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7830193</ArticleId><ArticleId IdType=\"pubmed\">33870249</ArticleId></ArticleIdList></Reference><Reference><Citation>Demographic, signs and symptoms, imaging characteristics of 2126 patients with COVID-19 pneumonia in the whole quarantine of Wuhan, China. Yin X, Li Q, Hou S, et al.   https://doi.org/10.1016/j.clinimag.2021.02.034&#xa0;. Clin Imaging. 2021;77:169&#x2013;174.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7901270</ArticleId><ArticleId IdType=\"pubmed\">33691264</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Symptoms of COVID-19.  [\\nOct;\\n2021 \\n];https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html 2021 4:2021.</Citation></Reference><Reference><Citation>Smoking and COVID-19: what we know so far. Shastri MD, Shukla SD, Chong WC, et al. Respir Med. 2021;176:106237.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7674982</ArticleId><ArticleId IdType=\"pubmed\">33246296</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Pavli A, Theodoridou M, Maltezou HC. Arch Med Res. 2021;52:575&#x2013;581.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8093949</ArticleId><ArticleId IdType=\"pubmed\">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Cuadrado ML, Florencio LL. Int J Environ Res Public Health. 2021;18:2621.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7967389</ArticleId><ArticleId IdType=\"pubmed\">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 and chronic fatigue syndrome: is the worst yet to come? Wostyn P. https://doi.org/10.1016/j.mehy.2020.110469. Med Hypotheses. 2021;146:110469.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7836544</ArticleId><ArticleId IdType=\"pubmed\">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae. Daher A, Balfanz P, Cornelissen C, et al.  https://doi.org/10.1016/j.rmed.2020.106197. Respir Med. 2020;174:106197.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7573668</ArticleId><ArticleId IdType=\"pubmed\">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Cort&#xe9;s-Telles A, L&#xf3;pez-Romero S, Figueroa-Hurtado E, et al. Respir Physiol Neurobiol. 2021;288:103644.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7910142</ArticleId><ArticleId IdType=\"pubmed\">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine. Washington, DC: National Academies Press; 2015. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37109676</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1648-9144</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>59</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>06</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>The Role of Psychotherapy in the Care of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">719</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/medicina59040719</ELocationID><Abstract><AbstractText>Myalgic encephalomyelitis/chronic fatigue (ME/CFS) is a post-infectious, chronic disease that can lead to severe impairment and, even, total disability. Although the disease has been known for a long time, and has been coded in the ICD since 1969 (G93.3), medical research has not yet been able to reach a consensus regarding its physiological basis and how best to treat it. Against the background of these shortcomings, psychosomatic disease models have been developed and psychotherapeutic treatments have been derived from them, but their empirical testing has led to sobering results. According to the current state of research, psychotherapy and psychosomatic rehabilitation have no curative effect in the treatment of ME/CFS. Nevertheless, we see numerous patients in practices and outpatient clinics who suffer severely as a result of their illness and whose mental well-being and coping strategies would benefit from psychotherapeutic help. In this article, we outline a psychotherapeutic approach that serves this need, taking into account two basic characteristics of ME/CFS: firstly, the fact that ME/CFS is a physical illness and that curative treatment must therefore be physical; and secondly, the fact that post exertional malaise (PEM) is a cardinal symptom of ME/CFS and thus warrants tailored psychotherapeutic attention.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Grande</LastName><ForeName>Tilman</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Independent Researcher, 69117 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Grande</LastName><ForeName>Bettina</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Independent Researcher, 69117 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gerner</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Kinder und Jugendmedizin, Ortenau Klinikum, 77654 Offenburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hammer</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Gesundheit &amp; Soziales, Hochschule Fresenius, 65510 Idstein, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stingl</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0009-0004-7220-0658</Identifier><AffiliationInfo><Affiliation>Facharztzentrum Votivpark, 1090 Wien, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vink</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0003-1079-5647</Identifier><AffiliationInfo><Affiliation>Independent Researcher, 1096 HZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hughes</LastName><ForeName>Brian M</ForeName><Initials>BM</Initials><Identifier Source=\"ORCID\">0000-0002-6545-9248</Identifier><AffiliationInfo><Affiliation>School of Psychology, University of Galway, H91 TK33 Galway, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011613\" MajorTopicYN=\"N\">Psychotherapy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">cognitive behavioral therapy</Keyword><Keyword MajorTopicYN=\"N\">exercise</Keyword><Keyword MajorTopicYN=\"N\">myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN=\"N\">pacing</Keyword><Keyword MajorTopicYN=\"N\">post-exertional malaise</Keyword><Keyword MajorTopicYN=\"N\">psychotherapy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>1</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37109676</ArticleId><ArticleId IdType=\"pmc\">PMC10145115</ArticleId><ArticleId IdType=\"doi\">10.3390/medicina59040719</ArticleId><ArticleId IdType=\"pii\">medicina59040719</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wong T.L., Weitz D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)&#x2014;A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57050418</ArticleId><ArticleId IdType=\"pmc\">PMC8145228</ArticleId><ArticleId IdType=\"pubmed\">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva O.A., Maksoud R., Beeraka N.M., Madhunapantula A.V., Sinelnikov M., Nikolenko V.N., Neganova M.E., Klochkov S.G., Kamal M.A., Staines D.R., et al. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J. Adv. Res. 2022;40:179&#x2013;196. doi: 10.1016/j.jare.2021.11.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType=\"pmc\">PMC8619886</ArticleId><ArticleId IdType=\"pubmed\">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType=\"pmc\">PMC9839201</ArticleId><ArticleId IdType=\"pubmed\">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.-C., Hsu C.-K., Yen M.-Y., Lee P.-I., Ko W.-C., Hsueh P.-R. Long COVID: An inevitable sequela of SARS-CoV-2 infection. J. Microbiol. Immunol. Infect. 2023;56:1&#x2013;9. doi: 10.1016/j.jmii.2022.10.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jmii.2022.10.003</ArticleId><ArticleId IdType=\"pmc\">PMC9576029</ArticleId><ArticleId IdType=\"pubmed\">36283919</ArticleId></ArticleIdList></Reference><Reference><Citation>Surawy C., Hackmann A., Hawton K., Sharpe M. Chronic fatigue syndrome: A cognitive approach. Behav. Res. Ther. 1995;33:535&#x2013;544. doi: 10.1016/0005-7967(94)00077-W.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0005-7967(94)00077-W</ArticleId><ArticleId IdType=\"pubmed\">7598674</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesseley S., Sharpe M., Hotopf M. Chronic Fatigue and Its Syndromes. Oxford University Press; Oxford, UK: 1998.</Citation></Reference><Reference><Citation>White P.D., Goldsmith K.A., Johnson A.L., Potts L., Walwyn R., DeCesare J.C., Baber H.L., Burgess M., Clark L.V., Cox D.L., et al. Comparison of adaptive pacing therapy, cognitive behavior therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): A randomized trial. Lancet. 2011;377:823&#x2013;836. doi: 10.1016/S0140-6736(11)60096-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(11)60096-2</ArticleId><ArticleId IdType=\"pmc\">PMC3065633</ArticleId><ArticleId IdType=\"pubmed\">21334061</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilshire C., Kindlon T., Matthees A., McGrath S. Can patients with chronic fatigue syndrome really recover after graded exercise or cognitive behavioral therapy? A critical commentary and preliminary re-analyses of the PACE-trial. Fatigue. 2017;5:43&#x2013;56. doi: 10.1080/21641846.2017.1259724.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21641846.2017.1259724</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilshire C.E., Kindlon T., Courtney R., Matthees A., Tuller D., Geraghty K., Levin B. Rethinking the treatment of chronic fatigue syndrome&#x2014;A reanalysis and evaluation of findings from a recent major trial of graded exercise an CBT. BMC Psychol. 2018;6:6. doi: 10.1186/s40359-018-0218-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40359-018-0218-3</ArticleId><ArticleId IdType=\"pmc\">PMC5863477</ArticleId><ArticleId IdType=\"pubmed\">29562932</ArticleId></ArticleIdList></Reference><Reference><Citation>McManimen S.L., McClellan D., Stoothoff J., Jason L.A. Effects of unsupportive social interactions, stigma, and symptoms on patients with myalgic encephalomyelitis and chronic fatigue syndrome. J. Community Psychol. 2018;46:959&#x2013;971. doi: 10.1002/jcop.21984.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jcop.21984</ArticleId><ArticleId IdType=\"pmc\">PMC7944645</ArticleId><ArticleId IdType=\"pubmed\">30311972</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE  Myalgic Encephalomyelitis (or Encephalopathy)/Chronic Fatigue Syndrome: Diagnosis and Management. NICE Guideline [NG206]. 29 October 2021.  [(accessed on 23 February 2023)].  Available online:  https://www.nice.org.uk/guidance/ng206.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35438859</ArticleId></ArticleIdList></Reference><Reference><Citation>IQWIG  Myalgische Enzephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Aktueller Kenntnisstand.  [(accessed on 23 February 2023)].  Available online:  https://www.iqwig.de/download/n21-01_me-cfs-aktueller-kenntnisstand_vorbericht_v1-0.pdf.</Citation></Reference><Reference><Citation>Vink M., Vink-Niese A. The Draft Report by the Institute for Quality and Efficiency in Healthcare Does Not Provide Any Evidence That Graded Exercise Therapy and Cognitive Behavioral Therapy Are Safe and Effective Treatments for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Diseases. 2023;11:11. doi: 10.3390/diseases11010011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diseases11010011</ArticleId><ArticleId IdType=\"pmc\">PMC9844345</ArticleId><ArticleId IdType=\"pubmed\">36648876</ArticleId></ArticleIdList></Reference><Reference><Citation>EMEC  Stellungnahme der European ME Coalition zum IQWiG Vorbericht N21-0: &#x201c;Aktueller wissenschaftlicher Erkenntnisstand zu Myalgischer Enzephalomyelitis/Chronic Fatigue Syndrom (ME/CFS)&#x201d;. 2022.  [(accessed on 26 February 2023)].  Available online:  https://europeanmecoalition.com/wp-content/uploads/2022/11/EMEC_IQWiQ-Stellungnahme_final-version.pdf.</Citation></Reference><Reference><Citation>Institute of Medicine (IOM) Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Board on the Health of Select Populations  . Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press; Washington, DC, USA: 2015.  [(accessed on 26 February 2023)].  Available online:  https://nap.nationalacademies.org/catalog/19012/beyond-myalgic-encephalomyelitischronic-fatigue-syndrome-redefining-an-illness.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischer M., Szepanowski F., Tovar M., Herchert K., Dinse H., Schweda A., Mausberg A.K., Holle-Lee D., K&#xf6;hrmann M., St&#xf6;gbauer J., et al. Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients. Neurol. Ther. 2022;11:1637&#x2013;1657. doi: 10.1007/s40120-022-00395-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40120-022-00395-z</ArticleId><ArticleId IdType=\"pmc\">PMC9417089</ArticleId><ArticleId IdType=\"pubmed\">36028604</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig B., Olbert E., Trimmel K., Seidel S., Rommer P.S., M&#xfc;ller C., Struhal W., Berger T. Myalgische Enzephalomyelitis/chronisches Fatigue Syndrom: Eine &#xdc;bersicht zur aktuellen Evidenz. Nervenarzt. 2023 doi: 10.1007/s00115-022-01431-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00115-022-01431-x</ArticleId><ArticleId IdType=\"pmc\">PMC9875188</ArticleId><ArticleId IdType=\"pubmed\">36695893</ArticleId></ArticleIdList></Reference><Reference><Citation>Deutsche Gesellschaft f&#xfc;r ME/CFS  Post Exertional Malaise. Belastungsintoleranz als Leitsymptom von ME/CFS.  [(accessed on 26 February 2023)].  Available online:  https://www.mecfs.de/was-ist-me-cfs/pem/</Citation></Reference><Reference><Citation>Goudsmit E. Pacing for ME and CFS: A Guide for Patients. May 2005.  [(accessed on 26 February 2023)].  Available online:  https://huisartsvink.files.wordpress.com/2023/02/goudsmit-pacing-for-me-and-cfs-a-guide-for-patients.pdf.</Citation></Reference><Reference><Citation>World Health Organization (WHO)  Clinical Management of COVID-19: Living Guideline. Published on 13 January 2023.  [(accessed on 26 February 2023)].  Available online:  https://app.magicapp.org/#/guideline/j1WBYn.</Citation></Reference><Reference><Citation>Fennel P.A., Dorr N., George S.S. Elements of Suffering in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Experience of Loss, Grief, Stigma, and Trauma in the Severely and Very Severely Affected. Healthcare. 2021;9:553. doi: 10.3390/healthcare9050553.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare9050553</ArticleId><ArticleId IdType=\"pmc\">PMC8150911</ArticleId><ArticleId IdType=\"pubmed\">34065069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L., Elliot M., Stein E., Jason L. Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Healthcare. 2021;9:629. doi: 10.3390/healthcare9060629.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare9060629</ArticleId><ArticleId IdType=\"pmc\">PMC8227525</ArticleId><ArticleId IdType=\"pubmed\">34070367</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens W. Was Z&#xe4;hlt Mehr: Laborwerte Oder Subjektives Krankheitserleben? S&#xfc;ddeutsche Zeitung 9-9-2023.  [(accessed on 26 February 2023)].  Available online:  https://www.s&#xfc;ddeutsche.de/gesundheit/medizin-1.5653659.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37064029</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">2296-858X</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>A review of cytokine-based pathophysiology of Long COVID symptoms.</ArticleTitle><Pagination><StartPage>1011936</StartPage><MedlinePgn>1011936</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">1011936</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3389/fmed.2023.1011936</ELocationID><Abstract><AbstractText>The Long COVID/Post Acute Sequelae of COVID-19 (PASC) group includes patients with initial mild-to-moderate symptoms during the acute phase of the illness, in whom recovery is prolonged, or new symptoms are developed over months. Here, we propose a description of the pathophysiology of the Long COVID presentation based on inflammatory cytokine cascades and the p38 MAP kinase signaling pathways that regulate cytokine production. In this model, the SARS-CoV-2 viral infection is hypothesized to trigger a dysregulated peripheral immune system activation with subsequent cytokine release. Chronic low-grade inflammation leads to dysregulated brain microglia with an exaggerated release of central cytokines, producing neuroinflammation. Immunothrombosis linked to chronic inflammation with microclot formation leads to decreased tissue perfusion and ischemia. Intermittent fatigue, Post Exertional Malaise (PEM), CNS symptoms with \"brain fog,\" arthralgias, paresthesias, dysautonomia, and GI and ophthalmic problems can consequently arise as result of the elevated peripheral and central cytokines. There are abundant similarities between symptoms in Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). DNA polymorphisms and viral-induced epigenetic changes to cytokine gene expression may lead to chronic inflammation in Long COVID patients, predisposing some to develop autoimmunity, which may be the gateway to ME/CFS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Low, Low and Akrami.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Low</LastName><ForeName>Russell N</ForeName><Initials>RN</Initials><AffiliationInfo><Affiliation>Retired, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Low</LastName><ForeName>Ryan J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Gatsby Computational Neuroscience Unit, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sainsbury Wellcome Centre, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Akrami</LastName><ForeName>Athena</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sainsbury Wellcome Centre, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">COVID-19</Keyword><Keyword MajorTopicYN=\"N\">Chronic Fatigue Syndrome</Keyword><Keyword MajorTopicYN=\"N\">Dysautonomia</Keyword><Keyword MajorTopicYN=\"N\">Long COVID</Keyword><Keyword MajorTopicYN=\"N\">Myalgic Encephalomyelitis (ME)</Keyword><Keyword MajorTopicYN=\"N\">cytokines</Keyword><Keyword MajorTopicYN=\"N\">neuroinflammation</Keyword><Keyword MajorTopicYN=\"N\">post-acute sequelae of COVID-19</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>3</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37064029</ArticleId><ArticleId IdType=\"pmc\">PMC10103649</ArticleId><ArticleId IdType=\"doi\">10.3389/fmed.2023.1011936</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. Geneva: World Health Organization; (2021).</Citation></Reference><Reference><Citation>Assaf G, Davis H, McCorkell L, Wei H, O&#x2019;Neill B, Akrami A, et al. . What does COVID-19 recovery actually look like? An analysis of the c survey by patient-led research team [internet]. London, UK: The COVID-19 Body Politic Slack Group; (2020).</Citation></Reference><Reference><Citation>Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. (2022) 13:1812. doi: 10.1038/s41467-022-29513-z, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType=\"pmc\">PMC8983754</ArticleId><ArticleId IdType=\"pubmed\">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Schiabor Barrett KM, Riffle S, Bolze A, Neveux I, Dabe S, et al. . (2020). Long-term COVID-19 symptoms in a large unselected population [internet]. medRxiv [Preprint]. doi: 10.1101/2020.10.07.20208702</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.10.07.20208702</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair PW, Brown DM, Jang M, Antar AAR, Keruly JC, Bachu V, et al. . (2020). The clinical course of COVID-19 in the outpatient setting: a prospective cohort study [internet]. medRxiv [Preprint]. doi: 10.1101/2020.09.01.20184937</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.09.01.20184937</ArticleId><ArticleId IdType=\"pmc\">PMC7881750</ArticleId><ArticleId IdType=\"pubmed\">33614816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding H, Yin S, Cheng Y, Cai Y, Huang W, Deng W. Neurologic manifestations of nonhospitalized patients with COVID-19 in Wuhan, China [internet]. MedComm. (2020) 1:253&#x2013;6. doi: 10.1002/mco2.13, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/mco2.13</ArticleId><ArticleId IdType=\"pmc\">PMC7362024</ArticleId><ArticleId IdType=\"pubmed\">34172986</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2014; United States, march&#x2013;June 2020. MMWR Morb Mortal Wkly Rep. (2020) 69:993&#x2013;8. Available from:. doi: 10.15585/mmwr.mm6930e1, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType=\"pmc\">PMC7392393</ArticleId><ArticleId IdType=\"pubmed\">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group . Landi F. persistent symptoms in patients after acute COVID-19. JAMA. (2020) 324:603&#x2013;5. doi: 10.1001/jama.2020.12603, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2020.12603</ArticleId><ArticleId IdType=\"pmc\">PMC7349096</ArticleId><ArticleId IdType=\"pubmed\">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, le Bot A, Hamon A, Gouze H, et al. . Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect [Internet]. (2020) 81:e4&#x2013;6. doi: 10.1016/j.jinf.2020.08.029, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType=\"pmc\">PMC7445491</ArticleId><ArticleId IdType=\"pubmed\">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, Morley A, Viner J, Attwood M, et al. . (2020). Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort. medRxiv [Preprint]. doi: 10.1101/2020.08.12.20173526</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.08.12.20173526</ArticleId><ArticleId IdType=\"pmc\">PMC7716340</ArticleId><ArticleId IdType=\"pubmed\">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bosworth ML, King S, Pouwels KB, Glickman M, Nafilyan V, et al. . (2022). Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study [internet]. medRxiv [Preprint]. doi: 10.1101/2022.02.23.22271388</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2022.02.23.22271388</ArticleId><ArticleId IdType=\"pmc\">PMC9494414</ArticleId><ArticleId IdType=\"pubmed\">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. (2022) 28:1461&#x2013;7. doi: 10.1038/s41591-022-01840-0, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType=\"pmc\">PMC9307472</ArticleId><ArticleId IdType=\"pubmed\">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. (2021) 38:101019. doi: 10.1016/j.eclinm.2021.101019, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType=\"pmc\">PMC8280690</ArticleId><ArticleId IdType=\"pubmed\">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoshal UC, Ghoshal U, Rahman MM, Mathur A, Rai S, Akhter M, et al. . Post-infection functional gastrointestinal disorders following coronavirus disease-19: a case-control study. J Gastroenterol Hepatol. (2022) 37:489&#x2013;98. doi: 10.1111/jgh.15717, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jgh.15717</ArticleId><ArticleId IdType=\"pmc\">PMC8657345</ArticleId><ArticleId IdType=\"pubmed\">34672022</ArticleId></ArticleIdList></Reference><Reference><Citation>de Rooij LPMH, Becker LM, Carmeliet P. A role for the vascular endothelium in post&#x2013;acute COVID-19? Circulation. (2022) 145:1503&#x2013;5. doi: 10.1161/circulationaha.122.059231, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/circulationaha.122.059231</ArticleId><ArticleId IdType=\"pubmed\">35576316</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz A, Ong P. Endothelial dysfunction in COVID-19: a potential predictor of long-COVID? Int J Cardiol. (2022) 349:155&#x2013;6. doi: 10.1016/j.ijcard.2021.11.051, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijcard.2021.11.051</ArticleId><ArticleId IdType=\"pmc\">PMC8610828</ArticleId><ArticleId IdType=\"pubmed\">34838682</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType=\"pmc\">PMC9839201</ArticleId><ArticleId IdType=\"pubmed\">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute Sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. (2021) 12:698169. doi: 10.3389/fmicb.2021.698169, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType=\"pmc\">PMC8260991</ArticleId><ArticleId IdType=\"pubmed\">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogensen TH, Paludan SR. Molecular pathways in virus-induced cytokine production [internet]. Microbiol Mol Biol Rev. (2001) 65:131&#x2013;50. Available from:. doi: 10.1128/MMBR.65.1.131-150.2001, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/MMBR.65.1.131-150.2001</ArticleId><ArticleId IdType=\"pmc\">PMC99022</ArticleId><ArticleId IdType=\"pubmed\">11238989</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. . Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. (2020) 71:762&#x2013;8. doi: 10.1093/cid/ciaa248, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cid/ciaa248</ArticleId><ArticleId IdType=\"pmc\">PMC7108125</ArticleId><ArticleId IdType=\"pubmed\">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. (2020) 53:25&#x2013;32. doi: 10.1016/j.cytogfr.2020.05.003, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cytogfr.2020.05.003</ArticleId><ArticleId IdType=\"pmc\">PMC7211650</ArticleId><ArticleId IdType=\"pubmed\">32446778</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. (2020) 395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType=\"pmc\">PMC7159299</ArticleId><ArticleId IdType=\"pubmed\">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, et al. . An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med [Internet]. (2020) 26:1636&#x2013;43. doi: 10.1038/s41591-020-1051-9, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType=\"pmc\">PMC7869028</ArticleId><ArticleId IdType=\"pubmed\">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng HY, Gao Y, Liu S, Sun D, Yang F, Zong L, et al. . Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. (2020) 17:1180&#x2013;2. doi: 10.1038/s41423-020-00551-1, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41423-020-00551-1</ArticleId><ArticleId IdType=\"pmc\">PMC7091621</ArticleId><ArticleId IdType=\"pubmed\">32203186</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. . Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science [Internet]. (2020) 369:718&#x2013;24. doi: 10.1126/science.abc6027, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.abc6027</ArticleId><ArticleId IdType=\"pmc\">PMC7402632</ArticleId><ArticleId IdType=\"pubmed\">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Dong X, Ma R, Wang W, Xiao X, Tian Z, et al. . Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun. (2020) 11:3810. doi: 10.1038/s41467-020-17665-9, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-020-17665-9</ArticleId><ArticleId IdType=\"pmc\">PMC7392898</ArticleId><ArticleId IdType=\"pubmed\">32733001</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. (2022) 23:210&#x2013;6. doi: 10.1038/s41590-021-01113-x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType=\"pubmed\">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Glasauer S, et al. . From online data collection to identification of disease mechanisms: the IL-1&#xdf;, IL-6 and TNF-&#x3b1; cytokine triad is associated with post-acute sequelae of COVID-19 in a digital research cohort. SSRN Electron J [Internet]. (2021). doi: 10.2139/ssrn.3963839</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2139/ssrn.3963839</ArticleId></ArticleIdList></Reference><Reference><Citation>VanElzakker MB, Brumfield SA, Lara Mejia PS. Neuroinflammation and cytokines in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a critical review of research methods. Front Neurol. (2018) 9:1033. doi: 10.3389/fneur.2018.01033, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2018.01033</ArticleId><ArticleId IdType=\"pmc\">PMC6335565</ArticleId><ArticleId IdType=\"pubmed\">30687207</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho HE, Goldberg SA, et al. . Markers of immune activation and inflammation in individuals with Postacute Sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. (2021) 224:1839&#x2013;48. doi: 10.1093/infdis/jiab490, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/infdis/jiab490</ArticleId><ArticleId IdType=\"pmc\">PMC8643408</ArticleId><ArticleId IdType=\"pubmed\">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, et al. . (2022). Distinguishing features of long COVID identified through immune profiling. medRxiv [Preprint]. doi: 10.1101/2022.08.09.22278592.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2022.08.09.22278592</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, Bamford CGG, Ho A. COVID-19 pandemic&#x2014;a focused review for clinicians. Clin Microbiol Infect. (2020) 26:842&#x2013;7. doi: 10.1016/j.cmi.2020.04.023, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmi.2020.04.023</ArticleId><ArticleId IdType=\"pmc\">PMC7182753</ArticleId><ArticleId IdType=\"pubmed\">32344166</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. . COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. (2020) 395:1033&#x2013;4. Available from:. doi: 10.1016/S0140-6736(20)30628-0, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType=\"pmc\">PMC7270045</ArticleId><ArticleId IdType=\"pubmed\">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Chen X, Cai Y, Xia J&#x2019;a, Zhou X, Xu S, et al. . Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. (2020) 180:934&#x2013;43. doi: 10.1001/jamainternmed.2020.0994, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType=\"pmc\">PMC7070509</ArticleId><ArticleId IdType=\"pubmed\">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. (2012) 76:16&#x2013;32. doi: 10.1128/MMBR.05015-11, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/MMBR.05015-11</ArticleId><ArticleId IdType=\"pmc\">PMC3294426</ArticleId><ArticleId IdType=\"pubmed\">22390970</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, et al. . Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19 [internet]. J Allergy Clin Immunol. (2020) 146:128&#x2013;36.e4. Available from:. doi: 10.1016/j.jaci.2020.05.008, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaci.2020.05.008</ArticleId><ArticleId IdType=\"pmc\">PMC7233239</ArticleId><ArticleId IdType=\"pubmed\">32425269</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Shen C, Li J, Yuan J, Yang M, Wang F, et al. . (2020). Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome. medRxiv [Preprint]. doi: 10.1101/2020.11.26.20152520.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.11.26.20152520</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimabukuro-Vornhagen A, G&#xf6;del P, Subklewe M, Stemmler HJ, Schl&#xf6;&#xdf;er HA, Schlaak M, et al. . Cytokine release syndrome. J Immunother. Cancer. (2018) 6:56. doi: 10.1186/s40425-018-0343-9, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40425-018-0343-9</ArticleId><ArticleId IdType=\"pmc\">PMC6003181</ArticleId><ArticleId IdType=\"pubmed\">29907163</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, et al. . Current concepts in the diagnosis and management of cytokine release syndrome. Blood. (2014) 124:188&#x2013;95. doi: 10.1182/blood-2014-05-552729, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood-2014-05-552729</ArticleId><ArticleId IdType=\"pmc\">PMC4093680</ArticleId><ArticleId IdType=\"pubmed\">24876563</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. (2020) 368:473&#x2013;4. doi: 10.1126/science.abb8925, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.abb8925</ArticleId><ArticleId IdType=\"pubmed\">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MD, Nedjai B, Hurst T, Pennington DF. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta&#x2014;Mol Cell Res. (2014) 1843:2563&#x2013;82. doi: 10.1016/j.bbamcr.2014.05.014, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamcr.2014.05.014</ArticleId><ArticleId IdType=\"pubmed\">24892271</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Author correction: pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. (2020) 20:448. doi: 10.1038/s41577-020-0353-y, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41577-020-0353-y</ArticleId><ArticleId IdType=\"pmc\">PMC7265161</ArticleId><ArticleId IdType=\"pubmed\">32488203</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q, Wang B, Mao J. The pathogenesis and treatment of the &#x2018;cytokine storm&#x2019; in COVID-19. J Infect. (2020) 80:607&#x2013;13. doi: 10.1016/j.jinf.2020.03.037, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jinf.2020.03.037</ArticleId><ArticleId IdType=\"pmc\">PMC7194613</ArticleId><ArticleId IdType=\"pubmed\">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lucena TMC, da Silva Santos AF, de Lima BR, de Albuquerque Borborema ME, de Azev&#xea;do Silva J. Mechanism of inflammatory response in associated comorbidities in COVID-19. Diabetes Metab Syndr. (2019) 14:597&#x2013;600. doi: 10.1016/j.dsx.2020.05.025</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.dsx.2020.05.025</ArticleId><ArticleId IdType=\"pmc\">PMC7215143</ArticleId><ArticleId IdType=\"pubmed\">32417709</ArticleId></ArticleIdList></Reference><Reference><Citation>Meftahi GH, Jangravi Z, Sahraei H, Bahari Z. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of &#x201c;inflame-aging.&#x201d;. Inflamm Res. (2020) 69:825&#x2013;39. doi: 10.1007/s00011-020-01372-8, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00011-020-01372-8</ArticleId><ArticleId IdType=\"pmc\">PMC7289226</ArticleId><ArticleId IdType=\"pubmed\">32529477</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakotoarivelo V, Lacraz G, Mayhue M, Brown C, Rottembourg D, Fradette J, et al. . Inflammatory cytokine profiles in visceral and subcutaneous adipose tissues of obese patients undergoing bariatric surgery reveal lack of correlation with obesity or diabetes [internet]. EBioMedicine. (2018) 30:237&#x2013;47. doi: 10.1016/j.ebiom.2018.03.004, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ebiom.2018.03.004</ArticleId><ArticleId IdType=\"pmc\">PMC5952229</ArticleId><ArticleId IdType=\"pubmed\">29548899</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J, Li J, Cai L, Chakrabarti S, Li X. Cytokines and diabetes research. J Diabetes Res [Internet]. (2014) 2014:1&#x2013;2. doi: 10.1155/2014/920613, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2014/920613</ArticleId><ArticleId IdType=\"pmc\">PMC3914520</ArticleId><ArticleId IdType=\"pubmed\">24551859</ArticleId></ArticleIdList></Reference><Reference><Citation>Randeria SN, Thomson GJA, Nell TA, Roberts T, Pretorius E. Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation. Cardiovasc Diabetol. (2019) 18:72&#x2013;15. doi: 10.1186/s12933-019-0870-9, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12933-019-0870-9</ArticleId><ArticleId IdType=\"pmc\">PMC6549308</ArticleId><ArticleId IdType=\"pubmed\">31164120</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanase DM, Gosav EM, Radu S, Ouatu A, Rezus C, Ciocoiu M, et al. . Arterial hypertension and interleukins: potential therapeutic target or future diagnostic marker? Int J Hypertens. (2019) 2019:3159283: 1&#x2013;17. doi: 10.1155/2019/3159283, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2019/3159283</ArticleId><ArticleId IdType=\"pmc\">PMC6521461</ArticleId><ArticleId IdType=\"pubmed\">31186952</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. . Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx. New York Metab. (2020) 108:154262. doi: 10.1016/j.metabol.2020.154262, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.metabol.2020.154262</ArticleId><ArticleId IdType=\"pmc\">PMC7228874</ArticleId><ArticleId IdType=\"pubmed\">32422233</ArticleId></ArticleIdList></Reference><Reference><Citation>Crayne CB, Albeituni S, Nichols KE, Cron RQ. The immunology of macrophage activation syndrome [internet]. Front Immunol. (2019) 10:119. doi: 10.3389/fimmu.2019.00119, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2019.00119</ArticleId><ArticleId IdType=\"pmc\">PMC6367262</ArticleId><ArticleId IdType=\"pubmed\">30774631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosyreva A, Dzhalilova D, Lokhonina A, Vishnyakova P, Fatkhudinov T. The role of macrophages in the pathogenesis of SARS-CoV-2-associated acute respiratory distress syndrome. Front Immunol. (2021) 12:682871. doi: 10.3389/fimmu.2021.682871, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2021.682871</ArticleId><ArticleId IdType=\"pmc\">PMC8141811</ArticleId><ArticleId IdType=\"pubmed\">34040616</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamato M, Kataoka Y. Fatigue sensation following peripheral viral infection is triggered by neuroinflammation: who will answer these questions? Neural Regen Res. (2015) 10:203&#x2013;4. doi: 10.4103/1673-5374.152369, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/1673-5374.152369</ArticleId><ArticleId IdType=\"pmc\">PMC4392663</ArticleId><ArticleId IdType=\"pubmed\">25883614</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler M, Pollak TA, Rooney AG, Michael BD, Nicholson TR. Neuropsychiatric complications of covid-19 [internet]. BMJ. (2020):m3871. doi: 10.1136/bmj.m3871, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.m3871</ArticleId><ArticleId IdType=\"pubmed\">33051183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima M, Siokas V, Aloizou AM, Liampas I, Mentis AA, Tsouris Z, et al. . Unraveling the possible routes of SARS-COV-2 invasion into the central nervous system. Curr Treat Options Neurol [Internet]. (2020) 22:37. doi: 10.1007/s11940-020-00647-z, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11940-020-00647-z</ArticleId><ArticleId IdType=\"pmc\">PMC7515807</ArticleId><ArticleId IdType=\"pubmed\">32994698</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, Sperhake JP, Schr&#xf6;der AS, Edler C, et al. . Neuropathology of patients with COVID-19 in Germany: a post-mortem case series [internet]. Lancet Neurol. (2020) 19:919&#x2013;29. doi: 10.1016/S1474-4422(20)30308-2, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType=\"pmc\">PMC7535629</ArticleId><ArticleId IdType=\"pubmed\">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, et al. . Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) [internet]. J Med Virol. (2020) 92:699&#x2013;702. doi: 10.1002/jmv.25915, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.25915</ArticleId><ArticleId IdType=\"pmc\">PMC7264598</ArticleId><ArticleId IdType=\"pubmed\">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K, G&#xe1;lvez NMS, R&#xed;os M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. (2018) 12:386. doi: 10.3389/fncel.2018.00386, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2018.00386</ArticleId><ArticleId IdType=\"pmc\">PMC6212673</ArticleId><ArticleId IdType=\"pubmed\">30416428</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi S, Moosaie F, Aarabi MH. Understanding the immunologic characteristics of neurologic manifestations of SARS-CoV-2 and potential immunological mechanisms. Mol Neurobiol [Internet]. (2020). doi: 10.1007/s12035-020-02094-y, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-020-02094-y</ArticleId><ArticleId IdType=\"pmc\">PMC7458880</ArticleId><ArticleId IdType=\"pubmed\">32869183</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev. (2018) 98:477&#x2013;504. doi: 10.1152/physrev.00039.2016, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/physrev.00039.2016</ArticleId><ArticleId IdType=\"pmc\">PMC5866360</ArticleId><ArticleId IdType=\"pubmed\">29351513</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R, Konsman JP, Bluth&#xe9; RM, Kelley KW. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton Neurosci. (2000) 85:60&#x2013;5. doi: 10.1016/S1566-0702(00)00220-4, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1566-0702(00)00220-4</ArticleId><ArticleId IdType=\"pubmed\">11189027</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit WJ, Mrak RE, Griffin WST. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation. (2004) 1:1&#x2013;4. doi: 10.1186/1742-2094-1-14, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1742-2094-1-14</ArticleId><ArticleId IdType=\"pmc\">PMC509427</ArticleId><ArticleId IdType=\"pubmed\">15285801</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabab T, Khanabdali R, Moghadamtousi SZ, Kadir HA, Mohan G. Neuroinflammation pathways: a general review [internet]. Int J Neurosci. (2017) 127:624&#x2013;33. doi: 10.1080/00207454.2016.1212854</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/00207454.2016.1212854</ArticleId><ArticleId IdType=\"pubmed\">27412492</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank-Cannon TC, Alto LT, McAlpine FE, Tansey MG. Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegener. (2009) 4:1&#x2013;13. doi: 10.1186/1750-1326-4-47, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1750-1326-4-47</ArticleId><ArticleId IdType=\"pmc\">PMC2784760</ArticleId><ArticleId IdType=\"pubmed\">19917131</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. J Neuroinflammation. (2013) 10:1&#x2013;24. doi: 10.1186/1742-2094-10-43, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1742-2094-10-43</ArticleId><ArticleId IdType=\"pmc\">PMC3626880</ArticleId><ArticleId IdType=\"pubmed\">23547920</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS, et al. . Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. (2020) 7:2221&#x2013;30. doi: 10.1002/acn3.51210, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/acn3.51210</ArticleId><ArticleId IdType=\"pmc\">PMC7664279</ArticleId><ArticleId IdType=\"pubmed\">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakhoum MF, Ritter M, Garg A, Chan AX, Bakhoum CY, Smith D. Subclinical ocular inflammation in persons recovered from ambulatory COVID-19 [internet]. medRxiv [Preprint]. doi: 10.1101/2020.09.22.20128140.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.09.22.20128140</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson MJ, Thrash JC, Walter B. The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci Res. (2006) 6:237&#x2013;45. doi: 10.1016/j.cnr.2006.09.004, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cnr.2006.09.004</ArticleId><ArticleId IdType=\"pmc\">PMC2630233</ArticleId><ArticleId IdType=\"pubmed\">19169437</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng ZV, Wong KCG. Microglial activation and polarization after subarachnoid hemorrhage. Neuroimmunol Neuroinflamm. (2019) 2019:1. doi: 10.20517/2347-8659.2018.52, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.20517/2347-8659.2018.52</ArticleId><ArticleId IdType=\"pubmed\">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur C, Rathnasamy G, Ling EA. Biology of microglia in the developing brain. J Neuropathol Exp Neurol. (2017) 76:736&#x2013;53. doi: 10.1093/jnen/nlx056</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jnen/nlx056</ArticleId><ArticleId IdType=\"pubmed\">28859332</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam SR, Federoff HJ. Targeting microglial activation states as a therapeutic avenue in Parkinson&#x2019;s disease. Front Aging Neurosci. (2017) 9:176. doi: 10.3389/fnagi.2017.00176, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2017.00176</ArticleId><ArticleId IdType=\"pmc\">PMC5463358</ArticleId><ArticleId IdType=\"pubmed\">28642697</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bernhardi R, Eugen&#xed;n-von Bernhardi L, Eugen&#xed;n J. Microglial cell dysregulation in brain aging and neurodegeneration. Front Aging Neurosci. (2015) 7:124. doi: 10.3389/fnagi.2015.00124, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2015.00124</ArticleId><ArticleId IdType=\"pmc\">PMC4507468</ArticleId><ArticleId IdType=\"pubmed\">26257642</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Mao S, Wang J, Ding X, Zen JY. Viral infection and neurological disorders&#x2014;potential role of extracellular nucleotides in neuroinflammation. ExRNA. (2019) 1:1&#x2013;5. doi: 10.1186/s41544-019-0031-z</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s41544-019-0031-z</ArticleId><ArticleId IdType=\"pubmed\">0</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xfc;ntener U, Booth SG, Perry VH, Teeling JL. Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia. J Neuroinflammation. (2012) 9:146. doi: 10.1186/1742-2094-9-146, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1742-2094-9-146</ArticleId><ArticleId IdType=\"pmc\">PMC3439352</ArticleId><ArticleId IdType=\"pubmed\">22738332</ArticleId></ArticleIdList></Reference><Reference><Citation>Godbout JP, Chen J, Abraham J, Richwine AF, Berg BM, Kelley KW, et al. . Exaggerated neuroinflammation and sickness behavior in aged mice after activation of the peripheral innate immune system [internet]. FASEB J. (2005) 19:1329&#x2013;31. Available from:. doi: 10.1096/fj.05-3776fje, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1096/fj.05-3776fje</ArticleId><ArticleId IdType=\"pubmed\">15919760</ArticleId></ArticleIdList></Reference><Reference><Citation>Niraula A, Sheridan JF, Godbout JP. Microglia priming with aging and stress. Neuropsychopharmacology [Internet]. (2017) 42:318&#x2013;33. doi: 10.1038/npp.2016.185, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/npp.2016.185</ArticleId><ArticleId IdType=\"pmc\">PMC5143497</ArticleId><ArticleId IdType=\"pubmed\">27604565</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay TL, B&#xe9;chade C, D&#x2019;Andrea I, St-Pierre MK, Henry MS, Roumier A, et al. . Microglia gone rogue: impacts on psychiatric disorders across the lifespan. Front Mol Neurosci. (2018) 10:421. doi: 10.3389/fnmol.2017.00421, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnmol.2017.00421</ArticleId><ArticleId IdType=\"pmc\">PMC5758507</ArticleId><ArticleId IdType=\"pubmed\">29354029</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. (1995) 18:130&#x2013;6. doi: 10.1016/0166-2236(95)93890-A, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0166-2236(95)93890-A</ArticleId><ArticleId IdType=\"pubmed\">7754524</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollmacher T, Haack M, Schuld A, Reichenberg A, Yirmiya R. Low levels of circulating inflammatory cytokines&#x2014;do they affect human brain functions? Brain Behav Immun. (2002) 16:525&#x2013;32. doi: 10.1016/S0889-1591(02)00004-1, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0889-1591(02)00004-1</ArticleId><ArticleId IdType=\"pubmed\">12401466</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa-Silva MC, Santos LE, Rangel B. The impact of non-neurotropic influenza strains on the brain: a role for microglial priming? J Neurosci. (2018) 38:7758&#x2013;60. doi: 10.1523/JNEUROSCI.1368-18.2018, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1368-18.2018</ArticleId><ArticleId IdType=\"pmc\">PMC6596083</ArticleId><ArticleId IdType=\"pubmed\">30185538</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R. Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun. (2001) 15:7&#x2013;24. doi: 10.1006/brbi.2000.0613, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1006/brbi.2000.0613</ArticleId><ArticleId IdType=\"pubmed\">11259077</ArticleId></ArticleIdList></Reference><Reference><Citation>Yirmiya R, Pollak Y, Morag M, Reichenberg A, Barak O, Avitsur R, et al. . Illness, cytokines, and depression [internet]. Ann N Y Acad Sci. (2000) 917:478&#x2013;87. doi: 10.1111/j.1749-6632.2000.tb05412.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1749-6632.2000.tb05412.x</ArticleId><ArticleId IdType=\"pubmed\">11268375</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou R, Garner M, Holmes C, Osmond C, Teeling J, Lau L, et al. . Peripheral inflammatory cytokines and immune balance in generalised anxiety disorder: case-controlled study. Brain Behav Immun. (2017) 62:212&#x2013;8. doi: 10.1016/j.bbi.2017.01.021, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2017.01.021</ArticleId><ArticleId IdType=\"pmc\">PMC5373436</ArticleId><ArticleId IdType=\"pubmed\">28161475</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell NJ, Luheshi G, Toulmond S. Cytokines and their receptors in the central nervous system: physiology, pharmacology, and pathology. Pharmacol Ther. (1996) 69:85&#x2013;95. doi: 10.1016/0163-7258(95)02033-0, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0163-7258(95)02033-0</ArticleId><ArticleId IdType=\"pubmed\">8984509</ArticleId></ArticleIdList></Reference><Reference><Citation>Khairova RA, Machado-Vieira R, Du J, Manji HK. A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol. (2009) 12:561&#x2013;78. doi: 10.1017/S1461145709009924, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S1461145709009924</ArticleId><ArticleId IdType=\"pmc\">PMC2771334</ArticleId><ArticleId IdType=\"pubmed\">19224657</ArticleId></ArticleIdList></Reference><Reference><Citation>McAfoose J, Baune BT. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev. (2009) 33:355&#x2013;66. doi: 10.1016/j.neubiorev.2008.10.005, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neubiorev.2008.10.005</ArticleId><ArticleId IdType=\"pubmed\">18996146</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson PH, Nawa H. Neuronal differentiation factors/cytokines and synaptic plasticity. Cells. (1993) 72:123&#x2013;37. doi: 10.1016/S0092-8674(05)80032-7, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0092-8674(05)80032-7</ArticleId><ArticleId IdType=\"pubmed\">8428374</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RJ, Jung H, Bhangoo SK, White FA. Cytokine and chemokine regulation of sensory neuron function In: Sensory nerves. ed. Canning Brendan J. Berlin, Heidelberg: Springer; (2009). 417&#x2013;49.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2746245</ArticleId><ArticleId IdType=\"pubmed\">19655114</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluger MJ. Fever: role of pyrogens and cryogens. Physiol Rev. (1991) 71:93&#x2013;127. doi: 10.1152/physrev.1991.71.1.93, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/physrev.1991.71.1.93</ArticleId><ArticleId IdType=\"pmc\">PMC7191625</ArticleId><ArticleId IdType=\"pubmed\">1986393</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivier C, Rivest S. (2007). Mechanisms mediating the effects of cytokines on neuroendocrine functions in the rat. Ciba Foundation Symposium 172&#x2014;Corticotropin-Releasing Factor, 204&#x2013;225.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8491087</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn AJ. Systematic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. Life Sci. (1988) 43:429&#x2013;35. doi: 10.1016/0024-3205(88)90522-X, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0024-3205(88)90522-X</ArticleId><ArticleId IdType=\"pubmed\">3260987</ArticleId></ArticleIdList></Reference><Reference><Citation>Fann MJ, Patterson PH. Neuropoietic cytokines and activin a differentially regulate the phenotype of cultured sympathetic neurons. Proc Natl Acad Sci U S A. (1994) 91:43&#x2013;7. doi: 10.1073/pnas.91.1.43, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.91.1.43</ArticleId><ArticleId IdType=\"pmc\">PMC42882</ArticleId><ArticleId IdType=\"pubmed\">7904069</ArticleId></ArticleIdList></Reference><Reference><Citation>Balter LJ, Bosch JA, Aldred S, Drayson MT, Veldhuijzen van Zanten JJCS, Higgs S, et al. . Selective effects of acute low-grade inflammation on human visual attention. Neuroimage. (2019) 202:116098. doi: 10.1016/j.neuroimage.2019.116098, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2019.116098</ArticleId><ArticleId IdType=\"pubmed\">31415883</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AH, Haroon E, Raison CL, Felger JC. Cytokine targets in the brain: impact on neurotransmitters and Neurocircuits. Depress Anxiety. (2013) 30:297. doi: 10.1002/da.22084, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/da.22084</ArticleId><ArticleId IdType=\"pmc\">PMC4141874</ArticleId><ArticleId IdType=\"pubmed\">23468190</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R, O&#x2019;Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. (2008) 9:46&#x2013;56. doi: 10.1038/nrn2297, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrn2297</ArticleId><ArticleId IdType=\"pmc\">PMC2919277</ArticleId><ArticleId IdType=\"pubmed\">18073775</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuron L, Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav Immun. (2003) 17 Suppl 1:S119&#x2013;24. doi: 10.1016/S0889-1591(02)00078-8, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0889-1591(02)00078-8</ArticleId><ArticleId IdType=\"pubmed\">12615197</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronfol Z. Cytokines and the brain: implications for clinical psychiatry [internet]. Am J Psychiatr. (2000) 157:683&#x2013;94. Available from:. doi: 10.1176/appi.ajp.157.5.683, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1176/appi.ajp.157.5.683</ArticleId><ArticleId IdType=\"pubmed\">10784457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappelmann N, Dantzer R, Khandaker GM. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology. (2021) 105295:105295. doi: 10.1016/j.psyneuen.2021.105295</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.psyneuen.2021.105295</ArticleId><ArticleId IdType=\"pmc\">PMC8172271</ArticleId><ArticleId IdType=\"pubmed\">34119855</ArticleId></ArticleIdList></Reference><Reference><Citation>Murta V, Villarreal A, Ramos AJ. (2020). SARS-CoV-2 impact on the central nervous system: are astrocytes and microglia main players or merely bystanders? Available at: https://www.preprints.org/manuscript/202006.0319/v1</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7476346</ArticleId><ArticleId IdType=\"pubmed\">32878468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasselbalch HC. The role of cytokines in the initiation and progression of myelofibrosis. Cytokine Growth Factor Rev. (2013) 24:133&#x2013;45. doi: 10.1016/j.cytogfr.2013.01.004, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cytogfr.2013.01.004</ArticleId><ArticleId IdType=\"pubmed\">23415024</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin N Am. (2009) 29:247&#x2013;64. doi: 10.1016/j.iac.2009.02.002, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.iac.2009.02.002</ArticleId><ArticleId IdType=\"pmc\">PMC2740752</ArticleId><ArticleId IdType=\"pubmed\">19389580</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogoina D. Fever, fever patterns and diseases called &#x201c;fever&#x201d; &#x2013; a review. J Infect Public Health. (2011) 4:108&#x2013;24. doi: 10.1016/j.jiph.2011.05.002, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jiph.2011.05.002</ArticleId><ArticleId IdType=\"pubmed\">21843857</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti B, Tabarean I, Andrei C, Bartfai T. Cytokines and fever. Front Biosci. (2004) 9:1433&#x2013;49. doi: 10.2741/1341, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2741/1341</ArticleId><ArticleId IdType=\"pubmed\">14977558</ArticleId></ArticleIdList></Reference><Reference><Citation>Netea MG, Kullberg BJ, Van der Meer JWM. Circulating cytokines as mediators of fever. Clin Infect Dis. (2000) 31:S178&#x2013;84. doi: 10.1086/317513, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1086/317513</ArticleId><ArticleId IdType=\"pubmed\">11113021</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams RMC, Simpson DM, Navis A, Jette N, Zhou L, Shin SC. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve. (2022) 65:440&#x2013;3. doi: 10.1002/mus.27458, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/mus.27458</ArticleId><ArticleId IdType=\"pmc\">PMC8661991</ArticleId><ArticleId IdType=\"pubmed\">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Magrinelli F, Briani C, Romano M, Ruggero S, Toffanin E, Triolo G, et al. . The association between serum cytokines and damage to large and small nerve fibers in diabetic peripheral neuropathy. J Diabetes Res. (2015) 2015:1&#x2013;7. doi: 10.1155/2015/547834, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2015/547834</ArticleId><ArticleId IdType=\"pmc\">PMC4415740</ArticleId><ArticleId IdType=\"pubmed\">25961054</ArticleId></ArticleIdList></Reference><Reference><Citation>Langjahr M, Schubert AL, Sommer C, &#xdc;&#xe7;eyler N. Increased pro-inflammatory cytokine gene expression in peripheral blood mononuclear cells of patients with polyneuropathies. J Neurol. (2018) 265:618&#x2013;27. doi: 10.1007/s00415-018-8748-4, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00415-018-8748-4</ArticleId><ArticleId IdType=\"pubmed\">29372388</ArticleId></ArticleIdList></Reference><Reference><Citation>England J. Parainfectious neuropathies [internet]. J Neurol Sci. (2019) 405:22. Available from:. doi: 10.1016/j.jns.2019.10.060, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jns.2019.10.060</ArticleId><ArticleId IdType=\"pubmed\">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Malcangio M, Clark AK, Old EA. Neuropathic pain and cytokines: current perspectives. JPR. (2013) 6:803&#x2013;14. doi: 10.2147/JPR.S53660, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/JPR.S53660</ArticleId><ArticleId IdType=\"pmc\">PMC3839806</ArticleId><ArticleId IdType=\"pubmed\">24294006</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung AL, Lim M, Doshi TL. Targeting cytokines for treatment of neuropathic pain. Scandinavian journal of pain. (2017) 17:287&#x2013;93. doi: 10.1016/j.sjpain.2017.08.002, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.sjpain.2017.08.002</ArticleId><ArticleId IdType=\"pmc\">PMC5774983</ArticleId><ArticleId IdType=\"pubmed\">29229214</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. . Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. (2022) 101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType=\"pmc\">PMC8715665</ArticleId><ArticleId IdType=\"pubmed\">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue Biomed Health Behav. (2020) 8:61&#x2013;9. doi: 10.1080/21641846.2020.1778227</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21641846.2020.1778227</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan JJ, Qin Z, Wang PY, Sun Y, Liu X. Muscle fatigue: general understanding and treatment. Exp Mol Med. (2017) 49:e384. doi: 10.1038/emm.2017.194, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/emm.2017.194</ArticleId><ArticleId IdType=\"pmc\">PMC5668469</ArticleId><ArticleId IdType=\"pubmed\">28983090</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri A, Behan PO. Fatigue and basal ganglia. J Neurol Sci. (2000) 179:34&#x2013;42. doi: 10.1016/S0022-510X(00)00411-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0022-510X(00)00411-1</ArticleId><ArticleId IdType=\"pubmed\">11054483</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AH, Miller JH, Pham DS, Beentjes KK, Unger ER, Pagnoni G. Decreased basal ganglia activation in subjects with chronic fatigue syndrome: association with symptoms of fatigue. PLoS 1. (2014) 9:e115750. doi: 10.1371/journal.pone.0115750, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0115750</ArticleId><ArticleId IdType=\"pmc\">PMC4032274</ArticleId><ArticleId IdType=\"pubmed\">24858857</ArticleId></ArticleIdList></Reference><Reference><Citation>Felger JC, Miller AH. Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol. (2012) 33:315&#x2013;27. doi: 10.1016/j.yfrne.2012.09.003, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.yfrne.2012.09.003</ArticleId><ArticleId IdType=\"pmc\">PMC3484236</ArticleId><ArticleId IdType=\"pubmed\">23000204</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordeiro LMS, Rabelo PCR, Moraes MM, Teixeira-Coelho F, Coimbra CC, Wanner SP, et al. . Physical exercise-induced fatigue: the role of serotonergic and dopaminergic systems. Braz J Med Biol Res. (2017) 50:e6432. doi: 10.1590/1414-431x20176432, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1590/1414-431x20176432</ArticleId><ArticleId IdType=\"pmc\">PMC5649871</ArticleId><ArticleId IdType=\"pubmed\">29069229</ArticleId></ArticleIdList></Reference><Reference><Citation>Sp&#xe4;th-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, Burger K, et al. . Acute effects of recombinant human Interleukin-6 on endocrine and central nervous sleep functions in healthy men 1. J Clin Endocrinol Metab. (1998) 83:1573&#x2013;9. doi: 10.1210/jcem.83.5.4795, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1210/jcem.83.5.4795</ArticleId><ArticleId IdType=\"pubmed\">9589658</ArticleId></ArticleIdList></Reference><Reference><Citation>Corominas H, Alegre C, Narv&#xe1;ez J, Fern&#xe1;ndez-Cid CM, Torrente-Segarra V, G&#xf3;mez MR, et al. . Correlation of fatigue with other disease related and psychosocial factors in patients with rheumatoid arthritis treated with tocilizumab: ACT-AXIS study. Medicine [Internet]. (2019) 98:e15947. doi: 10.1097/MD.0000000000015947, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MD.0000000000015947</ArticleId><ArticleId IdType=\"pmc\">PMC6617279</ArticleId><ArticleId IdType=\"pubmed\">31261500</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendling D, Racadot E, Wijdenes J. Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J Rheumatol [Internet]. (1993) 20:259&#x2013;62.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8474061</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Malovic E, Harishchandra DS, Ghaisas S, Panicker N, Charli A, et al. . Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson&#x2019;s disease. NPJ Parkinsons Dis. (2017) 3:30. doi: 10.1038/s41531-017-0032-2, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41531-017-0032-2</ArticleId><ArticleId IdType=\"pmc\">PMC5645400</ArticleId><ArticleId IdType=\"pubmed\">29057315</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti P, Ilamathi HS, Todkar K, Germain M. Mitochondria targeted viral replication and survival strategies&#x2014;prospective on SARS-CoV-2. Front Pharmacol [Internet]. (2020) 11:578599. doi: 10.3389/fphar.2020.578599</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2020.578599</ArticleId><ArticleId IdType=\"pmc\">PMC7485471</ArticleId><ArticleId IdType=\"pubmed\">32982760</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh KK, Chaubey G, Chen JY, Suravajhala P. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am J Physiol Cell Physiol. (2020) 319:C258&#x2013;67. doi: 10.1152/ajpcell.00224.2020, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpcell.00224.2020</ArticleId><ArticleId IdType=\"pmc\">PMC7381712</ArticleId><ArticleId IdType=\"pubmed\">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh J, Peyssonnaux C, Singh KK, Edeas M. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion. (2020) 54:1&#x2013;7. doi: 10.1016/j.mito.2020.06.008, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mito.2020.06.008</ArticleId><ArticleId IdType=\"pmc\">PMC7837003</ArticleId><ArticleId IdType=\"pubmed\">32574708</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Maes M. Mitochondrial dysfunctions in Myalgic encephalomyelitis / chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis. (2013) 29:19&#x2013;36. doi: 10.1007/s11011-013-9435-x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11011-013-9435-x</ArticleId><ArticleId IdType=\"pubmed\">24557875</ArticleId></ArticleIdList></Reference><Reference><Citation>Missiroli S, Genovese I, Perrone M, Vezzani B, Vitto VAM, Giorgi C. The role of mitochondria in inflammation: from cancer to neurodegenerative disorders [internet]. J Clin Med. (2020) 9:740. Available from:. doi: 10.3390/jcm9030740, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm9030740</ArticleId><ArticleId IdType=\"pmc\">PMC7141240</ArticleId><ArticleId IdType=\"pubmed\">32182899</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller C, Steensberg A, Hansen AK, Fischer CP, Plomgaard P, Pedersen BK. Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle. J Appl Physiol (1985). (2005) 99:2075&#x2013;9. doi: 10.1152/japplphysiol.00590.2005, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/japplphysiol.00590.2005</ArticleId><ArticleId IdType=\"pubmed\">16099893</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K. Characterization of exercise-induced cytokine release, the impacts on the body, the mechanisms and modulations. Int J Sports Exerc Med. (2019) 5:122. doi: 10.23937/2469-5718/1510122</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.23937/2469-5718/1510122</ArticleId></ArticleIdList></Reference><Reference><Citation>da Luz D, Scheffer AL. Exercise-induced immune system response: anti-inflammatory status on peripheral and central organs. Biochim Biophys Acta Mol basis Dis. (2020) 1866:165823. doi: 10.1016/j.bbadis.2020.165823, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2020.165823</ArticleId><ArticleId IdType=\"pmc\">PMC7188661</ArticleId><ArticleId IdType=\"pubmed\">32360589</ArticleId></ArticleIdList></Reference><Reference><Citation>Landers-Ramos RQ, Jenkins NT, Spangenburg EE, Hagberg JM, Prior SJ. Circulating angiogenic and inflammatory cytokine responses to acute aerobic exercise in trained and sedentary young men. Eur J Appl Physiol. (2014) 114:1377. doi: 10.1007/s00421-014-2861-6, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00421-014-2861-6</ArticleId><ArticleId IdType=\"pmc\">PMC4048778</ArticleId><ArticleId IdType=\"pubmed\">24643426</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer CP. Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev [Internet]. (2006) 12:6&#x2013;33.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17201070</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer CP. Interleukin-6 in acute exercise and training: what is the biological relevance. Exerc Immunol Rev. (2006) 12:41.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17201070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HK, Konishi M, Takahashi M, Tabata H, Endo N, Numao S, et al. . Effects of acute endurance exercise performed in the morning and evening on inflammatory cytokine and metabolic hormone responses. PLoS One [Internet]. (2015) 10:e0137567. doi: 10.1371/journal.pone.0137567, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0137567</ArticleId><ArticleId IdType=\"pmc\">PMC4564197</ArticleId><ArticleId IdType=\"pubmed\">26352938</ArticleId></ArticleIdList></Reference><Reference><Citation>Moneghetti KJ, Skhiri M, Contrepois K, Kobayashi Y, Maecker H, Davis M, et al. . Value of circulating cytokine profiling during submaximal exercise testing in Myalgic encephalomyelitis/chronic fatigue syndrome. Sci Rep. (2018) 8:2779. doi: 10.1038/s41598-018-20941-w, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-018-20941-w</ArticleId><ArticleId IdType=\"pmc\">PMC5807550</ArticleId><ArticleId IdType=\"pubmed\">29426834</ArticleId></ArticleIdList></Reference><Reference><Citation>White AT, Light AR, Hughen RW, Bateman L, Martins TB, Hill HR, et al. . Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology. (2010) 47:615&#x2013;24. doi: 10.1111/j.1469-8986.2010.00978.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1469-8986.2010.00978.x</ArticleId><ArticleId IdType=\"pmc\">PMC4378647</ArticleId><ArticleId IdType=\"pubmed\">20230500</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnell JE, Lombard CM, Melson MN, Singh NP, Nagarkatti M, Nagarkatti P, et al. . The protective effects of resveratrol on social stress-induced cytokine release and depressive-like behavior. Brain Behav Immun Health. (2017) 59:147&#x2013;57. doi: 10.1016/j.bbi.2016.08.019, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2016.08.019</ArticleId><ArticleId IdType=\"pmc\">PMC5154920</ArticleId><ArticleId IdType=\"pubmed\">27592314</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsland AL, Walsh C, Lockwood K, John-Henderson NA. The effects of acute psychological stress on circulating and stimulated inflammatory markers: a systematic review and meta-analysis. Brain Behav Immun. (2017) 64:208. doi: 10.1016/j.bbi.2017.01.011, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2017.01.011</ArticleId><ArticleId IdType=\"pmc\">PMC5553449</ArticleId><ArticleId IdType=\"pubmed\">28089638</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard-Raichon L, Venzon M, Klein J, Axelrad JE, Zhang C, Sullivan AP, et al. . Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nat Commun. (2022) 13:5926. doi: 10.1038/s41467-022-33395-6, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-33395-6</ArticleId><ArticleId IdType=\"pmc\">PMC9626559</ArticleId><ArticleId IdType=\"pubmed\">36319618</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Wu X, Wen W, Lan P. Gut microbiome alterations in COVID-19. Genomics Proteomics Bioinformatics. (2021) 19:679&#x2013;88. doi: 10.1016/j.gpb.2021.09.004, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.gpb.2021.09.004</ArticleId><ArticleId IdType=\"pmc\">PMC8478109</ArticleId><ArticleId IdType=\"pubmed\">34560321</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin B, Singh R, Ha SE, Zogg H, Park PJ, Ro S. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19. World J Gastroenterol. (2021) 27:2341&#x2013;52. doi: 10.3748/wjg.v27.i19.2341, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3748/wjg.v27.i19.2341</ArticleId><ArticleId IdType=\"pmc\">PMC8130047</ArticleId><ArticleId IdType=\"pubmed\">34040326</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management [internet]. Clin Gastroenterol Hepatol. (2020) 18:1663&#x2013;72. Available from:. doi: 10.1016/j.cgh.2020.04.001, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cgh.2020.04.001</ArticleId><ArticleId IdType=\"pmc\">PMC7141637</ArticleId><ArticleId IdType=\"pubmed\">32278065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, et al. . Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. (2020) 5:434&#x2013;5. doi: 10.1016/S2468-1253(20)30083-2, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S2468-1253(20)30083-2</ArticleId><ArticleId IdType=\"pmc\">PMC7158584</ArticleId><ArticleId IdType=\"pubmed\">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zheng J, Guo L, Yao H, Wang L, Xia X, et al. . Fecal viral shedding in COVID-19 patients: clinical significance, viral load dynamics and survival analysis. Virus Res. (2020) 289:198147. doi: 10.1016/j.virusres.2020.198147, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.virusres.2020.198147</ArticleId><ArticleId IdType=\"pmc\">PMC7455175</ArticleId><ArticleId IdType=\"pubmed\">32866537</ArticleId></ArticleIdList></Reference><Reference><Citation>Norouzi Masir M, Shirvaliloo M. Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions. JGH Open. (2022) 6:667&#x2013;76. doi: 10.1002/jgh3.12811, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jgh3.12811</ArticleId><ArticleId IdType=\"pmc\">PMC9538198</ArticleId><ArticleId IdType=\"pubmed\">36247234</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J. Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome. Exp Ther Med. (2013) 6:93. doi: 10.3892/etm.2013.1101, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/etm.2013.1101</ArticleId><ArticleId IdType=\"pmc\">PMC3735566</ArticleId><ArticleId IdType=\"pubmed\">23935726</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology. (1994) 106:533&#x2013;9. doi: 10.1016/0016-5085(94)90614-9, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0016-5085(94)90614-9</ArticleId><ArticleId IdType=\"pubmed\">8299918</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger EC, Fritzsche C, Krause R, Krejs GJ. Diarrhea caused by primarily non-gastrointestinal infections. Nat Clin Pract Gastroenterol Hepatol. (2005) 2:216&#x2013;22. doi: 10.1038/ncpgasthep0167, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncpgasthep0167</ArticleId><ArticleId IdType=\"pmc\">PMC7097032</ArticleId><ArticleId IdType=\"pubmed\">16265204</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana SV, Sharma S, Sinha SK, Parsad KK, Malik A, Singh K. Pro-inflammatory and anti-inflammatory cytokine response in diarrhoea-predominant irritable bowel syndrome patients. Trop Gastroenterol. (2013) 33:251&#x2013;6, 256. doi: 10.7869/tg.2012.66</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7869/tg.2012.66</ArticleId><ArticleId IdType=\"pubmed\">23923350</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal D, Ali SA, Singh RK. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer&#x2019;s disease. Prog Neuro-Psychopharmacol Biol Psychiatry. (2021) 106:110112. doi: 10.1016/j.pnpbp.2020.110112, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pnpbp.2020.110112</ArticleId><ArticleId IdType=\"pubmed\">32949638</ArticleId></ArticleIdList></Reference><Reference><Citation>Mou Y, du Y, Zhou L, Yue J, Hu X, Liu Y, et al. . Gut microbiota interact with the brain through systemic chronic inflammation: implications on Neuroinflammation, neurodegeneration, and aging. Front Immunol. (2022) 13:796288. doi: 10.3389/fimmu.2022.796288, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2022.796288</ArticleId><ArticleId IdType=\"pmc\">PMC9021448</ArticleId><ArticleId IdType=\"pubmed\">35464431</ArticleId></ArticleIdList></Reference><Reference><Citation>Schett G, Manger B, Simon D, Caporali R. COVID-19 revisiting inflammatory pathways of arthritis. Nat Rev Rheumatol. (2020) 16:465&#x2013;70. doi: 10.1038/s41584-020-0451-z, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41584-020-0451-z</ArticleId><ArticleId IdType=\"pmc\">PMC7304381</ArticleId><ArticleId IdType=\"pubmed\">32561873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S, Zimba O, Gasparyan AY. COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol. (2021) 40:2611&#x2013;9. doi: 10.1007/s10067-021-05691-x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10067-021-05691-x</ArticleId><ArticleId IdType=\"pmc\">PMC7968918</ArticleId><ArticleId IdType=\"pubmed\">33733315</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int. (2020) 40:1539&#x2013;54. doi: 10.1007/s00296-020-04639-9, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00296-020-04639-9</ArticleId><ArticleId IdType=\"pmc\">PMC7360125</ArticleId><ArticleId IdType=\"pubmed\">32666137</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. . Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. (2020) 138:575&#x2013;8. doi: 10.1001/jamaophthalmol.2020.1291, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamaophthalmol.2020.1291</ArticleId><ArticleId IdType=\"pmc\">PMC7110919</ArticleId><ArticleId IdType=\"pubmed\">32232433</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Bartolom&#xe9; F, S&#xe1;nchez-Quir&#xf3;s J. Ocular manifestations of SARS-CoV-2: literature review. Archivos De La Sociedad Espan~ola De Oftalmologi&#x2019;a. 96:32&#x2013;40. doi: 10.1016/j.oftale.2020.07.003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.oftale.2020.07.003</ArticleId><ArticleId IdType=\"pmc\">PMC7414418</ArticleId><ArticleId IdType=\"pubmed\">32873480</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold DM, Galetta SL. Neuro-ophthalmologic complications of coronavirus disease 2019 (COVID-19). Neurosci Lett. (2021) 742:135531. doi: 10.1016/j.neulet.2020.135531, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2020.135531</ArticleId><ArticleId IdType=\"pmc\">PMC7687583</ArticleId><ArticleId IdType=\"pubmed\">33248158</ArticleId></ArticleIdList></Reference><Reference><Citation>Church MK, McGill JI. Human ocular mast cells. Curr Opin Allergy Clin Immunol. (2002) 2:419&#x2013;22. doi: 10.1097/00130832-200210000-00009</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00130832-200210000-00009</ArticleId><ArticleId IdType=\"pubmed\">12582326</ArticleId></ArticleIdList></Reference><Reference><Citation>Badham SP, Hutchinson CV. Characterising eye movement dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome. German J Ophthalmol. (2013) 251:2769&#x2013;76. doi: 10.1007/s00417-013-2431-3, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00417-013-2431-3</ArticleId><ArticleId IdType=\"pubmed\">23918092</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco-Herrero M, Soto-Rojas LO, Harrington CR, Flores-Martinez YM, Villegas-Rojas MM, Le&#xf3;n-Aguilar AM, et al. . Elucidating the Neuropathologic mechanisms of SARS-CoV-2 infection. Front Neurol. (2021) 12:660087. doi: 10.3389/fneur.2021.660087, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2021.660087</ArticleId><ArticleId IdType=\"pmc\">PMC8072392</ArticleId><ArticleId IdType=\"pubmed\">33912129</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett JL. Optic neuritis. Continuum. (2019) 25:1236&#x2013;64. doi: 10.1212/CON.0000000000000768, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/CON.0000000000000768</ArticleId><ArticleId IdType=\"pmc\">PMC7395663</ArticleId><ArticleId IdType=\"pubmed\">31584536</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JJ, Flanagan EP, Jitprapaikulsan J, L&#xf3;pez-Chiriboga A, Fryer JP, Leavitt JA, et al. . Myelin oligodendrocyte glycoprotein antibody&#x2013;positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol. (2018) 195:8&#x2013;15. doi: 10.1016/j.ajo.2018.07.020, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajo.2018.07.020</ArticleId><ArticleId IdType=\"pmc\">PMC6371779</ArticleId><ArticleId IdType=\"pubmed\">30055153</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong GU, Kwon HJ, Ng WH, Liu X, Moon HW, Yoon GY, et al. . Ocular tropism of SARS-CoV-2 in animal models with retinal inflammation via neuronal invasion following intranasal inoculation. Nat Commun. (2022) 13:7675. doi: 10.1038/s41467-022-35225-1, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-35225-1</ArticleId><ArticleId IdType=\"pmc\">PMC9743116</ArticleId><ArticleId IdType=\"pubmed\">36509737</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, ver AT, Pangilinan FC, et al. . Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine. (2022) 53:101624. doi: 10.1016/j.eclinm.2022.101624, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType=\"pmc\">PMC9417563</ArticleId><ArticleId IdType=\"pubmed\">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsouris Z, Provatas A, Bakirtzis C, Aloizou AM, Siokas V, Tsimourtou V, et al. . Anti-MOG positive bilateral optic neuritis and brainstem encephalitis secondary to COVID-19 infection: a case report. Neurol Int. (2022) 14:991&#x2013;6. doi: 10.3390/neurolint14040078, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/neurolint14040078</ArticleId><ArticleId IdType=\"pmc\">PMC9782579</ArticleId><ArticleId IdType=\"pubmed\">36548183</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. (2021) 18:666&#x2013;82. doi: 10.1038/s41569-021-00552-1, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41569-021-00552-1</ArticleId><ArticleId IdType=\"pmc\">PMC8100938</ArticleId><ArticleId IdType=\"pubmed\">33958774</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. . Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. (2020) 191:145&#x2013;7. doi: 10.1016/j.thromres.2020.04.013, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.thromres.2020.04.013</ArticleId><ArticleId IdType=\"pmc\">PMC7146714</ArticleId><ArticleId IdType=\"pubmed\">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D, Sperhake JP, L&#xfc;tgehetmann M, Steurer S, Edler C, Heinemann A, et al. . Autopsy findings and venous thromboembolism in patients with COVID-19. ACP J Club. (2020) 173:1030. doi: 10.7326/L20-1206, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/L20-1206</ArticleId><ArticleId IdType=\"pubmed\">33316197</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksu K, Donmez A, Keser G. Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des. (2012) 18:1478&#x2013;93. doi: 10.2174/138161212799504731, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/138161212799504731</ArticleId><ArticleId IdType=\"pubmed\">22364132</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. (2020) 135:2033&#x2013;40. doi: 10.1182/blood.2020006000, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood.2020006000</ArticleId><ArticleId IdType=\"pmc\">PMC7273827</ArticleId><ArticleId IdType=\"pubmed\">32339221</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre TM. Inflammatory cytokines and thrombosis. Blood. (2012) 120. doi: 10.1182/blood.V120.21.SCI-44.SCI-44, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood.V120.21.SCI-44.SCI-44</ArticleId><ArticleId IdType=\"pubmed\">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Fibrinogen Studies Collaboration. Kaptoge S, White IR, Thompson SG, Wood AM, Lewington S, et al. . Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies. Am J Epidemiol. (2007) 166:867&#x2013;79. doi: 10.1093/aje/kwm191, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/aje/kwm191</ArticleId><ArticleId IdType=\"pubmed\">17785713</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh P, Woodward M, Rumley A, Lowe G. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haematol. (2008) 141:852&#x2013;61. doi: 10.1111/j.1365-2141.2008.07133.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2141.2008.07133.x</ArticleId><ArticleId IdType=\"pubmed\">18371109</ArticleId></ArticleIdList></Reference><Reference><Citation>Najem MY, Couturaud F, Lemari&#xe9; CA. Cytokine and chemokine regulation of venous thromboembolism. J Thromb Haemost. (2020) 18:1009&#x2013;19. doi: 10.1111/jth.14759, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jth.14759</ArticleId><ArticleId IdType=\"pubmed\">32020753</ArticleId></ArticleIdList></Reference><Reference><Citation>Branchford BR, Carpenter SL. The role of inflammation in venous thromboembolism. Front Pediatr. (2018) 6:142. doi: 10.3389/fped.2018.00142, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2018.00142</ArticleId><ArticleId IdType=\"pmc\">PMC5974100</ArticleId><ArticleId IdType=\"pubmed\">29876337</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, et al. . SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. (2020) 13:120&#x2013;2. doi: 10.1186/s13045-020-00954-7, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13045-020-00954-7</ArticleId><ArticleId IdType=\"pmc\">PMC7471641</ArticleId><ArticleId IdType=\"pubmed\">32887634</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrens K, Alexander WS. Alexander WS. Cytokine control of megakaryopoiesis. Growth Factors. (2018) 36:89&#x2013;103. doi: 10.1080/08977194.2018.1498487, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/08977194.2018.1498487</ArticleId><ArticleId IdType=\"pubmed\">30318940</ArticleId></ArticleIdList></Reference><Reference><Citation>Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, et al. . Platelet gene expression and function in patients with COVID-19. Blood. (2020) 136:1317&#x2013;29. doi: 10.1182/blood.2020007214, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood.2020007214</ArticleId><ArticleId IdType=\"pmc\">PMC7483430</ArticleId><ArticleId IdType=\"pubmed\">32573711</ArticleId></ArticleIdList></Reference><Reference><Citation>Aid M, Busman-Sahay K, Vidal SJ, Maliga Z, Bondoc S, Starke C, et al. . Vascular disease and thrombosis in SARS-CoV-2-infected rhesus macaques. Cell(Cambridge,Mass). (2020) 183:1354&#x2013;1366.e13. doi: 10.1016/j.cell.2020.10.005</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2020.10.005</ArticleId><ArticleId IdType=\"pmc\">PMC7546181</ArticleId><ArticleId IdType=\"pubmed\">33065030</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. . Persistent clotting protein pathology in Long COVID/post-acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. (2021) 20:172. doi: 10.1186/s12933-021-01359-7, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType=\"pmc\">PMC8381139</ArticleId><ArticleId IdType=\"pubmed\">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Moremi K, Oladejo S, et al. . Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC). Cardiovascular Diabetology. (2021) 148. doi: 10.1186/s12933-022-01579-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType=\"pmc\">PMC9356426</ArticleId><ArticleId IdType=\"pubmed\">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. . Autonomic dysfunction in &#x201c;long COVID&#x201d;: rationale, physiology and management strategies [internet]. Clin Med. (2021) 21:e63&#x2013;7. doi: 10.7861/clinmed.2020-0896, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType=\"pmc\">PMC7850225</ArticleId><ArticleId IdType=\"pubmed\">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A, Sutton R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat Rev Cardiol. (2023) 2:1&#x2013;2. doi: 10.1038/s41569-023-00842-w, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41569-023-00842-w</ArticleId><ArticleId IdType=\"pmc\">PMC9893964</ArticleId><ArticleId IdType=\"pubmed\">36732397</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoite Stella A, Furlanis G, Frezza NA, Valentinotti R, Ajcevic M, Manganotti P. Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study. J Neurol. (2022) 269:587&#x2013;96. doi: 10.1007/s00415-021-10735-y, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00415-021-10735-y</ArticleId><ArticleId IdType=\"pmc\">PMC8359764</ArticleId><ArticleId IdType=\"pubmed\">34386903</ArticleId></ArticleIdList></Reference><Reference><Citation>Eshak N, Abdelnabi M, Ball S, Elgwairi E, Creed K, Test V, et al. . Dysautonomia: an overlooked neurological manifestation in a critically ill COVID-19 patient [internet]. Am J Med Sci. (2020) 360:427&#x2013;9. doi: 10.1016/j.amjms.2020.07.022, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.amjms.2020.07.022</ArticleId><ArticleId IdType=\"pmc\">PMC7366085</ArticleId><ArticleId IdType=\"pubmed\">32739039</ArticleId></ArticleIdList></Reference><Reference><Citation>Astudillo L, Laure A, Fabry V, Pugnet G, Maury P, Labrun&#xe9;e M, et al. . Le syndrome de tachycardie posturale (PoTS): une maladie pour l&#x2019;interniste [Internet]. Rev Med Interne. (2018) 39:627&#x2013;34. Available from:. doi: 10.1016/j.revmed.2018.04.017, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.revmed.2018.04.017</ArticleId><ArticleId IdType=\"pubmed\">29909001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenney MJ, Ganta CK. Autonomic nervous system and immune system interactions [internet]. Comprehensive. Physiology. (2014) 4:1177&#x2013;200. Available from:. doi: 10.1002/cphy.c130051, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cphy.c130051</ArticleId><ArticleId IdType=\"pmc\">PMC4374437</ArticleId><ArticleId IdType=\"pubmed\">24944034</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto LE, Raj SR, Gamboa A, Shibao CA, Arnold AC, Garland EM, et al. . Sympathetic activation is associated with increased IL-6, but not CRP in the absence of obesity: lessons from postural tachycardia syndrome and obesity [internet]. Am J Phys Heart Circ Phys. (2015) 309:H2098&#x2013;107. Available from:. doi: 10.1152/ajpheart.00409.2015, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpheart.00409.2015</ArticleId><ArticleId IdType=\"pmc\">PMC4698423</ArticleId><ArticleId IdType=\"pubmed\">26453329</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Million M, Dudouet P, Tissot-Dupont H, Bregeon F, Cammilleri S, et al. . 18 F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. (2021) 48:592&#x2013;5. doi: 10.1007/s00259-020-04973-x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00259-020-04973-x</ArticleId><ArticleId IdType=\"pmc\">PMC7391029</ArticleId><ArticleId IdType=\"pubmed\">32728799</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Persistent brainstem dysfunction in Long-COVID: a hypothesis. ACS Chem Neurosci. (2021) 12:573&#x2013;80. doi: 10.1021/acschemneuro.0c00793, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acschemneuro.0c00793</ArticleId><ArticleId IdType=\"pmc\">PMC7874499</ArticleId><ArticleId IdType=\"pubmed\">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofield JR, Blitshteyn S, Shoenfeld Y, Hughes GRV. Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospholipid (Hughes) syndrome (APS). Lupus. (2014) 23:697&#x2013;702. doi: 10.1177/0961203314524468, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0961203314524468</ArticleId><ArticleId IdType=\"pubmed\">24569396</ArticleId></ArticleIdList></Reference><Reference><Citation>Noureldine HA, El Hasbani G, Nour Eldine M, Nour-Eldine W, Taher A, Uthman I. Postural tachycardia syndrome (POTS) and antiphospholipid syndrome (APS): what do we know so far? Rev neur, Par. (2022) 178:306&#x2013;14. doi: 10.1016/j.neurol.2021.10.006, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurol.2021.10.006</ArticleId><ArticleId IdType=\"pubmed\">34895744</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M, Yan H, Welinder C, V&#xe9;gv&#xe1;ri &#xc1;, Hamrefors V, B&#xe4;ck M, et al. . Plasma proteomic profiling in postural orthostatic tachycardia syndrome (POTS) reveals new disease pathways. Sci Rep. (2022) 12:1&#x2013;9. doi: 10.1038/s41598-022-24729-x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-022-24729-x</ArticleId><ArticleId IdType=\"pmc\">PMC9681882</ArticleId><ArticleId IdType=\"pubmed\">36414707</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan AC, Ebinger JE, Wei J, le CN, Oft JR, Zabner R, et al. . Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 infection. Nat Cardiovasc Res. (2022) 1:1187&#x2013;94. doi: 10.1038/s44161-022-00177-8</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s44161-022-00177-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A, Li H, Yu X, Koelsch KA, Harris VM, Liles C, et al. . Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace. (2017) 19:1211&#x2013;9. doi: 10.1093/europace/euw154, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/europace/euw154</ArticleId><ArticleId IdType=\"pmc\">PMC5834103</ArticleId><ArticleId IdType=\"pubmed\">27702852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal D, Moudgil DC. Cytokines in autoimmunity: role in induction, regulation, and treatment. J Interf Cytokine Res. (2011) 31:695&#x2013;703. doi: 10.1089/jir.2011.0065, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/jir.2011.0065</ArticleId><ArticleId IdType=\"pmc\">PMC3189547</ArticleId><ArticleId IdType=\"pubmed\">21942420</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et al. . Evolution of antibody immunity to SARS-CoV-2 [internet]. Cold Spring Harbor Laboratory. (2020) 591:639&#x2013;644. doi: 10.1101/2020.11.03.367391</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.11.03.367391</ArticleId><ArticleId IdType=\"pmc\">PMC8221082</ArticleId><ArticleId IdType=\"pubmed\">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Avanzato VA, Matson MJ, Seifert SN, Pryce R, Williamson BN, Anzick SL, et al. . Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised cancer patient [internet]. Cell. (2020) 183:1901&#x2013;1912.e9. doi: 10.1016/j.cell.2020.10.049, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2020.10.049</ArticleId><ArticleId IdType=\"pmc\">PMC7640888</ArticleId><ArticleId IdType=\"pubmed\">33248470</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, et al. . SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. (2022) 612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType=\"pmc\">PMC9749650</ArticleId><ArticleId IdType=\"pubmed\">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nature Rev Immun. (2020) 20:355&#x2013;62. doi: 10.1038/s41577-020-0331-4, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType=\"pmc\">PMC7201395</ArticleId><ArticleId IdType=\"pubmed\">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytokines in the balance [internet]. Nat Immunol. (2019) 20:1557&#x2013;7. doi: 10.1038/s41590-019-0557-0, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41590-019-0557-0</ArticleId><ArticleId IdType=\"pubmed\">31745347</ArticleId></ArticleIdList></Reference><Reference><Citation>Polidoro RB, Hagan RS, de Santis Santiago R, Schmidt NW. Overview: systemic inflammatory response derived from lung injury caused by SARS-CoV-2 infection explains severe outcomes in COVID-19. Front Immunol. (2020) 11:1626. doi: 10.3389/fimmu.2020.01626, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2020.01626</ArticleId><ArticleId IdType=\"pmc\">PMC7344249</ArticleId><ArticleId IdType=\"pubmed\">32714336</ArticleId></ArticleIdList></Reference><Reference><Citation>Besedovsky HO, del Rey A. The cytokine-HPA axis feed-back circuit. Zeitschrift f&#xfc;r Rheumaforschung. (2000) 59:II26&#x2013;30. doi: 10.1007/s003930070014</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s003930070014</ArticleId><ArticleId IdType=\"pubmed\">11155800</ArticleId></ArticleIdList></Reference><Reference><Citation>Somasundaram NP, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Dissanayake HA, Yogendranathan N, et al. . The impact of SARS-Cov-2 virus infection on the endocrine system. JES. (2020) 4. doi: 10.1210/jendso/bvaa082, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1210/jendso/bvaa082</ArticleId><ArticleId IdType=\"pmc\">PMC7337839</ArticleId><ArticleId IdType=\"pubmed\">32728654</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman MN, Pearce BD, Biron CA, Miller AH. Immune modulation of the hypothalamic-pituitary-adrenal (HPA) Axis during viral infection. Viral Immunol. (2005) 18:41&#x2013;78. doi: 10.1089/vim.2005.18.41, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/vim.2005.18.41</ArticleId><ArticleId IdType=\"pmc\">PMC1224723</ArticleId><ArticleId IdType=\"pubmed\">15802953</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman MN, Sternberg EM. Glucocorticoid regulation of inflammation and its behavioral and metabolic correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci. (2012) 1261:55&#x2013;63. doi: 10.1111/j.1749-6632.2012.06633.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1749-6632.2012.06633.x</ArticleId><ArticleId IdType=\"pmc\">PMC3572859</ArticleId><ArticleId IdType=\"pubmed\">22823394</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, Agarwal SK. Endocrine changes in SARS-CoV-2 patients and lessons from SARS-CoV. Postgrad Med J. (2020) 96:412&#x2013;6. doi: 10.1136/postgradmedj-2020-137934, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/postgradmedj-2020-137934</ArticleId><ArticleId IdType=\"pmc\">PMC7306278</ArticleId><ArticleId IdType=\"pubmed\">32527756</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongio&#xec; LM, Barbagallo F, Condorelli RA, Cannarella R, Aversa A, la Vignera S, et al. . Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model [internet]. Endocrine. (2020) 68:467&#x2013;70. doi: 10.1007/s12020-020-02349-7, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12020-020-02349-7</ArticleId><ArticleId IdType=\"pmc\">PMC7266418</ArticleId><ArticleId IdType=\"pubmed\">32488837</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocr. (2005) 63:197&#x2013;202. doi: 10.1111/j.1365-2265.2005.02325.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2265.2005.02325.x</ArticleId><ArticleId IdType=\"pmc\">PMC7188349</ArticleId><ArticleId IdType=\"pubmed\">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R. COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications. Endocrine. (2020) 68:251&#x2013;2. doi: 10.1007/s12020-020-02325-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12020-020-02325-1</ArticleId><ArticleId IdType=\"pmc\">PMC7186765</ArticleId><ArticleId IdType=\"pubmed\">32346813</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamaschi L, Mescia F, Turner L, Hanson A, Kotagiri P, Dunmore BJ, et al. . (2021). Delayed bystander CD8 T cell activation, early immune pathology and persistent dysregulation characterise severe COVID-19. medRxiv [Preprint]. doi: 10.1101/2021.01.11.20248765.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2021.01.11.20248765</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Guevara-Coto J, Yogendra R, Francisco E, Long E, Pise A, et al. . (2020). Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning [Internet]. bioRxiv [Preprint]. Available at: https://www.biorxiv.org/content/10.1101/2020.12.16.423122v1.abstract</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.12.16.423122v1.abstract</ArticleId><ArticleId IdType=\"pmc\">PMC8273732</ArticleId><ArticleId IdType=\"pubmed\">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Seif F, Khoshmirsafa M, Aazami H, Mohsenzadegan M, Sedighi G, Bahar M. The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal [Internet]. (2017) 15:23. doi: 10.1186/s12964-017-0177-y, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12964-017-0177-y</ArticleId><ArticleId IdType=\"pmc\">PMC5480189</ArticleId><ArticleId IdType=\"pubmed\">28637459</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha RN, Jana M, Pahan K. MAPK p38 Regulates Transcriptional Activity of NF-&#x3ba;B in Primary Human Astrocytes via Acetylation of p65. J Immunol. (2007) 179:7101&#x2013;9. doi: 10.4049/jimmunol.179.10.7101, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/jimmunol.179.10.7101</ArticleId><ArticleId IdType=\"pmc\">PMC2701546</ArticleId><ArticleId IdType=\"pubmed\">17982102</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuenda A, Rousseau S. p38 MAP-Kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta (BBA) Mol Cell Res. (2007) 1773:1358&#x2013;75. doi: 10.1016/j.bbamcr.2007.03.010</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamcr.2007.03.010</ArticleId><ArticleId IdType=\"pubmed\">17481747</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachstetter AD, Van Eldik LJ. The p38 MAP kinase family as regulators of Proinflammatory cytokine production in degenerative diseases of the CNS. Aging Dis. (2010) 1:199&#x2013;211. doi: 10.1101/2021.01.11.20248765, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2021.01.11.20248765</ArticleId><ArticleId IdType=\"pmc\">PMC3377763</ArticleId><ArticleId IdType=\"pubmed\">22720195</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimes JM, Grimes KV. p38 MAPK inhibition: a promising therapeutic approach for COVID-19. J Mol Cell Cardiol. (2020) 144:63&#x2013;5. doi: 10.1016/j.yjmcc.2020.05.007, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.yjmcc.2020.05.007</ArticleId><ArticleId IdType=\"pmc\">PMC7228886</ArticleId><ArticleId IdType=\"pubmed\">32422320</ArticleId></ArticleIdList></Reference><Reference><Citation>Huth TK, Staines D, Marshall-Gradisnik S. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/&#x2212; natural killer cells in chronic fatigue syndrome/Myalgic encephalomyelitis patients. J Transl Med. (2016) 14:97. doi: 10.1186/s12967-016-0859-z, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-016-0859-z</ArticleId><ArticleId IdType=\"pmc\">PMC4839077</ArticleId><ArticleId IdType=\"pubmed\">27098723</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni S, Anand P, Padwad YS. MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression. J Exp Clin Cancer Res. (2019) 38:121&#x2013;18. doi: 10.1186/s13046-019-1115-1, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13046-019-1115-1</ArticleId><ArticleId IdType=\"pmc\">PMC6408796</ArticleId><ArticleId IdType=\"pubmed\">30850014</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkowitz P, Hu P, Warren S, Liu Z, Diaz LA, Rubenstein DS. p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc Natl Acad Sci U S A. (2006) 103:12855&#x2013;60. doi: 10.1073/pnas.0602973103, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0602973103</ArticleId><ArticleId IdType=\"pmc\">PMC1568937</ArticleId><ArticleId IdType=\"pubmed\">16908851</ArticleId></ArticleIdList></Reference><Reference><Citation>Soukup K, Halfmann A, le Bras M, Sahin E, Vittori S, Poyer F, et al. . The MAPK-activated kinase MK2 attenuates dendritic cell&#x2013;mediated Th1 differentiation and autoimmune encephalomyelitis. J Immunol. (2015) 195:541&#x2013;52. doi: 10.4049/jimmunol.1401663, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/jimmunol.1401663</ArticleId><ArticleId IdType=\"pubmed\">26078274</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells. Biochem Biophys Res Commun. (2004) 319:1228&#x2013;34. doi: 10.1016/j.bbrc.2004.05.107, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2004.05.107</ArticleId><ArticleId IdType=\"pmc\">PMC7111015</ArticleId><ArticleId IdType=\"pubmed\">15194498</ArticleId></ArticleIdList></Reference><Reference><Citation>Faist A, Schloer S, Mecate-Zambrano A, Janowski J, Schreiber A, Boergeling Y, et al. . Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier. Antivir Res. (2023) 209:105475. doi: 10.1016/j.antiviral.2022.105475, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.antiviral.2022.105475</ArticleId><ArticleId IdType=\"pmc\">PMC9677559</ArticleId><ArticleId IdType=\"pubmed\">36423831</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhaddou M, Memon D, Meyer B, White KM, Rezelj VV, Correa Marrero M, et al. . The global phosphorylation landscape of SARS-CoV-2 infection. Cell(Cambridge,Mass). (2020) 182:685&#x2013;712.e19. doi: 10.1016/j.cell.2020.06.034, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2020.06.034</ArticleId><ArticleId IdType=\"pmc\">PMC7321036</ArticleId><ArticleId IdType=\"pubmed\">32645325</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Zhang L, Joo D, Sun SC. NF-&#x3ba;B signaling in inflammation. Signal Transduct Target Ther. (2017) 2. doi: 10.1038/sigtrans.2017.23, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sigtrans.2017.23</ArticleId><ArticleId IdType=\"pmc\">PMC5661633</ArticleId><ArticleId IdType=\"pubmed\">29158945</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano T, Murakami M. COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity. (2020) 52:731&#x2013;3. doi: 10.1016/j.immuni.2020.04.003, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.immuni.2020.04.003</ArticleId><ArticleId IdType=\"pmc\">PMC7175868</ArticleId><ArticleId IdType=\"pubmed\">32325025</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasmin R, Siraj S, Hassan A, Khan AR, Abbasi R, Ahmad N. Epigenetic regulation of inflammatory cytokines and associated genes in human malignancies. Mediat Inflamm. (2015) 2015:1&#x2013;8. doi: 10.1155/2015/201703, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2015/201703</ArticleId><ArticleId IdType=\"pmc\">PMC4359879</ArticleId><ArticleId IdType=\"pubmed\">25814785</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi SK, Lahesmaa R. Transcriptional and epigenetic regulation of T-helper lineage specification. Immunol Rev. (2014) 261:62&#x2013;83. doi: 10.1111/imr.12204, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/imr.12204</ArticleId><ArticleId IdType=\"pmc\">PMC4255756</ArticleId><ArticleId IdType=\"pubmed\">25123277</ArticleId></ArticleIdList></Reference><Reference><Citation>El Baba R, Herbein G. Management of epigenomic networks entailed in coronavirus infections and COVID-19. Epigenetics. (2020) 12:118. doi: 10.1186/s13148-020-00912-7, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13148-020-00912-7</ArticleId><ArticleId IdType=\"pmc\">PMC7404079</ArticleId><ArticleId IdType=\"pubmed\">32758273</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruimboom L. Methylation pathways and SARS-CoV-2 lung infiltration and cell membrane-virus fusion are both subject to epigenetics. Front Cell Infect Microbiol. (2020) 10:290. doi: 10.3389/fcimb.2020.00290, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcimb.2020.00290</ArticleId><ArticleId IdType=\"pmc\">PMC7265211</ArticleId><ArticleId IdType=\"pubmed\">32574283</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MAAK, ABMMK Islam. (2020). SARS-CoV-2 proteins exploit host&#x2019;s genetic and epigenetic mediators for the annexation of key host signaling pathways that confers its immune evasion and disease pathophysiology [internet]. bioRxiv [Preprint]. doi: 10.1101/2020.05.06.050260</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.05.06.050260</ArticleId><ArticleId IdType=\"pmc\">PMC7872968</ArticleId><ArticleId IdType=\"pubmed\">33585554</ArticleId></ArticleIdList></Reference><Reference><Citation>Paschos K, Allday MJ. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol. (2010) 18:439&#x2013;47. doi: 10.1016/j.tim.2010.07.003, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tim.2010.07.003</ArticleId><ArticleId IdType=\"pmc\">PMC3089700</ArticleId><ArticleId IdType=\"pubmed\">20724161</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong JG, Ravishankar A, Sharma S, Parkhurst CN, Nehar-Belaid D, Ma S, et al. . (2022). Epigenetic memory of COVID-19 in innate immune cells and their progenitors. bioRxiv [Preprint].</Citation></Reference><Reference><Citation>Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, et al. . Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transpl. (2002) 2:560&#x2013;7. doi: 10.1034/j.1600-6143.2002.20611.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1034/j.1600-6143.2002.20611.x</ArticleId><ArticleId IdType=\"pubmed\">12118901</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux CA, Camoin-Jau L. An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection. Front Microbiol. (2022) 13:1042200. doi: 10.3389/fmicb.2022.1042200, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmicb.2022.1042200</ArticleId><ArticleId IdType=\"pmc\">PMC9742611</ArticleId><ArticleId IdType=\"pubmed\">36519165</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh S, Lee S, Gym H, Jee SH, Yoon S, Park S, et al. . A systematic review on papers that study on SNPs that affect SARS-CoV-2 infection &amp; COVID-19 severity. doi: 10.21203/rs.3.rs-470358/v1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.21203/rs.3.rs-470358/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S, Song F, Guo W, Tan J, Zhang X, Qiao F, et al. . Potential genes associated with COVID-19 and comorbidity. Int J Med Sci. (2022) 19:402&#x2013;15. doi: 10.7150/ijms.67815, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7150/ijms.67815</ArticleId><ArticleId IdType=\"pmc\">PMC8795808</ArticleId><ArticleId IdType=\"pubmed\">35165525</ArticleId></ArticleIdList></Reference><Reference><Citation>Piraino B, Vollmer-Conna U, Lloyd AR. Genetic associations of fatigue and other symptom domains of the acute sickness response to infection. Brain Behav Immun. (2012) 26:552&#x2013;8. doi: 10.1016/j.bbi.2011.12.009, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2011.12.009</ArticleId><ArticleId IdType=\"pmc\">PMC7127134</ArticleId><ArticleId IdType=\"pubmed\">22227623</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollmer-Conna U, Piraino BF, Cameron B, Davenport T, Hickie I, Wakefield D, et al. . Cytokine polymorphisms have a synergistic effect on severity of the acute sickness response to infection. Clin Infect Dis. (2008) 47:1418&#x2013;25. doi: 10.1086/592967, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1086/592967</ArticleId><ArticleId IdType=\"pubmed\">18937577</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo YS, Luo L, Li W, Chen Y, Wu GF, Chen F, et al. . Evaluation of a Functional Single Nucleotide Polymorphism of the SARS-CoV-2 Receptor ACE2 That Is Potentially Involved in Long COVID. Front Genet. (2022) 13:931562. doi: 10.3389/fgene.2022.931562, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fgene.2022.931562</ArticleId><ArticleId IdType=\"pmc\">PMC9340221</ArticleId><ArticleId IdType=\"pubmed\">35923692</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Giordano R, D&#xed;az-Gil G, G&#xf3;mez-Esquer F, Ambite-Quesada S, Palomar-Gallego MA, et al. . Post-COVID pain is not associated with inflammatory polymorphisms in people who had been hospitalized by COVID-19. JCM. (2022) 11. doi: 10.3390/jcm11195645, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm11195645</ArticleId><ArticleId IdType=\"pmc\">PMC9570972</ArticleId><ArticleId IdType=\"pubmed\">36233516</ArticleId></ArticleIdList></Reference><Reference><Citation>Camhi SL, Lee P, Choi AM. The oxidative stress response. New Horiz. (1995) 3:170&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7583159</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmarakby AA, Sullivan JC. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther. (2012) 30:49&#x2013;59. doi: 10.1111/j.1755-5922.2010.00218.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1755-5922.2010.00218.x</ArticleId><ArticleId IdType=\"pubmed\">20718759</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas SK. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxid med cell Longev. (2016) 2016:1&#x2013;9. doi: 10.1155/2016/5698931, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2016/5698931</ArticleId><ArticleId IdType=\"pmc\">PMC4736408</ArticleId><ArticleId IdType=\"pubmed\">26881031</ArticleId></ArticleIdList></Reference><Reference><Citation>Son Y, Cheong YK, Kim NH, Chung HT, Kang DG, Pae HO. Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways? J Signal Transduct [Internet]. (2011) 2011:1&#x2013;6. doi: 10.1155/2011/792639, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2011/792639</ArticleId><ArticleId IdType=\"pmc\">PMC3100083</ArticleId><ArticleId IdType=\"pubmed\">21637379</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahirnyj A, Livne-Bar I, Guo X, Sivak JM. ROS detoxification and Proinflammatory cytokines are linked by p38 MAPK signaling in a model of mature astrocyte activation. PLoS One. (2013) 8:e83049. doi: 10.1371/journal.pone.0083049, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0083049</ArticleId><ArticleId IdType=\"pmc\">PMC3871647</ArticleId><ArticleId IdType=\"pubmed\">24376630</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. (2015) 97:55&#x2013;74. doi: 10.1016/j.ejmech.2015.04.040, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejmech.2015.04.040</ArticleId><ArticleId IdType=\"pubmed\">25942353</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadarani BN, Majumdar AS. Resveratrol potentiates the effect of dexamethasone in rat model of acute lung inflammation. Int Immunopharmacol. (2015) 28:773&#x2013;9. doi: 10.1016/j.intimp.2015.07.038, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.intimp.2015.07.038</ArticleId><ArticleId IdType=\"pubmed\">26283591</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R, Banerjee A, Baker MR, Dani M, Ford E, Hull JH, et al. . Long COVID: mechanisms, risk factors and recovery. Exp Physiol. (2023) 108:12&#x2013;27. doi: 10.1113/EP090802, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1113/EP090802</ArticleId><ArticleId IdType=\"pmc\">PMC10103775</ArticleId><ArticleId IdType=\"pubmed\">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 &#x201c;long-haulers&#x201d;? Chronic Dis Transl Med. (2021) 7:14&#x2013;26. doi: 10.1016/j.cdtm.2020.11.002, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cdtm.2020.11.002</ArticleId><ArticleId IdType=\"pmc\">PMC7680046</ArticleId><ArticleId IdType=\"pubmed\">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;, Mella O, Bruland O, Risa K, Dyrstad SE, Alme K, et al. . Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight. (2016) 1:e89376. doi: 10.1172/jci.insight.89376, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/jci.insight.89376</ArticleId><ArticleId IdType=\"pmc\">PMC5161229</ArticleId><ArticleId IdType=\"pubmed\">28018972</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. (2020) 11:102&#x2013;11. doi: 10.1038/s41467-019-13668-3, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-019-13668-3</ArticleId><ArticleId IdType=\"pmc\">PMC6941980</ArticleId><ArticleId IdType=\"pubmed\">31900386</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiurazzi M, Di Maro M, Cozzolino M, Colantuoni A. Mitochondrial dynamics and microglia as new targets in metabolism regulation. IJMS. (2020) 21:3450&#x2013;3564. doi: 10.3390/ijms21103450, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21103450</ArticleId><ArticleId IdType=\"pmc\">PMC7279384</ArticleId><ArticleId IdType=\"pubmed\">32414136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganji R, Reddy PH. Impact of COVID-19 on mitochondrial-based immunity in aging and age-related diseases. Front Aging Neurosci. (2020) 12:614650. doi: 10.3389/fnagi.2020.614650, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2020.614650</ArticleId><ArticleId IdType=\"pmc\">PMC7835331</ArticleId><ArticleId IdType=\"pubmed\">33510633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajaz S, McPhail MJ, Singh KK, Mujib S, Trovato FM, Napoli S, et al. . Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Physiol Cell Physiol. (2021) 320:C57&#x2013;65. doi: 10.1152/ajpcell.00426.2020, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpcell.00426.2020</ArticleId><ArticleId IdType=\"pmc\">PMC7816428</ArticleId><ArticleId IdType=\"pubmed\">33151090</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibellini L, De Biasi S, Paolini A, Borella R, Boraldi F, Mattioli M, et al. . Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol Med. (2020) 12:e13001. doi: 10.15252/emmm.202013001, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/emmm.202013001</ArticleId><ArticleId IdType=\"pmc\">PMC7645870</ArticleId><ArticleId IdType=\"pubmed\">33078545</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratto C, Caravita S, Soranna D, Faini A, Dewachter C, Zambon A, et al. . Current limitations of invasive exercise hemodynamics for the diagnosis of heart failure with preserved ejection fraction [internet]. Circu Heart Fail. (2021) 14:e007555. doi: 10.1161/circheartfailure.120.007555</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/circheartfailure.120.007555</ArticleId><ArticleId IdType=\"pubmed\">33951935</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, Joseph P, Heerdt PM, Cullinan M, Lutchmansingh DD, Gulati M, et al. . Persistent Exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest. (2022) 161:54&#x2013;63. doi: 10.1016/j.chest.2021.08.010, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType=\"pmc\">PMC8354807</ArticleId><ArticleId IdType=\"pubmed\">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MHB, Wing YK, Yu MWM, Leung CM, Ma RCW, Kong APS, et al. . Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: Long-term follow-up. Arch Intern Med. (2009) 169:2142&#x2013;7. doi: 10.1001/archinternmed.2009.384, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType=\"pubmed\">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, et al. . Covid-19 and autoimmunity. Autoimmun Rev. (2020) 19:102597. doi: 10.1016/j.autrev.2020.102597, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2020.102597</ArticleId><ArticleId IdType=\"pmc\">PMC7289100</ArticleId><ArticleId IdType=\"pubmed\">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et al. . Diverse functional autoantibodies in patients with COVID-19. Nature [Internet]. (2021) 595: 283&#x2013;288. doi: 10.1038/s41586-021-03631-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType=\"pubmed\">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. . Chronic inflammation in the etiology of disease across the life span. Nat Med. (2019) 25:1822&#x2013;32. doi: 10.1038/s41591-019-0675-0, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-019-0675-0</ArticleId><ArticleId IdType=\"pmc\">PMC7147972</ArticleId><ArticleId IdType=\"pubmed\">31806905</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner S, Becker SC, Hartwig J, Sotzny F, Lorenz S, Bauer S, et al. . Autoimmunity-related risk variants in PTPN22 and CTLA4 are associated with ME/CFS with infectious onset. Front Immunol. (2020) 11:578. doi: 10.3389/fimmu.2020.00578, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2020.00578</ArticleId><ArticleId IdType=\"pmc\">PMC7161310</ArticleId><ArticleId IdType=\"pubmed\">32328064</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome&#x2014;evidence for an autoimmune disease. Autoimmun Rev. (2018) 17:601&#x2013;9. doi: 10.1016/j.autrev.2018.01.009, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2018.01.009</ArticleId><ArticleId IdType=\"pubmed\">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Surace AEA, Hedrich CM. The role of epigenetics in autoimmune/inflammatory disease. Front Immunol. (2019) 10:1525&#x2013;1541. doi: 10.3389/fimmu.2019.01525</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2019.01525</ArticleId><ArticleId IdType=\"pmc\">PMC6620790</ArticleId><ArticleId IdType=\"pubmed\">31333659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YS, Lin CF, Fang YT, Kuo YM, Liao PC, Yeh TM, et al. . Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity. Clin Exp Immunol. (2005) 141:500&#x2013;8. doi: 10.1111/j.1365-2249.2005.02864.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2249.2005.02864.x</ArticleId><ArticleId IdType=\"pmc\">PMC1809466</ArticleId><ArticleId IdType=\"pubmed\">16045740</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti C, Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. (2020) 16:413&#x2013;4. doi: 10.1038/s41584-020-0448-7, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41584-020-0448-7</ArticleId><ArticleId IdType=\"pmc\">PMC7271827</ArticleId><ArticleId IdType=\"pubmed\">32499548</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate W, Walker M, Sweetman E, Helliwell A, Peppercorn K, Edgar C, et al. . Molecular mechanisms of Neuroinflammation in ME/CFS and Long COVID to sustain disease and promote relapses. Front Neurol. (2022) 13:877772. doi: 10.3389/fneur.2022.877772, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2022.877772</ArticleId><ArticleId IdType=\"pmc\">PMC9174654</ArticleId><ArticleId IdType=\"pubmed\">35693009</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, et al. . A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. (2022) 13:5104&#x2013;13. doi: 10.1038/s41467-022-32507-6, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType=\"pmc\">PMC9426365</ArticleId><ArticleId IdType=\"pubmed\">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini DM, Brunjes DL, Lala A, Trivieri MG, Contreras JP, Natelson BH. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. (2021) 9:927&#x2013;37. doi: 10.1016/j.jchf.2021.10.002, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType=\"pmc\">PMC8629098</ArticleId><ArticleId IdType=\"pubmed\">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, el Jammal T, et al. . Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions [internet]. Autoimmun Rev. (2020) 19:102567. doi: 10.1016/j.autrev.2020.102567, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2020.102567</ArticleId><ArticleId IdType=\"pmc\">PMC7196557</ArticleId><ArticleId IdType=\"pubmed\">32376392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyriazopoulou E, Poulakou G, Milionis H, Metallidis S, Adamis G, Tsiakos K, et al. . Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial [internet]. Nat Med. (2021) 27:1752&#x2013;60. doi: 10.1038/s41591-021-01499-z, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-021-01499-z</ArticleId><ArticleId IdType=\"pmc\">PMC8516650</ArticleId><ArticleId IdType=\"pubmed\">34480127</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai A, Diawara O, Nahass RG, Brunetti L. Impact of tocilizumab administration on mortality in severe COVID-19. Sci Rep. (2020) 10:19131. doi: 10.1038/s41598-020-76187-y, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-020-76187-y</ArticleId><ArticleId IdType=\"pmc\">PMC7645706</ArticleId><ArticleId IdType=\"pubmed\">33154452</ArticleId></ArticleIdList></Reference><Reference><Citation>Salama C, Han J, Yau L, Reiss WG, Kramer B, Neidhart JD, et al. . Tocilizumab in patients hospitalized with Covid-19 pneumonia. N Engl J Med. (2021) 384:20&#x2013;30. doi: 10.1056/NEJMoa2030340, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa2030340</ArticleId><ArticleId IdType=\"pmc\">PMC7781101</ArticleId><ArticleId IdType=\"pubmed\">33332779</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokkotis G, Kitsou K, Xynogalas I, Spoulou V, Magiorkinis G, Trontzas I, et al. . Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments. Aliment Pharmacol Ther. (2022) 55:154&#x2013;67. doi: 10.1111/apt.16717, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/apt.16717</ArticleId><ArticleId IdType=\"pubmed\">34881430</ArticleId></ArticleIdList></Reference><Reference><Citation>The RECOVERY Collaborative Group . Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. (2021) 384:693&#x2013;704. doi: 10.1056/NEJMoa2021436</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType=\"pmc\">PMC7383595</ArticleId><ArticleId IdType=\"pubmed\">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee YJ, Fan BE, Young BE, Dalan R, Lye DC. Clinical trials on the pharmacological treatment of long COVID: a systematic review. J Med Virol. (2023) 95:e28289. doi: 10.1002/jmv.28289, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.28289</ArticleId><ArticleId IdType=\"pmc\">PMC9878018</ArticleId><ArticleId IdType=\"pubmed\">36349400</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibnhadjamor H, Jdidi J, Torjmen S, Kraiem S, Bahloul A, et al. . Sulodexide significantly improves endothelial dysfunction and alleviates chest pain and palpitations in patients with Long-COVID-19: insights from TUN-EndCOV study. Front Cardiovasc Med. (2022) 9:866113. doi: 10.3389/fcvm.2022.866113, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcvm.2022.866113</ArticleId><ArticleId IdType=\"pmc\">PMC9133483</ArticleId><ArticleId IdType=\"pubmed\">35647070</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchhorn R. Therapeutic approaches to Dysautonomia in childhood, with a special focus on Long COVID [internet]. Children. (2023) 10:316. doi: 10.3390/children10020316, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/children10020316</ArticleId><ArticleId IdType=\"pmc\">PMC9955589</ArticleId><ArticleId IdType=\"pubmed\">36832445</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan X, Zhao Z, Li T. Post-inflammatory pulmonary fibrosis in a discharged COVID-19 patient: effectively treated with Pirfenidone [internet]. Arch Pulmonol Respir Care. (2020) 6:051&#x2013;3. doi: 10.17352/aprc.000053</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.17352/aprc.000053</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee T, Das M, Mitra K. The effect of Pirfenidone on pulmonary function parameters in post recovery COVID-19 patients with pulmonary fibrosis compared to placebo in a government medical college, West Bengal [internet]. Biomedicine. (2022) 42:1005&#x2013;7. doi: 10.51248/.v42i5.1996</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.51248/.v42i5.1996</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel N, Goyal N, Nagaraja R, Kumar R. Systemic corticosteroids for management of &#x201c;long-COVID&#x201d;: an evaluation after 3 months of treatment. Monaldi Arch Chest Dis [Internet]. (2021) 92:1981&#x2013;1987. doi: 10.4081/monaldi.2021.1981, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4081/monaldi.2021.1981</ArticleId><ArticleId IdType=\"pubmed\">34730322</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussein AARM, Mohamed Hussein AA, Ibrahim MEA, Makhlouf HA, Makhlouf NA, Abd-Elaal HK, et al. . Value of montelukast as a potential treatment of post-COVID-19 persistent cough: a non-randomized controlled pilot study [internet]. Egypt J Bronchol. (2022) 16:1&#x2013;5. doi: 10.1186/s43168-022-00154-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s43168-022-00154-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhooria S, Chaudhary S, Sehgal IS, Agarwal R, Arora S, Garg M, et al. . High-dose low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial). Eur Respir J [Internet]. (2022) 59:2102930. doi: 10.1183/13993003.02930-2021, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1183/13993003.02930-2021</ArticleId><ArticleId IdType=\"pmc\">PMC8850687</ArticleId><ArticleId IdType=\"pubmed\">34887325</ArticleId></ArticleIdList></Reference><Reference><Citation>Utrero-Rico A, Ruiz-Ruig&#xf3;mez M, Laguna-Goya R, Arrieta-Ortubay E, Chivite-Lacaba M, Gonz&#xe1;lez-Cuadrado C, et al. . A short corticosteroid course reduces symptoms and immunological alterations underlying Long-COVID [internet]. Biomedicine. (2021) 9:1540. doi: 10.3390/biomedicines9111540, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biomedicines9111540</ArticleId><ArticleId IdType=\"pmc\">PMC8614904</ArticleId><ArticleId IdType=\"pubmed\">34829769</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone IL, Tortorella C, Ghirelli A. Influence of pregnancy in multiple sclerosis and impact of disease-modifying therapies. Front Neurol. (2021) 12:697974. doi: 10.3389/fneur.2021.697974, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2021.697974</ArticleId><ArticleId IdType=\"pmc\">PMC8280312</ArticleId><ArticleId IdType=\"pubmed\">34276545</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stensen M, Villiger PM. The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol. (2007) 29:185&#x2013;91. doi: 10.1007/s00281-007-0072-5, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00281-007-0072-5</ArticleId><ArticleId IdType=\"pubmed\">17621703</ArticleId></ArticleIdList></Reference><Reference><Citation>Colle I, Hautekeete M. Remission of autoimmune hepatitis during pregnancy: a report of two cases. Liver. (1999) 19:55&#x2013;7. doi: 10.1111/j.1478-3231.1999.tb00010.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1478-3231.1999.tb00010.x</ArticleId><ArticleId IdType=\"pubmed\">9928767</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazos M, Sperling RS, Moran TM, Kraus TA. The influence of pregnancy on systemic immunity. Immunol Res. (2012) 54:254&#x2013;61. doi: 10.1007/s12026-012-8303-9, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12026-012-8303-9</ArticleId><ArticleId IdType=\"pmc\">PMC7091327</ArticleId><ArticleId IdType=\"pubmed\">22447351</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffer L. Lots of Long COVID treatment leads, but few are proven. PNAS. 119:e2213524119. doi: 10.1073/pnas.2213524119, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2213524119</ArticleId><ArticleId IdType=\"pmc\">PMC9456722</ArticleId><ArticleId IdType=\"pubmed\">36048910</ArticleId></ArticleIdList></Reference><Reference><Citation>Krist&#xf3;fi R, Eriksson JW. Metformin as an anti-inflammatory agent: a short review. J Endocrinol. (2021) 251:R11&#x2013;R22. doi: 10.1530/JOE-21-0194</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1530/JOE-21-0194</ArticleId><ArticleId IdType=\"pubmed\">34463292</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante C, Buse JB, Liebovitz D, Nicklas J, et al. . Outpatient treatment of COVID-19 and the development of Long COVID Over 10 Months: A Multi-Center, Quadruple-Blind, Parallel Group Randomized Phase 3 Trial. (2022) Available at SSRN: https://ssrn.com/abstract=4375620 or 10.2139/ssrn.4375620.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2139/ssrn.4375620</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi J, Hansen MK, O&#x2019;Connor KA, Biedenkapp JC, Watkins LR, Maier SF, et al. . Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challenge [internet]. J Appl Physiol. (2003) 95:1873&#x2013;82. doi: 10.1152/japplphysiol.00371.2003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/japplphysiol.00371.2003</ArticleId><ArticleId IdType=\"pubmed\">12871965</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37054777</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1931-3543</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2023</Year><Month>Apr</Month><Day>11</Day></PubDate></JournalIssue><Title>Chest</Title><ISOAbbreviation>Chest</ISOAbbreviation></Journal><ArticleTitle>Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-Acute Sequelae of SARS-CoV-2: More in Common Than Not?</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0012-3692(23)00502-0</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.chest.2023.03.049</ELocationID><Abstract><AbstractText Label=\"TOPIC IMPORTANCE\" NlmCategory=\"UNASSIGNED\">Postacute sequelae of SARS-CoV-2 (PASC) is a long-term consequence of acute infection from COVID-19. Clinical overlap between PASC and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has been observed, with shared symptoms, including intractable fatigue, postexertional malaise, and orthostatic intolerance. The mechanistic underpinnings of such symptoms are poorly understood.</AbstractText><AbstractText Label=\"REVIEW FINDINGS\" NlmCategory=\"RESULTS\">Early studies suggest deconditioning as the primary explanation for exertional intolerance in PASC. Cardiopulmonary exercise testing reveals perturbations related to systemic blood flow and ventilatory control associated with acute exercise intolerance in PASC, which are not typical of simple detraining. Hemodynamic and gas exchange derangements in PASC have substantial overlap with those observed with ME/CFS, suggestive of shared mechanisms.</AbstractText><AbstractText Label=\"SUMMARY\" NlmCategory=\"CONCLUSIONS\">This review illustrates exercise pathophysiological commonalities between PASC and ME/CFS that will help guide future diagnostics and treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Joseph</LastName><ForeName>Phillip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Yale-New Haven Hospital, Yale University, New Haven, CT.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Singh</LastName><ForeName>Inderjit</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Yale-New Haven Hospital, Yale University, New Haven, CT.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Oliveira</LastName><ForeName>Rudolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Respiratory Disease, Department of Medicine, Federal University of S&#xe3;o Paulo (UNIFESP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Capone</LastName><ForeName>Christine A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Division of Pediatric Cardiology Department of Pediatrics, Cohen Children\\'s Medical Center, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra, Manhasset, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mullen</LastName><ForeName>Mary P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Boston Children\\'s Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cook</LastName><ForeName>Dane B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Research Service, William S. Middleton Memorial Veterans Hospital &amp; Department of Kinesiology, University of Wisconsin-Madison, Madison, WI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stovall</LastName><ForeName>Mary Catherine</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\\'s Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Squires</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\\'s Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Madsen</LastName><ForeName>Kristine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\\'s Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Waxman</LastName><ForeName>Aaron B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\\'s Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Systrom</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\\'s Hospital, Harvard Medical School, Boston, MA. Electronic address: dsystrom@bwh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chest</MedlineTA><NlmUniqueID>0231335</NlmUniqueID><ISSNLinking>0012-3692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">CPET</Keyword><Keyword MajorTopicYN=\"N\">ME/CFS</Keyword><Keyword MajorTopicYN=\"N\">PASC</Keyword><Keyword MajorTopicYN=\"N\">hyperventilation</Keyword><Keyword MajorTopicYN=\"N\">neurovascular dysregulation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37054777</ArticleId><ArticleId IdType=\"pmc\">PMC10088277</ArticleId><ArticleId IdType=\"doi\">10.1016/j.chest.2023.03.049</ArticleId><ArticleId IdType=\"pii\">S0012-3692(23)00502-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8893149</ArticleId><ArticleId IdType=\"pubmed\">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Bektas A., Schurman S.H., Franceschi C., Ferrucci L. A&#xa0;public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging? Immun Ageing. 2020;17:23.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7443812</ArticleId><ArticleId IdType=\"pubmed\">32849908</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)&#x2014;a systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas) 2021;57(5)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8145228</ArticleId><ArticleId IdType=\"pubmed\">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton E.W. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA. 2015;313(11):1101&#x2013;1102.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25668027</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo R.F., Mondoni M., Parazzini E.M., et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J. 2021;58(2)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8082950</ArticleId><ArticleId IdType=\"pubmed\">33926969</ArticleId></ArticleIdList></Reference><Reference><Citation>Skjorten I., Ankerstjerne O.A.W., Trebinjac D., et al. Cardiopulmonary exercise capacity and limitations 3&#xa0;months after COVID-19 hospitalisation. Eur Respir J. 2021;58(2)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8247555</ArticleId><ArticleId IdType=\"pubmed\">34210791</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P., Arevalo C., Oliveira R.K.F., et al. Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest. 2021;160:642&#x2013;651.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8727854</ArticleId><ArticleId IdType=\"pubmed\">33577778</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P.M., et al. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest. 2022;161(1):54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8354807</ArticleId><ArticleId IdType=\"pubmed\">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwendinger F., Knaier R., Radtke T., Schmidt-Trucksass A. Low cardiorespiratory fitness post-COVID-19: a narrative review. Sports Med. 2023;53(1):51&#x2013;74.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9483283</ArticleId><ArticleId IdType=\"pubmed\">36115933</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7833295</ArticleId><ArticleId IdType=\"pubmed\">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7385689</ArticleId><ArticleId IdType=\"pubmed\">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Inbar O., Dlin R., Rotstein A., Whipp B.J. Physiological responses to incremental exercise in patients with chronic fatigue syndrome. Med Sci Sports Exerc. 2001;33(9):1463&#x2013;1470.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11528333</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D.B., VanRiper S., Dougherty R.J., et al. Cardiopulmonary, metabolic, and perceptual responses during exercise in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a Multi-Site Clinical Assessment of ME/CFS (MCAM) sub-study. PLoS One. 2022;17(3)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8923458</ArticleId><ArticleId IdType=\"pubmed\">35290404</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson M.J., Buckley J.D., Thomson R.L., Bellenger C.R., Davison K. Markers of cardiac autonomic function during consecutive day peak exercise tests in people with myalgic encephalomyelitis/chronic fatigue syndrome. Front Physiol. 2021;12</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8713453</ArticleId><ArticleId IdType=\"pubmed\">34970156</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens S., Snell C., Stevens J., Keller B., VanNess J.M. Cardiopulmonary exercise test methodology for assessing exertion intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. 2018;6:242.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6131594</ArticleId><ArticleId IdType=\"pubmed\">30234078</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller B.A., Pryor J.L., Giloteaux L. Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO(2)peak indicates functional impairment. J&#xa0;Transl Med. 2014;12:104.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4004422</ArticleId><ArticleId IdType=\"pubmed\">24755065</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.J., Kang E.B., Jang E.S., Son C.G. The prospects of the two-day cardiopulmonary exercise test (CPET) in ME/CFS patients: a meta-analysis. J&#xa0;Clin Med. 2020;9(12):4040.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7765094</ArticleId><ArticleId IdType=\"pubmed\">33327624</ArticleId></ArticleIdList></Reference><Reference><Citation>White A.T., Light A.R., Hughen R.W., et al. Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology. 2010;47(4):615&#x2013;624.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4378647</ArticleId><ArticleId IdType=\"pubmed\">20230500</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Oosterwijck J., Nijs J., Meeus M., et al. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an experimental study. J&#xa0;Intern Med. 2010;268(3):265&#x2013;278.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20412374</ArticleId></ArticleIdList></Reference><Reference><Citation>Smylie A.L., Broderick G., Fernandes H., et al. A&#xa0;comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome. BMC Immunol. 2013;14:29.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3698072</ArticleId><ArticleId IdType=\"pubmed\">23800166</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla S.K., Cook D., Meyer J., et al. Changes in gut and plasma microbiome following exercise challenge in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) PLoS One. 2015;10(12)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4684203</ArticleId><ArticleId IdType=\"pubmed\">26683192</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A., Giloteaux L., Moore G.E., et al. Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 2022;7(9)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9090259</ArticleId><ArticleId IdType=\"pubmed\">35358096</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D.B., Light A.R., Light K.C., et al. Neural consequences of post-exertion malaise in myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav Immun. 2017;62:87&#x2013;99.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28216087</ArticleId></ArticleIdList></Reference><Reference><Citation>McCully K.K., Natelson B.H. Impaired oxygen delivery to muscle in chronic fatigue syndrome. Clin Sci (Lond) 1999;97(5):603&#x2013;608.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10545311</ArticleId></ArticleIdList></Reference><Reference><Citation>Boruch A.E., Lindheimer J.B., Klein-Adams J.C., et al. Predicting post-exertional malaise in Gulf War illness based on acute exercise responses. Life Sci. 2021;280</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34119538</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R., DeMars J., Franklin K., Culos-Reed S.N., Weatherald J., Wrightson J.G. Chronic fatigue and postexertional malaise in people living with long COVID: an observational study. Phys Ther. 2022;102(4)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9383197</ArticleId><ArticleId IdType=\"pubmed\">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron B.A., Cockrill B.A., Waxman A.B., Systrom D.M. The invasive cardiopulmonary exercise test. Circulation. 2013;127(10):1157&#x2013;1164.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23479667</ArticleId></ArticleIdList></Reference><Reference><Citation>Boerrigter B.G., Waxman A.B., Westerhof N., Vonk-Noordegraaf A., Systrom D.M. Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects. Eur Respir J. 2014;43(5):1316&#x2013;1325.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24177003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasserman K. 5th ed. Wolters Kluwer Health/Lippincott Williams &amp; Wilkins; Philadelphia, PA: 2012. Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications.</Citation></Reference><Reference><Citation>Oliveira R.K., Agarwal M., Tracy J.A., et al. Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics. Eur Respir J. 2016;47(4):1179&#x2013;1188.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26677941</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeder K., Banfi C., Steinrisser-Allex G., et al. Diagnostic, prognostic and differential-diagnostic relevance of pulmonary hemodynamics during exercise&#x2014;a systematic review. Eur Respir J. 2022</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9556812</ArticleId><ArticleId IdType=\"pubmed\">35332069</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisman A.S., Shah R.V., Dhakal B.P., et al. Pulmonary capillary wedge pressure patterns during exercise predict exercise capacity and incident heart failure. Circ Heart Fail. 2018;11(5)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5937988</ArticleId><ArticleId IdType=\"pubmed\">29695381</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen J.E., Sue D.Y., Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis. 1984;129(2 pt 2):S49&#x2013;S55.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6421218</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldham W.M., Lewis G.D., Opotowsky A.R., Waxman A.B., Systrom D.M. Unexplained exertional dyspnea caused by low ventricular filling pressures: results from clinical invasive cardiopulmonary exercise testing. Pulm Circ. 2016;6(1):55&#x2013;62.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4860548</ArticleId><ArticleId IdType=\"pubmed\">27162614</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobrega A.C., O&#x2019;Leary D., Silva B.M., Marongiu E., Piepoli M.F., Crisafulli A. Neural regulation of cardiovascular response to exercise: role of central command and peripheral afferents. Biomed Res Int. 2014;2014</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4000959</ArticleId><ArticleId IdType=\"pubmed\">24818143</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P., Mukerji S.S., Alabsi H.S., et al. Multisystem involvement in post-acute sequelae of coronavirus disease 19. Ann Neurol. 2022;91(3):367&#x2013;379.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9011495</ArticleId><ArticleId IdType=\"pubmed\">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A.L., Herzog Z.D., Downs H.M., Klein M.M. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain. 2013;154(11):2310&#x2013;2316.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3845002</ArticleId><ArticleId IdType=\"pubmed\">23748113</ArticleId></ArticleIdList></Reference><Reference><Citation>Evdokimov D., Frank J., Klitsch A., et al. Reduction of skin innervation is associated with a severe fibromyalgia phenotype. Ann Neurol. 2019;86(4):504&#x2013;516.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31376174</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuller T.B., Hermann K., Baron R. Quantitative assessment and correlation of sympathetic, parasympathetic, and afferent small fiber function in peripheral neuropathy. J&#xa0;Neurol. 2000;247(4):267&#x2013;272.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10836618</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob G., Costa F., Shannon J.R., et al. The neuropathic postural tachycardia syndrome. N&#xa0;Engl J Med. 2000;343(14):1008&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11018167</ArticleId></ArticleIdList></Reference><Reference><Citation>Stringer W., Wasserman K., Casaburi R., Porszasz J., Maehara K., French W. Lactic acidosis as a facilitator of oxyhemoglobin dissociation during exercise. J&#xa0;Appl Physiol (1985) 1994;76(4):1462&#x2013;1467.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8045820</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakane S., Mukaino A., Higuchi O., et al. A&#xa0;comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy. J&#xa0;Autoimmun. 2020;108</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31924415</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrecht P.J., Hou Q., Argoff C.E., Storey J.R., Wymer J.P., Rice F.L. Excessive peptidergic sensory innervation of cutaneous arteriole-venule shunts (AVS) in the palmar glabrous skin of fibromyalgia patients: implications for widespread deep tissue pain and fatigue. Pain Med. 2013;14(6):895&#x2013;915.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23691965</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha A.K., Schmidt B.R., Wilhelmy J., et al. Red blood cell deformability is diminished in patients with chronic fatigue syndrome. Clin Hemorheol Microcirc. 2019;71(1):113&#x2013;116.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6398549</ArticleId><ArticleId IdType=\"pubmed\">30594919</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandvik M.K., S&#xf8;rland K., Leirgul E., et al. Endothelial dysfunction in ME/CFS patients. PLoS One. 2023;18(2)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9894436</ArticleId><ArticleId IdType=\"pubmed\">36730360</ArticleId></ArticleIdList></Reference><Reference><Citation>Wawrzyniak N.R., Joseph A.M., Levin D.G., et al. Idiopathic chronic fatigue in older adults is linked to impaired mitochondrial content and biogenesis signaling in skeletal muscle. Oncotarget. 2016;7(33):52695&#x2013;52709.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5288142</ArticleId><ArticleId IdType=\"pubmed\">27447862</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer E., Petrache I., Goldstein N.M., et al. Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome. Am J Respir Crit Care Med. 2022;205(1):126&#x2013;129.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8865580</ArticleId><ArticleId IdType=\"pubmed\">34665688</ArticleId></ArticleIdList></Reference><Reference><Citation>Taivassalo T., Jensen T.D., Kennaway N., DiMauro S., Vissing J., Haller R.G. The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients. Brain. 2003;126(pt 2):413&#x2013;423.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12538407</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell D.E., Ora J., Webb K.A., Laveneziana P., Jensen D. Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol. 2009;167(1):116&#x2013;132.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19450767</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini D.M., Brunjes D.L., Lala A., Trivieri M.G., Contreras J.P., Natelson B.H. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. 2021;9(12):927&#x2013;937.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8629098</ArticleId><ArticleId IdType=\"pubmed\">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed K.H., Santos M., Oliveira R.K.F., et al. Unexplained exertional intolerance associated with impaired systemic oxygen extraction. Eur J Appl Physiol. 2019;119(10):2375&#x2013;2389.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31493035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalande S., Cross T.J., Keller-Ross M.L., Morris N.R., Johnson B.D., Taylor B.J. Exercise intolerance in heart failure: central role for the pulmonary system. Exerc Sport Sci Rev. 2020;48(1):11&#x2013;19.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6910932</ArticleId><ArticleId IdType=\"pubmed\">31453845</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Hand G.A., Potts J.T., Wilson L.B., Mitchell J.H. c-Fos expression in the medulla induced by static muscle contraction in cats. Am J Physiol. 1997;272(1 pt 2):H48&#x2013;H56.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9038921</ArticleId></ArticleIdList></Reference><Reference><Citation>Saltin B., Blomqvist G., Mitchell J.H., Johnson R.L., Jr., Wildenthal K., Chapman C.B. Response to exercise after bed rest and after training. Circulation. 1968;38(suppl 5):VII1&#x2013;VII78.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">5696236</ArticleId></ArticleIdList></Reference><Reference><Citation>Stickland M.K., Welsh R.C., Petersen S.R., et al. Does fitness level modulate the cardiovascular hemodynamic response to exercise? J&#xa0;Appl Physiol (1985) 2006;100(6):1895&#x2013;1901.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16497838</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P., Pari R., Miller S., et al. Neurovascular dysregulation and acute exercise intolerance in ME/CFS: a randomized, placebo-controlled trial of pyridostigmine. Chest. 2022;162(5):1116&#x2013;1126.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35526605</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein L.R., Rose E.B., Horwitz S.M., et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N&#xa0;Engl J Med. 2020;383(4):334&#x2013;346.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7346765</ArticleId><ArticleId IdType=\"pubmed\">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Capone C.A., Subramony A., Sweberg T., et al. Characteristics, cardiac involvement, and outcomes of multisystem inflammatory syndrome of childhood associated with severe acute respiratory syndrome coronavirus 2 infection. J&#xa0;Pediatr. 2020;224:141&#x2013;145.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7293762</ArticleId><ArticleId IdType=\"pubmed\">32553873</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow A.K., Malone L.A., Kokorelis C., et al. Long-term COVID 19 sequelae in adolescents: the overlap with orthostatic intolerance and ME/CFS. Curr Pediatr Rep. 2022;10(2):31&#x2013;44.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8906524</ArticleId><ArticleId IdType=\"pubmed\">35287333</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Ayuzo Del Valle N.C., et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9226045</ArticleId><ArticleId IdType=\"pubmed\">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddux A.B., Berbert L., Young C.C., et al. Health impairments in children and adolescents after hospitalization for acute COVID-19 or MIS-C. Pediatrics. 2022;150(3)</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35765138</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7652254</ArticleId><ArticleId IdType=\"pubmed\">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Penner J., Abdel-Mannan O., Grant K., et al. 6-Month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study. Lancet Child Adolesc Health. 2021;5(7):473&#x2013;482.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34043958</ArticleId></ArticleIdList></Reference><Reference><Citation>Astley C., Badue Pereira M.F., Lima M.S., et al. In-depth cardiovascular and pulmonary assessments in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a case series study. Physiol Rep. 2022;10(5)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8915155</ArticleId><ArticleId IdType=\"pubmed\">35274818</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstein D.S., Edelson J., O&#x2019;Malley S., et al. Cardiopulmonary exercise performance in the pediatric and young adult population before and during the COVID-19 pandemic. Pediatr Cardiol. 2022;43(8):1832&#x2013;1837.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9062635</ArticleId><ArticleId IdType=\"pubmed\">35503116</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoke L., Schlegtendal A., Maier C., Eitner L., Lucke T., Brinkmann F. Pulmonary function and long-term respiratory symptoms in children and adolescents after COVID-19. Front Pediatr. 2022;10</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9081758</ArticleId><ArticleId IdType=\"pubmed\">35547532</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E., Corsetti G., Romano C., et al. Serum metabolic profile in patients with long-Covid (PASC) syndrome: clinical implications. Front Med (Lausanne) 2021;8</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8339407</ArticleId><ArticleId IdType=\"pubmed\">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieling W., Kaufmann H., Claydon V.E., et al. Diagnosis and treatment of orthostatic hypotension. Lancet Neurol. 2022;21(8):735&#x2013;746.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10024337</ArticleId><ArticleId IdType=\"pubmed\">35841911</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilshire C.E., Kindlon T., Courtney R., et al. Rethinking the treatment of chronic fatigue syndrome-a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT. BMC Psychol. 2018;6(1):6.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5863477</ArticleId><ArticleId IdType=\"pubmed\">29562932</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe K.S. Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents. J&#xa0;Psychiatr Res. 1997;31(1):133&#x2013;147.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9201655</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge O., Rekeland I.G., Lien K., et al. B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2019;170(9):585&#x2013;593.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30934066</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Treister R., Lang M., Oaklander A.L. IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety. Ther Adv Neurol Disord. 2018;11</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5791555</ArticleId><ArticleId IdType=\"pubmed\">29403541</ArticleId></ArticleIdList></Reference><Reference><Citation>NCT05152849.</Citation></Reference><Reference><Citation>Parikh S., Goldstein A., Koenig M.K., et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2015;17(9):689&#x2013;701.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5000852</ArticleId><ArticleId IdType=\"pubmed\">25503498</ArticleId></ArticleIdList></Reference><Reference><Citation>Cash A., Kaufman D.L. Oxaloacetate treatment for mental and physical fatigue in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long-COVID fatigue patients: a non-randomized controlled clinical trial. J&#xa0;Transl Med. 2022;20(1):295.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9238249</ArticleId><ArticleId IdType=\"pubmed\">35764955</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37046994</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>24</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>23</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>A Proposed New Model to Explain the Role of Low Dose Non-DNA Targeted Radiation Exposure in Chronic Fatigue and Immune Dysfunction Syndrome.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">6022</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms24076022</ELocationID><Abstract><AbstractText>Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) is considered to be a multidimensional illness whose etiology is unknown. However, reports from Chernobyl, as well as those from the United States, have revealed an association between radiation exposure and the development of CFIDS. As such, we present an expanded model using a systems biology approach to explain the etiology of CFIDS as it relates to this cohort of patients. This paper proposes an integrated model with ionizing radiation as a suggested trigger for CFIDS mediated through UVA induction and biophoton generation inside the body resulting from radiation-induced bystander effects (RIBE). Evidence in support of this approach has been organized into a systems view linking CFIDS illness markers with the initiating events, in this case, low-dose radiation exposure. This results in the formation of reactive oxygen species (ROS) as well as important immunologic and other downstream effects. Furthermore, the model implicates melanoma and subsequent hematopoietic dysregulation in this underlying process. Through the identification of this association with melanoma, clinical medicine, including dermatology, hematology, and oncology, can now begin to apply its expansive knowledge base to provide new treatment options for an illness that has had few effective treatments.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Cocchetto</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National CFIDS Foundation Inc., Hull, MA 02045-1602, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Seymour</LastName><ForeName>Colin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biology, McMaster University, Hamilton, ON L8S 4K1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mothersill</LastName><ForeName>Carmel</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biology, McMaster University, Hamilton, ON L8S 4K1, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D017382\">Reactive Oxygen Species</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000069079\" MajorTopicYN=\"Y\">Radiation Exposure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011832\" MajorTopicYN=\"Y\">Radiation Injuries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017382\" MajorTopicYN=\"N\">Reactive Oxygen Species</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007154\" MajorTopicYN=\"Y\">Immune System Diseases</DescriptorName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008545\" MajorTopicYN=\"Y\">Melanoma</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">CFIDS/ME/CFS</Keyword><Keyword MajorTopicYN=\"N\">UVA</Keyword><Keyword MajorTopicYN=\"N\">hematopoietic dysregulation</Keyword><Keyword MajorTopicYN=\"N\">ionizing radiation</Keyword><Keyword MajorTopicYN=\"N\">melanoma</Keyword><Keyword MajorTopicYN=\"N\">reactive oxygen species</Keyword><Keyword MajorTopicYN=\"N\">systems biology</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37046994</ArticleId><ArticleId IdType=\"pmc\">PMC10094351</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms24076022</ArticleId><ArticleId IdType=\"pii\">ijms24076022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bell D.S. The Disease of a Thousand Names: CFIDS&#x2014;CHRONIC Fatigue/Immune Dysfunction Syndrome. Pollard Publications; La Jolla, CA, USA: 1991.</Citation></Reference><Reference><Citation>Loganovsky K. Chronic Fatigue Syndrome as a Characteristic Aftermath of Radioecological Catastrophe. Int. J. Psychophysiol. 2000;35:69.</Citation></Reference><Reference><Citation>Loganovsky K.N. Chronic Fatigue Syndrome in the Chernobyl Accident Consequences Liquidators. Int. J. Radiat. Med. 2001;3:76.</Citation></Reference><Reference><Citation>Loganovsky K. Do Low Doses of Ionizing Radiation Affect the Human Brain? Data Sci. J. 2009;8:13&#x2013;35. doi: 10.2481/dsj.BR-04.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2481/dsj.BR-04</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang F.R., Loganovsky K. Low Dose or Low Dose Rate Ionizing Radiation-Induced Health Effect in the Human. J. Environ. Radioact. 2018;192:32&#x2013;47. doi: 10.1016/j.jenvrad.2018.05.018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jenvrad.2018.05.018</ArticleId><ArticleId IdType=\"pubmed\">29883875</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazyka D., Loganovsky K., Ilyenko I., Volovyk S., Perchuk I., Pleskach O., Nechayev S. Psychophysiological, Neuroimmune and Gene Expression Changes in Chronic Fatigue Syndrome after Low-Dose Radiation Exposure. Int. J. Psychophysiol. 2010;77:340. doi: 10.1016/j.ijpsycho.2010.06.282.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijpsycho.2010.06.282</ArticleId></ArticleIdList></Reference><Reference><Citation>Loganovsky K.N. Vegetative-Vascular Dystonia and Osteoalgetic Syndrome or Chronic Fatigue Syndrome as a Characteristic After-Effect of Radioecological Disaster. J. Chronic Fatigue Syndr. 2000;7:3&#x2013;16. doi: 10.1300/J092v07n03_02.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v07n03_02</ArticleId></ArticleIdList></Reference><Reference><Citation>National CFIDS Foundation . National CFIDS Foundation (NCF) Announces Link between Chronic Fatigue Syndrome and Low Level Radiation Exposure. PR Newswire; Chicago, IL, USA: 2010.</Citation></Reference><Reference><Citation>National CFIDS Foundation . National CFIDS Foundation&#x2019;s Research Finds Chromosome Damage in Patients Diagnosed with Chronic Fatigue Syndrome and Myalgic Encephalomyelitis. PR Newswire; Chicago, IL, USA: 2014.</Citation></Reference><Reference><Citation>Heng H.H.Q., Liu G., Stevens J.B., Abdallah B.Y., Horne S.D., Ye K.J., Bremer S.W., Chowdhury S.K., Ye C.J. Karyotype Heterogeneity and Unclassified Chromosomal Abnormalities. Cytogenet. Genome Res. 2013;139:144&#x2013;157. doi: 10.1159/000348682.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000348682</ArticleId><ArticleId IdType=\"pubmed\">23571381</ArticleId></ArticleIdList></Reference><Reference><Citation>Boubriak I., Akimkina T., Polischuk V., Dmitriev A., Mccready S., Grodzinsky D. Long term effects of chernobyl contamination on dna repair function and plant resistance to biotic and abiotic stress factors. TSitologiia Genet. 2016;50:34&#x2013;59. doi: 10.3103/S0095452716060049.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3103/S0095452716060049</ArticleId><ArticleId IdType=\"pubmed\">30484602</ArticleId></ArticleIdList></Reference><Reference><Citation>Yushkova E. Genetic mechanisms of formation of radiation-induced instability of the genome and its transgenerational effects in the descendants of chronically irradiated individuals of Drosophila melanogaster. Radiat. Environ. Biophys. 2020;59:221&#x2013;236. doi: 10.1007/s00411-020-00833-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00411-020-00833-2</ArticleId><ArticleId IdType=\"pubmed\">32076810</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S.B., McNeill F.E., Byun S.H., Prestwich W.V., Seymour C., Mothersill C.E. Ion Beam Induced Luminescence; Relevance to Radiation Induced Bystander Effects. Nucl. Instrum. Methods Phys. Res. Sect. B Beam Interact. Mater. At. 2012;288:81&#x2013;88. doi: 10.1016/j.nimb.2012.05.043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nimb.2012.05.043</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S.B., McNeill F.E., Byun S.H., Prestwich W.V., Mothersill C., Seymour C., Armstrong A., Fernandez C. Ultra-Violet Light Emission from HPV-G Cells Irradiated with Low Let Radiation From (90)Y; Consequences for Radiation Induced Bystander Effects. Dose Response. 2013;11:498&#x2013;516. doi: 10.2203/dose-response.12-048.Ahmad.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2203/dose-response.12-048.Ahmad</ArticleId><ArticleId IdType=\"pmc\">PMC3834743</ArticleId><ArticleId IdType=\"pubmed\">24298227</ArticleId></ArticleIdList></Reference><Reference><Citation>Mothersill C., Le M., Rusin A., Seymour C. Biophotons in Radiobiology: Inhibitors, Communicators and Reactors. Radiat. Prot. Dosim. 2019;183:136&#x2013;141. doi: 10.1093/rpd/ncy271.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/rpd/ncy271</ArticleId><ArticleId IdType=\"pubmed\">30624751</ArticleId></ArticleIdList></Reference><Reference><Citation>Le M., McNeill F.E., Seymour C., Rainbow A.J., Mothersill C.E. An observed effect of ultraviolet radiation emitted from beta-irradiated HaCaT cells upon non-beta-irradiated bystander cells. Radiat. Res. 2015;183:279&#x2013;290. doi: 10.1667/RR13827.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RR13827.1</ArticleId><ArticleId IdType=\"pubmed\">25710575</ArticleId></ArticleIdList></Reference><Reference><Citation>Le M., Mothersill C.E., Seymour C.B., Ahmad S.B., Armstrong A., Rainbow A.J., McNeill F.E. Factors affecting ultraviolet-A photon emission from &#x3b2;-irradiated human keratinocyte cells. Phys. Med. Biol. 2015;60:6371&#x2013;6389. doi: 10.1088/0031-9155/60/16/6371.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1088/0031-9155/60/16/6371</ArticleId><ArticleId IdType=\"pubmed\">26237407</ArticleId></ArticleIdList></Reference><Reference><Citation>Le M., Mothersill C.E., Seymour C.B., Rainbow A.J., McNeill F.E. An Observed Effect of p53 Status on the Bystander Response to Radiation-Induced Cellular Photon Emission. Radiat. Res. 2017;9187:169&#x2013;185. doi: 10.1667/RR14342.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RR14342.1</ArticleId><ArticleId IdType=\"pubmed\">28118118</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J., Vo N.T.K., Chettle D.R., McNeill F.E., Seymour C.B., Mothersill C.E. Quantifying Biophoton Emissions From Human Cells Directly Exposed to Low-Dose Gamma Radiation. Dose Response. 2020;18:1559325820926763. doi: 10.1177/1559325820926763.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1559325820926763</ArticleId><ArticleId IdType=\"pmc\">PMC7238447</ArticleId><ArticleId IdType=\"pubmed\">32489340</ArticleId></ArticleIdList></Reference><Reference><Citation>Le M., McNeill F.E., Seymour C.B., Rusin A., Diamond K., Rainbow A.J., Murphy J., Mothersill C.E. Modulation of oxidative phosphorylation (OXPHOS) by radiation- induced biophotons. Environ. Res. 2018;163:80&#x2013;87. doi: 10.1016/j.envres.2018.01.027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.envres.2018.01.027</ArticleId><ArticleId IdType=\"pubmed\">29427954</ArticleId></ArticleIdList></Reference><Reference><Citation>The Water in You: Water and the Human Body. Water Science School.  [(accessed on 13 March 2023)];2019  Available online:  https://www.usgs.gov/special-topics/water-science-school/science/water-you-water-and-human-body.</Citation></Reference><Reference><Citation>Le Caer S. Radiolysis: Influence of Oxide Surfaces on H2 Production under Ionizing Radiation. Water. 2011;3:235&#x2013;253. doi: 10.3390/w3010235.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/w3010235</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards R.S., Roberts T.K., McGregor N.R., Dunstan R.H., Butt H.L. Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep. 2000;5:35&#x2013;41. doi: 10.1179/rer.2000.5.1.35.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1179/rer.2000.5.1.35</ArticleId><ArticleId IdType=\"pubmed\">10905542</ArticleId></ArticleIdList></Reference><Reference><Citation>Clutton S.M., Townsend K.M., Walker C., Ansell J.D., Wright E.G. Radiation-induced genomic instability and persisting oxidative stress in primary bone marrow cultures. Carcinogenesis. 1996;17:1633&#x2013;1639. doi: 10.1093/carcin/17.8.1633.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/carcin/17.8.1633</ArticleId><ArticleId IdType=\"pubmed\">8761419</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Reilly J.P., Mothersill C. Comparative effects of UV A and UV B on clonogenic survival and delayed cell death in skin cell lines from humans and fish. Int. J. Radiat. Biol. 1997;72:111&#x2013;119.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9246200</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridley A.J., Whiteside J.R., McMillan T.J., Allinson S.L. Cellular and sub-cellular responses to UVA in relation to carcinogenesis. Int. J. Radiat. Biol. 2009;85:177&#x2013;195. doi: 10.1080/09553000902740150.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/09553000902740150</ArticleId><ArticleId IdType=\"pubmed\">19296341</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside J.R., McMillan T.J. A bystander effect is induced in human cells treated with UVA radiation but not UVB radiation. Radiat. Res. 2009;171:204&#x2013;211. doi: 10.1667/RR1508.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RR1508.1</ArticleId><ArticleId IdType=\"pubmed\">19267546</ArticleId></ArticleIdList></Reference><Reference><Citation>Jella K.K., Moriarty R., McClean B., Byrne H.J., Lyng F.M. Reactive oxygen species and nitric oxide signaling in bystander cells. PLoS ONE. 2018;13:e0195371. doi: 10.1371/journal.pone.0195371.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0195371</ArticleId><ArticleId IdType=\"pmc\">PMC5886541</ArticleId><ArticleId IdType=\"pubmed\">29621312</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH News in Health . Sun and Skin: The Dark Side of Sun Exposure. NIH News in Health; Bethesda, MD, USA: 2014.</Citation></Reference><Reference><Citation>Jin S.G., Padron F., Pfeifer G.P. UVA Radiation, DNA Damage, and Melanoma. ACS Omega. 2022;7:32936&#x2013;32948. doi: 10.1021/acsomega.2c04424.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsomega.2c04424</ArticleId><ArticleId IdType=\"pmc\">PMC9494637</ArticleId><ArticleId IdType=\"pubmed\">36157735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernerd F., Passeron T., Castiel I., Marionnet C. The Damaging Effects of Long UVA (UVA1) Rays: A Major Challenge to Preserve Skin Health and Integrity. Int. J. Mol. Sci. 2022;23:8243. doi: 10.3390/ijms23158243.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23158243</ArticleId><ArticleId IdType=\"pmc\">PMC9368482</ArticleId><ArticleId IdType=\"pubmed\">35897826</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A.Q., Travers J.B., Kemp M.G. Roles of UVA Radiation and DNA Damage Responses in Melanoma Pathogenesis. Environ. Mol. Mutagen. 2018;59:438&#x2013;460. doi: 10.1002/em.22176.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/em.22176</ArticleId><ArticleId IdType=\"pmc\">PMC6031472</ArticleId><ArticleId IdType=\"pubmed\">29466611</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapp F.G., Perlin J.R., Hagedorn E.J., Gansner J.M., Schwarz D.E., O&#x2019;Connell L.A., Johnson N.S., Amemiya C., Fisher D.E., Wolfle U., et al. Protection from UV light is an evolutionarily conserved feature of the hematopoietic niche. Nature. 2018;558:445&#x2013;448. doi: 10.1038/s41586-018-0213-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-018-0213-0</ArticleId><ArticleId IdType=\"pmc\">PMC6093292</ArticleId><ArticleId IdType=\"pubmed\">29899448</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamran N., Li Y., Sierra M., Alghamri M.S., Kadiyala P., Appelman H.D., Edwards M., Lowenstein P.R., Castro M.G. Melanoma induced immunosuppression is mediated by hematopoietic dysregulation. Oncoimmunology. 2017;7:e1408750. doi: 10.1080/2162402X.2017.1408750.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/2162402X.2017.1408750</ArticleId><ArticleId IdType=\"pmc\">PMC5790391</ArticleId><ArticleId IdType=\"pubmed\">29399415</ArticleId></ArticleIdList></Reference><Reference><Citation>Decker J.M. Immunology: B-Cell Development. Department of Veterinary Science and Microbiology, University of Arizona.  [(accessed on 13 March 2023)].  Available online:  http://microvet.arizona.edu/Courses/MIC419/Tutorials/Bcelldevelopment.html.</Citation></Reference><Reference><Citation>Chang C.M., Warren J.L., Engels E.A. Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults. Cancer. 2012;118:5929&#x2013;5936. doi: 10.1002/cncr.27612.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cncr.27612</ArticleId><ArticleId IdType=\"pmc\">PMC3434293</ArticleId><ArticleId IdType=\"pubmed\">22648858</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson H. Osler&#x2019;s Web: Inside the Labyrinth of the Chronic Fatigue Syndrome Epidemic. Crown Publishers; New York, NY, USA: 1996.</Citation></Reference><Reference><Citation>Lundell K., Qazi S., Eddy L., Uckun F.M. Clinical activity of folinic acid in patients with chronic fatigue syndrome. Arzneimittelforschung. 2006;56:399&#x2013;404. doi: 10.1055/s-0031-1296741.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1055/s-0031-1296741</ArticleId><ArticleId IdType=\"pubmed\">16889122</ArticleId></ArticleIdList></Reference><Reference><Citation>Turick C.E., Ekechukwu A.A., Milliken C.E., Casadevall A., Dadachova E. Gamma radiation interacts with melanin to alter its oxidation-reduction potential and results in electric current production. Bioelectrochemistry. 2011;82:69&#x2013;73. doi: 10.1016/j.bioelechem.2011.04.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bioelechem.2011.04.009</ArticleId><ArticleId IdType=\"pubmed\">21632287</ArticleId></ArticleIdList></Reference><Reference><Citation>Vienneau D., de Hoogh K., Hauri D., Vicedo-Cabrera A.M., Schindler C., Huss A., Roosli M., SNC Study Group Effects of Radon and UV Exposure on Skin Cancer Mortality in Switzerland. Environ. Health Perspect. 2017;125:067009.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5744747</ArticleId><ArticleId IdType=\"pubmed\">28686556</ArticleId></ArticleIdList></Reference><Reference><Citation>Knox K.K., Carrigan D.R. Potential Role of STAT1 in the Pathogenesis of Chronic Fatigue Syndrome. Institute for Viral Pathogenesis; Madison, WI, USA: 2003.</Citation></Reference><Reference><Citation>Knox K.K., Cocchetto A., Jordan E., Leech D., Carrigan D.R. Deficiency in the Expression of STAT1 Protein in a Subpopulation of Patients with Chronic Fatigue Syndrome (CFS); Proceedings of the Seventh International AACFS Conference on Chronic Fatigue Syndrome, Fibromyalgia and other Related Illnesses; Madison, WI, USA. 8&#x2013;10 October 2004.</Citation></Reference><Reference><Citation>Maziere C., Dantin F., Dubois F., Santus R., Maziere J. Biphasic Effect of UVA Radiation on Stat1 Activity and Tyrosine Phosphorylation in Cultured Human Keratinocytes. Free Radic. Bio. Med. 2000;28:1430&#x2013;1437. doi: 10.1016/S0891-5849(00)00264-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0891-5849(00)00264-1</ArticleId><ArticleId IdType=\"pubmed\">10924861</ArticleId></ArticleIdList></Reference><Reference><Citation>Aragane Y., Kulms D., Luger T.A., Schwarz T. Down-regulation of interferon gamma-activated STAT1 by UV light. Proc. Natl. Acad. Sci. USA. 1997;94:11490&#x2013;11495. doi: 10.1073/pnas.94.21.11490.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.94.21.11490</ArticleId><ArticleId IdType=\"pmc\">PMC23515</ArticleId><ArticleId IdType=\"pubmed\">9326637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon T.R., Oh C.T., Choi E.J., Kim S.R., Jang Y.J., Ko E.J., Suh D., Yoo K.H., Kim B.J. Ultraviolet light-emitting-diode irradiation inhibits TNF-&#x3b1; and IFN-&#x3b3;-induced expression of ICAM-1 and STAT1 phosphorylation in human keratinocytes. Lasers Surg. Med. 2015;47:824&#x2013;832. doi: 10.1002/lsm.22425.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/lsm.22425</ArticleId><ArticleId IdType=\"pubmed\">26413796</ArticleId></ArticleIdList></Reference><Reference><Citation>Eschrich S., Zhang H., Zhao H., Boulware D., Lee J.H., Bloom G., Torres-Roca J.F. Systems biology modeling of the radiation sensitivity network: A biomarker discovery platform. Int. J. Radiat. Oncol. Biol. Phys. 2009;75:497&#x2013;505. doi: 10.1016/j.ijrobp.2009.05.056.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijrobp.2009.05.056</ArticleId><ArticleId IdType=\"pmc\">PMC2762403</ArticleId><ArticleId IdType=\"pubmed\">19735874</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Chen J., Zhao Y., Gu L., Shao X., Li J., Xu Y., Liu Z., Xu Q. Key candidate genes of STAT1 and CXCL10 in melanoma identified by integrated bioinformatical analysis. IUBMB Life. 2019;71:1634&#x2013;1644. doi: 10.1002/iub.2103.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/iub.2103</ArticleId><ArticleId IdType=\"pubmed\">31216116</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman M.A., Fernandez M., Backer L.C., Dickey R.W., Bernstein J., Schrank K., Kibler S., Wendy S., Gribble M.O., Bienfang P., et al. An Updated Review of Ciguatera Fish Poisoning: Clinical, Epidemiological, Environmental, and Public Health Management. Mar. Drugs. 2017;15:72. doi: 10.3390/md15030072.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/md15030072</ArticleId><ArticleId IdType=\"pmc\">PMC5367029</ArticleId><ArticleId IdType=\"pubmed\">28335428</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearn J.H. Chronic fatigue syndrome: Chronic ciguatera poisoning as a differential diagnosis. Med. J. Aust. 1997;166:309&#x2013;310. doi: 10.5694/j.1326-5377.1997.tb122320.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5694/j.1326-5377.1997.tb122320.x</ArticleId><ArticleId IdType=\"pubmed\">9087189</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombet A., Bidard J.N., Lazdunski M. Ciguatoxin and brevetoxins share a common receptor site on the neuronal voltage-dependent Na+ channel. FEBS Lett. 1987;219:355&#x2013;359. doi: 10.1016/0014-5793(87)80252-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0014-5793(87)80252-1</ArticleId><ArticleId IdType=\"pubmed\">2440718</ArticleId></ArticleIdList></Reference><Reference><Citation>Rook M.B., Evers M.M., Vos M.A., Bierhuizen M.F.A. Biology of cardiac sodium channel Nav1. 5 expression. Cardiovasc. Res. 2012;93:12&#x2013;23. doi: 10.1093/cvr/cvr252.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cvr/cvr252</ArticleId><ArticleId IdType=\"pubmed\">21937582</ArticleId></ArticleIdList></Reference><Reference><Citation>Hokama Y. (John A Burns School of Medicine, University of Hawaii, Honolulu, HI, USA). Personal communication. 2008.</Citation></Reference><Reference><Citation>Hokama Y., Uto G.A., Palafox N.A., Enlander D., Jordan E., Cocchetto A. Chronic phase lipids in sera of chronic fatigue syndrome (CFS), chronic ciguatera fish poisoning (CCFP), hepatitis B, and cancer with antigenic epitope resembling ciguatoxin, as assessed with Mab-CTX. J. Clin. Lab. Anal. 2003;17:132&#x2013;139. doi: 10.1002/jcla.10079.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jcla.10079</ArticleId><ArticleId IdType=\"pmc\">PMC6807878</ArticleId><ArticleId IdType=\"pubmed\">12784262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hokama Y., Empey-Campora C., Hara C., Higa N., Siu N., Lau R., Kuribayashi T., Yabusaki K. Acute phase phospholipids related to the cardiolipin of mitochondria in the sera of patients with chronic fatigue syndrome (CFS), chronic Ciguatera fish poisoning (CCFP), and other diseases attributed to chemicals, Gulf War, and marine toxins. J. Clin. Lab. Anal. 2008;22:99&#x2013;105. doi: 10.1002/jcla.20217.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jcla.20217</ArticleId><ArticleId IdType=\"pmc\">PMC6649096</ArticleId><ArticleId IdType=\"pubmed\">18348309</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G.K., Wang S.Y. Modifications of human cardiac sodium channel gating by UVA light. J. Membr. Biol. 2002;189:153&#x2013;165. doi: 10.1007/s00232-002-1010-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00232-002-1010-z</ArticleId><ArticleId IdType=\"pubmed\">12235490</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie A., Gallant B., Guo H., Gonzalez A., Clark M., Madigan A., Feng F., Chen H.D., Cui Y., Dudley S.C., Jr., et al. Functional cardiac Na + channels are expressed in human melanoma cells. Onco. Lett. 2018;16:1689&#x2013;1695. doi: 10.3892/ol.2018.8865.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/ol.2018.8865</ArticleId><ArticleId IdType=\"pmc\">PMC6036419</ArticleId><ArticleId IdType=\"pubmed\">30008854</ArticleId></ArticleIdList></Reference><Reference><Citation>Djamgoz M.B.A., Fraser S.P., Brackenbury W.J. In Vivo Evidence for Voltage-Gated Sodium Channel Expression in Carcinomas and Potentiation of Metastasis. Cancers. 2019;11:1675. doi: 10.3390/cancers11111675.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cancers11111675</ArticleId><ArticleId IdType=\"pmc\">PMC6895836</ArticleId><ArticleId IdType=\"pubmed\">31661908</ArticleId></ArticleIdList></Reference><Reference><Citation>Roelant C.H.S., DeMeirleir K.L. Methods and means for diagnosing and and/or treating a fatiguing illness. WO2019012159. World Patent. 2018 July 16;</Citation></Reference><Reference><Citation>Hou G., Xu B., Bi Y., Wu C., Ru B., Sun B., Bai X. Recent advances in research on aspartate &#x3b2;-hydroxylase (ASPH) in pancreatic cancer: A brief update. Bosn. J. Basic Med. Sci. 2018;18:297&#x2013;304. doi: 10.17305/bjbms.2018.3539.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.17305/bjbms.2018.3539</ArticleId><ArticleId IdType=\"pmc\">PMC6252103</ArticleId><ArticleId IdType=\"pubmed\">30179586</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W., Wang X., Hu J., Bai B., Zhu H. Diverse molecular functions of aspartate &#x3b2;-hydroxylase in cancer (Review) Oncol. Rep. 2020;44:2364&#x2013;2372. doi: 10.3892/or.2020.7792.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/or.2020.7792</ArticleId><ArticleId IdType=\"pmc\">PMC7610305</ArticleId><ArticleId IdType=\"pubmed\">33125119</ArticleId></ArticleIdList></Reference><Reference><Citation>Wands J.R., De La Monte S., Aihara A., Olsen M.J., Thomas J.M. Inhibitors of beta-hydroxylase for treatment of cancer. 20200361925. U.S. Patent Application. 2020 June 2;</Citation></Reference><Reference><Citation>Radrezza S., Carini M., Baron G., Aldini G., Negre-Salvayre A., D&#x2019;Amat A. Study of Carnosine&#x2019;s effect on nude mice skin to prevent UV-A damage. Free Radic. Biol. Med. 2021;173:97&#x2013;103. doi: 10.1016/j.freeradbiomed.2021.07.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.freeradbiomed.2021.07.010</ArticleId><ArticleId IdType=\"pubmed\">34242794</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller J.S., McCullar V., Punzel M., Lemischka I.R., Moore K.A. Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood. 1999;93:96&#x2013;106. doi: 10.1182/blood.V93.1.96.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood.V93.1.96</ArticleId><ArticleId IdType=\"pubmed\">9864151</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E.W., Hardcastle S.L., Atkinson G.M., van Driel M.L., Kreijkamp-Kaspers S., Ashton K.J., Staines D.R., Marshall-Gradisnik S.M. Natural killer cells in patients with severe chronic fatigue syndrome. Auto Immun. Highlights. 2013;4:69&#x2013;80. doi: 10.1007/s13317-013-0051-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13317-013-0051-x</ArticleId><ArticleId IdType=\"pmc\">PMC4389023</ArticleId><ArticleId IdType=\"pubmed\">26000145</ArticleId></ArticleIdList></Reference><Reference><Citation>Vokurkova D., Vavrova J., Sinkora J., Stoklasova A., Blaha V., Rezacova M. Radiosensitivity of CD3-CD8+CD56+ NK cells. Radiat. Meas. 2010;45:1020&#x2013;1023. doi: 10.1016/j.radmeas.2010.07.028.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.radmeas.2010.07.028</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E.W., Staines D.R., Baskurt O.K., Ashton K.J., Ramos S.B., Christy R.M., Marshall-Gradisnik S.M. Immune and hemorheological changes in chronic fatigue syndrome. J. Transl. Med. 2010;8:1. doi: 10.1186/1479-5876-8-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-8-1</ArticleId><ArticleId IdType=\"pmc\">PMC2829521</ArticleId><ArticleId IdType=\"pubmed\">20064266</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E.W., van Driel M.L., Staines D.R., Ashton K.J., Ramos S.B., Keane J., Klimas N.G., Marshall-Gradisnik S.M. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J. Transl. Med. 2011;9:81. doi: 10.1186/1479-5876-9-81.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-9-81</ArticleId><ArticleId IdType=\"pmc\">PMC3120691</ArticleId><ArticleId IdType=\"pubmed\">21619669</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E.W., van Driel M.L., Staines D.R., Ashton K.J., Hardcastle S.L., Keane J., Tajouri L., Peterson D., Ramos S.B., Marshall-Gradisnik S.M. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. J. Transl. Med. 2012;10:88. doi: 10.1186/1479-5876-10-88.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-10-88</ArticleId><ArticleId IdType=\"pmc\">PMC3464733</ArticleId><ArticleId IdType=\"pubmed\">22571715</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersey P., MacDonald M., Henderson C., Schibeci S., D&#x2019;Alessandro G., Pryor M., Wilkinson F.J. Suppression of natural killer cell activity in humans by radiation from solarium lamps depleted of UVB. J. Investig. Dermatol. 1988;90:305&#x2013;310. doi: 10.1111/1523-1747.ep12456090.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/1523-1747.ep12456090</ArticleId><ArticleId IdType=\"pubmed\">3258001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersey P., Magrath H., Wilkinson F. Development of an in vitro system for the analysis of ultraviolet radiation-induced suppression of natural killer cell activity. Photochem. Photobiol. 1993;57:279&#x2013;284. doi: 10.1111/j.1751-1097.1993.tb02287.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1751-1097.1993.tb02287.x</ArticleId><ArticleId IdType=\"pubmed\">8451290</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jonge K., Ebering A., Nassiri S., Maby-El Hajjami H., Ouertatani-Sakouhi H., Baumgaertner P., Speiser D.E. Circulating CD56 bright NK cells inversely correlate with survival of melanoma patients. Sci. Rep. 2019;9:4487. doi: 10.1038/s41598-019-40933-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-40933-8</ArticleId><ArticleId IdType=\"pmc\">PMC6418246</ArticleId><ArticleId IdType=\"pubmed\">30872676</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson L.O. The role of nondiscocytic erythrocytes in the pathogenesis of myalgic encephalomyelitis/chronic fatigue syndrome. In: Hyde B.M., editor. The Clinical and Scientific Basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Volume 65. The Nightingale Research Foundation; Street Ottawa, ON, Canada: 1992. pp. 597&#x2013;605.</Citation></Reference><Reference><Citation>Richards R.S., Wang L., Jelinek H. Erythrocyte oxidative damage in chronic fatigue syndrome. Arch Med. Res. 2007;38:94&#x2013;98. doi: 10.1016/j.arcmed.2006.06.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arcmed.2006.06.008</ArticleId><ArticleId IdType=\"pubmed\">17174731</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha A.K., Schmidt B.R., Wilhelmy J., Nguyen V., Abugherir A., Do J.K., Nemat-Gorgani M., Davis R.W., Ramasubramanian A.K. Red blood cell deformability is diminished in patients with Chronic Fatigue Syndrome. Clin. Hemorheol. Microcirc. 2019;71:113&#x2013;116. doi: 10.3233/CH-180469.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/CH-180469</ArticleId><ArticleId IdType=\"pmc\">PMC6398549</ArticleId><ArticleId IdType=\"pubmed\">30594919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlova E., Chernysh A., Sergunova V., Gudkova O., Manchenko E., Kozlov A. Atomic force microscopy study of red blood cell membrane nanostructure during oxidation-reduction processes. J. Mol. Recognit. 2018;31:e2724. doi: 10.1002/jmr.2724.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmr.2724</ArticleId><ArticleId IdType=\"pubmed\">29740886</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen C.B., Als&#xf8;e L., Lindvall J.M., Sulheim D., Fagermoen E., Winger A., Kaarb&#xf8; M., Nilsen H., Wyller V.B. Whole blood gene expression in adolescent chronic fatigue syndrome: An exploratory cross-sectional study suggesting altered B cell differentiation and survival. J. Transl. Med. 2017;15:102. doi: 10.1186/s12967-017-1201-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-017-1201-0</ArticleId><ArticleId IdType=\"pmc\">PMC5426002</ArticleId><ArticleId IdType=\"pubmed\">28494812</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato W., Ono H., Matsutani T., Nakamura M., Shin I., Amano K., Suzuki R., Yamamura T. Skewing of the B cell receptor repertoire in myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav. Immun. 2021;95:245&#x2013;255. doi: 10.1016/j.bbi.2021.03.023.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2021.03.023</ArticleId><ArticleId IdType=\"pubmed\">33794313</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa S., Borgogna C., Mondini M., De Andrea M., Meroni P.L., Berti E., Gariglio M., Landolfo S. Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing. Br. J. Dermatol. 2011;164:282&#x2013;290. doi: 10.1111/j.1365-2133.2010.10097.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2133.2010.10097.x</ArticleId><ArticleId IdType=\"pubmed\">20973769</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Xie X., Zhu J., Qi S., Xie J. Comprehensive analysis identifies IFI16 as a novel signature associated with overall survival and immune infiltration of skin cutaneous melanoma. Cancer Cell Int. 2021;21:694. doi: 10.1186/s12935-021-02409-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12935-021-02409-6</ArticleId><ArticleId IdType=\"pmc\">PMC8690488</ArticleId><ArticleId IdType=\"pubmed\">34930258</ArticleId></ArticleIdList></Reference><Reference><Citation>Dibble J.J., McGrath S.J., Ponting C.P. Genetic risk factors of ME/CFS: A critical review. Hum. Mol. Genet. 2020;29:R117&#x2013;R124. doi: 10.1093/hmg/ddaa169.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddaa169</ArticleId><ArticleId IdType=\"pmc\">PMC7530519</ArticleId><ArticleId IdType=\"pubmed\">32744306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji S.M. Overexpression of SLC25A15 is involved in the proliferation of cutaneous melanoma and leads to poor prognosis. Med. Sci. (Paris) 2018;34:74&#x2013;80. doi: 10.1051/medsci/201834f113.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1051/medsci/201834f113</ArticleId><ArticleId IdType=\"pubmed\">30403179</ArticleId></ArticleIdList></Reference><Reference><Citation>Boix E., Carreras E., Nikolovski Z., Cuchillo C.M., Nogues M.V. Identification and characterization of human eosinophil cationic protein by an epitope-specific antibody. J. Leukoc. Biol. 2001;69:1027&#x2013;1035. doi: 10.1189/jlb.69.6.1027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1189/jlb.69.6.1027</ArticleId><ArticleId IdType=\"pubmed\">11404391</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti F., Magrini L., Priori R., Valesini G., Bonini S. Eosinophil cationic protein serum levels and allergy in chronic fatigue syndrome. Allergy. 1996;51:124&#x2013;127. doi: 10.1111/j.1398-9995.1996.tb00047.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1398-9995.1996.tb00047.x</ArticleId><ArticleId IdType=\"pubmed\">8738520</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorensen B., Streib J.E., Strand M., Make B., Giclas P.C., Fleshner M., Jones J.F. Complement activation in a model of chronic fatigue syndrome. J. Allergy Clin. Immunol. 2003;112:397&#x2013;403. doi: 10.1067/mai.2003.1615.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1067/mai.2003.1615</ArticleId><ArticleId IdType=\"pubmed\">12897748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruckel A., Moreira A., Frohlich W., Schuler G., Heinzerling L. Eosinophil-cationic protein&#x2014;A novel liquid prognostic biomarker in melanoma. BMC Cancer. 2019;19:207. doi: 10.1186/s12885-019-5384-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12885-019-5384-z</ArticleId><ArticleId IdType=\"pmc\">PMC6407264</ArticleId><ArticleId IdType=\"pubmed\">30845981</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C., Lin J.C., Sheriff S., Maudsley A.A., Younger J.W. Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: Assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging Behav. 2020;14:562&#x2013;572. doi: 10.1007/s11682-018-0029-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11682-018-0029-4</ArticleId><ArticleId IdType=\"pmc\">PMC6612467</ArticleId><ArticleId IdType=\"pubmed\">30617782</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanculescu D., Sepulveda N., Lim C.L., Bergquist J. Lessons From Heat Stroke for Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front. Neurol. 2021;12:789784. doi: 10.3389/fneur.2021.789784.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2021.789784</ArticleId><ArticleId IdType=\"pmc\">PMC8710546</ArticleId><ArticleId IdType=\"pubmed\">34966354</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasso E.M., Muraki K., Eaton-Fitch N., Smith P., Lesslar O.L., Deed G., Marshall-Gradisnik S. Transient Receptor Potential Melastatin 3 Dysfunction in Post COVID-19 Condition and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Mol. Med. 2022;28:98. doi: 10.1186/s10020-022-00528-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s10020-022-00528-y</ArticleId><ArticleId IdType=\"pmc\">PMC9388968</ArticleId><ArticleId IdType=\"pubmed\">35986236</ArticleId></ArticleIdList></Reference><Reference><Citation>Vriens J., Owsianik G., Hofmann T., Philipp S.E., Stab J., Chen X., Benoit M., Xue F., Janssens A., Kerselaers S., et al. TRPM3 is a Nociceptor Channel Involved in the Detection of Noxious Heat. Neuron. 2011;70:482&#x2013;494. doi: 10.1016/j.neuron.2011.02.051.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2011.02.051</ArticleId><ArticleId IdType=\"pubmed\">21555074</ArticleId></ArticleIdList></Reference><Reference><Citation>Caterina M.J. Transient Receptor Potential Ion Channels as Participants in Thermosensation and Thermoregulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007;292:R64&#x2013;R76. doi: 10.1152/ajpregu.00446.2006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpregu.00446.2006</ArticleId><ArticleId IdType=\"pubmed\">16973931</ArticleId></ArticleIdList></Reference><Reference><Citation>Okabe T., Fujimura T., Okajima J., Kambayashi Y., Aiba S., Maruyama S. First-in-human clinical study of novel technique to diagnose malignant melanoma via thermal conductivity measurements. Sci. Rep. 2019;9:3853. doi: 10.1038/s41598-019-40444-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-40444-6</ArticleId><ArticleId IdType=\"pmc\">PMC6405870</ArticleId><ArticleId IdType=\"pubmed\">30846837</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrotek S., Brycht L., Wrotek W., Kozak W. Fever as a factor contributing to long-term survival in a patient with metastatic melanoma: A case report. Complement. Ther. Med. 2018;38:7&#x2013;10. doi: 10.1016/j.ctim.2018.03.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ctim.2018.03.009</ArticleId><ArticleId IdType=\"pubmed\">29857883</ArticleId></ArticleIdList></Reference><Reference><Citation>Le M., Fernandez-Palomo C., McNeill F.E., Seymour C.B., Rainbow A.J., Mothersill C.E. Exosomes are released by bystander cells exposed to radiation-induced biophoton signals: Reconciling the mechanisms mediating the bystander effect. PLoS ONE. 2017;12:e0173685. doi: 10.1371/journal.pone.0173685.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0173685</ArticleId><ArticleId IdType=\"pmc\">PMC5344502</ArticleId><ArticleId IdType=\"pubmed\">28278290</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauensteiner J., Bertinat R., Leon L.E., Riederer M., Sepulveda N., Westermeier F. Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients. Sci. Rep. 2021;11:10604. doi: 10.1038/s41598-021-89834-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-021-89834-9</ArticleId><ArticleId IdType=\"pmc\">PMC8134566</ArticleId><ArticleId IdType=\"pubmed\">34011981</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E.W., Ashton K.J., van Driel M., Staines D.R., Peterson D., Atkinson G.M., Marshall-Gradisnik S.M. Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J. Affect Discord. 2012;141:261&#x2013;269. doi: 10.1016/j.jad.2012.03.037.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jad.2012.03.037</ArticleId><ArticleId IdType=\"pubmed\">22572093</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Ding N., Pei H., Hu W., Wei W., Zhang X., Zhou G., Wang J. MiR-21 is involved in radiation-induced bystander effects. RNA Biol. 2014;11:1161&#x2013;1170. doi: 10.4161/rna.34380.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4161/rna.34380</ArticleId><ArticleId IdType=\"pmc\">PMC4615763</ArticleId><ArticleId IdType=\"pubmed\">25483031</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Wang J., Ding N., Hu W., Zhang X., Wang B., Hua J., Wei W., Zhu Q. Exosome-mediated microRNA transfer plays a role in radiation-induced bystander effect. RNA Biol. 2015;12:1355&#x2013;1363. doi: 10.1080/15476286.2015.1100795.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/15476286.2015.1100795</ArticleId><ArticleId IdType=\"pmc\">PMC4829325</ArticleId><ArticleId IdType=\"pubmed\">26488306</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnik B.C., John S.M., Carrera-Bastos P., Schmitz G. MicroRNA-21-Enriched Exosomes as Epigenetic Regulators in Melanomagenesis and Melanoma Progression: The Impact of Western Lifestyle Factors. Cancers. 2020;12:2111. doi: 10.3390/cancers12082111.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cancers12082111</ArticleId><ArticleId IdType=\"pmc\">PMC7464294</ArticleId><ArticleId IdType=\"pubmed\">32751207</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J.Y., Luo J., O&#x2019;Connor C., Jing X., Nair V., Ju W., Randolph A., Ben-Dov I.Z., Matar R.N., Briskin D., et al. MicroRNA-21 in glomerular injury. J. Am. Soc. 2015;26:805&#x2013;816. doi: 10.1681/ASN.2013121274.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1681/ASN.2013121274</ArticleId><ArticleId IdType=\"pmc\">PMC4378097</ArticleId><ArticleId IdType=\"pubmed\">25145934</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., He S., Yang F., Yu H., Xie W., Dai Q., Zhang D., Liu X., Zhou S., Zhang K. Hyperoside ameliorates glomerulosclerosis in diabetic nephropathy by downregulating miR-21. Can. J. Physiol. Pharmacol. 2016;94:1249&#x2013;1256. doi: 10.1139/cjpp-2016-0066.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1139/cjpp-2016-0066</ArticleId><ArticleId IdType=\"pubmed\">27704873</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyde B.M., Goldstein J.A., Levine P.H. The Nightingale Research Foundation Review of the Clinical and Scientific Basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Nightingale Research Foundation; Ottawa, ON, Canada: 1992.</Citation></Reference><Reference><Citation>Englebienne P., DeMeirleir K. Chronic Fatigue Syndrome: A Biological Approach. CRC Press; Boca Raton, FL, USA: 2002.</Citation></Reference><Reference><Citation>Journal of Chronic Fatigue Syndrome. 1995:1(1)&#x2013;2007:14(4). Taylor &amp; Francis Publ.  [(accessed on 17 March 2023)].  Available online:  https://www.tandfonline.com/journals/icfs20.</Citation></Reference><Reference><Citation>Fitzpatrick T.B. Color Atlas and Synopsis of Clinical Dermatology: Common and Serious Diseases. McGraw-Hill; New York, NY, USA: 2001.</Citation></Reference><Reference><Citation>National Research Council, Committee on the Biological Effects of Ionizing Radiation . Health Effects of Exposure to Low Levels of Ionizing Radiation (BEIR V) National Academy Press; Washington, DC, USA: 1990.</Citation></Reference><Reference><Citation>Fink C.A., Bates M.N. Melanoma and ionizing radiation: Is there a causal relationship? Radiat. Res. 2005;164:701&#x2013;710. doi: 10.1667/RR3447.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RR3447.1</ArticleId><ArticleId IdType=\"pubmed\">16238450</ArticleId></ArticleIdList></Reference><Reference><Citation>Telle-Lamberton M., Samson E., Ca&#xeb;r S., Bergot D., Bard D., Bermann F., G&#xe9;las J.M., Giraud J.M., Hubert P., Metz-Flamant C., et al. External radiation exposure and mortality in a cohort of French nuclear workers. Occup. Environ. Med. 2007;64:694&#x2013;700. doi: 10.1136/oem.2007.032631.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/oem.2007.032631</ArticleId><ArticleId IdType=\"pmc\">PMC2078398</ArticleId><ArticleId IdType=\"pubmed\">17522135</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajeevan M.S., Murray J., Oakley L., Lin J.S., Unger E.R. Association of chronic fatigue syndrome with premature telomere attrition. J. Transl. Med. 2018;16:44. doi: 10.1186/s12967-018-1414-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-018-1414-x</ArticleId><ArticleId IdType=\"pmc\">PMC5830066</ArticleId><ArticleId IdType=\"pubmed\">29486769</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochette P.J., Brash D.E. Human telomeres are hypersensitive to UV-induced DNA Damage and refractory to repair. PLoS Genet. 2010;6:e1000926. doi: 10.1371/journal.pgen.1000926.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pgen.1000926</ArticleId><ArticleId IdType=\"pmc\">PMC2861706</ArticleId><ArticleId IdType=\"pubmed\">20442874</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikawa S., Tada-Oikawa S., Kawanishi S. Site-specific DNA damage at the GGG sequence by UVA involves acceleration of telomere shortening. Biochemistry. 2001;40:4763&#x2013;4768. doi: 10.1021/bi002721g.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/bi002721g</ArticleId><ArticleId IdType=\"pubmed\">11294644</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikawa S., Kawanishi S. Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett. 1999;453:365&#x2013;368. doi: 10.1016/S0014-5793(99)00748-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0014-5793(99)00748-6</ArticleId><ArticleId IdType=\"pubmed\">10405177</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim G., Ricoul M., Hempel W.M., Azzam E.I., Sabatier L. Crosstalk between telomere maintenance and radiation effects: A key player in the process of radiation-induced carcinogenesis. Mutat. Res. Rev. Mutat. Res. 2014;760:1&#x2013;17. doi: 10.1016/j.mrrev.2014.01.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mrrev.2014.01.001</ArticleId><ArticleId IdType=\"pmc\">PMC4119099</ArticleId><ArticleId IdType=\"pubmed\">24486376</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel P., Tsapekos M., de Pedro N., Liu A.G., Lippmeier J.C., Chen S. Ergothioneine mitigates telomere shortening under oxidative stress conditions. J. Diet. Suppl. 2020;19:212&#x2013;225. doi: 10.1080/19390211.2020.1854919.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/19390211.2020.1854919</ArticleId><ArticleId IdType=\"pubmed\">33287595</ArticleId></ArticleIdList></Reference><Reference><Citation>Marozik P., Mothersill C., Seymour C.B., Mosse I., Melnov S. Bystander effects induced by serum from survivors of the Chernobyl accident. Exp. Hematol. 2007;35:55&#x2013;63. doi: 10.1016/j.exphem.2007.01.029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.exphem.2007.01.029</ArticleId><ArticleId IdType=\"pubmed\">17379088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosse I., Marozik P., Seymour C., Mothersill C. The effect of melanin on the bystander effect in human keratinocytes. Mutat. Res. 2006;597:133&#x2013;137. doi: 10.1016/j.mrfmmm.2005.09.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mrfmmm.2005.09.006</ArticleId><ArticleId IdType=\"pubmed\">16412479</ArticleId></ArticleIdList></Reference><Reference><Citation>Lad J., Rusin A., Seymour C., Mothersill C. An investigation into neutron-induced bystander effects: How low can you go? Environ. Res. 2019;175:84&#x2013;99. doi: 10.1016/j.envres.2019.04.033.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.envres.2019.04.033</ArticleId><ArticleId IdType=\"pubmed\">31108356</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusin A., Li M., Cocchetto A., Seymour C., Mothersill C. Radiation exposure and mitochondrial insufficiency in chronic fatigue and immune dysfunction syndrome. Med. Hypotheses. 2021;154:110647. doi: 10.1016/j.mehy.2021.110647.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mehy.2021.110647</ArticleId><ArticleId IdType=\"pubmed\">34358921</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusin A., Seymour C., Cocchetto A., Mothersill C. Commonalities in the Features of Cancer and Chronic Fatigue Syndrome (CFS): Evidence for Stress-Induced Phenotype Instability? Int. J. Mol. Sci. 2022;23:691. doi: 10.3390/ijms23020691.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23020691</ArticleId><ArticleId IdType=\"pmc\">PMC8775947</ArticleId><ArticleId IdType=\"pubmed\">35054876</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37046554</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Print\">2075-4418</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>13</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>03</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Physical Activity Effects on Muscle Fatigue in Sport in Active Adults with Long COVID-19: An Observational Study.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">1336</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/diagnostics13071336</ELocationID><Abstract><AbstractText>Long COVID-19-related changes in physiology includes alterations in performing muscle work as fatigue. Data available do not allow us to define the usefulness of physical activity to attenuate long COVID-19 functional modifications. The present observational study investigates the effects of physical activity on the perception of fatigue, maximum power output, sleep, and cognitive modifications in subjects affected by long COVID-19, distinguishing between active and sedentary subjects. The data demonstrated the following: the perception of fatigue 1 year after the end of virus positivity was significantly reduced with respect to that observed after 6 months by more than 50% more in active subjects compared to sedentary ones; 6 months after the end of virus positivity, the force developed by active subjects was reduced (RM factor: <i>p</i> &lt; 0.001, &#x3b7;2p = 0.527, post hoc: <i>p</i> &lt; 0.001), but the reduction was more pronounced in sedentary ones (mean difference = 38.499 W); poor sleep quality and mild cognitive impairment were assessed in both active and sedentary subjects. In conclusion, the study suggests that the long COVID-19 fatigue was lower in active subjects respect to sedentary ones. A comparative analysis performed due to the overlap of functional alterations between long COVID-19 and ME/CFS showed that in a small percentage of the enrolled subjects (8%), the symptomatology reflected that of ME/CFS and was independent of the individual physical capacities.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Coscia</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Sports Medicine Service of the San Candido, Innichen and Brunico-Bruneck Hospitals, Bolzano-Bozen, 39038 San Candido, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mancinelli</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neuroscience Imaging and Clinical Sciences, University \"G. d\\'Annunzio\" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IIM-Interuniversity Institute of Myology, University \"G. d\\'Annunzio\" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gigliotti</LastName><ForeName>Paola Virginia</ForeName><Initials>PV</Initials><AffiliationInfo><Affiliation>Laboratory of Sport Physiology San Candido-Innichen, University of Perugia, 39038 San Candido, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Checcaglini</LastName><ForeName>Franco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Campus of Free University of Alcatraz, Free University of Alcatraz, Santa Cristina di Gubbio, 06024 Gubbio, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fan&#xf2;-Illic</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><Identifier Source=\"ORCID\">0000-0002-8753-5707</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience Imaging and Clinical Sciences, University \"G. d\\'Annunzio\" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IIM-Interuniversity Institute of Myology, University \"G. d\\'Annunzio\" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Campus of Free University of Alcatraz, Free University of Alcatraz, Santa Cristina di Gubbio, 06024 Gubbio, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>A&amp;C M-C Foundation for Translational Myology, 35100 Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">(EM/CFS)</Keyword><Keyword MajorTopicYN=\"N\">long COVID-19 syndrome</Keyword><Keyword MajorTopicYN=\"N\">mild cognitive impairment</Keyword><Keyword MajorTopicYN=\"N\">muscle fatigue</Keyword><Keyword MajorTopicYN=\"N\">myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">physical exercise</Keyword><Keyword MajorTopicYN=\"N\">sleep quality</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37046554</ArticleId><ArticleId IdType=\"pmc\">PMC10093327</ArticleId><ArticleId IdType=\"doi\">10.3390/diagnostics13071336</ArticleId><ArticleId IdType=\"pii\">diagnostics13071336</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients with COVID-19: A Systematic Review. JAMA Netw. Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType=\"pmc\">PMC8155823</ArticleId><ArticleId IdType=\"pubmed\">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez A., Abrigo J., Achiardi O., Simon F., Cabello-Verrugio C. Intensive Care Unit-Acquired Weakness: A Review from Molecular Mechanisms to Its Impact in COVID-2019. Eur. J. Transl. Myol. 2022;32:10511. doi: 10.4081/ejtm.2022.10511.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4081/ejtm.2022.10511</ArticleId><ArticleId IdType=\"pmc\">PMC9580540</ArticleId><ArticleId IdType=\"pubmed\">36036350</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco A.L., Pacheco R.L., Bagattini &#xc2;.M., Riera R. Frequency, Signs and Symptoms, and Criteria Adopted for Long COVID-19: A Systematic Review. Int. J. Clin. Pract. 2021;75:e14357. doi: 10.1111/ijcp.14357.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/ijcp.14357</ArticleId><ArticleId IdType=\"pmc\">PMC8236920</ArticleId><ArticleId IdType=\"pubmed\">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Vi&#xf1;as L., Vega-Villar J., Roc&#xed;o-Mart&#xed;n E., Garc&#xed;a-Garc&#xed;a P., De La Rosa Santiago E., Galv&#xe1;n-Rom&#xe1;n J.M., Wix-Ramos R. Diaphragm Impairment in Patients Admitted for Severe COVID-19. Eur. J. Transl. Myol. 2022;32:10460. doi: 10.4081/ejtm.2022.10460.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4081/ejtm.2022.10460</ArticleId><ArticleId IdType=\"pmc\">PMC9295177</ArticleId><ArticleId IdType=\"pubmed\">35727218</ArticleId></ArticleIdList></Reference><Reference><Citation>Azizmohammadi S., Azizmohammadi S., Dahmardeh S., Azargashb H., Shokouh S.J.H., Mohajeri-Iravani M., Mobasher M., Soleiman-Meigooni S., Zabihi M. Analysis of 239 Ordinary and Severe Cases of COVID-19: Clinical Features and Treatment. Eur. J. Transl. Myol. 2021;31:9579. doi: 10.4081/ejtm.2021.9579.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4081/ejtm.2021.9579</ArticleId><ArticleId IdType=\"pmc\">PMC8495366</ArticleId><ArticleId IdType=\"pubmed\">34579515</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouhpayeh H. Clinical Features Predicting COVID-19 Mortality Risk. Eur. J. Transl. Myol. 2022;32:10268. doi: 10.4081/ejtm.2022.10268.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4081/ejtm.2022.10268</ArticleId><ArticleId IdType=\"pmc\">PMC9295175</ArticleId><ArticleId IdType=\"pubmed\">35421918</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-Acute COVID-19 Syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType=\"pmc\">PMC8893149</ArticleId><ArticleId IdType=\"pubmed\">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., Huggins C.F., Kwong A.S.F., Silverwood R.J., Di Gessa G., et al. Long COVID Burden and Risk Factors in 10 UK Longitudinal Studies and Electronic Health Records. Nat. Commun. 2022;13:3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType=\"pmc\">PMC9240035</ArticleId><ArticleId IdType=\"pubmed\">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. For the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2020.12603</ArticleId><ArticleId IdType=\"pmc\">PMC7349096</ArticleId><ArticleId IdType=\"pubmed\">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi M.S., Omrani O.A., Fawzy N.A., Shaar B.A., Almamlouk R., Riaz M., Obeidat M., Obeidat Y., Gerberi D., Taha R.M., et al. Prevalence of Post-Acute COVID-19 Syndrome Symptoms at Different Follow-up Periods: A Systematic Review and Meta-Analysis. Clin. Microbiol. Infect. 2022;28:657&#x2013;666. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType=\"pmc\">PMC8812092</ArticleId><ArticleId IdType=\"pubmed\">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)&#x2014;A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57050418</ArticleId><ArticleId IdType=\"pmc\">PMC8145228</ArticleId><ArticleId IdType=\"pubmed\">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R., Banerjee A., Baker M.R., Dani M., Ford E., Hull J.H., Lim P.B., McNarry M., Morten K., O&#x2019;Sullivan O., et al. Long COVID: Mechanisms, Risk Factors and Recovery. Exp. Physiol. 2023;108:12&#x2013;27. doi: 10.1113/EP090802.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1113/EP090802</ArticleId><ArticleId IdType=\"pmc\">PMC10103775</ArticleId><ArticleId IdType=\"pubmed\">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C. Pathophysiology of Skeletal Muscle Disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) J. Transl. Med. 2021;19:162. doi: 10.1186/s12967-021-02833-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-021-02833-2</ArticleId><ArticleId IdType=\"pmc\">PMC8058748</ArticleId><ArticleId IdType=\"pubmed\">33882940</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrangelo T., Fulle S., Coscia F., Gigliotti P.V., Fan&#xf2;-Illic G. Old Muscle in Young Body: An Aphorism Describing the Chronic Fatigue Syndrome. Eur. J. Transl. Myol. 2018;28:7688. doi: 10.4081/ejtm.2018.7688.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4081/ejtm.2018.7688</ArticleId><ArticleId IdType=\"pmc\">PMC6176399</ArticleId><ArticleId IdType=\"pubmed\">30344981</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press; Washington, DC, USA: 2015.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghali A., Lacout C., Ghali M., Gury A., Delattre E., Lavigne C., Urbanski G. Warning Signals of Post-Exertional Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Retrospective Analysis of 197 Patients. J. Clin. Med. 2021;10:2517. doi: 10.3390/jcm10112517.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm10112517</ArticleId><ArticleId IdType=\"pmc\">PMC8201170</ArticleId><ArticleId IdType=\"pubmed\">34200126</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotler J., Holtzman C., Dudun C., Jason L. A Brief Questionnaire to Assess Post-Exertional Malaise. Diagnostics. 2018;8:66. doi: 10.3390/diagnostics8030066.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics8030066</ArticleId><ArticleId IdType=\"pmc\">PMC6165517</ArticleId><ArticleId IdType=\"pubmed\">30208578</ArticleId></ArticleIdList></Reference><Reference><Citation>Geraghty K., Hann M., Kurtev S. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients&#x2019; Reports of Symptom Changes Following Cognitive Behavioural Therapy, Graded Exercise Therapy and Pacing Treatments: Analysis of a Primary Survey Compared with Secondary Surveys. J. Health Psychol. 2019;24:1318&#x2013;1333. doi: 10.1177/1359105317726152.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1359105317726152</ArticleId><ArticleId IdType=\"pubmed\">28847166</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., Jain A.K., De Meirleir K.L., Peterson D.L., Klimas N.G., Lerner A.M., Bested A.C., Flor-Henry P., Joshi P., Powles A.C.P., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols. J. Chronic Fatigue Syndr. 2003;11:7&#x2013;115. doi: 10.1300/J092v11n01_02.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J., Astill S., Sivan M. The Relationship between Physical Activity and Long COVID: A Cross-Sectional Study. Int. J. Environ. Res. Public. Health. 2022;19:5093. doi: 10.3390/ijerph19095093.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijerph19095093</ArticleId><ArticleId IdType=\"pmc\">PMC9105041</ArticleId><ArticleId IdType=\"pubmed\">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Micklewright D., St Clair Gibson A., Gladwell V., Al Salman A. Development and Validity of the Rating-of-Fatigue Scale. Sports Med. 2017;47:2375&#x2013;2393. doi: 10.1007/s40279-017-0711-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40279-017-0711-5</ArticleId><ArticleId IdType=\"pmc\">PMC5633636</ArticleId><ArticleId IdType=\"pubmed\">28283993</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers J., Prakash M., Froelicher V., Do D., Partington S., Atwood J.E. Exercise Capacity and Mortality among Men Referred for Exercise Testing. N. Engl. J. Med. 2002;346:793&#x2013;801. doi: 10.1056/NEJMoa011858.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa011858</ArticleId><ArticleId IdType=\"pubmed\">11893790</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: A New Instrument for Psychiatric Practice and Research. Psychiatry Res. 1989;28:193&#x2013;213. doi: 10.1016/0165-1781(89)90047-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType=\"pubmed\">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental State. J. Psychiatr. Res. 1975;12:189&#x2013;198. doi: 10.1016/0022-3956(75)90026-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0022-3956(75)90026-6</ArticleId><ArticleId IdType=\"pubmed\">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai A.D., Lavelle M., Boursiquot B.C., Wan E.Y. Long-Term Complications of COVID-19. Am. J. Physiol.-Cell Physiol. 2022;322:C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType=\"pmc\">PMC8721906</ArticleId><ArticleId IdType=\"pubmed\">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Nemati H., Shahisavandi M., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Barzegar Z., Kabiri M., Zeraatpisheh Z., et al. Long COVID in Children and Adolescents. World J. Pediatr. WJP. 2021;17:495&#x2013;499. doi: 10.1007/s12519-021-00457-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12519-021-00457-6</ArticleId><ArticleId IdType=\"pmc\">PMC8414448</ArticleId><ArticleId IdType=\"pubmed\">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirer-Sastre R., Legaz-Arrese A., Corbi F., L&#xf3;pez-Laval I., Puente-Lanzarote J., Hern&#xe1;ndez-Gonz&#xe1;lez V., Reverter-Masi&#xe0; J. Effect of Training Load on Post-Exercise Cardiac Troponin T Elevations in Young Soccer Players. Int. J. Environ. Res. Public. Health. 2019;16:4853. doi: 10.3390/ijerph16234853.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijerph16234853</ArticleId><ArticleId IdType=\"pmc\">PMC6926666</ArticleId><ArticleId IdType=\"pubmed\">31810338</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascia G., Pescetelli F., Baldari A., Gatto P., Seitun S., Sartori P., Pieroni M., Cal&#xf2; L., Della Bona R., Porto I. Interpretation of Elevated High-Sensitivity Cardiac Troponin I in Elite Soccer Players Previously Infected by Severe Acute Respiratory Syndrome Coronavirus 2. Int. J. Cardiol. 2021;326:248&#x2013;251. doi: 10.1016/j.ijcard.2020.11.039.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijcard.2020.11.039</ArticleId><ArticleId IdType=\"pmc\">PMC7682525</ArticleId><ArticleId IdType=\"pubmed\">33242510</ArticleId></ArticleIdList></Reference><Reference><Citation>Godeau D., Petit A., Richard I., Roquelaure Y., Descatha A. Return-to-Work, Disabilities and Occupational Health in the Age of COVID-19. Scand. J. Work. Environ. Health. 2021;47:408&#x2013;409. doi: 10.5271/sjweh.3960.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5271/sjweh.3960</ArticleId><ArticleId IdType=\"pmc\">PMC8259700</ArticleId><ArticleId IdType=\"pubmed\">34003294</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel K.M., Carr M.J., Ashcroft D.M., Chalder T., Chew-Graham C.A., Hope H., Kapur N., McManus S., Steeg S., Webb R.T., et al. Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients. JAMA Netw. Open. 2021;4:e2134803. doi: 10.1001/jamanetworkopen.2021.34803.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamanetworkopen.2021.34803</ArticleId><ArticleId IdType=\"pmc\">PMC8596199</ArticleId><ArticleId IdType=\"pubmed\">34783824</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-Month Consequences of COVID-19 in Patients Discharged from Hospital: A Cohort Study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType=\"pmc\">PMC7833295</ArticleId><ArticleId IdType=\"pubmed\">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kern H., Carraro U. Home-Based Functional Electrical Stimulation of Human Permanent Denervated Muscles: A Narrative Review on Diagnostics, Managements, Results and Byproducts Revisited 2020. Diagnostics. 2020;10:529. doi: 10.3390/diagnostics10080529.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics10080529</ArticleId><ArticleId IdType=\"pmc\">PMC7460102</ArticleId><ArticleId IdType=\"pubmed\">32751308</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancinelli R., Checcaglini F., Coscia F., Gigliotti P., Fulle S., Fan&#xf2;-Illic G. Biological Aspects of Selected Myokines in Skeletal Muscle: Focus on Aging. Int. J. Mol. Sci. 2021;22:8520. doi: 10.3390/ijms22168520.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22168520</ArticleId><ArticleId IdType=\"pmc\">PMC8395159</ArticleId><ArticleId IdType=\"pubmed\">34445222</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato A., Messina G., Feka K., Genua D., Ragonese P., Kostrzewa-Nowak D., Fischetti F., Iovane A., Proia P. Taopatch&#xae; Combined with Home-Based Training Protocol to Prevent Sedentary Lifestyle and Biochemical Changes in MS Patients during COVID-19 Pandemic. Eur. J. Transl. Myol. 2021;31:9877. doi: 10.4081/ejtm.2021.9877.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4081/ejtm.2021.9877</ArticleId><ArticleId IdType=\"pmc\">PMC8495370</ArticleId><ArticleId IdType=\"pubmed\">34498450</ArticleId></ArticleIdList></Reference><Reference><Citation>Larun L., Brurberg K.G., Odgaard-Jensen J., Price J.R. Exercise Therapy for Chronic Fatigue Syndrome. Cochrane Database Syst. Rev. 2019;10:CD003200. doi: 10.1002/14651858.CD003200.pub8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/14651858.CD003200.pub8</ArticleId><ArticleId IdType=\"pmc\">PMC6953363</ArticleId><ArticleId IdType=\"pubmed\">31577366</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudsmit E.M., Nijs J., Jason L.A., Wallman K.E. Pacing as a Strategy to Improve Energy Management in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Consensus Document. Disabil. Rehabil. 2012;34:1140&#x2013;1147. doi: 10.3109/09638288.2011.635746.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/09638288.2011.635746</ArticleId><ArticleId IdType=\"pubmed\">22181560</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd C.B. PACE Trial Claims for Recovery in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome&#x2014;True or False? It&#x2019;s Time for an Independent Review of the Methodology and Results. J. Health Psychol. 2017;22:1187&#x2013;1191. doi: 10.1177/1359105317703786.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1359105317703786</ArticleId><ArticleId IdType=\"pubmed\">28805522</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirke K.D. PACE Investigators&#x2019; Response Is Misleading Regarding Patient Survey Results. J. Health Psychol. 2017;22:1168&#x2013;1176. doi: 10.1177/1359105317703787.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1359105317703787</ArticleId><ArticleId IdType=\"pubmed\">28805528</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xe9;cary S., Gaboury I., Poirier S., Garcia C., Simpson S., Bull M., Brown D., Daigle F. Humility and Acceptance: Working Within Our Limits With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Orthop. Sports Phys. Ther. 2021;51:197&#x2013;200. doi: 10.2519/jospt.2021.0106.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2519/jospt.2021.0106</ArticleId><ArticleId IdType=\"pubmed\">33930983</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. Insights from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome May Help Unravel the Pathogenesis of Postacute COVID-19 Syndrome. Trends Mol. Med. 2021;27:895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType=\"pmc\">PMC8180841</ArticleId><ArticleId IdType=\"pubmed\">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>The International Multiprofessional Steering Committee of Cochrane Rehabilitation REH-COVER Action. Negrini F., de Sire A., Andrenelli E., Lazzarini S.G., Patrini M., Ceravolo M.G. Rehabilitation and COVID-19: A Rapid Living Systematic Review 2020 by Cochrane Rehabilitation Field. Update as of October 31st, 2020. Eur. J. Phys. Rehabil. Med. 2021;57:181&#x2013;188. doi: 10.23736/S1973-9087.20.06723-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.23736/S1973-9087.20.06723-4</ArticleId><ArticleId IdType=\"pubmed\">33263249</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J., Jansari V., Hornig M., Iwasaki A. Unexplained Post-Acute Infection Syndromes. Nat. Med. 2022;28:911&#x2013;923. doi: 10.1038/s41591-022-01810-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType=\"pubmed\">35585196</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37013608</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1479-5876</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>03</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Natural killer cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study.</ArticleTitle><Pagination><StartPage>242</StartPage><MedlinePgn>242</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">242</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1186/s12967-023-03958-2</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\">Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multisystem illness characterized by substantial reduction in function accompanied by profound unexplained fatigue not significantly relieved by rest, post-exertional malaise, and other symptoms. Reduced natural killer (NK) cell count and cytotoxicity has been investigated as a biomarker for ME/CFS, but few clinical laboratories offer the test and multi-site verification studies have not been conducted.</AbstractText><AbstractText Label=\"METHODS\">We determined NK cell counts and cytotoxicity in 174 (65%) ME/CFS, 86 (32%) healthy control (HC) and 10 (3.7%) participants with other fatigue associated conditions (ill control [IC]) from the Multi-Site Clinical Assessment of ME/CFS (MCAM) study using an assay validated for samples shipped overnight instead of testing on day of venipuncture.</AbstractText><AbstractText Label=\"RESULTS\">We found a large variation in percent cytotoxicity [mean and (IQR) for ME/CFS and HC respectively, 34.1% (IQR 22.4-44.3%) and 33.6% (IQR 22.9-43.7%)] and no statistically significant differences between patients with ME/CFS and HC (p-value&#x2009;=&#x2009;0.79). Analysis stratified on illness domain measured with standardized questionnaires did not identify an association of NK cytotoxicity with domain scores. Among all participants, NK cytotoxicity was not associated with survey results of physical and mental well-being, or health factors such as history of infection, obesity, smoking, and co-morbid conditions.</AbstractText><AbstractText Label=\"CONCLUSION\">These results indicate this assay is not ready for clinical implementation and studies are needed to further explore immune parameters that may be involved in the pathophysiology of ME/CFS.</AbstractText><CopyrightInformation>&#xa9; 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Querec</LastName><ForeName>Troy D</ForeName><Initials>TD</Initials><Identifier Source=\"ORCID\">0000-0002-3787-6271</Identifier><AffiliationInfo><Affiliation>Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. hep0@cdc.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lin</LastName><ForeName>Jin-Mann S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chen</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Helton</LastName><ForeName>Britany</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kogelnik</LastName><ForeName>Andreas M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Open Medicine Clinic, Mountain View, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Klimas</LastName><ForeName>Nancy G</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>Institute for Neuro Immune Medicine, Miami, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Peterson</LastName><ForeName>Daniel L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Sierra Internal Medicine, Incline Village, NV, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bateman</LastName><ForeName>Lucinda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Bateman Horne Center, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lapp</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hunter-Hopkins Center, Charlotte, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Podell</LastName><ForeName>Richard N</ForeName><Initials>RN</Initials><AffiliationInfo><Affiliation>Richard N. Podell Medical, Summit, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Natelson</LastName><ForeName>Benjamin H</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mount Sinai Beth Israel, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Unger</LastName><ForeName>Elizabeth R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><CollectiveName>MCAM Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D050053\">TRPM Cation Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C497902\">MCAM protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D051929\">CD146 Antigen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007694\" MajorTopicYN=\"N\">Killer Cells, Natural</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D050053\" MajorTopicYN=\"Y\">TRPM Cation Channels</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D051929\" MajorTopicYN=\"N\">CD146 Antigen</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Comorbidity</Keyword><Keyword MajorTopicYN=\"N\">Cytotoxicity</Keyword><Keyword MajorTopicYN=\"N\">Multicenter study</Keyword><Keyword MajorTopicYN=\"N\">Multimorbidity (multiple medical conditions)</Keyword><Keyword MajorTopicYN=\"N\">Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)</Keyword><Keyword MajorTopicYN=\"N\">Natural killer cell (NK)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a competing interest.</CoiStatement><InvestigatorList><Investigator ValidYN=\"Y\"><LastName>Unger</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Lin</LastName><ForeName>Jin-Mann Sally</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Cornelius</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Dimulescu</LastName><ForeName>Irina</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Fall</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Khin</LastName><ForeName>Maung</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Rajeevan</LastName><ForeName>Mangalathu</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Bland</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Jeys</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Parkinson</LastName><ForeName>Veronica</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Springs</LastName><ForeName>Wendy</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Klimas</LastName><ForeName>Nancy</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Balbin</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Cournoyer</LastName><ForeName>Jeffry</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Fernandez</LastName><ForeName>Melissa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Parnell</LastName><ForeName>Shuntae</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Leaks-Gutierrez</LastName><ForeName>Precious</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Natelson</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Blate</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Lange</LastName><ForeName>Gudrun</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Khan</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Vu</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Kogelnik</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Danver</LastName><ForeName>Joan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Kaufman</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Pa</LastName><ForeName>Macy</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Phan</LastName><ForeName>Catt</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Taleghani</LastName><ForeName>Sophia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Podell</LastName><ForeName>Richard N</ForeName><Initials>RN</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Fitzpatrick</LastName><ForeName>Trisha</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Licata</LastName><ForeName>Beverly</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Peterson</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Lascu</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Gottschalk</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Maynard</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Smith</LastName><ForeName>Janet</ForeName><Initials>J</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>3</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37013608</ArticleId><ArticleId IdType=\"pmc\">PMC10069115</ArticleId><ArticleId IdType=\"doi\">10.1186/s12967-023-03958-2</ArticleId><ArticleId IdType=\"pii\">10.1186/s12967-023-03958-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue syndrome study group. Ann Intern Med. 1994;121(12):953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType=\"pubmed\">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. 2011;270(4):327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType=\"pmc\">PMC3427890</ArticleId><ArticleId IdType=\"pubmed\">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Evans M, Porter N, Brown M, Brown A, Hunnell J, et al. The development of a revised Canadian myalgic encephalomyelitis chronic fatigue syndrome case definition. Am J Biochem Biotechnol. 2010;6(2):120&#x2013;135. doi: 10.3844/ajbbsp.2010.120.135.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3844/ajbbsp.2010.120.135</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Populations; Institute of Medicine. In: Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. Washington: National Academies Press; p. 148&#x2013;50. 2015. https://www.ncbi.nlm.nih.gov/books/NBK284894/. Accessed 14 Nov 2022.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes Rivera M, Mastronardi C, Silva-Aldana C, Arcos-Burgos M, Lidbury B. Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review. Diagnostics. 2019;9(3):91. doi: 10.3390/diagnostics9030091.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics9030091</ArticleId><ArticleId IdType=\"pmc\">PMC6787585</ArticleId><ArticleId IdType=\"pubmed\">31394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheibenbogen C, Freitag H, Blanco J, Capelli E, Lacerda E, Authier J, et al. The European ME/CFS biomarker landscape project: an initiative of the European network EUROMENE. J Transl Med. 2017;15(1):1. doi: 10.1186/s12967-017-1263-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-017-1263-z</ArticleId><ArticleId IdType=\"pmc\">PMC5530475</ArticleId><ArticleId IdType=\"pubmed\">28747192</ArticleId></ArticleIdList></Reference><Reference><Citation>Cliff JM, King EC, Lee JS, Sepulveda N, Wolf AS, Kingdon C, et al. Cellular immune function in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Front Immunol. 2019;10:796. doi: 10.3389/fimmu.2019.00796.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2019.00796</ArticleId><ArticleId IdType=\"pmc\">PMC6477089</ArticleId><ArticleId IdType=\"pubmed\">31057538</ArticleId></ArticleIdList></Reference><Reference><Citation>Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J, et al. Screening NK-, B- and T-cell phenotype and function in patients suffering from chronic fatigue syndrome. J Transl Med. 2013;11:68. doi: 10.1186/1479-5876-11-68.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-11-68</ArticleId><ArticleId IdType=\"pmc\">PMC3614537</ArticleId><ArticleId IdType=\"pubmed\">23514202</ArticleId></ArticleIdList></Reference><Reference><Citation>Mawle AC, Nisenbaum R, Dobbins JG, Gary HE, Jr, Stewart JA, Reyes M, et al. Immune responses associated with chronic fatigue syndrome: a case&#x2013;control study. J Infect Dis. 1997;175(1):136&#x2013;141. doi: 10.1093/infdis/175.1.136.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/infdis/175.1.136</ArticleId><ArticleId IdType=\"pubmed\">8985207</ArticleId></ArticleIdList></Reference><Reference><Citation>Theorell J, Bileviciute-Ljungar I, Tesi B, Schlums H, Johnsgaard MS, Asadi-Azarbaijani B, et al. Unperturbed cytotoxic lymphocyte phenotype and function in myalgic encephalomyelitis/chronic fatigue syndrome patients. Front Immunol. 2017;8:723. doi: 10.3389/fimmu.2017.00723.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2017.00723</ArticleId><ArticleId IdType=\"pmc\">PMC5483846</ArticleId><ArticleId IdType=\"pubmed\">28694809</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, Staines DR, Baskurt OK, Ashton KJ, Ramos SB, Christy RM, et al. Immune and hemorheological changes in chronic fatigue syndrome. J Transl Med. 2010;8:1. doi: 10.1186/1479-5876-8-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-8-1</ArticleId><ArticleId IdType=\"pmc\">PMC2829521</ArticleId><ArticleId IdType=\"pubmed\">20064266</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, et al. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med. 2012;10:88. doi: 10.1186/1479-5876-10-88.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-10-88</ArticleId><ArticleId IdType=\"pmc\">PMC3464733</ArticleId><ArticleId IdType=\"pubmed\">22571715</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, et al. Immunological abnormalities as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med. 2011;9:81. doi: 10.1186/1479-5876-9-81.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-9-81</ArticleId><ArticleId IdType=\"pmc\">PMC3120691</ArticleId><ArticleId IdType=\"pubmed\">21619669</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher MA, Zeng XR, Maher K, Levis S, Hurwitz B, Antoni M, et al. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. PLoS ONE. 2010;5(5):e10817. doi: 10.1371/journal.pone.0010817.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0010817</ArticleId><ArticleId IdType=\"pmc\">PMC2876037</ArticleId><ArticleId IdType=\"pubmed\">20520837</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher KJ, Klimas NG, Fletcher MA. Chronic fatigue syndrome is associated with diminished intracellular perforin. Clin Exp Immunol. 2005;142(3):505&#x2013;511. doi: 10.1111/j.1365-2249.2005.02935.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2249.2005.02935.x</ArticleId><ArticleId IdType=\"pmc\">PMC1440524</ArticleId><ArticleId IdType=\"pubmed\">16297163</ArticleId></ArticleIdList></Reference><Reference><Citation>See DM, Cimoch P, Chou S, Chang J, Tilles J. The in vitro immunomodulatory effects of glyconutrients on peripheral blood mononuclear cells of patients with chronic fatigue syndrome. Integr Physiol Behav Sci. 1998;33(3):280&#x2013;287. doi: 10.1007/BF02688668.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/BF02688668</ArticleId><ArticleId IdType=\"pubmed\">9829439</ArticleId></ArticleIdList></Reference><Reference><Citation>Huth TK, Brenu EW, Ramos S, Nguyen T, Broadley S, Staines D, et al. Pilot study of natural killer cells in chronic fatigue syndrome/myalgic encephalomyelitis and multiple sclerosis. Scand J Immunol. 2016;83(1):44&#x2013;51. doi: 10.1111/sji.12388.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/sji.12388</ArticleId><ArticleId IdType=\"pubmed\">26381393</ArticleId></ArticleIdList></Reference><Reference><Citation>Falkenberg VR, Whistler T, Murray JR, Unger ER, Rajeevan MS. Acute psychosocial stress-mediated changes in the expression and methylation of perforin in chronic fatigue syndrome. Genet Epigenet. 2013;5:1&#x2013;9. doi: 10.4137/GEG.S10944.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4137/GEG.S10944</ArticleId><ArticleId IdType=\"pmc\">PMC4222335</ArticleId><ArticleId IdType=\"pubmed\">25512702</ArticleId></ArticleIdList></Reference><Reference><Citation>Querec TD, Abrams J, Stewart JJ, Barnes Z, Balbin E, Klimas N, et al. Evaluation of natural killer cell assay performance on shipped blood specimens. J Immunol Methods. 2021;495:113049. doi: 10.1016/j.jim.2021.113049.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jim.2021.113049</ArticleId><ArticleId IdType=\"pubmed\">33819446</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger ER, Lin JS, Tian H, Natelson BH, Lange G, Vu D, et al. Multi-site clinical assessment of myalgic encephalomyelitis/chronic fatigue syndrome (MCAM): design and implementation of a prospective/retrospective rolling cohort study. Am J Epidemiol. 2017;185(8):617&#x2013;626. doi: 10.1093/aje/kwx029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/aje/kwx029</ArticleId><ArticleId IdType=\"pmc\">PMC5565838</ArticleId><ArticleId IdType=\"pubmed\">28338983</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, et al. The patient-reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care. 2007;45(5 Suppl 1):S3&#x2013;S11. doi: 10.1097/01.mlr.0000258615.42478.55.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/01.mlr.0000258615.42478.55</ArticleId><ArticleId IdType=\"pmc\">PMC2829758</ArticleId><ArticleId IdType=\"pubmed\">17443116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114(1&#x2013;3):163&#x2013;173. doi: 10.1016/j.jad.2008.06.026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jad.2008.06.026</ArticleId><ArticleId IdType=\"pubmed\">18752852</ArticleId></ArticleIdList></Reference><Reference><Citation>Smets EM, Garssen B, Bonke B, De Haes JC. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315&#x2013;325. doi: 10.1016/0022-3999(94)00125-O.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0022-3999(94)00125-O</ArticleId><ArticleId IdType=\"pubmed\">7636775</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092&#x2013;1097. doi: 10.1001/archinte.166.10.1092.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType=\"pubmed\">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner D, Nisenbaum R, Heim C, Jones JF, Unger ER, Reeves WC. Psychometric properties of the CDC symptom inventory for assessment of chronic fatigue syndrome. Popul Health Metr. 2005;3:8. doi: 10.1186/1478-7954-3-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1478-7954-3-8</ArticleId><ArticleId IdType=\"pmc\">PMC1183246</ArticleId><ArticleId IdType=\"pubmed\">16042777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473&#x2013;483. doi: 10.1097/00005650-199206000-00002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00005650-199206000-00002</ArticleId><ArticleId IdType=\"pubmed\">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE. SF-36 health survey update. Spine. 2000;25(24):3130&#x2013;3139. doi: 10.1097/00007632-200012150-00008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00007632-200012150-00008</ArticleId><ArticleId IdType=\"pubmed\">11124729</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson M, Sergeant E, Nunes T, Heuer C, Marshall J, Sanchez J, et al. epiR: tools for the analysis of epidemiological data. R package version 2.0.26; 2018.</Citation></Reference><Reference><Citation>Wickham H. ggplot2: elegant graphics for data analysis. R package version 3.3.5. New York: Springer-Verlag; 2016.</Citation></Reference><Reference><Citation>See DM, Broumand N, Sahl L, Tilles JG. In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology. 1997;35(3):229&#x2013;235. doi: 10.1016/S0162-3109(96)00125-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0162-3109(96)00125-7</ArticleId><ArticleId IdType=\"pubmed\">9043936</ArticleId></ArticleIdList></Reference><Reference><Citation>See DM, Tilles JG. Alpha-interferon treatment of patients with chronic fatigue syndrome. Immunol Invest. 1996;25(1&#x2013;2):153&#x2013;164. doi: 10.3109/08820139609059298.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/08820139609059298</ArticleId><ArticleId IdType=\"pubmed\">8675231</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker E, Fujimura SF, Fadem MB, Landay AL, Levy JA. Immunological abnormalities associated with chronic fatigue syndrome. Clin Infect Dis. 1994;18:S136&#x2013;S141. doi: 10.1093/clinids/18.Supplement_1.S136.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/clinids/18.Supplement_1.S136</ArticleId><ArticleId IdType=\"pubmed\">8148441</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Curated\"><PMID Version=\"1\">37012343</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2045-2322</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>03</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Sex differences in post-exercise fatigue and function in myalgic encephalomyelitis/chronic fatigue syndrome.</ArticleTitle><Pagination><StartPage>5442</StartPage><MedlinePgn>5442</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">5442</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/s41598-023-32581-w</ELocationID><Abstract><AbstractText>To assess biobehavioral sex differences in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) utilizing a low burden exercise protocol, 22 females and 15 males with ME/CFS and 14 healthy controls underwent two six-min walk tests. Fifteen daily assessments were scheduled for fatigue and function ratings and heart monitoring. Six-min walk tests were conducted on days 8 and 9. The ME/CFS group showed high self-report fatigue and impaired physical function, whereas healthy controls did not show fatigue or function abnormalities. In patients, no significant post-exercise changes were found for heart rate variability (HRV); however, heart rate decreased in ME/CFS males from Day 14 to Day 15 (p&#x2009;=&#x2009;0.046). Female patients showed increased fatigue (p&#x2009;=&#x2009;0.006) after the initial walk test, but a downward slope (p&#x2009;=&#x2009;0.008) in fatigue following the second walk test. Male patients showed a decrease in self-report work limitation in the days after exercise (p&#x2009;=&#x2009;0.046). The healthy control group evidenced a decrease in HRV after the walk tests from Day 9-14 (p&#x2009;=&#x2009;0.038). This pilot study did not confirm hypotheses that females as compared to males would show slower exercise recovery on autonomic or self-report (e.g. fatigue) measures. A more exertion-sensitive test may be required to document prolonged post-exertional abnormalities in ME/CFS.Trial registration: NCT NCT03331419.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Friedberg</LastName><ForeName>Fred</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Stony Brook University, L10-060Y, 101 Nicolls Road, Stony Brook, NY, 11794-8101, USA. fred.friedberg@stonybrookmedicine.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Adamowicz</LastName><ForeName>Jenna L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Psychological and Brain Sciences, University of Iowa, 340 Iowa Avenue, G60 PBSB, Iowa City, IA, 52242, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bruckenthal</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Nursing, Health Sciences Center, Level 2, Stony Brook, NY, 11794-8240, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Milazzo</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Nursing, Health Sciences Center, Level 2, Stony Brook, NY, 11794-8240, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ramjan</LastName><ForeName>Sameera</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering Cancer Center, 641 Lexington Avenue, 7Th Floor, New York, NY, 10022, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Xiaoyue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Renaissance School of Medicine, Stony Brook University, L3-108, 101 Nicolls Road, Stony Brook, NY, 11794-8036, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Renaissance School of Medicine, Stony Brook University, L3-108, 101 Nicolls Road, Stony Brook, NY, 11794-8036, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN=\"Y\"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03331419</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN=\"Y\"><Grant><GrantID>R01 NR015850</GrantID><Acronym>NR</Acronym><Agency>NINR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D052061\">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015444\" MajorTopicYN=\"N\">Exercise</DescriptorName><QualifierName UI=\"Q000502\" MajorTopicYN=\"N\">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005080\" MajorTopicYN=\"N\">Exercise Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D010865\" MajorTopicYN=\"N\">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012727\" MajorTopicYN=\"N\">Sex Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016022\" MajorTopicYN=\"N\">Case-Control Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37012343</ArticleId><ArticleId IdType=\"pmc\">PMC10070276</ArticleId><ArticleId IdType=\"doi\">10.1038/s41598-023-32581-w</ArticleId><ArticleId IdType=\"pii\">10.1038/s41598-023-32581-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Montague TJ, Marrie TJ, Klassen GA, Bewick DJ, Horacek BM. Cardiac function at rest and with exercise in the chronic fatigue syndrome. Chest. 1989;95(4):779&#x2013;784. doi: 10.1378/chest.95.4.779.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1378/chest.95.4.779</ArticleId><ArticleId IdType=\"pubmed\">2924607</ArticleId></ArticleIdList></Reference><Reference><Citation>Black CD, O\\'Connor PJ, McCully KK. Increased daily physical activity and fatigue symptoms in chronic fatigue syndrome. Dyn. Med. 2005;4(1):3. doi: 10.1186/1476-5918-4-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1476-5918-4-3</ArticleId><ArticleId IdType=\"pmc\">PMC555551</ArticleId><ArticleId IdType=\"pubmed\">15745455</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson PK, Sirr SA, Grammith FC, Schenck CH, Pheley AM, Hu S, et al. Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome patients. Clin. Diagn. Lab. Immunol. 1994;1(2):222&#x2013;226. doi: 10.1128/cdli.1.2.222-226.1994.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/cdli.1.2.222-226.1994</ArticleId><ArticleId IdType=\"pmc\">PMC368231</ArticleId><ArticleId IdType=\"pubmed\">7496949</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley MS, O\\'Brien CJ, McCluskey DR, Bell NP, Nicholls DP. Aerobic work capacity in patients with chronic fatigue syndrome. BMJ. 1990;301(6758):953&#x2013;956. doi: 10.1136/bmj.301.6758.953.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.301.6758.953</ArticleId><ArticleId IdType=\"pmc\">PMC1664147</ArticleId><ArticleId IdType=\"pubmed\">2249024</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer JD, Light AR, Shukla SK, Clevidence D, Yale S, Stegner AJ, et al. Post-exertion malaise in chronic fatigue syndrome: Symptoms and gene expression. Fatigue. 2013;1(4):190&#x2013;209.</Citation></Reference><Reference><Citation>Keech A, Sandler CX, Vollmer-Conna U, Cvejic E, Lloyd AR, Barry BK. Capturing the post-exertional exacerbation of fatigue following physical and cognitive challenge in patients with chronic fatigue syndrome. J. Psychosom. Res. 2015;79(6):537&#x2013;549. doi: 10.1016/j.jpsychores.2015.08.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jpsychores.2015.08.008</ArticleId><ArticleId IdType=\"pubmed\">26359713</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook DB, Stegner AJ, Nagelkirk PR, Meyer JD, Togo F, Natelson BH. Responses to exercise differ for chronic fatigue syndrome patients with fibromyalgia. Med. Sci. Sports Exerc. 2012;44(6):1186&#x2013;1193. doi: 10.1249/MSS.0b013e3182417b9a.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1249/MSS.0b013e3182417b9a</ArticleId><ArticleId IdType=\"pmc\">PMC3319493</ArticleId><ArticleId IdType=\"pubmed\">22157881</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohashi K, Yamamoto Y, Natelson BH. Activity rhythm degrades after strenuous exercise in chronic fatigue syndrome. Physiol. Behav. 2002;77(1):39&#x2013;44. doi: 10.1016/S0031-9384(02)00808-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0031-9384(02)00808-9</ArticleId><ArticleId IdType=\"pubmed\">12213500</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanness JM, Snell CR, Stevens SR. Diminished cardiopulmonary capacity during post-exertional malaise. J. Chronic Fatigue Syndr. 2007;14(2):77&#x2013;85. doi: 10.1300/J092v14n02_07.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v14n02_07</ArticleId></ArticleIdList></Reference><Reference><Citation>LaManca JJ, Sisto SA, DeLuca J, Johnson SK, Lange G, Pareja J, et al. Influence of exhaustive treadmill exercise on cognitive functioning in chronic fatigue syndrome. Am. J. Med. 1998;105(3a):59s&#x2013;65s. doi: 10.1016/S0002-9343(98)00171-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0002-9343(98)00171-5</ArticleId><ArticleId IdType=\"pubmed\">9790484</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammes Y, Steinberg JG, Delliaux S, Br&#xe9;geon F. Chronic fatigue syndrome combines increased exercise-induced oxidative stress and reduced cytokine and Hsp responses. J. Intern. Med. 2009;266(2):196&#x2013;206. doi: 10.1111/j.1365-2796.2009.02079.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2796.2009.02079.x</ArticleId><ArticleId IdType=\"pubmed\">19457057</ArticleId></ArticleIdList></Reference><Reference><Citation>VanNess JM, Stevens SR, Bateman L, Stiles TL, Snell CR. Postexertional malaise in women with chronic fatigue syndrome. J. Womens Health. 2010;19(2):239&#x2013;244. doi: 10.1089/jwh.2009.1507.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/jwh.2009.1507</ArticleId><ArticleId IdType=\"pubmed\">20095909</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedberg F, Adamowicz JL, Bruckenthal P, Milazzo M, Ramjan S, Quintana D. Nonimprovement in chronic fatigue syndrome: Relation to activity patterns, uplifts and hassles, and autonomic dysfunction. Psychosom. Med. 2022;84(6):669&#x2013;678. doi: 10.1097/PSY.0000000000001082.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/PSY.0000000000001082</ArticleId><ArticleId IdType=\"pmc\">PMC9271593</ArticleId><ArticleId IdType=\"pubmed\">35420586</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller BA, Pryor JL, Giloteaux L. Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO2 peak indicates functional impairment. J. Transl. Med. 2014;12:104. doi: 10.1186/1479-5876-12-104.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-12-104</ArticleId><ArticleId IdType=\"pmc\">PMC4004422</ArticleId><ArticleId IdType=\"pubmed\">24755065</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazelmans E, Bleijenberg G, Van Der Meer JW, Folgering H. Is physical deconditioning a perpetuating factor in chronic fatigue syndrome? A controlled study on maximal exercise performance and relations with fatigue, impairment and physical activity. Psychol. Med. 2001;31(1):107&#x2013;114. doi: 10.1017/S0033291799003189.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S0033291799003189</ArticleId><ArticleId IdType=\"pubmed\">11200949</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson MJ, Buckley JD, Thomson RL, Bellenger CR, Davison K. Markers of cardiac autonomic function during consecutive day peak exercise tests in people with myalgic encephalomyelitis/chronic fatigue syndrome. Front. Physiol. 2021;12:771899. doi: 10.3389/fphys.2021.771899.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2021.771899</ArticleId><ArticleId IdType=\"pmc\">PMC8713453</ArticleId><ArticleId IdType=\"pubmed\">34970156</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Oosterwijck J, Marusic U, De Wandele I, Meeus M, Paul L, Lambrecht L, Moorkens G, Danneels L, Nijs J. Reduced parasympathetic reactivation during recovery from exercise in myalgic encephalomyelitis/chronic fatigue syndrome. J. Clin. Med. 2021;10:4527. doi: 10.3390/jcm10194527.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm10194527</ArticleId><ArticleId IdType=\"pmc\">PMC8509376</ArticleId><ArticleId IdType=\"pubmed\">34640544</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RR, Reid WD, Mattman A, Yamabayashi C, Steiner T, Parker S, et al. Submaximal exercise testing with near-infrared spectroscopy in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients compared to healthy controls: A case-control study. J. Transl. Med. 2015;13:159. doi: 10.1186/s12967-015-0527-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-015-0527-8</ArticleId><ArticleId IdType=\"pmc\">PMC4438583</ArticleId><ArticleId IdType=\"pubmed\">25990639</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason JA, Taylor R, Wagner L, Holden J, Farrari JR, Pliplys AV, Plioplys S, Lipkin D, Papernik M. Estimating rates of chronic fatigue syndrome from a community-based sample: A pilot study. Am. J. Community Psychol. 1995;23(4):557&#x2013;568. doi: 10.1007/BF02506968.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/BF02506968</ArticleId><ArticleId IdType=\"pubmed\">8546110</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult. Scler. 2008;14(3):383&#x2013;390. doi: 10.1177/1352458507082607.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1352458507082607</ArticleId><ArticleId IdType=\"pubmed\">17942508</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedberg F, Adamowicz J, Caikauskaite I, Seva V, Napoli A. Efficacy of two delivery modes of behavioral self-management in severe chronic fatigue syndrome. Fatigue. 2016;4(3):158&#x2013;174.</Citation></Reference><Reference><Citation>Friedberg F, Sohl SJ. Longitudinal change in chronic fatigue syndrome: What home-based assessments reveal. J. Behav. Med. 2009;32(2):209&#x2013;218. doi: 10.1007/s10865-008-9189-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10865-008-9189-9</ArticleId><ArticleId IdType=\"pubmed\">19101789</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendig H, Browning CJ, Young AE. Impacts of illness and disability on the well-being of older people. Disabil. Rehabil. 2000;22(1&#x2013;2):15&#x2013;22. doi: 10.1080/096382800297088.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/096382800297088</ArticleId><ArticleId IdType=\"pubmed\">10661754</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann. Intern. Med. 1994;121(12):953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType=\"pubmed\">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>King C, Jason LA. Improving the diagnostic criteria and procedures for chronic fatigue syndrome. Biol. Psychol. 2005;68(2):87&#x2013;106. doi: 10.1016/j.biopsycho.2004.03.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopsycho.2004.03.015</ArticleId><ArticleId IdType=\"pubmed\">15450690</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol. 1989;46(10):1121&#x2013;1123. doi: 10.1001/archneur.1989.00520460115022.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archneur.1989.00520460115022</ArticleId><ArticleId IdType=\"pubmed\">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor R, Jason LA, Torres A. Fatigue rating scales: An empirical comparison. Psychol. Med. 2000;30(4):849&#x2013;856. doi: 10.1017/S0033291799002500.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S0033291799002500</ArticleId><ArticleId IdType=\"pubmed\">11037093</ArticleId></ArticleIdList></Reference><Reference><Citation>Antony MM, Bieling PJ, Cox BJ, Enns MW, Swinson RP. Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. Psychol. Assess. 1998;10(2):176. doi: 10.1037/1040-3590.10.2.176.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1037/1040-3590.10.2.176</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasquez LM, McBride JM, Paul JA, Alley JR, Carson LT, Goodman CL. Effect of resistance exercise performed to volitional failure on ratings of perceived exertion. Percept Mot. Skills. 2013;117(3):881&#x2013;891. doi: 10.2466/27.29.PMS.117x30z8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2466/27.29.PMS.117x30z8</ArticleId><ArticleId IdType=\"pubmed\">24665804</ArticleId></ArticleIdList></Reference><Reference><Citation>Du H, Newton PJ, Salamonson Y, Carrieri-Kohlman VL, Davidson PM. A review of the six-minute walk test: Its implication as a self-administered assessment tool. Eur. J. Cardiovasc. Nurs. 2009;8(1):2&#x2013;8. doi: 10.1016/j.ejcnurse.2008.07.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejcnurse.2008.07.001</ArticleId><ArticleId IdType=\"pubmed\">18694656</ArticleId></ArticleIdList></Reference><Reference><Citation>Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. Br. Med. J. (Clin. Res. Ed.) 1982;284(6329):1607&#x2013;1608. doi: 10.1136/bmj.284.6329.1607.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.284.6329.1607</ArticleId><ArticleId IdType=\"pmc\">PMC1498516</ArticleId><ArticleId IdType=\"pubmed\">6805625</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan J, Tompkins WJ. A real-time QRS detection algorithm. IEEE Trans. Biomed. Eng. 1985;3:230&#x2013;236. doi: 10.1109/TBME.1985.325532.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1109/TBME.1985.325532</ArticleId><ArticleId IdType=\"pubmed\">3997178</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarvainen MP, Niskanen J-P, Lipponen JA, Ranta-Aho PO, Karjalainen PA. Kubios HRV&#x2013;heart rate variability analysis software. Comput. Methods Programs Biomed. 2014;113(1):210&#x2013;220. doi: 10.1016/j.cmpb.2013.07.024.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmpb.2013.07.024</ArticleId><ArticleId IdType=\"pubmed\">24054542</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffer F, McCraty R, Zerr CL. A healthy heart is not a metronome: An integrative review of the heart\\'s anatomy and heart rate variability. Front. Psychol. 2014;5:1040. doi: 10.3389/fpsyg.2014.01040.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fpsyg.2014.01040</ArticleId><ArticleId IdType=\"pmc\">PMC4179748</ArticleId><ArticleId IdType=\"pubmed\">25324790</ArticleId></ArticleIdList></Reference><Reference><Citation>Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger A, Cohen RJ. Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control. Science. 1981;213(4504):220&#x2013;222. doi: 10.1126/science.6166045.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.6166045</ArticleId><ArticleId IdType=\"pubmed\">6166045</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik M, Bigger JT, Camm AJ, Kleiger RE, Malliani A, Moss AJ, et al. Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Eur. Heart J. 1996;17(3):354&#x2013;381. doi: 10.1093/oxfordjournals.eurheartj.a014868.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/oxfordjournals.eurheartj.a014868</ArticleId><ArticleId IdType=\"pubmed\">8737210</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q. Hands-on tutorial for piecewise linear mixed-effects models using SAS&#xae; PROC MIXED. PharmaSUG China. 2015;8:2015.</Citation></Reference><Reference><Citation>Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis. Wiley; 2012.</Citation></Reference><Reference><Citation>Conroy KE, Islam MF, Jason LA. Evaluating case diagnostic criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Toward an empirical case definition. Disabil. Rehabil. 2023;45(5):840&#x2013;847. doi: 10.1080/09638288.2022.2043462.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/09638288.2022.2043462</ArticleId><ArticleId IdType=\"pmc\">PMC9437146</ArticleId><ArticleId IdType=\"pubmed\">35236205</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson MJ, Bahl JS, Buckley JD, Thomson RL, Davison K. Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis. Medicine. 2019;98(43):e17600. doi: 10.1097/MD.0000000000017600.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MD.0000000000017600</ArticleId><ArticleId IdType=\"pmc\">PMC6824690</ArticleId><ArticleId IdType=\"pubmed\">31651868</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper KH. A means of assessing maximal oxygen intake. Correlation between field and treadmill testing. JAMA. 1968;203:201&#x2013;204. doi: 10.1001/jama.1968.03140030033008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.1968.03140030033008</ArticleId><ArticleId IdType=\"pubmed\">5694044</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendonca GV, Heffernan KS, Rossow L, Guerra M, Pereira FD, Fernhall B. Sex differences in linear and nonlinear heart rate variability during early recovery from supramaximal exercise. Appl. Physiol. Nutr. Metab. 2010;35(S1):439&#x2013;446. doi: 10.1139/H10-028.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1139/H10-028</ArticleId><ArticleId IdType=\"pubmed\">20725109</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter R, Watenpaugh DE, Smith ML. Selected contribution: Gender differences in cardiovascular regulation during recovery from exercise. J. Appl. Physiol. 2001;91(4):1902&#x2013;1907. doi: 10.1152/jappl.2001.91.4.1902.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/jappl.2001.91.4.1902</ArticleId><ArticleId IdType=\"pubmed\">11568178</ArticleId></ArticleIdList></Reference><Reference><Citation>van Wijk CM, Kolk AM. Sex differences in physical symptoms: The contribution of symptom perception theory. Soc. Sci. Med. 1997;45(2):231&#x2013;246. doi: 10.1016/S0277-9536(96)00340-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0277-9536(96)00340-1</ArticleId><ArticleId IdType=\"pubmed\">9225411</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshiuchi K, Cook DB, Ohashi K, Kumano H, Kuboki T, Yamamoto Y, et al. A real-time assessment of the effect of exercise in chronic fatigue syndrome. Physiol. Behav. 2007;92(5):963&#x2013;968. doi: 10.1016/j.physbeh.2007.07.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.physbeh.2007.07.001</ArticleId><ArticleId IdType=\"pmc\">PMC2170105</ArticleId><ArticleId IdType=\"pubmed\">17655887</ArticleId></ArticleIdList></Reference><Reference><Citation>Young HA, Benton D. Heart-rate variability: A biomarker to study the influence of nutrition on physiological and psychological health? Behav. Pharmacol. 2018;29(2 and 3-Spec Issue):140&#x2013;151. doi: 10.1097/FBP.0000000000000383.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/FBP.0000000000000383</ArticleId><ArticleId IdType=\"pmc\">PMC5882295</ArticleId><ArticleId IdType=\"pubmed\">29543648</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunan D, Sandercock GR, Brodie DA. A quantitative systematic review of normal values for short-term heart rate variability in healthy adults. Pacing Clin. Electrophysiol. 2010;33(11):1407&#x2013;1417. doi: 10.1111/j.1540-8159.2010.02841.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1540-8159.2010.02841.x</ArticleId><ArticleId IdType=\"pubmed\">20663071</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Cauwenbergh D, Nijs J, Kos D, Van Weijnen L, Struyf F, Meeus M. Malfunctioning of the autonomic nervous system in patients with chronic fatigue syndrome: A systematic literature review. Eur. J. Clin. Invest. 2014;44(5):516&#x2013;526. doi: 10.1111/eci.12256.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/eci.12256</ArticleId><ArticleId IdType=\"pubmed\">24601948</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">36984572</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1648-9144</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>59</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>Recovery from Exercise in Persons with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">571</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/medicina59030571</ELocationID><Abstract><AbstractText><i>Background and Objectives</i>: Post-exertional malaise (PEM) is the hallmark of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), but there has been little effort to quantitate the duration of PEM symptoms following a known exertional stressor. Using a Symptom Severity Scale (SSS) that includes nine common symptoms of ME/CFS, we sought to characterize the duration and severity of PEM symptoms following two cardiopulmonary exercise tests separated by 24 h (2-day CPET). <i>Materials and Methods</i>: Eighty persons with ME/CFS and 64 controls (CTL) underwent a 2-day CPET. ME/CFS subjects met the Canadian Clinical Criteria for diagnosis of ME/CFS; controls were healthy but not participating in regular physical activity. All subjects who met maximal effort criteria on both CPETs were included. SSS scores were obtained at baseline, immediately prior to both CPETs, the day after the second CPET, and every two days after the CPET-1 for 10 days. <i>Results</i>: There was a highly significant difference in judged recovery time (ME/CFS = 12.7 &#xb1; 1.2 d; CTL = 2.1 &#xb1; 0.2 d, mean &#xb1; s.e.m., Chi<sup>2</sup> = 90.1, <i>p</i> &lt; 0.0001). The range of ME/CFS patient recovery was 1-64 days, while the range in CTL was 1-10 days; one subject with ME/CFS had not recovered after one year and was not included in the analysis. Less than 10% of subjects with ME/CFS took more than three weeks to recover. There was no difference in recovery time based on the level of pre-test symptoms prior to CPET-1 (F = 1.12, <i>p</i> = 0.33). Mean SSS scores at baseline were significantly higher than at pre-CPET-1 (5.70 &#xb1; 0.16 vs. 4.02 &#xb1; 0.18, <i>p</i> &lt; 0.0001). Pharmacokinetic models showed an extremely prolonged decay of the PEM response (Chi<sup>2</sup> &gt; 22, <i>p</i> &lt; 0.0001) to the 2-day CPET. <i>Conclusions</i>: ME/CFS subjects took an average of about two weeks to recover from a 2-day CPET, whereas sedentary controls needed only two days. These data quantitate the prolonged recovery time in ME/CFS and improve the ability to obtain well-informed consent prior to doing exercise testing in persons with ME/CFS. Quantitative monitoring of PEM symptoms may provide a method to help manage PEM.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Moore</LastName><ForeName>Geoffrey E</ForeName><Initials>GE</Initials><Identifier Source=\"ORCID\">0000-0002-5243-8106</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Keller</LastName><ForeName>Betsy A</ForeName><Initials>BA</Initials><Identifier Source=\"ORCID\">0000-0002-4927-5852</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Exercise Science &amp; Athletic Training, Ithaca College, Ithaca, NY 14850, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stevens</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Workwell Foundation, Ripon, CA 95366, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mao</LastName><ForeName>Xiangling</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Radiology, Weill Cornell Medical College, New York, NY 10021, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stevens</LastName><ForeName>Staci R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Workwell Foundation, Ripon, CA 95366, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chia</LastName><ForeName>John K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>EVMED Research, Torrance, CA 90505, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Levine</LastName><ForeName>Susan M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Medical Office of Susan Levine, Manhattan, NY 10021, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Franconi</LastName><ForeName>Carl J</ForeName><Initials>CJ</Initials><Identifier Source=\"ORCID\">0000-0001-5396-0935</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hanson</LastName><ForeName>Maureen R</ForeName><Initials>MR</Initials><Identifier Source=\"ORCID\">0000-0001-8141-3058</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>U54 NS105541</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002170\" MajorTopicYN=\"N\" Type=\"Geographic\">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015444\" MajorTopicYN=\"N\">Exercise</DescriptorName><QualifierName UI=\"Q000502\" MajorTopicYN=\"N\">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005080\" MajorTopicYN=\"N\">Exercise Test</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">2-day cardiopulmonary exercise test</Keyword><Keyword MajorTopicYN=\"N\">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">exercise recovery</Keyword><Keyword MajorTopicYN=\"N\">myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN=\"N\">post-exertional malaise</Keyword><Keyword MajorTopicYN=\"N\">specific symptom severity</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">36984572</ArticleId><ArticleId IdType=\"pmc\">PMC10059925</ArticleId><ArticleId IdType=\"doi\">10.3390/medicina59030571</ArticleId><ArticleId IdType=\"pii\">medicina59030571</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carruthers B.M., Jain A.K., De Meirleir K.L., Peterson D.L., Klimas N.G., Lerner A.M., Bested A.C., Flor-Henry P., Joshi P., Powles A.P., et al. Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols. J. Chronic Fatigue Syndr. 2003;11:7&#x2013;115. doi: 10.1300/J092v11n01_02.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>IOM (Institute of Medicine) Beyond Myalgic Encepha-Lomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. The National Academies Press; Washington, DC, USA: 2015.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport T.E., Stevens S.R., Stevens J., Snell C.R., Van Ness J.M. Properties of measurements obtained during cardiopulmonary exercise testing in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Work. 2020;66:247&#x2013;256. doi: 10.3233/WOR-203170.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/WOR-203170</ArticleId><ArticleId IdType=\"pubmed\">32568145</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport T.E., Lehnen M., Stevens S.R., VanNess J.M., Stevens J., Snell C.R. Chronotropic intolerance: An overlooked determinant of symptoms and activity limitation in myalgic encephalomyelitis/chronic fatigue syndrome? Front. Pediatr. 2019;7:82. doi: 10.3389/fped.2019.00082.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2019.00082</ArticleId><ArticleId IdType=\"pmc\">PMC6439478</ArticleId><ArticleId IdType=\"pubmed\">30968005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien K., Johansen B., Veier&#xf8;d M.B., Haslestad A.S., B&#xf8;hn S.K., Melsom M.N., Kardel K.R., Iversen P.O. Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis/chronic fatigue syndrome. Physiol. Rep. 2019;7:14138. doi: 10.14814/phy2.14138.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14814/phy2.14138</ArticleId><ArticleId IdType=\"pmc\">PMC6546966</ArticleId><ArticleId IdType=\"pubmed\">31161646</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson M.J., Buckley J.D., Thomson R.L., Clark D., Kwiatek R., Davison K. Diagnostic sensitivity of 2-day cardiopulmonary exercise testing in myalgic encephalomyelitis / chronic fatigue syndrome. J. Transl. Med. 2019;17:80. doi: 10.1186/s12967-019-1836-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-019-1836-0</ArticleId><ArticleId IdType=\"pmc\">PMC6417168</ArticleId><ArticleId IdType=\"pubmed\">30871578</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens S., Snell C., Stevens J., Keller B., VanNess J.M. Cardiopulmonary exercise test methodology for assessing exertion intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Front. Pediatr. 2018;6:242. doi: 10.3389/fped.2018.00242.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2018.00242</ArticleId><ArticleId IdType=\"pmc\">PMC6131594</ArticleId><ArticleId IdType=\"pubmed\">30234078</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateo L.J., Chu L., Stevens S., Stevens J., Snell C.R., Davenport T., Van Ness J.M. Post-exertional symptoms distinguish myalgic encephalomyelitis/chronic fatigue syndrome subjects from healthy controls. Work. 2020;66:265&#x2013;275. doi: 10.3233/WOR-203168.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/WOR-203168</ArticleId><ArticleId IdType=\"pubmed\">32568143</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraniuk J.N., Adewuyi O., Merck S.J., Ali M., Ravindran M.K., Timbol C.R., Rayhan R., Zheng Y., Le U., Esteitie R., et al. A chronic fatigue syndrome (CFS) severity score based on case designation criteria. Am. J. Transl. Res. 2013;5:53&#x2013;68.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3560481</ArticleId><ArticleId IdType=\"pubmed\">23390566</ArticleId></ArticleIdList></Reference><Reference><Citation>Haskell W.L., Wolffe J.B. Memorial Lecture. Health consequences of physical activity: Understanding and challenges regarding dose-response. Med. Sci. Sports Exerc. 1994;26:649&#x2013;660. doi: 10.1249/00005768-199406000-00001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1249/00005768-199406000-00001</ArticleId><ArticleId IdType=\"pubmed\">8052103</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindlon T. Do graded activity therapies cause harm in chronic fatigue syndrome? J. Health Psychol. 2017;22:1146&#x2013;1154. doi: 10.1177/1359105317697323.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1359105317697323</ArticleId><ArticleId IdType=\"pubmed\">28805516</ArticleId></ArticleIdList></Reference><Reference><Citation>McPhee G., Baldwin A., Kindlon T., Hughes B.M. Monitoring treatment harm in myalgic encephalomyelitis/chronic fatigue syndrome: A freedom-of-information study of National Health Service specialist centres in England. J. Health Psychol. 2021;26:975&#x2013;984. doi: 10.1177/1359105319854532.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1359105319854532</ArticleId><ArticleId IdType=\"pubmed\">31234662</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris P.A., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J.G. Research electronic data capture (REDCap)&#x2014;A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 2009;42:377&#x2013;381. doi: 10.1016/j.jbi.2008.08.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType=\"pmc\">PMC2700030</ArticleId><ArticleId IdType=\"pubmed\">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris P.A., Taylor R., Minor B.L., Elliott V., Fernandez M., O&#x2019;Neal L., McLeod L., Delacqua G., Delacqua F., Kirby J., et al. The REDCap consortium: Building an international community of software partners. J. Biomed. Inform. 2019;95:103208. doi: 10.1016/j.jbi.2019.103208.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType=\"pmc\">PMC7254481</ArticleId><ArticleId IdType=\"pubmed\">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Obeid J.S., McGraw C.A., Minor B.L., Conde J.G., Pawluk R., Lin M., Wang J., Banks S.R., Hemphill S.A., Taylor R., et al. Procurement of shared data instruments for Research Electronic Data Capture (REDCap) J. Biomed. Inform. 2013;46:259&#x2013;265. doi: 10.1016/j.jbi.2012.10.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jbi.2012.10.006</ArticleId><ArticleId IdType=\"pmc\">PMC3600393</ArticleId><ArticleId IdType=\"pubmed\">23149159</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindheimer J.B., Alexander T., Qian W., Klein-Adams J.C., Lange G., HNatelson B., Cook D.B., Hill H.Z., Falvo M.J. An analysis of 2-day cardiopulmonary exercise testing to assess unexplained fatigue. Physiol. Rep. 2020;17:e14564. doi: 10.14814/phy2.14564.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14814/phy2.14564</ArticleId><ArticleId IdType=\"pmc\">PMC7507580</ArticleId><ArticleId IdType=\"pubmed\">32889791</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin M., Jacobs I. Exercise is medicine, but does it interfere with medicine? Exerc. Sport Sci. Rev. 2017;45:127&#x2013;135. doi: 10.1249/JES.0000000000000111.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1249/JES.0000000000000111</ArticleId><ArticleId IdType=\"pubmed\">28418997</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType=\"pmc\">PMC9839201</ArticleId><ArticleId IdType=\"pubmed\">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Morton R.H., Fitz-Clarke J.R., Banister E.W. Modeling human performance in running. J. Appl. Physiol. 1990;69:1171&#x2013;1177. doi: 10.1152/jappl.1990.69.3.1171.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/jappl.1990.69.3.1171</ArticleId><ArticleId IdType=\"pubmed\">2246166</ArticleId></ArticleIdList></Reference><Reference><Citation>Banister E., Morton R., Fitz-Clarke J. Dose/response of exercise modeled from training: Physical and biochemical measures. Ann. Physiol. Anthrop. 1992;11:345&#x2013;356. doi: 10.2114/ahs1983.11.345.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2114/ahs1983.11.345</ArticleId><ArticleId IdType=\"pubmed\">1642735</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">36982194</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>24</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">5124</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms24065124</ELocationID><Abstract><AbstractText>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex condition arising in susceptible people, predominantly following viral infection, but also other stressful events. The susceptibility factors discussed here are both genetic and environmental although not well understood. While the dysfunctional physiology in ME/CFS is becoming clearer, understanding has been hampered by different combinations of symptoms in each affected person. A common core set of mainly neurological symptoms forms the modern clinical case definition, in the absence of an accessible molecular diagnostic test. This landscape has prompted interest in whether ME/CFS patients can be classified into a particular phenotype/subtype that might assist better management of their illness and suggest preferred therapeutic options. Currently, the same promising drugs, nutraceuticals, or behavioral therapies available can be beneficial, have no effect, or be detrimental to each individual patient. We have shown that individuals with the same disease profile exhibit unique molecular changes and physiological responses to stress, exercise and even vaccination. Key features of ME/CFS discussed here are the possible mechanisms determining the shift of an immune/inflammatory response from transient to chronic in ME/CFS, and how the brain and CNS manifests the neurological symptoms, likely with activation of its specific immune system and resulting neuroinflammation. The many cases of the post viral ME/CFS-like condition, Long COVID, following SARS-CoV-2 infection, and the intense research interest and investment in understanding this condition, provide exciting opportunities for the development of new therapeutics that will benefit ME/CFS patients.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Tate</LastName><ForeName>Warren P</ForeName><Initials>WP</Initials><Identifier Source=\"ORCID\">0000-0002-6971-7734</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, School of Biomedical Sciences, Division of Health Sciences, University of Otago, Dunedin 9054, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Walker</LastName><ForeName>Max O M</ForeName><Initials>MOM</Initials><Identifier Source=\"ORCID\">0009-0002-0173-5482</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, School of Biomedical Sciences, Division of Health Sciences, University of Otago, Dunedin 9054, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Peppercorn</LastName><ForeName>Katie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, School of Biomedical Sciences, Division of Health Sciences, University of Otago, Dunedin 9054, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Blair</LastName><ForeName>Anna L H</ForeName><Initials>ALH</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, School of Biomedical Sciences, Division of Health Sciences, University of Otago, Dunedin 9054, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Edgar</LastName><ForeName>Christina D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, School of Biomedical Sciences, Division of Health Sciences, University of Otago, Dunedin 9054, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>no grant number</GrantID><Agency>ANZMES -NZA ME/CFS natiuonal disease advisory association</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000094024\" MajorTopicYN=\"N\">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086382\" MajorTopicYN=\"Y\">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086402\" MajorTopicYN=\"N\">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015984\" MajorTopicYN=\"N\">Causality</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Long COVID</Keyword><Keyword MajorTopicYN=\"N\">ME/CFS</Keyword><Keyword MajorTopicYN=\"N\">disease models</Keyword><Keyword MajorTopicYN=\"N\">disease subtype/phenotype</Keyword><Keyword MajorTopicYN=\"N\">neuroinflammation</Keyword><Keyword MajorTopicYN=\"N\">susceptibility</Keyword><Keyword MajorTopicYN=\"N\">systemic inflammation</Keyword><Keyword MajorTopicYN=\"N\">therapeutics</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">36982194</ArticleId><ArticleId IdType=\"pmc\">PMC10048882</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms24065124</ArticleId><ArticleId IdType=\"pii\">ijms24065124</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Walker M.O.M., Hall K.H., Peppercorn K., Tate W.P. The significance of oxidative stress in the pathophysiology of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Med. Res. Arch. 2022;10:1&#x2013;22. doi: 10.18103/mra.v10i9.3050.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18103/mra.v10i9.3050</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidbury B.A., Fisher P.R. Biomedical Insights that Inform the Diagnosis of ME/CFS. Diagnostics. 2020;10:92. doi: 10.3390/diagnostics10020092.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics10020092</ArticleId><ArticleId IdType=\"pmc\">PMC7168303</ArticleId><ArticleId IdType=\"pubmed\">32046358</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol. Med. 2021;27:895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType=\"pmc\">PMC8180841</ArticleId><ArticleId IdType=\"pubmed\">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType=\"pmc\">PMC9839201</ArticleId><ArticleId IdType=\"pubmed\">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>White P.D., Thomas J.M., Amess J., Crawford D.H., Grover S.A., Kangro H.O., Clare A.W. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br. J. Psychiatry. 1998;173:475&#x2013;481. doi: 10.1192/bjp.173.6.475.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1192/bjp.173.6.475</ArticleId><ArticleId IdType=\"pubmed\">9926075</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L.L., Routen A., Gillies C., Ekezie W., Welford A., Zhang A., Karamchandani U., Simms-Williams N., Cassambai S., Ardavani A., et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. eClinicalMedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType=\"pmc\">PMC9714474</ArticleId><ArticleId IdType=\"pubmed\">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis R.H., Santillana M., Ognyanova K., Safarpour A., Lunz Trujillo K., Simonson M.D., Green J., Quintana A., Druckman J., Baum M.A., et al. Prevalence and Correlates of Long COVID Symptoms Among US Adults. JAMA Netw. Open. 2022;5:e2238804. doi: 10.1001/jamanetworkopen.2022.38804.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType=\"pmc\">PMC9614581</ArticleId><ArticleId IdType=\"pubmed\">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama A., Miwata K., Kitahara Y., Okimoto M., Abe K., Bunthen E., Ouoba S., Akita T., Tanimine N., Ohdan H., et al. Long COVID occurrence in COVID-19 survivors. Sci. Rep. 2022;12:6039. doi: 10.1038/s41598-022-10051-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-022-10051-z</ArticleId><ArticleId IdType=\"pmc\">PMC8996498</ArticleId><ArticleId IdType=\"pubmed\">35411017</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., Sudre C.H., Molteni E., Berry S., Canas L.S., Graham M.S., Klaser K., Modat M., et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, community-based, nested, case-control study. Lancet Infect. Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType=\"pmc\">PMC8409907</ArticleId><ArticleId IdType=\"pubmed\">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson C. Counterpoint: Yes, Long COVID is Helping Chronic Fatigue Syndrome (ME/CFS)&#x2026; Health Rising Blog. 2022.  [(accessed on 22 January 2023)].  Available online:  https://www.healthrising.org/blog/2022/10/25/counterpoint-long-covid-chronic-fatigue-syndrome/</Citation></Reference><Reference><Citation>Friedman K.J., Murovska M., Pheby D.F.H., Zalewski P. Our Evolving Understanding of ME/CFS. Medicina. 2021;57:200. doi: 10.3390/medicina57030200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57030200</ArticleId><ArticleId IdType=\"pmc\">PMC7996879</ArticleId><ArticleId IdType=\"pubmed\">33652622</ArticleId></ArticleIdList></Reference><Reference><Citation>Various  Topical Collection &#x201c;Why Some Patients Never Fully Recover: Post Active Phase of Infection Syndromes (PAPIS)&#x201d;.  [(accessed on 22 January 2023)];Healthcare. 2023  Available online:  https://www.mdpi.com/journal/healthcare/topical_collections/PAPIS.</Citation></Reference><Reference><Citation>Tate W., Walker M., Sweetman E., Helliwell A., Peppercorn K., Edgar C., Blair A., Chatterjee A. Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses. Front. Neurol. 2022;13:877772. doi: 10.3389/fneur.2022.877772.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2022.877772</ArticleId><ArticleId IdType=\"pmc\">PMC9174654</ArticleId><ArticleId IdType=\"pubmed\">35693009</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair A. A Quantitative Investigation into the Personal and Family Health Histories of Long COVID and ME/CFS Patients: Identifying Susceptibility Factors and Support Needs. University of Technology Sydney; Ultimo, NSW, Australia: 2022.</Citation></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)&#x2014;A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57050418</ArticleId><ArticleId IdType=\"pmc\">PMC8145228</ArticleId><ArticleId IdType=\"pubmed\">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType=\"pmc\">PMC8478580</ArticleId><ArticleId IdType=\"pubmed\">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long COVID&#x2014;Mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.n1648</ArticleId><ArticleId IdType=\"pubmed\">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt J., Blease C., Geraghty K.J. Long Covid at the crossroads: Comparisons and lessons from the treatment of patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J. Health Psychol. 2022;27:3106&#x2013;3120. doi: 10.1177/13591053221084494.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/13591053221084494</ArticleId><ArticleId IdType=\"pubmed\">35341334</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva O.A., Maksoud R., Beeraka N.M., Madhunapantula S.V., Sinelnikov M., Nikolenko V.N., Neganova M.E., Klochkov S.G., Amjad Kamal M., Staines D.R., et al. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J. Adv. Res. 2022;40:179&#x2013;196. doi: 10.1016/j.jare.2021.11.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType=\"pmc\">PMC8619886</ArticleId><ArticleId IdType=\"pubmed\">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherardi R.K., Cr&#xe9;peaux G., Authier F.J. Myalgia and chronic fatigue syndrome following immunization: Macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system. Autoimmun. Rev. 2019;18:691&#x2013;705. doi: 10.1016/j.autrev.2019.05.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2019.05.006</ArticleId><ArticleId IdType=\"pubmed\">31059838</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron B., Flamand L., Juwana H., Middeldorp J., Naing Z., Rawlinson W., Ablashi D., Lloyd A. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome. J. Med. Virol. 2010;82:1684&#x2013;1688. doi: 10.1002/jmv.21873.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.21873</ArticleId><ArticleId IdType=\"pubmed\">20827765</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatcher S., House A. Life events, difficulties and dilemmas in the onset of chronic fatigue syndrome: A case-control study. Psychol. Med. 2003;33:1185&#x2013;1192. doi: 10.1017/S0033291703008274.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S0033291703008274</ArticleId><ArticleId IdType=\"pubmed\">14580073</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlauch K.A., Khaiboullina S.F., De Meirleir K.L., Rawat S., Petereit J., Rizvanov A.A., Blatt N., Mijatovic T., Kulick D., Palot&#xe1;s A., et al. Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome. Transl. Psychiatry. 2016;6:e730. doi: 10.1038/tp.2015.208.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/tp.2015.208</ArticleId><ArticleId IdType=\"pmc\">PMC4872418</ArticleId><ArticleId IdType=\"pubmed\">26859813</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A.K., Fang H., Whistler T., Unger E.R., Rajeevan M.S. Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome. Neuropsychobiology. 2011;64:183&#x2013;194. doi: 10.1159/000326692.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000326692</ArticleId><ArticleId IdType=\"pmc\">PMC3701888</ArticleId><ArticleId IdType=\"pubmed\">21912186</ArticleId></ArticleIdList></Reference><Reference><Citation>Dibble J.J., McGrath S.J., Ponting C.P. Genetic risk factors of ME/CFS: A critical review. Hum. Mol. Genet. 2020;29:R117&#x2013;R124. doi: 10.1093/hmg/ddaa169.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddaa169</ArticleId><ArticleId IdType=\"pmc\">PMC7530519</ArticleId><ArticleId IdType=\"pubmed\">32744306</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajdarevic R., Lande A., Mehlsen J., Rydland A., Sosa D.D., Strand E.B., Mella O., Pociot F., Fluge &#xd8;., Lie B.A., et al. Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci. Brain Behav. Immun. 2022;102:362&#x2013;369. doi: 10.1016/j.bbi.2022.03.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2022.03.010</ArticleId><ArticleId IdType=\"pubmed\">35318112</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S., Taylor K., Kozubek J., Sardell J., Gardner S. Genetic risk factors for ME/CFS identified using combinatorial analysis. J. Transl. Med. 2022;20:598. doi: 10.1186/s12967-022-03815-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-022-03815-8</ArticleId><ArticleId IdType=\"pmc\">PMC9749644</ArticleId><ArticleId IdType=\"pubmed\">36517845</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., Jain A.K., De Meirleir K.L., Peterson D.L., Klimas N.G., Lerner A.M., Bested A.C., Flor-Henry P., Joshi P., Powles A.C.P., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Chronic Fatigue Syndr. 2003;11:7&#x2013;115. doi: 10.1300/J092v11n01_02.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., van de Sande M.I., De Meirleir K.L., Klimas N.G., Broderick G., Mitchell T., Staines D., Powles A.C.P., Speight N., Vallings R., et al. Myalgic encephalomyelitis: International Consensus Criteria. J. Intern. Med. 2011;270:327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType=\"pmc\">PMC3427890</ArticleId><ArticleId IdType=\"pubmed\">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A., Tate W.P. A compromised paraventricular nucleus within a dysfunctional hypothalamus: A novel neuroinflammatory paradigm for ME/CFS. Int. J. Immunopathol. Pharmacol. 2018;32:2342. doi: 10.1177/2058738418812342.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/2058738418812342</ArticleId></ArticleIdList></Reference><Reference><Citation>Murga I., Aranburu L., Gargiulo P.A., G&#xf3;mez Esteban J.C., Lafuente J.V. Clinical Heterogeneity in ME/CFS. A Way to Understand Long-COVID19 Fatigue. Front. Psychiatry. 2021;12:735784. doi: 10.3389/fpsyt.2021.735784.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fpsyt.2021.735784</ArticleId><ArticleId IdType=\"pmc\">PMC8542754</ArticleId><ArticleId IdType=\"pubmed\">34707521</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Zang C., Xu Z., Zhang Y., Xu J., Bian J., Morozyuk D., Khullar D., Zhang Y., Nordvig A.S., et al. Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat. Med. 2023;29:226&#x2013;235. doi: 10.1038/s41591-022-02116-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-022-02116-3</ArticleId><ArticleId IdType=\"pmc\">PMC9873564</ArticleId><ArticleId IdType=\"pubmed\">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>Schacterle R.S., Komaroff A.L. A comparison of pregnancies that occur before and after the onset of chronic fatigue syndrome. Arch. Intern. Med. 2004;164:401&#x2013;404. doi: 10.1001/archinte.164.4.401.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archinte.164.4.401</ArticleId><ArticleId IdType=\"pubmed\">14980991</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruun K.D., Amris K., Vaegter H.B., Blichfeldt-Eckhardt M.R., Holsgaard-Larsen A., Christensen R., Toft P. Low-dose naltrexone for the treatment of fibromyalgia: Protocol for a double-blind, randomized, placebo-controlled trial. Trials. 2021;22:804. doi: 10.1186/s13063-021-05776-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13063-021-05776-7</ArticleId><ArticleId IdType=\"pmc\">PMC8591911</ArticleId><ArticleId IdType=\"pubmed\">34781989</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosby L.D., Kalanidhi S., Bonilla A., Subramanian A., Ballon J.S., Bonilla H. Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A retrospective study of 101 patients treated with a low dose of Aripiprazole. J. Transl. Med. 2021;19:50. doi: 10.1186/s12967-021-02721-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-021-02721-9</ArticleId><ArticleId IdType=\"pmc\">PMC7860172</ArticleId><ArticleId IdType=\"pubmed\">33536023</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Mitoma F., Turgonyi E., Kumar A., Lim W., Larocque L., Hyde B.M. Clinical Improvement in Chronic Fatigue Syndrome Is Associated with Enhanced Natural Killer Cell-Mediated Cytotoxicity: odman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType=\"pmc\">PMC8155823</ArticleId><ArticleId IdType=\"pubmed\">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27:1507&#x2013;1513. doi: 10.1016/j.cmi.2021.05.033.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType=\"pmc\">PMC8180450</ArticleId><ArticleId IdType=\"pubmed\">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahey GM, Marshall KE, McDonald E, et al. Symptom profiles and progression in hospitalized and nonhospitalized patients with coronavirus disease, Colorado, USA, 2020. Emerg Infect Dis. 2021;27:385&#x2013;395. doi: 10.3201/eid2702.203729.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3201/eid2702.203729</ArticleId><ArticleId IdType=\"pmc\">PMC7853576</ArticleId><ArticleId IdType=\"pubmed\">33496225</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13:1957. doi: 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType=\"pmc\">PMC9005552</ArticleId><ArticleId IdType=\"pubmed\">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. 2022;74:1191&#x2013;1198. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cid/ciab611</ArticleId><ArticleId IdType=\"pmc\">PMC8394862</ArticleId><ArticleId IdType=\"pubmed\">34223884</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37205352</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>25</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2023</Year><Month>Apr</Month><Day>26</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>A Mixed Methods System for the Assessment of Post Exertional Malaise in Encephalomyelitis/Chronic Fatigue Syndrome.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">2023.04.24.23288821</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1101/2023.04.24.23288821</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">A central feature of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is post exertional malaise (PEM), which is an acute worsening of symptoms after a physical, emotional and/or mental exertion. PEM is also a feature of Long COVID. Dynamic measures of PEM have historically included scaled questionnaires which have not been validated in ME/CFS. To enhance our understanding of PEM and how best to measure it, we conducted semi-structured qualitative interviews (QIs) at the same intervals as Visual Analog Scale (VAS) measures after a Cardiopulmonary Exercise Test (CPET).</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">Ten ME/CFS and nine healthy volunteers participated in a CPET. For each participant, PEM symptom VAS (7 symptoms) and semi-structured QIs were administered at six timepoints over 72 hours before and after a single CPET. QI data were used to plot the severity of PEM at each time point and identify the self-described most bothersome symptom for each patient. QI data were used to determine the symptom trajectory and peak of PEM. Performance of QI and VAS data were compared to each other using Spearman correlations.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">QIs documented that each ME/CFS volunteer had a unique PEM experience, with differences noted in the onset, severity, trajectory over time, and most bothersome symptom. No healthy volunteers experienced PEM. Scaled QI data were able to identify PEM peaks and trajectories, even when VAS scales were unable to do so due to known ceiling and floor effects. QI and VAS fatigue data corresponded well prior to exercise (baseline, r=0.7) but poorly at peak PEM (r=0.28) and with the change from baseline to peak (r=0.20). When the most bothersome symptom identified from QIs was used, these correlations improved (r=.0.77, 0.42. and 0.54 respectively) and reduced the observed VAS scale ceiling and floor effects.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"UNASSIGNED\">QIs were able to capture changes in PEM severity and symptom quality over time in all the ME/CFS volunteers, even when VAS scales failed to do so. Information collected from QIs also improved the performance of VAS. Measurement of PEM can be improved by using a quantitative-qualitative mixed model approach.</AbstractText><AbstractText Label=\"DISCLAIMER\" NlmCategory=\"UNASSIGNED\">This research/work/investigator was supported (in part) by the Division of Intramural Research of the National Institutes of Health, NINDS. The content is solely the responsibility of the author(s) and does not necessarily represent the official views of the National Institutes of Health.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Stussman</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Author><Author ValidYN=\"Y\"><LastName>Calco</LastName><ForeName>Brice</ForeName><Initials>B</Initials></Author><Author ValidYN=\"Y\"><LastName>Norato</LastName><ForeName>Gina</ForeName><Initials>G</Initials></Author><Author ValidYN=\"Y\"><LastName>Gavin</LastName><ForeName>Angelique</ForeName><Initials>A</Initials></Author><Author ValidYN=\"Y\"><LastName>Chigurupati</LastName><ForeName>Snigdha</ForeName><Initials>S</Initials></Author><Author ValidYN=\"Y\"><LastName>Nath</LastName><ForeName>Avindra</ForeName><Initials>A</Initials></Author><Author ValidYN=\"Y\"><LastName>Walitt</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D000076942\">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37205352</ArticleId><ArticleId IdType=\"pmc\">PMC10187342</ArticleId><ArticleId IdType=\"doi\">10.1101/2023.04.24.23288821</ArticleId><ArticleId IdType=\"pii\">2023.04.24.23288821</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Unger ER, Lin JS, Brimmer DJ, Lapp CW, Komaroff AL, Nath A, Laird S, Iskander J. CDC Grand Rounds: Chronic Fatigue Syndrome Advancing Research and Clinical Education. MMWR Morb Mortal Wkly Rep. 2016. Dec 30;65(5051):1434 1438.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28033311</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Hartle M, Sullivan K, Bell J, Abbaszadeh S, Unutmaz D, Bateman L. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Work. 2023. Mar 7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Dorri JA. ME/CFS and Post-Exertional Malaise among Patients with Long COVID. Neurol Int. 2022. Dec 20;15(1):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9844405</ArticleId><ArticleId IdType=\"pubmed\">36648965</ArticleId></ArticleIdList></Reference><Reference><Citation>Stussman B, Williams A, Snow J, Gavin A, Scott R, Nath A, Walitt B. Characterization of Post-exertional Malaise in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Neurol. 2020. Sep 18;11:1025.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7530890</ArticleId><ArticleId IdType=\"pubmed\">33071931</ArticleId></ArticleIdList></Reference><Reference><Citation>IOM Report: https://www.ncbi.nlm.nih.gov/books/NBK274235/.</Citation></Reference><Reference><Citation>Stevens S, Snell C, Stevens J, Keller B, VanNess JM. Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Pediatr. 2018. Sep 4;6:242.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6131594</ArticleId><ArticleId IdType=\"pubmed\">30234078</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams VS, Morlock RJ, Feltner D. Psychometric evaluation of a visual analog scale for the assessment of anxiety. Health Qual Life Outcomes. 2010. Jun 8;8:57.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2904728</ArticleId><ArticleId IdType=\"pubmed\">20529361</ArticleId></ArticleIdList></Reference><Reference><Citation>Averbuch M, Katzper M. Assessment of visual analog versus categorical scale for measurement of osteoarthritis pain. J Clin Pharmacol. 2004. Apr;44(4):368&#x2013;72.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15051743</ArticleId></ArticleIdList></Reference><Reference><Citation>Buisman ETIA, Grens H, Wang R, Bhattacharya S, Braat DDM, Huppelschoten AG, van der Steeg JW. Trends in research on pain relief during oocyte retrieval for IVF/ICSI: a systematic, methodological review. Hum Reprod Open. 2022. Feb 16;2022(1):hoac006.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8868119</ArticleId><ArticleId IdType=\"pubmed\">35224230</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen CLMC, Rowe PC, Verheugt FWA, Visser FC. Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Med (Lausanne). 2021. Jan 27;7:602894.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7874746</ArticleId><ArticleId IdType=\"pubmed\">33585505</ArticleId></ArticleIdList></Reference><Reference><Citation>VanNess JM, Stevens SR, Bateman L, Stiles TL, Snell CR. Postexertional malaise in women with chronic fatigue syndrome. J Womens Health (Larchmt). 2010. Feb;19(2):239&#x2013;44.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20095909</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Oosterwijck J, Nijs J, Meeus M, Lefever I, Huybrechts L, Lambrecht L, Paul L. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an experimental study. J Intern Med. 2010. Sep;268(3):265&#x2013;78.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20412374</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook DB, Light AR, Light KC, Broderick G, Shields MR, Dougherty RJ, Meyer JD, VanRiper S, Stegner AJ, Ellingson LD, Vernon SD. Neural consequences of post-exertion malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Brain Behav Immun. 2017. May;62:87&#x2013;99.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28216087</ArticleId></ArticleIdList></Reference><Reference><Citation>Learmonth YC, Paul L, McFadyen AK, Marshall-McKenna R, Mattison P, Miller L, McFarlane NG. Short-term effect of aerobic exercise on symptoms in multiple sclerosis and chronic fatigue syndrome: a pilot study. Int J MS Care. 2014. Summer;16(2):76&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4106394</ArticleId><ArticleId IdType=\"pubmed\">25061431</ArticleId></ArticleIdList></Reference><Reference><Citation>Polli A, Van Oosterwijck J, Nijs J, Marusic U, De Wandele I, Paul L, Meeus M, Moorkens G, Lambrecht L, Ickmans K. Relationship Between Exercise-induced Oxidative Stress Changes and Parasympathetic Activity in Chronic Fatigue Syndrome: An Observational Study in Patients and Healthy Subjects. Clin Ther. 2019. Apr;41(4):641&#x2013;655.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30665828</ArticleId></ArticleIdList></Reference><Reference><Citation>Light AR, Bateman L, Jo D, Hughen RW, Vanhaitsma TA, White AT, Light KC. Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome. J Intern Med. 2012. Jan;271(1):64&#x2013;81.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3175315</ArticleId><ArticleId IdType=\"pubmed\">21615807</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Holtzman CS, Sunnquist M, Cotler J. The development of an instrument to assess post-exertional malaise in patients with myalgic encephalomyelitis and chronic fatigue syndrome. J Health Psychol. 2021. Feb;26(2):238&#x2013;248.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7988339</ArticleId><ArticleId IdType=\"pubmed\">30354489</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Evans M, So S, Scott J, Brown A. Problems in defining post-exertional malaise. J Prev Interv Community. 2015;43(1):20&#x2013;31.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4295644</ArticleId><ArticleId IdType=\"pubmed\">25584525</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock KW, Wang XS, Shi Q, Cleeland CS, Fagundes CP, Vernon SD. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome. Qual Life Res. 2017. Apr;26(4):913&#x2013;921.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5336422</ArticleId><ArticleId IdType=\"pubmed\">27600520</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L, Valencia IJ, Garvert DW, Montoya JG. Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey. PLoS One. 2018. Jun 1;13(6):e0197811.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5983853</ArticleId><ArticleId IdType=\"pubmed\">29856774</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtzman CS, Bhatia S, Cotler J, Jason LA. Assessment of Post Exertional Malaise (PEM) in Patients with Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS): A Patient Driven Survey. Diagnostics (Basel). 2019. Mar 2;9(1).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6468435</ArticleId><ArticleId IdType=\"pubmed\">30832336</ArticleId></ArticleIdList></Reference><Reference><Citation>Boruch AE, Lindheimer JB, Klein-Adams JC, Stegner AJ, Wylie GR, Ninneman JV, Alexander T, Gretzon NP, Samy B, Van Riper SM, Falvo MJ, Cook DB. Predicting post-exertional malaise in Gulf War Illness based on acute exercise responses. Life Sci. 2021. Sep 1;280:119701.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34119538</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindheimer JB, Alexander T, Qian W, Klein-Adams JC, Lange G, Natelson H B, Cook DB, Hill HZ, Falvo MJ. An analysis of 2-day cardiopulmonary exercise testing to assess unexplained fatigue. Physiol Rep. 2020. Sep;8(17):e14564.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7507580</ArticleId><ArticleId IdType=\"pubmed\">32889791</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimek L, Bergmann KC, Biedermann T, et al. Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care. Allergo J Int. 2017;26(1):16&#x2013;24.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5288410</ArticleId><ArticleId IdType=\"pubmed\">28217433</ArticleId></ArticleIdList></Reference><Reference><Citation>Haefeli M, Elfering A. Pain assessment. Eur Spine J. 2006. Jan;15 Suppl 1(Suppl 1):S17&#x2013;24.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3454549</ArticleId><ArticleId IdType=\"pubmed\">16320034</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, Fainsinger R, Aass N, Kaasa; European Palliative Care Research Collaborative (EPCRC). Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage. 2011. Jun;41(6):1073&#x2013;93.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21621130</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotler J, Holtzman C, Dudun C, Jason LA. A Brief Questionnaire to Assess Post-Exertional Malaise. Diagnostics (Basel). 2018. Sep 11;8(3):66.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6165517</ArticleId><ArticleId IdType=\"pubmed\">30208578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujawski S, S&#x142;omko J, Hodges L, Pheby DFH, Murovska M, Newton JL, Zalewski P. Post-Exertional Malaise May Be Related to Central Blood Pressure, Sympathetic Activity and Mental Fatigue in Chronic Fatigue Syndrome Patients. J Clin Med. 2021. May 26;10(11):2327.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8198768</ArticleId><ArticleId IdType=\"pubmed\">34073494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujawski S, S&#x142;omko J, Newton JL, Eaton-Fitch N, Staines DR, Marshall-Gradisnik S, Zalewski P. Network Analysis of Symptoms Co-Occurrence in Chronic Fatigue Syndrome. Int J Environ Res Public Health. 2021. Oct 13;18(20):10736.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8535251</ArticleId><ArticleId IdType=\"pubmed\">34682478</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R, Yeung ST, Wrightson JG, Millet GY, Culos-Reed SN. Post-exertional Malaise in People With Chronic Cancer-Related Fatigue. J Pain Symptom Manage. 2020. Aug;60(2):407&#x2013;416.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32105793</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateo LJ, Chu L, Stevens S, Stevens J, Snell CR, Davenport T, VanNess JM. Post-exertional symptoms distinguish Myalgic Encephalomyelitis/Chronic Fatigue Syndrome subjects from healthy controls. Work. 2020;66(2):265&#x2013;275.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32568143</ArticleId></ArticleIdList></Reference><Reference><Citation>Creswell JW, Plano Clark VL. Designing and conducting mixed methods research, 2nd edition. Thousand Oaks, CA: Sage Publications; 2011.</Citation></Reference><Reference><Citation>Mezzani A. Cardiopulmonary Exercise Testing: Basics of Methodology and Measurements. Ann Am Thorac Soc. 2017. Jul;14(Supplement_1):S3&#x2013;S11. doi: 10.1513/AnnalsATS.201612-997FR.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1513/AnnalsATS.201612-997FR</ArticleId><ArticleId IdType=\"pubmed\">28510504</ArticleId></ArticleIdList></Reference><Reference><Citation>Broderick G, Ben-Hamo R, Vashishtha S, Efroni S, Nathanson L, Barnes Z, Fletcher MA, Klimas N. Altered immune pathway activity under exercise challenge in Gulf War Illness: an exploratory analysis. Brain Behav Immun. 2013. Feb;28:159&#x2013;69.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23201588</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team (2022). R: A language and environment for statistical computing.\\nR Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.</Citation></Reference><Reference><Citation>Taylor R. Interpretation of the Correlation Coefficient: A Basic Review. Journal of Diagnostic Medical Sonography 1990;6:35&#x2013;39.</Citation></Reference><Reference><Citation>Chang CJ, Hung LY, Kogelnik AM, Kaufman D, Aiyar RS, Chu AM, Wilhelmy J, Li P, Tannenbaum L, Xiao W, Davis RW. A Comprehensive Examination of Severely Ill ME/CFS Patients. Healthcare (Basel). 2021. Sep 29;9(10):1290.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8535418</ArticleId><ArticleId IdType=\"pubmed\">34682970</ArticleId></ArticleIdList></Reference><Reference><Citation>May M, Milrad SF, Perdomo DM, Czaja SJ, Fletcher MA, Jutagir DR, Hall DL, Klimas N, Antoni MH. Post-exertional malaise is associated with greater symptom burden and psychological distress in patients diagnosed with Chronic Fatigue Syndrome. J Psychosom Res. 2020. Feb;129:109893.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7007968</ArticleId><ArticleId IdType=\"pubmed\">31884303</ArticleId></ArticleIdList></Reference><Reference><Citation>Beletsky A, Nwachukwu BU, Gorodischer T, Chahla J, Forsythe B, Cole BJ, Verma NN. Psychometric properties of visual analog scale assessments for function, pain, and strength compared with disease-specific upper extremity outcome measures in rotator cuff repair. JSES Int. 2020. May 23;4(3):619&#x2013;624.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7479024</ArticleId><ArticleId IdType=\"pubmed\">32939496</ArticleId></ArticleIdList></Reference><Reference><Citation>Filocamo G, Dav&#xec; S, Pistorio A, Bertamino M, Ruperto N, Lattanzi B, Consolaro A, Magni-Manzoni S, Galasso R, Varnier GC, Martini A, Ravelli A. Evaluation of 21-numbered circle and 10-centimeter horizontal line visual analog scales for physician and parent subjective ratings in juvenile idiopathic arthritis. J Rheumatol. 2010. Jul;37(7):1534.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20551105</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37193573</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Print\">1433-6251</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>99</Volume><Issue>3</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>ZFA. Zeitschrift fur Allgemeinmedizin</Title><ISOAbbreviation>ZFA (Stuttgart)</ISOAbbreviation></Journal><ArticleTitle>[Tiredness/Fatigue-S3&#xa0;guideline update].</ArticleTitle><Pagination><StartPage>127</StartPage><EndPage>132</EndPage><MedlinePgn>127-132</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s44266-023-00045-z</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">Fatigue is one of the most common reasons for seeking medical counseling in the family medicine (FM), often entailing diagnostic uncertainty. Patients use terms describing emotional, cognitive, physical, and behavioral aspects. A&#xa0;number of biological, mental, and social causes may underlie the symptom of fatigue, often in combination. This guideline describes the procedures to be applied for primary undetermined symptomatology.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">The experts involved conducted a&#xa0;systematic search using the terms for fatigue in the context of FM in PubMed, Cochrane Library and via manual search. Concerning related guidelines, the National Institute for Health and Care Excellence (NICE) guideline was used for myalgic encephalitis/chronic fatigue syndrome (ME/CFS). In a&#xa0;structured consensus process, broad approval of the core recommendations/background text of the revised guideline was attained.</AbstractText><AbstractText Label=\"MOST IMPORTANT MESSAGES\" NlmCategory=\"UNASSIGNED\">1)&#xa0;Alongside gathering information concerning the symptom characteristics, the anamnesis aims to collect information about pre-existing health conditions, sleeping behavior, use of drugs and psychosocial factors. 2)&#xa0;Depression and anxiety as two common causes will be identified based on screening questions. The occurrence of post-exertional malaise (PEM) will be inquired. 3)&#xa0;The following basic diagnostics are recommended: physical examination, laboratory tests (blood glucose, full blood count, blood sedimentation/CRP, transaminases/&#x3b3;-GT, TSH). 4)&#xa0;Further examinations should be conducted only in case of specific indications. 5)&#xa0;A biopsychosocial approach is to be adopted. 6)&#xa0;Behavioral therapy and symptom-oriented activating measures can improve fatigue in underlying diseases and undetermined fatigue. 7)&#xa0;In case of PEM, further ME/CFS criteria should be collected and patients have to be supervised accordingly.</AbstractText><CopyrightInformation>&#xa9; The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Kornder</LastName><ForeName>Nele</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Karl-von-Frisch-Str.&#xa0;4, 35043 Marburg, Deutschland Institut f&#xfc;r Allgemeinmedizin, Philipps-Universit&#xe4;t Marburg.</Affiliation><Identifier Source=\"GRID\">grid.10253.35</Identifier><Identifier Source=\"ISNI\">0000 0004 1936 9756</Identifier></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Baum</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Karl-von-Frisch-Str.&#xa0;4, 35043 Marburg, Deutschland Institut f&#xfc;r Allgemeinmedizin, Philipps-Universit&#xe4;t Marburg.</Affiliation><Identifier Source=\"GRID\">grid.10253.35</Identifier><Identifier Source=\"ISNI\">0000 0004 1936 9756</Identifier></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Maisel</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>M&#xfc;nster, Deutschland Centrum f&#xfc;r Allgemeinmedizin, Westf&#xe4;lische Wilhelms-Universit&#xe4;t M&#xfc;nster.</Affiliation><Identifier Source=\"GRID\">grid.5949.1</Identifier><Identifier Source=\"ISNI\">0000 0001 2172 9288</Identifier></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lindner</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Karl-von-Frisch-Str.&#xa0;4, 35043 Marburg, Deutschland Institut f&#xfc;r Allgemeinmedizin, Philipps-Universit&#xe4;t Marburg.</Affiliation><Identifier Source=\"GRID\">grid.10253.35</Identifier><Identifier Source=\"ISNI\">0000 0004 1936 9756</Identifier></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI=\"D004740\">English Abstract</PublicationType><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><VernacularTitle>M&#xfc;digkeit&#xa0;&#x2013; Update der S3-Leitlinie.</VernacularTitle><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>ZFA (Stuttgart)</MedlineTA><NlmUniqueID>7613263</NlmUniqueID><ISSNLinking>1433-6251</ISSNLinking></MedlineJournalInfo><OtherAbstract Type=\"Publisher\" Language=\"ger\"><AbstractText Label=\"HINTERGRUND\">M&#xfc;digkeit ist ein h&#xe4;ufiges Symptom in der Hausarztpraxis, bei dem oft diagnostische Unsicherheit besteht. Betroffene verwenden Beschreibungen, die emotionale, kognitive, k&#xf6;rperliche oder Verhaltensaspekte beinhalten. Eine Vielzahl biologischer, seelischer und sozialer Ursachen ist denkbar, oft in Kombination. Die Leitlinie bezieht sich auf das Vorgehen bei prim&#xe4;r ungekl&#xe4;rter Symptomatik.</AbstractText><AbstractText Label=\"SUCHMETHODEN\">Die beteiligten Expert:innen f&#xfc;hrten eine systematische Recherche mit den Begriffen f&#xfc;r M&#xfc;digkeit im Kontext haus&#xe4;rztlicher Versorgung in PubMed, Cochrane Library und mit Handsuche durch. Bez&#xfc;glich verwandter Leitlinien konnte f&#xfc;r die myalgische Enzephalitis/chronisches Fatigue-Syndrom (ME/CFS) auf die Leitlinie des National Institute of Health and Care Excellence (NICE) zur&#xfc;ckgegriffen werden. In einem strukturierten Konsensprozess wurde weitgehende Zustimmung zu Kernempfehlungen/Hintergrundtext der &#xfc;berarbeiteten Leitlinie erreicht.</AbstractText><AbstractText Label=\"WICHTIGSTE BOTSCHAFTEN\">1)&#xa0;Neben den Charakteristika des Symptoms sollen u.&#x202f;a. Vorerkrankungen, Schlafverhalten, Zufuhr psychotroper Substanzen, psychosoziale und Umweltfaktoren erfragt werden. 2)&#xa0;Depression und Angst sollen als h&#xe4;ufige Ursache anhand von Screeningfragen erfasst, zudem das Auftreten einer postexertionellen Malaise (PEM) erfragt werden. 3)&#xa0;Als Basisdiagnostik wird empfohlen: k&#xf6;rperliche Untersuchung, Laboruntersuchungen (Blutglukose, gro&#xdf;es Blutbild, BSG/CRP, Transaminasen/&#x3b3;-GT, TSH). 4)&#xa0;Weitere Untersuchungen sind nur bei spezifischen Hinweisen indiziert. 5)&#xa0;Ein biopsychosozialer Ansatz ist anzustreben. 6)&#xa0;Verhaltenstherapie und symptomorientierte aktivierende Ma&#xdf;nahmen k&#xf6;nnen M&#xfc;digkeit bei zugrunde liegender Erkrankung sowie bei ungekl&#xe4;rter Ursache verbessern. 7)&#xa0;Bei PEM werden weitere ME/CFS-Kriterien erfasst und Betroffene dementsprechend betreut.</AbstractText><CopyrightInformation>&#xa9; The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2023.</CopyrightInformation></OtherAbstract><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Biopsychosocial approach</Keyword><Keyword MajorTopicYN=\"N\">Family medicine</Keyword><Keyword MajorTopicYN=\"N\">Fatigue</Keyword><Keyword MajorTopicYN=\"N\">General practice</Keyword><Keyword MajorTopicYN=\"N\">Leading symptom</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>21</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37193573</ArticleId><ArticleId IdType=\"pmc\">PMC10124695</ArticleId><ArticleId IdType=\"doi\">10.1007/s44266-023-00045-z</ArticleId><ArticleId IdType=\"pii\">45</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stadje R. M&#xfc;digkeit als Symptom in der Prim&#xe4;rversorgung: eine systematische &#xdc;bersichtsarbeit. Marburg: Philipps-Universit&#xe4;t; 2015.</Citation></Reference><Reference><Citation>W&#xfc;bken M, B&#xfc;hner M, Barth N, Schneider A. Welche Aspekte tragen in der t&#xe4;glichen Routine zur diagnostischen Unsicherheit bei?: Ergebnisse einer haus&#xe4;rztlichen Befragung. Z Allg Med. 2015;2015(92):392&#x2013;398. doi: 10.3238/zfa.2015.0392-0398.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3238/zfa.2015.0392-0398</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely JW, Kaldjian LC, D&#x2019;Alessandro DM. Diagnostic errors in primary care: lessons learned. J Am Board Fam Med. 2012;25(1):87&#x2013;97. doi: 10.3122/jabfm.2012.01.110174.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3122/jabfm.2012.01.110174</ArticleId><ArticleId IdType=\"pubmed\">22218629</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S, Henderson KM, Tapley A, et al. Investigation of fatigue by Australian general practice registrars: a&#xa0;cross-sectional study. J Prim Health Care. 2015;7(2):109&#x2013;116. doi: 10.1071/HC15109.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1071/HC15109</ArticleId><ArticleId IdType=\"pubmed\">26125056</ArticleId></ArticleIdList></Reference><Reference><Citation>Maisel P, Baum E, Donner-Banzhoff N. Fatigue as the chief complaint&#x2014;epidemiology, causes, diagnosis, and treatment. Dtsch Arztebl Int. 2021;118(33&#x2013;34):566&#x2013;576. doi: 10.3238/arztebl.m2021.0192.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3238/arztebl.m2021.0192</ArticleId><ArticleId IdType=\"pmc\">PMC8579431</ArticleId><ArticleId IdType=\"pubmed\">34196270</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum E, Lindner N, Andreas S et&#xa0;al (2022) S3 Leitlinie M&#xfc;digkeit der Deutschen Gesellschaft f&#xfc;r Allgemeinmedizin. https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S3-Leitlinien/053-002_Leitlinie%20Muedigkeit/Aktualisierung%20Dezember%202022/Langfassung%20Leitlinie%20Mu%CC%88digkeit.pdf. Zugegriffen: 10. Jan. 2023</Citation></Reference><Reference><Citation>Baum E, Lindner N, Andreas S et al Deutsche Gesellschaft f&#xfc;r Allgemeinmedizin und Familienmedizin. M&#xfc;digkeit S3-Leitlinie, Leitlinienreport, AWMF-Register-Nr.&#xa0;053-002, Stand Dezember 2022. https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S3-Leitlinien/053-002_Leitlinie%20Muedigkeit/Aktualisierung%20Dezember%202022/Leitlinienreport%20Leitlinie%20Mu%CC%88digkeit.pdf. Zugegriffen: 10. Jan. 2023</Citation></Reference><Reference><Citation>Nacul L, Authier FJ, Scheibenbogen C, et al. European network on myalgic encephalomyelitis/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in europe. Medicina. 2021;57(5):510. doi: 10.3390/medicina57050510.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57050510</ArticleId><ArticleId IdType=\"pmc\">PMC8161074</ArticleId><ArticleId IdType=\"pubmed\">34069603</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview | Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management | Guidance | NICE; 2023 [cited 2023 January 16] Available from: URL: https://www.nice.org.uk/guidance/ng206.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35438859</ArticleId></ArticleIdList></Reference><Reference><Citation> (2022) Homepage GIN. https://g-i-n.net/. Zugegriffen: 16. Jan. 2023</Citation></Reference><Reference><Citation> (2022) S3 Leitlinie M&#xfc;digkeit, Fragebogen zur Anamnese. https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S3-Leitlinien/053-002_Leitlinie%20Muedigkeit/Aktualisierung%20Dezember%202022/Fragebogen%20Leitlinie%20Mu%CC%88digkeit.pdf. Zugegriffen: 10. Jan. 2023</Citation></Reference><Reference><Citation>Baum E, Lindner N, Maisel P (2022) S3 Leitlinie M&#xfc;digkeit Kurzversion. https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S3-Leitlinien/053-002_Leitlinie%20Muedigkeit/Aktualisierung%20Dezember%202022/Kurzfassung%20Leitlinie%20Mu%CC%88digkeit.pdf. Zugegriffen: 10. Jan. 2023</Citation></Reference><Reference><Citation>Horton M, Perry AE. Screening for depression in primary care: a&#xa0;Rasch analysis of the PHQ-9. BJPsych Bull. 2016;40(5):237&#x2013;243. doi: 10.1192/pb.bp.114.050294.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1192/pb.bp.114.050294</ArticleId><ArticleId IdType=\"pmc\">PMC5046780</ArticleId><ArticleId IdType=\"pubmed\">27752340</ArticleId></ArticleIdList></Reference><Reference><Citation>Blank T (2018) Gesundheitsfragebogen f&#xfc;r Patienten (PHQ-9): Psychische Erkrankungen in der Hausarztpraxis:: Abteilung Allgemeinmedizin der Universit&#xe4;t Greifswald. https://kompetenzzentrum-allgemeinmedizin-mv.de/wp-content/uploads/2018/07/PHQ9-Depressionsfragebogen-2018.pdf. Zugegriffen: 10.&#xa0;Jan. 2023</Citation></Reference><Reference><Citation>Katon W, Kleinman A, Rosen G. Depression and somatization: a&#xa0;review. Am J Med. 1982;72(2):241&#x2013;247. doi: 10.1016/0002-9343(82)90816-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0002-9343(82)90816-6</ArticleId><ArticleId IdType=\"pubmed\">6460443</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37182295</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1873-5347</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>327</Volume><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Social science &amp; medicine (1982)</Title><ISOAbbreviation>Soc Sci Med</ISOAbbreviation></Journal><ArticleTitle>Contesting misrecognition online: Experiences of epistemic in/justice by vloggers with contested illnesses.</ArticleTitle><Pagination><StartPage>115951</StartPage><MedlinePgn>115951</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.socscimed.2023.115951</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0277-9536(23)00308-8</ELocationID><Abstract><AbstractText>Contested illnesses, such as fibromyalgia, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and chronic Lyme disease (CLD), are surrounded by polemic debates regarding their etiology, symptomology, treatment, and even their existence. People who suffer from these contested illnesses arguably also suffer from \"epistemic injustice.\" This concept, coined by the philosopher Miranda Fricker, captures how people\\'s knowledge may be discredited because of identity prejudices. In our paper, this concept is used to understand how seven Dutch women with contested illnesses experience the emancipatory potential of their vlogging practices. Our findings show how these women understood their vlogging as a means to break with epistemic smothering, understood as the propensity to cater ones testimony to one\\'s audience (Dotson, 2011), and as a means to attain and enhance epistemic justice. However, our findings also show how vlogging about contested illnesses did not seem to allow these women to fully break with their epistemic smothering practices, and that the ableist design and gendered norms of YouTube were experienced as obstacles to attaining epistemic justice. We conclude that, even though social media do seem to hold emancipatory potential for these women, the experiences of individual users are diverse and ambiguous.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Groenevelt</LastName><ForeName>I P Irene</ForeName><Initials>IPI</Initials><AffiliationInfo><Affiliation>Department of Culture Studies, Tilburg School of Humanities and Digital Sciences, Tilburg University, the Netherlands. Electronic address: I.P.Groenevelt@tilburguniversity.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>de Boer</LastName><ForeName>M L Marjolein</ForeName><Initials>MLM</Initials><AffiliationInfo><Affiliation>Department of Culture Studies, Tilburg School of Humanities and Digital Sciences, Tilburg University, the Netherlands. Electronic address: M.L.deBoer@tilburguniversity.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\\'t</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>05</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Soc Sci Med</MedlineTA><NlmUniqueID>8303205</NlmUniqueID><ISSNLinking>0277-9536</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012935\" MajorTopicYN=\"N\">Social Justice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005356\" MajorTopicYN=\"Y\">Fibromyalgia</DescriptorName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011287\" MajorTopicYN=\"N\">Prejudice</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Contested illness</Keyword><Keyword MajorTopicYN=\"N\">Epistemic injustice</Keyword><Keyword MajorTopicYN=\"N\">Illness experiences</Keyword><Keyword MajorTopicYN=\"N\">Recognition</Keyword><Keyword MajorTopicYN=\"N\">Vlogging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>18</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37182295</ArticleId><ArticleId IdType=\"doi\">10.1016/j.socscimed.2023.115951</ArticleId><ArticleId IdType=\"pii\">S0277-9536(23)00308-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" VersionID=\"2\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"2\">37179299</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1479-5876</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.</ArticleTitle><Pagination><StartPage>322</StartPage><MedlinePgn>322</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">322</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1186/s12967-023-04179-3</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\">Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, heterogenous disease characterized by unexplained persistent fatigue and other features including cognitive impairment, myalgias, post-exertional malaise, and immune system dysfunction. Cytokines are present in plasma and encapsulated in extracellular vesicles (EVs), but there have been only a few reports of EV characteristics and cargo in ME/CFS. Several small studies have previously described plasma proteins or protein pathways that are associated with ME/CFS.</AbstractText><AbstractText Label=\"METHODS\">We prepared extracellular vesicles (EVs) from frozen plasma samples from a cohort of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) cases and controls with prior published plasma cytokine and plasma proteomics data. The cytokine content of the plasma-derived extracellular vesicles was determined by a multiplex assay and differences between patients and controls were assessed. We then performed multi-omic statistical analyses that considered not only this new data, but extensive clinical data describing the health of the subjects.</AbstractText><AbstractText Label=\"RESULTS\">ME/CFS cases exhibited greater size and concentration of EVs in plasma. Assays of cytokine content in EVs revealed IL2 was significantly higher in cases. We observed numerous correlations among EV cytokines, among plasma cytokines, and among plasma proteins from mass spectrometry proteomics. Significant correlations between clinical data and protein levels suggest roles of particular proteins and pathways in the disease. For example, higher levels of the pro-inflammatory cytokines Granulocyte-Monocyte Colony-Stimulating Factor (CSF2) and Tumor Necrosis Factor (TNF&#x3b1;) were correlated with greater physical and fatigue symptoms in ME/CFS cases. Higher serine protease SERPINA5, which is involved in hemostasis, was correlated with higher SF-36 general health scores in ME/CFS. Machine learning classifiers were able to identify a list of 20 proteins that could discriminate between cases and controls, with XGBoost providing the best classification with 86.1% accuracy and a cross-validated AUROC value of 0.947. Random Forest distinguished cases from controls with 79.1% accuracy and an AUROC value of 0.891 using only 7 proteins.</AbstractText><AbstractText Label=\"CONCLUSIONS\">These findings add to the substantial number of objective differences in biomolecules that have been identified in individuals with ME/CFS. The observed correlations of proteins important in immune responses and hemostasis with clinical data further implicates a disturbance of these functions in ME/CFS.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Giloteaux</LastName><ForeName>Ludovic</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Genetics, Cornell University, 323 Biotechnology Building, 526 Campus Road, Ithaca, NY, 14853, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Li</LastName><ForeName>Jiayin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Statistics and Data Science, Cornell University, Ithaca, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hornig</LastName><ForeName>Mady</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lipkin</LastName><ForeName>W Ian</ForeName><Initials>WI</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Columbia University Mailman School of Public Health, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Neurology and Pathology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ruppert</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Statistics and Data Science, Cornell University, Ithaca, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Operations Research and Information Engineering, Cornell University, Ithaca, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hanson</LastName><ForeName>Maureen R</ForeName><Initials>MR</Initials><Identifier Source=\"ORCID\">0000-0001-8141-3058</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology and Genetics, Cornell University, 323 Biotechnology Building, 526 Campus Road, Ithaca, NY, 14853, USA. mrh5@cornell.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>U54NS105541</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI109761</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013486\">Research Support, U.S. Gov\\'t, Non-P.H.S.</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\\'t</PublicationType><PublicationType UI=\"D052061\">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016207\">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016207\" MajorTopicYN=\"Y\">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D040901\" MajorTopicYN=\"N\">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002450\" MajorTopicYN=\"N\">Cell Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016022\" MajorTopicYN=\"N\">Case-Control Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Cytokines</Keyword><Keyword MajorTopicYN=\"N\">Extracellular vesicles</Keyword><Keyword MajorTopicYN=\"N\">Myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">Plasma</Keyword><Keyword MajorTopicYN=\"N\">Proteomics</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37179299</ArticleId><ArticleId IdType=\"pmc\">PMC10182359</ArticleId><ArticleId IdType=\"doi\">10.1186/s12967-023-04179-3</ArticleId><ArticleId IdType=\"pii\">10.1186/s12967-023-04179-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>IoM C. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness . Washington: National Academies Press; 2015.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia JKS. The role of enterovirus in chronic fatigue syndrome. J Clin Pathol. 2005;11:1126. doi: 10.1136/jcp.2004.020255.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jcp.2004.020255</ArticleId><ArticleId IdType=\"pmc\">PMC1770761</ArticleId><ArticleId IdType=\"pubmed\">16254097</ArticleId></ArticleIdList></Reference><Reference><Citation>O\\'Neal AJ, Hanson MR. The enterovirus theory of disease etiology in myalgic encephalomyelitis/chronic fatigue syndrome: a critical review. Front Med. 2021;8:688486. doi: 10.3389/fmed.2021.688486.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmed.2021.688486</ArticleId><ArticleId IdType=\"pmc\">PMC8253308</ArticleId><ArticleId IdType=\"pubmed\">34222292</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson MR, Germain A. Letter to the editor of metabolites. Metabolites. 2020;10(5):216. doi: 10.3390/metabo10050216.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/metabo10050216</ArticleId><ArticleId IdType=\"pmc\">PMC7281557</ArticleId><ArticleId IdType=\"pubmed\">32466160</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re\\'em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType=\"pmc\">PMC8280690</ArticleId><ArticleId IdType=\"pubmed\">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva OA, Maksoud R, Beeraka NM, Madhunapantula SV, Sinelnikov M, Nikolenko VN, et al. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J Adv Res. 2022;40:179&#x2013;196. doi: 10.1016/j.jare.2021.11.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType=\"pmc\">PMC8619886</ArticleId><ArticleId IdType=\"pubmed\">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Gifford EJ, Vahey J, Hauser ER, Sims KJ, Efird JT, Dursa EK, et al. Gulf War illness in the Gulf War era cohort and biorepository: the Kansas and centers for disease control definitions. Life Sci. 2021;278:119454. doi: 10.1016/j.lfs.2021.119454.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.lfs.2021.119454</ArticleId><ArticleId IdType=\"pmc\">PMC10148241</ArticleId><ArticleId IdType=\"pubmed\">33811897</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraniuk JN. Review of the midbrain ascending arousal network nuclei and implications for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Gulf War Illness (GWI) and Postexertional Malaise (PEM) Brain Sci. 2022;12(2):132. doi: 10.3390/brainsci12020132.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/brainsci12020132</ArticleId><ArticleId IdType=\"pmc\">PMC8870178</ArticleId><ArticleId IdType=\"pubmed\">35203896</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraniuk JN, Casado B, Maibach H, Clauw DJ, Pannell LK, Hess SS. A chronic fatigue syndrome&#x2013;related proteome in human cerebrospinal fluid. BMC Neurol. 2005;5(1):1&#x2013;19. doi: 10.1186/1471-2377-5-22.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2377-5-22</ArticleId><ArticleId IdType=\"pmc\">PMC1326206</ArticleId><ArticleId IdType=\"pubmed\">16321154</ArticleId></ArticleIdList></Reference><Reference><Citation>Schutzer SE, Angel TE, Liu T, Schepmoes AA, Clauss TR, Adkins JN, et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS ONE. 2011;6(2):e17287. doi: 10.1371/journal.pone.0017287.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0017287</ArticleId><ArticleId IdType=\"pmc\">PMC3044169</ArticleId><ArticleId IdType=\"pubmed\">21383843</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Ruppert D, Levine SM, Hanson MR. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism. Mol BioSyst. 2017;13(2):371&#x2013;379. doi: 10.1039/C6MB00600K.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C6MB00600K</ArticleId><ArticleId IdType=\"pmc\">PMC5365380</ArticleId><ArticleId IdType=\"pubmed\">28059425</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Ruppert D, Levine SM, Hanson MR. Prospective biomarkers from plasma metabolomics of myalgic encephalomyelitis/chronic fatigue syndrome implicate redox imbalance in disease symptomatology. Metabolites. 2018;8(4):90. doi: 10.3390/metabo8040090.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/metabo8040090</ArticleId><ArticleId IdType=\"pmc\">PMC6315598</ArticleId><ArticleId IdType=\"pubmed\">30563204</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy-Szakal D, Barupal DK, Lee B, Che X, Williams BL, Kahn EJ, et al. Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. Sci Rep. 2018;8(1):10056. doi: 10.1038/s41598-018-28477-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-018-28477-9</ArticleId><ArticleId IdType=\"pmc\">PMC6030047</ArticleId><ArticleId IdType=\"pubmed\">29968805</ArticleId></ArticleIdList></Reference><Reference><Citation>Milivojevic M, Che X, Bateman L, Cheng A, Garcia BA, Hornig M, et al. Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS. PLoS ONE. 2020;15(7):e0236148. doi: 10.1371/journal.pone.0236148.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0236148</ArticleId><ArticleId IdType=\"pmc\">PMC7373296</ArticleId><ArticleId IdType=\"pubmed\">32692761</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleshner M, Crane CR. Exosomes, DAMPs and miRNA: features of stress physiology and immune homeostasis. Trends Immunol. 2017;38(10):768&#x2013;776. doi: 10.1016/j.it.2017.08.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.it.2017.08.002</ArticleId><ArticleId IdType=\"pmc\">PMC5624844</ArticleId><ArticleId IdType=\"pubmed\">28838855</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes BJ, Somerville CC. Modulating cytokine production via select packaging and secretion from extracellular vesicles. Front Immunol. 2020;11:1040. doi: 10.3389/fimmu.2020.01040.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2020.01040</ArticleId><ArticleId IdType=\"pmc\">PMC7272603</ArticleId><ArticleId IdType=\"pubmed\">32547552</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, et al. Alzheimer&#x2019;s disease &#x3b2;-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci. 2006;103(30):11172&#x2013;11177. doi: 10.1073/pnas.0603838103.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0603838103</ArticleId><ArticleId IdType=\"pmc\">PMC1544060</ArticleId><ArticleId IdType=\"pubmed\">16837572</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#x142;omka A, Urban SK, Lukacs-Kornek V, &#x17b;ekanowska E, Kornek M. Large extracellular vesicles: have we found the holy grail of inflammation? Front Immunol. 2018;9:2723. doi: 10.3389/fimmu.2018.02723.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2018.02723</ArticleId><ArticleId IdType=\"pmc\">PMC6300519</ArticleId><ArticleId IdType=\"pubmed\">30619239</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon YJ, Kim OY, Gho YS. Extracellular vesicles as emerging intercellular communicasomes. BMB Rep. 2014;47(10):531. doi: 10.5483/BMBRep.2014.47.10.164.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5483/BMBRep.2014.47.10.164</ArticleId><ArticleId IdType=\"pmc\">PMC4261509</ArticleId><ArticleId IdType=\"pubmed\">25104400</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung KH, Chu K, Lee ST, Park HK, Bahn JJ, Kim DH, et al. Circulating endothelial microparticles as a marker of cerebrovascular disease. Ann Neurol Off J Am Neurol Assoc Child Neurol Soc. 2009;66(2):191&#x2013;199.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19743467</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;nig L, Kasimir-Bauer S, Bittner A-K, Hoffmann O, Wagner B, Santos Manvailer LF, et al. Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy. Oncoimmunology. 2018;7(1):e1376153. doi: 10.1080/2162402X.2017.1376153.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/2162402X.2017.1376153</ArticleId><ArticleId IdType=\"pmc\">PMC5739576</ArticleId><ArticleId IdType=\"pubmed\">29296534</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C-H, Im E-J, Moon P-G, Baek M-C. Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles. BMC Cancer. 2018;18(1):1&#x2013;11. doi: 10.1186/s12885-018-4952-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12885-018-4952-y</ArticleId><ArticleId IdType=\"pmc\">PMC6211419</ArticleId><ArticleId IdType=\"pubmed\">30382917</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Serrano-Pertierra E, Oliveira-Rodr&#xed;guez M, Zaragoz&#xe1; MC, Mart&#xed;nez-Mart&#xed;nez A, Blanco-L&#xf3;pez MC, et al. Circulating extracellular vesicles as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis: an exploratory pilot study. J Extracell Vesicles. 2018;7(1):1453730. doi: 10.1080/20013078.2018.1453730.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/20013078.2018.1453730</ArticleId><ArticleId IdType=\"pmc\">PMC5912186</ArticleId><ArticleId IdType=\"pubmed\">29696075</ArticleId></ArticleIdList></Reference><Reference><Citation>Eguchi A, Fukuda S, Kuratsune H, Nojima J, Nakatomi Y, Watanabe Y, et al. Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav Immun. 2020;84:106&#x2013;114. doi: 10.1016/j.bbi.2019.11.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2019.11.015</ArticleId><ArticleId IdType=\"pmc\">PMC7010541</ArticleId><ArticleId IdType=\"pubmed\">31759091</ArticleId></ArticleIdList></Reference><Reference><Citation>Giloteaux L, O\\'Neal A, Castro-Marrero J, Levine SM, Hanson MR. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study. J Transl Med. 2020;18(1):387. doi: 10.1186/s12967-020-02560-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-020-02560-0</ArticleId><ArticleId IdType=\"pmc\">PMC7552484</ArticleId><ArticleId IdType=\"pubmed\">33046133</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy-Szakal D, Williams BL, Mishra N, Che X, Lee B, Bateman L, et al. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome. 2017;5(1):44. doi: 10.1186/s40168-017-0261-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40168-017-0261-y</ArticleId><ArticleId IdType=\"pmc\">PMC5405467</ArticleId><ArticleId IdType=\"pubmed\">28441964</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimas NG, Ironson G, Carter A, Balbin E, Bateman L, Felsenstein D, et al. Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome. Fatigue Biomed Health Behav. 2015;3:75&#x2013;96. doi: 10.1080/21641846.2015.1023652.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21641846.2015.1023652</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121(12):953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType=\"pubmed\">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndrome. 2003;11:7&#x2013;115. doi: 10.1300/J092v11n01_02.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30(6):473&#x2013;483. doi: 10.1097/00005650-199206000-00002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00005650-199206000-00002</ArticleId><ArticleId IdType=\"pubmed\">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Smets EM, Garssen B, Bonke B, De Haes JC. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315&#x2013;325. doi: 10.1016/0022-3999(94)00125-O.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0022-3999(94)00125-O</ArticleId><ArticleId IdType=\"pubmed\">7636775</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald W, Freeman ML, Lederman MM, Vasilieva E, Romero R, Margolis L. A System of cytokines encapsulated in extracellular vesicles. Sci Rep. 2018;8(1):8973. doi: 10.1038/s41598-018-27190-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-018-27190-x</ArticleId><ArticleId IdType=\"pmc\">PMC5997670</ArticleId><ArticleId IdType=\"pubmed\">29895824</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber PJ. Robust statistics. New York: John Wiley &amp; Sons; 1981.</Citation></Reference><Reference><Citation>Huber PJ. Robust estimation of a location parameter. Ann Math Stat. 1964;35:73&#x2013;101. doi: 10.1214/aoms/1177703732.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1214/aoms/1177703732</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg FH. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57(1):289&#x2013;300.</Citation></Reference><Reference><Citation>Benjamini Y, Krieger AM, Yekutieli D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika. 2006;3(3):491&#x2013;507. doi: 10.1093/biomet/93.3.491.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/biomet/93.3.491</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiman L. Random forests. Mach Learn. 2001;45:5&#x2013;32. doi: 10.1023/A:1010933404324.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1023/A:1010933404324</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Guestrin C, editors. XGBoost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining KDD 16; 2016.</Citation></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the lasso. J Roy Stat Soc Ser B. 1996;58:267&#x2013;288.</Citation></Reference><Reference><Citation>Yanez-Mo M, Siljander PR, Andreu Z, Zavec AB, Borras FE, Buzas EI, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066. doi: 10.3402/jev.v4.27066.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3402/jev.v4.27066</ArticleId><ArticleId IdType=\"pmc\">PMC4433489</ArticleId><ArticleId IdType=\"pubmed\">25979354</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Montoya JG, Klimas NG, Levine S, Felsenstein D, Bateman L, et al. Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci Adv. 2015;1(1):e1400121. doi: 10.1126/sciadv.1400121.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/sciadv.1400121</ArticleId><ArticleId IdType=\"pmc\">PMC4465185</ArticleId><ArticleId IdType=\"pubmed\">26079000</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Serrano-Pertierra E, Oliveira-Rodriguez M, Zaragoza MC, Martinez-Martinez A, Blanco-Lopez MDC, et al. Circulating extracellular vesicles as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis: an exploratory pilot study. J Extracell Vesicles. 2018;7(1):1453730. doi: 10.1080/20013078.2018.1453730.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/20013078.2018.1453730</ArticleId><ArticleId IdType=\"pmc\">PMC5912186</ArticleId><ArticleId IdType=\"pubmed\">29696075</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ, et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci USA. 2017;114(34):E7150&#x2013;E7158. doi: 10.1073/pnas.1710519114.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1710519114</ArticleId><ArticleId IdType=\"pmc\">PMC5576836</ArticleId><ArticleId IdType=\"pubmed\">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Gaglio CL, Furst J, Islam M, Sorenson M, Conroy KE, et al. Cytokine network analysis in a community-based pediatric sample of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chronic Illn. 2022 doi: 10.1177/17423953221101606.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/17423953221101606</ArticleId><ArticleId IdType=\"pmc\">PMC9666669</ArticleId><ArticleId IdType=\"pubmed\">35570777</ArticleId></ArticleIdList></Reference><Reference><Citation>Strawbridge R, Sartor ML, Scott F, Cleare AJ. Inflammatory proteins are altered in chronic fatigue syndrome&#x2014;a systematic review and meta-analysis. Neurosci Biobehav Rev. 2019;107:69&#x2013;83. doi: 10.1016/j.neubiorev.2019.08.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neubiorev.2019.08.011</ArticleId><ArticleId IdType=\"pubmed\">31465778</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Gottschalk G, Peterson D, Knox K, Schultz A, Eddy M, et al. Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. Mol Psychiatry. 2016;21(2):261&#x2013;269. doi: 10.1038/mp.2015.29.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/mp.2015.29</ArticleId><ArticleId IdType=\"pubmed\">25824300</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheney PR, Dorman SE, Bell DS. Interleukin-2 and the chronic fatigue syndrome. Ann Intern Med. 1989;110(4):321. doi: 10.7326/0003-4819-110-4-321_1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-110-4-321_1</ArticleId><ArticleId IdType=\"pubmed\">2783643</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Cotler J, Islam MF, Furst J, Sorenson M, Katz BZ. Cytokine networks analysis uncovers further differences between those who develop myalgic encephalomyelitis/chronic fatigue syndrome following infectious mononucleosis. Fatigue Biomed Health Behav. 2021;9(1):45&#x2013;57. doi: 10.1080/21641846.2021.1915131.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21641846.2021.1915131</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Dorling A. Critical roles for thrombin in acute and chronic inflammation. J Thromb Haemost. 2009;7(Suppl 1):122&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19630783</ArticleId></ArticleIdList></Reference><Reference><Citation>Hercus TR, Broughton SE, Ekert PG, Ramshaw HS, Perugini M, Grimbaldeston M, et al. The GM-CSF receptor family: mechanism of activation and implications for disease. Growth Factors. 2012;30(2):63&#x2013;75. doi: 10.3109/08977194.2011.649919.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/08977194.2011.649919</ArticleId><ArticleId IdType=\"pubmed\">22257375</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyette LB, Macedo C, Hadi K, Elinoff BD, Walters JT, Ramaswami B, et al. Phenotype, function, and differentiation potential of human monocyte subsets. PLoS ONE. 2017;12(4):e0176460. doi: 10.1371/journal.pone.0176460.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0176460</ArticleId><ArticleId IdType=\"pmc\">PMC5406034</ArticleId><ArticleId IdType=\"pubmed\">28445506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed F, Vu LT, Zhu H, Iu DSH, Fogarty EA, Kwak Y, et al. Single-cell transcriptomics of the immune system in ME/CFS at baseline and following symptom provocation. BioRXiv. 2022 doi: 10.1101/2022.10.13.512091.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2022.10.13.512091</ArticleId><ArticleId IdType=\"pubmed\">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29(6):313&#x2013;326. doi: 10.1089/jir.2008.0027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/jir.2008.0027</ArticleId><ArticleId IdType=\"pmc\">PMC2755091</ArticleId><ArticleId IdType=\"pubmed\">19441883</ArticleId></ArticleIdList></Reference><Reference><Citation>Stringer EA, Baker KS, Carroll IR, Montoya JG, Chu L, Maecker HT, et al. Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology. J Transl Med. 2013;11:93. doi: 10.1186/1479-5876-11-93.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-11-93</ArticleId><ArticleId IdType=\"pmc\">PMC3637529</ArticleId><ArticleId IdType=\"pubmed\">23570606</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazirinejad R, Ahmadi Z, Kazemi Arababadi M, Hassanshahi G, Kennedy D. The biological functions, structure and sources of CXCL10 and its outstanding part in the pathophysiology of multiple sclerosis. NeuroImmunoModulation. 2014;21(6):322&#x2013;330. doi: 10.1159/000357780.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000357780</ArticleId><ArticleId IdType=\"pubmed\">24642726</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011;477(7362):90&#x2013;94. doi: 10.1038/nature10357.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature10357</ArticleId><ArticleId IdType=\"pmc\">PMC3170097</ArticleId><ArticleId IdType=\"pubmed\">21886162</ArticleId></ArticleIdList></Reference><Reference><Citation>Patarca R, Klimas NG, Lugtendorf S, Antoni M, Fletcher MA. Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. Clin Infect Dis. 1994;18(Suppl 1):S147&#x2013;S153. doi: 10.1093/clinids/18.Supplement_1.S147.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/clinids/18.Supplement_1.S147</ArticleId><ArticleId IdType=\"pubmed\">8148443</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss RB, Mercandetti A, Vojdani A. TNF-alpha and chronic fatigue syndrome. J Clin Immunol. 1999;19(5):314&#x2013;316. doi: 10.1023/A:1020595709352.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1023/A:1020595709352</ArticleId><ArticleId IdType=\"pubmed\">10535608</ArticleId></ArticleIdList></Reference><Reference><Citation>Fruhbeck G, Catalan V, Ramirez B, Valenti V, Becerril S, Rodriguez A, et al. Serum levels of IL-1 RA increase with obesity and type 2 diabetes in relation to adipose tissue dysfunction and are reduced after bariatric surgery in parallel to adiposity. J Inflamm Res. 2022;15:1331&#x2013;1345. doi: 10.2147/JIR.S354095.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/JIR.S354095</ArticleId><ArticleId IdType=\"pmc\">PMC8884708</ArticleId><ArticleId IdType=\"pubmed\">35237063</ArticleId></ArticleIdList></Reference><Reference><Citation>Luotola K. IL-1 receptor antagonist (IL-1Ra) levels and management of metabolic disorders. Nutrients. 2022;14(16):3422. doi: 10.3390/nu14163422.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu14163422</ArticleId><ArticleId IdType=\"pmc\">PMC9415765</ArticleId><ArticleId IdType=\"pubmed\">36014927</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher MA, Zeng XR, Barnes Z, Levis S, Klimas NG. Plasma cytokines in women with chronic fatigue syndrome. J Transl Med. 2009;7:96. doi: 10.1186/1479-5876-7-96.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-7-96</ArticleId><ArticleId IdType=\"pmc\">PMC2779802</ArticleId><ArticleId IdType=\"pubmed\">19909538</ArticleId></ArticleIdList></Reference><Reference><Citation>Gierula M, Ahnstrom J. Anticoagulant protein S-New insights on interactions and functions. J Thromb Haemost. 2020;18(11):2801&#x2013;2811. doi: 10.1111/jth.15025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jth.15025</ArticleId><ArticleId IdType=\"pubmed\">32702208</ArticleId></ArticleIdList></Reference><Reference><Citation>Taheri H, Filion KB, Windle SB, Reynier P, Eisenberg MJ. Cholesteryl ester transfer protein inhibitors and cardiovascular outcomes: a systematic review and meta-analysis of randomized controlled trials. Cardiology. 2020;145(4):236&#x2013;250. doi: 10.1159/000505365.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000505365</ArticleId><ArticleId IdType=\"pubmed\">32172237</ArticleId></ArticleIdList></Reference><Reference><Citation>Maya J, Leddy S, Gottschalk C, Peterson D, Hanson MR. Altered fatty acid oxidation in lymphocyte populations of myalgic encephalomyelitis/chronic fatigue syndrome. Int J Mol Med. 2023;24(3):2010.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9916395</ArticleId><ArticleId IdType=\"pubmed\">36768336</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Geiger M. Cell penetrating SERPINA5 (ProteinC inhibitor, PCI): more questions than answers. Semin Cell Dev Biol. 2017;62:187&#x2013;193. doi: 10.1016/j.semcdb.2016.10.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.semcdb.2016.10.007</ArticleId><ArticleId IdType=\"pubmed\">27989561</ArticleId></ArticleIdList></Reference><Reference><Citation>Marlar RA, Griffin JH. Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J Clin Invest. 1980;66(5):1186&#x2013;1189. doi: 10.1172/JCI109952.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI109952</ArticleId><ArticleId IdType=\"pmc\">PMC371561</ArticleId><ArticleId IdType=\"pubmed\">6253526</ArticleId></ArticleIdList></Reference><Reference><Citation>Elisen MG, von dem Borne PA, Bouma BN, Meijers JC. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma. Blood. 1998;91(5):1542&#x2013;1547. doi: 10.1182/blood.V91.5.1542.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood.V91.5.1542</ArticleId><ArticleId IdType=\"pubmed\">9473218</ArticleId></ArticleIdList></Reference><Reference><Citation>Prendes MJ, Bielek E, Zechmeister-Machhart M, Vanyek-Zavadil E, Carroll VA, Breuss J, et al. Synthesis and ultrastructural localization of protein C inhibitor in human platelets and megakaryocytes. Blood. 1999;94(4):1300&#x2013;1312. doi: 10.1182/blood.V94.4.1300.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood.V94.4.1300</ArticleId><ArticleId IdType=\"pubmed\">10438718</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes JM, Kruger A, Proal A, Kell DB, Pretorius E. The occurrence of hyperactivated platelets and fibrinaloid microclots in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Pharmaceuticals. 2022;15(8):931. doi: 10.3390/ph15080931.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ph15080931</ArticleId><ArticleId IdType=\"pmc\">PMC9413879</ArticleId><ArticleId IdType=\"pubmed\">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajeevan MS, Dimulescu I, Murray J, Falkenberg VR, Unger ER. Pathway-focused genetic evaluation of immune and inflammation related genes with chronic fatigue syndrome. Hum Immunol. 2015;76(8):553&#x2013;560. doi: 10.1016/j.humimm.2015.06.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.humimm.2015.06.014</ArticleId><ArticleId IdType=\"pubmed\">26116897</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilli C, Hoeh AE, De Rossi G, Moss SE, Greenwood J. LRG1: an emerging player in disease pathogenesis. J Biomed Sci. 2022;29(1):6. doi: 10.1186/s12929-022-00790-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12929-022-00790-6</ArticleId><ArticleId IdType=\"pmc\">PMC8781713</ArticleId><ArticleId IdType=\"pubmed\">35062948</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 2002;110(6):771&#x2013;781. doi: 10.1172/JCI0215463.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI0215463</ArticleId><ArticleId IdType=\"pmc\">PMC151128</ArticleId><ArticleId IdType=\"pubmed\">12235108</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemmons DR. The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity. J Clin Invest. 2004;113(1):25&#x2013;27. doi: 10.1172/JCI20660.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI20660</ArticleId><ArticleId IdType=\"pmc\">PMC300772</ArticleId><ArticleId IdType=\"pubmed\">14702105</ArticleId></ArticleIdList></Reference><Reference><Citation>Bittermann E, Abdelhamed Z, Liegel RP, Menke C, Timms A, Beier DR, et al. Differential requirements of tubulin genes in mammalian forebrain development. PLoS Genet. 2019;15(8):e1008243. doi: 10.1371/journal.pgen.1008243.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pgen.1008243</ArticleId><ArticleId IdType=\"pmc\">PMC6697361</ArticleId><ArticleId IdType=\"pubmed\">31386652</ArticleId></ArticleIdList></Reference><Reference><Citation>Sordillo PP, Sordillo LA. The mystery of chemotherapy brain: kynurenines, tubulin and biophoton release. Anticancer Res. 2020;40(3):1189&#x2013;1200. doi: 10.21873/anticanres.14061.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.21873/anticanres.14061</ArticleId><ArticleId IdType=\"pubmed\">32132016</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez AR, Hancock EE, Adebayo S, Kiernicki DJ, Proskauer D, Attewell JR, et al. Estimating prevalence, demographics, and costs of ME/CFS using large scale medical claims data and machine learning. Front Pediatr. 2019;6:412. doi: 10.3389/fped.2018.00412.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2018.00412</ArticleId><ArticleId IdType=\"pmc\">PMC6331450</ArticleId><ArticleId IdType=\"pubmed\">30671425</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Giloteaux L, Moore GE, Levine SM, Chia JK, Keller BA, et al. Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 2022 doi: 10.1172/jci.insight.157621.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/jci.insight.157621</ArticleId><ArticleId IdType=\"pmc\">PMC9090259</ArticleId><ArticleId IdType=\"pubmed\">35358096</ArticleId></ArticleIdList></Reference><Reference><Citation>Nkiliza A, Parks M, Cseresznye A, Oberlin S, Evans JE, Darcey T, et al. Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms. J Transl Med. 2021;19(1):1&#x2013;15. doi: 10.1186/s12967-021-03035-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-021-03035-6</ArticleId><ArticleId IdType=\"pmc\">PMC8401202</ArticleId><ArticleId IdType=\"pubmed\">34454515</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson D, Brenu E, Gottschalk G, Ramos S, Nguyen T, Staines D, et al. Cytokines in the cerebrospinal fluids of patients with chronic fatigue syndrome/myalgic encephalomyelitis. Mediat Inflamm. 2015;2015:1&#x2013;4. doi: 10.1155/2015/929720.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2015/929720</ArticleId><ArticleId IdType=\"pmc\">PMC4365360</ArticleId><ArticleId IdType=\"pubmed\">25834308</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning PJ, Sutherland WH, McGrath MM, De Jong SA, Walker RJ, Williams MJ. Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity. 2008;16(9):2046&#x2013;2052. doi: 10.1038/oby.2008.334.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/oby.2008.334</ArticleId><ArticleId IdType=\"pubmed\">19186329</ArticleId></ArticleIdList></Reference><Reference><Citation>Netea SA, Janssen SA, Jaeger M, Jansen T, Jacobs L, Miller-Tomaszewska G, et al. Chocolate consumption modulates cytokine production in healthy individuals. Cytokine. 2013;62(1):40&#x2013;43. doi: 10.1016/j.cyto.2013.02.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cyto.2013.02.003</ArticleId><ArticleId IdType=\"pubmed\">23465690</ArticleId></ArticleIdList></Reference><Reference><Citation>Solis-Pereyra B, Aattouri N, Lemonnier D. Role of food in the stimulation of cytokine production. Am J Clin Nutr. 1997;66(2):521S&#x2013;S525. doi: 10.1093/ajcn/66.2.521S.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ajcn/66.2.521S</ArticleId><ArticleId IdType=\"pubmed\">9250142</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37177559</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1424-8220</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>23</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>Broadband Electrical Spectroscopy to Distinguish Single-Cell Ca<sup>2+</sup> Changes Due to Ionomycin Treatment in a Skeletal Muscle Cell Line.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">4358</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/s23094358</ELocationID><Abstract><AbstractText>Many skeletal muscle diseases such as muscular dystrophy, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and sarcopenia share the dysregulation of calcium (Ca<sup>2+</sup>) as a key mechanism of disease at a cellular level. Cytosolic concentrations of Ca<sup>2+</sup> can signal dysregulation in organelles including the mitochondria, nucleus, and sarcoplasmic reticulum in skeletal muscle. In this work, a treatment is applied to mimic the Ca<sup>2+</sup> increase associated with these atrophy-related disease states, and broadband impedance measurements are taken for single cells with and without this treatment using a microfluidic device. The resulting impedance measurements are fitted using a single-shell circuit simulation to show calculated electrical dielectric property contributions based on these Ca<sup>2+</sup> changes. From this, similar distributions were seen in the Ca<sup>2+</sup> from fluorescence measurements and the distribution of the S-parameter at a single frequency, identifying Ca<sup>2+</sup> as the main contributor to the electrical differences being identified. Extracted dielectric parameters also showed different distribution patterns between the untreated and ionomycin-treated groups; however, the overall electrical parameters suggest the impact of Ca<sup>2+</sup>-induced changes at a wider range of frequencies.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Ferguson</LastName><ForeName>Caroline A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, P.C. Rossin College of Engineering and Applied Sciences, Lehigh University, Bethlehem, PA 18015, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Santangelo</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Imaging and Clinical Sciences, University \"G. d\\'Annunzio\" Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Marramiero</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Imaging and Clinical Sciences, University \"G. d\\'Annunzio\" Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Farina</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Engineering of Information, University Politecnica delle Marche, 60131 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pietrangelo</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><Identifier Source=\"ORCID\">0000-0002-7507-1255</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Imaging and Clinical Sciences, University \"G. d\\'Annunzio\" Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cheng</LastName><ForeName>Xuanhong</ForeName><Initials>X</Initials><Identifier Source=\"ORCID\">0000-0002-6331-8572</Identifier><AffiliationInfo><Affiliation>Department of Bioengineering, P.C. Rossin College of Engineering and Applied Sciences, Lehigh University, Bethlehem, PA 18015, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Materials Science and Engineering, P.C. Rossin College of Engineering and Applied Sciences, Lehigh University, Bethlehem, PA 18015, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>1809623</GrantID><Agency>National Science Foundation, Division of Electrical, Communications &amp; Cyber Systems</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>56092-81-0</RegistryNumber><NameOfSubstance UI=\"D015759\">Ionomycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI=\"D002118\">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D015759\" MajorTopicYN=\"N\">Ionomycin</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D018485\" MajorTopicYN=\"Y\">Muscle Fibers, Skeletal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018482\" MajorTopicYN=\"Y\">Muscle, Skeletal</DescriptorName><QualifierName UI=\"Q000502\" MajorTopicYN=\"N\">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002460\" MajorTopicYN=\"N\">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D013057\" MajorTopicYN=\"N\">Spectrum Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002118\" MajorTopicYN=\"N\">Calcium</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">broadband impedance spectroscopy</Keyword><Keyword MajorTopicYN=\"N\">circuit modeling</Keyword><Keyword MajorTopicYN=\"N\">intracellular calcium</Keyword><Keyword MajorTopicYN=\"N\">single-cell characterization</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>1</Hour><Minute>39</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37177559</ArticleId><ArticleId IdType=\"pmc\">PMC10181519</ArticleId><ArticleId IdType=\"doi\">10.3390/s23094358</ArticleId><ArticleId IdType=\"pii\">s23094358</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beccafico S., Puglielli C., Pietrangelo T., Bellomo R., Fano G., Fulle S. Age-Dependent Effects on Functional Aspects in Human Satellite Cells. Ann. N. Y. Acad. Sci. 2007;1100:345&#x2013;352. doi: 10.1196/annals.1395.037.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1196/annals.1395.037</ArticleId><ArticleId IdType=\"pubmed\">17460197</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo-Sagua R., Parra V., Mu&#xf1;oz-Cordova F., Sanchez-Aguilera P., Garrido V., Contreras-Ferrat A., Chiong M., Lavandero S. Chapter Five&#x2014;Sarcoplasmic Reticulum and Calcium Signaling in Muscle Cells: Homeostasis and Disease. In: Kepp O., Galluzzi L., editors. International Review of Cell and Molecular Biology. Volume 350. Academic Press; Cambridge, MA, USA: 2020. pp. 197&#x2013;264. Biology of the Endoplasmic Reticulum.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32138900</ArticleId></ArticleIdList></Reference><Reference><Citation>Protasi F., Pietrangelo L., Boncompagni S. Calcium Entry Units (CEUs): Perspectives in Skeletal Muscle Function and Disease. J. Muscle Res. Cell Motil. 2021;42:233&#x2013;249. doi: 10.1007/s10974-020-09586-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10974-020-09586-3</ArticleId><ArticleId IdType=\"pmc\">PMC8332569</ArticleId><ArticleId IdType=\"pubmed\">32812118</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa A., Henr&#xed;quez-Olgu&#xed;n C., Jaimovich E. Reactive Oxygen Species and Calcium Signals in Skeletal Muscle: A Crosstalk Involved in Both Normal Signaling and Disease. Cell Calcium. 2016;60:172&#x2013;179. doi: 10.1016/j.ceca.2016.02.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ceca.2016.02.010</ArticleId><ArticleId IdType=\"pubmed\">26965208</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal A., Suryakumar G., Rathor R. Role of Defective Ca2+ Signaling in Skeletal Muscle Weakness: Pharmacological Implications. J. Cell Commun. Signal. 2018;12:645&#x2013;659. doi: 10.1007/s12079-018-0477-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12079-018-0477-z</ArticleId><ArticleId IdType=\"pmc\">PMC6235775</ArticleId><ArticleId IdType=\"pubmed\">29982883</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerwyn M., Maes M. Mechanisms Explaining Muscle Fatigue and Muscle Pain in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Review of Recent Findings. Curr. Rheumatol. Rep. 2017;19:1. doi: 10.1007/s11926-017-0628-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11926-017-0628-x</ArticleId><ArticleId IdType=\"pubmed\">28116577</ArticleId></ArticleIdList></Reference><Reference><Citation>Dargelos E., Brul&#xe9; C., Combaret L., Hadj-Sassi A., Dulong S., Poussard S., Cottin P. Involvement of the Calcium-Dependent Proteolytic System in Skeletal Muscle Aging. Exp. Gerontol. 2007;42:1088&#x2013;1098. doi: 10.1016/j.exger.2007.08.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.exger.2007.08.009</ArticleId><ArticleId IdType=\"pubmed\">17937979</ArticleId></ArticleIdList></Reference><Reference><Citation>Leijendekker W.J., Passaquin A.-C., Metzinger L., R&#xfc;egg U.T. Regulation of Cytosolic Calcium in Skeletal Muscle Cells of the Mdx Mouse under Conditions of Stress. Br. J. Pharmacol. 1996;118:611&#x2013;616. doi: 10.1111/j.1476-5381.1996.tb15445.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1476-5381.1996.tb15445.x</ArticleId><ArticleId IdType=\"pmc\">PMC1909736</ArticleId><ArticleId IdType=\"pubmed\">8762085</ArticleId></ArticleIdList></Reference><Reference><Citation>Berchtold M.W., Brinkmeier H., M&#xfc;ntener M. Calcium Ion in Skeletal Muscle: Its Crucial Role for Muscle Function, Plasticity, and Disease. Physiol. Rev. 2000;80:1215&#x2013;1265. doi: 10.1152/physrev.2000.80.3.1215.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/physrev.2000.80.3.1215</ArticleId><ArticleId IdType=\"pubmed\">10893434</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W., Tang D., Ni Z., Xiang N., Yi H. A Portable Single-Cell Analysis System Integrating Hydrodynamic Trapping with Broadband Impedance Spectroscopy. Sci. China Technol. Sci. 2017;60:1707&#x2013;1715. doi: 10.1007/s11431-017-9129-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11431-017-9129-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao X., Ocket I., Bao J., Doijen J., Zheng J., Kil D., Liu Z., Puers B., Schreurs D., Nauwelaers B. Broadband Dielectric Spectroscopy of Cell Cultures. IEEE Trans. Microw. Theory Tech. 2018;66:5750&#x2013;5759. doi: 10.1109/TMTT.2018.2873395.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1109/TMTT.2018.2873395</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning Y., Multari C., Luo X., Palego C., Cheng X., Hwang J.C.M., Denzi A., Merla C., Apollonio F., Liberti M. Broadband Electrical Detection of Individual Biological Cells. IEEE Trans. Microw. Theory Tech. 2014;62:1905&#x2013;1911. doi: 10.1109/TMTT.2014.2342660.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1109/TMTT.2014.2342660</ArticleId></ArticleIdList></Reference><Reference><Citation>Grenier K., Tamra A., Zedek A., Poiroux G., Artis F., Chen T., Chen W., Poupot M., Fournie J.-J., Dubuc D. Low Volume and Label-Free Molecules Characterization and Cell Monitoring with Microwave Dielectric Spectroscopy; Proceedings of the 2018 IEEE International Microwave Biomedical Conference (IMBioC); Philadelphia, PA, USA. 14&#x2013;15 June 2018; Piscataway, NJ, USA: IEEE; 2018. pp. 82&#x2013;84.</Citation></Reference><Reference><Citation>Foster K.R., Schwan H.P. Dielectric Properties of Tissues and Biological Materials: A Critical Review. Crit. Rev. Biomed. Eng. 1989;17:25&#x2013;104.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2651001</ArticleId></ArticleIdList></Reference><Reference><Citation>Markx G.H., Davey C.L. The Dielectric Properties of Biological Cells at Radiofrequencies: Applications in Biotechnology. Enzym. Microb. Technol. 1999;25:161&#x2013;171. doi: 10.1016/S0141-0229(99)00008-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0141-0229(99)00008-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasir N., Al Ahmad M. Cells Electrical Characterization: Dielectric Properties, Mixture, and Modeling Theories. J. Eng. 2020;2020:9475490. doi: 10.1155/2020/9475490.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2020/9475490</ArticleId></ArticleIdList></Reference><Reference><Citation>Grenier K., Dubuc D., Chen T., Artis F., Chretiennot T., Poupot M., Fournie J.-J. Recent Advances in Microwave-Based Dielectric Spectroscopy at the Cellular Level for Cancer Investigations. IEEE Trans. Microw. Theory Tech. 2013;61:2023&#x2013;2030. doi: 10.1109/TMTT.2013.2255885.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1109/TMTT.2013.2255885</ArticleId></ArticleIdList></Reference><Reference><Citation>ATCC  L6&#x2014;CRL-1458.  [(accessed on 24 October 2022)].  Available online:  https://www.atcc.org/products/crl-1458.</Citation></Reference><Reference><Citation>Fioretti B., Pietrangelo T., Catacuzzeno L., Franciolini F. Intermediate-Conductance Ca2+-Activated K+ Channel Is Expressed in C2C12 Myoblasts and Is Downregulated during Myogenesis. Am. J. Physiol. Cell Physiol. 2005;289:C89&#x2013;C96. doi: 10.1152/ajpcell.00369.2004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpcell.00369.2004</ArticleId><ArticleId IdType=\"pubmed\">15743891</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrangelo T., Mariggi&#xf2; M.A., Lorenzon P., Fulle S., Protasi F., Rathbone M., Werstiuk E., Fan&#xf2; G. Characterization of Specific GTP Binding Sites in C2C12 Mouse Skeletal Muscle Cells. J. Muscle Res. Cell Motil. 2002;23:107&#x2013;118. doi: 10.1023/A:1020288117082.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1023/A:1020288117082</ArticleId><ArticleId IdType=\"pubmed\">12416717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson C., Pini N., Du X., Farina M., Hwang J.M.C., Pietrangelo T., Cheng X. Broadband Electrical Impedance as a Novel Characterization of Oxidative Stress in Single L6 Skeletal Muscle Cells. Anal. Chim. Acta. 2021;1173:338678. doi: 10.1016/j.aca.2021.338678.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.aca.2021.338678</ArticleId><ArticleId IdType=\"pubmed\">34172152</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X., Ferguson C., Ma X., Cheng X., Hwang J.C.M. Ultra-Wideband Impedance Spectroscopy of the Nucleus in a Live Cell. IEEE J. Electromagn. RF Microw. Med. Biol. 2021;6:267&#x2013;272. doi: 10.1109/JERM.2021.3121258.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1109/JERM.2021.3121258</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X., Ladegard C., Ma X., Cheng X., Hwang J.C.M. Broadband Electrical Sensing of Nucleus Size in a Live Cell from 900 Hz to 40 GHz; Proceedings of the 2020 IEEE MTT-S International Microwave Biomedical Conference (IMBioC); Toulouse, France. 14&#x2013;17 December 2020; pp. 1&#x2013;4.</Citation></Reference><Reference><Citation>Caspers F. RF Engineering Basic Concepts: S-Parameters. arXiv. 20121201.2346v1</Citation></Reference><Reference><Citation>Kidokoro Y. Developmental Changes of Membrane Electrical Properties in a Rat Skeletal Muscle Cell Line. J. Physiol. 1975;244:129&#x2013;143. doi: 10.1113/jphysiol.1975.sp010787.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1113/jphysiol.1975.sp010787</ArticleId><ArticleId IdType=\"pmc\">PMC1330748</ArticleId><ArticleId IdType=\"pubmed\">1168256</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., Du X., Multari C.R., Ning Y., Luo X., Gholizadeh V., Palego C., Cheng X., Hwang J.C.M. Reproducible Broadband Measurement for Cytoplasm Capacitance of a Biological Cell; Proceedings of the 2016 IEEE MTT-S International Microwave Symposium (IMS); San Francisco, CA, USA. 22&#x2013;27 May 2016; Piscataway, NJ, USA: IEEE; 2016. pp. 1&#x2013;4.</Citation></Reference><Reference><Citation>Erdahl W.L., Chapman C.J., Taylor R.W., Pfeiffer D.R. Ca2+ Transport Properties of Ionophores A23187, Ionomycin, and 4-BrA23187 in a Well Defined Model System. Biophys. J. 1994;66:1678&#x2013;1693. doi: 10.1016/S0006-3495(94)80959-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0006-3495(94)80959-2</ArticleId><ArticleId IdType=\"pmc\">PMC1275887</ArticleId><ArticleId IdType=\"pubmed\">8061216</ArticleId></ArticleIdList></Reference><Reference><Citation>Caridha D., Yourick D., Cabezas M., Wolf L., Hudson T.H., Dow G.S. Mefloquine-Induced Disruption of Calcium Homeostasis in Mammalian Cells Is Similar to That Induced by Ionomycin. Antimicrob. Agents Chemother. 2008;52:684&#x2013;693. doi: 10.1128/AAC.00874-07.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/AAC.00874-07</ArticleId><ArticleId IdType=\"pmc\">PMC2224738</ArticleId><ArticleId IdType=\"pubmed\">17999964</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf6;zer E.B., Vernier P.T. Modulation of Biological Responses to 2 ns Electrical Stimuli by Field Reversal. Biochim. Biophys. Acta (BBA)&#x2014;Biomembr. 2019;1861:1228&#x2013;1239. doi: 10.1016/j.bbamem.2019.03.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamem.2019.03.019</ArticleId><ArticleId IdType=\"pubmed\">30981731</ArticleId></ArticleIdList></Reference><Reference><Citation>Pakhomova O.N., Gregory B., Semenov I., Pakhomov A.G. Calcium-Mediated Pore Expansion and Cell Death Following Nanoelectroporation. Biochim. Biophys. Acta. 2014;1838:2547&#x2013;2554. doi: 10.1016/j.bbamem.2014.06.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamem.2014.06.015</ArticleId><ArticleId IdType=\"pmc\">PMC4125538</ArticleId><ArticleId IdType=\"pubmed\">24978108</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke R.C., Bardet S.M., Carr L., Romanenko S., Arnaud-Cormos D., Leveque P., O&#x2019;Connor R.P. Nanosecond Pulsed Electric Fields Depolarize Transmembrane Potential via Voltage-Gated K+, Ca2+ and TRPM8 Channels in U87 Glioblastoma Cells. Biochim. Biophys. Acta Biomembr. 2017;1859:2040&#x2013;2050. doi: 10.1016/j.bbamem.2017.07.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamem.2017.07.004</ArticleId><ArticleId IdType=\"pubmed\">28693898</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Blackmore P.F., Hargrave B.Y., Xiao S., Beebe S.J., Schoenbach K.H. Nanosecond Pulse Electric Field (Nanopulse): A Novel Non-Ligand Agonist for Platelet Activation. Arch. Biochem. Biophys. 2008;471:240&#x2013;248. doi: 10.1016/j.abb.2007.12.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.abb.2007.12.009</ArticleId><ArticleId IdType=\"pubmed\">18177729</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller C., Hellsten Y., Steensberg A., Klarlund Pedersen B. Differential Regulation of IL-6 and TNF-&#x3b1; via Calcineurin in Human Skeletal Muscle Cells. Cytokine. 2006;36:141&#x2013;147. doi: 10.1016/j.cyto.2006.10.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cyto.2006.10.014</ArticleId><ArticleId IdType=\"pubmed\">17197194</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes A.G., Watt M.J., Carey A.L., Febbraio M.A. Ionomycin, but Not Physiologic Doses of Epinephrine, Stimulates Skeletal Muscle Interleukin-6 MRNA Expression and Protein Release. Metabolism. 2004;53:1492&#x2013;1495. doi: 10.1016/j.metabol.2004.05.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.metabol.2004.05.015</ArticleId><ArticleId IdType=\"pubmed\">15536607</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Zhao Y., Shang X., Ren H., Zhao Y., Liu X. CAIII Expression in Skeletal Muscle Is Regulated by Ca2+&#x2013;CaMKII&#x2013;MEF2C Signaling. Exp. Cell Res. 2019;385:111672. doi: 10.1016/j.yexcr.2019.111672.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.yexcr.2019.111672</ArticleId><ArticleId IdType=\"pubmed\">31614133</ArticleId></ArticleIdList></Reference><Reference><Citation>Roufa D., Wu F.S., Martonosi A.N. The Effect of Ca2+ Ionophores upon the Synthesis of Proteins in Cultured Skeletal Muscle. Biochim. Biophys. Acta (BBA)&#x2014;Gen. Subj. 1981;674:225&#x2013;237. doi: 10.1016/0304-4165(81)90380-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0304-4165(81)90380-9</ArticleId><ArticleId IdType=\"pubmed\">6786362</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrangelo T., Di Filippo E.S., Mancinelli R., Doria C., Rotini A., Fan&#xf2;-Illic G., Fulle S. Low Intensity Exercise Training Improves Skeletal Muscle Regeneration Potential. Front. Physiol. 2015;6:399. doi: 10.3389/fphys.2015.00399.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2015.00399</ArticleId><ArticleId IdType=\"pmc\">PMC4689811</ArticleId><ArticleId IdType=\"pubmed\">26733888</ArticleId></ArticleIdList></Reference><Reference><Citation>Petchakup C., Tay H.M., Li K.H.H., Hou H.W. Integrated Inertial-Impedance Cytometry for Rapid Label-Free Leukocyte Isolation and Profiling of Neutrophil Extracellular Traps (NETs) Lab Chip. 2019;19:1736&#x2013;1746. doi: 10.1039/C9LC00250B.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C9LC00250B</ArticleId><ArticleId IdType=\"pubmed\">31020286</ArticleId></ArticleIdList></Reference><Reference><Citation>Funkner S., Niehues G., Schmidt D.A., Heyden M., Schwaab G., Callahan K.M., Tobias D.J., Havenith M. Watching the Low-Frequency Motions in Aqueous Salt Solutions: The Terahertz Vibrational Signatures of Hydrated Ions. J. Am. Chem. Soc. 2012;134:1030&#x2013;1035. doi: 10.1021/ja207929u.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/ja207929u</ArticleId><ArticleId IdType=\"pubmed\">22124334</ArticleId></ArticleIdList></Reference><Reference><Citation>Balos V., Kaliannan N.K., Elgabarty H., Wolf M., K&#xfc;hne T.D., Sajadi M. Time-Resolved Terahertz&#x2013;Raman Spectroscopy Reveals That Cations and Anions Distinctly Modify Intermolecular Interactions of Water. Nat. Chem. 2022;14:1031&#x2013;1037. doi: 10.1038/s41557-022-00977-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41557-022-00977-2</ArticleId><ArticleId IdType=\"pmc\">PMC9417992</ArticleId><ArticleId IdType=\"pubmed\">35773490</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleichmann M., Mattson M.P. Neuronal Calcium Homeostasis and Dysregulation. Antioxid. Redox Signal. 2011;14:1261&#x2013;1273. doi: 10.1089/ars.2010.3386.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/ars.2010.3386</ArticleId><ArticleId IdType=\"pmc\">PMC3048837</ArticleId><ArticleId IdType=\"pubmed\">20626318</ArticleId></ArticleIdList></Reference><Reference><Citation>Brini M., Cal&#xec; T., Ottolini D., Carafoli E. Neuronal Calcium Signaling: Function and Dysfunction. Cell. Mol. Life Sci. 2014;71:2787&#x2013;2814. doi: 10.1007/s00018-013-1550-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00018-013-1550-7</ArticleId><ArticleId IdType=\"pubmed\">24442513</ArticleId></ArticleIdList></Reference><Reference><Citation>Mil&#xe1;n A.F., Rinc&#xf3;n O.A., Arango L.B., Reutovich A.A., Smith G.L., Giraldo M.A., Bou-Abdallah F., Calder&#xf3;n J.C. Calibration of Mammalian Skeletal Muscle Ca2+ Transients Recorded with the Fast Ca2+ Dye Mag-Fluo-4. Biochim. Biophys. Acta (BBA)&#x2014;Gen. Subj. 2021;1865:129939. doi: 10.1016/j.bbagen.2021.129939.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbagen.2021.129939</ArticleId><ArticleId IdType=\"pubmed\">34082059</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37170956</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Electronic\">1471-8391</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>146</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>21</Day></PubDate></JournalIssue><Title>British medical bulletin</Title><ISOAbbreviation>Br Med Bull</ISOAbbreviation></Journal><ArticleTitle>Whole-body cryotherapy as a treatment for chronic medical conditions?</ArticleTitle><Pagination><StartPage>43</StartPage><EndPage>72</EndPage><MedlinePgn>43-72</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1093/bmb/ldad007</ELocationID><Abstract><AbstractText Label=\"INTRODUCTION\" NlmCategory=\"BACKGROUND\">Whole-body cryotherapy (WBC) is a controlled exposure of the whole body to cold to gain health benefits. In recent years, data on potential applications of WBC in multiple clinical settings have emerged.</AbstractText><AbstractText Label=\"SOURCES OF DATA\" NlmCategory=\"METHODS\">PubMed, EBSCO and Clinical Key search using keywords including terms \\'whole body\\', \\'cryotherapy\\' and \\'cryostimulation\\'.</AbstractText><AbstractText Label=\"AREAS OF AGREEMENT\" NlmCategory=\"RESULTS\">WBC could be applied as adjuvant therapy in multiple conditions involving chronic inflammation because of its potent anti-inflammatory effects. Those might include systemic inflammation as in rheumatoid arthritis. In addition, WBC could serve as adjuvant therapy for chronic inflammation in some patients with obesity.</AbstractText><AbstractText Label=\"AREAS OF CONTROVERSY\" NlmCategory=\"RESULTS\">WBC probably might be applied as an adjuvant treatment in patients with chronic brain disorders including mild cognitive impairment and general anxiety disorder and in patients with depressive episodes and neuroinflammation reduction as in multiple sclerosis. WBC effects in metabolic disorder treatment are yet to be determined. WBC presumably exerts pleiotropic effects and therefore might serve as adjuvant therapy in multi-systemic disorders, including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).</AbstractText><AbstractText Label=\"GROWING POINTS\" NlmCategory=\"CONCLUSIONS\">The quality of studies on the effects of WBC in the clinical setting is in general low; hence, randomized controlled trials with adequate sample size and longer follow-up periods are needed.</AbstractText><AbstractText Label=\"AREAS ARE TIMELY FOR DEVELOPING RESEARCH\" NlmCategory=\"UNASSIGNED\">Further studies should examine the mechanism underlying the clinical efficacy of WBC. Multiple conditions might involve chronic inflammation, which in turn could be a potential target of WBC. Further research on the application of WBC in neurodegenerative disorders, neuropsychiatric disorders and ME/CFS should be conducted.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Tabisz</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, &#x15a;wi&#x119;toja&#x144;ska 20, Bydgoszcz 85-077, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Modlinska</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, &#x15a;wi&#x119;toja&#x144;ska 20, Bydgoszcz 85-077, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kujawski</LastName><ForeName>S&#x142;awomir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, &#x15a;wi&#x119;toja&#x144;ska 20, Bydgoszcz 85-077, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>S&#x142;omko</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, &#x15a;wi&#x119;toja&#x144;ska 20, Bydgoszcz 85-077, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zalewski</LastName><ForeName>Pawel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, &#x15a;wi&#x119;toja&#x144;ska 20, Bydgoszcz 85-077, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Warsaw Medical University, 1b Banacha Street, Warsaw 02-097, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br Med Bull</MedlineTA><NlmUniqueID>0376542</NlmUniqueID><ISSNLinking>0007-1420</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">chronic inflammation</Keyword><Keyword MajorTopicYN=\"N\">cognitive function</Keyword><Keyword MajorTopicYN=\"N\">cryotherapy</Keyword><Keyword MajorTopicYN=\"N\">metabolic disorders</Keyword><Keyword MajorTopicYN=\"N\">neurodegenerative disorders</Keyword><Keyword MajorTopicYN=\"N\">neuropsychiatric disorders</Keyword><Keyword MajorTopicYN=\"N\">obesity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37170956</ArticleId><ArticleId IdType=\"doi\">10.1093/bmb/ldad007</ArticleId><ArticleId IdType=\"pii\">7160593</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37155451</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">2168-8184</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Corona With Lyme: A Long COVID Case Study.</ArticleTitle><Pagination><StartPage>e36624</StartPage><MedlinePgn>e36624</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">e36624</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.7759/cureus.36624</ELocationID><Abstract><AbstractText>The longevity of the coronavirus disease 2019 (COVID-19) pandemic has necessitated continued discussion about the long-term impacts of SARS-CoV-2 infection. Many who develop an acute COVID-19 infection will later face a constellation of enduring symptoms of varying severity, otherwise known as long COVID. As the pandemic reaches its inevitable endemicity, the long COVID patient population will undoubtedly grow and require improved recognition and management. The case presented describes the three-year arc of a previously healthy 26-year-old female medical student from initial infection and induction of long COVID symptomology to near-total remission of the disease. In doing so, the course of this unique post-viral illness and the trials and errors of myriad treatment options will be chronologized, thereby contributing to the continued demand for understanding this mystifying disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Thor et al.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Thor</LastName><ForeName>Danielle C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Internal Medicine, Touro College of Osteopathic Medicine, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Suarez</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Osteopathic Medicine, Touro College of Osteopathic Medicine, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D002363\">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">covid long haul syndrome</Keyword><Keyword MajorTopicYN=\"N\">covid-19</Keyword><Keyword MajorTopicYN=\"N\">dysautonomia</Keyword><Keyword MajorTopicYN=\"N\">long covid</Keyword><Keyword MajorTopicYN=\"N\">lyme disease</Keyword><Keyword MajorTopicYN=\"N\">me/cfs</Keyword><Keyword MajorTopicYN=\"N\">pacs</Keyword><Keyword MajorTopicYN=\"N\">post-covid syndrome</Keyword><Keyword MajorTopicYN=\"N\">post-viral illness</Keyword><Keyword MajorTopicYN=\"N\">pots</Keyword></KeywordList><CoiStatement>A preliminary overview of this case study was previously presented as a virtual poster at the American Academy of Family Physicians\\' 2022 FMX Conference. The authorship of both the poster and case report are identical; the poster served as an introductory presentation to this far more extensive and up-to-date case report submitted here. The poster can be found here: https://www.researchgate.net/publication/364154743_Corona_with_Lyme_An_Overview_of_A_Long_COVID_Case_Study?channel=doi&amp;linkId=633ccaa2769781354ebc8723&amp;showFulltext=true#fullTextFileContent.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>13</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37155451</ArticleId><ArticleId IdType=\"pmc\">PMC10122830</ArticleId><ArticleId IdType=\"doi\">10.7759/cureus.36624</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. J Infect Dis. 2022;226:1593&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9047189</ArticleId><ArticleId IdType=\"pubmed\">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus.  [\\nMar;\\n2023 \\n];https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 World Health Organization. 2021 1</Citation></Reference><Reference><Citation>Multiple early factors anticipate post-acute COVID-19 sequelae. Su Y, Yuan D, Chen DG, et al. Cell. 2022;185:881&#x2013;895.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8786632</ArticleId><ArticleId IdType=\"pubmed\">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: major findings, mechanisms and recommendations. Davis HE, McCorkell L, Vogel JM, Topol EJ. Nat Rev Microbiol. 2023;21:133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9839201</ArticleId><ArticleId IdType=\"pubmed\">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID-19: challenges in the diagnosis and proposed diagnostic criteria. Raveendran AV. Diabetes Metab Syndr. 2021;15:145&#x2013;146.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7737559</ArticleId><ArticleId IdType=\"pubmed\">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>The relationship between physical activity and long COVID: a cross-sectional study. Wright J, Astill SL, Sivan M. Int J Environ Res Public Health. 2022;19:5093.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9105041</ArticleId><ArticleId IdType=\"pubmed\">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of COVID-19 vaccination on long COVID: systematic review. Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. BMJ Med. 2023;2:0.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9978692</ArticleId><ArticleId IdType=\"pubmed\">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Ormiston CK, &#x15a;wi&#x105;tkiewicz I, Taub PR. Heart Rhythm. 2022;19:1880&#x2013;1889.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9287587</ArticleId><ArticleId IdType=\"pubmed\">35853576</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: distinction between organ damage and deconditioning. Kersten J, Baumhardt M, Hartveg P, et al. J Clin Med. 2021;10:3782.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8432179</ArticleId><ArticleId IdType=\"pubmed\">34501230</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID and the risk of suicide. Sher L. Gen Hosp Psychiatry. 2023;80:66&#x2013;67.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9721155</ArticleId><ArticleId IdType=\"pubmed\">36494289</ArticleId></ArticleIdList></Reference><Reference><Citation>Could cognitive behavioural therapy be an effective treatment for long COVID and post COVID-19 fatigue syndrome? Lessons from the Qure study for Q-fever fatigue syndrome. Vink M, Vink-Niese A. Healthcare (Basel) 2020;8:552.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7764131</ArticleId><ArticleId IdType=\"pubmed\">33322316</ArticleId></ArticleIdList></Reference><Reference><Citation>Using crowdsourced medicine to manage uncertainty on Reddit: the case of COVID-19 long-haulers. Thompson CM, Rhidenour KB, Blackburn KG, Barrett AK, Babu S. Patient Educ Couns. 2022;105:322&#x2013;330.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8805953</ArticleId><ArticleId IdType=\"pubmed\">34281723</ArticleId></ArticleIdList></Reference><Reference><Citation>Outpatient treatment of COVID-19 with metformin, ivermectin, and fluvoxamine and the development of long COVID over 10-month follow-up. [PREPRINT] Bramante CT, Buse JB, Liebovitz D, et al. medRxiv. 2022</Citation></Reference><Reference><Citation>Estrogen hormone is an essential sex factor inhibiting inflammation and immune response in COVID-19. Li F, Boon AC, Michelson AP, Foraker RE, Zhan M, Payne PR. Sci Rep. 2022;12:9462.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9175532</ArticleId><ArticleId IdType=\"pubmed\">35676404</ArticleId></ArticleIdList></Reference><Reference><Citation>Lots of long COVID treatment leads, but few are proven. Shaffer L. Proc Natl Acad Sci U S A. 2022;119:0.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9456722</ArticleId><ArticleId IdType=\"pubmed\">36048910</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37131449</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">2405-8440</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>9</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A preliminary survey among patients in Switzerland.</ArticleTitle><Pagination><StartPage>e15595</StartPage><MedlinePgn>e15595</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">e15595</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.heliyon.2023.e15595</ELocationID><Abstract><AbstractText>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a multi-factorial systemic chronic debilitating disease of poorly understood etiology and limited systematic evidence. The questionnaire and interview-based survey included 169 ME/CFS patients from the Swiss ME/CFS association. The majority of patients were females (72.2%), single (55.7%) and without children (62.5%). Only one third were working (full/part-time). The mean onset of ME/CFS was 31.6 years of age with 15% of patients being symptomatic before their 18th birthday. In this cohort, patients had documented ME/CFS for a mean 13.7 years, whereby half (50.3%) stated their condition was progressively worsening. Triggering events and times of disease onset were recalled by 90% of the participants. An infectious disease was associated with a singular or part of multiple events by 72.9% and 80.6%, respectively. Prior to disease onset, a third of the patients reported respiratory infections; followed by gastro-intestinal infections (15.4%) and tick-borne diseases (16.2%). Viral infections were recalled by 77.8% of the respondents, with Epstein Barr Virus being the most commonly reported agent. Patients self-reported an average number of 13 different symptoms, all described specific triggers of symptoms exacerbation and 82.2% suffered from co-morbidities. This study collated clinically relevant information on ME/CFS patients in Switzerland, highlighting the extent of disease severity, the associated factors negatively affecting daily life activities and work status as well as potential socio-economic impact.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Tschopp</LastName><ForeName>Rea</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of University of Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Armauer Hansen Research Institute, Jimma Road, PO Box 1005, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>K&#xf6;nig</LastName><ForeName>Rahel S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Basel, Klingelbergstrasse 61, 4056 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rejmer</LastName><ForeName>Protazy</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Seegarten Clinic, Seestrasse 155A, 8802 Kilchberg ZH, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Paris</LastName><ForeName>Daniel H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of University of Basel, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Co-morbidity</Keyword><Keyword MajorTopicYN=\"N\">Demography</Keyword><Keyword MajorTopicYN=\"N\">Myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">Switzerland</Keyword><Keyword MajorTopicYN=\"N\">Symptoms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>1</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37131449</ArticleId><ArticleId IdType=\"pmc\">PMC10149204</ArticleId><ArticleId IdType=\"doi\">10.1016/j.heliyon.2023.e15595</ArticleId><ArticleId IdType=\"pii\">S2405-8440(23)02802-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Poenaru S., Abdallah S.J., Corrales-Medina V., Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther. Adv. Infect. Dis. 2021;8 doi: 10.1177/20499361211009385.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/20499361211009385</ArticleId><ArticleId IdType=\"pmc\">PMC8060761</ArticleId><ArticleId IdType=\"pubmed\">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. https://www.cdc.gov/me-cfs/index.html. Accessed 15 January 2022.</Citation></Reference><Reference><Citation>Hickie I., Davenport T., Wakefield D., Vollmer-Conna U., Cameron B., et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333:575&#x2013;577. doi: 10.1136/bmj.38933.585764.AE.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType=\"pmc\">PMC1569956</ArticleId><ArticleId IdType=\"pubmed\">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampton T. Researchers find genetic clues to chronic fatigue syndrome. JAMA. 2006;295(21):2466&#x2013;2467. doi: 10.1001/jama.295.21.2466.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.295.21.2466</ArticleId><ArticleId IdType=\"pubmed\">16757709</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhill S., Booth N., Mclaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int. J. Clin. Exp. Med. 2009;2:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2680051</ArticleId><ArticleId IdType=\"pubmed\">19436827</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Elzakker M. Chronic fatigue syndrome from vagus nerve infection: a psycho-neuro-immunological hypothesis. Med. Hypotheses. 2013;81:414&#x2013;423. doi: 10.1016/j.mehy.2013.05.034.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mehy.2013.05.034</ArticleId><ArticleId IdType=\"pubmed\">23790471</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassford J.A.G. The neuroinflammatory etiopathology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Front. Physiol. 2017;8:88. doi: 10.3389/fphys.2017.00088.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2017.00088</ArticleId><ArticleId IdType=\"pmc\">PMC5314655</ArticleId><ArticleId IdType=\"pubmed\">28261110</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S., Nora Krukle Z., Henning N., Eliassen E., Shikova E., et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2018;16:268. doi: 10.1186/s12967-018-1644-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType=\"pmc\">PMC6167797</ArticleId><ArticleId IdType=\"pubmed\">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E., Noble A., Edgar C., Mackay A., Helliwell A., Vallings R., Ryan M., Tate W. Current research provides insight into the biological basis and diagnostic potential for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Diagnostics. 2019;9:73. doi: 10.3390/diagnostics9030073.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics9030073</ArticleId><ArticleId IdType=\"pmc\">PMC6787691</ArticleId><ArticleId IdType=\"pubmed\">31295930</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E.W., Van Driel M.L., Staines D.R., Ashton K.J., Ramos S.B., et al. Immunological abnormalities as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis. J. Transl. Med. 2011;9:81. doi: 10.1186/1479-5876-9-81.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-9-81</ArticleId><ArticleId IdType=\"pmc\">PMC3120691</ArticleId><ArticleId IdType=\"pubmed\">21619669</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya J.G., Holmes T.H., Anderson J.N., Maecker H.T., Rosenberg-Hasson Y., et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc. Natl. Acad. Sci. USA. 2017;114(34):E7150&#x2013;E7158.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5576836</ArticleId><ArticleId IdType=\"pubmed\">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano A.H., Maya J., Giloteaux L., Peterson D.L., Maynard M., et al. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J. Clin. Invest. 2020 doi: 10.1172/JCI132185.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI132185</ArticleId><ArticleId IdType=\"pmc\">PMC7269566</ArticleId><ArticleId IdType=\"pubmed\">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K., Scheibenbogen C. A unifying hypothesis of the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): recognitions from the finding of autoantibodies against &#xdf;2-adrenergic receptors. Autoimmun. Rev. 2020;19(6) doi: 10.1016/j.autrev.2020.102527.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2020.102527</ArticleId><ArticleId IdType=\"pubmed\">32247028</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall-Gradisnik S.M., Smith P., Brenu E.W., Nilius B., Ramos S.B., et al. Examination of single nucleotide polymorphisms (SNPs) in transient receptor potential (TRP) ion channels in chronic fatigue syndrome patients. Immunol. Immunogenetics Insights. 2015;5:1&#x2013;6. doi: 10.4137/III.S25.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4137/III.S25</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T., Staines D., Nilius B., Smith P., Marshall-Gradisnik S. Novel identification and characterization of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signaling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients. Biol. Res. 2016;49:27. doi: 10.1186/s40659-016-0087-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40659-016-0087-2</ArticleId><ArticleId IdType=\"pmc\">PMC4888729</ArticleId><ArticleId IdType=\"pubmed\">27245705</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall-Gradisnik S., Huth T., Chacko Anu, Johnston S., Smith P., et al. Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in Myalgic Encephalomyelitis/chronic fatigue syndrome. Appl. Clin. Genet. 2016;9:39&#x2013;47. doi: 10.2147/TACG.S99405.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/TACG.S99405</ArticleId><ArticleId IdType=\"pmc\">PMC4821384</ArticleId><ArticleId IdType=\"pubmed\">27099524</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K., Straus S.E., Hickie I., et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med. 1994;121(12):953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType=\"pubmed\">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., Van de Sande M.I., De Meirleir K.L., Klimas N.G., Broderick G., et al. Myalgic encephalomyelitis: international consensus criteria. J. Intern. Med. 2011;270(4):327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType=\"pmc\">PMC3427890</ArticleId><ArticleId IdType=\"pubmed\">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine (IOM) National Academies Press (US); Washington (DC): 2015. 2015. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.17226/19012</ArticleId><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.J., Son C.G. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2020;18(1):289. doi: 10.1186/s12967-020-02455-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-020-02455-0</ArticleId><ArticleId IdType=\"pmc\">PMC7391812</ArticleId><ArticleId IdType=\"pubmed\">32727489</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Ness J., Stevens S., Bateman L., Stiles T.L., Snell C.R. Postexertional malaise in women with chronic fatigue syndrome. J. Womens Health. 2010;19:239&#x2013;244. doi: 10.1089/jwh.2009.1507.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/jwh.2009.1507</ArticleId><ArticleId IdType=\"pubmed\">20095909</ArticleId></ArticleIdList></Reference><Reference><Citation>Lengert N., Drossel B. In silico analysis of exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Biophys. Chem. 2015;202:21&#x2013;31. doi: 10.1016/j.bpc.2015.03.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bpc.2015.03.009</ArticleId><ArticleId IdType=\"pubmed\">25899994</ArticleId></ArticleIdList></Reference><Reference><Citation>Twisk F.N. A definition of recovery in myalgic encephalomyelitis and chronic fatigue syndrome should be based upon objective measures. Qual. Life Res. 2014;23(9):2417&#x2013;2418. doi: 10.1007/s11136-014-0737-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11136-014-0737-1</ArticleId><ArticleId IdType=\"pubmed\">24935018</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamowicz J.L., Caikauskaite I., Friedberg F. Defining recovery in chronic fatigue syndrome: a critical review. Qual. Life Res. 2014;23(9):2407&#x2013;2416. doi: 10.1007/s11136-014-0705-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11136-014-0705-9</ArticleId><ArticleId IdType=\"pubmed\">24791749</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe P., Fontaine K., Lauver M., Jasion S.E., Marden C.L., et al. Neuromuscular strain increases symptom intensity in chronic fatigue syndrome. PLoS One. 2016;11 doi: 10.1371/journal.pone.0159386.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0159386</ArticleId><ArticleId IdType=\"pmc\">PMC4948885</ArticleId><ArticleId IdType=\"pubmed\">27428358</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L., Authier F.J., Scheibenbogen C., Lorusso L., Helland I.B., et al. Network on myalgic encephalomyelitis/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in Europe. Medicina. 2021;57(5):510. doi: 10.3390/medicina57050510. 19.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57050510</ArticleId><ArticleId IdType=\"pmc\">PMC8161074</ArticleId><ArticleId IdType=\"pubmed\">34069603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C.H., Shin H.C., Won C.W. Prevalence of chronic fatigue and chronic fatigue syndrome in Korea: community-based primary care study. J. Kor. Med. Sci. 2005;20(4):529&#x2013;534. doi: 10.3346/jkms.2005.20.4.529.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3346/jkms.2005.20.4.529</ArticleId><ArticleId IdType=\"pmc\">PMC2782143</ArticleId><ArticleId IdType=\"pubmed\">16100439</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L.C., Lacerda E.M., Pheby D., Campion P., Molokhia M al. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care. BMC Med. 2011;9:91. doi: 10.1186/1741-7015-9-91.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1741-7015-9-91</ArticleId><ArticleId IdType=\"pmc\">PMC3170215</ArticleId><ArticleId IdType=\"pubmed\">21794183</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston S., Brenu E.W., Staines D., et al. The prevalence of chronic fatigue syndrome/myalgic encephalomyelitis: a meta-analysis. Clin. Epidemiol. 2013;5:105&#x2013;110.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3616604</ArticleId><ArticleId IdType=\"pubmed\">23576883</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez A.R., Hancock E.E., Adebayo S., Kiernicki D.J., Proskauer D., et al. Estimating prevalence, demographics, and costs of ME/CFS using large scale medical claims data and machine learning. Front. Pediatr. 2019;6:412. doi: 10.3389/fped.2018.00412.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2018.00412</ArticleId><ArticleId IdType=\"pmc\">PMC6331450</ArticleId><ArticleId IdType=\"pubmed\">30671425</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.J., Ahn Y.C., Jang E.S., Lee S.W., Lee S.H., Son C.G. Systematic review and meta&#x2010;analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) J. Transl. Med. 2020;18:100. doi: 10.1186/s12967&#x2010;020&#x2010;02269&#x2010;0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967&#x2010;020&#x2010;02269&#x2010;0</ArticleId><ArticleId IdType=\"pmc\">PMC7038594</ArticleId><ArticleId IdType=\"pubmed\">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Mirin A.A. Updating the National Academy of Medicine ME/CFS prevalence and economic impact figures to account for population growth and inflation. Fatigue: Biomed., Health Behav. 2021 doi: 10.1080/21641846.2021.1878716.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21641846.2021.1878716</ArticleId></ArticleIdList></Reference><Reference><Citation>Estevez-Lopez F., Mudie K., Wang-Steverding X., Bakken I.J., Ivanovs A., et al. Systematic review of the epidemiological burden of myalgic encephalomyelitis/chronic fatigue syndrome across Europe: current evidence and EUROMENE research recommendations for epidemiology. J. Clin. Med. 2020;9(5):1557. doi: 10.3390/jcm9051557.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm9051557</ArticleId><ArticleId IdType=\"pmc\">PMC7290765</ArticleId><ArticleId IdType=\"pubmed\">32455633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hvidberg F.M., Brinth L.S., Olesen A.V., Petersen K.D., Ehlers L. The health-related quality of life for patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) PLoS One. 2015;10(7) doi: 10.1371/journal.pone.0132421.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0132421</ArticleId><ArticleId IdType=\"pmc\">PMC4492975</ArticleId><ArticleId IdType=\"pubmed\">26147503</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesamt f&#xfc;r Statistik  Familien in der Schweiz. Statistischer Bericht 2021; Neuchatel. BSF Nr. 1010-2100 (in German) 2021. https://www.bfs.admin.ch/bfs/de/home/statistiken/bevoelkerung/familien.assetdetail.17084546.html Accessed 10 January 2022.</Citation></Reference><Reference><Citation>Buchwald D., Herrell R., Ashton S., Belcourt M., Schmaling K., et al. A twin study of chronic fatigue. Psychosom. Med. 2001;63(6):936&#x2013;943. doi: 10.1097/00006842-200111000-00012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00006842-200111000-00012</ArticleId><ArticleId IdType=\"pubmed\">11719632</ArticleId></ArticleIdList></Reference><Reference><Citation>Albright F., Light K., Light A., Bateman L., Cannon-Albright L.A. Evidence for a heritable predisposition to chronic fatigue syndrome. BMC Neurol. 2011;11(1):62. doi: 10.1186/1471-2377-11-62.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2377-11-62</ArticleId><ArticleId IdType=\"pmc\">PMC3128000</ArticleId><ArticleId IdType=\"pubmed\">21619629</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L., Valencia I.J., Garvert D.W., Montoya J.G. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front. Pediatrics. 2019;7:12. doi: 10.3389/fped.2019.00012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2019.00012</ArticleId><ArticleId IdType=\"pmc\">PMC6370741</ArticleId><ArticleId IdType=\"pubmed\">30805319</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C., Brown A., Strassheim V., Elson J., Newton J., et al. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS One. 2017;12 doi: 10.1371/journal.pone.0186802.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0186802</ArticleId><ArticleId IdType=\"pmc\">PMC5655451</ArticleId><ArticleId IdType=\"pubmed\">29065167</ArticleId></ArticleIdList></Reference><Reference><Citation>Esterhuizen K., van der Westhuizen F.H., Louw R. Metabolomics of mitochondrial disease. Mitochondrion. 2017:97&#x2013;110. doi: 10.1016/j.mito.2017.05.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mito.2017.05.012</ArticleId><ArticleId IdType=\"pubmed\">28576558</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C., Newton J. Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review. Biochem. Soc. Trans. 2018;46:547&#x2013;553. doi: 10.1042/BST20170503.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/BST20170503</ArticleId><ArticleId IdType=\"pubmed\">29666214</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorman G.S., Elson J.L., Newman J., Payne B., McFarland R., et al. Perceived fatigue is highly prevalent and debilitating in patients with mitochondrial disease. Neuromuscul. Disord. 2015;25:563&#x2013;566. doi: 10.1016/j.nmd.2015.1003.1001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nmd.2015.1003.1001</ArticleId><ArticleId IdType=\"pmc\">PMC4502433</ArticleId><ArticleId IdType=\"pubmed\">26031904</ArticleId></ArticleIdList></Reference><Reference><Citation>Venter M., Tomas C., Pienaar I.S., Strassheim V., Erasmus E., et al. MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants. Sci. Rep. 2019;9(1):2914. doi: 10.1038/s41598-019-39060-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-39060-1</ArticleId><ArticleId IdType=\"pmc\">PMC6393470</ArticleId><ArticleId IdType=\"pubmed\">30814539</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi I.G., Sein-Echaluce M.L.G., Aubach L.R., Puig-Gros J.T., Sol&#xe0; J.F. Stressful events in the onset of chronic fatigue syndrome. Rev. Esp. Salud Publica. 2016:e1&#x2013;e7. PMID: 27535808.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27535808</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel S., Chapman J., Shoenfeld Y. Infection and vaccination in chronic fatigue syndrome: myth or reality? Autoimmunity. 2007;40(1):48&#x2013;53. doi: 10.1080/08916930701197273.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/08916930701197273</ArticleId><ArticleId IdType=\"pubmed\">17364497</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus P., Brubakk O., Nyland H., Wold B.H., Gjessing H.K., et al. Vaccination as teenagers against meningococcal disease and the risk of the chronic fatigue syndrome. Vaccine. 2009;27(1):23&#x2013;27. doi: 10.1016/j.vaccine.2008.10.043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.vaccine.2008.10.043</ArticleId><ArticleId IdType=\"pubmed\">18984023</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus P., Gunnes N., Tveito K., Bakken I.J., Ghaderi S., et al. Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine. 2015;33(46):6173&#x2013;6177. doi: 10.1016/j.vaccine.2015.10.018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.vaccine.2015.10.018</ArticleId><ArticleId IdType=\"pubmed\">26475444</ArticleId></ArticleIdList></Reference><Reference><Citation>Principi N., Esposito S. Aluminum in vaccines: does it create a safety problem? Vaccine. 2018;36(39):5825&#x2013;5831. doi: 10.1016/j.vaccine.2018.08.036.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.vaccine.2018.08.036</ArticleId><ArticleId IdType=\"pubmed\">30139653</ArticleId></ArticleIdList></Reference><Reference><Citation>Exley C., Swarbrick L., Gherardi R.K., Authier F.J. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med. Hypotheses. 2009;72(2):135&#x2013;139. doi: 10.1016/j.mehy.2008.09.040.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mehy.2008.09.040</ArticleId><ArticleId IdType=\"pubmed\">19004564</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherardi R.K., Cr&#xe9;peaux G., Authier F.J. Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system. Autoimmun. Rev. 2019;18(7):691&#x2013;705. doi: 10.1016/j.autrev.2019.05.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2019.05.006</ArticleId><ArticleId IdType=\"pubmed\">31059838</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., van de Sande M.I., De Meirleir K.L., Klimas N.G. Myalgic Encephalomyelitis: Adult &amp; Paediatric: International Consensus Primer for Medical Practitioners. 2012. http://www.investinme.org/Documents/Guidelines/Myalgic%20Encephalomyelitis%20International%20Consensus%20Primer%20-2012-11-26.pdf</Citation></Reference><Reference><Citation>Wagner N., Assmus F., Arendt G., Baum E., Baumann U., et al. Impfen bei Immundefizienz. Bundesgesundheitlbl. 2019;62:494&#x2013;515. doi: 10.1007/s00103-019-02905-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00103-019-02905-1</ArticleId><ArticleId IdType=\"pubmed\">30899964</ArticleId></ArticleIdList></Reference><Reference><Citation>Karrer U., Nadal D. Epstein-Barr Virus und infekti&#xf6;se Mononukleose. Swiss Med. Forum. 2014;14(11):226&#x2013;232. doi: 10.5167/uzh-96029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5167/uzh-96029</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikova E., Reshkova V., Kumanova &#x410;., Raleva S., Alexandrova D., et al. Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic &#x435;ncephalomyelitis/chronic fatigue syndrome. J. Med. Virol. 2020;92(12):3682&#x2013;3688. doi: 10.1002/jmv.25744.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.25744</ArticleId><ArticleId IdType=\"pmc\">PMC7687071</ArticleId><ArticleId IdType=\"pubmed\">32129496</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M., Strohschein K., Giannini C., Koelsch U., Bauer S., et al. Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome. PLoS One. 2014;9 doi: 10.1371/journal.pone.0085387.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0085387</ArticleId><ArticleId IdType=\"pmc\">PMC3893202</ArticleId><ArticleId IdType=\"pubmed\">24454857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M., Paiva B., Montero-Mateo R., Garcia N., Zabaleta A. Epstein-barr virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.656797.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2021.656797</ArticleId><ArticleId IdType=\"pmc\">PMC8634673</ArticleId><ArticleId IdType=\"pubmed\">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza M.E. Myalgic encephalomyelitis/chronic fatigue syndrome: the human herpesviruses are back. Biomolecules. 2021;11(2):185. doi: 10.3390/biom11020185.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom11020185</ArticleId><ArticleId IdType=\"pmc\">PMC7912523</ArticleId><ArticleId IdType=\"pubmed\">33572802</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa-Dzelzkaleja S., Krumina A., Capenko S., Nora-Krukle Z., Gravelsina S., et al. The persistent viral infections in the development and severity of myalgic encephalomyelitis/chronic fatigue syndrome. J. Transl. Med. 2023;21:33. doi: 10.1186/s12967-023-03887-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-023-03887-0</ArticleId><ArticleId IdType=\"pmc\">PMC9847171</ArticleId><ArticleId IdType=\"pubmed\">36653846</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold J.E., Okyay R.A., Licht W.E., Hurley D.J. Investigation of long COVID prevalence and its relationship to epstein-barr virus reactivation. Pathogens. 2021;10(6):763. doi: 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pathogens10060763</ArticleId><ArticleId IdType=\"pmc\">PMC8233978</ArticleId><ArticleId IdType=\"pubmed\">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J., Faro M., Aliste L., S&#xe1;ez-Franc&#xe0;s N., Calvo N., et al. Comorbidity in chronic fatigue syndrome/myalgic encephalomyelitis: a nationwide population-based cohort study. Psychosomatics. 2017;58(5):533&#x2013;543. doi: 10.1016/j.psym.2017.04.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.psym.2017.04.010</ArticleId><ArticleId IdType=\"pubmed\">28596045</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L., Darakjy S., Klimas N., Peterson D., Levine S.M., et al. Chronic fatigue syndrome and Co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study. Fatigue: Biomed. Health Behav. 2014;31:1&#x2013;15. doi: 10.1080/21641846.2014.978109.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21641846.2014.978109</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken I.J., Tveito K., Gunnes N., Ghadori S., Stoltenberg C., et al. Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008-2012. BMC Med. 2014;12:167. doi: 10.1186/s12916-014-0167-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12916-014-0167-5</ArticleId><ArticleId IdType=\"pmc\">PMC4189623</ArticleId><ArticleId IdType=\"pubmed\">25274261</ArticleId></ArticleIdList></Reference><Reference><Citation>Capelli E., Lorusso L., Ghitti M., Venturini L., Cusa C., Ricevuti G. Chronic fatigue syndrome: features of a population of patients from northern Italy. Internl. J. Immunopath. Pharmacol. 2015;28(1):53&#x2013;59. doi: 10.1177/0394632015572074.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0394632015572074</ArticleId><ArticleId IdType=\"pubmed\">25816406</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns R., Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup. Med. (Oxf.) 2005;55(1):20&#x2013;31. doi: 10.1093/occmed/kqi013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/occmed/kqi013</ArticleId><ArticleId IdType=\"pubmed\">15699087</ArticleId></ArticleIdList></Reference><Reference><Citation>Pheby D.F.H., Araja D., Berkis U., Brenna E., Cullinan J., et al. Literature review of GP knowledge and understanding of ME/CFS: a report from the socioeconomic working group of the European Network on ME/CFS (EUROMENE) Medicina. 2020;57(1):7. doi: 10.3390/medicina57010007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57010007</ArticleId><ArticleId IdType=\"pmc\">PMC7823627</ArticleId><ArticleId IdType=\"pubmed\">33374291</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37129123</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Print\">1565-1088</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The Israel Medical Association journal : IMAJ</Title><ISOAbbreviation>Isr Med Assoc J</ISOAbbreviation></Journal><ArticleTitle>Modulation of Beta-Adrenergic Autoantibodies Over Time in Post-Viral ME/CFS is Related to Fatigue and Pain Symptoms.</ArticleTitle><Pagination><StartPage>259</StartPage><EndPage>264</EndPage><MedlinePgn>259-264</MedlinePgn></Pagination><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Myalgic encephalomyelits/chronic fatigue syndrome (ME/CFS) is an acquired disease with symptoms of fatigue and pain. In pathogenesis, the induction of autoantibodies (AAB) against G-protein coupled receptors (GPCR), such as &#x3b2;-adrenergic receptors (&#x3b2;-AdR), has been suspected. GPCR-AAB correlate with symptom severity and autonomic dysfunction in ME/CFS. Objectives: To describe symptoms and treatment of a patient presenting with infection-triggered ME/CFS demonstrating that levels of &#x3b2;-AdR-AAB underlie modulation over time, correlating with the severity of symptoms.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">At T1 and T2, GPCR-AAB were measured and questionnaires assessing symptom severity were completed. TSHDS-IgM-AAB were tested, and SF density was analyzed via skin probe.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">At T2, elevated levels of &#x3b2;-AdR-AAB were found, corresponding with an aggravation of fatigue and pain symptoms. Elevated TSHDS-IgM-AAB were found, which corresponded with reduced fiber density from the skin probe.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">The levels of &#x3b2;-AdR-AAB in post-infectious ME/CFS can be modulated. Future studies might target interventions to reduce these AAB.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Busch</LastName><ForeName>Lena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Academy for Diagnostics and Prevention M&#xfc;nster, M&#xfc;nster, Germany, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Schriek</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Academy for Diagnostics and Prevention M&#xfc;nster, M&#xfc;nster, Germany, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Paul</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academy for Diagnostics and Prevention M&#xfc;nster, M&#xfc;nster, Germany, Department of Cardiovascular Medicine, University Hospital M&#xfc;nster, Steinfurt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Heidecke</LastName><ForeName>Harald</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>CellTrend GmbH, Luckenwalde, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Israel</Country><MedlineTA>Isr Med Assoc J</MedlineTA><NlmUniqueID>100930740</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D001323\">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018663\">Adrenergic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011943\">Receptors, Adrenergic, beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D007075\">Immunoglobulin M</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001323\" MajorTopicYN=\"Y\">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018663\" MajorTopicYN=\"N\">Adrenergic Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D063806\" MajorTopicYN=\"N\">Myalgia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011943\" MajorTopicYN=\"N\">Receptors, Adrenergic, beta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007075\" MajorTopicYN=\"N\">Immunoglobulin M</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>7</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37129123</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37128534</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">2168-8184</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>COVID-19: Post-recovery Manifestations.</ArticleTitle><Pagination><StartPage>e36886</StartPage><MedlinePgn>e36886</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">e36886</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.7759/cureus.36886</ELocationID><Abstract><AbstractText>Background Post-COVID-19 syndrome, also known as long COVID, is a disorder that has many characteristics, one of which is chronic fatigue following acute infection with the SARS-CoV-2 virus. Methodology We distributed a web-based survey among patients diagnosed with COVID-19&#xa0;across the world and collected 190 responses regarding their demographics, histories, COVID-19 infection courses, and common symptoms. Results We found that about 85.3% of the patients experienced some form of symptom following recovery from the infection. Among the reported symptoms, 59% of patients experienced fatigue or lethargy, 48.9% reported decreased stamina, 32.6% reported&#xa0;shortness of breath, 16.8% had a persistent cough, and 23.7% experienced anxiety following recovery from COVID-19. Conclusions Reported symptoms closely resembled myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); however, a deeper biochemical understanding of ME/CFS is required to confirm causation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Shaikh et al.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Shaikh</LastName><ForeName>Safia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Research, Southwest Family Medicine Associates, Dallas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Siddiqi</LastName><ForeName>Zunaira</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>General Medicine, Dow University of Health Sciences, Civil Hospital Karachi, Karachi, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ukachukwu</LastName><ForeName>Crystal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>General Medicine, University College Hospital, Ibadan, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mehkari</LastName><ForeName>Zainab</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Khan</LastName><ForeName>Sadaf</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Approval, PPD Inc, Houston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pamurthy</LastName><ForeName>Ketan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Medical School, Brown University, Providence, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jahan</LastName><ForeName>Farhat</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Research, St. Michael Hospital Research Laboratory, Ontario, CAN.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Brown</LastName><ForeName>Amaiya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical School, University of Arlington, Arlington, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">covid-19</Keyword><Keyword MajorTopicYN=\"N\">covid-19 manifestation</Keyword><Keyword MajorTopicYN=\"N\">long covid</Keyword><Keyword MajorTopicYN=\"N\">post-covid-19 recovery symptoms</Keyword><Keyword MajorTopicYN=\"N\">post-covid-19 syndrome</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>1</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37128534</ArticleId><ArticleId IdType=\"pmc\">PMC10147564</ArticleId><ArticleId IdType=\"doi\">10.7759/cureus.36886</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johns Hopkins Coronavirus Resource Center. Covid-19 map.  [\\nOct;\\n2021 \\n];https://coronavirus.jhu.edu/map.html 2021 REFERENCES</Citation></Reference><Reference><Citation>Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Komaroff AL, Bateman L. https://www.frontiersin.org/articles/10.3389/fmed.2020.606824/full. Front Med (Lausanne) 2020;7:606824.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7848220</ArticleId><ArticleId IdType=\"pubmed\">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Redefining the chronic fatigue syndrome. Ganiats TG. https://www.acpjournals.org/doi/abs/10.7326/M15-0357. Ann Intern Med. 2015;162:653&#x2013;654.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25668185</ArticleId></ArticleIdList></Reference><Reference><Citation>Chronic fatigue syndrome/myalgic encephalomyelitis is a legitimate disease that needs proper diagnosis and treatment, says IOM; report identifies five symptoms to diagnose disease.  [\\nOct;\\n2021 \\n]. 2021. https://www.nationalacademies.org/news/2015/02/chronic-fatigue-syndrome-myalgic-encephalomyelitis-is-a-legitimate-disease-that-needs-proper-diagnosis-and-treatment-says-iom-report-identifies-five-symptoms-to-diagnose-disease https://www.nationalacademies.org/news/2015/02/chronic-fatigue-syndrome-myalgic-encephalomyelitis-is-a-legitimate-disease-that-needs-proper-diagnosis-and-treatment-says-iom-report-identifies-five-symptoms-to-diagnose-disease</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. (2021, September 8. Centers for Disease Control and Prevention. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)  [\\nOct;\\n2021 \\n]. 2021. https://www.cdc.gov/me-cfs/index.html https://www.cdc.gov/me-cfs/index.html</Citation></Reference><Reference><Citation>Sickness: from the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons. Poon DC, Ho YS, Chiu K, Wong HL, Chang RC. Neurosci Biobehav Rev. 2015;57:30&#x2013;45.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26363665</ArticleId></ArticleIdList></Reference><Reference><Citation>The neuroimmune basis of fatigue. Dantzer R, Heijnen CJ, Kavelaars A, Laye S, Capuron L. https://doi.org/10.1016/j.tins.2013.10.003. Trends Neurosci. 2014;37:39&#x2013;46.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3889707</ArticleId><ArticleId IdType=\"pubmed\">24239063</ArticleId></ArticleIdList></Reference><Reference><Citation>Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 \\'long-haulers\\'? Wood E, Hall KH, Tate W. https://doi.org/10.1016/j.cdtm.2020.11.002. Chronic Dis Transl Med. 2021;7:14&#x2013;26.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7680046</ArticleId><ArticleId IdType=\"pubmed\">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. Grasselli G, Zangrillo A, Zanella A, et al. JAMA. 2020;323:1574&#x2013;1581.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7136855</ArticleId><ArticleId IdType=\"pubmed\">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends in mortality of hospitalised COVID-19 patients: a single centre observational cohort study from Spain. Garcia-Vidal C, C&#xf3;zar-Llist&#xf3; A, Meira F, et al.  https://doi.org/10.1016/j.lanepe.2021.100041. Lancet Reg Health Eur. 2021;3:100041.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7830193</ArticleId><ArticleId IdType=\"pubmed\">33870249</ArticleId></ArticleIdList></Reference><Reference><Citation>Demographic, signs and symptoms, imaging characteristics of 2126 patients with COVID-19 pneumonia in the whole quarantine of Wuhan, China. Yin X, Li Q, Hou S, et al.   https://doi.org/10.1016/j.clinimag.2021.02.034&#xa0;. Clin Imaging. 2021;77:169&#x2013;174.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7901270</ArticleId><ArticleId IdType=\"pubmed\">33691264</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Symptoms of COVID-19.  [\\nOct;\\n2021 \\n];https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html 2021 4:2021.</Citation></Reference><Reference><Citation>Smoking and COVID-19: what we know so far. Shastri MD, Shukla SD, Chong WC, et al. Respir Med. 2021;176:106237.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7674982</ArticleId><ArticleId IdType=\"pubmed\">33246296</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Pavli A, Theodoridou M, Maltezou HC. Arch Med Res. 2021;52:575&#x2013;581.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8093949</ArticleId><ArticleId IdType=\"pubmed\">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Cuadrado ML, Florencio LL. Int J Environ Res Public Health. 2021;18:2621.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7967389</ArticleId><ArticleId IdType=\"pubmed\">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 and chronic fatigue syndrome: is the worst yet to come? Wostyn P. https://doi.org/10.1016/j.mehy.2020.110469. Med Hypotheses. 2021;146:110469.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7836544</ArticleId><ArticleId IdType=\"pubmed\">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae. Daher A, Balfanz P, Cornelissen C, et al.  https://doi.org/10.1016/j.rmed.2020.106197. Respir Med. 2020;174:106197.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7573668</ArticleId><ArticleId IdType=\"pubmed\">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Cort&#xe9;s-Telles A, L&#xf3;pez-Romero S, Figueroa-Hurtado E, et al. Respir Physiol Neurobiol. 2021;288:103644.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7910142</ArticleId><ArticleId IdType=\"pubmed\">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine. Washington, DC: National Academies Press; 2015. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37109676</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1648-9144</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>59</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>06</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>The Role of Psychotherapy in the Care of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">719</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/medicina59040719</ELocationID><Abstract><AbstractText>Myalgic encephalomyelitis/chronic fatigue (ME/CFS) is a post-infectious, chronic disease that can lead to severe impairment and, even, total disability. Although the disease has been known for a long time, and has been coded in the ICD since 1969 (G93.3), medical research has not yet been able to reach a consensus regarding its physiological basis and how best to treat it. Against the background of these shortcomings, psychosomatic disease models have been developed and psychotherapeutic treatments have been derived from them, but their empirical testing has led to sobering results. According to the current state of research, psychotherapy and psychosomatic rehabilitation have no curative effect in the treatment of ME/CFS. Nevertheless, we see numerous patients in practices and outpatient clinics who suffer severely as a result of their illness and whose mental well-being and coping strategies would benefit from psychotherapeutic help. In this article, we outline a psychotherapeutic approach that serves this need, taking into account two basic characteristics of ME/CFS: firstly, the fact that ME/CFS is a physical illness and that curative treatment must therefore be physical; and secondly, the fact that post exertional malaise (PEM) is a cardinal symptom of ME/CFS and thus warrants tailored psychotherapeutic attention.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Grande</LastName><ForeName>Tilman</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Independent Researcher, 69117 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Grande</LastName><ForeName>Bettina</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Independent Researcher, 69117 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gerner</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Kinder und Jugendmedizin, Ortenau Klinikum, 77654 Offenburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hammer</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Gesundheit &amp; Soziales, Hochschule Fresenius, 65510 Idstein, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stingl</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0009-0004-7220-0658</Identifier><AffiliationInfo><Affiliation>Facharztzentrum Votivpark, 1090 Wien, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vink</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0003-1079-5647</Identifier><AffiliationInfo><Affiliation>Independent Researcher, 1096 HZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hughes</LastName><ForeName>Brian M</ForeName><Initials>BM</Initials><Identifier Source=\"ORCID\">0000-0002-6545-9248</Identifier><AffiliationInfo><Affiliation>School of Psychology, University of Galway, H91 TK33 Galway, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011613\" MajorTopicYN=\"N\">Psychotherapy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">cognitive behavioral therapy</Keyword><Keyword MajorTopicYN=\"N\">exercise</Keyword><Keyword MajorTopicYN=\"N\">myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN=\"N\">pacing</Keyword><Keyword MajorTopicYN=\"N\">post-exertional malaise</Keyword><Keyword MajorTopicYN=\"N\">psychotherapy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>1</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37109676</ArticleId><ArticleId IdType=\"pmc\">PMC10145115</ArticleId><ArticleId IdType=\"doi\">10.3390/medicina59040719</ArticleId><ArticleId IdType=\"pii\">medicina59040719</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wong T.L., Weitz D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)&#x2014;A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57050418</ArticleId><ArticleId IdType=\"pmc\">PMC8145228</ArticleId><ArticleId IdType=\"pubmed\">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva O.A., Maksoud R., Beeraka N.M., Madhunapantula A.V., Sinelnikov M., Nikolenko V.N., Neganova M.E., Klochkov S.G., Kamal M.A., Staines D.R., et al. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J. Adv. Res. 2022;40:179&#x2013;196. doi: 10.1016/j.jare.2021.11.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType=\"pmc\">PMC8619886</ArticleId><ArticleId IdType=\"pubmed\">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType=\"pmc\">PMC9839201</ArticleId><ArticleId IdType=\"pubmed\">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.-C., Hsu C.-K., Yen M.-Y., Lee P.-I., Ko W.-C., Hsueh P.-R. Long COVID: An inevitable sequela of SARS-CoV-2 infection. J. Microbiol. Immunol. Infect. 2023;56:1&#x2013;9. doi: 10.1016/j.jmii.2022.10.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jmii.2022.10.003</ArticleId><ArticleId IdType=\"pmc\">PMC9576029</ArticleId><ArticleId IdType=\"pubmed\">36283919</ArticleId></ArticleIdList></Reference><Reference><Citation>Surawy C., Hackmann A., Hawton K., Sharpe M. Chronic fatigue syndrome: A cognitive approach. Behav. Res. Ther. 1995;33:535&#x2013;544. doi: 10.1016/0005-7967(94)00077-W.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0005-7967(94)00077-W</ArticleId><ArticleId IdType=\"pubmed\">7598674</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesseley S., Sharpe M., Hotopf M. Chronic Fatigue and Its Syndromes. Oxford University Press; Oxford, UK: 1998.</Citation></Reference><Reference><Citation>White P.D., Goldsmith K.A., Johnson A.L., Potts L., Walwyn R., DeCesare J.C., Baber H.L., Burgess M., Clark L.V., Cox D.L., et al. Comparison of adaptive pacing therapy, cognitive behavior therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): A randomized trial. Lancet. 2011;377:823&#x2013;836. doi: 10.1016/S0140-6736(11)60096-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(11)60096-2</ArticleId><ArticleId IdType=\"pmc\">PMC3065633</ArticleId><ArticleId IdType=\"pubmed\">21334061</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilshire C., Kindlon T., Matthees A., McGrath S. Can patients with chronic fatigue syndrome really recover after graded exercise or cognitive behavioral therapy? A critical commentary and preliminary re-analyses of the PACE-trial. Fatigue. 2017;5:43&#x2013;56. doi: 10.1080/21641846.2017.1259724.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21641846.2017.1259724</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilshire C.E., Kindlon T., Courtney R., Matthees A., Tuller D., Geraghty K., Levin B. Rethinking the treatment of chronic fatigue syndrome&#x2014;A reanalysis and evaluation of findings from a recent major trial of graded exercise an CBT. BMC Psychol. 2018;6:6. doi: 10.1186/s40359-018-0218-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40359-018-0218-3</ArticleId><ArticleId IdType=\"pmc\">PMC5863477</ArticleId><ArticleId IdType=\"pubmed\">29562932</ArticleId></ArticleIdList></Reference><Reference><Citation>McManimen S.L., McClellan D., Stoothoff J., Jason L.A. Effects of unsupportive social interactions, stigma, and symptoms on patients with myalgic encephalomyelitis and chronic fatigue syndrome. J. Community Psychol. 2018;46:959&#x2013;971. doi: 10.1002/jcop.21984.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jcop.21984</ArticleId><ArticleId IdType=\"pmc\">PMC7944645</ArticleId><ArticleId IdType=\"pubmed\">30311972</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE  Myalgic Encephalomyelitis (or Encephalopathy)/Chronic Fatigue Syndrome: Diagnosis and Management. NICE Guideline [NG206]. 29 October 2021.  [(accessed on 23 February 2023)].  Available online:  https://www.nice.org.uk/guidance/ng206.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35438859</ArticleId></ArticleIdList></Reference><Reference><Citation>IQWIG  Myalgische Enzephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Aktueller Kenntnisstand.  [(accessed on 23 February 2023)].  Available online:  https://www.iqwig.de/download/n21-01_me-cfs-aktueller-kenntnisstand_vorbericht_v1-0.pdf.</Citation></Reference><Reference><Citation>Vink M., Vink-Niese A. The Draft Report by the Institute for Quality and Efficiency in Healthcare Does Not Provide Any Evidence That Graded Exercise Therapy and Cognitive Behavioral Therapy Are Safe and Effective Treatments for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Diseases. 2023;11:11. doi: 10.3390/diseases11010011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diseases11010011</ArticleId><ArticleId IdType=\"pmc\">PMC9844345</ArticleId><ArticleId IdType=\"pubmed\">36648876</ArticleId></ArticleIdList></Reference><Reference><Citation>EMEC  Stellungnahme der European ME Coalition zum IQWiG Vorbericht N21-0: &#x201c;Aktueller wissenschaftlicher Erkenntnisstand zu Myalgischer Enzephalomyelitis/Chronic Fatigue Syndrom (ME/CFS)&#x201d;. 2022.  [(accessed on 26 February 2023)].  Available online:  https://europeanmecoalition.com/wp-content/uploads/2022/11/EMEC_IQWiQ-Stellungnahme_final-version.pdf.</Citation></Reference><Reference><Citation>Institute of Medicine (IOM) Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Board on the Health of Select Populations  . Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press; Washington, DC, USA: 2015.  [(accessed on 26 February 2023)].  Available online:  https://nap.nationalacademies.org/catalog/19012/beyond-myalgic-encephalomyelitischronic-fatigue-syndrome-redefining-an-illness.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischer M., Szepanowski F., Tovar M., Herchert K., Dinse H., Schweda A., Mausberg A.K., Holle-Lee D., K&#xf6;hrmann M., St&#xf6;gbauer J., et al. Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients. Neurol. Ther. 2022;11:1637&#x2013;1657. doi: 10.1007/s40120-022-00395-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40120-022-00395-z</ArticleId><ArticleId IdType=\"pmc\">PMC9417089</ArticleId><ArticleId IdType=\"pubmed\">36028604</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig B., Olbert E., Trimmel K., Seidel S., Rommer P.S., M&#xfc;ller C., Struhal W., Berger T. Myalgische Enzephalomyelitis/chronisches Fatigue Syndrom: Eine &#xdc;bersicht zur aktuellen Evidenz. Nervenarzt. 2023 doi: 10.1007/s00115-022-01431-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00115-022-01431-x</ArticleId><ArticleId IdType=\"pmc\">PMC9875188</ArticleId><ArticleId IdType=\"pubmed\">36695893</ArticleId></ArticleIdList></Reference><Reference><Citation>Deutsche Gesellschaft f&#xfc;r ME/CFS  Post Exertional Malaise. Belastungsintoleranz als Leitsymptom von ME/CFS.  [(accessed on 26 February 2023)].  Available online:  https://www.mecfs.de/was-ist-me-cfs/pem/</Citation></Reference><Reference><Citation>Goudsmit E. Pacing for ME and CFS: A Guide for Patients. May 2005.  [(accessed on 26 February 2023)].  Available online:  https://huisartsvink.files.wordpress.com/2023/02/goudsmit-pacing-for-me-and-cfs-a-guide-for-patients.pdf.</Citation></Reference><Reference><Citation>World Health Organization (WHO)  Clinical Management of COVID-19: Living Guideline. Published on 13 January 2023.  [(accessed on 26 February 2023)].  Available online:  https://app.magicapp.org/#/guideline/j1WBYn.</Citation></Reference><Reference><Citation>Fennel P.A., Dorr N., George S.S. Elements of Suffering in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Experience of Loss, Grief, Stigma, and Trauma in the Severely and Very Severely Affected. Healthcare. 2021;9:553. doi: 10.3390/healthcare9050553.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare9050553</ArticleId><ArticleId IdType=\"pmc\">PMC8150911</ArticleId><ArticleId IdType=\"pubmed\">34065069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L., Elliot M., Stein E., Jason L. Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Healthcare. 2021;9:629. doi: 10.3390/healthcare9060629.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare9060629</ArticleId><ArticleId IdType=\"pmc\">PMC8227525</ArticleId><ArticleId IdType=\"pubmed\">34070367</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens W. Was Z&#xe4;hlt Mehr: Laborwerte Oder Subjektives Krankheitserleben? S&#xfc;ddeutsche Zeitung 9-9-2023.  [(accessed on 26 February 2023)].  Available online:  https://www.s&#xfc;ddeutsche.de/gesundheit/medizin-1.5653659.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37064029</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">2296-858X</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>A review of cytokine-based pathophysiology of Long COVID symptoms.</ArticleTitle><Pagination><StartPage>1011936</StartPage><MedlinePgn>1011936</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">1011936</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3389/fmed.2023.1011936</ELocationID><Abstract><AbstractText>The Long COVID/Post Acute Sequelae of COVID-19 (PASC) group includes patients with initial mild-to-moderate symptoms during the acute phase of the illness, in whom recovery is prolonged, or new symptoms are developed over months. Here, we propose a description of the pathophysiology of the Long COVID presentation based on inflammatory cytokine cascades and the p38 MAP kinase signaling pathways that regulate cytokine production. In this model, the SARS-CoV-2 viral infection is hypothesized to trigger a dysregulated peripheral immune system activation with subsequent cytokine release. Chronic low-grade inflammation leads to dysregulated brain microglia with an exaggerated release of central cytokines, producing neuroinflammation. Immunothrombosis linked to chronic inflammation with microclot formation leads to decreased tissue perfusion and ischemia. Intermittent fatigue, Post Exertional Malaise (PEM), CNS symptoms with \"brain fog,\" arthralgias, paresthesias, dysautonomia, and GI and ophthalmic problems can consequently arise as result of the elevated peripheral and central cytokines. There are abundant similarities between symptoms in Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). DNA polymorphisms and viral-induced epigenetic changes to cytokine gene expression may lead to chronic inflammation in Long COVID patients, predisposing some to develop autoimmunity, which may be the gateway to ME/CFS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Low, Low and Akrami.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Low</LastName><ForeName>Russell N</ForeName><Initials>RN</Initials><AffiliationInfo><Affiliation>Retired, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Low</LastName><ForeName>Ryan J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Gatsby Computational Neuroscience Unit, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sainsbury Wellcome Centre, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Akrami</LastName><ForeName>Athena</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sainsbury Wellcome Centre, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">COVID-19</Keyword><Keyword MajorTopicYN=\"N\">Chronic Fatigue Syndrome</Keyword><Keyword MajorTopicYN=\"N\">Dysautonomia</Keyword><Keyword MajorTopicYN=\"N\">Long COVID</Keyword><Keyword MajorTopicYN=\"N\">Myalgic Encephalomyelitis (ME)</Keyword><Keyword MajorTopicYN=\"N\">cytokines</Keyword><Keyword MajorTopicYN=\"N\">neuroinflammation</Keyword><Keyword MajorTopicYN=\"N\">post-acute sequelae of COVID-19</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>3</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37064029</ArticleId><ArticleId IdType=\"pmc\">PMC10103649</ArticleId><ArticleId IdType=\"doi\">10.3389/fmed.2023.1011936</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. Geneva: World Health Organization; (2021).</Citation></Reference><Reference><Citation>Assaf G, Davis H, McCorkell L, Wei H, O&#x2019;Neill B, Akrami A, et al. . What does COVID-19 recovery actually look like? An analysis of the c survey by patient-led research team [internet]. London, UK: The COVID-19 Body Politic Slack Group; (2020).</Citation></Reference><Reference><Citation>Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. (2022) 13:1812. doi: 10.1038/s41467-022-29513-z, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType=\"pmc\">PMC8983754</ArticleId><ArticleId IdType=\"pubmed\">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Schiabor Barrett KM, Riffle S, Bolze A, Neveux I, Dabe S, et al. . (2020). Long-term COVID-19 symptoms in a large unselected population [internet]. medRxiv [Preprint]. doi: 10.1101/2020.10.07.20208702</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.10.07.20208702</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair PW, Brown DM, Jang M, Antar AAR, Keruly JC, Bachu V, et al. . (2020). The clinical course of COVID-19 in the outpatient setting: a prospective cohort study [internet]. medRxiv [Preprint]. doi: 10.1101/2020.09.01.20184937</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.09.01.20184937</ArticleId><ArticleId IdType=\"pmc\">PMC7881750</ArticleId><ArticleId IdType=\"pubmed\">33614816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding H, Yin S, Cheng Y, Cai Y, Huang W, Deng W. Neurologic manifestations of nonhospitalized patients with COVID-19 in Wuhan, China [internet]. MedComm. (2020) 1:253&#x2013;6. doi: 10.1002/mco2.13, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/mco2.13</ArticleId><ArticleId IdType=\"pmc\">PMC7362024</ArticleId><ArticleId IdType=\"pubmed\">34172986</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2014; United States, march&#x2013;June 2020. MMWR Morb Mortal Wkly Rep. (2020) 69:993&#x2013;8. Available from:. doi: 10.15585/mmwr.mm6930e1, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType=\"pmc\">PMC7392393</ArticleId><ArticleId IdType=\"pubmed\">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group . Landi F. persistent symptoms in patients after acute COVID-19. JAMA. (2020) 324:603&#x2013;5. doi: 10.1001/jama.2020.12603, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2020.12603</ArticleId><ArticleId IdType=\"pmc\">PMC7349096</ArticleId><ArticleId IdType=\"pubmed\">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, le Bot A, Hamon A, Gouze H, et al. . Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect [Internet]. (2020) 81:e4&#x2013;6. doi: 10.1016/j.jinf.2020.08.029, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType=\"pmc\">PMC7445491</ArticleId><ArticleId IdType=\"pubmed\">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, Morley A, Viner J, Attwood M, et al. . (2020). Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort. medRxiv [Preprint]. doi: 10.1101/2020.08.12.20173526</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.08.12.20173526</ArticleId><ArticleId IdType=\"pmc\">PMC7716340</ArticleId><ArticleId IdType=\"pubmed\">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bosworth ML, King S, Pouwels KB, Glickman M, Nafilyan V, et al. . (2022). Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study [internet]. medRxiv [Preprint]. doi: 10.1101/2022.02.23.22271388</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2022.02.23.22271388</ArticleId><ArticleId IdType=\"pmc\">PMC9494414</ArticleId><ArticleId IdType=\"pubmed\">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. (2022) 28:1461&#x2013;7. doi: 10.1038/s41591-022-01840-0, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType=\"pmc\">PMC9307472</ArticleId><ArticleId IdType=\"pubmed\">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. (2021) 38:101019. doi: 10.1016/j.eclinm.2021.101019, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType=\"pmc\">PMC8280690</ArticleId><ArticleId IdType=\"pubmed\">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoshal UC, Ghoshal U, Rahman MM, Mathur A, Rai S, Akhter M, et al. . Post-infection functional gastrointestinal disorders following coronavirus disease-19: a case-control study. J Gastroenterol Hepatol. (2022) 37:489&#x2013;98. doi: 10.1111/jgh.15717, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jgh.15717</ArticleId><ArticleId IdType=\"pmc\">PMC8657345</ArticleId><ArticleId IdType=\"pubmed\">34672022</ArticleId></ArticleIdList></Reference><Reference><Citation>de Rooij LPMH, Becker LM, Carmeliet P. A role for the vascular endothelium in post&#x2013;acute COVID-19? Circulation. (2022) 145:1503&#x2013;5. doi: 10.1161/circulationaha.122.059231, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/circulationaha.122.059231</ArticleId><ArticleId IdType=\"pubmed\">35576316</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz A, Ong P. Endothelial dysfunction in COVID-19: a potential predictor of long-COVID? Int J Cardiol. (2022) 349:155&#x2013;6. doi: 10.1016/j.ijcard.2021.11.051, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijcard.2021.11.051</ArticleId><ArticleId IdType=\"pmc\">PMC8610828</ArticleId><ArticleId IdType=\"pubmed\">34838682</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType=\"pmc\">PMC9839201</ArticleId><ArticleId IdType=\"pubmed\">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute Sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. (2021) 12:698169. doi: 10.3389/fmicb.2021.698169, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType=\"pmc\">PMC8260991</ArticleId><ArticleId IdType=\"pubmed\">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogensen TH, Paludan SR. Molecular pathways in virus-induced cytokine production [internet]. Microbiol Mol Biol Rev. (2001) 65:131&#x2013;50. Available from:. doi: 10.1128/MMBR.65.1.131-150.2001, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/MMBR.65.1.131-150.2001</ArticleId><ArticleId IdType=\"pmc\">PMC99022</ArticleId><ArticleId IdType=\"pubmed\">11238989</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. . Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. (2020) 71:762&#x2013;8. doi: 10.1093/cid/ciaa248, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cid/ciaa248</ArticleId><ArticleId IdType=\"pmc\">PMC7108125</ArticleId><ArticleId IdType=\"pubmed\">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. (2020) 53:25&#x2013;32. doi: 10.1016/j.cytogfr.2020.05.003, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cytogfr.2020.05.003</ArticleId><ArticleId IdType=\"pmc\">PMC7211650</ArticleId><ArticleId IdType=\"pubmed\">32446778</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. (2020) 395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType=\"pmc\">PMC7159299</ArticleId><ArticleId IdType=\"pubmed\">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, et al. . An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med [Internet]. (2020) 26:1636&#x2013;43. doi: 10.1038/s41591-020-1051-9, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType=\"pmc\">PMC7869028</ArticleId><ArticleId IdType=\"pubmed\">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng HY, Gao Y, Liu S, Sun D, Yang F, Zong L, et al. . Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. (2020) 17:1180&#x2013;2. doi: 10.1038/s41423-020-00551-1, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41423-020-00551-1</ArticleId><ArticleId IdType=\"pmc\">PMC7091621</ArticleId><ArticleId IdType=\"pubmed\">32203186</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. . Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science [Internet]. (2020) 369:718&#x2013;24. doi: 10.1126/science.abc6027, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.abc6027</ArticleId><ArticleId IdType=\"pmc\">PMC7402632</ArticleId><ArticleId IdType=\"pubmed\">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Dong X, Ma R, Wang W, Xiao X, Tian Z, et al. . Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun. (2020) 11:3810. doi: 10.1038/s41467-020-17665-9, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-020-17665-9</ArticleId><ArticleId IdType=\"pmc\">PMC7392898</ArticleId><ArticleId IdType=\"pubmed\">32733001</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. (2022) 23:210&#x2013;6. doi: 10.1038/s41590-021-01113-x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType=\"pubmed\">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Glasauer S, et al. . From online data collection to identification of disease mechanisms: the IL-1&#xdf;, IL-6 and TNF-&#x3b1; cytokine triad is associated with post-acute sequelae of COVID-19 in a digital research cohort. SSRN Electron J [Internet]. (2021). doi: 10.2139/ssrn.3963839</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2139/ssrn.3963839</ArticleId></ArticleIdList></Reference><Reference><Citation>VanElzakker MB, Brumfield SA, Lara Mejia PS. Neuroinflammation and cytokines in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a critical review of research methods. Front Neurol. (2018) 9:1033. doi: 10.3389/fneur.2018.01033, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2018.01033</ArticleId><ArticleId IdType=\"pmc\">PMC6335565</ArticleId><ArticleId IdType=\"pubmed\">30687207</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho HE, Goldberg SA, et al. . Markers of immune activation and inflammation in individuals with Postacute Sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. (2021) 224:1839&#x2013;48. doi: 10.1093/infdis/jiab490, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/infdis/jiab490</ArticleId><ArticleId IdType=\"pmc\">PMC8643408</ArticleId><ArticleId IdType=\"pubmed\">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, et al. . (2022). Distinguishing features of long COVID identified through immune profiling. medRxiv [Preprint]. doi: 10.1101/2022.08.09.22278592.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2022.08.09.22278592</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, Bamford CGG, Ho A. COVID-19 pandemic&#x2014;a focused review for clinicians. Clin Microbiol Infect. (2020) 26:842&#x2013;7. doi: 10.1016/j.cmi.2020.04.023, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmi.2020.04.023</ArticleId><ArticleId IdType=\"pmc\">PMC7182753</ArticleId><ArticleId IdType=\"pubmed\">32344166</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. . COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. (2020) 395:1033&#x2013;4. Available from:. doi: 10.1016/S0140-6736(20)30628-0, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType=\"pmc\">PMC7270045</ArticleId><ArticleId IdType=\"pubmed\">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Chen X, Cai Y, Xia J&#x2019;a, Zhou X, Xu S, et al. . Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. (2020) 180:934&#x2013;43. doi: 10.1001/jamainternmed.2020.0994, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType=\"pmc\">PMC7070509</ArticleId><ArticleId IdType=\"pubmed\">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. (2012) 76:16&#x2013;32. doi: 10.1128/MMBR.05015-11, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/MMBR.05015-11</ArticleId><ArticleId IdType=\"pmc\">PMC3294426</ArticleId><ArticleId IdType=\"pubmed\">22390970</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, et al. . Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19 [internet]. J Allergy Clin Immunol. (2020) 146:128&#x2013;36.e4. Available from:. doi: 10.1016/j.jaci.2020.05.008, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaci.2020.05.008</ArticleId><ArticleId IdType=\"pmc\">PMC7233239</ArticleId><ArticleId IdType=\"pubmed\">32425269</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Shen C, Li J, Yuan J, Yang M, Wang F, et al. . (2020). Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome. medRxiv [Preprint]. doi: 10.1101/2020.11.26.20152520.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.11.26.20152520</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimabukuro-Vornhagen A, G&#xf6;del P, Subklewe M, Stemmler HJ, Schl&#xf6;&#xdf;er HA, Schlaak M, et al. . Cytokine release syndrome. J Immunother. Cancer. (2018) 6:56. doi: 10.1186/s40425-018-0343-9, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40425-018-0343-9</ArticleId><ArticleId IdType=\"pmc\">PMC6003181</ArticleId><ArticleId IdType=\"pubmed\">29907163</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, et al. . Current concepts in the diagnosis and management of cytokine release syndrome. Blood. (2014) 124:188&#x2013;95. doi: 10.1182/blood-2014-05-552729, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood-2014-05-552729</ArticleId><ArticleId IdType=\"pmc\">PMC4093680</ArticleId><ArticleId IdType=\"pubmed\">24876563</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. (2020) 368:473&#x2013;4. doi: 10.1126/science.abb8925, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.abb8925</ArticleId><ArticleId IdType=\"pubmed\">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MD, Nedjai B, Hurst T, Pennington DF. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta&#x2014;Mol Cell Res. (2014) 1843:2563&#x2013;82. doi: 10.1016/j.bbamcr.2014.05.014, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamcr.2014.05.014</ArticleId><ArticleId IdType=\"pubmed\">24892271</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Author correction: pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. (2020) 20:448. doi: 10.1038/s41577-020-0353-y, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41577-020-0353-y</ArticleId><ArticleId IdType=\"pmc\">PMC7265161</ArticleId><ArticleId IdType=\"pubmed\">32488203</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q, Wang B, Mao J. The pathogenesis and treatment of the &#x2018;cytokine storm&#x2019; in COVID-19. J Infect. (2020) 80:607&#x2013;13. doi: 10.1016/j.jinf.2020.03.037, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jinf.2020.03.037</ArticleId><ArticleId IdType=\"pmc\">PMC7194613</ArticleId><ArticleId IdType=\"pubmed\">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lucena TMC, da Silva Santos AF, de Lima BR, de Albuquerque Borborema ME, de Azev&#xea;do Silva J. Mechanism of inflammatory response in associated comorbidities in COVID-19. Diabetes Metab Syndr. (2019) 14:597&#x2013;600. doi: 10.1016/j.dsx.2020.05.025</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.dsx.2020.05.025</ArticleId><ArticleId IdType=\"pmc\">PMC7215143</ArticleId><ArticleId IdType=\"pubmed\">32417709</ArticleId></ArticleIdList></Reference><Reference><Citation>Meftahi GH, Jangravi Z, Sahraei H, Bahari Z. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of &#x201c;inflame-aging.&#x201d;. Inflamm Res. (2020) 69:825&#x2013;39. doi: 10.1007/s00011-020-01372-8, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00011-020-01372-8</ArticleId><ArticleId IdType=\"pmc\">PMC7289226</ArticleId><ArticleId IdType=\"pubmed\">32529477</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakotoarivelo V, Lacraz G, Mayhue M, Brown C, Rottembourg D, Fradette J, et al. . Inflammatory cytokine profiles in visceral and subcutaneous adipose tissues of obese patients undergoing bariatric surgery reveal lack of correlation with obesity or diabetes [internet]. EBioMedicine. (2018) 30:237&#x2013;47. doi: 10.1016/j.ebiom.2018.03.004, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ebiom.2018.03.004</ArticleId><ArticleId IdType=\"pmc\">PMC5952229</ArticleId><ArticleId IdType=\"pubmed\">29548899</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J, Li J, Cai L, Chakrabarti S, Li X. Cytokines and diabetes research. J Diabetes Res [Internet]. (2014) 2014:1&#x2013;2. doi: 10.1155/2014/920613, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2014/920613</ArticleId><ArticleId IdType=\"pmc\">PMC3914520</ArticleId><ArticleId IdType=\"pubmed\">24551859</ArticleId></ArticleIdList></Reference><Reference><Citation>Randeria SN, Thomson GJA, Nell TA, Roberts T, Pretorius E. Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation. Cardiovasc Diabetol. (2019) 18:72&#x2013;15. doi: 10.1186/s12933-019-0870-9, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12933-019-0870-9</ArticleId><ArticleId IdType=\"pmc\">PMC6549308</ArticleId><ArticleId IdType=\"pubmed\">31164120</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanase DM, Gosav EM, Radu S, Ouatu A, Rezus C, Ciocoiu M, et al. . Arterial hypertension and interleukins: potential therapeutic target or future diagnostic marker? Int J Hypertens. (2019) 2019:3159283: 1&#x2013;17. doi: 10.1155/2019/3159283, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2019/3159283</ArticleId><ArticleId IdType=\"pmc\">PMC6521461</ArticleId><ArticleId IdType=\"pubmed\">31186952</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. . Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx. New York Metab. (2020) 108:154262. doi: 10.1016/j.metabol.2020.154262, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.metabol.2020.154262</ArticleId><ArticleId IdType=\"pmc\">PMC7228874</ArticleId><ArticleId IdType=\"pubmed\">32422233</ArticleId></ArticleIdList></Reference><Reference><Citation>Crayne CB, Albeituni S, Nichols KE, Cron RQ. The immunology of macrophage activation syndrome [internet]. Front Immunol. (2019) 10:119. doi: 10.3389/fimmu.2019.00119, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2019.00119</ArticleId><ArticleId IdType=\"pmc\">PMC6367262</ArticleId><ArticleId IdType=\"pubmed\">30774631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosyreva A, Dzhalilova D, Lokhonina A, Vishnyakova P, Fatkhudinov T. The role of macrophages in the pathogenesis of SARS-CoV-2-associated acute respiratory distress syndrome. Front Immunol. (2021) 12:682871. doi: 10.3389/fimmu.2021.682871, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2021.682871</ArticleId><ArticleId IdType=\"pmc\">PMC8141811</ArticleId><ArticleId IdType=\"pubmed\">34040616</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamato M, Kataoka Y. Fatigue sensation following peripheral viral infection is triggered by neuroinflammation: who will answer these questions? Neural Regen Res. (2015) 10:203&#x2013;4. doi: 10.4103/1673-5374.152369, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/1673-5374.152369</ArticleId><ArticleId IdType=\"pmc\">PMC4392663</ArticleId><ArticleId IdType=\"pubmed\">25883614</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler M, Pollak TA, Rooney AG, Michael BD, Nicholson TR. Neuropsychiatric complications of covid-19 [internet]. BMJ. (2020):m3871. doi: 10.1136/bmj.m3871, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.m3871</ArticleId><ArticleId IdType=\"pubmed\">33051183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima M, Siokas V, Aloizou AM, Liampas I, Mentis AA, Tsouris Z, et al. . Unraveling the possible routes of SARS-COV-2 invasion into the central nervous system. Curr Treat Options Neurol [Internet]. (2020) 22:37. doi: 10.1007/s11940-020-00647-z, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11940-020-00647-z</ArticleId><ArticleId IdType=\"pmc\">PMC7515807</ArticleId><ArticleId IdType=\"pubmed\">32994698</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, Sperhake JP, Schr&#xf6;der AS, Edler C, et al. . Neuropathology of patients with COVID-19 in Germany: a post-mortem case series [internet]. Lancet Neurol. (2020) 19:919&#x2013;29. doi: 10.1016/S1474-4422(20)30308-2, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType=\"pmc\">PMC7535629</ArticleId><ArticleId IdType=\"pubmed\">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, et al. . Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) [internet]. J Med Virol. (2020) 92:699&#x2013;702. doi: 10.1002/jmv.25915, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.25915</ArticleId><ArticleId IdType=\"pmc\">PMC7264598</ArticleId><ArticleId IdType=\"pubmed\">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K, G&#xe1;lvez NMS, R&#xed;os M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. (2018) 12:386. doi: 10.3389/fncel.2018.00386, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2018.00386</ArticleId><ArticleId IdType=\"pmc\">PMC6212673</ArticleId><ArticleId IdType=\"pubmed\">30416428</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi S, Moosaie F, Aarabi MH. Understanding the immunologic characteristics of neurologic manifestations of SARS-CoV-2 and potential immunological mechanisms. Mol Neurobiol [Internet]. (2020). doi: 10.1007/s12035-020-02094-y, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-020-02094-y</ArticleId><ArticleId IdType=\"pmc\">PMC7458880</ArticleId><ArticleId IdType=\"pubmed\">32869183</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev. (2018) 98:477&#x2013;504. doi: 10.1152/physrev.00039.2016, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/physrev.00039.2016</ArticleId><ArticleId IdType=\"pmc\">PMC5866360</ArticleId><ArticleId IdType=\"pubmed\">29351513</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R, Konsman JP, Bluth&#xe9; RM, Kelley KW. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton Neurosci. (2000) 85:60&#x2013;5. doi: 10.1016/S1566-0702(00)00220-4, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1566-0702(00)00220-4</ArticleId><ArticleId IdType=\"pubmed\">11189027</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit WJ, Mrak RE, Griffin WST. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation. (2004) 1:1&#x2013;4. doi: 10.1186/1742-2094-1-14, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1742-2094-1-14</ArticleId><ArticleId IdType=\"pmc\">PMC509427</ArticleId><ArticleId IdType=\"pubmed\">15285801</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabab T, Khanabdali R, Moghadamtousi SZ, Kadir HA, Mohan G. Neuroinflammation pathways: a general review [internet]. Int J Neurosci. (2017) 127:624&#x2013;33. doi: 10.1080/00207454.2016.1212854</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/00207454.2016.1212854</ArticleId><ArticleId IdType=\"pubmed\">27412492</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank-Cannon TC, Alto LT, McAlpine FE, Tansey MG. Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegener. (2009) 4:1&#x2013;13. doi: 10.1186/1750-1326-4-47, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1750-1326-4-47</ArticleId><ArticleId IdType=\"pmc\">PMC2784760</ArticleId><ArticleId IdType=\"pubmed\">19917131</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. J Neuroinflammation. (2013) 10:1&#x2013;24. doi: 10.1186/1742-2094-10-43, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1742-2094-10-43</ArticleId><ArticleId IdType=\"pmc\">PMC3626880</ArticleId><ArticleId IdType=\"pubmed\">23547920</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS, et al. . Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. (2020) 7:2221&#x2013;30. doi: 10.1002/acn3.51210, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/acn3.51210</ArticleId><ArticleId IdType=\"pmc\">PMC7664279</ArticleId><ArticleId IdType=\"pubmed\">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakhoum MF, Ritter M, Garg A, Chan AX, Bakhoum CY, Smith D. Subclinical ocular inflammation in persons recovered from ambulatory COVID-19 [internet]. medRxiv [Preprint]. doi: 10.1101/2020.09.22.20128140.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.09.22.20128140</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson MJ, Thrash JC, Walter B. The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci Res. (2006) 6:237&#x2013;45. doi: 10.1016/j.cnr.2006.09.004, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cnr.2006.09.004</ArticleId><ArticleId IdType=\"pmc\">PMC2630233</ArticleId><ArticleId IdType=\"pubmed\">19169437</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng ZV, Wong KCG. Microglial activation and polarization after subarachnoid hemorrhage. Neuroimmunol Neuroinflamm. (2019) 2019:1. doi: 10.20517/2347-8659.2018.52, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.20517/2347-8659.2018.52</ArticleId><ArticleId IdType=\"pubmed\">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur C, Rathnasamy G, Ling EA. Biology of microglia in the developing brain. J Neuropathol Exp Neurol. (2017) 76:736&#x2013;53. doi: 10.1093/jnen/nlx056</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jnen/nlx056</ArticleId><ArticleId IdType=\"pubmed\">28859332</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam SR, Federoff HJ. Targeting microglial activation states as a therapeutic avenue in Parkinson&#x2019;s disease. Front Aging Neurosci. (2017) 9:176. doi: 10.3389/fnagi.2017.00176, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2017.00176</ArticleId><ArticleId IdType=\"pmc\">PMC5463358</ArticleId><ArticleId IdType=\"pubmed\">28642697</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bernhardi R, Eugen&#xed;n-von Bernhardi L, Eugen&#xed;n J. Microglial cell dysregulation in brain aging and neurodegeneration. Front Aging Neurosci. (2015) 7:124. doi: 10.3389/fnagi.2015.00124, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2015.00124</ArticleId><ArticleId IdType=\"pmc\">PMC4507468</ArticleId><ArticleId IdType=\"pubmed\">26257642</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Mao S, Wang J, Ding X, Zen JY. Viral infection and neurological disorders&#x2014;potential role of extracellular nucleotides in neuroinflammation. ExRNA. (2019) 1:1&#x2013;5. doi: 10.1186/s41544-019-0031-z</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s41544-019-0031-z</ArticleId><ArticleId IdType=\"pubmed\">0</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xfc;ntener U, Booth SG, Perry VH, Teeling JL. Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia. J Neuroinflammation. (2012) 9:146. doi: 10.1186/1742-2094-9-146, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1742-2094-9-146</ArticleId><ArticleId IdType=\"pmc\">PMC3439352</ArticleId><ArticleId IdType=\"pubmed\">22738332</ArticleId></ArticleIdList></Reference><Reference><Citation>Godbout JP, Chen J, Abraham J, Richwine AF, Berg BM, Kelley KW, et al. . Exaggerated neuroinflammation and sickness behavior in aged mice after activation of the peripheral innate immune system [internet]. FASEB J. (2005) 19:1329&#x2013;31. Available from:. doi: 10.1096/fj.05-3776fje, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1096/fj.05-3776fje</ArticleId><ArticleId IdType=\"pubmed\">15919760</ArticleId></ArticleIdList></Reference><Reference><Citation>Niraula A, Sheridan JF, Godbout JP. Microglia priming with aging and stress. Neuropsychopharmacology [Internet]. (2017) 42:318&#x2013;33. doi: 10.1038/npp.2016.185, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/npp.2016.185</ArticleId><ArticleId IdType=\"pmc\">PMC5143497</ArticleId><ArticleId IdType=\"pubmed\">27604565</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay TL, B&#xe9;chade C, D&#x2019;Andrea I, St-Pierre MK, Henry MS, Roumier A, et al. . Microglia gone rogue: impacts on psychiatric disorders across the lifespan. Front Mol Neurosci. (2018) 10:421. doi: 10.3389/fnmol.2017.00421, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnmol.2017.00421</ArticleId><ArticleId IdType=\"pmc\">PMC5758507</ArticleId><ArticleId IdType=\"pubmed\">29354029</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. (1995) 18:130&#x2013;6. doi: 10.1016/0166-2236(95)93890-A, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0166-2236(95)93890-A</ArticleId><ArticleId IdType=\"pubmed\">7754524</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollmacher T, Haack M, Schuld A, Reichenberg A, Yirmiya R. Low levels of circulating inflammatory cytokines&#x2014;do they affect human brain functions? Brain Behav Immun. (2002) 16:525&#x2013;32. doi: 10.1016/S0889-1591(02)00004-1, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0889-1591(02)00004-1</ArticleId><ArticleId IdType=\"pubmed\">12401466</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa-Silva MC, Santos LE, Rangel B. The impact of non-neurotropic influenza strains on the brain: a role for microglial priming? J Neurosci. (2018) 38:7758&#x2013;60. doi: 10.1523/JNEUROSCI.1368-18.2018, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1368-18.2018</ArticleId><ArticleId IdType=\"pmc\">PMC6596083</ArticleId><ArticleId IdType=\"pubmed\">30185538</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R. Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun. (2001) 15:7&#x2013;24. doi: 10.1006/brbi.2000.0613, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1006/brbi.2000.0613</ArticleId><ArticleId IdType=\"pubmed\">11259077</ArticleId></ArticleIdList></Reference><Reference><Citation>Yirmiya R, Pollak Y, Morag M, Reichenberg A, Barak O, Avitsur R, et al. . Illness, cytokines, and depression [internet]. Ann N Y Acad Sci. (2000) 917:478&#x2013;87. doi: 10.1111/j.1749-6632.2000.tb05412.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1749-6632.2000.tb05412.x</ArticleId><ArticleId IdType=\"pubmed\">11268375</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou R, Garner M, Holmes C, Osmond C, Teeling J, Lau L, et al. . Peripheral inflammatory cytokines and immune balance in generalised anxiety disorder: case-controlled study. Brain Behav Immun. (2017) 62:212&#x2013;8. doi: 10.1016/j.bbi.2017.01.021, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2017.01.021</ArticleId><ArticleId IdType=\"pmc\">PMC5373436</ArticleId><ArticleId IdType=\"pubmed\">28161475</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell NJ, Luheshi G, Toulmond S. Cytokines and their receptors in the central nervous system: physiology, pharmacology, and pathology. Pharmacol Ther. (1996) 69:85&#x2013;95. doi: 10.1016/0163-7258(95)02033-0, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0163-7258(95)02033-0</ArticleId><ArticleId IdType=\"pubmed\">8984509</ArticleId></ArticleIdList></Reference><Reference><Citation>Khairova RA, Machado-Vieira R, Du J, Manji HK. A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol. (2009) 12:561&#x2013;78. doi: 10.1017/S1461145709009924, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S1461145709009924</ArticleId><ArticleId IdType=\"pmc\">PMC2771334</ArticleId><ArticleId IdType=\"pubmed\">19224657</ArticleId></ArticleIdList></Reference><Reference><Citation>McAfoose J, Baune BT. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev. (2009) 33:355&#x2013;66. doi: 10.1016/j.neubiorev.2008.10.005, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neubiorev.2008.10.005</ArticleId><ArticleId IdType=\"pubmed\">18996146</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson PH, Nawa H. Neuronal differentiation factors/cytokines and synaptic plasticity. Cells. (1993) 72:123&#x2013;37. doi: 10.1016/S0092-8674(05)80032-7, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0092-8674(05)80032-7</ArticleId><ArticleId IdType=\"pubmed\">8428374</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RJ, Jung H, Bhangoo SK, White FA. Cytokine and chemokine regulation of sensory neuron function In: Sensory nerves. ed. Canning Brendan J. Berlin, Heidelberg: Springer; (2009). 417&#x2013;49.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2746245</ArticleId><ArticleId IdType=\"pubmed\">19655114</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluger MJ. Fever: role of pyrogens and cryogens. Physiol Rev. (1991) 71:93&#x2013;127. doi: 10.1152/physrev.1991.71.1.93, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/physrev.1991.71.1.93</ArticleId><ArticleId IdType=\"pmc\">PMC7191625</ArticleId><ArticleId IdType=\"pubmed\">1986393</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivier C, Rivest S. (2007). Mechanisms mediating the effects of cytokines on neuroendocrine functions in the rat. Ciba Foundation Symposium 172&#x2014;Corticotropin-Releasing Factor, 204&#x2013;225.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8491087</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn AJ. Systematic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. Life Sci. (1988) 43:429&#x2013;35. doi: 10.1016/0024-3205(88)90522-X, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0024-3205(88)90522-X</ArticleId><ArticleId IdType=\"pubmed\">3260987</ArticleId></ArticleIdList></Reference><Reference><Citation>Fann MJ, Patterson PH. Neuropoietic cytokines and activin a differentially regulate the phenotype of cultured sympathetic neurons. Proc Natl Acad Sci U S A. (1994) 91:43&#x2013;7. doi: 10.1073/pnas.91.1.43, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.91.1.43</ArticleId><ArticleId IdType=\"pmc\">PMC42882</ArticleId><ArticleId IdType=\"pubmed\">7904069</ArticleId></ArticleIdList></Reference><Reference><Citation>Balter LJ, Bosch JA, Aldred S, Drayson MT, Veldhuijzen van Zanten JJCS, Higgs S, et al. . Selective effects of acute low-grade inflammation on human visual attention. Neuroimage. (2019) 202:116098. doi: 10.1016/j.neuroimage.2019.116098, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2019.116098</ArticleId><ArticleId IdType=\"pubmed\">31415883</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AH, Haroon E, Raison CL, Felger JC. Cytokine targets in the brain: impact on neurotransmitters and Neurocircuits. Depress Anxiety. (2013) 30:297. doi: 10.1002/da.22084, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/da.22084</ArticleId><ArticleId IdType=\"pmc\">PMC4141874</ArticleId><ArticleId IdType=\"pubmed\">23468190</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R, O&#x2019;Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. (2008) 9:46&#x2013;56. doi: 10.1038/nrn2297, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrn2297</ArticleId><ArticleId IdType=\"pmc\">PMC2919277</ArticleId><ArticleId IdType=\"pubmed\">18073775</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuron L, Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav Immun. (2003) 17 Suppl 1:S119&#x2013;24. doi: 10.1016/S0889-1591(02)00078-8, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0889-1591(02)00078-8</ArticleId><ArticleId IdType=\"pubmed\">12615197</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronfol Z. Cytokines and the brain: implications for clinical psychiatry [internet]. Am J Psychiatr. (2000) 157:683&#x2013;94. Available from:. doi: 10.1176/appi.ajp.157.5.683, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1176/appi.ajp.157.5.683</ArticleId><ArticleId IdType=\"pubmed\">10784457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappelmann N, Dantzer R, Khandaker GM. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology. (2021) 105295:105295. doi: 10.1016/j.psyneuen.2021.105295</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.psyneuen.2021.105295</ArticleId><ArticleId IdType=\"pmc\">PMC8172271</ArticleId><ArticleId IdType=\"pubmed\">34119855</ArticleId></ArticleIdList></Reference><Reference><Citation>Murta V, Villarreal A, Ramos AJ. (2020). SARS-CoV-2 impact on the central nervous system: are astrocytes and microglia main players or merely bystanders? Available at: https://www.preprints.org/manuscript/202006.0319/v1</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7476346</ArticleId><ArticleId IdType=\"pubmed\">32878468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasselbalch HC. The role of cytokines in the initiation and progression of myelofibrosis. Cytokine Growth Factor Rev. (2013) 24:133&#x2013;45. doi: 10.1016/j.cytogfr.2013.01.004, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cytogfr.2013.01.004</ArticleId><ArticleId IdType=\"pubmed\">23415024</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin N Am. (2009) 29:247&#x2013;64. doi: 10.1016/j.iac.2009.02.002, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.iac.2009.02.002</ArticleId><ArticleId IdType=\"pmc\">PMC2740752</ArticleId><ArticleId IdType=\"pubmed\">19389580</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogoina D. Fever, fever patterns and diseases called &#x201c;fever&#x201d; &#x2013; a review. J Infect Public Health. (2011) 4:108&#x2013;24. doi: 10.1016/j.jiph.2011.05.002, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jiph.2011.05.002</ArticleId><ArticleId IdType=\"pubmed\">21843857</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti B, Tabarean I, Andrei C, Bartfai T. Cytokines and fever. Front Biosci. (2004) 9:1433&#x2013;49. doi: 10.2741/1341, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2741/1341</ArticleId><ArticleId IdType=\"pubmed\">14977558</ArticleId></ArticleIdList></Reference><Reference><Citation>Netea MG, Kullberg BJ, Van der Meer JWM. Circulating cytokines as mediators of fever. Clin Infect Dis. (2000) 31:S178&#x2013;84. doi: 10.1086/317513, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1086/317513</ArticleId><ArticleId IdType=\"pubmed\">11113021</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams RMC, Simpson DM, Navis A, Jette N, Zhou L, Shin SC. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve. (2022) 65:440&#x2013;3. doi: 10.1002/mus.27458, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/mus.27458</ArticleId><ArticleId IdType=\"pmc\">PMC8661991</ArticleId><ArticleId IdType=\"pubmed\">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Magrinelli F, Briani C, Romano M, Ruggero S, Toffanin E, Triolo G, et al. . The association between serum cytokines and damage to large and small nerve fibers in diabetic peripheral neuropathy. J Diabetes Res. (2015) 2015:1&#x2013;7. doi: 10.1155/2015/547834, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2015/547834</ArticleId><ArticleId IdType=\"pmc\">PMC4415740</ArticleId><ArticleId IdType=\"pubmed\">25961054</ArticleId></ArticleIdList></Reference><Reference><Citation>Langjahr M, Schubert AL, Sommer C, &#xdc;&#xe7;eyler N. Increased pro-inflammatory cytokine gene expression in peripheral blood mononuclear cells of patients with polyneuropathies. J Neurol. (2018) 265:618&#x2013;27. doi: 10.1007/s00415-018-8748-4, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00415-018-8748-4</ArticleId><ArticleId IdType=\"pubmed\">29372388</ArticleId></ArticleIdList></Reference><Reference><Citation>England J. Parainfectious neuropathies [internet]. J Neurol Sci. (2019) 405:22. Available from:. doi: 10.1016/j.jns.2019.10.060, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jns.2019.10.060</ArticleId><ArticleId IdType=\"pubmed\">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Malcangio M, Clark AK, Old EA. Neuropathic pain and cytokines: current perspectives. JPR. (2013) 6:803&#x2013;14. doi: 10.2147/JPR.S53660, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/JPR.S53660</ArticleId><ArticleId IdType=\"pmc\">PMC3839806</ArticleId><ArticleId IdType=\"pubmed\">24294006</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung AL, Lim M, Doshi TL. Targeting cytokines for treatment of neuropathic pain. Scandinavian journal of pain. (2017) 17:287&#x2013;93. doi: 10.1016/j.sjpain.2017.08.002, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.sjpain.2017.08.002</ArticleId><ArticleId IdType=\"pmc\">PMC5774983</ArticleId><ArticleId IdType=\"pubmed\">29229214</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. . Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. (2022) 101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType=\"pmc\">PMC8715665</ArticleId><ArticleId IdType=\"pubmed\">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue Biomed Health Behav. (2020) 8:61&#x2013;9. doi: 10.1080/21641846.2020.1778227</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21641846.2020.1778227</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan JJ, Qin Z, Wang PY, Sun Y, Liu X. Muscle fatigue: general understanding and treatment. Exp Mol Med. (2017) 49:e384. doi: 10.1038/emm.2017.194, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/emm.2017.194</ArticleId><ArticleId IdType=\"pmc\">PMC5668469</ArticleId><ArticleId IdType=\"pubmed\">28983090</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri A, Behan PO. Fatigue and basal ganglia. J Neurol Sci. (2000) 179:34&#x2013;42. doi: 10.1016/S0022-510X(00)00411-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0022-510X(00)00411-1</ArticleId><ArticleId IdType=\"pubmed\">11054483</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AH, Miller JH, Pham DS, Beentjes KK, Unger ER, Pagnoni G. Decreased basal ganglia activation in subjects with chronic fatigue syndrome: association with symptoms of fatigue. PLoS 1. (2014) 9:e115750. doi: 10.1371/journal.pone.0115750, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0115750</ArticleId><ArticleId IdType=\"pmc\">PMC4032274</ArticleId><ArticleId IdType=\"pubmed\">24858857</ArticleId></ArticleIdList></Reference><Reference><Citation>Felger JC, Miller AH. Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol. (2012) 33:315&#x2013;27. doi: 10.1016/j.yfrne.2012.09.003, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.yfrne.2012.09.003</ArticleId><ArticleId IdType=\"pmc\">PMC3484236</ArticleId><ArticleId IdType=\"pubmed\">23000204</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordeiro LMS, Rabelo PCR, Moraes MM, Teixeira-Coelho F, Coimbra CC, Wanner SP, et al. . Physical exercise-induced fatigue: the role of serotonergic and dopaminergic systems. Braz J Med Biol Res. (2017) 50:e6432. doi: 10.1590/1414-431x20176432, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1590/1414-431x20176432</ArticleId><ArticleId IdType=\"pmc\">PMC5649871</ArticleId><ArticleId IdType=\"pubmed\">29069229</ArticleId></ArticleIdList></Reference><Reference><Citation>Sp&#xe4;th-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, Burger K, et al. . Acute effects of recombinant human Interleukin-6 on endocrine and central nervous sleep functions in healthy men 1. J Clin Endocrinol Metab. (1998) 83:1573&#x2013;9. doi: 10.1210/jcem.83.5.4795, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1210/jcem.83.5.4795</ArticleId><ArticleId IdType=\"pubmed\">9589658</ArticleId></ArticleIdList></Reference><Reference><Citation>Corominas H, Alegre C, Narv&#xe1;ez J, Fern&#xe1;ndez-Cid CM, Torrente-Segarra V, G&#xf3;mez MR, et al. . Correlation of fatigue with other disease related and psychosocial factors in patients with rheumatoid arthritis treated with tocilizumab: ACT-AXIS study. Medicine [Internet]. (2019) 98:e15947. doi: 10.1097/MD.0000000000015947, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MD.0000000000015947</ArticleId><ArticleId IdType=\"pmc\">PMC6617279</ArticleId><ArticleId IdType=\"pubmed\">31261500</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendling D, Racadot E, Wijdenes J. Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J Rheumatol [Internet]. (1993) 20:259&#x2013;62.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8474061</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Malovic E, Harishchandra DS, Ghaisas S, Panicker N, Charli A, et al. . Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson&#x2019;s disease. NPJ Parkinsons Dis. (2017) 3:30. doi: 10.1038/s41531-017-0032-2, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41531-017-0032-2</ArticleId><ArticleId IdType=\"pmc\">PMC5645400</ArticleId><ArticleId IdType=\"pubmed\">29057315</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti P, Ilamathi HS, Todkar K, Germain M. Mitochondria targeted viral replication and survival strategies&#x2014;prospective on SARS-CoV-2. Front Pharmacol [Internet]. (2020) 11:578599. doi: 10.3389/fphar.2020.578599</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2020.578599</ArticleId><ArticleId IdType=\"pmc\">PMC7485471</ArticleId><ArticleId IdType=\"pubmed\">32982760</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh KK, Chaubey G, Chen JY, Suravajhala P. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am J Physiol Cell Physiol. (2020) 319:C258&#x2013;67. doi: 10.1152/ajpcell.00224.2020, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpcell.00224.2020</ArticleId><ArticleId IdType=\"pmc\">PMC7381712</ArticleId><ArticleId IdType=\"pubmed\">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh J, Peyssonnaux C, Singh KK, Edeas M. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion. (2020) 54:1&#x2013;7. doi: 10.1016/j.mito.2020.06.008, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mito.2020.06.008</ArticleId><ArticleId IdType=\"pmc\">PMC7837003</ArticleId><ArticleId IdType=\"pubmed\">32574708</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Maes M. Mitochondrial dysfunctions in Myalgic encephalomyelitis / chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis. (2013) 29:19&#x2013;36. doi: 10.1007/s11011-013-9435-x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11011-013-9435-x</ArticleId><ArticleId IdType=\"pubmed\">24557875</ArticleId></ArticleIdList></Reference><Reference><Citation>Missiroli S, Genovese I, Perrone M, Vezzani B, Vitto VAM, Giorgi C. The role of mitochondria in inflammation: from cancer to neurodegenerative disorders [internet]. J Clin Med. (2020) 9:740. Available from:. doi: 10.3390/jcm9030740, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm9030740</ArticleId><ArticleId IdType=\"pmc\">PMC7141240</ArticleId><ArticleId IdType=\"pubmed\">32182899</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller C, Steensberg A, Hansen AK, Fischer CP, Plomgaard P, Pedersen BK. Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle. J Appl Physiol (1985). (2005) 99:2075&#x2013;9. doi: 10.1152/japplphysiol.00590.2005, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/japplphysiol.00590.2005</ArticleId><ArticleId IdType=\"pubmed\">16099893</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K. Characterization of exercise-induced cytokine release, the impacts on the body, the mechanisms and modulations. Int J Sports Exerc Med. (2019) 5:122. doi: 10.23937/2469-5718/1510122</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.23937/2469-5718/1510122</ArticleId></ArticleIdList></Reference><Reference><Citation>da Luz D, Scheffer AL. Exercise-induced immune system response: anti-inflammatory status on peripheral and central organs. Biochim Biophys Acta Mol basis Dis. (2020) 1866:165823. doi: 10.1016/j.bbadis.2020.165823, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2020.165823</ArticleId><ArticleId IdType=\"pmc\">PMC7188661</ArticleId><ArticleId IdType=\"pubmed\">32360589</ArticleId></ArticleIdList></Reference><Reference><Citation>Landers-Ramos RQ, Jenkins NT, Spangenburg EE, Hagberg JM, Prior SJ. Circulating angiogenic and inflammatory cytokine responses to acute aerobic exercise in trained and sedentary young men. Eur J Appl Physiol. (2014) 114:1377. doi: 10.1007/s00421-014-2861-6, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00421-014-2861-6</ArticleId><ArticleId IdType=\"pmc\">PMC4048778</ArticleId><ArticleId IdType=\"pubmed\">24643426</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer CP. Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev [Internet]. (2006) 12:6&#x2013;33.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17201070</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer CP. Interleukin-6 in acute exercise and training: what is the biological relevance. Exerc Immunol Rev. (2006) 12:41.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17201070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HK, Konishi M, Takahashi M, Tabata H, Endo N, Numao S, et al. . Effects of acute endurance exercise performed in the morning and evening on inflammatory cytokine and metabolic hormone responses. PLoS One [Internet]. (2015) 10:e0137567. doi: 10.1371/journal.pone.0137567, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0137567</ArticleId><ArticleId IdType=\"pmc\">PMC4564197</ArticleId><ArticleId IdType=\"pubmed\">26352938</ArticleId></ArticleIdList></Reference><Reference><Citation>Moneghetti KJ, Skhiri M, Contrepois K, Kobayashi Y, Maecker H, Davis M, et al. . Value of circulating cytokine profiling during submaximal exercise testing in Myalgic encephalomyelitis/chronic fatigue syndrome. Sci Rep. (2018) 8:2779. doi: 10.1038/s41598-018-20941-w, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-018-20941-w</ArticleId><ArticleId IdType=\"pmc\">PMC5807550</ArticleId><ArticleId IdType=\"pubmed\">29426834</ArticleId></ArticleIdList></Reference><Reference><Citation>White AT, Light AR, Hughen RW, Bateman L, Martins TB, Hill HR, et al. . Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology. (2010) 47:615&#x2013;24. doi: 10.1111/j.1469-8986.2010.00978.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1469-8986.2010.00978.x</ArticleId><ArticleId IdType=\"pmc\">PMC4378647</ArticleId><ArticleId IdType=\"pubmed\">20230500</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnell JE, Lombard CM, Melson MN, Singh NP, Nagarkatti M, Nagarkatti P, et al. . The protective effects of resveratrol on social stress-induced cytokine release and depressive-like behavior. Brain Behav Immun Health. (2017) 59:147&#x2013;57. doi: 10.1016/j.bbi.2016.08.019, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2016.08.019</ArticleId><ArticleId IdType=\"pmc\">PMC5154920</ArticleId><ArticleId IdType=\"pubmed\">27592314</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsland AL, Walsh C, Lockwood K, John-Henderson NA. The effects of acute psychological stress on circulating and stimulated inflammatory markers: a systematic review and meta-analysis. Brain Behav Immun. (2017) 64:208. doi: 10.1016/j.bbi.2017.01.011, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2017.01.011</ArticleId><ArticleId IdType=\"pmc\">PMC5553449</ArticleId><ArticleId IdType=\"pubmed\">28089638</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard-Raichon L, Venzon M, Klein J, Axelrad JE, Zhang C, Sullivan AP, et al. . Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nat Commun. (2022) 13:5926. doi: 10.1038/s41467-022-33395-6, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-33395-6</ArticleId><ArticleId IdType=\"pmc\">PMC9626559</ArticleId><ArticleId IdType=\"pubmed\">36319618</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Wu X, Wen W, Lan P. Gut microbiome alterations in COVID-19. Genomics Proteomics Bioinformatics. (2021) 19:679&#x2013;88. doi: 10.1016/j.gpb.2021.09.004, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.gpb.2021.09.004</ArticleId><ArticleId IdType=\"pmc\">PMC8478109</ArticleId><ArticleId IdType=\"pubmed\">34560321</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin B, Singh R, Ha SE, Zogg H, Park PJ, Ro S. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19. World J Gastroenterol. (2021) 27:2341&#x2013;52. doi: 10.3748/wjg.v27.i19.2341, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3748/wjg.v27.i19.2341</ArticleId><ArticleId IdType=\"pmc\">PMC8130047</ArticleId><ArticleId IdType=\"pubmed\">34040326</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management [internet]. Clin Gastroenterol Hepatol. (2020) 18:1663&#x2013;72. Available from:. doi: 10.1016/j.cgh.2020.04.001, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cgh.2020.04.001</ArticleId><ArticleId IdType=\"pmc\">PMC7141637</ArticleId><ArticleId IdType=\"pubmed\">32278065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, et al. . Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. (2020) 5:434&#x2013;5. doi: 10.1016/S2468-1253(20)30083-2, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S2468-1253(20)30083-2</ArticleId><ArticleId IdType=\"pmc\">PMC7158584</ArticleId><ArticleId IdType=\"pubmed\">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zheng J, Guo L, Yao H, Wang L, Xia X, et al. . Fecal viral shedding in COVID-19 patients: clinical significance, viral load dynamics and survival analysis. Virus Res. (2020) 289:198147. doi: 10.1016/j.virusres.2020.198147, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.virusres.2020.198147</ArticleId><ArticleId IdType=\"pmc\">PMC7455175</ArticleId><ArticleId IdType=\"pubmed\">32866537</ArticleId></ArticleIdList></Reference><Reference><Citation>Norouzi Masir M, Shirvaliloo M. Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions. JGH Open. (2022) 6:667&#x2013;76. doi: 10.1002/jgh3.12811, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jgh3.12811</ArticleId><ArticleId IdType=\"pmc\">PMC9538198</ArticleId><ArticleId IdType=\"pubmed\">36247234</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J. Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome. Exp Ther Med. (2013) 6:93. doi: 10.3892/etm.2013.1101, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/etm.2013.1101</ArticleId><ArticleId IdType=\"pmc\">PMC3735566</ArticleId><ArticleId IdType=\"pubmed\">23935726</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology. (1994) 106:533&#x2013;9. doi: 10.1016/0016-5085(94)90614-9, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0016-5085(94)90614-9</ArticleId><ArticleId IdType=\"pubmed\">8299918</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger EC, Fritzsche C, Krause R, Krejs GJ. Diarrhea caused by primarily non-gastrointestinal infections. Nat Clin Pract Gastroenterol Hepatol. (2005) 2:216&#x2013;22. doi: 10.1038/ncpgasthep0167, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncpgasthep0167</ArticleId><ArticleId IdType=\"pmc\">PMC7097032</ArticleId><ArticleId IdType=\"pubmed\">16265204</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana SV, Sharma S, Sinha SK, Parsad KK, Malik A, Singh K. Pro-inflammatory and anti-inflammatory cytokine response in diarrhoea-predominant irritable bowel syndrome patients. Trop Gastroenterol. (2013) 33:251&#x2013;6, 256. doi: 10.7869/tg.2012.66</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7869/tg.2012.66</ArticleId><ArticleId IdType=\"pubmed\">23923350</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal D, Ali SA, Singh RK. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer&#x2019;s disease. Prog Neuro-Psychopharmacol Biol Psychiatry. (2021) 106:110112. doi: 10.1016/j.pnpbp.2020.110112, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pnpbp.2020.110112</ArticleId><ArticleId IdType=\"pubmed\">32949638</ArticleId></ArticleIdList></Reference><Reference><Citation>Mou Y, du Y, Zhou L, Yue J, Hu X, Liu Y, et al. . Gut microbiota interact with the brain through systemic chronic inflammation: implications on Neuroinflammation, neurodegeneration, and aging. Front Immunol. (2022) 13:796288. doi: 10.3389/fimmu.2022.796288, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2022.796288</ArticleId><ArticleId IdType=\"pmc\">PMC9021448</ArticleId><ArticleId IdType=\"pubmed\">35464431</ArticleId></ArticleIdList></Reference><Reference><Citation>Schett G, Manger B, Simon D, Caporali R. COVID-19 revisiting inflammatory pathways of arthritis. Nat Rev Rheumatol. (2020) 16:465&#x2013;70. doi: 10.1038/s41584-020-0451-z, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41584-020-0451-z</ArticleId><ArticleId IdType=\"pmc\">PMC7304381</ArticleId><ArticleId IdType=\"pubmed\">32561873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S, Zimba O, Gasparyan AY. COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol. (2021) 40:2611&#x2013;9. doi: 10.1007/s10067-021-05691-x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10067-021-05691-x</ArticleId><ArticleId IdType=\"pmc\">PMC7968918</ArticleId><ArticleId IdType=\"pubmed\">33733315</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int. (2020) 40:1539&#x2013;54. doi: 10.1007/s00296-020-04639-9, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00296-020-04639-9</ArticleId><ArticleId IdType=\"pmc\">PMC7360125</ArticleId><ArticleId IdType=\"pubmed\">32666137</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. . Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. (2020) 138:575&#x2013;8. doi: 10.1001/jamaophthalmol.2020.1291, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamaophthalmol.2020.1291</ArticleId><ArticleId IdType=\"pmc\">PMC7110919</ArticleId><ArticleId IdType=\"pubmed\">32232433</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Bartolom&#xe9; F, S&#xe1;nchez-Quir&#xf3;s J. Ocular manifestations of SARS-CoV-2: literature review. Archivos De La Sociedad Espan~ola De Oftalmologi&#x2019;a. 96:32&#x2013;40. doi: 10.1016/j.oftale.2020.07.003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.oftale.2020.07.003</ArticleId><ArticleId IdType=\"pmc\">PMC7414418</ArticleId><ArticleId IdType=\"pubmed\">32873480</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold DM, Galetta SL. Neuro-ophthalmologic complications of coronavirus disease 2019 (COVID-19). Neurosci Lett. (2021) 742:135531. doi: 10.1016/j.neulet.2020.135531, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2020.135531</ArticleId><ArticleId IdType=\"pmc\">PMC7687583</ArticleId><ArticleId IdType=\"pubmed\">33248158</ArticleId></ArticleIdList></Reference><Reference><Citation>Church MK, McGill JI. Human ocular mast cells. Curr Opin Allergy Clin Immunol. (2002) 2:419&#x2013;22. doi: 10.1097/00130832-200210000-00009</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00130832-200210000-00009</ArticleId><ArticleId IdType=\"pubmed\">12582326</ArticleId></ArticleIdList></Reference><Reference><Citation>Badham SP, Hutchinson CV. Characterising eye movement dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome. German J Ophthalmol. (2013) 251:2769&#x2013;76. doi: 10.1007/s00417-013-2431-3, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00417-013-2431-3</ArticleId><ArticleId IdType=\"pubmed\">23918092</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco-Herrero M, Soto-Rojas LO, Harrington CR, Flores-Martinez YM, Villegas-Rojas MM, Le&#xf3;n-Aguilar AM, et al. . Elucidating the Neuropathologic mechanisms of SARS-CoV-2 infection. Front Neurol. (2021) 12:660087. doi: 10.3389/fneur.2021.660087, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2021.660087</ArticleId><ArticleId IdType=\"pmc\">PMC8072392</ArticleId><ArticleId IdType=\"pubmed\">33912129</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett JL. Optic neuritis. Continuum. (2019) 25:1236&#x2013;64. doi: 10.1212/CON.0000000000000768, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/CON.0000000000000768</ArticleId><ArticleId IdType=\"pmc\">PMC7395663</ArticleId><ArticleId IdType=\"pubmed\">31584536</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JJ, Flanagan EP, Jitprapaikulsan J, L&#xf3;pez-Chiriboga A, Fryer JP, Leavitt JA, et al. . Myelin oligodendrocyte glycoprotein antibody&#x2013;positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol. (2018) 195:8&#x2013;15. doi: 10.1016/j.ajo.2018.07.020, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajo.2018.07.020</ArticleId><ArticleId IdType=\"pmc\">PMC6371779</ArticleId><ArticleId IdType=\"pubmed\">30055153</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong GU, Kwon HJ, Ng WH, Liu X, Moon HW, Yoon GY, et al. . Ocular tropism of SARS-CoV-2 in animal models with retinal inflammation via neuronal invasion following intranasal inoculation. Nat Commun. (2022) 13:7675. doi: 10.1038/s41467-022-35225-1, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-35225-1</ArticleId><ArticleId IdType=\"pmc\">PMC9743116</ArticleId><ArticleId IdType=\"pubmed\">36509737</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, ver AT, Pangilinan FC, et al. . Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine. (2022) 53:101624. doi: 10.1016/j.eclinm.2022.101624, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType=\"pmc\">PMC9417563</ArticleId><ArticleId IdType=\"pubmed\">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsouris Z, Provatas A, Bakirtzis C, Aloizou AM, Siokas V, Tsimourtou V, et al. . Anti-MOG positive bilateral optic neuritis and brainstem encephalitis secondary to COVID-19 infection: a case report. Neurol Int. (2022) 14:991&#x2013;6. doi: 10.3390/neurolint14040078, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/neurolint14040078</ArticleId><ArticleId IdType=\"pmc\">PMC9782579</ArticleId><ArticleId IdType=\"pubmed\">36548183</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. (2021) 18:666&#x2013;82. doi: 10.1038/s41569-021-00552-1, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41569-021-00552-1</ArticleId><ArticleId IdType=\"pmc\">PMC8100938</ArticleId><ArticleId IdType=\"pubmed\">33958774</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. . Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. (2020) 191:145&#x2013;7. doi: 10.1016/j.thromres.2020.04.013, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.thromres.2020.04.013</ArticleId><ArticleId IdType=\"pmc\">PMC7146714</ArticleId><ArticleId IdType=\"pubmed\">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D, Sperhake JP, L&#xfc;tgehetmann M, Steurer S, Edler C, Heinemann A, et al. . Autopsy findings and venous thromboembolism in patients with COVID-19. ACP J Club. (2020) 173:1030. doi: 10.7326/L20-1206, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/L20-1206</ArticleId><ArticleId IdType=\"pubmed\">33316197</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksu K, Donmez A, Keser G. Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des. (2012) 18:1478&#x2013;93. doi: 10.2174/138161212799504731, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/138161212799504731</ArticleId><ArticleId IdType=\"pubmed\">22364132</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. (2020) 135:2033&#x2013;40. doi: 10.1182/blood.2020006000, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood.2020006000</ArticleId><ArticleId IdType=\"pmc\">PMC7273827</ArticleId><ArticleId IdType=\"pubmed\">32339221</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre TM. Inflammatory cytokines and thrombosis. Blood. (2012) 120. doi: 10.1182/blood.V120.21.SCI-44.SCI-44, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood.V120.21.SCI-44.SCI-44</ArticleId><ArticleId IdType=\"pubmed\">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Fibrinogen Studies Collaboration. Kaptoge S, White IR, Thompson SG, Wood AM, Lewington S, et al. . Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies. Am J Epidemiol. (2007) 166:867&#x2013;79. doi: 10.1093/aje/kwm191, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/aje/kwm191</ArticleId><ArticleId IdType=\"pubmed\">17785713</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh P, Woodward M, Rumley A, Lowe G. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haematol. (2008) 141:852&#x2013;61. doi: 10.1111/j.1365-2141.2008.07133.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2141.2008.07133.x</ArticleId><ArticleId IdType=\"pubmed\">18371109</ArticleId></ArticleIdList></Reference><Reference><Citation>Najem MY, Couturaud F, Lemari&#xe9; CA. Cytokine and chemokine regulation of venous thromboembolism. J Thromb Haemost. (2020) 18:1009&#x2013;19. doi: 10.1111/jth.14759, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jth.14759</ArticleId><ArticleId IdType=\"pubmed\">32020753</ArticleId></ArticleIdList></Reference><Reference><Citation>Branchford BR, Carpenter SL. The role of inflammation in venous thromboembolism. Front Pediatr. (2018) 6:142. doi: 10.3389/fped.2018.00142, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2018.00142</ArticleId><ArticleId IdType=\"pmc\">PMC5974100</ArticleId><ArticleId IdType=\"pubmed\">29876337</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, et al. . SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. (2020) 13:120&#x2013;2. doi: 10.1186/s13045-020-00954-7, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13045-020-00954-7</ArticleId><ArticleId IdType=\"pmc\">PMC7471641</ArticleId><ArticleId IdType=\"pubmed\">32887634</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrens K, Alexander WS. Alexander WS. Cytokine control of megakaryopoiesis. Growth Factors. (2018) 36:89&#x2013;103. doi: 10.1080/08977194.2018.1498487, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/08977194.2018.1498487</ArticleId><ArticleId IdType=\"pubmed\">30318940</ArticleId></ArticleIdList></Reference><Reference><Citation>Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, et al. . Platelet gene expression and function in patients with COVID-19. Blood. (2020) 136:1317&#x2013;29. doi: 10.1182/blood.2020007214, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood.2020007214</ArticleId><ArticleId IdType=\"pmc\">PMC7483430</ArticleId><ArticleId IdType=\"pubmed\">32573711</ArticleId></ArticleIdList></Reference><Reference><Citation>Aid M, Busman-Sahay K, Vidal SJ, Maliga Z, Bondoc S, Starke C, et al. . Vascular disease and thrombosis in SARS-CoV-2-infected rhesus macaques. Cell(Cambridge,Mass). (2020) 183:1354&#x2013;1366.e13. doi: 10.1016/j.cell.2020.10.005</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2020.10.005</ArticleId><ArticleId IdType=\"pmc\">PMC7546181</ArticleId><ArticleId IdType=\"pubmed\">33065030</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. . Persistent clotting protein pathology in Long COVID/post-acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. (2021) 20:172. doi: 10.1186/s12933-021-01359-7, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType=\"pmc\">PMC8381139</ArticleId><ArticleId IdType=\"pubmed\">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Moremi K, Oladejo S, et al. . Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC). Cardiovascular Diabetology. (2021) 148. doi: 10.1186/s12933-022-01579-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType=\"pmc\">PMC9356426</ArticleId><ArticleId IdType=\"pubmed\">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. . Autonomic dysfunction in &#x201c;long COVID&#x201d;: rationale, physiology and management strategies [internet]. Clin Med. (2021) 21:e63&#x2013;7. doi: 10.7861/clinmed.2020-0896, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType=\"pmc\">PMC7850225</ArticleId><ArticleId IdType=\"pubmed\">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A, Sutton R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat Rev Cardiol. (2023) 2:1&#x2013;2. doi: 10.1038/s41569-023-00842-w, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41569-023-00842-w</ArticleId><ArticleId IdType=\"pmc\">PMC9893964</ArticleId><ArticleId IdType=\"pubmed\">36732397</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoite Stella A, Furlanis G, Frezza NA, Valentinotti R, Ajcevic M, Manganotti P. Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study. J Neurol. (2022) 269:587&#x2013;96. doi: 10.1007/s00415-021-10735-y, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00415-021-10735-y</ArticleId><ArticleId IdType=\"pmc\">PMC8359764</ArticleId><ArticleId IdType=\"pubmed\">34386903</ArticleId></ArticleIdList></Reference><Reference><Citation>Eshak N, Abdelnabi M, Ball S, Elgwairi E, Creed K, Test V, et al. . Dysautonomia: an overlooked neurological manifestation in a critically ill COVID-19 patient [internet]. Am J Med Sci. (2020) 360:427&#x2013;9. doi: 10.1016/j.amjms.2020.07.022, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.amjms.2020.07.022</ArticleId><ArticleId IdType=\"pmc\">PMC7366085</ArticleId><ArticleId IdType=\"pubmed\">32739039</ArticleId></ArticleIdList></Reference><Reference><Citation>Astudillo L, Laure A, Fabry V, Pugnet G, Maury P, Labrun&#xe9;e M, et al. . Le syndrome de tachycardie posturale (PoTS): une maladie pour l&#x2019;interniste [Internet]. Rev Med Interne. (2018) 39:627&#x2013;34. Available from:. doi: 10.1016/j.revmed.2018.04.017, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.revmed.2018.04.017</ArticleId><ArticleId IdType=\"pubmed\">29909001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenney MJ, Ganta CK. Autonomic nervous system and immune system interactions [internet]. Comprehensive. Physiology. (2014) 4:1177&#x2013;200. Available from:. doi: 10.1002/cphy.c130051, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cphy.c130051</ArticleId><ArticleId IdType=\"pmc\">PMC4374437</ArticleId><ArticleId IdType=\"pubmed\">24944034</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto LE, Raj SR, Gamboa A, Shibao CA, Arnold AC, Garland EM, et al. . Sympathetic activation is associated with increased IL-6, but not CRP in the absence of obesity: lessons from postural tachycardia syndrome and obesity [internet]. Am J Phys Heart Circ Phys. (2015) 309:H2098&#x2013;107. Available from:. doi: 10.1152/ajpheart.00409.2015, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpheart.00409.2015</ArticleId><ArticleId IdType=\"pmc\">PMC4698423</ArticleId><ArticleId IdType=\"pubmed\">26453329</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Million M, Dudouet P, Tissot-Dupont H, Bregeon F, Cammilleri S, et al. . 18 F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. (2021) 48:592&#x2013;5. doi: 10.1007/s00259-020-04973-x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00259-020-04973-x</ArticleId><ArticleId IdType=\"pmc\">PMC7391029</ArticleId><ArticleId IdType=\"pubmed\">32728799</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Persistent brainstem dysfunction in Long-COVID: a hypothesis. ACS Chem Neurosci. (2021) 12:573&#x2013;80. doi: 10.1021/acschemneuro.0c00793, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acschemneuro.0c00793</ArticleId><ArticleId IdType=\"pmc\">PMC7874499</ArticleId><ArticleId IdType=\"pubmed\">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofield JR, Blitshteyn S, Shoenfeld Y, Hughes GRV. Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospholipid (Hughes) syndrome (APS). Lupus. (2014) 23:697&#x2013;702. doi: 10.1177/0961203314524468, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0961203314524468</ArticleId><ArticleId IdType=\"pubmed\">24569396</ArticleId></ArticleIdList></Reference><Reference><Citation>Noureldine HA, El Hasbani G, Nour Eldine M, Nour-Eldine W, Taher A, Uthman I. Postural tachycardia syndrome (POTS) and antiphospholipid syndrome (APS): what do we know so far? Rev neur, Par. (2022) 178:306&#x2013;14. doi: 10.1016/j.neurol.2021.10.006, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurol.2021.10.006</ArticleId><ArticleId IdType=\"pubmed\">34895744</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M, Yan H, Welinder C, V&#xe9;gv&#xe1;ri &#xc1;, Hamrefors V, B&#xe4;ck M, et al. . Plasma proteomic profiling in postural orthostatic tachycardia syndrome (POTS) reveals new disease pathways. Sci Rep. (2022) 12:1&#x2013;9. doi: 10.1038/s41598-022-24729-x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-022-24729-x</ArticleId><ArticleId IdType=\"pmc\">PMC9681882</ArticleId><ArticleId IdType=\"pubmed\">36414707</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan AC, Ebinger JE, Wei J, le CN, Oft JR, Zabner R, et al. . Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 infection. Nat Cardiovasc Res. (2022) 1:1187&#x2013;94. doi: 10.1038/s44161-022-00177-8</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s44161-022-00177-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A, Li H, Yu X, Koelsch KA, Harris VM, Liles C, et al. . Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace. (2017) 19:1211&#x2013;9. doi: 10.1093/europace/euw154, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/europace/euw154</ArticleId><ArticleId IdType=\"pmc\">PMC5834103</ArticleId><ArticleId IdType=\"pubmed\">27702852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal D, Moudgil DC. Cytokines in autoimmunity: role in induction, regulation, and treatment. J Interf Cytokine Res. (2011) 31:695&#x2013;703. doi: 10.1089/jir.2011.0065, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/jir.2011.0065</ArticleId><ArticleId IdType=\"pmc\">PMC3189547</ArticleId><ArticleId IdType=\"pubmed\">21942420</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et al. . Evolution of antibody immunity to SARS-CoV-2 [internet]. Cold Spring Harbor Laboratory. (2020) 591:639&#x2013;644. doi: 10.1101/2020.11.03.367391</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.11.03.367391</ArticleId><ArticleId IdType=\"pmc\">PMC8221082</ArticleId><ArticleId IdType=\"pubmed\">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Avanzato VA, Matson MJ, Seifert SN, Pryce R, Williamson BN, Anzick SL, et al. . Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised cancer patient [internet]. Cell. (2020) 183:1901&#x2013;1912.e9. doi: 10.1016/j.cell.2020.10.049, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2020.10.049</ArticleId><ArticleId IdType=\"pmc\">PMC7640888</ArticleId><ArticleId IdType=\"pubmed\">33248470</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, et al. . SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. (2022) 612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType=\"pmc\">PMC9749650</ArticleId><ArticleId IdType=\"pubmed\">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nature Rev Immun. (2020) 20:355&#x2013;62. doi: 10.1038/s41577-020-0331-4, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType=\"pmc\">PMC7201395</ArticleId><ArticleId IdType=\"pubmed\">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytokines in the balance [internet]. Nat Immunol. (2019) 20:1557&#x2013;7. doi: 10.1038/s41590-019-0557-0, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41590-019-0557-0</ArticleId><ArticleId IdType=\"pubmed\">31745347</ArticleId></ArticleIdList></Reference><Reference><Citation>Polidoro RB, Hagan RS, de Santis Santiago R, Schmidt NW. Overview: systemic inflammatory response derived from lung injury caused by SARS-CoV-2 infection explains severe outcomes in COVID-19. Front Immunol. (2020) 11:1626. doi: 10.3389/fimmu.2020.01626, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2020.01626</ArticleId><ArticleId IdType=\"pmc\">PMC7344249</ArticleId><ArticleId IdType=\"pubmed\">32714336</ArticleId></ArticleIdList></Reference><Reference><Citation>Besedovsky HO, del Rey A. The cytokine-HPA axis feed-back circuit. Zeitschrift f&#xfc;r Rheumaforschung. (2000) 59:II26&#x2013;30. doi: 10.1007/s003930070014</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s003930070014</ArticleId><ArticleId IdType=\"pubmed\">11155800</ArticleId></ArticleIdList></Reference><Reference><Citation>Somasundaram NP, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Dissanayake HA, Yogendranathan N, et al. . The impact of SARS-Cov-2 virus infection on the endocrine system. JES. (2020) 4. doi: 10.1210/jendso/bvaa082, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1210/jendso/bvaa082</ArticleId><ArticleId IdType=\"pmc\">PMC7337839</ArticleId><ArticleId IdType=\"pubmed\">32728654</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman MN, Pearce BD, Biron CA, Miller AH. Immune modulation of the hypothalamic-pituitary-adrenal (HPA) Axis during viral infection. Viral Immunol. (2005) 18:41&#x2013;78. doi: 10.1089/vim.2005.18.41, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/vim.2005.18.41</ArticleId><ArticleId IdType=\"pmc\">PMC1224723</ArticleId><ArticleId IdType=\"pubmed\">15802953</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman MN, Sternberg EM. Glucocorticoid regulation of inflammation and its behavioral and metabolic correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci. (2012) 1261:55&#x2013;63. doi: 10.1111/j.1749-6632.2012.06633.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1749-6632.2012.06633.x</ArticleId><ArticleId IdType=\"pmc\">PMC3572859</ArticleId><ArticleId IdType=\"pubmed\">22823394</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, Agarwal SK. Endocrine changes in SARS-CoV-2 patients and lessons from SARS-CoV. Postgrad Med J. (2020) 96:412&#x2013;6. doi: 10.1136/postgradmedj-2020-137934, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/postgradmedj-2020-137934</ArticleId><ArticleId IdType=\"pmc\">PMC7306278</ArticleId><ArticleId IdType=\"pubmed\">32527756</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongio&#xec; LM, Barbagallo F, Condorelli RA, Cannarella R, Aversa A, la Vignera S, et al. . Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model [internet]. Endocrine. (2020) 68:467&#x2013;70. doi: 10.1007/s12020-020-02349-7, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12020-020-02349-7</ArticleId><ArticleId IdType=\"pmc\">PMC7266418</ArticleId><ArticleId IdType=\"pubmed\">32488837</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocr. (2005) 63:197&#x2013;202. doi: 10.1111/j.1365-2265.2005.02325.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2265.2005.02325.x</ArticleId><ArticleId IdType=\"pmc\">PMC7188349</ArticleId><ArticleId IdType=\"pubmed\">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R. COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications. Endocrine. (2020) 68:251&#x2013;2. doi: 10.1007/s12020-020-02325-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12020-020-02325-1</ArticleId><ArticleId IdType=\"pmc\">PMC7186765</ArticleId><ArticleId IdType=\"pubmed\">32346813</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamaschi L, Mescia F, Turner L, Hanson A, Kotagiri P, Dunmore BJ, et al. . (2021). Delayed bystander CD8 T cell activation, early immune pathology and persistent dysregulation characterise severe COVID-19. medRxiv [Preprint]. doi: 10.1101/2021.01.11.20248765.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2021.01.11.20248765</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Guevara-Coto J, Yogendra R, Francisco E, Long E, Pise A, et al. . (2020). Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning [Internet]. bioRxiv [Preprint]. Available at: https://www.biorxiv.org/content/10.1101/2020.12.16.423122v1.abstract</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.12.16.423122v1.abstract</ArticleId><ArticleId IdType=\"pmc\">PMC8273732</ArticleId><ArticleId IdType=\"pubmed\">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Seif F, Khoshmirsafa M, Aazami H, Mohsenzadegan M, Sedighi G, Bahar M. The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal [Internet]. (2017) 15:23. doi: 10.1186/s12964-017-0177-y, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12964-017-0177-y</ArticleId><ArticleId IdType=\"pmc\">PMC5480189</ArticleId><ArticleId IdType=\"pubmed\">28637459</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha RN, Jana M, Pahan K. MAPK p38 Regulates Transcriptional Activity of NF-&#x3ba;B in Primary Human Astrocytes via Acetylation of p65. J Immunol. (2007) 179:7101&#x2013;9. doi: 10.4049/jimmunol.179.10.7101, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/jimmunol.179.10.7101</ArticleId><ArticleId IdType=\"pmc\">PMC2701546</ArticleId><ArticleId IdType=\"pubmed\">17982102</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuenda A, Rousseau S. p38 MAP-Kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta (BBA) Mol Cell Res. (2007) 1773:1358&#x2013;75. doi: 10.1016/j.bbamcr.2007.03.010</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamcr.2007.03.010</ArticleId><ArticleId IdType=\"pubmed\">17481747</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachstetter AD, Van Eldik LJ. The p38 MAP kinase family as regulators of Proinflammatory cytokine production in degenerative diseases of the CNS. Aging Dis. (2010) 1:199&#x2013;211. doi: 10.1101/2021.01.11.20248765, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2021.01.11.20248765</ArticleId><ArticleId IdType=\"pmc\">PMC3377763</ArticleId><ArticleId IdType=\"pubmed\">22720195</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimes JM, Grimes KV. p38 MAPK inhibition: a promising therapeutic approach for COVID-19. J Mol Cell Cardiol. (2020) 144:63&#x2013;5. doi: 10.1016/j.yjmcc.2020.05.007, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.yjmcc.2020.05.007</ArticleId><ArticleId IdType=\"pmc\">PMC7228886</ArticleId><ArticleId IdType=\"pubmed\">32422320</ArticleId></ArticleIdList></Reference><Reference><Citation>Huth TK, Staines D, Marshall-Gradisnik S. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/&#x2212; natural killer cells in chronic fatigue syndrome/Myalgic encephalomyelitis patients. J Transl Med. (2016) 14:97. doi: 10.1186/s12967-016-0859-z, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-016-0859-z</ArticleId><ArticleId IdType=\"pmc\">PMC4839077</ArticleId><ArticleId IdType=\"pubmed\">27098723</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni S, Anand P, Padwad YS. MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression. J Exp Clin Cancer Res. (2019) 38:121&#x2013;18. doi: 10.1186/s13046-019-1115-1, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13046-019-1115-1</ArticleId><ArticleId IdType=\"pmc\">PMC6408796</ArticleId><ArticleId IdType=\"pubmed\">30850014</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkowitz P, Hu P, Warren S, Liu Z, Diaz LA, Rubenstein DS. p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc Natl Acad Sci U S A. (2006) 103:12855&#x2013;60. doi: 10.1073/pnas.0602973103, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0602973103</ArticleId><ArticleId IdType=\"pmc\">PMC1568937</ArticleId><ArticleId IdType=\"pubmed\">16908851</ArticleId></ArticleIdList></Reference><Reference><Citation>Soukup K, Halfmann A, le Bras M, Sahin E, Vittori S, Poyer F, et al. . The MAPK-activated kinase MK2 attenuates dendritic cell&#x2013;mediated Th1 differentiation and autoimmune encephalomyelitis. J Immunol. (2015) 195:541&#x2013;52. doi: 10.4049/jimmunol.1401663, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/jimmunol.1401663</ArticleId><ArticleId IdType=\"pubmed\">26078274</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells. Biochem Biophys Res Commun. (2004) 319:1228&#x2013;34. doi: 10.1016/j.bbrc.2004.05.107, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2004.05.107</ArticleId><ArticleId IdType=\"pmc\">PMC7111015</ArticleId><ArticleId IdType=\"pubmed\">15194498</ArticleId></ArticleIdList></Reference><Reference><Citation>Faist A, Schloer S, Mecate-Zambrano A, Janowski J, Schreiber A, Boergeling Y, et al. . Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier. Antivir Res. (2023) 209:105475. doi: 10.1016/j.antiviral.2022.105475, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.antiviral.2022.105475</ArticleId><ArticleId IdType=\"pmc\">PMC9677559</ArticleId><ArticleId IdType=\"pubmed\">36423831</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhaddou M, Memon D, Meyer B, White KM, Rezelj VV, Correa Marrero M, et al. . The global phosphorylation landscape of SARS-CoV-2 infection. Cell(Cambridge,Mass). (2020) 182:685&#x2013;712.e19. doi: 10.1016/j.cell.2020.06.034, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2020.06.034</ArticleId><ArticleId IdType=\"pmc\">PMC7321036</ArticleId><ArticleId IdType=\"pubmed\">32645325</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Zhang L, Joo D, Sun SC. NF-&#x3ba;B signaling in inflammation. Signal Transduct Target Ther. (2017) 2. doi: 10.1038/sigtrans.2017.23, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sigtrans.2017.23</ArticleId><ArticleId IdType=\"pmc\">PMC5661633</ArticleId><ArticleId IdType=\"pubmed\">29158945</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano T, Murakami M. COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity. (2020) 52:731&#x2013;3. doi: 10.1016/j.immuni.2020.04.003, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.immuni.2020.04.003</ArticleId><ArticleId IdType=\"pmc\">PMC7175868</ArticleId><ArticleId IdType=\"pubmed\">32325025</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasmin R, Siraj S, Hassan A, Khan AR, Abbasi R, Ahmad N. Epigenetic regulation of inflammatory cytokines and associated genes in human malignancies. Mediat Inflamm. (2015) 2015:1&#x2013;8. doi: 10.1155/2015/201703, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2015/201703</ArticleId><ArticleId IdType=\"pmc\">PMC4359879</ArticleId><ArticleId IdType=\"pubmed\">25814785</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi SK, Lahesmaa R. Transcriptional and epigenetic regulation of T-helper lineage specification. Immunol Rev. (2014) 261:62&#x2013;83. doi: 10.1111/imr.12204, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/imr.12204</ArticleId><ArticleId IdType=\"pmc\">PMC4255756</ArticleId><ArticleId IdType=\"pubmed\">25123277</ArticleId></ArticleIdList></Reference><Reference><Citation>El Baba R, Herbein G. Management of epigenomic networks entailed in coronavirus infections and COVID-19. Epigenetics. (2020) 12:118. doi: 10.1186/s13148-020-00912-7, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13148-020-00912-7</ArticleId><ArticleId IdType=\"pmc\">PMC7404079</ArticleId><ArticleId IdType=\"pubmed\">32758273</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruimboom L. Methylation pathways and SARS-CoV-2 lung infiltration and cell membrane-virus fusion are both subject to epigenetics. Front Cell Infect Microbiol. (2020) 10:290. doi: 10.3389/fcimb.2020.00290, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcimb.2020.00290</ArticleId><ArticleId IdType=\"pmc\">PMC7265211</ArticleId><ArticleId IdType=\"pubmed\">32574283</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MAAK, ABMMK Islam. (2020). SARS-CoV-2 proteins exploit host&#x2019;s genetic and epigenetic mediators for the annexation of key host signaling pathways that confers its immune evasion and disease pathophysiology [internet]. bioRxiv [Preprint]. doi: 10.1101/2020.05.06.050260</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2020.05.06.050260</ArticleId><ArticleId IdType=\"pmc\">PMC7872968</ArticleId><ArticleId IdType=\"pubmed\">33585554</ArticleId></ArticleIdList></Reference><Reference><Citation>Paschos K, Allday MJ. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol. (2010) 18:439&#x2013;47. doi: 10.1016/j.tim.2010.07.003, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tim.2010.07.003</ArticleId><ArticleId IdType=\"pmc\">PMC3089700</ArticleId><ArticleId IdType=\"pubmed\">20724161</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong JG, Ravishankar A, Sharma S, Parkhurst CN, Nehar-Belaid D, Ma S, et al. . (2022). Epigenetic memory of COVID-19 in innate immune cells and their progenitors. bioRxiv [Preprint].</Citation></Reference><Reference><Citation>Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, et al. . Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transpl. (2002) 2:560&#x2013;7. doi: 10.1034/j.1600-6143.2002.20611.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1034/j.1600-6143.2002.20611.x</ArticleId><ArticleId IdType=\"pubmed\">12118901</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux CA, Camoin-Jau L. An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection. Front Microbiol. (2022) 13:1042200. doi: 10.3389/fmicb.2022.1042200, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmicb.2022.1042200</ArticleId><ArticleId IdType=\"pmc\">PMC9742611</ArticleId><ArticleId IdType=\"pubmed\">36519165</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh S, Lee S, Gym H, Jee SH, Yoon S, Park S, et al. . A systematic review on papers that study on SNPs that affect SARS-CoV-2 infection &amp; COVID-19 severity. doi: 10.21203/rs.3.rs-470358/v1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.21203/rs.3.rs-470358/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S, Song F, Guo W, Tan J, Zhang X, Qiao F, et al. . Potential genes associated with COVID-19 and comorbidity. Int J Med Sci. (2022) 19:402&#x2013;15. doi: 10.7150/ijms.67815, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7150/ijms.67815</ArticleId><ArticleId IdType=\"pmc\">PMC8795808</ArticleId><ArticleId IdType=\"pubmed\">35165525</ArticleId></ArticleIdList></Reference><Reference><Citation>Piraino B, Vollmer-Conna U, Lloyd AR. Genetic associations of fatigue and other symptom domains of the acute sickness response to infection. Brain Behav Immun. (2012) 26:552&#x2013;8. doi: 10.1016/j.bbi.2011.12.009, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2011.12.009</ArticleId><ArticleId IdType=\"pmc\">PMC7127134</ArticleId><ArticleId IdType=\"pubmed\">22227623</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollmer-Conna U, Piraino BF, Cameron B, Davenport T, Hickie I, Wakefield D, et al. . Cytokine polymorphisms have a synergistic effect on severity of the acute sickness response to infection. Clin Infect Dis. (2008) 47:1418&#x2013;25. doi: 10.1086/592967, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1086/592967</ArticleId><ArticleId IdType=\"pubmed\">18937577</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo YS, Luo L, Li W, Chen Y, Wu GF, Chen F, et al. . Evaluation of a Functional Single Nucleotide Polymorphism of the SARS-CoV-2 Receptor ACE2 That Is Potentially Involved in Long COVID. Front Genet. (2022) 13:931562. doi: 10.3389/fgene.2022.931562, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fgene.2022.931562</ArticleId><ArticleId IdType=\"pmc\">PMC9340221</ArticleId><ArticleId IdType=\"pubmed\">35923692</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Giordano R, D&#xed;az-Gil G, G&#xf3;mez-Esquer F, Ambite-Quesada S, Palomar-Gallego MA, et al. . Post-COVID pain is not associated with inflammatory polymorphisms in people who had been hospitalized by COVID-19. JCM. (2022) 11. doi: 10.3390/jcm11195645, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm11195645</ArticleId><ArticleId IdType=\"pmc\">PMC9570972</ArticleId><ArticleId IdType=\"pubmed\">36233516</ArticleId></ArticleIdList></Reference><Reference><Citation>Camhi SL, Lee P, Choi AM. The oxidative stress response. New Horiz. (1995) 3:170&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7583159</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmarakby AA, Sullivan JC. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther. (2012) 30:49&#x2013;59. doi: 10.1111/j.1755-5922.2010.00218.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1755-5922.2010.00218.x</ArticleId><ArticleId IdType=\"pubmed\">20718759</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas SK. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxid med cell Longev. (2016) 2016:1&#x2013;9. doi: 10.1155/2016/5698931, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2016/5698931</ArticleId><ArticleId IdType=\"pmc\">PMC4736408</ArticleId><ArticleId IdType=\"pubmed\">26881031</ArticleId></ArticleIdList></Reference><Reference><Citation>Son Y, Cheong YK, Kim NH, Chung HT, Kang DG, Pae HO. Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways? J Signal Transduct [Internet]. (2011) 2011:1&#x2013;6. doi: 10.1155/2011/792639, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2011/792639</ArticleId><ArticleId IdType=\"pmc\">PMC3100083</ArticleId><ArticleId IdType=\"pubmed\">21637379</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahirnyj A, Livne-Bar I, Guo X, Sivak JM. ROS detoxification and Proinflammatory cytokines are linked by p38 MAPK signaling in a model of mature astrocyte activation. PLoS One. (2013) 8:e83049. doi: 10.1371/journal.pone.0083049, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0083049</ArticleId><ArticleId IdType=\"pmc\">PMC3871647</ArticleId><ArticleId IdType=\"pubmed\">24376630</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. (2015) 97:55&#x2013;74. doi: 10.1016/j.ejmech.2015.04.040, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejmech.2015.04.040</ArticleId><ArticleId IdType=\"pubmed\">25942353</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadarani BN, Majumdar AS. Resveratrol potentiates the effect of dexamethasone in rat model of acute lung inflammation. Int Immunopharmacol. (2015) 28:773&#x2013;9. doi: 10.1016/j.intimp.2015.07.038, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.intimp.2015.07.038</ArticleId><ArticleId IdType=\"pubmed\">26283591</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R, Banerjee A, Baker MR, Dani M, Ford E, Hull JH, et al. . Long COVID: mechanisms, risk factors and recovery. Exp Physiol. (2023) 108:12&#x2013;27. doi: 10.1113/EP090802, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1113/EP090802</ArticleId><ArticleId IdType=\"pmc\">PMC10103775</ArticleId><ArticleId IdType=\"pubmed\">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 &#x201c;long-haulers&#x201d;? Chronic Dis Transl Med. (2021) 7:14&#x2013;26. doi: 10.1016/j.cdtm.2020.11.002, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cdtm.2020.11.002</ArticleId><ArticleId IdType=\"pmc\">PMC7680046</ArticleId><ArticleId IdType=\"pubmed\">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;, Mella O, Bruland O, Risa K, Dyrstad SE, Alme K, et al. . Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight. (2016) 1:e89376. doi: 10.1172/jci.insight.89376, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/jci.insight.89376</ArticleId><ArticleId IdType=\"pmc\">PMC5161229</ArticleId><ArticleId IdType=\"pubmed\">28018972</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. (2020) 11:102&#x2013;11. doi: 10.1038/s41467-019-13668-3, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-019-13668-3</ArticleId><ArticleId IdType=\"pmc\">PMC6941980</ArticleId><ArticleId IdType=\"pubmed\">31900386</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiurazzi M, Di Maro M, Cozzolino M, Colantuoni A. Mitochondrial dynamics and microglia as new targets in metabolism regulation. IJMS. (2020) 21:3450&#x2013;3564. doi: 10.3390/ijms21103450, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21103450</ArticleId><ArticleId IdType=\"pmc\">PMC7279384</ArticleId><ArticleId IdType=\"pubmed\">32414136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganji R, Reddy PH. Impact of COVID-19 on mitochondrial-based immunity in aging and age-related diseases. Front Aging Neurosci. (2020) 12:614650. doi: 10.3389/fnagi.2020.614650, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2020.614650</ArticleId><ArticleId IdType=\"pmc\">PMC7835331</ArticleId><ArticleId IdType=\"pubmed\">33510633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajaz S, McPhail MJ, Singh KK, Mujib S, Trovato FM, Napoli S, et al. . Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Physiol Cell Physiol. (2021) 320:C57&#x2013;65. doi: 10.1152/ajpcell.00426.2020, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpcell.00426.2020</ArticleId><ArticleId IdType=\"pmc\">PMC7816428</ArticleId><ArticleId IdType=\"pubmed\">33151090</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibellini L, De Biasi S, Paolini A, Borella R, Boraldi F, Mattioli M, et al. . Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol Med. (2020) 12:e13001. doi: 10.15252/emmm.202013001, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/emmm.202013001</ArticleId><ArticleId IdType=\"pmc\">PMC7645870</ArticleId><ArticleId IdType=\"pubmed\">33078545</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratto C, Caravita S, Soranna D, Faini A, Dewachter C, Zambon A, et al. . Current limitations of invasive exercise hemodynamics for the diagnosis of heart failure with preserved ejection fraction [internet]. Circu Heart Fail. (2021) 14:e007555. doi: 10.1161/circheartfailure.120.007555</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/circheartfailure.120.007555</ArticleId><ArticleId IdType=\"pubmed\">33951935</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, Joseph P, Heerdt PM, Cullinan M, Lutchmansingh DD, Gulati M, et al. . Persistent Exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest. (2022) 161:54&#x2013;63. doi: 10.1016/j.chest.2021.08.010, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType=\"pmc\">PMC8354807</ArticleId><ArticleId IdType=\"pubmed\">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MHB, Wing YK, Yu MWM, Leung CM, Ma RCW, Kong APS, et al. . Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: Long-term follow-up. Arch Intern Med. (2009) 169:2142&#x2013;7. doi: 10.1001/archinternmed.2009.384, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType=\"pubmed\">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, et al. . Covid-19 and autoimmunity. Autoimmun Rev. (2020) 19:102597. doi: 10.1016/j.autrev.2020.102597, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2020.102597</ArticleId><ArticleId IdType=\"pmc\">PMC7289100</ArticleId><ArticleId IdType=\"pubmed\">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et al. . Diverse functional autoantibodies in patients with COVID-19. Nature [Internet]. (2021) 595: 283&#x2013;288. doi: 10.1038/s41586-021-03631-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType=\"pubmed\">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. . Chronic inflammation in the etiology of disease across the life span. Nat Med. (2019) 25:1822&#x2013;32. doi: 10.1038/s41591-019-0675-0, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-019-0675-0</ArticleId><ArticleId IdType=\"pmc\">PMC7147972</ArticleId><ArticleId IdType=\"pubmed\">31806905</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner S, Becker SC, Hartwig J, Sotzny F, Lorenz S, Bauer S, et al. . Autoimmunity-related risk variants in PTPN22 and CTLA4 are associated with ME/CFS with infectious onset. Front Immunol. (2020) 11:578. doi: 10.3389/fimmu.2020.00578, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2020.00578</ArticleId><ArticleId IdType=\"pmc\">PMC7161310</ArticleId><ArticleId IdType=\"pubmed\">32328064</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome&#x2014;evidence for an autoimmune disease. Autoimmun Rev. (2018) 17:601&#x2013;9. doi: 10.1016/j.autrev.2018.01.009, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2018.01.009</ArticleId><ArticleId IdType=\"pubmed\">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Surace AEA, Hedrich CM. The role of epigenetics in autoimmune/inflammatory disease. Front Immunol. (2019) 10:1525&#x2013;1541. doi: 10.3389/fimmu.2019.01525</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2019.01525</ArticleId><ArticleId IdType=\"pmc\">PMC6620790</ArticleId><ArticleId IdType=\"pubmed\">31333659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YS, Lin CF, Fang YT, Kuo YM, Liao PC, Yeh TM, et al. . Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity. Clin Exp Immunol. (2005) 141:500&#x2013;8. doi: 10.1111/j.1365-2249.2005.02864.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2249.2005.02864.x</ArticleId><ArticleId IdType=\"pmc\">PMC1809466</ArticleId><ArticleId IdType=\"pubmed\">16045740</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti C, Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. (2020) 16:413&#x2013;4. doi: 10.1038/s41584-020-0448-7, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41584-020-0448-7</ArticleId><ArticleId IdType=\"pmc\">PMC7271827</ArticleId><ArticleId IdType=\"pubmed\">32499548</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate W, Walker M, Sweetman E, Helliwell A, Peppercorn K, Edgar C, et al. . Molecular mechanisms of Neuroinflammation in ME/CFS and Long COVID to sustain disease and promote relapses. Front Neurol. (2022) 13:877772. doi: 10.3389/fneur.2022.877772, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2022.877772</ArticleId><ArticleId IdType=\"pmc\">PMC9174654</ArticleId><ArticleId IdType=\"pubmed\">35693009</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, et al. . A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. (2022) 13:5104&#x2013;13. doi: 10.1038/s41467-022-32507-6, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType=\"pmc\">PMC9426365</ArticleId><ArticleId IdType=\"pubmed\">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini DM, Brunjes DL, Lala A, Trivieri MG, Contreras JP, Natelson BH. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. (2021) 9:927&#x2013;37. doi: 10.1016/j.jchf.2021.10.002, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType=\"pmc\">PMC8629098</ArticleId><ArticleId IdType=\"pubmed\">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, el Jammal T, et al. . Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions [internet]. Autoimmun Rev. (2020) 19:102567. doi: 10.1016/j.autrev.2020.102567, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2020.102567</ArticleId><ArticleId IdType=\"pmc\">PMC7196557</ArticleId><ArticleId IdType=\"pubmed\">32376392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyriazopoulou E, Poulakou G, Milionis H, Metallidis S, Adamis G, Tsiakos K, et al. . Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial [internet]. Nat Med. (2021) 27:1752&#x2013;60. doi: 10.1038/s41591-021-01499-z, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-021-01499-z</ArticleId><ArticleId IdType=\"pmc\">PMC8516650</ArticleId><ArticleId IdType=\"pubmed\">34480127</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai A, Diawara O, Nahass RG, Brunetti L. Impact of tocilizumab administration on mortality in severe COVID-19. Sci Rep. (2020) 10:19131. doi: 10.1038/s41598-020-76187-y, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-020-76187-y</ArticleId><ArticleId IdType=\"pmc\">PMC7645706</ArticleId><ArticleId IdType=\"pubmed\">33154452</ArticleId></ArticleIdList></Reference><Reference><Citation>Salama C, Han J, Yau L, Reiss WG, Kramer B, Neidhart JD, et al. . Tocilizumab in patients hospitalized with Covid-19 pneumonia. N Engl J Med. (2021) 384:20&#x2013;30. doi: 10.1056/NEJMoa2030340, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa2030340</ArticleId><ArticleId IdType=\"pmc\">PMC7781101</ArticleId><ArticleId IdType=\"pubmed\">33332779</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokkotis G, Kitsou K, Xynogalas I, Spoulou V, Magiorkinis G, Trontzas I, et al. . Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments. Aliment Pharmacol Ther. (2022) 55:154&#x2013;67. doi: 10.1111/apt.16717, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/apt.16717</ArticleId><ArticleId IdType=\"pubmed\">34881430</ArticleId></ArticleIdList></Reference><Reference><Citation>The RECOVERY Collaborative Group . Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. (2021) 384:693&#x2013;704. doi: 10.1056/NEJMoa2021436</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType=\"pmc\">PMC7383595</ArticleId><ArticleId IdType=\"pubmed\">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee YJ, Fan BE, Young BE, Dalan R, Lye DC. Clinical trials on the pharmacological treatment of long COVID: a systematic review. J Med Virol. (2023) 95:e28289. doi: 10.1002/jmv.28289, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.28289</ArticleId><ArticleId IdType=\"pmc\">PMC9878018</ArticleId><ArticleId IdType=\"pubmed\">36349400</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibnhadjamor H, Jdidi J, Torjmen S, Kraiem S, Bahloul A, et al. . Sulodexide significantly improves endothelial dysfunction and alleviates chest pain and palpitations in patients with Long-COVID-19: insights from TUN-EndCOV study. Front Cardiovasc Med. (2022) 9:866113. doi: 10.3389/fcvm.2022.866113, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcvm.2022.866113</ArticleId><ArticleId IdType=\"pmc\">PMC9133483</ArticleId><ArticleId IdType=\"pubmed\">35647070</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchhorn R. Therapeutic approaches to Dysautonomia in childhood, with a special focus on Long COVID [internet]. Children. (2023) 10:316. doi: 10.3390/children10020316, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/children10020316</ArticleId><ArticleId IdType=\"pmc\">PMC9955589</ArticleId><ArticleId IdType=\"pubmed\">36832445</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan X, Zhao Z, Li T. Post-inflammatory pulmonary fibrosis in a discharged COVID-19 patient: effectively treated with Pirfenidone [internet]. Arch Pulmonol Respir Care. (2020) 6:051&#x2013;3. doi: 10.17352/aprc.000053</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.17352/aprc.000053</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee T, Das M, Mitra K. The effect of Pirfenidone on pulmonary function parameters in post recovery COVID-19 patients with pulmonary fibrosis compared to placebo in a government medical college, West Bengal [internet]. Biomedicine. (2022) 42:1005&#x2013;7. doi: 10.51248/.v42i5.1996</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.51248/.v42i5.1996</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel N, Goyal N, Nagaraja R, Kumar R. Systemic corticosteroids for management of &#x201c;long-COVID&#x201d;: an evaluation after 3 months of treatment. Monaldi Arch Chest Dis [Internet]. (2021) 92:1981&#x2013;1987. doi: 10.4081/monaldi.2021.1981, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4081/monaldi.2021.1981</ArticleId><ArticleId IdType=\"pubmed\">34730322</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussein AARM, Mohamed Hussein AA, Ibrahim MEA, Makhlouf HA, Makhlouf NA, Abd-Elaal HK, et al. . Value of montelukast as a potential treatment of post-COVID-19 persistent cough: a non-randomized controlled pilot study [internet]. Egypt J Bronchol. (2022) 16:1&#x2013;5. doi: 10.1186/s43168-022-00154-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s43168-022-00154-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhooria S, Chaudhary S, Sehgal IS, Agarwal R, Arora S, Garg M, et al. . High-dose low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial). Eur Respir J [Internet]. (2022) 59:2102930. doi: 10.1183/13993003.02930-2021, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1183/13993003.02930-2021</ArticleId><ArticleId IdType=\"pmc\">PMC8850687</ArticleId><ArticleId IdType=\"pubmed\">34887325</ArticleId></ArticleIdList></Reference><Reference><Citation>Utrero-Rico A, Ruiz-Ruig&#xf3;mez M, Laguna-Goya R, Arrieta-Ortubay E, Chivite-Lacaba M, Gonz&#xe1;lez-Cuadrado C, et al. . A short corticosteroid course reduces symptoms and immunological alterations underlying Long-COVID [internet]. Biomedicine. (2021) 9:1540. doi: 10.3390/biomedicines9111540, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biomedicines9111540</ArticleId><ArticleId IdType=\"pmc\">PMC8614904</ArticleId><ArticleId IdType=\"pubmed\">34829769</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone IL, Tortorella C, Ghirelli A. Influence of pregnancy in multiple sclerosis and impact of disease-modifying therapies. Front Neurol. (2021) 12:697974. doi: 10.3389/fneur.2021.697974, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2021.697974</ArticleId><ArticleId IdType=\"pmc\">PMC8280312</ArticleId><ArticleId IdType=\"pubmed\">34276545</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stensen M, Villiger PM. The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol. (2007) 29:185&#x2013;91. doi: 10.1007/s00281-007-0072-5, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00281-007-0072-5</ArticleId><ArticleId IdType=\"pubmed\">17621703</ArticleId></ArticleIdList></Reference><Reference><Citation>Colle I, Hautekeete M. Remission of autoimmune hepatitis during pregnancy: a report of two cases. Liver. (1999) 19:55&#x2013;7. doi: 10.1111/j.1478-3231.1999.tb00010.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1478-3231.1999.tb00010.x</ArticleId><ArticleId IdType=\"pubmed\">9928767</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazos M, Sperling RS, Moran TM, Kraus TA. The influence of pregnancy on systemic immunity. Immunol Res. (2012) 54:254&#x2013;61. doi: 10.1007/s12026-012-8303-9, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12026-012-8303-9</ArticleId><ArticleId IdType=\"pmc\">PMC7091327</ArticleId><ArticleId IdType=\"pubmed\">22447351</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffer L. Lots of Long COVID treatment leads, but few are proven. PNAS. 119:e2213524119. doi: 10.1073/pnas.2213524119, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2213524119</ArticleId><ArticleId IdType=\"pmc\">PMC9456722</ArticleId><ArticleId IdType=\"pubmed\">36048910</ArticleId></ArticleIdList></Reference><Reference><Citation>Krist&#xf3;fi R, Eriksson JW. Metformin as an anti-inflammatory agent: a short review. J Endocrinol. (2021) 251:R11&#x2013;R22. doi: 10.1530/JOE-21-0194</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1530/JOE-21-0194</ArticleId><ArticleId IdType=\"pubmed\">34463292</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante C, Buse JB, Liebovitz D, Nicklas J, et al. . Outpatient treatment of COVID-19 and the development of Long COVID Over 10 Months: A Multi-Center, Quadruple-Blind, Parallel Group Randomized Phase 3 Trial. (2022) Available at SSRN: https://ssrn.com/abstract=4375620 or 10.2139/ssrn.4375620.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2139/ssrn.4375620</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi J, Hansen MK, O&#x2019;Connor KA, Biedenkapp JC, Watkins LR, Maier SF, et al. . Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challenge [internet]. J Appl Physiol. (2003) 95:1873&#x2013;82. doi: 10.1152/japplphysiol.00371.2003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/japplphysiol.00371.2003</ArticleId><ArticleId IdType=\"pubmed\">12871965</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37054777</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1931-3543</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2023</Year><Month>Apr</Month><Day>11</Day></PubDate></JournalIssue><Title>Chest</Title><ISOAbbreviation>Chest</ISOAbbreviation></Journal><ArticleTitle>Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-Acute Sequelae of SARS-CoV-2: More in Common Than Not?</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0012-3692(23)00502-0</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.chest.2023.03.049</ELocationID><Abstract><AbstractText Label=\"TOPIC IMPORTANCE\" NlmCategory=\"UNASSIGNED\">Postacute sequelae of SARS-CoV-2 (PASC) is a long-term consequence of acute infection from COVID-19. Clinical overlap between PASC and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has been observed, with shared symptoms, including intractable fatigue, postexertional malaise, and orthostatic intolerance. The mechanistic underpinnings of such symptoms are poorly understood.</AbstractText><AbstractText Label=\"REVIEW FINDINGS\" NlmCategory=\"RESULTS\">Early studies suggest deconditioning as the primary explanation for exertional intolerance in PASC. Cardiopulmonary exercise testing reveals perturbations related to systemic blood flow and ventilatory control associated with acute exercise intolerance in PASC, which are not typical of simple detraining. Hemodynamic and gas exchange derangements in PASC have substantial overlap with those observed with ME/CFS, suggestive of shared mechanisms.</AbstractText><AbstractText Label=\"SUMMARY\" NlmCategory=\"CONCLUSIONS\">This review illustrates exercise pathophysiological commonalities between PASC and ME/CFS that will help guide future diagnostics and treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Joseph</LastName><ForeName>Phillip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Yale-New Haven Hospital, Yale University, New Haven, CT.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Singh</LastName><ForeName>Inderjit</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Yale-New Haven Hospital, Yale University, New Haven, CT.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Oliveira</LastName><ForeName>Rudolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Respiratory Disease, Department of Medicine, Federal University of S&#xe3;o Paulo (UNIFESP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Capone</LastName><ForeName>Christine A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Division of Pediatric Cardiology Department of Pediatrics, Cohen Children\\'s Medical Center, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra, Manhasset, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mullen</LastName><ForeName>Mary P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Boston Children\\'s Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cook</LastName><ForeName>Dane B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Research Service, William S. Middleton Memorial Veterans Hospital &amp; Department of Kinesiology, University of Wisconsin-Madison, Madison, WI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stovall</LastName><ForeName>Mary Catherine</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\\'s Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Squires</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\\'s Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Madsen</LastName><ForeName>Kristine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\\'s Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Waxman</LastName><ForeName>Aaron B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\\'s Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Systrom</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\\'s Hospital, Harvard Medical School, Boston, MA. Electronic address: dsystrom@bwh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chest</MedlineTA><NlmUniqueID>0231335</NlmUniqueID><ISSNLinking>0012-3692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">CPET</Keyword><Keyword MajorTopicYN=\"N\">ME/CFS</Keyword><Keyword MajorTopicYN=\"N\">PASC</Keyword><Keyword MajorTopicYN=\"N\">hyperventilation</Keyword><Keyword MajorTopicYN=\"N\">neurovascular dysregulation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37054777</ArticleId><ArticleId IdType=\"pmc\">PMC10088277</ArticleId><ArticleId IdType=\"doi\">10.1016/j.chest.2023.03.049</ArticleId><ArticleId IdType=\"pii\">S0012-3692(23)00502-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8893149</ArticleId><ArticleId IdType=\"pubmed\">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Bektas A., Schurman S.H., Franceschi C., Ferrucci L. A&#xa0;public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging? Immun Ageing. 2020;17:23.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7443812</ArticleId><ArticleId IdType=\"pubmed\">32849908</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)&#x2014;a systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas) 2021;57(5)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8145228</ArticleId><ArticleId IdType=\"pubmed\">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton E.W. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA. 2015;313(11):1101&#x2013;1102.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25668027</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo R.F., Mondoni M., Parazzini E.M., et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J. 2021;58(2)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8082950</ArticleId><ArticleId IdType=\"pubmed\">33926969</ArticleId></ArticleIdList></Reference><Reference><Citation>Skjorten I., Ankerstjerne O.A.W., Trebinjac D., et al. Cardiopulmonary exercise capacity and limitations 3&#xa0;months after COVID-19 hospitalisation. Eur Respir J. 2021;58(2)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8247555</ArticleId><ArticleId IdType=\"pubmed\">34210791</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P., Arevalo C., Oliveira R.K.F., et al. Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest. 2021;160:642&#x2013;651.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8727854</ArticleId><ArticleId IdType=\"pubmed\">33577778</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P.M., et al. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest. 2022;161(1):54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8354807</ArticleId><ArticleId IdType=\"pubmed\">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwendinger F., Knaier R., Radtke T., Schmidt-Trucksass A. Low cardiorespiratory fitness post-COVID-19: a narrative review. Sports Med. 2023;53(1):51&#x2013;74.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9483283</ArticleId><ArticleId IdType=\"pubmed\">36115933</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7833295</ArticleId><ArticleId IdType=\"pubmed\">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7385689</ArticleId><ArticleId IdType=\"pubmed\">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Inbar O., Dlin R., Rotstein A., Whipp B.J. Physiological responses to incremental exercise in patients with chronic fatigue syndrome. Med Sci Sports Exerc. 2001;33(9):1463&#x2013;1470.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11528333</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D.B., VanRiper S., Dougherty R.J., et al. Cardiopulmonary, metabolic, and perceptual responses during exercise in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a Multi-Site Clinical Assessment of ME/CFS (MCAM) sub-study. PLoS One. 2022;17(3)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8923458</ArticleId><ArticleId IdType=\"pubmed\">35290404</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson M.J., Buckley J.D., Thomson R.L., Bellenger C.R., Davison K. Markers of cardiac autonomic function during consecutive day peak exercise tests in people with myalgic encephalomyelitis/chronic fatigue syndrome. Front Physiol. 2021;12</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8713453</ArticleId><ArticleId IdType=\"pubmed\">34970156</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens S., Snell C., Stevens J., Keller B., VanNess J.M. Cardiopulmonary exercise test methodology for assessing exertion intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. 2018;6:242.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6131594</ArticleId><ArticleId IdType=\"pubmed\">30234078</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller B.A., Pryor J.L., Giloteaux L. Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO(2)peak indicates functional impairment. J&#xa0;Transl Med. 2014;12:104.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4004422</ArticleId><ArticleId IdType=\"pubmed\">24755065</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.J., Kang E.B., Jang E.S., Son C.G. The prospects of the two-day cardiopulmonary exercise test (CPET) in ME/CFS patients: a meta-analysis. J&#xa0;Clin Med. 2020;9(12):4040.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7765094</ArticleId><ArticleId IdType=\"pubmed\">33327624</ArticleId></ArticleIdList></Reference><Reference><Citation>White A.T., Light A.R., Hughen R.W., et al. Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology. 2010;47(4):615&#x2013;624.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4378647</ArticleId><ArticleId IdType=\"pubmed\">20230500</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Oosterwijck J., Nijs J., Meeus M., et al. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an experimental study. J&#xa0;Intern Med. 2010;268(3):265&#x2013;278.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20412374</ArticleId></ArticleIdList></Reference><Reference><Citation>Smylie A.L., Broderick G., Fernandes H., et al. A&#xa0;comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome. BMC Immunol. 2013;14:29.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3698072</ArticleId><ArticleId IdType=\"pubmed\">23800166</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla S.K., Cook D., Meyer J., et al. Changes in gut and plasma microbiome following exercise challenge in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) PLoS One. 2015;10(12)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4684203</ArticleId><ArticleId IdType=\"pubmed\">26683192</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A., Giloteaux L., Moore G.E., et al. Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 2022;7(9)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9090259</ArticleId><ArticleId IdType=\"pubmed\">35358096</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D.B., Light A.R., Light K.C., et al. Neural consequences of post-exertion malaise in myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav Immun. 2017;62:87&#x2013;99.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28216087</ArticleId></ArticleIdList></Reference><Reference><Citation>McCully K.K., Natelson B.H. Impaired oxygen delivery to muscle in chronic fatigue syndrome. Clin Sci (Lond) 1999;97(5):603&#x2013;608.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10545311</ArticleId></ArticleIdList></Reference><Reference><Citation>Boruch A.E., Lindheimer J.B., Klein-Adams J.C., et al. Predicting post-exertional malaise in Gulf War illness based on acute exercise responses. Life Sci. 2021;280</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34119538</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R., DeMars J., Franklin K., Culos-Reed S.N., Weatherald J., Wrightson J.G. Chronic fatigue and postexertional malaise in people living with long COVID: an observational study. Phys Ther. 2022;102(4)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9383197</ArticleId><ArticleId IdType=\"pubmed\">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron B.A., Cockrill B.A., Waxman A.B., Systrom D.M. The invasive cardiopulmonary exercise test. Circulation. 2013;127(10):1157&#x2013;1164.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23479667</ArticleId></ArticleIdList></Reference><Reference><Citation>Boerrigter B.G., Waxman A.B., Westerhof N., Vonk-Noordegraaf A., Systrom D.M. Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects. Eur Respir J. 2014;43(5):1316&#x2013;1325.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24177003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasserman K. 5th ed. Wolters Kluwer Health/Lippincott Williams &amp; Wilkins; Philadelphia, PA: 2012. Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications.</Citation></Reference><Reference><Citation>Oliveira R.K., Agarwal M., Tracy J.A., et al. Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics. Eur Respir J. 2016;47(4):1179&#x2013;1188.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26677941</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeder K., Banfi C., Steinrisser-Allex G., et al. Diagnostic, prognostic and differential-diagnostic relevance of pulmonary hemodynamics during exercise&#x2014;a systematic review. Eur Respir J. 2022</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9556812</ArticleId><ArticleId IdType=\"pubmed\">35332069</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisman A.S., Shah R.V., Dhakal B.P., et al. Pulmonary capillary wedge pressure patterns during exercise predict exercise capacity and incident heart failure. Circ Heart Fail. 2018;11(5)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5937988</ArticleId><ArticleId IdType=\"pubmed\">29695381</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen J.E., Sue D.Y., Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis. 1984;129(2 pt 2):S49&#x2013;S55.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6421218</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldham W.M., Lewis G.D., Opotowsky A.R., Waxman A.B., Systrom D.M. Unexplained exertional dyspnea caused by low ventricular filling pressures: results from clinical invasive cardiopulmonary exercise testing. Pulm Circ. 2016;6(1):55&#x2013;62.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4860548</ArticleId><ArticleId IdType=\"pubmed\">27162614</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobrega A.C., O&#x2019;Leary D., Silva B.M., Marongiu E., Piepoli M.F., Crisafulli A. Neural regulation of cardiovascular response to exercise: role of central command and peripheral afferents. Biomed Res Int. 2014;2014</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4000959</ArticleId><ArticleId IdType=\"pubmed\">24818143</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P., Mukerji S.S., Alabsi H.S., et al. Multisystem involvement in post-acute sequelae of coronavirus disease 19. Ann Neurol. 2022;91(3):367&#x2013;379.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9011495</ArticleId><ArticleId IdType=\"pubmed\">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A.L., Herzog Z.D., Downs H.M., Klein M.M. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain. 2013;154(11):2310&#x2013;2316.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3845002</ArticleId><ArticleId IdType=\"pubmed\">23748113</ArticleId></ArticleIdList></Reference><Reference><Citation>Evdokimov D., Frank J., Klitsch A., et al. Reduction of skin innervation is associated with a severe fibromyalgia phenotype. Ann Neurol. 2019;86(4):504&#x2013;516.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31376174</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuller T.B., Hermann K., Baron R. Quantitative assessment and correlation of sympathetic, parasympathetic, and afferent small fiber function in peripheral neuropathy. J&#xa0;Neurol. 2000;247(4):267&#x2013;272.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10836618</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob G., Costa F., Shannon J.R., et al. The neuropathic postural tachycardia syndrome. N&#xa0;Engl J Med. 2000;343(14):1008&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11018167</ArticleId></ArticleIdList></Reference><Reference><Citation>Stringer W., Wasserman K., Casaburi R., Porszasz J., Maehara K., French W. Lactic acidosis as a facilitator of oxyhemoglobin dissociation during exercise. J&#xa0;Appl Physiol (1985) 1994;76(4):1462&#x2013;1467.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8045820</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakane S., Mukaino A., Higuchi O., et al. A&#xa0;comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy. J&#xa0;Autoimmun. 2020;108</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31924415</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrecht P.J., Hou Q., Argoff C.E., Storey J.R., Wymer J.P., Rice F.L. Excessive peptidergic sensory innervation of cutaneous arteriole-venule shunts (AVS) in the palmar glabrous skin of fibromyalgia patients: implications for widespread deep tissue pain and fatigue. Pain Med. 2013;14(6):895&#x2013;915.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23691965</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha A.K., Schmidt B.R., Wilhelmy J., et al. Red blood cell deformability is diminished in patients with chronic fatigue syndrome. Clin Hemorheol Microcirc. 2019;71(1):113&#x2013;116.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6398549</ArticleId><ArticleId IdType=\"pubmed\">30594919</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandvik M.K., S&#xf8;rland K., Leirgul E., et al. Endothelial dysfunction in ME/CFS patients. PLoS One. 2023;18(2)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9894436</ArticleId><ArticleId IdType=\"pubmed\">36730360</ArticleId></ArticleIdList></Reference><Reference><Citation>Wawrzyniak N.R., Joseph A.M., Levin D.G., et al. Idiopathic chronic fatigue in older adults is linked to impaired mitochondrial content and biogenesis signaling in skeletal muscle. Oncotarget. 2016;7(33):52695&#x2013;52709.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5288142</ArticleId><ArticleId IdType=\"pubmed\">27447862</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer E., Petrache I., Goldstein N.M., et al. Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome. Am J Respir Crit Care Med. 2022;205(1):126&#x2013;129.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8865580</ArticleId><ArticleId IdType=\"pubmed\">34665688</ArticleId></ArticleIdList></Reference><Reference><Citation>Taivassalo T., Jensen T.D., Kennaway N., DiMauro S., Vissing J., Haller R.G. The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients. Brain. 2003;126(pt 2):413&#x2013;423.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12538407</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell D.E., Ora J., Webb K.A., Laveneziana P., Jensen D. Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol. 2009;167(1):116&#x2013;132.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19450767</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini D.M., Brunjes D.L., Lala A., Trivieri M.G., Contreras J.P., Natelson B.H. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. 2021;9(12):927&#x2013;937.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8629098</ArticleId><ArticleId IdType=\"pubmed\">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed K.H., Santos M., Oliveira R.K.F., et al. Unexplained exertional intolerance associated with impaired systemic oxygen extraction. Eur J Appl Physiol. 2019;119(10):2375&#x2013;2389.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31493035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalande S., Cross T.J., Keller-Ross M.L., Morris N.R., Johnson B.D., Taylor B.J. Exercise intolerance in heart failure: central role for the pulmonary system. Exerc Sport Sci Rev. 2020;48(1):11&#x2013;19.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6910932</ArticleId><ArticleId IdType=\"pubmed\">31453845</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Hand G.A., Potts J.T., Wilson L.B., Mitchell J.H. c-Fos expression in the medulla induced by static muscle contraction in cats. Am J Physiol. 1997;272(1 pt 2):H48&#x2013;H56.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9038921</ArticleId></ArticleIdList></Reference><Reference><Citation>Saltin B., Blomqvist G., Mitchell J.H., Johnson R.L., Jr., Wildenthal K., Chapman C.B. Response to exercise after bed rest and after training. Circulation. 1968;38(suppl 5):VII1&#x2013;VII78.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">5696236</ArticleId></ArticleIdList></Reference><Reference><Citation>Stickland M.K., Welsh R.C., Petersen S.R., et al. Does fitness level modulate the cardiovascular hemodynamic response to exercise? J&#xa0;Appl Physiol (1985) 2006;100(6):1895&#x2013;1901.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16497838</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P., Pari R., Miller S., et al. Neurovascular dysregulation and acute exercise intolerance in ME/CFS: a randomized, placebo-controlled trial of pyridostigmine. Chest. 2022;162(5):1116&#x2013;1126.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35526605</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein L.R., Rose E.B., Horwitz S.M., et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N&#xa0;Engl J Med. 2020;383(4):334&#x2013;346.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7346765</ArticleId><ArticleId IdType=\"pubmed\">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Capone C.A., Subramony A., Sweberg T., et al. Characteristics, cardiac involvement, and outcomes of multisystem inflammatory syndrome of childhood associated with severe acute respiratory syndrome coronavirus 2 infection. J&#xa0;Pediatr. 2020;224:141&#x2013;145.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7293762</ArticleId><ArticleId IdType=\"pubmed\">32553873</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow A.K., Malone L.A., Kokorelis C., et al. Long-term COVID 19 sequelae in adolescents: the overlap with orthostatic intolerance and ME/CFS. Curr Pediatr Rep. 2022;10(2):31&#x2013;44.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8906524</ArticleId><ArticleId IdType=\"pubmed\">35287333</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Ayuzo Del Valle N.C., et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9226045</ArticleId><ArticleId IdType=\"pubmed\">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddux A.B., Berbert L., Young C.C., et al. Health impairments in children and adolescents after hospitalization for acute COVID-19 or MIS-C. Pediatrics. 2022;150(3)</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35765138</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7652254</ArticleId><ArticleId IdType=\"pubmed\">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Penner J., Abdel-Mannan O., Grant K., et al. 6-Month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study. Lancet Child Adolesc Health. 2021;5(7):473&#x2013;482.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34043958</ArticleId></ArticleIdList></Reference><Reference><Citation>Astley C., Badue Pereira M.F., Lima M.S., et al. In-depth cardiovascular and pulmonary assessments in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a case series study. Physiol Rep. 2022;10(5)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8915155</ArticleId><ArticleId IdType=\"pubmed\">35274818</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstein D.S., Edelson J., O&#x2019;Malley S., et al. Cardiopulmonary exercise performance in the pediatric and young adult population before and during the COVID-19 pandemic. Pediatr Cardiol. 2022;43(8):1832&#x2013;1837.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9062635</ArticleId><ArticleId IdType=\"pubmed\">35503116</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoke L., Schlegtendal A., Maier C., Eitner L., Lucke T., Brinkmann F. Pulmonary function and long-term respiratory symptoms in children and adolescents after COVID-19. Front Pediatr. 2022;10</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9081758</ArticleId><ArticleId IdType=\"pubmed\">35547532</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E., Corsetti G., Romano C., et al. Serum metabolic profile in patients with long-Covid (PASC) syndrome: clinical implications. Front Med (Lausanne) 2021;8</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8339407</ArticleId><ArticleId IdType=\"pubmed\">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieling W., Kaufmann H., Claydon V.E., et al. Diagnosis and treatment of orthostatic hypotension. Lancet Neurol. 2022;21(8):735&#x2013;746.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10024337</ArticleId><ArticleId IdType=\"pubmed\">35841911</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilshire C.E., Kindlon T., Courtney R., et al. Rethinking the treatment of chronic fatigue syndrome-a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT. BMC Psychol. 2018;6(1):6.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5863477</ArticleId><ArticleId IdType=\"pubmed\">29562932</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe K.S. Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents. J&#xa0;Psychiatr Res. 1997;31(1):133&#x2013;147.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9201655</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge O., Rekeland I.G., Lien K., et al. B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2019;170(9):585&#x2013;593.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30934066</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Treister R., Lang M., Oaklander A.L. IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety. Ther Adv Neurol Disord. 2018;11</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5791555</ArticleId><ArticleId IdType=\"pubmed\">29403541</ArticleId></ArticleIdList></Reference><Reference><Citation>NCT05152849.</Citation></Reference><Reference><Citation>Parikh S., Goldstein A., Koenig M.K., et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2015;17(9):689&#x2013;701.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5000852</ArticleId><ArticleId IdType=\"pubmed\">25503498</ArticleId></ArticleIdList></Reference><Reference><Citation>Cash A., Kaufman D.L. Oxaloacetate treatment for mental and physical fatigue in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long-COVID fatigue patients: a non-randomized controlled clinical trial. J&#xa0;Transl Med. 2022;20(1):295.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9238249</ArticleId><ArticleId IdType=\"pubmed\">35764955</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37046994</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>24</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>23</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>A Proposed New Model to Explain the Role of Low Dose Non-DNA Targeted Radiation Exposure in Chronic Fatigue and Immune Dysfunction Syndrome.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">6022</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms24076022</ELocationID><Abstract><AbstractText>Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) is considered to be a multidimensional illness whose etiology is unknown. However, reports from Chernobyl, as well as those from the United States, have revealed an association between radiation exposure and the development of CFIDS. As such, we present an expanded model using a systems biology approach to explain the etiology of CFIDS as it relates to this cohort of patients. This paper proposes an integrated model with ionizing radiation as a suggested trigger for CFIDS mediated through UVA induction and biophoton generation inside the body resulting from radiation-induced bystander effects (RIBE). Evidence in support of this approach has been organized into a systems view linking CFIDS illness markers with the initiating events, in this case, low-dose radiation exposure. This results in the formation of reactive oxygen species (ROS) as well as important immunologic and other downstream effects. Furthermore, the model implicates melanoma and subsequent hematopoietic dysregulation in this underlying process. Through the identification of this association with melanoma, clinical medicine, including dermatology, hematology, and oncology, can now begin to apply its expansive knowledge base to provide new treatment options for an illness that has had few effective treatments.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Cocchetto</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National CFIDS Foundation Inc., Hull, MA 02045-1602, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Seymour</LastName><ForeName>Colin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biology, McMaster University, Hamilton, ON L8S 4K1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mothersill</LastName><ForeName>Carmel</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biology, McMaster University, Hamilton, ON L8S 4K1, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D017382\">Reactive Oxygen Species</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000069079\" MajorTopicYN=\"Y\">Radiation Exposure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011832\" MajorTopicYN=\"Y\">Radiation Injuries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017382\" MajorTopicYN=\"N\">Reactive Oxygen Species</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007154\" MajorTopicYN=\"Y\">Immune System Diseases</DescriptorName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008545\" MajorTopicYN=\"Y\">Melanoma</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">CFIDS/ME/CFS</Keyword><Keyword MajorTopicYN=\"N\">UVA</Keyword><Keyword MajorTopicYN=\"N\">hematopoietic dysregulation</Keyword><Keyword MajorTopicYN=\"N\">ionizing radiation</Keyword><Keyword MajorTopicYN=\"N\">melanoma</Keyword><Keyword MajorTopicYN=\"N\">reactive oxygen species</Keyword><Keyword MajorTopicYN=\"N\">systems biology</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37046994</ArticleId><ArticleId IdType=\"pmc\">PMC10094351</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms24076022</ArticleId><ArticleId IdType=\"pii\">ijms24076022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bell D.S. The Disease of a Thousand Names: CFIDS&#x2014;CHRONIC Fatigue/Immune Dysfunction Syndrome. Pollard Publications; La Jolla, CA, USA: 1991.</Citation></Reference><Reference><Citation>Loganovsky K. Chronic Fatigue Syndrome as a Characteristic Aftermath of Radioecological Catastrophe. Int. J. Psychophysiol. 2000;35:69.</Citation></Reference><Reference><Citation>Loganovsky K.N. Chronic Fatigue Syndrome in the Chernobyl Accident Consequences Liquidators. Int. J. Radiat. Med. 2001;3:76.</Citation></Reference><Reference><Citation>Loganovsky K. Do Low Doses of Ionizing Radiation Affect the Human Brain? Data Sci. J. 2009;8:13&#x2013;35. doi: 10.2481/dsj.BR-04.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2481/dsj.BR-04</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang F.R., Loganovsky K. Low Dose or Low Dose Rate Ionizing Radiation-Induced Health Effect in the Human. J. Environ. Radioact. 2018;192:32&#x2013;47. doi: 10.1016/j.jenvrad.2018.05.018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jenvrad.2018.05.018</ArticleId><ArticleId IdType=\"pubmed\">29883875</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazyka D., Loganovsky K., Ilyenko I., Volovyk S., Perchuk I., Pleskach O., Nechayev S. Psychophysiological, Neuroimmune and Gene Expression Changes in Chronic Fatigue Syndrome after Low-Dose Radiation Exposure. Int. J. Psychophysiol. 2010;77:340. doi: 10.1016/j.ijpsycho.2010.06.282.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijpsycho.2010.06.282</ArticleId></ArticleIdList></Reference><Reference><Citation>Loganovsky K.N. Vegetative-Vascular Dystonia and Osteoalgetic Syndrome or Chronic Fatigue Syndrome as a Characteristic After-Effect of Radioecological Disaster. J. Chronic Fatigue Syndr. 2000;7:3&#x2013;16. doi: 10.1300/J092v07n03_02.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v07n03_02</ArticleId></ArticleIdList></Reference><Reference><Citation>National CFIDS Foundation . National CFIDS Foundation (NCF) Announces Link between Chronic Fatigue Syndrome and Low Level Radiation Exposure. PR Newswire; Chicago, IL, USA: 2010.</Citation></Reference><Reference><Citation>National CFIDS Foundation . National CFIDS Foundation&#x2019;s Research Finds Chromosome Damage in Patients Diagnosed with Chronic Fatigue Syndrome and Myalgic Encephalomyelitis. PR Newswire; Chicago, IL, USA: 2014.</Citation></Reference><Reference><Citation>Heng H.H.Q., Liu G., Stevens J.B., Abdallah B.Y., Horne S.D., Ye K.J., Bremer S.W., Chowdhury S.K., Ye C.J. Karyotype Heterogeneity and Unclassified Chromosomal Abnormalities. Cytogenet. Genome Res. 2013;139:144&#x2013;157. doi: 10.1159/000348682.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000348682</ArticleId><ArticleId IdType=\"pubmed\">23571381</ArticleId></ArticleIdList></Reference><Reference><Citation>Boubriak I., Akimkina T., Polischuk V., Dmitriev A., Mccready S., Grodzinsky D. Long term effects of chernobyl contamination on dna repair function and plant resistance to biotic and abiotic stress factors. TSitologiia Genet. 2016;50:34&#x2013;59. doi: 10.3103/S0095452716060049.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3103/S0095452716060049</ArticleId><ArticleId IdType=\"pubmed\">30484602</ArticleId></ArticleIdList></Reference><Reference><Citation>Yushkova E. Genetic mechanisms of formation of radiation-induced instability of the genome and its transgenerational effects in the descendants of chronically irradiated individuals of Drosophila melanogaster. Radiat. Environ. Biophys. 2020;59:221&#x2013;236. doi: 10.1007/s00411-020-00833-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00411-020-00833-2</ArticleId><ArticleId IdType=\"pubmed\">32076810</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S.B., McNeill F.E., Byun S.H., Prestwich W.V., Seymour C., Mothersill C.E. Ion Beam Induced Luminescence; Relevance to Radiation Induced Bystander Effects. Nucl. Instrum. Methods Phys. Res. Sect. B Beam Interact. Mater. At. 2012;288:81&#x2013;88. doi: 10.1016/j.nimb.2012.05.043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nimb.2012.05.043</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S.B., McNeill F.E., Byun S.H., Prestwich W.V., Mothersill C., Seymour C., Armstrong A., Fernandez C. Ultra-Violet Light Emission from HPV-G Cells Irradiated with Low Let Radiation From (90)Y; Consequences for Radiation Induced Bystander Effects. Dose Response. 2013;11:498&#x2013;516. doi: 10.2203/dose-response.12-048.Ahmad.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2203/dose-response.12-048.Ahmad</ArticleId><ArticleId IdType=\"pmc\">PMC3834743</ArticleId><ArticleId IdType=\"pubmed\">24298227</ArticleId></ArticleIdList></Reference><Reference><Citation>Mothersill C., Le M., Rusin A., Seymour C. Biophotons in Radiobiology: Inhibitors, Communicators and Reactors. Radiat. Prot. Dosim. 2019;183:136&#x2013;141. doi: 10.1093/rpd/ncy271.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/rpd/ncy271</ArticleId><ArticleId IdType=\"pubmed\">30624751</ArticleId></ArticleIdList></Reference><Reference><Citation>Le M., McNeill F.E., Seymour C., Rainbow A.J., Mothersill C.E. An observed effect of ultraviolet radiation emitted from beta-irradiated HaCaT cells upon non-beta-irradiated bystander cells. Radiat. Res. 2015;183:279&#x2013;290. doi: 10.1667/RR13827.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RR13827.1</ArticleId><ArticleId IdType=\"pubmed\">25710575</ArticleId></ArticleIdList></Reference><Reference><Citation>Le M., Mothersill C.E., Seymour C.B., Ahmad S.B., Armstrong A., Rainbow A.J., McNeill F.E. Factors affecting ultraviolet-A photon emission from &#x3b2;-irradiated human keratinocyte cells. Phys. Med. Biol. 2015;60:6371&#x2013;6389. doi: 10.1088/0031-9155/60/16/6371.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1088/0031-9155/60/16/6371</ArticleId><ArticleId IdType=\"pubmed\">26237407</ArticleId></ArticleIdList></Reference><Reference><Citation>Le M., Mothersill C.E., Seymour C.B., Rainbow A.J., McNeill F.E. An Observed Effect of p53 Status on the Bystander Response to Radiation-Induced Cellular Photon Emission. Radiat. Res. 2017;9187:169&#x2013;185. doi: 10.1667/RR14342.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RR14342.1</ArticleId><ArticleId IdType=\"pubmed\">28118118</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J., Vo N.T.K., Chettle D.R., McNeill F.E., Seymour C.B., Mothersill C.E. Quantifying Biophoton Emissions From Human Cells Directly Exposed to Low-Dose Gamma Radiation. Dose Response. 2020;18:1559325820926763. doi: 10.1177/1559325820926763.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1559325820926763</ArticleId><ArticleId IdType=\"pmc\">PMC7238447</ArticleId><ArticleId IdType=\"pubmed\">32489340</ArticleId></ArticleIdList></Reference><Reference><Citation>Le M., McNeill F.E., Seymour C.B., Rusin A., Diamond K., Rainbow A.J., Murphy J., Mothersill C.E. Modulation of oxidative phosphorylation (OXPHOS) by radiation- induced biophotons. Environ. Res. 2018;163:80&#x2013;87. doi: 10.1016/j.envres.2018.01.027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.envres.2018.01.027</ArticleId><ArticleId IdType=\"pubmed\">29427954</ArticleId></ArticleIdList></Reference><Reference><Citation>The Water in You: Water and the Human Body. Water Science School.  [(accessed on 13 March 2023)];2019  Available online:  https://www.usgs.gov/special-topics/water-science-school/science/water-you-water-and-human-body.</Citation></Reference><Reference><Citation>Le Caer S. Radiolysis: Influence of Oxide Surfaces on H2 Production under Ionizing Radiation. Water. 2011;3:235&#x2013;253. doi: 10.3390/w3010235.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/w3010235</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards R.S., Roberts T.K., McGregor N.R., Dunstan R.H., Butt H.L. Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep. 2000;5:35&#x2013;41. doi: 10.1179/rer.2000.5.1.35.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1179/rer.2000.5.1.35</ArticleId><ArticleId IdType=\"pubmed\">10905542</ArticleId></ArticleIdList></Reference><Reference><Citation>Clutton S.M., Townsend K.M., Walker C., Ansell J.D., Wright E.G. Radiation-induced genomic instability and persisting oxidative stress in primary bone marrow cultures. Carcinogenesis. 1996;17:1633&#x2013;1639. doi: 10.1093/carcin/17.8.1633.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/carcin/17.8.1633</ArticleId><ArticleId IdType=\"pubmed\">8761419</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Reilly J.P., Mothersill C. Comparative effects of UV A and UV B on clonogenic survival and delayed cell death in skin cell lines from humans and fish. Int. J. Radiat. Biol. 1997;72:111&#x2013;119.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9246200</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridley A.J., Whiteside J.R., McMillan T.J., Allinson S.L. Cellular and sub-cellular responses to UVA in relation to carcinogenesis. Int. J. Radiat. Biol. 2009;85:177&#x2013;195. doi: 10.1080/09553000902740150.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/09553000902740150</ArticleId><ArticleId IdType=\"pubmed\">19296341</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside J.R., McMillan T.J. A bystander effect is induced in human cells treated with UVA radiation but not UVB radiation. Radiat. Res. 2009;171:204&#x2013;211. doi: 10.1667/RR1508.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RR1508.1</ArticleId><ArticleId IdType=\"pubmed\">19267546</ArticleId></ArticleIdList></Reference><Reference><Citation>Jella K.K., Moriarty R., McClean B., Byrne H.J., Lyng F.M. Reactive oxygen species and nitric oxide signaling in bystander cells. PLoS ONE. 2018;13:e0195371. doi: 10.1371/journal.pone.0195371.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0195371</ArticleId><ArticleId IdType=\"pmc\">PMC5886541</ArticleId><ArticleId IdType=\"pubmed\">29621312</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH News in Health . Sun and Skin: The Dark Side of Sun Exposure. NIH News in Health; Bethesda, MD, USA: 2014.</Citation></Reference><Reference><Citation>Jin S.G., Padron F., Pfeifer G.P. UVA Radiation, DNA Damage, and Melanoma. ACS Omega. 2022;7:32936&#x2013;32948. doi: 10.1021/acsomega.2c04424.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsomega.2c04424</ArticleId><ArticleId IdType=\"pmc\">PMC9494637</ArticleId><ArticleId IdType=\"pubmed\">36157735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernerd F., Passeron T., Castiel I., Marionnet C. The Damaging Effects of Long UVA (UVA1) Rays: A Major Challenge to Preserve Skin Health and Integrity. Int. J. Mol. Sci. 2022;23:8243. doi: 10.3390/ijms23158243.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23158243</ArticleId><ArticleId IdType=\"pmc\">PMC9368482</ArticleId><ArticleId IdType=\"pubmed\">35897826</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A.Q., Travers J.B., Kemp M.G. Roles of UVA Radiation and DNA Damage Responses in Melanoma Pathogenesis. Environ. Mol. Mutagen. 2018;59:438&#x2013;460. doi: 10.1002/em.22176.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/em.22176</ArticleId><ArticleId IdType=\"pmc\">PMC6031472</ArticleId><ArticleId IdType=\"pubmed\">29466611</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapp F.G., Perlin J.R., Hagedorn E.J., Gansner J.M., Schwarz D.E., O&#x2019;Connell L.A., Johnson N.S., Amemiya C., Fisher D.E., Wolfle U., et al. Protection from UV light is an evolutionarily conserved feature of the hematopoietic niche. Nature. 2018;558:445&#x2013;448. doi: 10.1038/s41586-018-0213-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-018-0213-0</ArticleId><ArticleId IdType=\"pmc\">PMC6093292</ArticleId><ArticleId IdType=\"pubmed\">29899448</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamran N., Li Y., Sierra M., Alghamri M.S., Kadiyala P., Appelman H.D., Edwards M., Lowenstein P.R., Castro M.G. Melanoma induced immunosuppression is mediated by hematopoietic dysregulation. Oncoimmunology. 2017;7:e1408750. doi: 10.1080/2162402X.2017.1408750.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/2162402X.2017.1408750</ArticleId><ArticleId IdType=\"pmc\">PMC5790391</ArticleId><ArticleId IdType=\"pubmed\">29399415</ArticleId></ArticleIdList></Reference><Reference><Citation>Decker J.M. Immunology: B-Cell Development. Department of Veterinary Science and Microbiology, University of Arizona.  [(accessed on 13 March 2023)].  Available online:  http://microvet.arizona.edu/Courses/MIC419/Tutorials/Bcelldevelopment.html.</Citation></Reference><Reference><Citation>Chang C.M., Warren J.L., Engels E.A. Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults. Cancer. 2012;118:5929&#x2013;5936. doi: 10.1002/cncr.27612.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cncr.27612</ArticleId><ArticleId IdType=\"pmc\">PMC3434293</ArticleId><ArticleId IdType=\"pubmed\">22648858</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson H. Osler&#x2019;s Web: Inside the Labyrinth of the Chronic Fatigue Syndrome Epidemic. Crown Publishers; New York, NY, USA: 1996.</Citation></Reference><Reference><Citation>Lundell K., Qazi S., Eddy L., Uckun F.M. Clinical activity of folinic acid in patients with chronic fatigue syndrome. Arzneimittelforschung. 2006;56:399&#x2013;404. doi: 10.1055/s-0031-1296741.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1055/s-0031-1296741</ArticleId><ArticleId IdType=\"pubmed\">16889122</ArticleId></ArticleIdList></Reference><Reference><Citation>Turick C.E., Ekechukwu A.A., Milliken C.E., Casadevall A., Dadachova E. Gamma radiation interacts with melanin to alter its oxidation-reduction potential and results in electric current production. Bioelectrochemistry. 2011;82:69&#x2013;73. doi: 10.1016/j.bioelechem.2011.04.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bioelechem.2011.04.009</ArticleId><ArticleId IdType=\"pubmed\">21632287</ArticleId></ArticleIdList></Reference><Reference><Citation>Vienneau D., de Hoogh K., Hauri D., Vicedo-Cabrera A.M., Schindler C., Huss A., Roosli M., SNC Study Group Effects of Radon and UV Exposure on Skin Cancer Mortality in Switzerland. Environ. Health Perspect. 2017;125:067009.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5744747</ArticleId><ArticleId IdType=\"pubmed\">28686556</ArticleId></ArticleIdList></Reference><Reference><Citation>Knox K.K., Carrigan D.R. Potential Role of STAT1 in the Pathogenesis of Chronic Fatigue Syndrome. Institute for Viral Pathogenesis; Madison, WI, USA: 2003.</Citation></Reference><Reference><Citation>Knox K.K., Cocchetto A., Jordan E., Leech D., Carrigan D.R. Deficiency in the Expression of STAT1 Protein in a Subpopulation of Patients with Chronic Fatigue Syndrome (CFS); Proceedings of the Seventh International AACFS Conference on Chronic Fatigue Syndrome, Fibromyalgia and other Related Illnesses; Madison, WI, USA. 8&#x2013;10 October 2004.</Citation></Reference><Reference><Citation>Maziere C., Dantin F., Dubois F., Santus R., Maziere J. Biphasic Effect of UVA Radiation on Stat1 Activity and Tyrosine Phosphorylation in Cultured Human Keratinocytes. Free Radic. Bio. Med. 2000;28:1430&#x2013;1437. doi: 10.1016/S0891-5849(00)00264-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0891-5849(00)00264-1</ArticleId><ArticleId IdType=\"pubmed\">10924861</ArticleId></ArticleIdList></Reference><Reference><Citation>Aragane Y., Kulms D., Luger T.A., Schwarz T. Down-regulation of interferon gamma-activated STAT1 by UV light. Proc. Natl. Acad. Sci. USA. 1997;94:11490&#x2013;11495. doi: 10.1073/pnas.94.21.11490.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.94.21.11490</ArticleId><ArticleId IdType=\"pmc\">PMC23515</ArticleId><ArticleId IdType=\"pubmed\">9326637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon T.R., Oh C.T., Choi E.J., Kim S.R., Jang Y.J., Ko E.J., Suh D., Yoo K.H., Kim B.J. Ultraviolet light-emitting-diode irradiation inhibits TNF-&#x3b1; and IFN-&#x3b3;-induced expression of ICAM-1 and STAT1 phosphorylation in human keratinocytes. Lasers Surg. Med. 2015;47:824&#x2013;832. doi: 10.1002/lsm.22425.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/lsm.22425</ArticleId><ArticleId IdType=\"pubmed\">26413796</ArticleId></ArticleIdList></Reference><Reference><Citation>Eschrich S., Zhang H., Zhao H., Boulware D., Lee J.H., Bloom G., Torres-Roca J.F. Systems biology modeling of the radiation sensitivity network: A biomarker discovery platform. Int. J. Radiat. Oncol. Biol. Phys. 2009;75:497&#x2013;505. doi: 10.1016/j.ijrobp.2009.05.056.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijrobp.2009.05.056</ArticleId><ArticleId IdType=\"pmc\">PMC2762403</ArticleId><ArticleId IdType=\"pubmed\">19735874</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Chen J., Zhao Y., Gu L., Shao X., Li J., Xu Y., Liu Z., Xu Q. Key candidate genes of STAT1 and CXCL10 in melanoma identified by integrated bioinformatical analysis. IUBMB Life. 2019;71:1634&#x2013;1644. doi: 10.1002/iub.2103.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/iub.2103</ArticleId><ArticleId IdType=\"pubmed\">31216116</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman M.A., Fernandez M., Backer L.C., Dickey R.W., Bernstein J., Schrank K., Kibler S., Wendy S., Gribble M.O., Bienfang P., et al. An Updated Review of Ciguatera Fish Poisoning: Clinical, Epidemiological, Environmental, and Public Health Management. Mar. Drugs. 2017;15:72. doi: 10.3390/md15030072.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/md15030072</ArticleId><ArticleId IdType=\"pmc\">PMC5367029</ArticleId><ArticleId IdType=\"pubmed\">28335428</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearn J.H. Chronic fatigue syndrome: Chronic ciguatera poisoning as a differential diagnosis. Med. J. Aust. 1997;166:309&#x2013;310. doi: 10.5694/j.1326-5377.1997.tb122320.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5694/j.1326-5377.1997.tb122320.x</ArticleId><ArticleId IdType=\"pubmed\">9087189</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombet A., Bidard J.N., Lazdunski M. Ciguatoxin and brevetoxins share a common receptor site on the neuronal voltage-dependent Na+ channel. FEBS Lett. 1987;219:355&#x2013;359. doi: 10.1016/0014-5793(87)80252-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0014-5793(87)80252-1</ArticleId><ArticleId IdType=\"pubmed\">2440718</ArticleId></ArticleIdList></Reference><Reference><Citation>Rook M.B., Evers M.M., Vos M.A., Bierhuizen M.F.A. Biology of cardiac sodium channel Nav1. 5 expression. Cardiovasc. Res. 2012;93:12&#x2013;23. doi: 10.1093/cvr/cvr252.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cvr/cvr252</ArticleId><ArticleId IdType=\"pubmed\">21937582</ArticleId></ArticleIdList></Reference><Reference><Citation>Hokama Y. (John A Burns School of Medicine, University of Hawaii, Honolulu, HI, USA). Personal communication. 2008.</Citation></Reference><Reference><Citation>Hokama Y., Uto G.A., Palafox N.A., Enlander D., Jordan E., Cocchetto A. Chronic phase lipids in sera of chronic fatigue syndrome (CFS), chronic ciguatera fish poisoning (CCFP), hepatitis B, and cancer with antigenic epitope resembling ciguatoxin, as assessed with Mab-CTX. J. Clin. Lab. Anal. 2003;17:132&#x2013;139. doi: 10.1002/jcla.10079.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jcla.10079</ArticleId><ArticleId IdType=\"pmc\">PMC6807878</ArticleId><ArticleId IdType=\"pubmed\">12784262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hokama Y., Empey-Campora C., Hara C., Higa N., Siu N., Lau R., Kuribayashi T., Yabusaki K. Acute phase phospholipids related to the cardiolipin of mitochondria in the sera of patients with chronic fatigue syndrome (CFS), chronic Ciguatera fish poisoning (CCFP), and other diseases attributed to chemicals, Gulf War, and marine toxins. J. Clin. Lab. Anal. 2008;22:99&#x2013;105. doi: 10.1002/jcla.20217.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jcla.20217</ArticleId><ArticleId IdType=\"pmc\">PMC6649096</ArticleId><ArticleId IdType=\"pubmed\">18348309</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G.K., Wang S.Y. Modifications of human cardiac sodium channel gating by UVA light. J. Membr. Biol. 2002;189:153&#x2013;165. doi: 10.1007/s00232-002-1010-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00232-002-1010-z</ArticleId><ArticleId IdType=\"pubmed\">12235490</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie A., Gallant B., Guo H., Gonzalez A., Clark M., Madigan A., Feng F., Chen H.D., Cui Y., Dudley S.C., Jr., et al. Functional cardiac Na + channels are expressed in human melanoma cells. Onco. Lett. 2018;16:1689&#x2013;1695. doi: 10.3892/ol.2018.8865.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/ol.2018.8865</ArticleId><ArticleId IdType=\"pmc\">PMC6036419</ArticleId><ArticleId IdType=\"pubmed\">30008854</ArticleId></ArticleIdList></Reference><Reference><Citation>Djamgoz M.B.A., Fraser S.P., Brackenbury W.J. In Vivo Evidence for Voltage-Gated Sodium Channel Expression in Carcinomas and Potentiation of Metastasis. Cancers. 2019;11:1675. doi: 10.3390/cancers11111675.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cancers11111675</ArticleId><ArticleId IdType=\"pmc\">PMC6895836</ArticleId><ArticleId IdType=\"pubmed\">31661908</ArticleId></ArticleIdList></Reference><Reference><Citation>Roelant C.H.S., DeMeirleir K.L. Methods and means for diagnosing and and/or treating a fatiguing illness. WO2019012159. World Patent. 2018 July 16;</Citation></Reference><Reference><Citation>Hou G., Xu B., Bi Y., Wu C., Ru B., Sun B., Bai X. Recent advances in research on aspartate &#x3b2;-hydroxylase (ASPH) in pancreatic cancer: A brief update. Bosn. J. Basic Med. Sci. 2018;18:297&#x2013;304. doi: 10.17305/bjbms.2018.3539.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.17305/bjbms.2018.3539</ArticleId><ArticleId IdType=\"pmc\">PMC6252103</ArticleId><ArticleId IdType=\"pubmed\">30179586</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W., Wang X., Hu J., Bai B., Zhu H. Diverse molecular functions of aspartate &#x3b2;-hydroxylase in cancer (Review) Oncol. Rep. 2020;44:2364&#x2013;2372. doi: 10.3892/or.2020.7792.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/or.2020.7792</ArticleId><ArticleId IdType=\"pmc\">PMC7610305</ArticleId><ArticleId IdType=\"pubmed\">33125119</ArticleId></ArticleIdList></Reference><Reference><Citation>Wands J.R., De La Monte S., Aihara A., Olsen M.J., Thomas J.M. Inhibitors of beta-hydroxylase for treatment of cancer. 20200361925. U.S. Patent Application. 2020 June 2;</Citation></Reference><Reference><Citation>Radrezza S., Carini M., Baron G., Aldini G., Negre-Salvayre A., D&#x2019;Amat A. Study of Carnosine&#x2019;s effect on nude mice skin to prevent UV-A damage. Free Radic. Biol. Med. 2021;173:97&#x2013;103. doi: 10.1016/j.freeradbiomed.2021.07.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.freeradbiomed.2021.07.010</ArticleId><ArticleId IdType=\"pubmed\">34242794</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller J.S., McCullar V., Punzel M., Lemischka I.R., Moore K.A. Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood. 1999;93:96&#x2013;106. doi: 10.1182/blood.V93.1.96.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood.V93.1.96</ArticleId><ArticleId IdType=\"pubmed\">9864151</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E.W., Hardcastle S.L., Atkinson G.M., van Driel M.L., Kreijkamp-Kaspers S., Ashton K.J., Staines D.R., Marshall-Gradisnik S.M. Natural killer cells in patients with severe chronic fatigue syndrome. Auto Immun. Highlights. 2013;4:69&#x2013;80. doi: 10.1007/s13317-013-0051-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13317-013-0051-x</ArticleId><ArticleId IdType=\"pmc\">PMC4389023</ArticleId><ArticleId IdType=\"pubmed\">26000145</ArticleId></ArticleIdList></Reference><Reference><Citation>Vokurkova D., Vavrova J., Sinkora J., Stoklasova A., Blaha V., Rezacova M. Radiosensitivity of CD3-CD8+CD56+ NK cells. Radiat. Meas. 2010;45:1020&#x2013;1023. doi: 10.1016/j.radmeas.2010.07.028.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.radmeas.2010.07.028</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E.W., Staines D.R., Baskurt O.K., Ashton K.J., Ramos S.B., Christy R.M., Marshall-Gradisnik S.M. Immune and hemorheological changes in chronic fatigue syndrome. J. Transl. Med. 2010;8:1. doi: 10.1186/1479-5876-8-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-8-1</ArticleId><ArticleId IdType=\"pmc\">PMC2829521</ArticleId><ArticleId IdType=\"pubmed\">20064266</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E.W., van Driel M.L., Staines D.R., Ashton K.J., Ramos S.B., Keane J., Klimas N.G., Marshall-Gradisnik S.M. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J. Transl. Med. 2011;9:81. doi: 10.1186/1479-5876-9-81.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-9-81</ArticleId><ArticleId IdType=\"pmc\">PMC3120691</ArticleId><ArticleId IdType=\"pubmed\">21619669</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E.W., van Driel M.L., Staines D.R., Ashton K.J., Hardcastle S.L., Keane J., Tajouri L., Peterson D., Ramos S.B., Marshall-Gradisnik S.M. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. J. Transl. Med. 2012;10:88. doi: 10.1186/1479-5876-10-88.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-10-88</ArticleId><ArticleId IdType=\"pmc\">PMC3464733</ArticleId><ArticleId IdType=\"pubmed\">22571715</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersey P., MacDonald M., Henderson C., Schibeci S., D&#x2019;Alessandro G., Pryor M., Wilkinson F.J. Suppression of natural killer cell activity in humans by radiation from solarium lamps depleted of UVB. J. Investig. Dermatol. 1988;90:305&#x2013;310. doi: 10.1111/1523-1747.ep12456090.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/1523-1747.ep12456090</ArticleId><ArticleId IdType=\"pubmed\">3258001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersey P., Magrath H., Wilkinson F. Development of an in vitro system for the analysis of ultraviolet radiation-induced suppression of natural killer cell activity. Photochem. Photobiol. 1993;57:279&#x2013;284. doi: 10.1111/j.1751-1097.1993.tb02287.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1751-1097.1993.tb02287.x</ArticleId><ArticleId IdType=\"pubmed\">8451290</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jonge K., Ebering A., Nassiri S., Maby-El Hajjami H., Ouertatani-Sakouhi H., Baumgaertner P., Speiser D.E. Circulating CD56 bright NK cells inversely correlate with survival of melanoma patients. Sci. Rep. 2019;9:4487. doi: 10.1038/s41598-019-40933-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-40933-8</ArticleId><ArticleId IdType=\"pmc\">PMC6418246</ArticleId><ArticleId IdType=\"pubmed\">30872676</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson L.O. The role of nondiscocytic erythrocytes in the pathogenesis of myalgic encephalomyelitis/chronic fatigue syndrome. In: Hyde B.M., editor. The Clinical and Scientific Basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Volume 65. The Nightingale Research Foundation; Street Ottawa, ON, Canada: 1992. pp. 597&#x2013;605.</Citation></Reference><Reference><Citation>Richards R.S., Wang L., Jelinek H. Erythrocyte oxidative damage in chronic fatigue syndrome. Arch Med. Res. 2007;38:94&#x2013;98. doi: 10.1016/j.arcmed.2006.06.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arcmed.2006.06.008</ArticleId><ArticleId IdType=\"pubmed\">17174731</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha A.K., Schmidt B.R., Wilhelmy J., Nguyen V., Abugherir A., Do J.K., Nemat-Gorgani M., Davis R.W., Ramasubramanian A.K. Red blood cell deformability is diminished in patients with Chronic Fatigue Syndrome. Clin. Hemorheol. Microcirc. 2019;71:113&#x2013;116. doi: 10.3233/CH-180469.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/CH-180469</ArticleId><ArticleId IdType=\"pmc\">PMC6398549</ArticleId><ArticleId IdType=\"pubmed\">30594919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlova E., Chernysh A., Sergunova V., Gudkova O., Manchenko E., Kozlov A. Atomic force microscopy study of red blood cell membrane nanostructure during oxidation-reduction processes. J. Mol. Recognit. 2018;31:e2724. doi: 10.1002/jmr.2724.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmr.2724</ArticleId><ArticleId IdType=\"pubmed\">29740886</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen C.B., Als&#xf8;e L., Lindvall J.M., Sulheim D., Fagermoen E., Winger A., Kaarb&#xf8; M., Nilsen H., Wyller V.B. Whole blood gene expression in adolescent chronic fatigue syndrome: An exploratory cross-sectional study suggesting altered B cell differentiation and survival. J. Transl. Med. 2017;15:102. doi: 10.1186/s12967-017-1201-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-017-1201-0</ArticleId><ArticleId IdType=\"pmc\">PMC5426002</ArticleId><ArticleId IdType=\"pubmed\">28494812</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato W., Ono H., Matsutani T., Nakamura M., Shin I., Amano K., Suzuki R., Yamamura T. Skewing of the B cell receptor repertoire in myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav. Immun. 2021;95:245&#x2013;255. doi: 10.1016/j.bbi.2021.03.023.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2021.03.023</ArticleId><ArticleId IdType=\"pubmed\">33794313</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa S., Borgogna C., Mondini M., De Andrea M., Meroni P.L., Berti E., Gariglio M., Landolfo S. Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing. Br. J. Dermatol. 2011;164:282&#x2013;290. doi: 10.1111/j.1365-2133.2010.10097.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2133.2010.10097.x</ArticleId><ArticleId IdType=\"pubmed\">20973769</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Xie X., Zhu J., Qi S., Xie J. Comprehensive analysis identifies IFI16 as a novel signature associated with overall survival and immune infiltration of skin cutaneous melanoma. Cancer Cell Int. 2021;21:694. doi: 10.1186/s12935-021-02409-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12935-021-02409-6</ArticleId><ArticleId IdType=\"pmc\">PMC8690488</ArticleId><ArticleId IdType=\"pubmed\">34930258</ArticleId></ArticleIdList></Reference><Reference><Citation>Dibble J.J., McGrath S.J., Ponting C.P. Genetic risk factors of ME/CFS: A critical review. Hum. Mol. Genet. 2020;29:R117&#x2013;R124. doi: 10.1093/hmg/ddaa169.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddaa169</ArticleId><ArticleId IdType=\"pmc\">PMC7530519</ArticleId><ArticleId IdType=\"pubmed\">32744306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji S.M. Overexpression of SLC25A15 is involved in the proliferation of cutaneous melanoma and leads to poor prognosis. Med. Sci. (Paris) 2018;34:74&#x2013;80. doi: 10.1051/medsci/201834f113.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1051/medsci/201834f113</ArticleId><ArticleId IdType=\"pubmed\">30403179</ArticleId></ArticleIdList></Reference><Reference><Citation>Boix E., Carreras E., Nikolovski Z., Cuchillo C.M., Nogues M.V. Identification and characterization of human eosinophil cationic protein by an epitope-specific antibody. J. Leukoc. Biol. 2001;69:1027&#x2013;1035. doi: 10.1189/jlb.69.6.1027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1189/jlb.69.6.1027</ArticleId><ArticleId IdType=\"pubmed\">11404391</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti F., Magrini L., Priori R., Valesini G., Bonini S. Eosinophil cationic protein serum levels and allergy in chronic fatigue syndrome. Allergy. 1996;51:124&#x2013;127. doi: 10.1111/j.1398-9995.1996.tb00047.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1398-9995.1996.tb00047.x</ArticleId><ArticleId IdType=\"pubmed\">8738520</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorensen B., Streib J.E., Strand M., Make B., Giclas P.C., Fleshner M., Jones J.F. Complement activation in a model of chronic fatigue syndrome. J. Allergy Clin. Immunol. 2003;112:397&#x2013;403. doi: 10.1067/mai.2003.1615.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1067/mai.2003.1615</ArticleId><ArticleId IdType=\"pubmed\">12897748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruckel A., Moreira A., Frohlich W., Schuler G., Heinzerling L. Eosinophil-cationic protein&#x2014;A novel liquid prognostic biomarker in melanoma. BMC Cancer. 2019;19:207. doi: 10.1186/s12885-019-5384-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12885-019-5384-z</ArticleId><ArticleId IdType=\"pmc\">PMC6407264</ArticleId><ArticleId IdType=\"pubmed\">30845981</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C., Lin J.C., Sheriff S., Maudsley A.A., Younger J.W. Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: Assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging Behav. 2020;14:562&#x2013;572. doi: 10.1007/s11682-018-0029-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11682-018-0029-4</ArticleId><ArticleId IdType=\"pmc\">PMC6612467</ArticleId><ArticleId IdType=\"pubmed\">30617782</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanculescu D., Sepulveda N., Lim C.L., Bergquist J. Lessons From Heat Stroke for Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front. Neurol. 2021;12:789784. doi: 10.3389/fneur.2021.789784.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2021.789784</ArticleId><ArticleId IdType=\"pmc\">PMC8710546</ArticleId><ArticleId IdType=\"pubmed\">34966354</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasso E.M., Muraki K., Eaton-Fitch N., Smith P., Lesslar O.L., Deed G., Marshall-Gradisnik S. Transient Receptor Potential Melastatin 3 Dysfunction in Post COVID-19 Condition and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Mol. Med. 2022;28:98. doi: 10.1186/s10020-022-00528-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s10020-022-00528-y</ArticleId><ArticleId IdType=\"pmc\">PMC9388968</ArticleId><ArticleId IdType=\"pubmed\">35986236</ArticleId></ArticleIdList></Reference><Reference><Citation>Vriens J., Owsianik G., Hofmann T., Philipp S.E., Stab J., Chen X., Benoit M., Xue F., Janssens A., Kerselaers S., et al. TRPM3 is a Nociceptor Channel Involved in the Detection of Noxious Heat. Neuron. 2011;70:482&#x2013;494. doi: 10.1016/j.neuron.2011.02.051.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2011.02.051</ArticleId><ArticleId IdType=\"pubmed\">21555074</ArticleId></ArticleIdList></Reference><Reference><Citation>Caterina M.J. Transient Receptor Potential Ion Channels as Participants in Thermosensation and Thermoregulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007;292:R64&#x2013;R76. doi: 10.1152/ajpregu.00446.2006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpregu.00446.2006</ArticleId><ArticleId IdType=\"pubmed\">16973931</ArticleId></ArticleIdList></Reference><Reference><Citation>Okabe T., Fujimura T., Okajima J., Kambayashi Y., Aiba S., Maruyama S. First-in-human clinical study of novel technique to diagnose malignant melanoma via thermal conductivity measurements. Sci. Rep. 2019;9:3853. doi: 10.1038/s41598-019-40444-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-40444-6</ArticleId><ArticleId IdType=\"pmc\">PMC6405870</ArticleId><ArticleId IdType=\"pubmed\">30846837</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrotek S., Brycht L., Wrotek W., Kozak W. Fever as a factor contributing to long-term survival in a patient with metastatic melanoma: A case report. Complement. Ther. Med. 2018;38:7&#x2013;10. doi: 10.1016/j.ctim.2018.03.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ctim.2018.03.009</ArticleId><ArticleId IdType=\"pubmed\">29857883</ArticleId></ArticleIdList></Reference><Reference><Citation>Le M., Fernandez-Palomo C., McNeill F.E., Seymour C.B., Rainbow A.J., Mothersill C.E. Exosomes are released by bystander cells exposed to radiation-induced biophoton signals: Reconciling the mechanisms mediating the bystander effect. PLoS ONE. 2017;12:e0173685. doi: 10.1371/journal.pone.0173685.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0173685</ArticleId><ArticleId IdType=\"pmc\">PMC5344502</ArticleId><ArticleId IdType=\"pubmed\">28278290</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauensteiner J., Bertinat R., Leon L.E., Riederer M., Sepulveda N., Westermeier F. Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients. Sci. Rep. 2021;11:10604. doi: 10.1038/s41598-021-89834-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-021-89834-9</ArticleId><ArticleId IdType=\"pmc\">PMC8134566</ArticleId><ArticleId IdType=\"pubmed\">34011981</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E.W., Ashton K.J., van Driel M., Staines D.R., Peterson D., Atkinson G.M., Marshall-Gradisnik S.M. Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J. Affect Discord. 2012;141:261&#x2013;269. doi: 10.1016/j.jad.2012.03.037.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jad.2012.03.037</ArticleId><ArticleId IdType=\"pubmed\">22572093</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Ding N., Pei H., Hu W., Wei W., Zhang X., Zhou G., Wang J. MiR-21 is involved in radiation-induced bystander effects. RNA Biol. 2014;11:1161&#x2013;1170. doi: 10.4161/rna.34380.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4161/rna.34380</ArticleId><ArticleId IdType=\"pmc\">PMC4615763</ArticleId><ArticleId IdType=\"pubmed\">25483031</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Wang J., Ding N., Hu W., Zhang X., Wang B., Hua J., Wei W., Zhu Q. Exosome-mediated microRNA transfer plays a role in radiation-induced bystander effect. RNA Biol. 2015;12:1355&#x2013;1363. doi: 10.1080/15476286.2015.1100795.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/15476286.2015.1100795</ArticleId><ArticleId IdType=\"pmc\">PMC4829325</ArticleId><ArticleId IdType=\"pubmed\">26488306</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnik B.C., John S.M., Carrera-Bastos P., Schmitz G. MicroRNA-21-Enriched Exosomes as Epigenetic Regulators in Melanomagenesis and Melanoma Progression: The Impact of Western Lifestyle Factors. Cancers. 2020;12:2111. doi: 10.3390/cancers12082111.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cancers12082111</ArticleId><ArticleId IdType=\"pmc\">PMC7464294</ArticleId><ArticleId IdType=\"pubmed\">32751207</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J.Y., Luo J., O&#x2019;Connor C., Jing X., Nair V., Ju W., Randolph A., Ben-Dov I.Z., Matar R.N., Briskin D., et al. MicroRNA-21 in glomerular injury. J. Am. Soc. 2015;26:805&#x2013;816. doi: 10.1681/ASN.2013121274.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1681/ASN.2013121274</ArticleId><ArticleId IdType=\"pmc\">PMC4378097</ArticleId><ArticleId IdType=\"pubmed\">25145934</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., He S., Yang F., Yu H., Xie W., Dai Q., Zhang D., Liu X., Zhou S., Zhang K. Hyperoside ameliorates glomerulosclerosis in diabetic nephropathy by downregulating miR-21. Can. J. Physiol. Pharmacol. 2016;94:1249&#x2013;1256. doi: 10.1139/cjpp-2016-0066.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1139/cjpp-2016-0066</ArticleId><ArticleId IdType=\"pubmed\">27704873</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyde B.M., Goldstein J.A., Levine P.H. The Nightingale Research Foundation Review of the Clinical and Scientific Basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Nightingale Research Foundation; Ottawa, ON, Canada: 1992.</Citation></Reference><Reference><Citation>Englebienne P., DeMeirleir K. Chronic Fatigue Syndrome: A Biological Approach. CRC Press; Boca Raton, FL, USA: 2002.</Citation></Reference><Reference><Citation>Journal of Chronic Fatigue Syndrome. 1995:1(1)&#x2013;2007:14(4). Taylor &amp; Francis Publ.  [(accessed on 17 March 2023)].  Available online:  https://www.tandfonline.com/journals/icfs20.</Citation></Reference><Reference><Citation>Fitzpatrick T.B. Color Atlas and Synopsis of Clinical Dermatology: Common and Serious Diseases. McGraw-Hill; New York, NY, USA: 2001.</Citation></Reference><Reference><Citation>National Research Council, Committee on the Biological Effects of Ionizing Radiation . Health Effects of Exposure to Low Levels of Ionizing Radiation (BEIR V) National Academy Press; Washington, DC, USA: 1990.</Citation></Reference><Reference><Citation>Fink C.A., Bates M.N. Melanoma and ionizing radiation: Is there a causal relationship? Radiat. Res. 2005;164:701&#x2013;710. doi: 10.1667/RR3447.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RR3447.1</ArticleId><ArticleId IdType=\"pubmed\">16238450</ArticleId></ArticleIdList></Reference><Reference><Citation>Telle-Lamberton M., Samson E., Ca&#xeb;r S., Bergot D., Bard D., Bermann F., G&#xe9;las J.M., Giraud J.M., Hubert P., Metz-Flamant C., et al. External radiation exposure and mortality in a cohort of French nuclear workers. Occup. Environ. Med. 2007;64:694&#x2013;700. doi: 10.1136/oem.2007.032631.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/oem.2007.032631</ArticleId><ArticleId IdType=\"pmc\">PMC2078398</ArticleId><ArticleId IdType=\"pubmed\">17522135</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajeevan M.S., Murray J., Oakley L., Lin J.S., Unger E.R. Association of chronic fatigue syndrome with premature telomere attrition. J. Transl. Med. 2018;16:44. doi: 10.1186/s12967-018-1414-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-018-1414-x</ArticleId><ArticleId IdType=\"pmc\">PMC5830066</ArticleId><ArticleId IdType=\"pubmed\">29486769</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochette P.J., Brash D.E. Human telomeres are hypersensitive to UV-induced DNA Damage and refractory to repair. PLoS Genet. 2010;6:e1000926. doi: 10.1371/journal.pgen.1000926.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pgen.1000926</ArticleId><ArticleId IdType=\"pmc\">PMC2861706</ArticleId><ArticleId IdType=\"pubmed\">20442874</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikawa S., Tada-Oikawa S., Kawanishi S. Site-specific DNA damage at the GGG sequence by UVA involves acceleration of telomere shortening. Biochemistry. 2001;40:4763&#x2013;4768. doi: 10.1021/bi002721g.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/bi002721g</ArticleId><ArticleId IdType=\"pubmed\">11294644</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikawa S., Kawanishi S. Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett. 1999;453:365&#x2013;368. doi: 10.1016/S0014-5793(99)00748-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0014-5793(99)00748-6</ArticleId><ArticleId IdType=\"pubmed\">10405177</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim G., Ricoul M., Hempel W.M., Azzam E.I., Sabatier L. Crosstalk between telomere maintenance and radiation effects: A key player in the process of radiation-induced carcinogenesis. Mutat. Res. Rev. Mutat. Res. 2014;760:1&#x2013;17. doi: 10.1016/j.mrrev.2014.01.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mrrev.2014.01.001</ArticleId><ArticleId IdType=\"pmc\">PMC4119099</ArticleId><ArticleId IdType=\"pubmed\">24486376</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel P., Tsapekos M., de Pedro N., Liu A.G., Lippmeier J.C., Chen S. Ergothioneine mitigates telomere shortening under oxidative stress conditions. J. Diet. Suppl. 2020;19:212&#x2013;225. doi: 10.1080/19390211.2020.1854919.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/19390211.2020.1854919</ArticleId><ArticleId IdType=\"pubmed\">33287595</ArticleId></ArticleIdList></Reference><Reference><Citation>Marozik P., Mothersill C., Seymour C.B., Mosse I., Melnov S. Bystander effects induced by serum from survivors of the Chernobyl accident. Exp. Hematol. 2007;35:55&#x2013;63. doi: 10.1016/j.exphem.2007.01.029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.exphem.2007.01.029</ArticleId><ArticleId IdType=\"pubmed\">17379088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosse I., Marozik P., Seymour C., Mothersill C. The effect of melanin on the bystander effect in human keratinocytes. Mutat. Res. 2006;597:133&#x2013;137. doi: 10.1016/j.mrfmmm.2005.09.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mrfmmm.2005.09.006</ArticleId><ArticleId IdType=\"pubmed\">16412479</ArticleId></ArticleIdList></Reference><Reference><Citation>Lad J., Rusin A., Seymour C., Mothersill C. An investigation into neutron-induced bystander effects: How low can you go? Environ. Res. 2019;175:84&#x2013;99. doi: 10.1016/j.envres.2019.04.033.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.envres.2019.04.033</ArticleId><ArticleId IdType=\"pubmed\">31108356</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusin A., Li M., Cocchetto A., Seymour C., Mothersill C. Radiation exposure and mitochondrial insufficiency in chronic fatigue and immune dysfunction syndrome. Med. Hypotheses. 2021;154:110647. doi: 10.1016/j.mehy.2021.110647.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mehy.2021.110647</ArticleId><ArticleId IdType=\"pubmed\">34358921</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusin A., Seymour C., Cocchetto A., Mothersill C. Commonalities in the Features of Cancer and Chronic Fatigue Syndrome (CFS): Evidence for Stress-Induced Phenotype Instability? Int. J. Mol. Sci. 2022;23:691. doi: 10.3390/ijms23020691.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23020691</ArticleId><ArticleId IdType=\"pmc\">PMC8775947</ArticleId><ArticleId IdType=\"pubmed\">35054876</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">37046554</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Print\">2075-4418</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>13</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>03</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Physical Activity Effects on Muscle Fatigue in Sport in Active Adults with Long COVID-19: An Observational Study.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">1336</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/diagnostics13071336</ELocationID><Abstract><AbstractText>Long COVID-19-related changes in physiology includes alterations in performing muscle work as fatigue. Data available do not allow us to define the usefulness of physical activity to attenuate long COVID-19 functional modifications. The present observational study investigates the effects of physical activity on the perception of fatigue, maximum power output, sleep, and cognitive modifications in subjects affected by long COVID-19, distinguishing between active and sedentary subjects. The data demonstrated the following: the perception of fatigue 1 year after the end of virus positivity was significantly reduced with respect to that observed after 6 months by more than 50% more in active subjects compared to sedentary ones; 6 months after the end of virus positivity, the force developed by active subjects was reduced (RM factor: <i>p</i> &lt; 0.001, &#x3b7;2p = 0.527, post hoc: <i>p</i> &lt; 0.001), but the reduction was more pronounced in sedentary ones (mean difference = 38.499 W); poor sleep quality and mild cognitive impairment were assessed in both active and sedentary subjects. In conclusion, the study suggests that the long COVID-19 fatigue was lower in active subjects respect to sedentary ones. A comparative analysis performed due to the overlap of functional alterations between long COVID-19 and ME/CFS showed that in a small percentage of the enrolled subjects (8%), the symptomatology reflected that of ME/CFS and was independent of the individual physical capacities.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Coscia</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Sports Medicine Service of the San Candido, Innichen and Brunico-Bruneck Hospitals, Bolzano-Bozen, 39038 San Candido, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mancinelli</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neuroscience Imaging and Clinical Sciences, University \"G. d\\'Annunzio\" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IIM-Interuniversity Institute of Myology, University \"G. d\\'Annunzio\" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gigliotti</LastName><ForeName>Paola Virginia</ForeName><Initials>PV</Initials><AffiliationInfo><Affiliation>Laboratory of Sport Physiology San Candido-Innichen, University of Perugia, 39038 San Candido, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Checcaglini</LastName><ForeName>Franco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Campus of Free University of Alcatraz, Free University of Alcatraz, Santa Cristina di Gubbio, 06024 Gubbio, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fan&#xf2;-Illic</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><Identifier Source=\"ORCID\">0000-0002-8753-5707</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience Imaging and Clinical Sciences, University \"G. d\\'Annunzio\" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IIM-Interuniversity Institute of Myology, University \"G. d\\'Annunzio\" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Campus of Free University of Alcatraz, Free University of Alcatraz, Santa Cristina di Gubbio, 06024 Gubbio, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>A&amp;C M-C Foundation for Translational Myology, 35100 Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">(EM/CFS)</Keyword><Keyword MajorTopicYN=\"N\">long COVID-19 syndrome</Keyword><Keyword MajorTopicYN=\"N\">mild cognitive impairment</Keyword><Keyword MajorTopicYN=\"N\">muscle fatigue</Keyword><Keyword MajorTopicYN=\"N\">myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">physical exercise</Keyword><Keyword MajorTopicYN=\"N\">sleep quality</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">37046554</ArticleId><ArticleId IdType=\"pmc\">PMC10093327</ArticleId><ArticleId IdType=\"doi\">10.3390/diagnostics13071336</ArticleId><ArticleId IdType=\"pii\">diagnostics13071336</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients with COVID-19: A Systematic Review. JAMA Netw. Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType=\"pmc\">PMC8155823</ArticleId><ArticleId IdType=\"pubmed\">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez A., Abrigo J., Achiardi O., Simon F., Cabello-Verrugio C. Intensive Care Unit-Acquired Weakness: A Review from Molecular Mechanisms to Its Impact in COVID-2019. Eur. J. Transl. Myol. 2022;32:10511. doi: 10.4081/ejtm.2022.10511.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4081/ejtm.2022.10511</ArticleId><ArticleId IdType=\"pmc\">PMC9580540</ArticleId><ArticleId IdType=\"pubmed\">36036350</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco A.L., Pacheco R.L., Bagattini &#xc2;.M., Riera R. Frequency, Signs and Symptoms, and Criteria Adopted for Long COVID-19: A Systematic Review. Int. J. Clin. Pract. 2021;75:e14357. doi: 10.1111/ijcp.14357.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/ijcp.14357</ArticleId><ArticleId IdType=\"pmc\">PMC8236920</ArticleId><ArticleId IdType=\"pubmed\">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Vi&#xf1;as L., Vega-Villar J., Roc&#xed;o-Mart&#xed;n E., Garc&#xed;a-Garc&#xed;a P., De La Rosa Santiago E., Galv&#xe1;n-Rom&#xe1;n J.M., Wix-Ramos R. Diaphragm Impairment in Patients Admitted for Severe COVID-19. Eur. J. Transl. Myol. 2022;32:10460. doi: 10.4081/ejtm.2022.10460.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4081/ejtm.2022.10460</ArticleId><ArticleId IdType=\"pmc\">PMC9295177</ArticleId><ArticleId IdType=\"pubmed\">35727218</ArticleId></ArticleIdList></Reference><Reference><Citation>Azizmohammadi S., Azizmohammadi S., Dahmardeh S., Azargashb H., Shokouh S.J.H., Mohajeri-Iravani M., Mobasher M., Soleiman-Meigooni S., Zabihi M. Analysis of 239 Ordinary and Severe Cases of COVID-19: Clinical Features and Treatment. Eur. J. Transl. Myol. 2021;31:9579. doi: 10.4081/ejtm.2021.9579.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4081/ejtm.2021.9579</ArticleId><ArticleId IdType=\"pmc\">PMC8495366</ArticleId><ArticleId IdType=\"pubmed\">34579515</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouhpayeh H. Clinical Features Predicting COVID-19 Mortality Risk. Eur. J. Transl. Myol. 2022;32:10268. doi: 10.4081/ejtm.2022.10268.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4081/ejtm.2022.10268</ArticleId><ArticleId IdType=\"pmc\">PMC9295175</ArticleId><ArticleId IdType=\"pubmed\">35421918</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-Acute COVID-19 Syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType=\"pmc\">PMC8893149</ArticleId><ArticleId IdType=\"pubmed\">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., Huggins C.F., Kwong A.S.F., Silverwood R.J., Di Gessa G., et al. Long COVID Burden and Risk Factors in 10 UK Longitudinal Studies and Electronic Health Records. Nat. Commun. 2022;13:3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType=\"pmc\">PMC9240035</ArticleId><ArticleId IdType=\"pubmed\">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. For the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2020.12603</ArticleId><ArticleId IdType=\"pmc\">PMC7349096</ArticleId><ArticleId IdType=\"pubmed\">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi M.S., Omrani O.A., Fawzy N.A., Shaar B.A., Almamlouk R., Riaz M., Obeidat M., Obeidat Y., Gerberi D., Taha R.M., et al. Prevalence of Post-Acute COVID-19 Syndrome Symptoms at Different Follow-up Periods: A Systematic Review and Meta-Analysis. Clin. Microbiol. Infect. 2022;28:657&#x2013;666. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType=\"pmc\">PMC8812092</ArticleId><ArticleId IdType=\"pubmed\">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)&#x2014;A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57050418</ArticleId><ArticleId IdType=\"pmc\">PMC8145228</ArticleId><ArticleId IdType=\"pubmed\">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R., Banerjee A., Baker M.R., Dani M., Ford E., Hull J.H., Lim P.B., McNarry M., Morten K., O&#x2019;Sullivan O., et al. Long COVID: Mechanisms, Risk Factors and Recovery. Exp. Physiol. 2023;108:12&#x2013;27. doi: 10.1113/EP090802.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1113/EP090802</ArticleId><ArticleId IdType=\"pmc\">PMC10103775</ArticleId><ArticleId IdType=\"pubmed\">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C. Pathophysiology of Skeletal Muscle Disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) J. Transl. Med. 2021;19:162. doi: 10.1186/s12967-021-02833-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-021-02833-2</ArticleId><ArticleId IdType=\"pmc\">PMC8058748</ArticleId><ArticleId IdType=\"pubmed\">33882940</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrangelo T., Fulle S., Coscia F., Gigliotti P.V., Fan&#xf2;-Illic G. Old Muscle in Young Body: An Aphorism Describing the Chronic Fatigue Syndrome. Eur. J. Transl. Myol. 2018;28:7688. doi: 10.4081/ejtm.2018.7688.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4081/ejtm.2018.7688</ArticleId><ArticleId IdType=\"pmc\">PMC6176399</ArticleId><ArticleId IdType=\"pubmed\">30344981</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press; Washington, DC, USA: 2015.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghali A., Lacout C., Ghali M., Gury A., Delattre E., Lavigne C., Urbanski G. Warning Signals of Post-Exertional Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Retrospective Analysis of 197 Patients. J. Clin. Med. 2021;10:2517. doi: 10.3390/jcm10112517.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm10112517</ArticleId><ArticleId IdType=\"pmc\">PMC8201170</ArticleId><ArticleId IdType=\"pubmed\">34200126</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotler J., Holtzman C., Dudun C., Jason L. A Brief Questionnaire to Assess Post-Exertional Malaise. Diagnostics. 2018;8:66. doi: 10.3390/diagnostics8030066.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics8030066</ArticleId><ArticleId IdType=\"pmc\">PMC6165517</ArticleId><ArticleId IdType=\"pubmed\">30208578</ArticleId></ArticleIdList></Reference><Reference><Citation>Geraghty K., Hann M., Kurtev S. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients&#x2019; Reports of Symptom Changes Following Cognitive Behavioural Therapy, Graded Exercise Therapy and Pacing Treatments: Analysis of a Primary Survey Compared with Secondary Surveys. J. Health Psychol. 2019;24:1318&#x2013;1333. doi: 10.1177/1359105317726152.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1359105317726152</ArticleId><ArticleId IdType=\"pubmed\">28847166</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., Jain A.K., De Meirleir K.L., Peterson D.L., Klimas N.G., Lerner A.M., Bested A.C., Flor-Henry P., Joshi P., Powles A.C.P., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols. J. Chronic Fatigue Syndr. 2003;11:7&#x2013;115. doi: 10.1300/J092v11n01_02.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J., Astill S., Sivan M. The Relationship between Physical Activity and Long COVID: A Cross-Sectional Study. Int. J. Environ. Res. Public. Health. 2022;19:5093. doi: 10.3390/ijerph19095093.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijerph19095093</ArticleId><ArticleId IdType=\"pmc\">PMC9105041</ArticleId><ArticleId IdType=\"pubmed\">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Micklewright D., St Clair Gibson A., Gladwell V., Al Salman A. Development and Validity of the Rating-of-Fatigue Scale. Sports Med. 2017;47:2375&#x2013;2393. doi: 10.1007/s40279-017-0711-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40279-017-0711-5</ArticleId><ArticleId IdType=\"pmc\">PMC5633636</ArticleId><ArticleId IdType=\"pubmed\">28283993</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers J., Prakash M., Froelicher V., Do D., Partington S., Atwood J.E. Exercise Capacity and Mortality among Men Referred for Exercise Testing. N. Engl. J. Med. 2002;346:793&#x2013;801. doi: 10.1056/NEJMoa011858.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa011858</ArticleId><ArticleId IdType=\"pubmed\">11893790</ArticleId></ArticleIdList></Reference><Refe/ArticleTitle><Pagination><StartPage>8</StartPage><MedlinePgn>8</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">8</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1186/s13030-022-00260-3</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Some patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complain of persistent fatigue, dyspnea, pain, and cognitive dysfunction. These symptoms are often described as \"long COVID\". Whether a patient with long COVID might develop myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is of interest, as is the treatment and management of ME/CFS in a post-COVID patient. Here I report a patient, who, after an infection with SARS-CoV-2, developed ME/CFS and recovered after treatment.</AbstractText><AbstractText Label=\"CASE PRESENTATION\" NlmCategory=\"METHODS\">The patient was a previously healthy 55-year-old woman who worked as a nurse and became ill with COVID-19 pneumonia. She then presented with severe fatigue, post-exertional malaise, dyspnea, pain, cognitive dysfunction, tachycardia, and exacerbation of fatigue on physical exertion, which persisted for more than 6&#xa0;months after her recovery from COVID-19 pneumonia. She was bedridden for more than half of each day. The patient was treated from multiple perspectives, which included (1) instructions on eating habits and supplements; (2) cognitive and behavioral modifications for coping with physical, emotional, and cognitive fatigue; (3) instructions on conditioning exercises to improve deconditioning due to fatigue and dyspnea; and (4) pharmacotherapy with amitriptyline and hochuekkito, a Japanese herbal (Kampo) medicine. The patient made a complete recovery after completing the prescribed regimen and was able to return to work as a nurse.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">To the best of my knowledge, this is the first detailed report on a patient infected with SARS-CoV-2 followed by long COVID with the signs/symptoms of ME/CFS who recovered after treatment. I hope this case report will be helpful to health care practitioners by its presentation of some of the therapeutic options for alleviating disabling signs/symptoms in patients with post-COVID ME/CFS.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Oka</LastName><ForeName>Takakazu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychosomatic Medicine, International University of Health and Welfare Narita Hospital, 852 Hatakeda, Narita, Chiba, 286-8520, Japan. okatakakazu@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biopsychosoc Med</MedlineTA><NlmUniqueID>101286572</NlmUniqueID><ISSNLinking>1751-0759</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">COVID-19</Keyword><Keyword MajorTopicYN=\"N\">Chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">Long COVID</Keyword><Keyword MajorTopicYN=\"N\">Myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN=\"N\">Post-COVID ME/CFS</Keyword><Keyword MajorTopicYN=\"N\">Post-viral fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The author declares that he has no competing interests in relation to this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2022</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">36855180</ArticleId><ArticleId IdType=\"pmc\">PMC9971667</ArticleId><ArticleId IdType=\"doi\">10.1186/s13030-022-00260-3</ArticleId><ArticleId IdType=\"pii\">10.1186/s13030-022-00260-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carfi A, Bernabei R, Landi F. Gemelli Against C-P-ACSG: persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2020.12603</ArticleId><ArticleId IdType=\"pmc\">PMC7349096</ArticleId><ArticleId IdType=\"pubmed\">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType=\"pmc\">PMC7445491</ArticleId><ArticleId IdType=\"pubmed\">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, Haroon S, Price G, Davies EH, Nirantharakumar K, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/01410768211032850</ArticleId><ArticleId IdType=\"pmc\">PMC8450986</ArticleId><ArticleId IdType=\"pubmed\">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.n1648</ArticleId><ArticleId IdType=\"pubmed\">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study international chronic fatigue syndrome study group. Ann Intern Med. 1994;121(12):953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType=\"pubmed\">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, Bested AC, Flor-Henry P, Joshi P, Powles P, Sherkey JA, van de Sande MI. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Chron Fatigue Synd. 2003;11(1):7-115. 10.1300/J092v11n01_02.</Citation></Reference><Reference><Citation>Lam MH, Wing YK, Yu MW, Leung CM, Ma RC, Kong AP, So WY, Fong SY, Lam SP. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType=\"pubmed\">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType=\"pmc\">PMC3071317</ArticleId><ArticleId IdType=\"pubmed\">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther Adv Infect Dis. 2021;8:20499361211009385.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8060761</ArticleId><ArticleId IdType=\"pubmed\">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI. Myalgic encephalomyelitis/chronic fatigue syndrome: a clinical case definition and guidelines for medical practitioners - An Overview of the Canadian Consensus Document 2005. (ISBN: 0-9739335-0-X). http://www.investinme.org/Documents/PDFdocuments/Canadian_ME_Overview_A4.pdf. Accessed 10 July 2022.</Citation></Reference><Reference><Citation>Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y. Validation study of the Japanese version of the brief fatigue inventory. J Pain Symptom Manage. 2003;25(2):106&#x2013;117. doi: 10.1016/S0885-3924(02)00596-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0885-3924(02)00596-1</ArticleId><ArticleId IdType=\"pubmed\">12590026</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnett JA, Labovitz SS. Effect of physical layout in performance of the Trail Making Test. Psychol Assess. 1995;7(2):220&#x2013;221. doi: 10.1037/1040-3590.7.2.220.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1037/1040-3590.7.2.220</ArticleId></ArticleIdList></Reference><Reference><Citation>Japan Society for Higher Brain Dysfunction. BFTC: TMT-J. Tokyo (Japan): Shinkoh-Igaku Shuppansha; 2019.</Citation></Reference><Reference><Citation>Oka T, Kanemitsu Y, Sudo N, Hayashi H, Oka K. Psychological stress contributed to the development of low-grade fever in a patient with chronic fatigue syndrome: a case report. Biopsychosoc Med. 2013;7(1):7. doi: 10.1186/1751-0759-7-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1751-0759-7-7</ArticleId><ArticleId IdType=\"pmc\">PMC3599992</ArticleId><ArticleId IdType=\"pubmed\">23497734</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka T. Efficacy and limitations of autogenic training as a treatment of chronic fatigue syndrome. Jpn J Autogenic Ther. 2015;35(1):12&#x2013;19.</Citation></Reference><Reference><Citation>Oka T. Usefulness of a &#x201c;fever-fatigue diary&#x201d; and &#x201c;energy savings passbook&#x201d; in treating patients with ME/CFS. J Fatigue Sci. 2019;14(2):16&#x2013;22.</Citation></Reference><Reference><Citation>Vollbracht C, Kraft K. Feasibility of vitamin C in the treatment of post viral fatigue with focus on long COVID, based on a systematic review of IV vitamin C on fatigue. Nutrients. 2021;13(4):1154. doi: 10.3390/nu13041154.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu13041154</ArticleId><ArticleId IdType=\"pmc\">PMC8066596</ArticleId><ArticleId IdType=\"pubmed\">33807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda S, Nojima J, Motoki Y, Yamaguti K, Nakatomi Y, Okawa N, Fujiwara K, Watanabe Y, Kuratsune H. A potential biomarker for fatigue: oxidative stress and anti-oxidative activity. Biol Psychol. 2016;118:88&#x2013;93. doi: 10.1016/j.biopsycho.2016.05.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopsycho.2016.05.005</ArticleId><ArticleId IdType=\"pubmed\">27224647</ArticleId></ArticleIdList></Reference><Reference><Citation>Varesi A, Deumer US, Ananth S, Ricevuti G. The emerging role of gut microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): current evidence and potential therapeutic applications. J Clin Med. 2021;10(21):5077. doi: 10.3390/jcm10215077.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm10215077</ArticleId><ArticleId IdType=\"pmc\">PMC8584653</ArticleId><ArticleId IdType=\"pubmed\">34768601</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka T. Shitsu-taikan-sho (alexisomia): a historical review and its clinical importance. Biopsychosoc Med. 2020;14:23. doi: 10.1186/s13030-020-00193-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13030-020-00193-9</ArticleId><ArticleId IdType=\"pmc\">PMC7520027</ArticleId><ArticleId IdType=\"pubmed\">32999684</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine S, Nguyen T, Taylor N, Friscia ME, Budak MT, Rothenberg P, Zhu J, Sachdeva R, Sonnad S, Kaiser LR, et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008;358(13):1327&#x2013;1335. doi: 10.1056/NEJMoa070447.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa070447</ArticleId><ArticleId IdType=\"pubmed\">18367735</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, Lim PB. Autonomic dysfunction in \\'long COVID\\': rationale, physiology and management strategies. Clin Med (Lond) 2021;21(1):e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType=\"pmc\">PMC7850225</ArticleId><ArticleId IdType=\"pubmed\">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, Shoenfeld Y. Post-COVID syndrome: the aftershock of SARS-CoV-2. Int J Infect Dis. 2022;114:233&#x2013;235. doi: 10.1016/j.ijid.2021.11.020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijid.2021.11.020</ArticleId><ArticleId IdType=\"pmc\">PMC8590600</ArticleId><ArticleId IdType=\"pubmed\">34785367</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi H, Ishii M, Takeuchi S, Tanaka Y, Shintani T, Yamatodani A, Kusunoki T, Furue M. Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study. Evid Based Complement Alternat Med. 2010;7(3):367&#x2013;373. doi: 10.1093/ecam/nen003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ecam/nen003</ArticleId><ArticleId IdType=\"pmc\">PMC2887326</ArticleId><ArticleId IdType=\"pubmed\">18955318</ArticleId></ArticleIdList></Reference><Reference><Citation>Takayama S, Kikuchi A, Makino T, Kainuma M, Namiki T, Ito T. Basic pharmacological mechanisms and clinical evidence of the efficacy of Hochuekkito against infectious diseases and its potential for use against COVID-19. Traditional &amp; Kampo Medicine. 2021;8(1):3&#x2013;21. doi: 10.1002/tkm2.1264.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/tkm2.1264</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka T. Kampo therapy for ME/CFS in Japan. Clin J Trad Chin Med. 2021;42(4):468&#x2013;473.</Citation></Reference><Reference><Citation>Jeong JS, Ryu BH, Kim JS, Park JW, Choi WC, Yoon SW. Bojungikki-tang for cancer-related fatigue: a pilot randomized clinical trial. Integr Cancer Ther. 2010;9(4):331&#x2013;338. doi: 10.1177/1534735410383170.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1534735410383170</ArticleId><ArticleId IdType=\"pubmed\">21059621</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka T, Komiyama H, Nakagawa T. MAtsuura T, Oka K: Studies on the effects of rikkunshi-to and hochuekki-to on adrenal and autonomic nervous functions. Jpn J Oriental Med. 1993;43(3):439&#x2013;446.</Citation></Reference><Reference><Citation>He Q, Sawada M, Yamasaki N, Akazawa S, Furuta H, Uenishi H, Meng X, Nakahashi T, Ishigaki Y, Moriya J. Neuroinflammation, oxidative stress, and neurogenesis in a mouse model of chronic fatigue syndrome, and the treatment with kampo medicine. Biol Pharm Bull. 2020;43(1):110&#x2013;115. doi: 10.1248/bpb.b19-00616.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1248/bpb.b19-00616</ArticleId><ArticleId IdType=\"pubmed\">31902915</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">36852237</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">1658-3612</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>18</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of Taibah University Medical Sciences</Title><ISOAbbreviation>J Taibah Univ Med Sci</ISOAbbreviation></Journal><ArticleTitle>Health system support among patients with ME/CFS in Switzerland.</ArticleTitle><Pagination><StartPage>876</StartPage><EndPage>885</EndPage><MedlinePgn>876-885</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.jtumed.2022.12.019</ELocationID><Abstract><AbstractText Label=\"OBJECTIVES\" NlmCategory=\"UNASSIGNED\">Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex chronic and debilitating multifactorial disease. Adequate patient care is challenged by poor knowledge among health care professionals and the historical misconception that the disease is psychological in nature. This study assessed the health-related challenges faced by patients with ME/CFS in Switzerland and examined whether they receive adequate health care.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">Quantitative and qualitative data were collected through a self-administered questionnaire between June and September of 2021, among 169 patients with ME/CFS in Switzerland.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">The mean age at diagnosis was 38.8 years. Only one-third of ME/CFS affected children and youth were correctly diagnosed before their 18th birthday. The mean time from disease onset to diagnosis was 6.7 years, and patients had an average of 11.1 different appointments and 2.6 misdiagnoses. A poor diagnosis rate and insufficient disease knowledge among health professionals in Switzerland led 13.5% of the patients to travel abroad to seek a diagnosis. Most patients (90.5%) were told at least once that their symptoms were psychosomatic. Swiss patients expressed high dissatisfaction with the health system and indicated that physicians lacked knowledge regarding ME/CFS. Therapies prescribed by physicians or tried by patients, as well as their perceived efficacy, were described. Graded Exercise Therapy (GET) was perceived as harmful by patients, whereas pacing, complementary/alternative medicine, and dietary supplements and medications to alleviate symptoms were reported to be helpful to varying degrees.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"UNASSIGNED\">This study highlights that poor disease knowledge among health care providers in Switzerland has led to high patient dissatisfaction, and delays in ME/CFS diagnoses and prescription of inappropriate therapies, thus adding to patient distress and disease burden.</AbstractText><CopyrightInformation>&#xa9; 2023 [The Author/The Authors].</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Tschopp</LastName><ForeName>Rea</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Armauer Hansen Research Institute, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>K&#xf6;nig</LastName><ForeName>Rahel S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rejmer</LastName><ForeName>Protazy</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Seegarten Clinic, Kilchberg, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Paris</LastName><ForeName>Daniel H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Basel, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Saudi Arabia</Country><MedlineTA>J Taibah Univ Med Sci</MedlineTA><NlmUniqueID>101621911</NlmUniqueID><ISSNLinking>1658-3612</ISSNLinking></MedlineJournalInfo><OtherAbstract Type=\"Publisher\" Language=\"ara\"><AbstractText Label=\"&#x623;&#x647;&#x62f;&#x627;&#x641; &#x627;&#x644;&#x628;&#x62d;&#x62b;\" NlmCategory=\"UNASSIGNED\">&#x627;&#x644;&#x62a;&#x647;&#x627;&#x628; &#x627;&#x644;&#x62f;&#x645;&#x627;&#x63a; &#x648;&#x627;&#x644;&#x646;&#x62e;&#x627;&#x639; &#x627;&#x644;&#x639;&#x636;&#x644;&#x64a; / &#x645;&#x62a;&#x644;&#x627;&#x632;&#x645;&#x629; &#x627;&#x644;&#x62a;&#x639;&#x628; &#x627;&#x644;&#x645;&#x632;&#x645;&#x646; &#x647;&#x648; &#x645;&#x631;&#x636; &#x645;&#x632;&#x645;&#x646; &#x645;&#x639;&#x642;&#x62f; &#x645;&#x62a;&#x639;&#x62f;&#x62f; &#x627;&#x644;&#x639;&#x648;&#x627;&#x645;&#x644;. &#x62a;&#x648;&#x627;&#x62c;&#x647; &#x631;&#x639;&#x627;&#x64a;&#x629; &#x627;&#x644;&#x645;&#x631;&#x636;&#x649; &#x627;&#x644;&#x643;&#x627;&#x641;&#x64a;&#x629; &#x62a;&#x62d;&#x62f;&#x64a;&#x627; &#x628;&#x633;&#x628;&#x628; &#x636;&#x639;&#x641; &#x627;&#x644;&#x645;&#x639;&#x631;&#x641;&#x629; &#x628;&#x64a;&#x646; &#x627;&#x644;&#x645;&#x62a;&#x62e;&#x635;&#x635;&#x64a;&#x646; &#x641;&#x64a; &#x627;&#x644;&#x631;&#x639;&#x627;&#x64a;&#x629; &#x627;&#x644;&#x635;&#x62d;&#x64a;&#x629; &#x648;&#x627;&#x644;&#x627;&#x639;&#x62a;&#x642;&#x627;&#x62f; &#x627;&#x644;&#x62a;&#x627;&#x631;&#x64a;&#x62e;&#x64a; &#x627;&#x644;&#x62e;&#x627;&#x637;&#x626; &#x628;&#x623;&#x646; &#x627;&#x644;&#x645;&#x631;&#x636; &#x644;&#x647; &#x637;&#x628;&#x64a;&#x639;&#x629; &#x646;&#x641;&#x633;&#x64a;&#x629;. &#x642;&#x64a;&#x645;&#x62a; &#x647;&#x630;&#x647; &#x627;&#x644;&#x62f;&#x631;&#x627;&#x633;&#x629; &#x627;&#x644;&#x62a;&#x62d;&#x62f;&#x64a;&#x627;&#x62a; &#x627;&#x644;&#x645;&#x62a;&#x639;&#x644;&#x642;&#x629; &#x628;&#x627;&#x644;&#x635;&#x62d;&#x629; &#x627;&#x644;&#x62a;&#x64a; &#x64a;&#x648;&#x627;&#x62c;&#x647;&#x647;&#x627; &#x645;&#x631;&#x636;&#x649; &#x627;&#x644;&#x62a;&#x647;&#x627;&#x628; &#x627;&#x644;&#x62f;&#x645;&#x627;&#x63a; &#x648;&#x627;&#x644;&#x646;&#x62e;&#x627;&#x639; &#x627;&#x644;&#x639;&#x636;&#x644;&#x64a; / &#x645;&#x62a;&#x644;&#x627;&#x632;&#x645;&#x629; &#x627;&#x644;&#x62a;&#x639;&#x628; &#x627;&#x644;&#x645;&#x632;&#x645;&#x646; &#x641;&#x64a; &#x633;&#x648;&#x64a;&#x633;&#x631;&#x627;&#x60c; &#x648;&#x645;&#x627; &#x625;&#x630;&#x627; &#x643;&#x627;&#x646;&#x648;&#x627; &#x64a;&#x62a;&#x644;&#x642;&#x648;&#x646; &#x631;&#x639;&#x627;&#x64a;&#x629; &#x635;&#x62d;&#x64a;&#x629; &#x643;&#x627;&#x641;&#x64a;&#x629; &#x623;&#x645; &#x644;&#x627;.</AbstractText><AbstractText Label=\"&#x637;&#x631;&#x64a;&#x642;&#x629; &#x627;&#x644;&#x628;&#x62d;&#x62b;\" NlmCategory=\"UNASSIGNED\">&#x62a;&#x645; &#x62c;&#x645;&#x639; &#x627;&#x644;&#x628;&#x64a;&#x627;&#x646;&#x627;&#x62a; &#x627;&#x644;&#x643;&#x645;&#x64a;&#x629; &#x648;&#x627;&#x644;&#x646;&#x648;&#x639;&#x64a;&#x629; &#x645;&#x646; &#x627;&#x633;&#x62a;&#x628;&#x64a;&#x627;&#x646; &#x62a;&#x645; &#x625;&#x62c;&#x631;&#x627;&#x624;&#x647; &#x630;&#x627;&#x62a;&#x64a;&#x627; &#x628;&#x64a;&#x646; &#x64a;&#x648;&#x646;&#x64a;&#x648; &#x648;&#x633;&#x628;&#x62a;&#x645;&#x628;&#x631; 2021 &#x628;&#x64a;&#x646; 169 &#x645;&#x631;&#x64a;&#x636;&#x627; &#x628;&#x627;&#x644;&#x62a;&#x647;&#x627;&#x628; &#x627;&#x644;&#x62f;&#x645;&#x627;&#x63a; &#x648;&#x627;&#x644;&#x646;&#x62e;&#x627;&#x639; &#x627;&#x644;&#x639;&#x636;&#x644;&#x64a; / &#x645;&#x62a;&#x644;&#x627;&#x632;&#x645;&#x629; &#x627;&#x644;&#x62a;&#x639;&#x628; &#x627;&#x644;&#x645;&#x632;&#x645;&#x646; &#x641;&#x64a; &#x633;&#x648;&#x64a;&#x633;&#x631;&#x627;.</AbstractText><AbstractText Label=\"&#x627;&#x644;&#x646;&#x62a;&#x627;&#x626;&#x62c;\" NlmCategory=\"UNASSIGNED\">&#x643;&#x627;&#x646; &#x645;&#x62a;&#x648;&#x633;&#x637; &#x627;&#x644;&#x639;&#x645;&#x631; &#x639;&#x646;&#x62f; &#x627;&#x644;&#x62a;&#x634;&#x62e;&#x64a;&#x635; 38.8 &#x633;&#x646;&#x629;. &#x643;&#x627;&#x646; &#x627;&#x644;&#x62a;&#x634;&#x62e;&#x64a;&#x635; &#x641;&#x64a; &#x627;&#x644;&#x623;&#x639;&#x645;&#x627;&#x631; &#x62f;&#x648;&#x646; 18 &#x639;&#x627;&#x645;&#x627; &#x633;&#x64a;&#x626;&#x627; &#x644;&#x644;&#x63a;&#x627;&#x64a;&#x629;. &#x643;&#x627;&#x646; &#x645;&#x62a;&#x648;&#x633;&#x637; &#x627;&#x644;&#x648;&#x642;&#x62a; &#x645;&#x646; &#x628;&#x62f;&#x627;&#x64a;&#x629; &#x627;&#x644;&#x645;&#x631;&#x636; &#x625;&#x644;&#x649; &#x627;&#x644;&#x62a;&#x634;&#x62e;&#x64a;&#x635; 6.7 &#x633;&#x646;&#x648;&#x627;&#x62a; &#x60c; &#x645;&#x639; &#x623;&#x62e;&#x630; 11.1 &#x645;&#x648;&#x639;&#x62f;&#x627; &#x645;&#x62e;&#x62a;&#x644;&#x641;&#x627; &#x641;&#x64a; &#x627;&#x644;&#x645;&#x62a;&#x648;&#x633;&#x637; &#x648; 2.6 &#x62a;&#x634;&#x62e;&#x64a;&#x635;&#x627; &#x62e;&#x627;&#x637;&#x626;&#x627;. &#x623;&#x62f;&#x649; &#x636;&#x639;&#x641; &#x645;&#x639;&#x62f;&#x644; &#x627;&#x644;&#x62a;&#x634;&#x62e;&#x64a;&#x635; &#x648;&#x627;&#x644;&#x645;&#x639;&#x631;&#x641;&#x629; &#x628;&#x627;&#x644;&#x623;&#x645;&#x631;&#x627;&#x636; &#x628;&#x64a;&#x646; &#x627;&#x644;&#x645;&#x647;&#x646;&#x64a;&#x64a;&#x646; &#x627;&#x644;&#x635;&#x62d;&#x64a;&#x64a;&#x646; &#x641;&#x64a; &#x633;&#x648;&#x64a;&#x633;&#x631;&#x627; &#x625;&#x644;&#x649; &#x633;&#x641;&#x631; 13.5&#x66a; &#x645;&#x646; &#x627;&#x644;&#x645;&#x631;&#x636;&#x649; &#x625;&#x644;&#x649; &#x627;&#x644;&#x62e;&#x627;&#x631;&#x62c; &#x644;&#x644;&#x628;&#x62d;&#x62b; &#x639;&#x646; &#x627;&#x644;&#x62a;&#x634;&#x62e;&#x64a;&#x635;. &#x62a;&#x645; &#x625;&#x62e;&#x628;&#x627;&#x631; &#x627;&#x644;&#x63a;&#x627;&#x644;&#x628;&#x64a;&#x629; &#x627;&#x644;&#x639;&#x638;&#x645;&#x649; &#x645;&#x646; &#x627;&#x644;&#x645;&#x631;&#x636;&#x649; (90.5&#x66a;) &#x645;&#x631;&#x629; &#x648;&#x627;&#x62d;&#x62f;&#x629; &#x639;&#x644;&#x649; &#x627;&#x644;&#x623;&#x642;&#x644; &#x623;&#x646; &#x623;&#x639;&#x631;&#x627;&#x636;&#x647;&#x645; &#x646;&#x641;&#x633;&#x64a;&#x629; &#x62c;&#x633;&#x62f;&#x64a;&#x629;. &#x623;&#x639;&#x631;&#x628; &#x627;&#x644;&#x645;&#x631;&#x636;&#x649; &#x627;&#x644;&#x633;&#x648;&#x64a;&#x633;&#x631;&#x64a;&#x648;&#x646; &#x639;&#x646; &#x645;&#x633;&#x62a;&#x648;&#x649; &#x639;&#x627;&#x644; &#x645;&#x646; &#x639;&#x62f;&#x645; &#x627;&#x644;&#x631;&#x636;&#x627; &#x639;&#x646; &#x627;&#x644;&#x646;&#x638;&#x627;&#x645; &#x627;&#x644;&#x635;&#x62d;&#x64a; &#x648;&#x623;&#x634;&#x627;&#x631;&#x648;&#x627; &#x625;&#x644;&#x649; &#x646;&#x642;&#x635; &#x627;&#x644;&#x645;&#x639;&#x631;&#x641;&#x629; &#x628;&#x64a;&#x646; &#x627;&#x644;&#x623;&#x637;&#x628;&#x627;&#x621; &#x641;&#x64a;&#x645;&#x627; &#x64a;&#x62a;&#x639;&#x644;&#x642; &#x628;&#x627;&#x644;&#x62a;&#x647;&#x627;&#x628; &#x627;&#x644;&#x62f;&#x645;&#x627;&#x63a; &#x648;&#x627;&#x644;&#x646;&#x62e;&#x627;&#x639; &#x627;&#x644;&#x639;&#x636;&#x644;&#x64a; / &#x645;&#x62a;&#x644;&#x627;&#x632;&#x645;&#x629; &#x627;&#x644;&#x62a;&#x639;&#x628; &#x627;&#x644;&#x645;&#x632;&#x645;&#x646;. &#x62a;&#x645; &#x648;&#x635;&#x641; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62c;&#x627;&#x62a; &#x627;&#x644;&#x645;&#x648;&#x635;&#x648;&#x641;&#x629; &#x645;&#x646; &#x642;&#x628;&#x644; &#x627;&#x644;&#x623;&#x637;&#x628;&#x627;&#x621; &#x623;&#x648; &#x627;&#x644;&#x62a;&#x64a; &#x62c;&#x631;&#x628;&#x647;&#x627; &#x627;&#x644;&#x645;&#x631;&#x636;&#x649; &#x628;&#x627;&#x644;&#x625;&#x636;&#x627;&#x641;&#x629; &#x625;&#x644;&#x649; &#x641;&#x639;&#x627;&#x644;&#x64a;&#x62a;&#x647;&#x627; &#x627;&#x644;&#x645;&#x62a;&#x635;&#x648;&#x631;&#x629;. &#x627;&#x639;&#x62a;&#x628;&#x631; &#x627;&#x644;&#x645;&#x631;&#x636;&#x649; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62c; &#x627;&#x644;&#x62a;&#x62f;&#x631;&#x64a;&#x62c;&#x64a; &#x627;&#x644;&#x62a;&#x62f;&#x631;&#x64a;&#x62c;&#x64a; &#x636;&#x627;&#x631;&#x627;&#x60c; &#x641;&#x64a; &#x62d;&#x64a;&#x646; &#x62a;&#x645; &#x627;&#x644;&#x625;&#x628;&#x644;&#x627;&#x63a; &#x639;&#x646; &#x641;&#x627;&#x626;&#x62f;&#x629; (&#x623;&#x62b;&#x646;&#x627;&#x621; &#x62a;&#x646;&#x638;&#x64a;&#x645;&#x647;) &#x627;&#x644;&#x637;&#x628; &#x627;&#x644;&#x62a;&#x643;&#x645;&#x64a;&#x644;&#x64a; / &#x627;&#x644;&#x628;&#x62f;&#x64a;&#x644;&#x60c; &#x648;&#x627;&#x644;&#x645;&#x643;&#x645;&#x644;&#x627;&#x62a; &#x627;&#x644;&#x63a;&#x630;&#x627;&#x626;&#x64a;&#x629; &#x648;&#x627;&#x644;&#x623;&#x62f;&#x648;&#x64a;&#x629; &#x644;&#x62a;&#x62e;&#x641;&#x64a;&#x641; &#x627;&#x644;&#x623;&#x639;&#x631;&#x627;&#x636; &#x628;&#x62f;&#x631;&#x62c;&#x627;&#x62a; &#x645;&#x62a;&#x641;&#x627;&#x648;&#x62a;&#x629;.</AbstractText><AbstractText Label=\"&#x627;&#x644;&#x627;&#x633;&#x62a;&#x646;&#x62a;&#x627;&#x62c;&#x627;&#x62a;\" NlmCategory=\"UNASSIGNED\">&#x633;&#x644;&#x637;&#x62a; &#x647;&#x630;&#x647; &#x627;&#x644;&#x62f;&#x631;&#x627;&#x633;&#x629; &#x627;&#x644;&#x636;&#x648;&#x621; &#x639;&#x644;&#x649; &#x636;&#x639;&#x641; &#x627;&#x644;&#x645;&#x639;&#x631;&#x641;&#x629; &#x628;&#x627;&#x644;&#x623;&#x645;&#x631;&#x627;&#x636; &#x628;&#x64a;&#x646; &#x645;&#x642;&#x62f;&#x645;&#x64a; &#x627;&#x644;&#x631;&#x639;&#x627;&#x64a;&#x629; &#x627;&#x644;&#x635;&#x62d;&#x64a;&#x629; &#x641;&#x64a; &#x633;&#x648;&#x64a;&#x633;&#x631;&#x627;&#x60c; &#x645;&#x645;&#x627; &#x623;&#x62f;&#x649; &#x625;&#x644;&#x649; &#x627;&#x631;&#x62a;&#x641;&#x627;&#x639; &#x645;&#x633;&#x62a;&#x648;&#x649; &#x639;&#x62f;&#x645; &#x631;&#x636;&#x627; &#x627;&#x644;&#x645;&#x631;&#x636;&#x649;&#x60c; &#x648;&#x62a;&#x623;&#x62e;&#x631; &#x62a;&#x634;&#x62e;&#x64a;&#x635; &#x627;&#x644;&#x62a;&#x647;&#x627;&#x628; &#x627;&#x644;&#x62f;&#x645;&#x627;&#x63a; &#x648;&#x627;&#x644;&#x646;&#x62e;&#x627;&#x639; &#x627;&#x644;&#x639;&#x636;&#x644;&#x64a; / &#x645;&#x62a;&#x644;&#x627;&#x632;&#x645;&#x629; &#x627;&#x644;&#x62a;&#x639;&#x628; &#x627;&#x644;&#x645;&#x632;&#x645;&#x646; &#x648;&#x648;&#x635;&#x641; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62c;&#x627;&#x62a; &#x63a;&#x64a;&#x631; &#x627;&#x644;&#x645;&#x646;&#x627;&#x633;&#x628;&#x629;&#x60c; &#x645;&#x645;&#x627; &#x64a;&#x632;&#x64a;&#x62f; &#x645;&#x646; &#x636;&#x627;&#x626;&#x642;&#x629; &#x627;&#x644;&#x645;&#x631;&#x64a;&#x636; &#x648;&#x639;&#x628;&#x621; &#x627;&#x644;&#x645;&#x631;&#x636;.</AbstractText><CopyrightInformation>&#xa9; 2023 [The Author/The Authors].</CopyrightInformation></OtherAbstract><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Diagnostic</Keyword><Keyword MajorTopicYN=\"N\">Knowledge</Keyword><Keyword MajorTopicYN=\"N\">Medical care</Keyword><Keyword MajorTopicYN=\"N\">Myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">Switzerland</Keyword><Keyword MajorTopicYN=\"N\">Therapies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2022</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2022</Year><Month>12</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>2</Month><Day>28</Day><Hour>2</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">36852237</ArticleId><ArticleId IdType=\"pmc\">PMC9957780</ArticleId><ArticleId IdType=\"doi\">10.1016/j.jtumed.2022.12.019</ArticleId><ArticleId IdType=\"pii\">S1658-3612(22)00239-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Friedberg F., Bateman L., Bested A., Davenport T., Friedman K., Gurwitt A., et al.   IACFS/ME; Chicago, IL: 2014. ME/CFS: A Primer for Clinical Practioners.https://iacfsme.org/portals/0/pdf/Primer_Post_2014_conference.pdf Available online at:</Citation></Reference><Reference><Citation>Glassford J.A.G. The neuroinflammatory etiopathology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Front Physiol. 2017;8:88.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5314655</ArticleId><ArticleId IdType=\"pubmed\">28261110</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano A.H., Maya J., Giloteaux L., Peterson D.L., Maynard M., et al. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J&#xa0;Clin Invest. 2020 doi: 10.1172/JCI132185.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI132185</ArticleId><ArticleId IdType=\"pmc\">PMC7269566</ArticleId><ArticleId IdType=\"pubmed\">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall-Gradisnik S., Huth T., Anu C., Johnston S., Smith P., et al. Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in Myalgic Encephalomyelitis/chronic fatigue syndrome. Appl Clin Genet. 2016;9:39&#x2013;47.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4821384</ArticleId><ArticleId IdType=\"pubmed\">27099524</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K., Scheibenbogen C. A&#xa0;unifying hypothesis of the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): recognitions from the finding of autoantibodies against &#xdf;2-adrenergic receptors. Autoimmun Rev. 2020;19(6) doi: 10.1016/j.autrev.2020.102527.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2020.102527</ArticleId><ArticleId IdType=\"pubmed\">32247028</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC)   2022. Myalgic encephalomyelitis/chronic fatigue syndrome.https://www.cdc.gov/me-cfs/index.html</Citation></Reference><Reference><Citation>Sweetman E., Noble A., Edgar C., Mackay A., Helliwell A., Vallings R., et al. Current research provides insight into the biological basis and diagnostic potential for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Diagnostics. 2019;9:73. doi: 10.3390/diagnostics9030073.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics9030073</ArticleId><ArticleId IdType=\"pmc\">PMC6787691</ArticleId><ArticleId IdType=\"pubmed\">31295930</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S., Abdallah S.J., Corrales-Medina V., Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther Adv Infect Dis. 2021;8 doi: 10.1177/20499361211009385.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/20499361211009385</ArticleId><ArticleId IdType=\"pmc\">PMC8060761</ArticleId><ArticleId IdType=\"pubmed\">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya J.G., Holmes T.H., Anderson J.N., Maecker H.T., Rosenberg-Hasson Y., et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci USA. 2017;114(34):E7150&#x2013;E7158.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5576836</ArticleId><ArticleId IdType=\"pubmed\">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson G., Maes M. Mitochondria and immunity in chronic fatigue syndrome. Prog Neuro-Psychopharmacol Biol Psychiatry. 2020;103 doi: 10.1016/j.pnpbp.2020.109976.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pnpbp.2020.109976</ArticleId><ArticleId IdType=\"pubmed\">32470498</ArticleId></ArticleIdList></Reference><Reference><Citation>Albright F., Light K., Light A., Bateman L., Cannon-Albright L.A. Evidence for a heritable predisposition to chronic fatigue syndrome. BMC Neurol. 2011;11(1):62. doi: 10.1186/1471-2377-11-62.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2377-11-62</ArticleId><ArticleId IdType=\"pmc\">PMC3128000</ArticleId><ArticleId IdType=\"pubmed\">21619629</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamowicz J.L., Caikauskaite I., Friedberg F. Defining recovery in chronic fatigue syndrome: a critical review. Qual Life Res. 2014;23(9):2407&#x2013;2416.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24791749</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe P., Fontaine K., Lauver M., Jasion S.E., Marden C.L., et al. Neuromuscular strain increases symptom intensity in chronic fatigue syndrome. PLoS One. 2016;11</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4948885</ArticleId><ArticleId IdType=\"pubmed\">27428358</ArticleId></ArticleIdList></Reference><Reference><Citation>Neu D., Mairesse O., Montana X., Gilson M., Corazza F., Lefevre N., et al. Dimensions of pure chronic fatigue: psychophysical, cognitive and biological correlates in the chronic fatigue syndrome. Eur J Appl Physiol. 2014;114:1841&#x2013;1851. doi: 10.1007/s00421-014-2910-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00421-014-2910-1</ArticleId><ArticleId IdType=\"pubmed\">24878689</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman K.J. Advances in ME/CFS: past, present, and future. Front Pediat. 2019;7:131. doi: 10.3389/fped.2019.00131.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2019.00131</ArticleId><ArticleId IdType=\"pmc\">PMC6482157</ArticleId><ArticleId IdType=\"pubmed\">31058116</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon L., Reeves W.C. Factors influencing the diagnosis of chronic fatigue syndrome. Arch Intern Med. 2004;164(20):2241&#x2013;2245. doi: 10.1001/archinte.164.20.2241.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archinte.164.20.2241</ArticleId><ArticleId IdType=\"pubmed\">15534161</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Katz B.Z., Sunnquist M., Torres C., Cotler J., Bhatia S. The prevalence of pediatric myalgic encephalomyelitis/chronic fatigue syndrome in a community-based sample. Child Youth Care Forum. 2020;49:563&#x2013;579. doi: 10.1007/s10566-019-09543-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10566-019-09543-3</ArticleId><ArticleId IdType=\"pmc\">PMC8186295</ArticleId><ArticleId IdType=\"pubmed\">34113066</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanawala S., Taylor R.R. Service utilization, barriers to service access, and coping in adults with Chronic Fatigue Syndrome. J&#xa0;Chronic Fatigue Syndrome. 2007;14:5&#x2013;21. doi: 10.1300/J092v14n01_02.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v14n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Froehlich L., Hattesohl D.B.R., Jason L.A., Scheibenbogen C., Behrends U., Thoma M. Medical care situation of people with myalgic encephalomyelitis/chronic fatigue syndrome in Germany. Medicina. 2021;57(7):646. doi: 10.3390/medicina57070646.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57070646</ArticleId><ArticleId IdType=\"pmc\">PMC8306083</ArticleId><ArticleId IdType=\"pubmed\">34201825</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen J., Pheby D.F.H., Charlett A., McNulty C. Chronic Fatigue Syndrome: a survey of GPs\\' attitudes and knowledge. Fam Pract. 2005;22:389&#x2013;393. doi: 10.1093/fampra/cmi019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/fampra/cmi019</ArticleId><ArticleId IdType=\"pubmed\">15805128</ArticleId></ArticleIdList></Reference><Reference><Citation>Tidmore T., Jason L.A., Chapo-Kroger L., So S., Brown A., Silverman M. Lack of knowledgeable healthcare access for patients with neuro-endocrine-immune diseases. Front Clin Med. 2015;2:46&#x2013;54.</Citation></Reference><Reference><Citation>Timbol C.R., Baraniuk J.N. Chronic fatigue syndrome in the emergency department. Open Access Emerg Med. 2019;11:15&#x2013;28. doi: 10.2147/OAEM.S176843.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/OAEM.S176843</ArticleId><ArticleId IdType=\"pmc\">PMC6333158</ArticleId><ArticleId IdType=\"pubmed\">30666170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunnquist M., Nicholson L., Jason L.A., Friedman K.J. Access to medical care for individuals with Myalgic Encephalo-myelitis and Chronic Fatigue Syndrome: a call for centers of excellence. Mod. Clin. Med. Res. 2017;1:28&#x2013;35. doi: 10.22606/mcmr.2017.11005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.22606/mcmr.2017.11005</ArticleId><ArticleId IdType=\"pmc\">PMC5510655</ArticleId><ArticleId IdType=\"pubmed\">28713878</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderbilt A.A., Dail M.D., Jaberi P. Reducing health disparities in underserved communities via interprofessional collaboration across health care professions. J&#xa0;Multidiscip Healthc. 2015;8:205&#x2013;208. doi: 10.2147/JMDH.S74129.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/JMDH.S74129</ArticleId><ArticleId IdType=\"pmc\">PMC4411015</ArticleId><ArticleId IdType=\"pubmed\">25960659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.J., Ahn Y.C., Jang E.S., Lee S.W., Lee S.H., Son C.G. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) J&#xa0;Transl Med. 2020;18(1):100. doi: 10.1186/s12967-020-02269-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType=\"pmc\">PMC7038594</ArticleId><ArticleId IdType=\"pubmed\">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann M., Puhan M.A., Kuhle J., Yaldizli &#xd6;., Magnusson T., Kamm C.P., et al. A&#xa0;framework for estimating the burden of chronic diseases: design and application in the context of multiple sclerosis. Front Neurol. 2019;10:953. doi: 10.3389/fneur.2019.00953.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2019.00953</ArticleId><ArticleId IdType=\"pmc\">PMC6742909</ArticleId><ArticleId IdType=\"pubmed\">31555205</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes M., Nisenbaum R., Hoaglin D.C., Unger E.R., Emmons C., Randall B., et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med. 2003;163(13):1530&#x2013;1536.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12860574</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Richman J.A., Rademaker A.W., Jordan K.M., Plioplys A.V., Taylor R.R., et al. A&#xa0;community-based study of chronic fatigue syndrome. Arch Intern Med. 1999;159(18):2129&#x2013;2137.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10527290</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawley E.M., Emond A.M., Sterne J.A.C. Unidentified chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a major cause of school absence: surveillance outcomes from school-based clinics. BMJ Open. 2011;1(2)</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3244656</ArticleId><ArticleId IdType=\"pubmed\">22155938</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken I.J., Tveito K., Gunnes N., Ghadori S., Stoltenberg C., et al. Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008-2012. BMC Med. 2014;12:167. doi: 10.1186/s12916-014-0167-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12916-014-0167-5</ArticleId><ArticleId IdType=\"pmc\">PMC4189623</ArticleId><ArticleId IdType=\"pubmed\">25274261</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijhof S.L., Maijer K., Bleijenberg G., Uiterwaal C., Kimpen J.L.L., van de Putte E.M. Adolescent chronic fatigue syndrome: prevalence, incidence, and morbidity. Pediatrics. 2011;127(5):E1169&#x2013;E1175.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21502228</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimes K.A., Goodman R., Hotopf M., Wessely S., Meltzer H., Chalder T. Incidence, prognosis, and risk factors for fatigue and chronic fatigue syndrome in adolescents: a prospective community study. Pediatrics. 2007;119(3):e603&#x2013;e609.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17332180</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Anderson G., Maes M. Hypothalamic-Pituitary-adrenal hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a consequence of activated immune-inflammatory and oxidative and nitrosative pathways. Mol Neurobiol. 2017;54:6806&#x2013;6819.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27766535</ArticleId></ArticleIdList></Reference><Reference><Citation>Hng K.N., Geraghty K., Pheby D.F.H. An audit of UK hospital doctors\\' knowledge and experience of myalgic encephalomyelitis. Medicina. 2021;57:885. doi: 10.3390/medicina57090885.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57090885</ArticleId><ArticleId IdType=\"pmc\">PMC8464998</ArticleId><ArticleId IdType=\"pubmed\">34577808</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleare A.J. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev. 2003;24:236&#x2013;252. PMID:12700181.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12700181</ArticleId></ArticleIdList></Reference><Reference><Citation>Anglin R., Rosebush P., Mazurek M. Psychotropic medications and mitochondrial toxicity. Nat Rev Neurosci. 2012;13:650. doi: 10.1038/nrn3229-c1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrn3229-c1</ArticleId><ArticleId IdType=\"pubmed\">22828984</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan S.T., McCarthy M.J., Vawter M.P. Psychiatric drugs impact mitochondrial function in brain and other tissues. Schizophr Res. 2020;217:136&#x2013;147. doi: 10.1016/j.schres.2019.09.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.schres.2019.09.007</ArticleId><ArticleId IdType=\"pmc\">PMC7228833</ArticleId><ArticleId IdType=\"pubmed\">31744750</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmerzaal T.L., Nijkamp G., Veldic M., Rahman S., Andreazza A.C., Morava E., et al. Effect of neuropsychiatric medications on mitochondrial function: for better or for worse. Neurosci Biobehav Rev. 2021;127:555&#x2013;571. doi: 10.1016/j.neubiorev.2021.05.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neubiorev.2021.05.001</ArticleId><ArticleId IdType=\"pubmed\">34000348</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerwyn M., Maes M. Mechanisms explaining muscle fatigue and muscle pain in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a review of recent findings. Curr Rheumatol Rep. 2017;19(1) doi: 10.1007/s11926-017-0628-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11926-017-0628-x</ArticleId><ArticleId IdType=\"pubmed\">28116577</ArticleId></ArticleIdList></Reference><Reference><Citation>Twisk F.N., Maes M. A&#xa0;review on cognitive behavioral therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS. Neuroendocrinol Lett. 2009;30(3):284&#x2013;299.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19855350</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink M., Vink-Niese F. Graded exercise therapy does not restore the ability to work in ME/CFS &#x2013; rethinking of a cochrane review. Work. 2020;20:283&#x2013;308.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32568149</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. ME/CFS: exercise goals should be set by patients and not driven by treatment plan, says NICE. BMJ. 2021;375:n2643. doi: 10.1136/bmj.n2643.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.n2643</ArticleId><ArticleId IdType=\"pubmed\">34716175</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J., Saez-Francas N., Santillo D., Alegre J. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome. Br J Pharmacol. 2017;174:345&#x2013;369. PMCID:5301046.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5301046</ArticleId><ArticleId IdType=\"pubmed\">28052319</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner A.M., Beqaj S.H., Deeter R.G., Fitzgerald J.T. Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up. In&#xa0;Vivo. 2007;21:707&#x2013;713.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18019402</ArticleId></ArticleIdList></Reference><Reference><Citation>Watt T., Oberfoell S., Balise R., Lunn M.R., Kar A.K., Merrihew L., et al. Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers. J&#xa0;Med Virol. 2012;84:1967&#x2013;1974.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23080504</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya J.G., Kogelnik A.M., Bhangoo M., Lunn M.R., Flamand L., Merrihew L.E., et al. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. J&#xa0;Med Virol. 2013;85:2101&#x2013;2109.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23959519</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe K.S. Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents. J&#xa0;Psychiatr Res. 1997;31:133&#x2013;147.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9201655</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;., Risa K., Lunde S., Alme K., Rekeland I.G., Sapkota D., et al. B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment. PLoS One. 2015;10 PMCID: 4488509.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4488509</ArticleId><ArticleId IdType=\"pubmed\">26132314</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser J.D. A&#xa0;prospective, proof-of-concept investigation of KPAX002 in chronic fatigue syndrome. Int J Clin Exp Med. 2015;8:11064&#x2013;11074.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4565289</ArticleId><ArticleId IdType=\"pubmed\">26379906</ArticleId></ArticleIdList></Reference><Reference><Citation>Roerink M.E., Sebastian M.D., Bredie J.H., Heijnen M., Dinarello C.A., Knoop H., et al. Cytokine inhibition in patients with chronic fatigue syndrome. Ann Intern Med. 2017;166:557&#x2013;564.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28265678</ArticleId></ArticleIdList></Reference><Reference><Citation>Rekeland I.G., Fossa A., Lande A., Ktoridou-Valen I., Sorland K., Holsen M., et al. Intravenous cyclophosphamide in myalgic encephalomyelitis/chronic fatigue syndrome. An open-label phase II study. Front Med. 2020;7:162.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7201056</ArticleId><ArticleId IdType=\"pubmed\">32411717</ArticleId></ArticleIdList></Reference><Reference><Citation>Toogood P.L., Clauw D.J., Phadke S., Hoffman D. Myalgic&#xa0;encephalomyelitis/chronic fatigue syndrome (ME/CFS): where will the drugs come from? Pharmacol Res. 2021;165 doi: 10.1016/j.phrs.2021.105465.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.phrs.2021.105465</ArticleId><ArticleId IdType=\"pubmed\">33529750</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell W.M. Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) Expet Rev Clin Pharmacol. 2016;9:755&#x2013;770.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4917909</ArticleId><ArticleId IdType=\"pubmed\">27045557</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">36851614</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1999-4915</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>15</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">400</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/v15020400</ELocationID><Abstract><AbstractText>A novel syndrome called long-haul COVID or long COVID is increasingly recognized in a significant percentage of individuals within a few months after infection with SARS-CoV-2. This disorder is characterized by a wide range of persisting, returning or even new but related symptoms that involve different tissues and organs, including respiratory, cardiac, vascular, gastrointestinal, musculo-skeletal, neurological, endocrine and systemic. Some overlapping symptomatologies exist between long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Very much like with long ME/CFS, infections with herpes family viruses, immune dysregulation, and the persistence of inflammation have been reported as the most common pattern for the development of long COVID. This review describes several factors and determinants of long COVID that have been proposed, elaborating mainly on viral persistence, reactivation of latent viruses such as Epstein-Barr virus and human herpesvirus 6 which are also associated with the pathology of ME/CFS, viral superantigen activation of the immune system, disturbance in the gut microbiome, and multiple tissue damage and autoimmunity. Based on these factors, we propose diagnostic strategies such as the measurement of IgG and IgM antibodies against SARS-CoV-2, EBV, HHV-6, viral superantigens, gut microbiota, and biomarkers of autoimmunity to better understand and manage this multi-factorial disorder that continues to affect millions of people in the world.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Vojdani</LastName><ForeName>Aristo</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0003-2925-9334</Identifier><AffiliationInfo><Affiliation>Immunosciences Lab, Inc., Los Angeles, CA 90035, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cyrex Laboratories, LLC, Phoenix, AZ 85034, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vojdani</LastName><ForeName>Elroy</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Regenera Medical, Los Angeles, CA 90025, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Saidara</LastName><ForeName>Evan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Maes</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, 1873 Rama 4 Road, Pathumwan, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000094024\" MajorTopicYN=\"N\">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086382\" MajorTopicYN=\"Y\">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D004854\" MajorTopicYN=\"N\">Herpesvirus 4, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015654\" MajorTopicYN=\"Y\">Herpesvirus 6, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015551\" MajorTopicYN=\"N\">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D020031\" MajorTopicYN=\"Y\">Epstein-Barr Virus Infections</DescriptorName><QualifierName UI=\"Q000150\" MajorTopicYN=\"N\">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086402\" MajorTopicYN=\"N\">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">EBV</Keyword><Keyword MajorTopicYN=\"N\">HHV-6</Keyword><Keyword MajorTopicYN=\"N\">autoimmunity</Keyword><Keyword MajorTopicYN=\"N\">gut microbiota</Keyword><Keyword MajorTopicYN=\"N\">long COVID</Keyword><Keyword MajorTopicYN=\"N\">myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)</Keyword><Keyword MajorTopicYN=\"N\">viral reactivation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>2</Month><Day>28</Day><Hour>1</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">36851614</ArticleId><ArticleId IdType=\"pmc\">PMC9967513</ArticleId><ArticleId IdType=\"doi\">10.3390/v15020400</ArticleId><ArticleId IdType=\"pii\">v15020400</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sun Y., Dong Y., Wang L., Xie H., Li B., Chang C., Wand F.-S. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. J. Autoimmun. 2020;112:102473. doi: 10.1016/j.jaut.2020.102473.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaut.2020.102473</ArticleId><ArticleId IdType=\"pmc\">PMC7180376</ArticleId><ArticleId IdType=\"pubmed\">32439209</ArticleId></ArticleIdList></Reference><Reference><Citation>Setiati S., Harimurti K., Safitri E.D., Ranakusuma R.W., Saldi S.R.F., Azwar M.K., Marsigit J., Pitoyo Y., Widyaningsih W. Risk factors and laboratory test results associated with severe illness and mortality in COVID-19 patients: A systematic review. Acts Med. Indones. 2020;52:227&#x2013;245.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33020334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kifer D., Bugada D., Villar-Garcia J., Gudelj I., Menni C., Sudre C., Vuckovic F., Ugrina I., Lorini L.F., Posso M., et al. Effects of environmental factors on severity and mortality of COVID-19. Front. Med. 2021;7:607786. doi: 10.3389/fmed.2020.607786.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmed.2020.607786</ArticleId><ArticleId IdType=\"pmc\">PMC7855590</ArticleId><ArticleId IdType=\"pubmed\">33553204</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Vojdani E., FRosenberg A.Z., Shoenfeld Y. The role of exposomes in the pathophysiology of autoimmune diseases II: Pathogens. Pathophysiology. 2022;29:243&#x2013;280. doi: 10.3390/pathophysiology29020020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pathophysiology29020020</ArticleId><ArticleId IdType=\"pmc\">PMC9231084</ArticleId><ArticleId IdType=\"pubmed\">35736648</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappaport S.M., Smith M.T. Epidemiology, environment and disease risks. Science. 2010;330:460&#x2013;461. doi: 10.1126/science.1192603.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1192603</ArticleId><ArticleId IdType=\"pmc\">PMC4841276</ArticleId><ArticleId IdType=\"pubmed\">20966241</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen R., Scymanski E.L., Barabasi A.L., Miller G.W. The exposome and health: Where chemistry meets biology. Science. 2020;367:392&#x2013;396. doi: 10.1126/science.aay3164.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.aay3164</ArticleId><ArticleId IdType=\"pmc\">PMC7227413</ArticleId><ArticleId IdType=\"pubmed\">31974245</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franco N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType=\"pmc\">PMC7896197</ArticleId><ArticleId IdType=\"pubmed\">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made long COVID. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType=\"pmc\">PMC7539940</ArticleId><ArticleId IdType=\"pubmed\">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType=\"pmc\">PMC9127978</ArticleId><ArticleId IdType=\"pubmed\">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.m3026</ArticleId><ArticleId IdType=\"pubmed\">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Jahdhami I., Al-Naamani K., Al-Mawali A. The post-acute COVID-19 syndrome (long COVID) Oman Med. J. 2021;36:e220. doi: 10.5001/omj.2021.91.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5001/omj.2021.91</ArticleId><ArticleId IdType=\"pmc\">PMC7838343</ArticleId><ArticleId IdType=\"pubmed\">33537155</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., Doucet L., Berkani S., Oliosi E., Mallart E., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType=\"pmc\">PMC7445491</ArticleId><ArticleId IdType=\"pubmed\">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType=\"pmc\">PMC7833295</ArticleId><ArticleId IdType=\"pubmed\">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deeks S.G. Early clues regarding the pathogenesis of long COVID. Trends Immunol. 2022;43:268&#x2013;270. doi: 10.1016/j.it.2022.02.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.it.2022.02.008</ArticleId><ArticleId IdType=\"pmc\">PMC8901423</ArticleId><ArticleId IdType=\"pubmed\">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hadrawi D.S., Al-Rubaye H.T., Almulla A.F., Al-Hakeim H.K., Maes M. Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to Long COVID: A precision nomothetic approach. Acta Neuropsychiatr. 2022;22:1&#x2013;12. doi: 10.1017/neu.2022.21.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/neu.2022.21</ArticleId><ArticleId IdType=\"pubmed\">36134517</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType=\"pmc\">PMC8786632</ArticleId><ArticleId IdType=\"pubmed\">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and myalgic enchepalomyelitis/chronic fatigue syndrome (MW/CFS)&#x2014;A systematic review and comparison of clinical presentation and symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57050418</ArticleId><ArticleId IdType=\"pmc\">PMC8145228</ArticleId><ArticleId IdType=\"pubmed\">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman K.J., Murovska M., Pheby D., Zalewski P. Our evolving understanding of ME/CFS. Medicina. 2021;57:200. doi: 10.3390/medicina57030200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/medicina57030200</ArticleId><ArticleId IdType=\"pmc\">PMC7996879</ArticleId><ArticleId IdType=\"pubmed\">33652622</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendergrast T., Brown A., Sunnquist M., Jantke R., Newton J.L., Strand E.B., Jason L.A. Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illn. 2016;12:292&#x2013;307. doi: 10.1177/1742395316644770.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1742395316644770</ArticleId><ArticleId IdType=\"pmc\">PMC5464362</ArticleId><ArticleId IdType=\"pubmed\">27127189</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L., Valencia I.J., Garvert D.W., Montoya J.G. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front. Pediatr. 2019;7:12. doi: 10.3389/fped.2019.00012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2019.00012</ArticleId><ArticleId IdType=\"pmc\">PMC6370741</ArticleId><ArticleId IdType=\"pubmed\">30805319</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Anderson G., Galecki P., Berk M., Maes M. A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior. BMC Med. 2013;11:64. doi: 10.1186/1741-7015-11-64.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1741-7015-11-64</ArticleId><ArticleId IdType=\"pmc\">PMC3751187</ArticleId><ArticleId IdType=\"pubmed\">23497361</ArticleId></ArticleIdList></Reference><Reference><Citation>Straus S.E., Tosato G., Armstrong G., Lawley T., Preble O.T., Henle W., Davey R., Pearson G., Epstein J., Brus I., et al. Persistence illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann. Intern. Med. 1985;102:7&#x2013;16. doi: 10.7326/0003-4819-102-1-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-102-1-7</ArticleId><ArticleId IdType=\"pubmed\">2578268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai K., Kawai A. Studies on the relationship between chronic fatigue syndrome and Epstein-Barr virus in Japan. Intern. Med. 1992;31:313&#x2013;318. doi: 10.2169/internalmedicine.31.313.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2169/internalmedicine.31.313</ArticleId><ArticleId IdType=\"pubmed\">1319246</ArticleId></ArticleIdList></Reference><Reference><Citation>Sairenji T., Yamanishi K., Tachibana Y., Bertoni G., Kurata T. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. Intervirology. 1995;38:269&#x2013;273. doi: 10.1159/000150450.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000150450</ArticleId><ArticleId IdType=\"pubmed\">8724857</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron B., Flamand L., Juwana H., Middledorp J., Naing Z., Rawlinson W., Ablashi D., Lloyd A. Serological and virological investigation of the role of the herpesviruses EBV, CMV, and HHV-6 in post-infective fatigue syndrome. J. Med. Virol. 2010;62:1684&#x2013;1688. doi: 10.1002/jmv.21873.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.21873</ArticleId><ArticleId IdType=\"pubmed\">20827765</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox B.S., Alharshawi K., Mena-Palomo I., Lafuse W.P., Ariza M.E. EBV/HHV-6A dUTPases contribute to myalgic encephalomyelitis/chronic fatigue syndrome pathophysiology by enhancing Tfh cell differentiation and extrafollicular activities. JCI Insight. 2022;11:e158193. doi: 10.1172/jci.insight.158193.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/jci.insight.158193</ArticleId><ArticleId IdType=\"pmc\">PMC9220958</ArticleId><ArticleId IdType=\"pubmed\">35482424</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza M.E. Myalgic encephalomyelitis/chronic fatigue syndrome: The human herpesviruses are back. Biomolecules. 2021;11:185. doi: 10.3390/biom11020185.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom11020185</ArticleId><ArticleId IdType=\"pmc\">PMC7912523</ArticleId><ArticleId IdType=\"pubmed\">33572802</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Schneider A.M., Mehta A., Sade-Feldman M., Kays K.R., Gentili M., Charland N.C., Gonye A.L.K., Gushterova I., Khanna H.K., et al. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes. J. Clin. Investig. 2021;131:e148635. doi: 10.1172/JCI148635.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI148635</ArticleId><ArticleId IdType=\"pmc\">PMC8245177</ArticleId><ArticleId IdType=\"pubmed\">34196300</ArticleId></ArticleIdList></Reference><Reference><Citation>Silberry V.G.R., Rowe P. Pediatric long COVID and myalgic encephalomyelitis/chronic fatigue syndrome. Ped. Inf. Dis. 2022;41:e139&#x2013;e141. doi: 10.1097/INF.0000000000003477.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/INF.0000000000003477</ArticleId><ArticleId IdType=\"pmc\">PMC8919937</ArticleId><ArticleId IdType=\"pubmed\">35121715</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard-Jones A.R., Burgner D.P., Crawford N.W., Goeman E., Gray P.E., Hsu P., Kuek S., McMullan B.J., Tosif S., Wurzel D., et al. COVID-19 in children. II: Pathogenesis, disease spectrum and management. J. Pediatr. Child. Health. 2022;58:46&#x2013;53. doi: 10.1111/jpc.15811.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jpc.15811</ArticleId><ArticleId IdType=\"pmc\">PMC8662268</ArticleId><ArticleId IdType=\"pubmed\">34694037</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType=\"pmc\">PMC8260991</ArticleId><ArticleId IdType=\"pubmed\">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H.K., Al-Rubaye H.T., Al-Hadrawi D.S., Almulla A.F., Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: A proof of concept and mechanism study. Mol. Psychiatry. 2022;24:1&#x2013;15. doi: 10.1038/s41380-022-01836-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType=\"pmc\">PMC9589528</ArticleId><ArticleId IdType=\"pubmed\">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze J.L., Aschenbrenner A.C. COVID-19 and the human innate immune system. Cell. 2021;184:1671&#x2013;1692. doi: 10.1016/j.cell.2021.02.029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2021.02.029</ArticleId><ArticleId IdType=\"pmc\">PMC7885626</ArticleId><ArticleId IdType=\"pubmed\">33743212</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumi T., Harada K. Immune response to SARS-CoV-2 in severe disease and long COVID-19. iScience. 2022;25:104723. doi: 10.1016/j.isci.2022.104723.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.isci.2022.104723</ArticleId><ArticleId IdType=\"pmc\">PMC9251893</ArticleId><ArticleId IdType=\"pubmed\">35813874</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin D.E. Why does viral RNA sometimes persist after recovery from acute infections? PLoS Biol. 2022;20:e3001687. doi: 10.1371/journal.pbio.3001687.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pbio.3001687</ArticleId><ArticleId IdType=\"pmc\">PMC9191737</ArticleId><ArticleId IdType=\"pubmed\">35648781</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasuga Y., Zhu B., Jang K.-J., Yoo J.-S. Innate immune sensing of coronavirus and viral evasion strategies. Exp. Mol. Med. 2021;53:723&#x2013;736. doi: 10.1038/s12276-021-00602-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s12276-021-00602-1</ArticleId><ArticleId IdType=\"pmc\">PMC8099713</ArticleId><ArticleId IdType=\"pubmed\">33953325</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Li S., Pan Y., Qin L., Yang S., Tan D., Hu Y., Knoll M.D., Wang X., Wang L., et al. An immunocompetent patient with high neutralizing antibody titers who shed COVID-18 virus for 169 days&#x2014;China, 2020. China CDC Wkly. 2021;3:688&#x2013;691. doi: 10.46234/ccdcw2021.163.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.46234/ccdcw2021.163</ArticleId><ArticleId IdType=\"pmc\">PMC8393007</ArticleId><ArticleId IdType=\"pubmed\">34594968</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A., Zlitni S., Brooks E.F., Vance S.E., Dahlen A., Hedlin H., Park R.M., Han A., Schmidtke D.T., Verma R., et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 2022;3:371&#x2013;387. doi: 10.1016/j.medj.2022.04.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType=\"pmc\">PMC9005383</ArticleId><ArticleId IdType=\"pubmed\">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., R&#xf6;ssler A., Kimpel J., Adolph T.E., Tilg H. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163:495&#x2013;506.e8. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType=\"pmc\">PMC9057012</ArticleId><ArticleId IdType=\"pubmed\">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmani A., Dino G., Leso V., Montecucco A., Vitturi B.N.K., Iavicoli I., Durando P. Duration of SARS-CoV-2 shedding and infectivity in the working population: A systematic review and meta-analysis. Med. Lav. 2022;113:e2022014.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9073762</ArticleId><ArticleId IdType=\"pubmed\">35481581</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung C.C.L., Goh D., Lim X., Tien T.Z., Lim J.C.T., Lee J.N., Tan B., Tay Z.E.A., Wan W.Y., Chen E.X. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. 2022;71:226&#x2013;229. doi: 10.1136/gutjnl-2021-324280.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType=\"pubmed\">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs J.J.L. Persistent SARS-CoV-2 infections contribute to long COVID. Med. Hypotheses. 2021;149:110538. doi: 10.1016/j.mehy.2021.110538.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mehy.2021.110538</ArticleId><ArticleId IdType=\"pmc\">PMC7884250</ArticleId><ArticleId IdType=\"pubmed\">33621843</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonnet A., Engelmann I., Moreau A.-S., Garcia B., Six S., El Kalioubie A., Robriquet L., Hober D., Jourdain M. High incidence of Epstein-Barr virus, cytomegalovirus and human-herpes 6 reactivation in critically ill patients with COVID-19. Infect. Dis. Now. 2021;51:296&#x2013;299. doi: 10.1016/j.idnow.2021.01.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.idnow.2021.01.005</ArticleId><ArticleId IdType=\"pmc\">PMC7816954</ArticleId><ArticleId IdType=\"pubmed\">33495765</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S., Kril I., Nadizhko O., Matsyura O., Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: A pilot observational study. Rheumatol. Int. 2022;42:1523&#x2013;1530. doi: 10.1007/s00296-022-05146-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00296-022-05146-9</ArticleId><ArticleId IdType=\"pmc\">PMC9159383</ArticleId><ArticleId IdType=\"pubmed\">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoover K., Higginbotham K. StatPearls. StatPearls Publishing LLC; Treasure Island, FL, USA: 2022. Epstein Barr Virus.</Citation></Reference><Reference><Citation>Rasa S., Nora-Krukle Z., Henning N., Eliassen E., Shikova E., Harrer T., Scheibenbogen C., Murovska M., Prusty B.K., European Network on ME/CFS (EUROMENE) Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome {ME/CFS) J. Transl. Med. 2018;16:268. doi: 10.1186/s12967-018-1644-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType=\"pmc\">PMC6167797</ArticleId><ArticleId IdType=\"pubmed\">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadinoto V., Shapiro M., Sun C.C., Thorley-Lawson D.A. The dynamics of EBV shedding implicates a central role for epithelial cells in amplifying viral output. PLoS Pathog. 2009;5:e1000496. doi: 10.1371/journal.ppat.1000496.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.ppat.1000496</ArticleId><ArticleId IdType=\"pmc\">PMC2698984</ArticleId><ArticleId IdType=\"pubmed\">19578433</ArticleId></ArticleIdList></Reference><Reference><Citation>Agut H. Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections. J. Clin. Virol. 2011;52:164&#x2013;171. doi: 10.1016/j.jcv.2011.06.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jcv.2011.06.008</ArticleId><ArticleId IdType=\"pubmed\">21782505</ArticleId></ArticleIdList></Reference><Reference><Citation>Borza C.M., Hutt-Fletcher L.M. Alternative replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat. Med. 2002;8:594&#x2013;599. doi: 10.1038/nm0602-594.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nm0602-594</ArticleId><ArticleId IdType=\"pubmed\">12042810</ArticleId></ArticleIdList></Reference><Reference><Citation>Aimola G., Beythien G., Aswad A., Kaufer B.B. Current understanding of human herpesvirus 6 (HHV-6) chromosomal integration. Antivir. Res. 2020;176:104720. doi: 10.1016/j.antiviral.2020.104720.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.antiviral.2020.104720</ArticleId><ArticleId IdType=\"pubmed\">32044155</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma D., Church T.M., Swaminathan S. Epstein-Barr virus lytic replication induxces ACE2 expression and enhances SARS-CoV-2 pseudotyped virus entry in epithelial cells. J. Virol. 2021;95:e0019221. doi: 10.1128/JVI.00192-21.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/JVI.00192-21</ArticleId><ArticleId IdType=\"pmc\">PMC8316011</ArticleId><ArticleId IdType=\"pubmed\">33853968</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolucci S., Cassaniti I., Novazzi F., Fiorina L., Piralla A., Commoli G., Bruno R., Maserati R., Gulminetti R., Novati S., et al. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. Int. J. Infect. Dis. 2021;104:315&#x2013;319. doi: 10.1016/j.ijid.2020.12.051.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijid.2020.12.051</ArticleId><ArticleId IdType=\"pmc\">PMC7833117</ArticleId><ArticleId IdType=\"pubmed\">33359064</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold J.E., Okyay R.A., Licht W.E., Hurley D.J. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens. 2021;10:763. doi: 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pathogens10060763</ArticleId><ArticleId IdType=\"pmc\">PMC8233978</ArticleId><ArticleId IdType=\"pubmed\">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Balandraud N., Roudier J. Epstein-Barr virus and rheumatoid arthritis. Jt. Bone Spine. 2018;85:165&#x2013;170. doi: 10.1016/j.jbspin.2017.04.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jbspin.2017.04.011</ArticleId><ArticleId IdType=\"pubmed\">28499895</ArticleId></ArticleIdList></Reference><Reference><Citation>Drosos A.A., Pelechas E., Voiulgari P.V. Long COVID from rheumatology perspective: A simple mimicker or promoter of autoimmunity? Clin. Rheumatol. 2022;41:957&#x2013;958. doi: 10.1007/s10067-022-06092-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10067-022-06092-4</ArticleId><ArticleId IdType=\"pmc\">PMC8831874</ArticleId><ArticleId IdType=\"pubmed\">35147823</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota H.R., Nune A. Long COVID from rheumatology perspective&#x2014;A narrative review. Clin. Rheumatol. 2022;41:337&#x2013;348. doi: 10.1007/s10067-021-06001-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10067-021-06001-1</ArticleId><ArticleId IdType=\"pmc\">PMC8629735</ArticleId><ArticleId IdType=\"pubmed\">34845562</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan R., Mao S.Q., Gu T.L., Zhong F.D., Gong M.L., Hao L.M., Yin F.Y., Dong C.Z., Zhang L.N. Preliminary analysis of the association between methylation of the ACE2 promoter and essential hypertension. Mol. Med. Rep. 2017;15:3905&#x2013;3911. doi: 10.3892/mmr.2017.6460.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/mmr.2017.6460</ArticleId><ArticleId IdType=\"pubmed\">28440441</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichelberg M.R., Welch R., Guidry J.T., Ali A., Ohashi M., Makielski K.R., McChesney K., Van Sciver N., Lambert P.F., Keles S., et al. Epstein-Barr virus infection promotes epithelial cell growth by attenuating differentiation-dependent exit from the cell cycle. mBio. 2019;10:e01332. doi: 10.1128/mBio.01332-19.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/mBio.01332-19</ArticleId><ArticleId IdType=\"pmc\">PMC6703421</ArticleId><ArticleId IdType=\"pubmed\">31431547</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams M.V., Cox B., Ariza M.E. Herpesviruses dUTPases: A new family of pathogen-associated molecular pattern (PAMP) proteins with implications for human disease. Pathogens. 2017;6:2. doi: 10.3390/pathogens6010002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pathogens6010002</ArticleId><ArticleId IdType=\"pmc\">PMC5371890</ArticleId><ArticleId IdType=\"pubmed\">28036046</ArticleId></ArticleIdList></Reference><Reference><Citation>Doitsh G., Galloway N.L.K., Geng X., Yang Z., Monroe K.M., Zependa O., Hunt P.W., Hatano H., Sowinski S., Munoz-Arias I., et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature. 2014;505:509&#x2013;514. doi: 10.1038/nature12940.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature12940</ArticleId><ArticleId IdType=\"pmc\">PMC4047036</ArticleId><ArticleId IdType=\"pubmed\">24356306</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.C., Chan J., Clement M.-V., Pervaiz S. Functional proteomics of resveratrol-induced colon cancer cell apoptosis: Caspase-6-mediated cleavage of lamin A is a major signaling loop. Proteomics. 2006;6:2386&#x2013;2394. doi: 10.1002/pmic.200500366.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/pmic.200500366</ArticleId><ArticleId IdType=\"pubmed\">16518869</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M., Shen J., Zhan J., Yu Y. dUTP pyrophosphatase, its appearance in extracellular compartment may serve as a potential biomarker for N-methyl-N&#x2019;-nitro-N-nitrosoguanadine exposure in mammalian cells. Proteomics. 2006;6:3001&#x2013;3007. doi: 10.1002/pmic.200500767.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/pmic.200500767</ArticleId><ArticleId IdType=\"pubmed\">16619294</ArticleId></ArticleIdList></Reference><Reference><Citation>Riza M.E., Rivailler P., Glaser R., Chen M., Williams M.V. Epstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cells. PLoS ONE. 2014;8:e69827</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3718799</ArticleId><ArticleId IdType=\"pubmed\">23894549</ArticleId></ArticleIdList></Reference><Reference><Citation>Beutler B. Interferences, questions and possibilities in Toll-like receptor signaling. Nature. 2004;430:257&#x2013;263. doi: 10.1038/nature02761.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature02761</ArticleId><ArticleId IdType=\"pubmed\">15241424</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T., Akira S. Innate immune recognition of viral infection. Nat. Immunol. 2006;7:131&#x2013;137. doi: 10.1038/ni1303.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ni1303</ArticleId><ArticleId IdType=\"pubmed\">16424890</ArticleId></ArticleIdList></Reference><Reference><Citation>Guggemoos S., Hangel D., Hamm S., Heit A., Bauer S., Adler H. TLR9 contributes to the antiviral immunity during gamma herpesvirus infection. J. Immunol. 2008;80:438&#x2013;443. doi: 10.4049/jimmunol.180.1.438.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/jimmunol.180.1.438</ArticleId><ArticleId IdType=\"pubmed\">18097045</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Yin H., Zhao M., Lu Q. TLR2 and TLR4 in autoimmune diseases: A comprehensive review. Clin. Rev. Allergy Immunol. 2014;47:136&#x2013;147. doi: 10.1007/s12016-013-8402-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12016-013-8402-y</ArticleId><ArticleId IdType=\"pubmed\">24352680</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato A., Linehan M.M., Iwasaki A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc. Natl. Acad. Sci. USA. 2006;103:17343&#x2013;17348. doi: 10.1073/pnas.0605102103.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0605102103</ArticleId><ArticleId IdType=\"pmc\">PMC1859932</ArticleId><ArticleId IdType=\"pubmed\">17085599</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehme K.W., Guerrero M., Compton T. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J. Immunol. 2006;177:7094&#x2013;7102. doi: 10.4049/jimmunol.177.10.7094.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/jimmunol.177.10.7094</ArticleId><ArticleId IdType=\"pubmed\">17082626</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudreault E., Fiola S., Olivier M., Gosselin J. Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J. Virol. 2007;81:8016&#x2013;8024. doi: 10.1128/JVI.00403-07.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/JVI.00403-07</ArticleId><ArticleId IdType=\"pmc\">PMC1951286</ArticleId><ArticleId IdType=\"pubmed\">17522215</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza M.E., Glaser R., Williams M.V. Human herpesviruses-encoded dUTPases: A family of proteins that modulate dendritic cell function and innate immunity. Front. Microbiol. 2014;5:504. doi: 10.3389/fmicb.2014.00504.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmicb.2014.00504</ArticleId><ArticleId IdType=\"pmc\">PMC4176148</ArticleId><ArticleId IdType=\"pubmed\">25309527</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza M.E., Glaser R., Kaumaya P.T.P., Jones C., Williams M. The Epstein-Barr virus (EBV)-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway. J. Immunol. 2009;182:851&#x2013;859. doi: 10.4049/jimmunol.182.2.851.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/jimmunol.182.2.851</ArticleId><ArticleId IdType=\"pubmed\">19124728</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldman W.J., Williams M.V., Lemeshow S.A., Binkley P., Guttridge D., Kiecolt-Glaser J.K., Knight D.A., Ladner K.J., Glaser R. Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: Evidence for depression-induced atherosclerotic risk. Brain Behav. Immun. 2008;22:215&#x2013;223. doi: 10.1016/j.bbi.2007.07.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2007.07.007</ArticleId><ArticleId IdType=\"pmc\">PMC2245868</ArticleId><ArticleId IdType=\"pubmed\">17845840</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin P., Williams M.V., Klimas N.G., Fletcher M.A., Varnes Z., Ariza M.E. Myalgic encephalomyelitis/chronic fatigue syndrome and Gulf War illness patients exhibit increased humoral responses to the Herpesviruses-encoded dUTPase: Implications in disease pathophysiology. J. Med. Virol. 2017;89:1636&#x2013;1645. doi: 10.1002/jmv.24810.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.24810</ArticleId><ArticleId IdType=\"pmc\">PMC5513753</ArticleId><ArticleId IdType=\"pubmed\">28303641</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva O.A., Maksoud R., Beeraka N.M., Madhunapantula S.V., Sinelnikov M., Nikolenko V.N., Neganova N.E., Klochkov S.G., Kamal M.A., Staines D.R., et al. Analysis of postCOVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J. Adv. Res. 2022;40:179&#x2013;196. doi: 10.1016/j.jare.2021.11.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType=\"pmc\">PMC8619886</ArticleId><ArticleId IdType=\"pubmed\">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow A.K., Malone L.A., Kokorelis C., Petracek L.S., Eastin E.F., Lobner K.L., Neuendorff L., Rowe P.C. Long-term COVID-19 sequelae in adolescents: The overlap with orthostatic intolerance and ME/CFS. Curr. Ped. Rep. 2022;10:31&#x2013;44. doi: 10.1007/s40124-022-00261-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40124-022-00261-4</ArticleId><ArticleId IdType=\"pmc\">PMC8906524</ArticleId><ArticleId IdType=\"pubmed\">35287333</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y., Balshaw D.M., Kwok R.K., Thompson C.L., Collman G.W., Birnbaum L.S. The exposome: Embracing the complexity for discovery in environmental health. Environ. Health. Perspect. 2016;124:A137&#x2013;A140. doi: 10.1289/EHP412.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1289/EHP412</ArticleId><ArticleId IdType=\"pmc\">PMC4977033</ArticleId><ArticleId IdType=\"pubmed\">27479988</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamdy A., Leonardi A. Superantigens and SARS-CoV-2. Pathogens. 2022;11:390. doi: 10.3390/pathogens11040390.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pathogens11040390</ArticleId><ArticleId IdType=\"pmc\">PMC9026686</ArticleId><ArticleId IdType=\"pubmed\">35456065</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng M.H., Zhang S., Porrit R.A., Rivas M.N., Pschold L., Willscher E., Binder M., Arditi M., Bahar I. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Prot. Nat. Acad. Sci. USA. 2020;117:25254&#x2013;25262. doi: 10.1073/pnas.2010722117.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2010722117</ArticleId><ArticleId IdType=\"pmc\">PMC7568239</ArticleId><ArticleId IdType=\"pubmed\">32989130</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaglioni V., Soriano E.R. Are superantigens the cause of cytokine storm and viral sepsis in severe COVID-19? Observations and hypothesis. Scand. J. Immunol. 2020;92:e12944. doi: 10.1111/sji.12944.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/sji.12944</ArticleId><ArticleId IdType=\"pmc\">PMC7404497</ArticleId><ArticleId IdType=\"pubmed\">32697367</ArticleId></ArticleIdList></Reference><Reference><Citation>Gammazza A.M., L&#xe9;gar&#xe9; S., Lo Bosco G., Fucarino A., Angileri F., de Macario E.C., Macario A.J.L., Cappello F. Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: Possible role of molecular mimicry in COVID-19. Cell Stress Chaperones. 2020;25:737&#x2013;741. doi: 10.1007/s12192-020-01148-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12192-020-01148-3</ArticleId><ArticleId IdType=\"pmc\">PMC7402394</ArticleId><ArticleId IdType=\"pubmed\">32754823</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubkowska A., Pluta W., Stronska A., Lalko A. Role of heat shock proteins (Hsp70 and Hsp90) in viral infection. Int. J. Mol. Sci. 2021;22:9366. doi: 10.3390/ijms22179366.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22179366</ArticleId><ArticleId IdType=\"pmc\">PMC8430838</ArticleId><ArticleId IdType=\"pubmed\">34502274</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanneau D., Brunet M., Frisan E., Solary E., Fontenay M., Garrido C. Heat shock proteins: Essential proteins for apoptosis regulation: Apoptosis Review Series. J. Cell. Mol. Med. 2008;12:743&#x2013;761. doi: 10.1111/j.1582-4934.2008.00273.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1582-4934.2008.00273.x</ArticleId><ArticleId IdType=\"pmc\">PMC4401125</ArticleId><ArticleId IdType=\"pubmed\">18266962</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard F.H.N., Kwan A., Winder N., Mughal A., Collado-Rojas C., Muthana M. Understanding immune response to viruses&#x2014;Do underlying Th1/Th2 cell biases predict outcome? Viruses. 2022;14:1493. doi: 10.3390/v14071493.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/v14071493</ArticleId><ArticleId IdType=\"pmc\">PMC9324514</ArticleId><ArticleId IdType=\"pubmed\">35891472</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagler C.R. Modern World Influences on the Microbiome and Their Consequences for Immune-Mediated Disease. J. Immunol. 2021;207:1695&#x2013;1696. doi: 10.4049/jimmunol.2190016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/jimmunol.2190016</ArticleId><ArticleId IdType=\"pubmed\">34544809</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaser M. The theory of disappearing microbiota and the epidemics of chronic diseases. Nat. Rev. Immunol. 2017;17:461&#x2013;463. doi: 10.1038/nri.2017.77.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nri.2017.77</ArticleId><ArticleId IdType=\"pubmed\">28749457</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M.F., Wang G. Environmental agents, oxidative stress and autoimmunity. Curr. Opin. Toxicol. 2017;7:22&#x2013;27. doi: 10.1016/j.cotox.2017.10.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cotox.2017.10.012</ArticleId><ArticleId IdType=\"pmc\">PMC5844495</ArticleId><ArticleId IdType=\"pubmed\">29532040</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehner C., Fine R., Kriegel M. The microbiome in systemic autoimmune disease: Mechanistic insights from recent studies. Curr. Opin. Rheumatol. 2019;31:201&#x2013;207. doi: 10.1097/BOR.0000000000000574.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/BOR.0000000000000574</ArticleId><ArticleId IdType=\"pmc\">PMC6408954</ArticleId><ArticleId IdType=\"pubmed\">30624285</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luca F., Shoenfeld Y. The microbiome in autoimmune diseases. Clin. Exp. Immunol. 2018;195:74&#x2013;85. doi: 10.1111/cei.13158.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/cei.13158</ArticleId><ArticleId IdType=\"pmc\">PMC6300652</ArticleId><ArticleId IdType=\"pubmed\">29920643</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Selmi C., Tang R., Gershwin M.E., Ma X. The microbiome and autoimmunity: A paradigm from the gut&#x2013;liver axis. Cell. Mol. Immunol. 2018;15:595&#x2013;609. doi: 10.1038/cmi.2018.7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/cmi.2018.7</ArticleId><ArticleId IdType=\"pmc\">PMC6079090</ArticleId><ArticleId IdType=\"pubmed\">29706647</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., Mahroum N., Bogdanos D.P., Shoenfeld Y. COVID-19 as an infectome paradigm of autoimmunity. J. Allergy Clin. Immunol. 2022;149:63&#x2013;64. doi: 10.1016/j.jaci.2021.11.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaci.2021.11.009</ArticleId><ArticleId IdType=\"pmc\">PMC8610602</ArticleId><ArticleId IdType=\"pubmed\">34826507</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Wang H., Sun Y., Ren Z., Zhu W., Li A., Cui G. Potential associations between microbiome and COVID-19. Front. Med. 2021;8:785496. doi: 10.3389/fmed.2021.785496.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmed.2021.785496</ArticleId><ArticleId IdType=\"pmc\">PMC8727742</ArticleId><ArticleId IdType=\"pubmed\">35004750</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType=\"pmc\">PMC7804842</ArticleId><ArticleId IdType=\"pubmed\">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinold J., Farahpour F., Schoerding A.-K., Fehring C., Dolff S., Konik M., Korth J., van Baal L., Buer J., Witzke O., et al. The fungal gut microbiome exhibits reduced diversity and increased relative abundance of Ascomycota in severe COVID illness and distinct interconnected communities in SARS-CoV-2 positive patients. Front. Cell. Infect. Microbiol. 2022;12:848650. doi: 10.3389/fcimb.2022.848650.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcimb.2022.848650</ArticleId><ArticleId IdType=\"pmc\">PMC9062042</ArticleId><ArticleId IdType=\"pubmed\">35521219</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhan H., Zhang F., Liu Q., Tso E.Y.K., Lui G.C.Y., Chen N., Li A., Lu W., Chan F.K.L., et al. Alterations in fecal fungal microbiome of patients with covid-19 during time of hospitalization until discharge. Gastroenterology. 2020;159:1302&#x2013;1310. doi: 10.1053/j.gastro.2020.06.048.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1053/j.gastro.2020.06.048</ArticleId><ArticleId IdType=\"pmc\">PMC7318920</ArticleId><ArticleId IdType=\"pubmed\">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C.Y., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S.C., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType=\"pmc\">PMC8814432</ArticleId><ArticleId IdType=\"pubmed\">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Wan Y., Zuo T., Yeoh Y.K., Liu Q., Zhang L., Zhan H., Lu W., Xu W., Lui G.C.Y., et al. Prolonged impairment of short-chain fatty acid and l-isoleucine biosynthesis in gut microbiome in patients with COVID-19. Gastroenterology. 2022;162:548&#x2013;561. doi: 10.1053/j.gastro.2021.10.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1053/j.gastro.2021.10.013</ArticleId><ArticleId IdType=\"pmc\">PMC8529231</ArticleId><ArticleId IdType=\"pubmed\">34687739</ArticleId></ArticleIdList></Reference><Reference><Citation>Venzon M., Cadwell K. COVID-19 and the forgotten organ: Prolonged changes to the metabolic ouptut of the gut microbiome. Gastroenterology. 2022;162:394&#x2013;396. doi: 10.1053/j.gastro.2021.11.017.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1053/j.gastro.2021.11.017</ArticleId><ArticleId IdType=\"pmc\">PMC8596650</ArticleId><ArticleId IdType=\"pubmed\">34800482</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Liu Q., Zhang F., Lui G.C.-Y., Tso E.Y., Yeoh Y.K., Chen Z., Boon S.S., Chan F.K., Chan P.K., et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. 2021;70:276&#x2013;284. doi: 10.1136/gutjnl-2020-322294.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/gutjnl-2020-322294</ArticleId><ArticleId IdType=\"pmc\">PMC7385744</ArticleId><ArticleId IdType=\"pubmed\">32690600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hejrati A., Rafiei A., Soltanshahi M., Hosseinzadeh S., DAbiri M., Taghadosi M., Taghiloo S., Bashash D., Khorsidi F., Zafari P. Innate immune response in systemic autoimmune diseases: A potential target of therapy. Inflammopharmacology. 2020;28:1421&#x2013;1438. doi: 10.1007/s10787-020-00762-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10787-020-00762-y</ArticleId><ArticleId IdType=\"pubmed\">33006718</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordin P., Casari G., Townsend L., O&#x2019;Farrelly C., Tancevski I., L&#xf6;ffler-Ragg J., Mogensen T.H., Casanova J.L., COVID Human Genetic Effort Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat. Med. 2022;28:879&#x2013;889. doi: 10.1038/s41591-022-01766-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-022-01766-7</ArticleId><ArticleId IdType=\"pubmed\">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin. Immunol. 2020;217:108480. doi: 10.1016/j.clim.2020.108480.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.clim.2020.108480</ArticleId><ArticleId IdType=\"pmc\">PMC7246018</ArticleId><ArticleId IdType=\"pubmed\">32461193</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Vojdani E., Melgar A.L., Redd J. Reaction of SARS-CoV-2 antibodies with other pathogens, vaccines, and food antigens. Front. Immunol. 2022;13:1003094. doi: 10.3389/fimmu.2022.1003094.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2022.1003094</ArticleId><ArticleId IdType=\"pmc\">PMC9537454</ArticleId><ArticleId IdType=\"pubmed\">36211404</ArticleId></ArticleIdList></Reference><Reference><Citation>Churilov L.P., Normatov M.G., Utekhin V.J. Molecular mimicry between SARS-CoV-2 and human endocrinocytes: A prerequisite of post-COVID-19 endocrine autoimmunity? Pathophysiology. 2022;29:486&#x2013;494. doi: 10.3390/pathophysiology29030039.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pathophysiology29030039</ArticleId><ArticleId IdType=\"pmc\">PMC9504401</ArticleId><ArticleId IdType=\"pubmed\">36136066</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston C.K., Swiatkiewicz I., Taub P.R. Postural orthostatic syndrome as a sequela of COVID-19. Heart Rhythm. 2022;19:1880&#x2013;1889. doi: 10.1016/j.hrthm.2022.07.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.hrthm.2022.07.014</ArticleId><ArticleId IdType=\"pmc\">PMC9287587</ArticleId><ArticleId IdType=\"pubmed\">35853576</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Marques O., Halpert G., Schimke L.F., Ostrinski Y., Vojdani A., Baiocchi G.C., Freire P.P., Filgueiras I.S., Zyskind I., Lattin M.T., et al. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nat. Commun. 2022;13:1220. doi: 10.1038/s41467-022-28905-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-28905-5</ArticleId><ArticleId IdType=\"pmc\">PMC8907309</ArticleId><ArticleId IdType=\"pubmed\">35264564</ArticleId></ArticleIdList></Reference><Reference><Citation>Sancho-Shimizu V., Brodin P., Cobat A., Biggs C.M., Toubiana J., Lucas C.L., Henrickson S.E., Belot A., MIS-C@CHGE. Tangye S.G. SARS-CoV-2&#x2013;related MIS-C: A key to the viral and genetic causes of Kawasaki disease? J. Exp. Med. 2021;218:e20210446. doi: 10.1084/jem.20210446.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1084/jem.20210446</ArticleId><ArticleId IdType=\"pmc\">PMC8080850</ArticleId><ArticleId IdType=\"pubmed\">33904890</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio C.R., Cotugno N., Sardh F., Pou C., Amodio D., Rodriguez L., Tan Z., Zicari S., Ruggiero A., Pascucci G.R., et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183:968&#x2013;981. doi: 10.1016/j.cell.2020.09.016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType=\"pmc\">PMC7474869</ArticleId><ArticleId IdType=\"pubmed\">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Novelli L., Motta F., De Santis M., Ansari A.A., Gershwin M.E., Selmi C. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19&#x2014;A systematic review of the literature. J. Autoimmun. 2021;117:102592. doi: 10.1016/j.jaut.2020.102592.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaut.2020.102592</ArticleId><ArticleId IdType=\"pmc\">PMC7833462</ArticleId><ArticleId IdType=\"pubmed\">33401171</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez Y., Novelli L., Rojas M., De Santis M., Acosta-Ampudia Y., Monsalve D.M., Ramirez-Santana C., Cistanzo A., Ridgway W.M., Ansari A.A., et al. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J. Autoimmun. 2020;114:102506. doi: 10.1016/j.jaut.2020.102506.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaut.2020.102506</ArticleId><ArticleId IdType=\"pmc\">PMC7296326</ArticleId><ArticleId IdType=\"pubmed\">32563547</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianini M., Ohana M., Nespola B., Zanframundo G., Geny B., Meyer A. Similarities between COVID-19 and anti-MDA5 syndrome: What can we learn for better care? Eur. Respir. J. 2020;56:2001618. doi: 10.1183/13993003.01618-2020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1183/13993003.01618-2020</ArticleId><ArticleId IdType=\"pmc\">PMC7338399</ArticleId><ArticleId IdType=\"pubmed\">32631836</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Du G., Zhang G., Matucci-Cerinic M., Furst D.E. Similarities and differences between severe COVID-19 pneumonia and MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: A challenge for the future. Ann. Rheum. Dis. 2022;81:e192. doi: 10.1136/annrheumdis-2020-218594.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/annrheumdis-2020-218594</ArticleId><ArticleId IdType=\"pubmed\">32759260</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Bastard P., Liu Z., Le Pen J., Moncada-Velez M., Chen J., Ogishi M., Sabli I.K.D., Hodeib S., Korol C., et al. Inborn errors of type 1 IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570. doi: 10.1126/science.abd4570.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.abd4570</ArticleId><ArticleId IdType=\"pmc\">PMC7857407</ArticleId><ArticleId IdType=\"pubmed\">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.-H., Zhang Y., Dorgham K., Philippot Q., Rosain J., B&#xe9;ziat V., et al. Autoantibodies against type1 IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.abd4585</ArticleId><ArticleId IdType=\"pmc\">PMC7857397</ArticleId><ArticleId IdType=\"pubmed\">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>De Stefano L., Rossi S., Montecucco C., Bugatti S. Transient monoarthritis and psoriatic skin lesions following COVID-19. Ann. Rheum. Dis. 2020;2020:218520. doi: 10.1136/annrheumdis-2020-218520.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/annrheumdis-2020-218520</ArticleId><ArticleId IdType=\"pubmed\">32753423</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew I.Y., Mak T.M., Cui L., Vasoo S., Lim X.R. A case of reactive arthritis secondary to Coronavirus Disease 2019 infection. J. Clin. Rheumatol. 2020;26:233. doi: 10.1097/RHU.0000000000001560.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/RHU.0000000000001560</ArticleId><ArticleId IdType=\"pmc\">PMC7437408</ArticleId><ArticleId IdType=\"pubmed\">32694352</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono K., Kishimoto M., Shimasaki T., Uchida H., Kurai D., Deshpande G.A., Komagata Y., Kaname S. Reactive arthritis after COVID-19 infection. R.M.D. Open. 2020;6:e001350. doi: 10.1136/rmdopen-2020-001350.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/rmdopen-2020-001350</ArticleId><ArticleId IdType=\"pmc\">PMC7722270</ArticleId><ArticleId IdType=\"pubmed\">32763956</ArticleId></ArticleIdList></Reference><Reference><Citation>Novelli L., Motta F., Ceribelli A., Guidelli G.M., Luciano N., Isailovic N., Vecellio M., Caprioli M., Clementi N., Clementi M., et al. A case of psoriatic arthritis triggered by SARS-CoV-2 infection. Rheumatology. 2021;60:e21&#x2013;e23. doi: 10.1093/rheumatology/keaa691.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/rheumatology/keaa691</ArticleId><ArticleId IdType=\"pmc\">PMC7717387</ArticleId><ArticleId IdType=\"pubmed\">33206980</ArticleId></ArticleIdList></Reference><Reference><Citation>Talarico R., Stagnaro C., Ferro F., Carli L., Mosca M. Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection. Lancet Rheumatol. 2020;2:e518&#x2013;e519. doi: 10.1016/S2665-9913(20)30216-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S2665-9913(20)30216-2</ArticleId><ArticleId IdType=\"pmc\">PMC7357970</ArticleId><ArticleId IdType=\"pubmed\">32838313</ArticleId></ArticleIdList></Reference><Reference><Citation>Saricaoglu E.M., Hasanoglu I., Guner R. The first reactive arthritis case associated with COVID-19. J. Med. Virol. 2021;93:192&#x2013;193. doi: 10.1002/jmv.26296.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.26296</ArticleId><ArticleId IdType=\"pmc\">PMC7405389</ArticleId><ArticleId IdType=\"pubmed\">32652541</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokogawa N., Minematsu M., Katano H., Suzuki T. Case of acute arthritis following SARS-CoV-2 infection. Ann. Rheum. Dis. 2021;80:e101. doi: 10.1136/annrheumdis-2020-218281.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/annrheumdis-2020-218281</ArticleId><ArticleId IdType=\"pubmed\">32591356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Estes S.K., Ali R.A., Gandhi A.A., Yalavarthi S., Shi H., Sule G., Gockma K., Madison J.A., Zuo M., et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl. Med. 2020;12:eabd3876. doi: 10.1126/scitranslmed.abd3876.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/scitranslmed.abd3876</ArticleId><ArticleId IdType=\"pmc\">PMC7724273</ArticleId><ArticleId IdType=\"pubmed\">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H., Zuo Y., Navaz S., Harbaugh A., Hoy C.K., Gandhi A.A., Sule G., Yalavarthi S., Gockman K., Madison J.A., et al. Endothelial cell-activating antibodies in COVID-19. medRxiv. 2022 doi: 10.1002/art.42094.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/art.42094</ArticleId><ArticleId IdType=\"pmc\">PMC9082472</ArticleId><ArticleId IdType=\"pubmed\">35174669</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Ramos A.E., Martin-Nares E., Hern&#xe1;ndez-Molina G. New onset of autoimmune diseases following COVID-19 diagnosis. Cells. 2021;10:3592. doi: 10.3390/cells10123592.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells10123592</ArticleId><ArticleId IdType=\"pmc\">PMC8700122</ArticleId><ArticleId IdType=\"pubmed\">34944099</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini P., Fallahi M.S., Erabi G., Pakdin M., Zarezadeh S.M., Faridzadeh A., Entezari S., Ansari A., Poudineh M., Deravi N. Multisystem inflammatory syndrome and autoimmune disease following COVID-19: Molecular mechanisms and therapeutic opportunities. Front. Mol. Biosci. 2022;9:804109. doi: 10.3389/fmolb.2022.804109.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmolb.2022.804109</ArticleId><ArticleId IdType=\"pmc\">PMC9046575</ArticleId><ArticleId IdType=\"pubmed\">35495619</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpert G., Shoenfeld Y. SARS-CoV-2, the Autoimmune virus. Autoimmun. Rev. 2020;19:102695. doi: 10.1016/j.autrev.2020.102695.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2020.102695</ArticleId><ArticleId IdType=\"pmc\">PMC7598743</ArticleId><ArticleId IdType=\"pubmed\">33130000</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., Muller S., Kanduc D., David P., Halpert G., Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun. Rev. 2021;20:102792. doi: 10.1016/j.autrev.2021.102792.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2021.102792</ArticleId><ArticleId IdType=\"pmc\">PMC7892316</ArticleId><ArticleId IdType=\"pubmed\">33610751</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoenfeld Y. Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning. Autoimmune Res. 2020;19:102538. doi: 10.1016/j.autrev.2020.102538.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2020.102538</ArticleId><ArticleId IdType=\"pmc\">PMC7131471</ArticleId><ArticleId IdType=\"pubmed\">32268212</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons-Weiler J. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. J. Transl. Autoimmun. 2020;3:100051. doi: 10.1016/j.jtauto.2020.100051.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jtauto.2020.100051</ArticleId><ArticleId IdType=\"pmc\">PMC7142689</ArticleId><ArticleId IdType=\"pubmed\">32292901</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamarellos-Bourboulis E.J., Netea M.G., Rovina N., Akinosoglou K., Antoniadou A., Antonakos N., Damorakin G., Gkavogianni T., Adami M.-E., Katsaounou P., et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27:992&#x2013;1000.e3.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7172841</ArticleId><ArticleId IdType=\"pubmed\">32320677</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Vojdani E., Kharrazian D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: Implications for autoimmune diseases. Front. Immunol. 2021;11:617089. doi: 10.3389/fimmu.2020.617089.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2020.617089</ArticleId><ArticleId IdType=\"pmc\">PMC7873987</ArticleId><ArticleId IdType=\"pubmed\">33584709</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanduc D., Shoenfeld Y. On the molecular determinants of the SARS-CoV-2 attack. Clin. Immunol. 2020;215:108426. doi: 10.1016/j.clim.2020.108426.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.clim.2020.108426</ArticleId><ArticleId IdType=\"pmc\">PMC7165084</ArticleId><ArticleId IdType=\"pubmed\">32311462</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanduc D., Shoenfeld Y. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: Implications for the vaccine. Immunol. Res. 2020;68:310&#x2013;313. doi: 10.1007/s12026-020-09152-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12026-020-09152-6</ArticleId><ArticleId IdType=\"pmc\">PMC7499017</ArticleId><ArticleId IdType=\"pubmed\">32946016</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker R.C. COVID-19-associated coagulopathy. J. Thromb. Thrombolysis. 2020;50:54&#x2013;67.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7225095</ArticleId><ArticleId IdType=\"pubmed\">32415579</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Xiao M., Zhang S., Xia P., Cao W., Jiang W., Chen H., Ding X., Zhao H., Zhang H., et al. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N. Engl. J. Med. 2020;382:e38. doi: 10.1056/NEJMc2007575.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMc2007575</ArticleId><ArticleId IdType=\"pmc\">PMC7161262</ArticleId><ArticleId IdType=\"pubmed\">32268022</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Sawalha A.H., Lu Q. COVID-19 and autoimmune diseases. Curr. Opin. Rheumatol. 2020;33:155&#x2013;162.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7880581</ArticleId><ArticleId IdType=\"pubmed\">33332890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M., Tincani A., Andreoli L., Cattalini M., Greenbaum A., Kanduc D., Alijotas-Reig J., Zinserling V., Semenova N., Amital H., et al. COVID-19 and autoimmunity. Autoimmun. Rev. 2020;19:102597.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7289100</ArticleId><ArticleId IdType=\"pubmed\">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryabkova V.A., Churilov L.P., Shoenfeld Y. Influenza infection, SARS, MERS and COVID-19: Cytokine storm&#x2014;The common denominator and the lessons to be learned. Clin. Immunol. 2020;223:108652.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7832378</ArticleId><ArticleId IdType=\"pubmed\">33333256</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A., Kudlay D., Kudryavtsev I., Starshinova A., Yablonskiy P., Shoenfeld Y. Immunogenetic predictors of severe COVID-19. Vaccines. 2021;9:211. doi: 10.3390/vaccines9030211.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/vaccines9030211</ArticleId><ArticleId IdType=\"pmc\">PMC8001669</ArticleId><ArticleId IdType=\"pubmed\">33802310</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahroum N., Alghory A., Kiyak Z., Alwani A., Seida R., Alrais M., Shoenfeld Y. Ferritin&#x2014;From iron, through inflammation and autoimmunity, to COVID-19. J. Autoimmun. 2021;126:102778.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8647584</ArticleId><ArticleId IdType=\"pubmed\">34883281</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A. Molecular and immunological evidence for SARS-CoV-2 being the autoimmune virus; Proceedings of the Abstract, Oral Presentation, 13th International Congress on Autoimmunity; Athens, Greece. 10&#x2013;13 June 2022..</Citation></Reference><Reference><Citation>Nahmias A.J. Clinical aspects of infection with herpes simplex viruses 1 and 2. In: Nahmias A., Dowdle W.R., Shinazai R.F., editors. The Human Herpesviruses: An Interdisciplinary Perspective. Elsevier; Amsterdam, The Netherlands: 1981.</Citation></Reference><Reference><Citation>Virtanen J.O., Jacobson S. Viruses and multiple sclerosis. C.N.S. Neurol. Disord.-Drug Targets. 2012;11:528&#x2013;544. doi: 10.2174/187152712801661220.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/187152712801661220</ArticleId><ArticleId IdType=\"pmc\">PMC4758194</ArticleId><ArticleId IdType=\"pubmed\">22583435</ArticleId></ArticleIdList></Reference><Reference><Citation>Draborg A.H., Duus K., Houen G. Epstein-Barr virus and systemic lupus erythematosus. Clin. Dev. Immunol. 2012;2012:370516.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3395176</ArticleId><ArticleId IdType=\"pubmed\">22811739</ArticleId></ArticleIdList></Reference><Reference><Citation>Draborg A.H., Duus K., Houen G. Epstein-Barr virus in systemic autoimmune diseases. Clin. Dev. Immunol. 2013;2013:535738. doi: 10.1155/2013/535738.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2013/535738</ArticleId><ArticleId IdType=\"pmc\">PMC3766599</ArticleId><ArticleId IdType=\"pubmed\">24062777</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S.-F., Wu H.-C., Tsai W.-C., Yen J.-H., Chiang W., You C.-Y., Lu S.-N., Chiang L.-C., Chen C.-J. Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan. Med. Microbiol. Immunol. 2004;194:115&#x2013;120. doi: 10.1007/s00430-004-0230-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00430-004-0230-5</ArticleId><ArticleId IdType=\"pubmed\">15378356</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon U.Y., Park S.J., Oh S.T., Kim W.-U., Park S.-H., Lee C.-H., Cho C.-S., Kim H.-Y., Lee W.-K. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res. Ther. 2004;6:R295&#x2013;R302. doi: 10.1186/ar1181.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/ar1181</ArticleId><ArticleId IdType=\"pmc\">PMC464871</ArticleId><ArticleId IdType=\"pubmed\">15225364</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross A.J., Hochberg D., Rand W.M., Thorley-Lawson D.A. EBV and systemic lupus erythematosus: A new perspective. J. Immunol. 2005;174:6599&#x2013;6607. doi: 10.4049/jimmunol.174.11.6599.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/jimmunol.174.11.6599</ArticleId><ArticleId IdType=\"pubmed\">15905498</ArticleId></ArticleIdList></Reference><Reference><Citation>Draborg A.H., Jorgensen J.M., M&#xfc;ller H., Nielsen C.T., Jacobsen S., Iversen L.V., Theander E., Nielsen L.P., Houen G., Duus K. Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients. Scand. J. Rheumatol. 2012;41:280&#x2013;289. doi: 10.3109/03009742.2012.665944.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/03009742.2012.665944</ArticleId><ArticleId IdType=\"pubmed\">22646970</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole B.D., Scofield R.H., Harley J.B., James J.A. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity. 2006;39:63&#x2013;70. doi: 10.1080/08916930500484849.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/08916930500484849</ArticleId><ArticleId IdType=\"pubmed\">16455583</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwakiri D., Zhou L., Samanta M., Matsumoto M., Ebihara T., Seya T., Imai S., Fujieda M., Kawa K., Takada K. Epstein-Barr-virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3. J. Exp. Med. 2009;206:2091&#x2013;2099.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2757889</ArticleId><ArticleId IdType=\"pubmed\">19720839</ArticleId></ArticleIdList></Reference><Reference><Citation>Jog N.R. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Ann. Rheum. Dis. 2019;78:1235&#x2013;1241. doi: 10.1136/annrheumdis-2019-215361.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/annrheumdis-2019-215361</ArticleId><ArticleId IdType=\"pmc\">PMC6692217</ArticleId><ArticleId IdType=\"pubmed\">31217170</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.J. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: Case control studies. J. Rheumatol. 2005;32:44&#x2013;47.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15630723</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman K.M. Peptide mimics of a major lupus epitope of SmB/B&#x2032;. Ann. N. Y. Acad. Sci. 2003;987:215&#x2013;229. doi: 10.1111/j.1749-6632.2003.tb06051.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1749-6632.2003.tb06051.x</ArticleId><ArticleId IdType=\"pubmed\">12727642</ArticleId></ArticleIdList></Reference><Reference><Citation>Mclain M.T. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis Rheum. 2006;54:360&#x2013;368.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16385527</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole B.D. Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments. J Autoimmun. 2008;31:362371. doi: 10.1016/j.jaut.2008.08.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaut.2008.08.007</ArticleId><ArticleId IdType=\"pmc\">PMC2852321</ArticleId><ArticleId IdType=\"pubmed\">18849143</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandman-Goddard G. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease. Ann. N. Y. Acad. Sci. 2009;1173:658&#x2013;663. doi: 10.1111/j.1749-6632.2009.04754.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1749-6632.2009.04754.x</ArticleId><ArticleId IdType=\"pubmed\">19758212</ArticleId></ArticleIdList></Reference><Reference><Citation>Esen B.A. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: A controlled study. Rheumatol. Int. 2012;32:79&#x2013;83. doi: 10.1007/s00296-010-1573-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00296-010-1573-4</ArticleId><ArticleId IdType=\"pubmed\">20661740</ArticleId></ArticleIdList></Reference><Reference><Citation>Vista E.S. Strong viral associations with SLE among Filipinos. Lupus Sci. Med. 2017;4:e000214.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5704743</ArticleId><ArticleId IdType=\"pubmed\">29214036</ArticleId></ArticleIdList></Reference><Reference><Citation>Morissette G., Flamand L. Herpesviruses and chromosomal integration. J. Virol. 2010;84:12100&#x2013;12109. doi: 10.1128/JVI.01169-10.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/JVI.01169-10</ArticleId><ArticleId IdType=\"pmc\">PMC2976420</ArticleId><ArticleId IdType=\"pubmed\">20844040</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Lafuente R., Fern&#xe1;ndez-Guti&#xe9;rrez B., de Miguel S., Jover J.A., Rollin R., Loza E., Clemente D., Lamas J.R. Potential relationship between herpes viruses and rheumatoid arthritis: Analysis with qualitative real time polymerase chain reaction. Ann. Rheum. Dis. 2005;64:1357&#x2013;1359. doi: 10.1136/ard.2004.033514.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/ard.2004.033514</ArticleId><ArticleId IdType=\"pmc\">PMC1755640</ArticleId><ArticleId IdType=\"pubmed\">16100341</ArticleId></ArticleIdList></Reference><Reference><Citation>Krueger G.R.F., Sander C., Hoffmann A., Barth A., Koch B., Braun M. Isolation of human herpesvirus-6 (HHV-6) from patients with collagen vascular diseases. In Vivo. 1991;5:217&#x2013;225.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1654147</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman A., Kirn E., Kuerten A., Sander C., Krueger G.R.F., Ablashi D.V. Active human herpesvirus-6 (HHV-6) infection associated with Kikuchi-Fujimoto disease and systemic lupus erythematosus (SLE) In Vivo. 1991;5:265&#x2013;269.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1654149</ArticleId></ArticleIdList></Reference><Reference><Citation>Broccolo F., Drago F., Paolino S., Cassina G., Gatto F., Fusetti L., Matteoli B., Zaccaria E., Parodi A., Lusso P., et al. Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases. J. Clin. Virol. 2009;46:43&#x2013;46.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19515610</ArticleId></ArticleIdList></Reference><Reference><Citation>Broccolo F., Drago F., Cassina G., Fava A., Fusetti L., Matteoli B., Ceccherini-Nelli L., Sabbadini M.G., Lusso P., Parodi A., et al. Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases. J. Med. Virol. 2013;85:1925&#x2013;1934.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23983182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranger-Rogez S., Vidal E., Liozon F., Denis F. Primary Sj&#xf6;gren&#x2019;s syndrome and antibodies to human herpesvirus type 6. Clin. Infect. Dis. 1994;19:1159&#x2013;1160. doi: 10.1093/clinids/19.6.1159.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/clinids/19.6.1159</ArticleId><ArticleId IdType=\"pubmed\">7888554</ArticleId></ArticleIdList></Reference><Reference><Citation>Caselli E., Soffritti I., D&#x2019;Accolti M., Bortolotti D., Sighinolfi G., Giuggioli D., Ferri C. HHV-6A infection and systemic sclerosis: Clues of a possible association. Microorganisms. 2020;8:39. doi: 10.3390/microorganisms8010039.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/microorganisms8010039</ArticleId><ArticleId IdType=\"pmc\">PMC7022325</ArticleId><ArticleId IdType=\"pubmed\">31878218</ArticleId></ArticleIdList></Reference><Reference><Citation>Caselli E., Zatelli M.C., Rizzo R., Benedetti S., Martorelli D., Trasforini G., Cassai E., degli Uberti E.C., Di Luca D., Dolcetti R. Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto&#x2019;s thyroiditis. PLoS Pathog. 2012;8:100295</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3464215</ArticleId><ArticleId IdType=\"pubmed\">23055929</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultanova A., Cistjakovs M., Gravelsina S., Chapenko S., Roga S., Cunskis E., Nore-Krukle Z., Groma V., Ventina I., Murovska M. Association of active human herpesvirus 6 (HHV-6) infection with autoimmune thyroid gland diseases. Clin. Microbiol. Infect. 2017;23:e1&#x2013;e50. doi: 10.1016/j.cmi.2016.09.023.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmi.2016.09.023</ArticleId><ArticleId IdType=\"pubmed\">27693656</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldan S.S., Berti R., Salem N., Secchiero P., Flamand L., Calabresi P.A., Brennan M.B., Maloni H.W., McFarland H.F., Lin H.C., et al. Association of human herpesvirus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nature Med. 1997;3:1394&#x2013;1397. doi: 10.1038/nm1297-1394.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nm1297-1394</ArticleId><ArticleId IdType=\"pubmed\">9396611</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillet A.M., Lozeron P., Augt H., Lyon-Caen O., Liblau R. HHV-6 and multiple sclerosis. Nat. Med. 1998;4:537. doi: 10.1038/nm0598-537a.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nm0598-537a</ArticleId><ArticleId IdType=\"pubmed\">9585208</ArticleId></ArticleIdList></Reference><Reference><Citation>Coates A.R., Bell J. HHV-6 and multiple sclerosis. Nat. Med. 1998;4:537&#x2013;538. doi: 10.1038/nm0598-537b.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nm0598-537b</ArticleId><ArticleId IdType=\"pubmed\">9585209</ArticleId></ArticleIdList></Reference><Reference><Citation>Ablashi D.V., Lapps W., Kaplan M., Whitman J.E., Richert J.R., Pearson G.R. Human herpesvirus-6 (HHV-6) in multiple sclerosis: A preliminary report. Mult. Scler. 1998;4:490&#x2013;496. doi: 10.1177/135245859800400606.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/135245859800400606</ArticleId><ArticleId IdType=\"pubmed\">9987758</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman J.E., Lyons M.J., Cu G., Ablashi D.V., Whitman J.E., Edgar M., Koskiniemi M., Vaheri A., Zabriskie J.B. The association of the human herpesvirus-6 and MS. Mult. Scler. 1999;5:355&#x2013;362. doi: 10.1177/135245859900500509.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/135245859900500509</ArticleId><ArticleId IdType=\"pubmed\">10516780</ArticleId></ArticleIdList></Reference><Reference><Citation>Voumvourakis K.I., Kitsos D.K., Tsiodras S., Petrikkos G., Stamboulis E. Human herpesvirus 6 infection as a trigger of multiple sclerosis. Mayo Clin. Proc. 2010;11:1023&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2966366</ArticleId><ArticleId IdType=\"pubmed\">20926836</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhyani N., Berti R., Brennan M.B., Soldan S.S., Eaton J.M., McFarland H.F., Jacobson S. Tissue distribution and variant characterization of human herpesvirus (HHV-6) increased prevalence of HHV-6A in patients with multiple sclerosis. J. Infect. Dis. 2000;182:1321&#x2013;1325. doi: 10.1086/315893.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1086/315893</ArticleId><ArticleId IdType=\"pubmed\">11023456</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders V.J., Felisan S., Waddell A., Tourtellotte W.W. Detection of Herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J. Neurovirol. 1996;2:249&#x2013;258. doi: 10.3109/13550289609146888.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/13550289609146888</ArticleId><ArticleId IdType=\"pubmed\">8799216</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.-S., Lee K.-S., Park J.-H., Kim M.-Y., Shin W.-S. Detection of human herpesvirus 6 variant A in peripheral blood mononuclear cells from multiple sclerosis patients. Eur. Neurol. 2000;43:170&#x2013;173. doi: 10.1159/000008158.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000008158</ArticleId><ArticleId IdType=\"pubmed\">10765058</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapenko S., Millers A., Nora Z., Logina I., Kukaine R., Murovska M. Correlation beteeen HHV-6 reactivation and multiple sclerosis disease activity. J. Med. Virol. 2003;69:111&#x2013;117. doi: 10.1002/jmv.10258.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.10258</ArticleId><ArticleId IdType=\"pubmed\">12436486</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotola A., Merlotti I., Caniatti L., Caselli E., Granieri E., Tola M.R., Di Luca D., Cassai E. Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease. Mult. Scler. 2004;10:348&#x2013;354. doi: 10.1191/1352458504ms1045oa.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1191/1352458504ms1045oa</ArticleId><ArticleId IdType=\"pubmed\">15327028</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman A.D., Mock D.J., Powers J.M., Baker J.V., Blumberg B.M. Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J. Infect. Dis. 2003;187:1365&#x2013;1376. doi: 10.1086/368172.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1086/368172</ArticleId><ArticleId IdType=\"pubmed\">12717617</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilborn F., Schmidt C.A., Brinckmann V., Jendroska K., Oettle H., Siegert W. A potential role for human herpesvirus type 6 in nervous system disease. J. Neuroimmunol. 1994;49:213&#x2013;214. doi: 10.1016/0165-5728(94)90198-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0165-5728(94)90198-8</ArticleId><ArticleId IdType=\"pubmed\">8294559</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Lafuente R., De Las Heras V., Bartolome M., Picazo J.J., Arroyo R. Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch. Neurol. 2004;61:1523&#x2013;1527. doi: 10.1001/archneur.61.10.1523.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archneur.61.10.1523</ArticleId><ArticleId IdType=\"pubmed\">15477505</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson S., Taylor B., Dwyer D.E., Taylor J., Blizzard L., Ponsonby A.-L., Pittas F., Dwyer T., van der Mei I. Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis. Mult. Scler. 2012;18:799&#x2013;806. doi: 10.1177/1352458511428081.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1352458511428081</ArticleId><ArticleId IdType=\"pubmed\">22084489</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-P&#xe9;rez S., Dominguez-Mozo M., Garc&#xed;a-Martinez M.A., Garcia-Frontini M.C., Villarubia N., Costa-Frossard L., Villar L.M., Arroyo R., Alvarez-Lafuente R. Anti-human herpesvirus 6 A/B antibodies titers correlate with multiple sclerosis-associated retrovirus envelope expression. Front. Immunol. 2021;12:798003. doi: 10.3389/fimmu.2021.798003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2021.798003</ArticleId><ArticleId IdType=\"pmc\">PMC8666430</ArticleId><ArticleId IdType=\"pubmed\">34912348</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez-Mozo M.I., Perez-Perez S., Villarubia N., Costa-Frossard L., Fernandez-Velasco J.I., Ortega-Madue&#xf1;o I., Garcia-Martinez M.A., Garcia-Calvo E., Estevez H., Garcia J.L.L., et al. Herpesvirus antibodies, vitamin D and short-chain fatty acids: Their correlation with cell subsets in multiple sclerosis patients and healthy controls. Cells. 2021;10:119. doi: 10.3390/cells10010119.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells10010119</ArticleId><ArticleId IdType=\"pmc\">PMC7826528</ArticleId><ArticleId IdType=\"pubmed\">33435197</ArticleId></ArticleIdList></Reference><Reference><Citation>Grima P., Chiavaroli R., Calabrese P., Tundo P. Severe hepatitis with autoimmune features following a HHV-6: A case report. Cases J. 2008;1:110. doi: 10.1186/1757-1626-1-110.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1757-1626-1-110</ArticleId><ArticleId IdType=\"pmc\">PMC2531091</ArticleId><ArticleId IdType=\"pubmed\">18710564</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagasaki H., Kato M., Shimizu N., Shichino H., Chin M., Mugishima H. Autoimmune hemolytic anemia and autoimmune neutropenia in a child with erythroblastopenia of childhood (TEC) caused by human herpesvirus-6 (HHV-6) Ann. Hematol. 2011;90:851. doi: 10.1007/s00277-010-1095-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00277-010-1095-x</ArticleId><ArticleId IdType=\"pubmed\">20922523</ArticleId></ArticleIdList></Reference><Reference><Citation>Faierstein K., Shilo N., Levartovsky A., Raphael R., Givon A., Agmon-Levin N., Mayan H. Autoimmune neutropenia associated with HHV-6 virus infection: A case report. Front. Immunol. 2022;13:880016. doi: 10.3389/fimmu.2022.880016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2022.880016</ArticleId><ArticleId IdType=\"pmc\">PMC9124847</ArticleId><ArticleId IdType=\"pubmed\">35615353</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapenko S., Krumina A., Kozireva S., Nora Z., Sultanova A., Viksna L., Murovska M. Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome. J. Clin. Virol. 2006;37((Suppl. S1)):S47&#x2013;S51. doi: 10.1016/S1386-6532(06)70011-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1386-6532(06)70011-7</ArticleId><ArticleId IdType=\"pubmed\">17276369</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapenko S., Krumina A., Logina I., Rasa S., Chistjakovs M., Sultanova A., Viksna L., Murovska M. Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Adv. Virol. 2012;2012:205085. doi: 10.1155/2012/205085.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2012/205085</ArticleId><ArticleId IdType=\"pmc\">PMC3426163</ArticleId><ArticleId IdType=\"pubmed\">22927850</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhill S., Booth N.E., McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfuncrtion. Int. J. Clin. Exp. Med. 2009;2:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2680051</ArticleId><ArticleId IdType=\"pubmed\">19436827</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Maes M. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab. Brain Dis. 2014;29:19&#x2013;36. doi: 10.1007/s11011-013-9435-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11011-013-9435-x</ArticleId><ArticleId IdType=\"pubmed\">24557875</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiner P., Harrer T., Scheibenbogen C., Lamer S., Schlosser A., Naviaux R.K., Prusty B.K. Human herpesvirus-6 reactivation, mitochondrial fragmentation, and the coordination of antiviral and metabolic phenotypes in myalgic encephalomyelitis/chronic fatigue syndrome. Immunohorizons. 2020;4:201&#x2013;215. doi: 10.4049/immunohorizons.2000006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/immunohorizons.2000006</ArticleId><ArticleId IdType=\"pubmed\">32327453</ArticleId></ArticleIdList></Reference><Reference><Citation>Lino K., Alves L.S., Raposo J.V., Medeiros T., Souza C.F., da Silva A.A., de Paula V.S., Almeida J.R. Presence and clinical impact of human herpesvirus-6 infection in patients with moderate to critical coronavirus disease-19. J. Med. Virol. 2022;94:1212&#x2013;1216. doi: 10.1002/jmv.27392.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.27392</ArticleId><ArticleId IdType=\"pmc\">PMC8662171</ArticleId><ArticleId IdType=\"pubmed\">34647632</ArticleId></ArticleIdList></Reference><Reference><Citation>Drago F., Ciccarese G., Rebora A., Parodi A. Human herpesvirus-6, -7, and Epstein-Barr virus reactivation inpityriasis roseaduring COVID-19. J. Med. Virol. 2020;93:1850&#x2013;1851. doi: 10.1002/jmv.26549.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.26549</ArticleId><ArticleId IdType=\"pmc\">PMC7537064</ArticleId><ArticleId IdType=\"pubmed\">32970319</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigley T.M., Yang L., Kang L.-I., Saenz J.B., Victorino F., Yokoyama W.M. Disruption of thymic central tolerance by infection with murine roseolovirus induces autoimmune gastritis. J. Exp. Med. 2022;219:e20211403. doi: 10.1084/jem.20211403.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1084/jem.20211403</ArticleId><ArticleId IdType=\"pmc\">PMC8932538</ArticleId><ArticleId IdType=\"pubmed\">35226043</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M., Rodriguez Y., Acosta-Ampudia Y., Monsalve D.M., Zhu C., Li Q.-Z., Ramirez-Santana C., Anaya J.-M. Autoimmunity is a hallmark of post-COVID syndrome. J. Transl. Med. 2022;20:129. doi: 10.1186/s12967-022-03328-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType=\"pmc\">PMC8924736</ArticleId><ArticleId IdType=\"pubmed\">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType=\"pubmed\">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Derwand R., Scholz M., Zelenko V. COVID-19 outpatients: Early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azythromycin. A retrospective case series study. Int. J. Antimicrob. Agents. 2020;56:106214. doi: 10.1016/j.ijantimicag.2020.106214.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijantimicag.2020.106214</ArticleId><ArticleId IdType=\"pmc\">PMC7587171</ArticleId><ArticleId IdType=\"pubmed\">33122096</ArticleId></ArticleIdList></Reference><Reference><Citation>Formiga F.R., Leblanc R., Reboucas J.S., FariS L.P., De Oliveira R.N., Pena L. Ivermectin: An award-winning drug with expected antiviral activity against COVID-19. J. Control. Release. 2021;329:758&#x2013;761. doi: 10.1016/j.jconrel.2020.10.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jconrel.2020.10.009</ArticleId><ArticleId IdType=\"pmc\">PMC7539925</ArticleId><ArticleId IdType=\"pubmed\">33038449</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazan S. Microbiome-based hypothesis on Ivermectin&#x2019;s mechanism in COVID-19: Ivermectin feeds Bifidobacteria to boost immunity. Front. Microbiol. 2022;13:952321. doi: 10.3389/fmicb.2022.952321.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmicb.2022.952321</ArticleId><ArticleId IdType=\"pmc\">PMC9309549</ArticleId><ArticleId IdType=\"pubmed\">35898916</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M., Schultz M.B., Sinclair D.A. NAD+ in COVID-19 and viral infections. Trends Immunol. 2022;43:283&#x2013;295. doi: 10.1016/j.it.2022.02.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.it.2022.02.001</ArticleId><ArticleId IdType=\"pmc\">PMC8831132</ArticleId><ArticleId IdType=\"pubmed\">35221228</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoust L., Pilon G., Marette A. Perspective: Nutritional strategies targeting the gut microbiome to mitigate COVID-19 outcomes. Adv. Nutr. 2021;12:1074&#x2013;1086. doi: 10.1093/advances/nmab031.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/advances/nmab031</ArticleId><ArticleId IdType=\"pmc\">PMC8083677</ArticleId><ArticleId IdType=\"pubmed\">33783468</ArticleId></ArticleIdList></Reference><Reference><Citation>Gang J., Wang H., Xue X., Zhang S. Microbiota and COVID-19: Long-term and complex influencing factors. Front. Microbiol. 2022;13:963488. doi: 10.3389/fmicb.2022.963488.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmicb.2022.963488</ArticleId><ArticleId IdType=\"pmc\">PMC9417543</ArticleId><ArticleId IdType=\"pubmed\">36033885</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Zhang L., Wang Y., Dai T., Qin Z., Zhou F., Zhang L. Alterations in microbiota of patients with COVID-19: Potential and therapeutic interventions. Signal Transduct. Target. Ther. 2022;7:143. doi: 10.1038/s41392-022-00986-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-022-00986-0</ArticleId><ArticleId IdType=\"pmc\">PMC9052735</ArticleId><ArticleId IdType=\"pubmed\">35487886</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda Y., Motooka D., Kawasaki T., Oki H., Noda Y., Adachi Y., Niitsu T., Okamoto S., Tanaka K., Fukushima K., et al. Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity. BMC Infect. Dis. 2022;22:572. doi: 10.1186/s12879-022-07358-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12879-022-07358-7</ArticleId><ArticleId IdType=\"pmc\">PMC9233337</ArticleId><ArticleId IdType=\"pubmed\">35751044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wu G., Zhao L., Wang W. Nutritional modulation of gut microbiota alleviates severe gastrointestinal symptoms in patients with post-acute COVID-19 syndrome. mBio. 2022;13:e0380121. doi: 10.1128/mbio.03801-21.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/mbio.03801-21</ArticleId><ArticleId IdType=\"pmc\">PMC9040862</ArticleId><ArticleId IdType=\"pubmed\">35254129</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran J.P., Zheng Y., Knobil K., Palma N.A., Lawrence J.F., Wingertzahn M.A. Targeting the microbiome with KB109 in outpatients with mild to moderate COVID-19 reduced medically attended acute care visits and improved symptoms in patients with comorbidities. medRxiv. 2021 doi: 10.1101/2021.03.26.21254422.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2021.03.26.21254422</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto T., Perlot T., Rehman A., Trichereau J., Ishiguro H., Paolino M., Sigl V., Hanada T., Hanada R., Lipinski S., et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487:477&#x2013;481. doi: 10.1038/nature11228.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature11228</ArticleId><ArticleId IdType=\"pmc\">PMC7095315</ArticleId><ArticleId IdType=\"pubmed\">22837003</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., Geng Q., Auerbach A., Li F. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581:221&#x2013;224. doi: 10.1038/s41586-020-2179-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-020-2179-y</ArticleId><ArticleId IdType=\"pmc\">PMC7328981</ArticleId><ArticleId IdType=\"pubmed\">32225175</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M.M., Beumer J., van der Vaart J., Knoops K., Puschhof J., Breugem T.I., Ravelli R.B.G., van Schayck J.P., Mykytyn A.Z., Duimel H.Q., et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369:50&#x2013;54. doi: 10.1126/science.abc1669.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.abc1669</ArticleId><ArticleId IdType=\"pmc\">PMC7199907</ArticleId><ArticleId IdType=\"pubmed\">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Penninger J.M., Grant M.B., Sung J.J.Y. The role of angiotensin converting enzyme 2 in modulating gut microbiota, intestinal inflammation, and coronavirus infection. Gastroenterology. 2021;160:39&#x2013;46. doi: 10.1053/j.gastro.2020.07.067.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1053/j.gastro.2020.07.067</ArticleId><ArticleId IdType=\"pmc\">PMC7836226</ArticleId><ArticleId IdType=\"pubmed\">33130103</ArticleId></ArticleIdList></Reference><Reference><Citation>Foolchand A., Mazaleni S., Ghazi T., Chuturgoon A.A. A review: Highlighting the links between epigenetics, COVID-19 infection, and vitamin D. Int. J. Mol. Sci. 2022;23:12292. doi: 10.3390/ijms232012292.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms232012292</ArticleId><ArticleId IdType=\"pmc\">PMC9603374</ArticleId><ArticleId IdType=\"pubmed\">36293144</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannis F., Peukert K., Surace L., Michla M., Nikolka F., Fox M., Weiss P., Feuerborn C., Maier P., Schulz S., et al. Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19. Nature. 2022;609:801&#x2013;807. doi: 10.1038/s41586-022-05128-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-022-05128-8</ArticleId><ArticleId IdType=\"pmc\">PMC9428867</ArticleId><ArticleId IdType=\"pubmed\">35901960</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Vargas J., Shapira T., Olmstead A.D., Villanueva I., Thompson C.A.H., Ennis S., Gao G., De Guzman J., Williams D.E., Wang M. Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics. Antivir. Res. 2023;209:105484. doi: 10.1016/j.antiviral.2022.105484.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.antiviral.2022.105484</ArticleId><ArticleId IdType=\"pmc\">PMC9729583</ArticleId><ArticleId IdType=\"pubmed\">36503013</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G.-I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.-A., Lartey S., Onyango T.B., Kuwelker K., Saeqvik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType=\"pmc\">PMC8440190</ArticleId><ArticleId IdType=\"pubmed\">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Zhang S., Wu Z., Shang Y., Dong X., Li G., Zhang L., Chen Y., Ye X., Du H., et al. Clinical outcomes of COVID-19 in Wuhan, China: A large cohort study. Ann. Intensive Care. 2020;10:99. doi: 10.1186/s13613-020-00706-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13613-020-00706-3</ArticleId><ArticleId IdType=\"pmc\">PMC7393341</ArticleId><ArticleId IdType=\"pubmed\">32737627</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshino Y., Katano H., Zou P., Hohman P., Marques A., Tyring S.K., Follmann D., Cohen J.I. Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of DNA copies per B cell in healthy volunteers. J. Virol. 2009;83:11857&#x2013;11861. doi: 10.1128/JVI.01005-09.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/JVI.01005-09</ArticleId><ArticleId IdType=\"pmc\">PMC2772668</ArticleId><ArticleId IdType=\"pubmed\">19740997</ArticleId></ArticleIdList></Reference><Reference><Citation>Verna D., Thompson J., Swaminathan S. Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function. Proc. Natl. Acad. Sci. USA. 2016;113:3609&#x2013;3614. doi: 10.1073/pnas.1523686113.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1523686113</ArticleId><ArticleId IdType=\"pmc\">PMC4822607</ArticleId><ArticleId IdType=\"pubmed\">26976570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kottis K., Lechowicz K., Drozdzal S., Niedzwiedzka-Rystwej P., Wojdacz T.K., Grywalska E., Biernawska J., Wisniewska M., Parczewski M. COVID-19: The potential beneficial therapeutic effects of Spironolactone during SARS-CoV-2 infection. Pharmaceuticals. 2021;14:71.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7830835</ArticleId><ArticleId IdType=\"pubmed\">33477294</ArticleId></ArticleIdList></Reference><Reference><Citation>Mareev V.Y., Orlova Y.A., Plisyk A.G., Pavlikova E.P., Matskeplishvili S.T., Akopyan Z.A., Seredenina E.M., Potapenko A.V., Agapov M.A., Asratyan D.A., et al. Results of open-label non-randomized comparative clinical trial: BromhexIne and Spironolactone for CoronavirUs Infection requiring hospiTalization (BISCUIT) Kardologia. 2020;60:4&#x2013;15. doi: 10.18087/cardio.2020.11.n1440.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18087/cardio.2020.11.n1440</ArticleId><ArticleId IdType=\"pubmed\">33487145</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinnon K.H., Leist S.R., Okuda K., Dang H., Fritch E.J., Gully K.L., De la Cruz G., Evangelista M.D., Asakura T., Gilmore R.C., et al. SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice. Sci. Transl. Med. 2022;14:eabo5070. doi: 10.1126/scitranslmed.abo5070.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/scitranslmed.abo5070</ArticleId><ArticleId IdType=\"pmc\">PMC9273046</ArticleId><ArticleId IdType=\"pubmed\">35857635</ArticleId></ArticleIdList></Reference><Reference><Citation>National Center for Advancing Translational Sciences (NCATS)   NIH Begins Large Clinical Trial to Test Immune Modulators for Treatment of COVID-19. National Institutes of Health (NIH); Bethesda, MD, USA: 2020.  [(accessed on 19 September 2022)].  Available online:  https://www.nih.gov/news-events/news-releases/nih-begins-large-clinical-trial-test-immune-modulators-treatment-covid-19.</Citation></Reference><Reference><Citation>National Institutes of Health (NIH)   Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19. National Institutes of Health (NIH); Bethesda, MD, USA: 2022.  [(accessed on 19 September 2022)].  Available online:  https://www.nih.gov/news-events/news-releases/immune-modulator-drugs-improved-survival-people-hospitalized-covid-19.</Citation></Reference><Reference><Citation>Pinto M.D., Lambert N., Downs C.A., Abrahim H., Hughes T.D., Rahmani A.M., Burton C.W., Chakraborty R. Antihistamines for postacute sequelae of SARS-CoV-2 infection. J. Nurse Pract. 2022;18:335&#x2013;338. doi: 10.1016/j.nurpra.2021.12.016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nurpra.2021.12.016</ArticleId><ArticleId IdType=\"pmc\">PMC8820139</ArticleId><ArticleId IdType=\"pubmed\">35153633</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihistamines. J. Investig. Med. 2021;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jim-2021-002051</ArticleId><ArticleId IdType=\"pmc\">PMC8494538</ArticleId><ArticleId IdType=\"pubmed\">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  Interim Guidance on Evaluating and Caring for Patients with Post-COVID Conditions.  [(accessed on 11 October 2022)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covidindex.html.</Citation></Reference><Reference><Citation>Herman E., Shih E., Cheng A. Long COVID: Rapid evidence review. Am. Fam. Physician. 2022;106:523&#x2013;553.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36379497</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera J.E., Niehaus W.N., Whiteson J., Azola A., Baratta J.M., Fleming T.K., Kim S.Y., Naqvi H., Sampsel S., Silver J.K., et al. Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) Pm R. 2021;13:1027&#x2013;1043. doi: 10.1002/pmrj.12684. corrected in Pm R 2022, 14, 164.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/pmrj.12684</ArticleId><ArticleId IdType=\"pmc\">PMC8441628</ArticleId><ArticleId IdType=\"pubmed\">34346558</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen L.R., Sami S., Vuong N., Pathela P., Weiss D., Morgenthau B.M., Henseler R.A., Daskalakis D.C., Atas J., Patel A., et al. Lack of antibodies to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) in a large cohort of previously infected persons. Clin. Infect. Dis. 2021;73:e3066&#x2013;e3073. doi: 10.1093/cid/ciaa1685.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cid/ciaa1685</ArticleId><ArticleId IdType=\"pmc\">PMC7665429</ArticleId><ArticleId IdType=\"pubmed\">33147319</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M. Long COVID: A primer for family physicians. Am. Fam. Physician. 2020;102:716&#x2013;717.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33320511</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EclinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType=\"pmc\">PMC8280690</ArticleId><ArticleId IdType=\"pubmed\">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance H., Maslach A., Stoneman E., Harmes K., Ransom A., Seagly K., Furst W. Addressing post-COVID symptoms: A guide for primary care physicians. J. Am. Board Fam. Med. 2021;34:1229&#x2013;1242. doi: 10.3122/jabfm.2021.06.210254.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3122/jabfm.2021.06.210254</ArticleId><ArticleId IdType=\"pubmed\">34772779</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine J.S., Ambrose A.F., Didehbani N., Fleming T.K., Glashan L., Longo M., Merlino A., Ng R., Nora G.J., Rolin S., et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection (PASC) PM R. 2022;14:96&#x2013;111. doi: 10.1002/pmrj.12745.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/pmrj.12745</ArticleId><ArticleId IdType=\"pubmed\">34902226</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: A systematic review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType=\"pmc\">PMC8515212</ArticleId><ArticleId IdType=\"pubmed\">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaylis N.B., Ritter A., Kelly S.A., Pourhassan N.Z., Tiwary M., Sacha J.B., Hansen S.G., Recknor C., Yang O.O. Reduced cell surface levels of C-C chemokine receptor 5 and immunosuppression in long coronavirus disease 2019 syndrome. Clin. Infect. Dis. 2022;75:1232&#x2013;1234. doi: 10.1093/cid/ciac226.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cid/ciac226</ArticleId><ArticleId IdType=\"pmc\">PMC9383814</ArticleId><ArticleId IdType=\"pubmed\">35452519</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil S., Gualano B., Ladeira de Araujo A., Nascimento de Oliveira G., Jr., Damiano R.F., Pinna F., Imamura M., Rocha V., Kallas E., Batistella L.R., et al. Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors. Sci. Rep. 2023;13:215. doi: 10.1038/s41598-022-26888-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-022-26888-3</ArticleId><ArticleId IdType=\"pmc\">PMC9813883</ArticleId><ArticleId IdType=\"pubmed\">36604523</ArticleId></ArticleIdList></Reference><Reference><Citation>Scurati R., Papini N., Alberti G., Tringali C. The challenge of long COVID-19 management: From disease molecular hallmarks to the proposal of exercise as therapy. Int. J. Mol. Sci. 2022;23:12311. doi: 10.3390/ijms232012311.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms232012311</ArticleId><ArticleId IdType=\"pmc\">PMC9603679</ArticleId><ArticleId IdType=\"pubmed\">36293160</ArticleId></ArticleIdList></Reference><Reference><Citation>Iddir M., Brito A., Dingeo G., Del Campo S.S.F., Samouda H., La Frano M.R., Bohn T. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: Considerations during the COVID-19 crisis. Nutrients. 2020;12:1562. doi: 10.3390/nu12061562.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu12061562</ArticleId><ArticleId IdType=\"pmc\">PMC7352291</ArticleId><ArticleId IdType=\"pubmed\">32471251</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilleri M., Lyle B.J., Madsen K.L., Sonnenburg J., Verbeke K., Wu G.D. Role for diet in normal gut barrier function: Developing guidance within the framework of food-labeling regulations. Am. J. Physiol. Gastrointest. Liver Physiol. 2019;317:G17&#x2013;G39. doi: 10.1152/ajpgi.00063.2019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpgi.00063.2019</ArticleId><ArticleId IdType=\"pmc\">PMC6689735</ArticleId><ArticleId IdType=\"pubmed\">31125257</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Xu Z., Mak J.W.Y., Chan F.K.L., Ng S.C. SIM01 as a novel microbiome replacement therapy for COVID-19: An open-label pilot study. J. Gastroenterol. Hepatol. 2021;36:272.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9115073</ArticleId><ArticleId IdType=\"pubmed\">35170078</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders J.M., Monogue M.L., Jodlowski T.Z., Cutrell J.B. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review. JAMA. 2020;323:1824&#x2013;1836. doi: 10.1001/jama.2020.6019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2020.6019</ArticleId><ArticleId IdType=\"pubmed\">32282022</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoufaly A., Poglitsch M., Aberle J.H., Hoepler W., Seitz T., Traugott M., Grieb A., Pawelka E., Laferi H., Wenisch C. Human recombinant soluble ACE2 in severe COVID-19. Lancet Respir. Med. 2020;8:1154&#x2013;1158. doi: 10.1016/S2213-2600(20)30418-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S2213-2600(20)30418-5</ArticleId><ArticleId IdType=\"pmc\">PMC7515587</ArticleId><ArticleId IdType=\"pubmed\">33131609</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A., Xu K., Du T., Zhu P., Liang Z., Liao S., Zhang J., Raizada M.K., Grant M.B., Li Q. Expression of human ACE2 in Lactobacillus and beneficial effects in diabetic retinopathy in mice. Mol. Ther. Methods Clin. Dev. 2019;14:161&#x2013;170. doi: 10.1016/j.omtm.2019.06.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.omtm.2019.06.007</ArticleId><ArticleId IdType=\"pmc\">PMC6661465</ArticleId><ArticleId IdType=\"pubmed\">31380462</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinski J., Winter K., Jasinski M., Szczes A., Bilinska N., Mullish B.H., Malecka-Panas E., Basak G.W. Rapid resolution of COVID-19 after faecal microbiota transplantation. Gut. 2022;71:230&#x2013;232. doi: 10.1136/gutjnl-2021-325010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/gutjnl-2021-325010</ArticleId><ArticleId IdType=\"pubmed\">34230217</ArticleId></ArticleIdList></Reference><Reference><Citation>Ianiro G., Mullish B.H., Kelly C.R., Kassam Z., Kujiper E.J., Ng S.C., Iqbal T.H., Allegretti J.R., Bibb&#xf3; S., Sokol H., et al. Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut. 2020;69:1555&#x2013;1563. doi: 10.1136/gutjnl-2020-321829.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/gutjnl-2020-321829</ArticleId><ArticleId IdType=\"pmc\">PMC7456726</ArticleId><ArticleId IdType=\"pubmed\">32620549</ArticleId></ArticleIdList></Reference><Reference><Citation>Laursen R.P., Hojsak I. Probiotics for respiratory tract infections in children attending day care centers&#x2014;A systematic review. Eur. J. Pediatr. 2018;177:979&#x2013;994. doi: 10.1007/s00431-018-3167-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00431-018-3167-1</ArticleId><ArticleId IdType=\"pubmed\">29752587</ArticleId></ArticleIdList></Reference><Reference><Citation>De Filippis F., Pellegrini N., Vannini L., Jeffery I.B., La Storia A., Laghi L., Serrazenetti D.I., Di Cagno R., Ferrocino I., Lazzi C., et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2016;65:1812&#x2013;1821. doi: 10.1136/gutjnl-2015-309957.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/gutjnl-2015-309957</ArticleId><ArticleId IdType=\"pubmed\">26416813</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarado D.M., Son J., Thackray L.B., Diamond M.S., Ding S., Ciorba M.A. IBD Investigators Group at Washington University. Mesalamine reduces intestinal ACE2 expression without modifying SARS-CoV-2 infection or disease severity in mice. bioRxiv. 2021 bioRxiv:2021.07.23.453393.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8690199</ArticleId><ArticleId IdType=\"pubmed\">34849936</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudryavtsev I., Rubinstein A., Golovkin A., Kalinina O., Vasilyev K., Rudenko L., Isakova-Sivak I. Dysregulated immune responses in SARS-CoV-2-infected patients: A comprehensive overview. Viruses. 2022;14:1082. doi: 10.3390/v14051082.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/v14051082</ArticleId><ArticleId IdType=\"pmc\">PMC9147674</ArticleId><ArticleId IdType=\"pubmed\">35632823</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A., Kudryavtsev I., Starshinova A., Kudlay D., Zinchenko Y., Glushkova A., Yablonskiy P., Shoenfeld Y. Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form. Pathogens. 2021;10:1408. doi: 10.3390/pathogens10111408.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pathogens10111408</ArticleId><ArticleId IdType=\"pmc\">PMC8620929</ArticleId><ArticleId IdType=\"pubmed\">34832564</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G., Diodati F., Puntoni M., Lazzarelli S., Marcomini B., Patrizi L., Caminiti C. Prognostic factors for post-COVID-19 syndrome: A systematic review and meta-analysis. J. Clin. Med. 2022;11:1541. doi: 10.3390/jcm11061541.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm11061541</ArticleId><ArticleId IdType=\"pmc\">PMC8948827</ArticleId><ArticleId IdType=\"pubmed\">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler C.X., Wyller V.B.B., Moss-Morris R., Buchwald D., Crawley E., Hautvast J., Katz B.Z., Knoop H., Little P., Taylor R., et al. Long COVID and post-infective fatigue syndrome: A review. Open Forum Infect. Dis. 2021;8:ofab440. doi: 10.1093/ofid/ofab440.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ofid/ofab440</ArticleId><ArticleId IdType=\"pmc\">PMC8496765</ArticleId><ArticleId IdType=\"pubmed\">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  Nearly One in Five American Adults Who Have Had COVID-19 Still Have &#x201c;Long COVID&#x201d;.  [(accessed on 4 October 2022)]; Available online:  https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/20220622.htm.</Citation></Reference><Reference><Citation>Datta S.D., Talwar A., Lee J.T. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: Illness beyond acute infection and public health implications. JAMA. 2020;324:2251&#x2013;2252. doi: 10.1001/jama.2020.22717.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2020.22717</ArticleId><ArticleId IdType=\"pubmed\">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Darby J.B., Jackson J.M. Kawasaki disease and multisystem inflammatory syndrome in children: An overview and comparison. Am. Fam. Physician. 2021;104:244&#x2013;252.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34523885</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne A.B., Gilani Z., Godfred-Cato S., Belay E.D., Feldstein L.R., Patel M.M., Randolph A.G., Newhams M., Thomas D., Magleby R., et al. Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2. JAMA Netw. Open. 2021;4:e2116420. doi: 10.1001/jamanetworkopen.2021.16420.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamanetworkopen.2021.16420</ArticleId><ArticleId IdType=\"pmc\">PMC8193431</ArticleId><ArticleId IdType=\"pubmed\">34110391</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  Infectious Diseases Society of America. Multisystem Inflammatory Syndrome in Adults (MIS-A). Updated June 24, 2022.  [(accessed on 31 August 2022)].  Available online:  https://www.idsociety.org/covid-19-real-time-learning-network/disease-manifestations--complications/multisystem-inflammatory-syndrome-inadults-mis-a/</Citation></Reference><Reference><Citation>Nath A. Long-haul COVID. Neurology. 2020;95:559&#x2013;560. doi: 10.1212/WNL.0000000000010640.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0000000000010640</ArticleId><ArticleId IdType=\"pubmed\">32788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Rose E.B., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., et al. IVY Network Investigators; CDC COVID-19 Response Team. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March-June 2020. MMWR Morb. Mortal Wkly. Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType=\"pmc\">PMC7392393</ArticleId><ArticleId IdType=\"pubmed\">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/01410768211032850</ArticleId><ArticleId IdType=\"pmc\">PMC8450986</ArticleId><ArticleId IdType=\"pubmed\">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., Sudre C.H., Molteni E., Bewrry S., Canas L.S., Graham M.S., Klaser K., Modat M., et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, community-based, nested, case-control study. Lancet Infect. Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType=\"pmc\">PMC8409907</ArticleId><ArticleId IdType=\"pubmed\">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long COVID-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648. corrected in BMJ 2021, 374, n1944.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.n1648</ArticleId><ArticleId IdType=\"pubmed\">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M., Omirah M.A., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int. J. Clin. Pract. 2021;75:e13746. doi: 10.1111/ijcp.13746.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/ijcp.13746</ArticleId><ArticleId IdType=\"pmc\">PMC7536922</ArticleId><ArticleId IdType=\"pubmed\">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneller M.C., Liang C.J., Marques A.R., Chung J.Y., Shanbhag S.M., Fontsana J.R., Raza H., Okeke O., Dewar R.L., Higgins B.P., et al. A longitudinal study of COVID-19 sequelae and immunity: Baseline findings. Ann. Intern. Med. 2022;175:969&#x2013;979. doi: 10.7326/M21-4905.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/M21-4905</ArticleId><ArticleId IdType=\"pmc\">PMC9128805</ArticleId><ArticleId IdType=\"pubmed\">35605238</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrich W.C., Ghosh T.S., Ahearn-Ford S., Mikaeloff F., Lunjani N., Forde B., Suh N., Kleger G.-R., Pietsch U., Frischknecht M., et al. A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2. Gut Microbes. 2022;14:e2073131. doi: 10.1080/19490976.2022.2073131.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/19490976.2022.2073131</ArticleId><ArticleId IdType=\"pmc\">PMC9116414</ArticleId><ArticleId IdType=\"pubmed\">35574937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau H.C.-H., Ng S.C., Yu J. Targeting the gut microbiota in coronavirus disease 2019: Hype or hope? Gastroenterology. 2022;162:9&#x2013;16. doi: 10.1053/j.gastro.2021.09.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1053/j.gastro.2021.09.009</ArticleId><ArticleId IdType=\"pmc\">PMC8425294</ArticleId><ArticleId IdType=\"pubmed\">34508775</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsakos M., Rowntree L.C., Hensen L., Chua B.Y., van de Sandt C.E., Habel J.R., Zhang W., Jia X., Kedzierski L., Ashhurst T.M., et al. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell. Rep. Med. 2021;2:100208. doi: 10.1016/j.xcrm.2021.100208.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.xcrm.2021.100208</ArticleId><ArticleId IdType=\"pmc\">PMC7862905</ArticleId><ArticleId IdType=\"pubmed\">33564749</ArticleId></ArticleIdList></Reference><Reference><Citation>Leviatan S., Segai E. Identifying gut microbes that affect human health. Nature. 2020;587:373&#x2013;374. doi: 10.1038/d41586-020-03069-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/d41586-020-03069-8</ArticleId><ArticleId IdType=\"pubmed\">33149313</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmae S., Franasiak J.M., Mandar R. The seminal microbe in health and disease. Nat. Rev. Urol. 2019;16:703&#x2013;721. doi: 10.1038/s41585-019-0250-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41585-019-0250-y</ArticleId><ArticleId IdType=\"pubmed\">31732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Treuren W., Dodd D. Microbial contribution to the human metabolome: Implications for health and disease. Annu. Rev. Pathol. 2020;15:345&#x2013;369. doi: 10.1146/annurev-pathol-020117-043559.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-pathol-020117-043559</ArticleId><ArticleId IdType=\"pmc\">PMC7678725</ArticleId><ArticleId IdType=\"pubmed\">31622559</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie P., Li Z., Wang Y., Zhang Y., Zhao M., Luo J., Du S., Deng Z., Chen J., Wang Y., et al. Gut microbiome interventions in human health and diseases. Med. Res. Rev. 2019;39:2286&#x2013;2313. doi: 10.1002/med.21584.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/med.21584</ArticleId><ArticleId IdType=\"pubmed\">30994937</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley A., Turner J.R. Cell biology of tight junction barrier regulation and mucosal disease. Cold Spring Harb. Perspect. Biol. 2018;10:a029314. doi: 10.1101/cshperspect.a029314.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/cshperspect.a029314</ArticleId><ArticleId IdType=\"pmc\">PMC5749156</ArticleId><ArticleId IdType=\"pubmed\">28507021</ArticleId></ArticleIdList></Reference><Reference><Citation>Velikova T., Snegarova V., Kukov A., Batselova H., Mihova A., Nakov R. Gastrointestinal mucosal immunity and COVID-19. World J. Gastroenterol. 2021;27:5047&#x2013;5059. doi: 10.3748/wjg.v27.i30.5047.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3748/wjg.v27.i30.5047</ArticleId><ArticleId IdType=\"pmc\">PMC8384742</ArticleId><ArticleId IdType=\"pubmed\">34497434</ArticleId></ArticleIdList></Reference><Reference><Citation>Elizalde-Diaz J.P., Miranda-Narvaez C.L., Martinez-Lazcano J.C., Martinez-Martinez E. The relationship between chronic immune response and neurodegenerative damage in long COVID-19. Front. Immunol. 2022;13:1039427. doi: 10.3389/fimmu.2022.1039427.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2022.1039427</ArticleId><ArticleId IdType=\"pmc\">PMC9800881</ArticleId><ArticleId IdType=\"pubmed\">36591299</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B., Zhong M., Yang Q., Hong K., Xia J., Li X., Liu Y., Chen Y.Q., Yang J., Huang C., et al. Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study. Virol. Sin. 2021;36:859&#x2013;868. doi: 10.1007/s12250-021-00348-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12250-021-00348-0</ArticleId><ArticleId IdType=\"pmc\">PMC7871951</ArticleId><ArticleId IdType=\"pubmed\">33560482</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">36836022</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Print\">2077-0383</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Severe and Very Severe Myalgic Encephalopathy/Chronic Fatigue Syndrome ME/CFS in Norway: Symptom Burden and Access to Care.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">1487</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/jcm12041487</ELocationID><Abstract><AbstractText>There is a striking lack of systematic knowledge regarding the symptom burden, capacity for activities of daily living, and supportive measures for the most severely ill ME/CFS patients. The present study seeks to address this through a national, Internet-based survey targeting patients with severe and very severe ME/CFS and their carers. Responses from 491 patients were included, with 444 having severe and 47 very severe ME/CFS with the classification based on the best estimate from patient responses. In addition, 95 respondents were reclassified from patients\\' own classification to moderate and included for comparison. The onset was before 15 years of age for 45% in the very severe and 32% in the severe group. Disease duration was more than 15 years for 19% in the very severe and 27% in the severe group. Patient symptom burden was extensive. The most severely affected were totally bedridden, unable to talk, and experienced dramatic worsening of symptoms after minimal activity or sensory stimuli. Care and assistance from healthcare and social services were often described as insufficient or inadequate, often worsening the symptom load and burden of care. A substantial lack of disease knowledge among healthcare providers in general was reported. Yet approximately 60% in the severe and very severe groups found services provided by occupational therapists and family doctors (general practitioners) helpful, while a smaller proportion experienced appropriate help from other health personnel groups. This indicates that help and support are highly needed and possible to provide. On the other hand, this must be approached carefully, as a substantial number of patients experienced deterioration from contact with healthcare personnel. Family carers described an extensive burden of care with often inadequate help from healthcare providers or municipal authorities. Patient care by family members of very severe ME/CFS patients constituted more than 40 h a week for 71% of this patient group. The carers described a large negative impact on their work and financial situation, and on their mental wellbeing. We conclude that childhood onset was common, burden of disease was extensive, and support from responsible societal health and social support providers was commonly grossly inadequate.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Sommerfelt</LastName><ForeName>Kristian</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Children and Youth Clinic, Institute of Clinical Medicine 2, University of Bergen, P.O. Box 7804, 5020 Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Schei</LastName><ForeName>Trude</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Norwegian ME Association, Nedre Slottsgate 4 M, 0157 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Angelsen</LastName><ForeName>Arild</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-6037-6849</Identifier><AffiliationInfo><Affiliation>School of Economics and Business, Norwegian University of Life Sciences (NMBU), P.O. Box 5003, 1432 &#xc5;s, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>No grant number given.</GrantID><Agency>Den Norske ME forening (NMEF). (The Norwegian ME-patient Organization)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">ME/CFS</Keyword><Keyword MajorTopicYN=\"N\">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN=\"N\">national survey</Keyword><Keyword MajorTopicYN=\"N\">severe</Keyword><Keyword MajorTopicYN=\"N\">symptom burden</Keyword><Keyword MajorTopicYN=\"N\">very severe</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>3</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">36836022</ArticleId><ArticleId IdType=\"pmc\">PMC9963221</ArticleId><ArticleId IdType=\"doi\">10.3390/jcm12041487</ArticleId><ArticleId IdType=\"pii\">jcm12041487</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Board on the Health of Select Populations. Institute of Medicine . Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press (US); Washington, DC, USA: 2015. The National Academies Collection: Reports funded by National Institutes of Health.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.J., Ahn Y.C., Jang E.S., Lee S.W., Lee S.H., Son C.G. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) J. Transl. Med. 2020;18:100. doi: 10.1186/s12967-020-02269-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType=\"pmc\">PMC7038594</ArticleId><ArticleId IdType=\"pubmed\">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez A.R., Hancock E.E., Adebayo S., Kiernicki D.J., Proskauer D., Attewell J.R., Bateman L., DeMaria A., Jr., Lapp C.W., Rowe P.C., et al. Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning. Front Pediatr. 2018;6:412. doi: 10.3389/fped.2018.00412.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2018.00412</ArticleId><ArticleId IdType=\"pmc\">PMC6331450</ArticleId><ArticleId IdType=\"pubmed\">30671425</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., Jain A.K., De Meirleir K.L., Peterson D.L., Klimas N.G., Lerner A.M., Bested A.C., Flor-Henry P., Joshi P., Powles A.C.P., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Chronic Fatigue Syndr. 2003;11:7&#x2013;115. doi: 10.1300/J092v11n01_02.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern Med. 1994;121:953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType=\"pubmed\">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Jordan K., Miike T., Bell D.S., Lapp C., Torres-Harding S., Rowe K., Gurwitt A., De Meirleir K., Van Hoof E.L.S. A Pediatric Case Definition for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome. J. Chronic Fatigue Syndr. 2006;13:1&#x2013;44. doi: 10.1300/J092v13n02_01.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v13n02_01</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowhurst G. Supporting people with severe myalgic encephalomyelitis. Nurs. Stand. 2005;19:38&#x2013;43. doi: 10.7748/ns2005.02.19.21.38.c3796.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7748/ns2005.02.19.21.38.c3796</ArticleId><ArticleId IdType=\"pubmed\">15727017</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris K., Band R.J., Cooper H., Macintyre V.G., Mejia A., Wearden A.J. Distress in significant others of patients with chronic fatigue syndrome: A systematic review of the literature. Br. J. Health Psychol. 2016;21:881&#x2013;893. doi: 10.1111/bjhp.12202.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/bjhp.12202</ArticleId><ArticleId IdType=\"pubmed\">27255790</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., van de Sande M.I., De Meirleir K.L., Klimas N.G., Broderick G., Mitchell T., Staines D., Powles A.C., Speight N., Vallings R., et al. Myalgic encephalomyelitis: International Consensus Criteria. J. Intern. Med. 2011;270:327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType=\"pmc\">PMC3427890</ArticleId><ArticleId IdType=\"pubmed\">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghali A., Lacout C., Fortrat J.O., Depres K., Ghali M., Lavigne C. Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Diagnostics. 2022;12:2540. doi: 10.3390/diagnostics12102540.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics12102540</ArticleId><ArticleId IdType=\"pmc\">PMC9600584</ArticleId><ArticleId IdType=\"pubmed\">36292229</ArticleId></ArticleIdList></Reference><Reference><Citation>Conroy K., Bhatia S., Islam M., Jason L.A. Homebound versus Bedridden Status among Those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Healthcare. 2021;9:106. doi: 10.3390/healthcare9020106.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare9020106</ArticleId><ArticleId IdType=\"pmc\">PMC7909520</ArticleId><ArticleId IdType=\"pubmed\">33498489</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken I.J., Tveito K., Gunnes N., Ghaderi S., Stoltenberg C., Trogstad L., H&#xe5;berg S.E., Magnus P. Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: A population-based registry study from Norway 2008&#x2013;2012. BMC Med. 2014;12:167. doi: 10.1186/s12916-014-0167-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12916-014-0167-5</ArticleId><ArticleId IdType=\"pmc\">PMC4189623</ArticleId><ArticleId IdType=\"pubmed\">25274261</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingdon C., Giotas D., Nacul L., Lacerda E. Health Care Responsibility and Compassion-Visiting the Housebound Patient Severely Affected by ME/CFS. Healthcare. 2020;8:197. doi: 10.3390/healthcare8030197.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare8030197</ArticleId><ArticleId IdType=\"pmc\">PMC7551603</ArticleId><ArticleId IdType=\"pubmed\">32635535</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulazreg S., Rokach A. The Lonely, Isolating, and Alienating Implications of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Healthcare. 2020;8:413. doi: 10.3390/healthcare8040413.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare8040413</ArticleId><ArticleId IdType=\"pmc\">PMC7711762</ArticleId><ArticleId IdType=\"pubmed\">33092097</ArticleId></ArticleIdList></Reference><Reference><Citation>Strassheim V., Newton J.L., Collins T. Experiences of Living with Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Healthcare. 2021;9:168. doi: 10.3390/healthcare9020168.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare9020168</ArticleId><ArticleId IdType=\"pmc\">PMC7914910</ArticleId><ArticleId IdType=\"pubmed\">33562474</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafoe W. Extremely Severe ME/CFS-A Personal Account. Healthcare. 2021;9:504. doi: 10.3390/healthcare9050504.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare9050504</ArticleId><ArticleId IdType=\"pmc\">PMC8145314</ArticleId><ArticleId IdType=\"pubmed\">33925566</ArticleId></ArticleIdList></Reference><Reference><Citation>Fennell P.A., Dorr N., George S.S. Elements of Suffering in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Experience of Loss, Grief, Stigma, and Trauma in the Severely and Very Severely Affected. Healthcare. 2021;9:553. doi: 10.3390/healthcare9050553.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare9050553</ArticleId><ArticleId IdType=\"pmc\">PMC8150911</ArticleId><ArticleId IdType=\"pubmed\">34065069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L., Elliott M., Stein E., Jason L.A. Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Healthcare. 2021;9:629. doi: 10.3390/healthcare9060629.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare9060629</ArticleId><ArticleId IdType=\"pmc\">PMC8227525</ArticleId><ArticleId IdType=\"pubmed\">34070367</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: When Suffering Is Multiplied. Healthcare. 2021;9:919. doi: 10.3390/healthcare9070919.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare9070919</ArticleId><ArticleId IdType=\"pmc\">PMC8307552</ArticleId><ArticleId IdType=\"pubmed\">34356297</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.J., Hung L.Y., Kogelnik A.M., Kaufman D., Aiyar R.S., Chu A.M., Wilhelmy J., Li P., Tannenbaum L., Xiao W., et al. A Comprehensive Examination of Severely Ill ME/CFS Patients. Healthcare. 2021;9:1290. doi: 10.3390/healthcare9101290.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare9101290</ArticleId><ArticleId IdType=\"pmc\">PMC8535418</ArticleId><ArticleId IdType=\"pubmed\">34682970</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Katz B.Z., Sunnquist M., Torres C., Cotler J., Bhatia S. The Prevalence of Pediatric Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in a Community-Based Sample. Child Youth Care Forum. 2020;49:563&#x2013;579. doi: 10.1007/s10566-019-09543-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10566-019-09543-3</ArticleId><ArticleId IdType=\"pmc\">PMC8186295</ArticleId><ArticleId IdType=\"pubmed\">34113066</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya J.G., Dowell T.G., Mooney A.E., Dimmock M.E., Chu L. Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Healthcare. 2021;9:1331. doi: 10.3390/healthcare9101331.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/healthcare9101331</ArticleId><ArticleId IdType=\"pmc\">PMC8544443</ArticleId><ArticleId IdType=\"pubmed\">34683011</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">36835097</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>24</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Urine Metabolomics Exposes Anomalous Recovery after Maximal Exertion in Female ME/CFS Patients.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">3685</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms24043685</ELocationID><Abstract><AbstractText>Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease with unknown etiology or effective treatments. Post-exertional malaise (PEM) is a key symptom that distinguishes ME/CFS patients. Investigating changes in the urine metabolome between ME/CFS patients and healthy subjects following exertion may help us understand PEM. The aim of this pilot study was to comprehensively characterize the urine metabolomes of eight female healthy sedentary control subjects and ten female ME/CFS patients in response to a maximal cardiopulmonary exercise test (CPET). Each subject provided urine samples at baseline and 24 h post-exercise. A total of 1403 metabolites were detected via LC-MS/MS by Metabolon<sup>&#xae;</sup> including amino acids, carbohydrates, lipids, nucleotides, cofactors and vitamins, xenobiotics, and unknown compounds. Using a linear mixed effects model, pathway enrichment analysis, topology analysis, and correlations between urine and plasma metabolite levels, significant differences were discovered between controls and ME/CFS patients in many lipid (steroids, acyl carnitines and acyl glycines) and amino acid subpathways (cysteine, methionine, SAM, and taurine; leucine, isoleucine, and valine; polyamine; tryptophan; and urea cycle, arginine and proline). Our most unanticipated discovery is the lack of changes in the urine metabolome of ME/CFS patients during recovery while significant changes are induced in controls after CPET, potentially demonstrating the lack of adaptation to a severe stress in ME/CFS patients.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Glass</LastName><ForeName>Katherine A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Germain</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-0111-0012</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Huang</LastName><ForeName>Yuhsin V</ForeName><Initials>YV</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hanson</LastName><ForeName>Maureen R</ForeName><Initials>MR</Initials><Identifier Source=\"ORCID\">0000-0001-8141-3058</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>U54NS105541</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>0000</GrantID><Agency>Amar Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015673\" MajorTopicYN=\"Y\">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005082\" MajorTopicYN=\"N\">Physical Exertion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002853\" MajorTopicYN=\"N\">Chromatography, Liquid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D010865\" MajorTopicYN=\"N\">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D053719\" MajorTopicYN=\"N\">Tandem Mass Spectrometry</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">ME/CFS</Keyword><Keyword MajorTopicYN=\"N\">exercise</Keyword><Keyword MajorTopicYN=\"N\">metabolomics</Keyword><Keyword MajorTopicYN=\"N\">urine</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>2</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">36835097</ArticleId><ArticleId IdType=\"pmc\">PMC9958671</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms24043685</ArticleId><ArticleId IdType=\"pii\">ijms24043685</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jason L.A., Mirin A.A. Updating the National Academy of Medicine ME/CFS prevalence and economic impact figures to account for population growth and inflation. Fatigue Biomed. Health Behav. 2021;9:9&#x2013;13. doi: 10.1080/21641846.2021.1878716.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21641846.2021.1878716</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez A.R., Hancock E.E., Adebayo S., Kiernicki D.J., Proskauer D., Attewell J.R., Bateman L., DeMaria A., Jr., Lapp C.W., Rowe P.C., et al. Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning. Front. Pediatr. 2018;6:412. doi: 10.3389/fped.2018.00412.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2018.00412</ArticleId><ArticleId IdType=\"pmc\">PMC6331450</ArticleId><ArticleId IdType=\"pubmed\">30671425</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., Jain A.K., De Meirleir K.L., Peterson D.L., Klimas N.G., Lerner A.M., Bested A.C., Flor-Henry P., Joshi P., Powles A.P., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols. J. Chronic Fatigue Syndr. 2003;11:7&#x2013;115. doi: 10.1300/J092v11n01_02.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L., Valencia I.J., Garvert D.W., Montoya J.G. Deconstructing post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: A patient-centered, cross-sectional survey. PLoS ONE. 2018;13:e0197811. doi: 10.1371/journal.pone.0197811.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0197811</ArticleId><ArticleId IdType=\"pmc\">PMC5983853</ArticleId><ArticleId IdType=\"pubmed\">29856774</ArticleId></ArticleIdList></Reference><Reference><Citation>Stussman B., Williams A., Snow J., Gavin A., Scott R., Nath A., Walitt B. Characterization of Post-exertional Malaise in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front. Neurol. 2020;11:1025. doi: 10.3389/fneur.2020.01025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2020.01025</ArticleId><ArticleId IdType=\"pmc\">PMC7530890</ArticleId><ArticleId IdType=\"pubmed\">33071931</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens S., Snell C., Stevens J., Keller B., VanNess J.M. Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front. Pediatr. 2018;6:242. doi: 10.3389/fped.2018.00242.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fped.2018.00242</ArticleId><ArticleId IdType=\"pmc\">PMC6131594</ArticleId><ArticleId IdType=\"pubmed\">30234078</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanness J.M., Snell C.R., Stevens S.R. Diminished Cardiopulmonary Capacity During Post-Exertional Malaise. J. Chronic Fatigue Syndr. 2007;14:77&#x2013;85. doi: 10.1300/J092v14n02_07.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v14n02_07</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller B.A., Pryor J.L., Giloteaux L. Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO(2)peak indicates functional impairment. J. Transl. Med. 2014;12:104. doi: 10.1186/1479-5876-12-104.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1479-5876-12-104</ArticleId><ArticleId IdType=\"pmc\">PMC4004422</ArticleId><ArticleId IdType=\"pubmed\">24755065</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D., Annesley S.J., Fisher P.R. Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Diagnostics. 2019;9:80. doi: 10.3390/diagnostics9030080.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics9030080</ArticleId><ArticleId IdType=\"pmc\">PMC6787592</ArticleId><ArticleId IdType=\"pubmed\">31330791</ArticleId></ArticleIdList></Reference><Reference><Citation>Huth T.K., Eaton-Fitch N., Staines D., Marshall-Gradisnik S. A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID) J. Transl. Med. 2020;18:198. doi: 10.1186/s12967-020-02356-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-020-02356-2</ArticleId><ArticleId IdType=\"pmc\">PMC7222338</ArticleId><ArticleId IdType=\"pubmed\">32404171</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A., Barupal D.K., Levine S.M., Hanson M.R. Comprehensive Circulatory Metabolomics in ME/CFS Reveals Disrupted Metabolism of Acyl Lipids and Steroids. Metabolites. 2020;10:34. doi: 10.3390/metabo10010034.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/metabo10010034</ArticleId><ArticleId IdType=\"pmc\">PMC7023305</ArticleId><ArticleId IdType=\"pubmed\">31947545</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A., Ruppert D., Levine S.M., Hanson M.R. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism. Mol. Biosyst. 2017;13:371&#x2013;379. doi: 10.1039/C6MB00600K.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C6MB00600K</ArticleId><ArticleId IdType=\"pmc\">PMC5365380</ArticleId><ArticleId IdType=\"pubmed\">28059425</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A., Ruppert D., Levine S.M., Hanson M.R. Prospective Biomarkers from Plasma Metabolomics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Implicate Redox Imbalance in Disease Symptomatology. Metabolites. 2018;8:90. doi: 10.3390/metabo8040090.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/metabo8040090</ArticleId><ArticleId IdType=\"pmc\">PMC6315598</ArticleId><ArticleId IdType=\"pubmed\">30563204</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamano E., Sugimoto M., Hirayama A., Kume S., Yamato M., Jin G., Tajima S., Goda N., Iwai K., Fukuda S., et al. Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles. Sci. Rep. 2016;6:34990. doi: 10.1038/srep34990.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/srep34990</ArticleId><ArticleId IdType=\"pmc\">PMC5057083</ArticleId><ArticleId IdType=\"pubmed\">27725700</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong C.W., McGregor N.R., Sheedy J.R., Buttfield I., Butt H.L., Gooley P.R. NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome. Clin. Chim. Acta. 2012;413:1525&#x2013;1531. doi: 10.1016/j.cca.2012.06.022.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cca.2012.06.022</ArticleId><ArticleId IdType=\"pubmed\">22728138</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong C.W., McGregor N.R., Lewis D.P., Butt H.L., Gooley P.R. The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome. Metabolomics. 2016;13:8. doi: 10.1007/s11306-016-1145-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11306-016-1145-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoel F., Hoel A., Pettersen I.K., Rekeland I.G., Risa K., Alme K., Sorland K., Fossa A., Lien K., Herder I., et al. A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 2021;6:e149217. doi: 10.1172/jci.insight.149217.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/jci.insight.149217</ArticleId><ArticleId IdType=\"pmc\">PMC8409979</ArticleId><ArticleId IdType=\"pubmed\">34423789</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy-Szakal D., Barupal D.K., Lee B., Che X., Williams B.L., Kahn E.J.R., Ukaigwe J.E., Bateman L., Klimas N.G., Komaroff A.L., et al. Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. Sci. Rep. 2018;8:10056. doi: 10.1038/s41598-018-28477-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-018-28477-9</ArticleId><ArticleId IdType=\"pmc\">PMC6030047</ArticleId><ArticleId IdType=\"pubmed\">29968805</ArticleId></ArticleIdList></Reference><Reference><Citation>McGregor N.R., Armstrong C.W., Lewis D.P., Gooley P.R. Post-Exertional Malaise Is Associated with Hypermetabolism, Hypoacetylation and Purine Metabolism Deregulation in ME/CFS Cases. Diagnostics. 2019;9:70. doi: 10.3390/diagnostics9030070.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics9030070</ArticleId><ArticleId IdType=\"pmc\">PMC6787670</ArticleId><ArticleId IdType=\"pubmed\">31277442</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong C.W., McGregor N.R., Lewis D.P., Butt H.L., Gooley P.R. Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients. Metabolomics. 2015;11:1626&#x2013;1639. doi: 10.1007/s11306-015-0816-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11306-015-0816-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge O., Mella O., Bruland O., Risa K., Dyrstad S.E., Alme K., Rekeland I.G., Sapkota D., Rosland G.V., Fossa A., et al. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight. 2016;1:e89376. doi: 10.1172/jci.insight.89376.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/jci.insight.89376</ArticleId><ArticleId IdType=\"pmc\">PMC5161229</ArticleId><ArticleId IdType=\"pubmed\">28018972</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux R.K., Naviaux J.C., Li K., Bright A.T., Alaynick W.A., Wang L., Baxter A., Nathan N., Anderson W., Gordon E. Metabolic features of chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA. 2016;113:E5472&#x2013;E5480. doi: 10.1073/pnas.1607571113.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1607571113</ArticleId><ArticleId IdType=\"pmc\">PMC5027464</ArticleId><ArticleId IdType=\"pubmed\">27573827</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones M.G., Cooper E., Amjad S., Goodwin C.S., Barron J.L., Chalmers R.A. Urinary and plasma organic acids and amino acids in chronic fatigue syndrome. Clin. Chim. Acta. 2005;361:150&#x2013;158. doi: 10.1016/j.cccn.2005.05.023.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cccn.2005.05.023</ArticleId><ArticleId IdType=\"pubmed\">15992788</ArticleId></ArticleIdList></Reference><Reference><Citation>Niblett S.H., King K.E., Dunstan R.H., Clifton-Bligh P., Hoskin L.A., Roberts T.K., Fulcher G.R., McGregor N.R., Dunsmore J.C., Butt H.L., et al. Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome. Exp. Biol. Med. 2007;232:1041&#x2013;1049. doi: 10.3181/0702-RM-44.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3181/0702-RM-44</ArticleId><ArticleId IdType=\"pubmed\">17720950</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A., Giloteaux L., Moore G.E., Levine S.M., Chia J.K., Keller B.A., Stevens J., Franconi C.J., Mao X., Shungu D.C., et al. Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 2022;7:e157621. doi: 10.1172/jci.insight.157621.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/jci.insight.157621</ArticleId><ArticleId IdType=\"pmc\">PMC9090259</ArticleId><ArticleId IdType=\"pubmed\">35358096</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell D.S. The Doctor&#x2019;s Guide to Chronic Fatigue Syndrome. Understanding, Treating, and Living with CFIDS. Addison-Wesley Publishing Company; Reading, MA, USA: 1994.</Citation></Reference><Reference><Citation>Yang J., Zhao X., Lu X., Lin X., Xu G. A data preprocessing strategy for metabolomics to reduce the mask effect in data analysis. Front. Mol. Biosci. 2015;2:4. doi: 10.3389/fmolb.2015.00004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmolb.2015.00004</ArticleId><ArticleId IdType=\"pmc\">PMC4428451</ArticleId><ArticleId IdType=\"pubmed\">25988172</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y., Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B. 1995;57:289&#x2013;300. doi: 10.1111/j.2517-6161.1995.tb02031.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.2517-6161.1995.tb02031.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Barupal D.K., Fan S., Fiehn O. Integrating bioinformatics approaches for a comprehensive interpretation of metabolomics datasets. Curr. Opin. Biotechnol. 2018;54:1&#x2013;9. doi: 10.1016/j.copbio.2018.01.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.copbio.2018.01.010</ArticleId><ArticleId IdType=\"pmc\">PMC6358024</ArticleId><ArticleId IdType=\"pubmed\">29413745</ArticleId></ArticleIdList></Reference><Reference><Citation>Barupal D.K., Fiehn O. Chemical Similarity Enrichment Analysis (ChemRICH) as alternative to biochemical pathway mapping for metabolomic datasets. Sci. Rep. 2017;7:14567. doi: 10.1038/s41598-017-15231-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-017-15231-w</ArticleId><ArticleId IdType=\"pmc\">PMC5673929</ArticleId><ArticleId IdType=\"pubmed\">29109515</ArticleId></ArticleIdList></Reference><Reference><Citation>Goeman J.J., van de Geer S.A., de Kort F., van Houwelingen H.C. A global test for groups of genes: Testing association with a clinical outcome. Bioinformatics. 2004;20:93&#x2013;99. doi: 10.1093/bioinformatics/btg382.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/bioinformatics/btg382</ArticleId><ArticleId IdType=\"pubmed\">14693814</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosato A., Tenori L., Cascante M., De Atauri Carulla P.R., Martins Dos Santos V.A.P., Saccenti E. From correlation to causation: Analysis of metabolomics data using systems biology approaches. Metabolomics. 2018;14:37. doi: 10.1007/s11306-018-1335-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11306-018-1335-y</ArticleId><ArticleId IdType=\"pmc\">PMC5829120</ArticleId><ArticleId IdType=\"pubmed\">29503602</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardounel A.J., Cui H., Samouilov A., Johnson W., Kearns P., Tsai A.L., Berka V., Zweier J.L. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J. Biol. Chem. 2007;282:879&#x2013;887. doi: 10.1074/jbc.M603606200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M603606200</ArticleId><ArticleId IdType=\"pubmed\">17082183</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrasekharan U.M., Wang Z., Wu Y., Wilson Tang W.H., Hazen S.L., Wang S., Elaine Husni M. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis. Arthritis Res. Ther. 2018;20:123. doi: 10.1186/s13075-018-1616-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13075-018-1616-x</ArticleId><ArticleId IdType=\"pmc\">PMC5994036</ArticleId><ArticleId IdType=\"pubmed\">29884228</ArticleId></ArticleIdList></Reference><Reference><Citation>Siroen M.P., Teerlink T., Nijveldt R.J., Prins H.A., Richir M.C., van Leeuwen P.A. The clinical significance of asymmetric dimethylarginine. Annu. Rev. Nutr. 2006;26:203&#x2013;228. doi: 10.1146/annurev.nutr.26.061505.111320.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev.nutr.26.061505.111320</ArticleId><ArticleId IdType=\"pubmed\">16848705</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertinat R., Villalobos-Labra R., Hofmann L., Blauensteiner J., Sepulveda N., Westermeier F. Decreased NO production in endothelial cells exposed to plasma from ME/CFS patients. Vasc. Pharmacol. 2022;143:106953. doi: 10.1016/j.vph.2022.106953.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.vph.2022.106953</ArticleId><ArticleId IdType=\"pubmed\">35074481</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosnan J.T., Brosnan M.E. The sulfur-containing amino acids: An overview. J. Nutr. 2006;136:1636S&#x2013;1640S. doi: 10.1093/jn/136.6.1636S.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jn/136.6.1636S</ArticleId><ArticleId IdType=\"pubmed\">16702333</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Garc&#xed;a J.C., Mart&#xed;nez-S&#xe1;nchez M.A., Bernal-L&#xf3;pez M.R., Mu&#xf1;oz-Garach A., Mart&#xed;nez-Gonz&#xe1;lez M.A., Fit&#xf3; M., Salas-Salvad&#xf3; J., Tinahones F.J., Ramos-Molina B. Effect of a lifestyle intervention program with energy-restricted Mediterranean diet and exercise on the serum polyamine metabolome in individuals at high cardiovascular disease risk: A randomized clinical trial. Am. J. Clin. Nutr. 2020;111:975&#x2013;982. doi: 10.1093/ajcn/nqaa064.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ajcn/nqaa064</ArticleId><ArticleId IdType=\"pubmed\">32246717</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Zhang H., Xue G., Zhang L., Zhang W., Wang L., Lu F., Li H., Bai S., Lin Y., et al. Exercise training preserves ischemic preconditioning in aged rat hearts by restoring the myocardial polyamine pool. Oxid. Med. Cell. Longev. 2014;2014:457429. doi: 10.1155/2014/457429.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2014/457429</ArticleId><ArticleId IdType=\"pmc\">PMC4227379</ArticleId><ArticleId IdType=\"pubmed\">25404991</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomstrand E., Eliasson J., Karlsson H.K., Kohnke R. Branched-chain amino acids activate key enzymes in protein synthesis after physical exercise. J. Nutr. 2006;136:269S&#x2013;273S. doi: 10.1093/jn/136.1.269S.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jn/136.1.269S</ArticleId><ArticleId IdType=\"pubmed\">16365096</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsholme P., Stenson L., Sulvucci M., Sumayao R., Krause M. 1.02-Amino Acid Metabolism. In: Moo-Young M., editor. Comprehensive Biotechnology. 2nd ed. Academic Press; Burlington, ON, Canada: 2011. pp. 3&#x2013;14.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/B978-0-08-088504-9.00002-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Gao D., Jiang Y. Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma. Metabolites. 2019;9:36. doi: 10.3390/metabo9020036.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/metabo9020036</ArticleId><ArticleId IdType=\"pmc\">PMC6410233</ArticleId><ArticleId IdType=\"pubmed\">30795537</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun T.P., Marks D.L. The regulation of muscle mass by endogenous glucocorticoids. Front. Physiol. 2015;6:12. doi: 10.3389/fphys.2015.00012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2015.00012</ArticleId><ArticleId IdType=\"pmc\">PMC4315033</ArticleId><ArticleId IdType=\"pubmed\">25691871</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman B.L. Mineralocorticoids. In: Enna S.J., Bylund D.B., editors. xPharm: The Comprehensive Pharmacology Reference. Elsevier; New York, NY, USA: 2007. p. 1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/B978-008055232-3.61052-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavyani B., Lidbury B.A., Schloeffel R., Fisher P.R., Missailidis D., Annesley S.J., Dehhaghi M., Heng B., Guillemin G.J. Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle? Cell. Mol. Life Sci. 2022;79:412. doi: 10.1007/s00018-022-04380-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00018-022-04380-5</ArticleId><ArticleId IdType=\"pmc\">PMC9276562</ArticleId><ArticleId IdType=\"pubmed\">35821534</ArticleId></ArticleIdList></Reference><Reference><Citation>Kossman D.A., Williams N.I., Domchek S.M., Kurzer M.S., Stopfer J.E., Schmitz K.H. Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer. J. Appl. Physiol. 2011;111:1687&#x2013;1693. doi: 10.1152/japplphysiol.00319.2011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/japplphysiol.00319.2011</ArticleId><ArticleId IdType=\"pmc\">PMC4116411</ArticleId><ArticleId IdType=\"pubmed\">21903887</ArticleId></ArticleIdList></Reference><Reference><Citation>De Souza M.J., Van Heest J., Demers L.M., Lasley B.L. Luteal Phase Deficiency in Recreational Runners: Evidence for a Hypometabolic State. J. Clin. Endocrinol. Metab. 2003;88:337&#x2013;346. doi: 10.1210/jc.2002-020958.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1210/jc.2002-020958</ArticleId><ArticleId IdType=\"pubmed\">12519874</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee K., Edgett B.A., Burrows H.W., Castro C., Griffin J.L., Schwertani A.G., Gurd B.J., Funk C.D. Whole blood transcriptomics and urinary metabolomics to define adaptive biochemical pathways of high-intensity exercise in 50&#x2013;60 year old masters athletes. PLoS ONE. 2014;9:e92031. doi: 10.1371/journal.pone.0092031.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0092031</ArticleId><ArticleId IdType=\"pmc\">PMC3958411</ArticleId><ArticleId IdType=\"pubmed\">24643011</ArticleId></ArticleIdList></Reference><Reference><Citation>Schranner D., Kastenmuller G., Schonfelder M., Romisch-Margl W., Wackerhage H. Metabolite Concentration Changes in Humans After a Bout of Exercise: A Systematic Review of Exercise Metabolomics Studies. Sports Med. Open. 2020;6:11. doi: 10.1186/s40798-020-0238-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40798-020-0238-4</ArticleId><ArticleId IdType=\"pmc\">PMC7010904</ArticleId><ArticleId IdType=\"pubmed\">32040782</ArticleId></ArticleIdList></Reference><Reference><Citation>Kistner S., Rist M.J., Doring M., Dorr C., Neumann R., Hartel S., Bub A. An NMR-Based Approach to Identify Urinary Metabolites Associated with Acute Physical Exercise and Cardiorespiratory Fitness in Healthy Humans-Results of the KarMeN Study. Metabolites. 2020;10:212. doi: 10.3390/metabo10050212.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/metabo10050212</ArticleId><ArticleId IdType=\"pmc\">PMC7281079</ArticleId><ArticleId IdType=\"pubmed\">32455749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuratsune H., Yamaguti K., Takahashi M., Misaki H., Tagawa S., Kitani T. Acylcarnitine deficiency in chronic fatigue syndrome. Clin. Infect. Dis. 1994;18((Suppl. 1)):S62&#x2013;S67. doi: 10.1093/clinids/18.Supplement_1.S62.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/clinids/18.Supplement_1.S62</ArticleId><ArticleId IdType=\"pubmed\">8148455</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones M.G., Goodwin C.S., Amjad S., Chalmers R.A. Plasma and urinary carnitine and acylcarnitines in chronic fatigue syndrome. Clin. Chim. Acta. 2005;360:173&#x2013;177. doi: 10.1016/j.cccn.2005.04.029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cccn.2005.04.029</ArticleId><ArticleId IdType=\"pubmed\">15967423</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Light A.R., Hoppel C.L., Campbell C., Chandler C.J., Burnett D.J., Souza E.C., Casazza G.A., Hughen R.W., Keim N.L., et al. Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons. Exp. Physiol. 2017;102:48&#x2013;69. doi: 10.1113/EP086019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1113/EP086019</ArticleId><ArticleId IdType=\"pmc\">PMC5209287</ArticleId><ArticleId IdType=\"pubmed\">27730694</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa C.G., Guerand W.S., Struys E.A., Holwerda U., ten Brink H.J., Tavares de Almeida I., Duran M., Jakobs C. Quantitative analysis of urinary acylglycines for the diagnosis of beta-oxidation defects using GC-NCI-MS. J. Pharm. Biomed. Anal. 2000;21:1215&#x2013;1224. doi: 10.1016/S0731-7085(99)00235-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0731-7085(99)00235-6</ArticleId><ArticleId IdType=\"pubmed\">10708405</ArticleId></ArticleIdList></Reference><Reference><Citation>Maya J., Leddy S.M., Gottschalk C.G., Peterson D.L., Hanson M.R. Altered Fatty Acid Oxidation in Lymphocyte Populations of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Int. J. Mol. Sci. 2023;24:2010. doi: 10.3390/ijms24032010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms24032010</ArticleId><ArticleId IdType=\"pmc\">PMC9916395</ArticleId><ArticleId IdType=\"pubmed\">36768336</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson D.J., Smeeton N.J., Watt P.W. Ammonia metabolism, the brain and fatigue; revisiting the link. Prog. Neurobiol. 2010;91:200&#x2013;219. doi: 10.1016/j.pneurobio.2010.01.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pneurobio.2010.01.012</ArticleId><ArticleId IdType=\"pubmed\">20138956</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Minegishi Y., Hasumura T., Shimotoyodome A., Ota N. Involvement of ammonia metabolism in the improvement of endurance performance by tea catechins in mice. Sci. Rep. 2020;10:6065. doi: 10.1038/s41598-020-63139-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-020-63139-9</ArticleId><ArticleId IdType=\"pmc\">PMC7142105</ArticleId><ArticleId IdType=\"pubmed\">32269254</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B.D., Sbodio J.I., Snyder S.H. Cysteine Metabolism in Neuronal Redox Homeostasis. Trends Pharmacol. Sci. 2018;39:513&#x2013;524. doi: 10.1016/j.tips.2018.02.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tips.2018.02.007</ArticleId><ArticleId IdType=\"pmc\">PMC5912966</ArticleId><ArticleId IdType=\"pubmed\">29530337</ArticleId></ArticleIdList></Reference><Reference><Citation>Nkiliza A., Parks M., Cseresznye A., Oberlin S., Evans J.E., Darcey T., Aenlle K., Niedospial D., Mullan M., Crawford F., et al. Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms. J. Transl. Med. 2021;19:370. doi: 10.1186/s12967-021-03035-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-021-03035-6</ArticleId><ArticleId IdType=\"pmc\">PMC8401202</ArticleId><ArticleId IdType=\"pubmed\">34454515</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neal A.J., Glass K.A., Emig C.J., Vitug A.A., Henry S.J., Shungu D.C., Mao X., Levine S.M., Hanson M.R. Survey of Anti-Pathogen Antibody Levels in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Proteomes. 2022;10:21. doi: 10.3390/proteomes10020021.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/proteomes10020021</ArticleId><ArticleId IdType=\"pmc\">PMC9228258</ArticleId><ArticleId IdType=\"pubmed\">35736801</ArticleId></ArticleIdList></Reference><Reference><Citation>Analysis of Post-Exertional Malaise Using a Two-Day CPET in People with ME/CFS.  [(accessed on 14 December 2022)]; Available online:  https://clinicaltrials.gov/ct2/show/NCT04026425.</Citation></Reference><Reference><Citation>Ware J.E., Jr., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care. 1992;30:473&#x2013;483. doi: 10.1097/00005650-199206000-00002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00005650-199206000-00002</ArticleId><ArticleId IdType=\"pubmed\">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Smets E.M., Garssen B., Bonke B., De Haes J.C. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 1995;39:315&#x2013;325. doi: 10.1016/0022-3999(94)00125-O.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0022-3999(94)00125-O</ArticleId><ArticleId IdType=\"pubmed\">7636775</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford L., Kennedy A.D., Goodman K.D., Pappan K.L., Evans A.M., Miller L.A.D., Wulff J.E., Wiggs B.R., Lennon J.J., Elsea S., et al. Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism. J. Appl. Lab. Med. 2020;5:342&#x2013;356. doi: 10.1093/jalm/jfz026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jalm/jfz026</ArticleId><ArticleId IdType=\"pubmed\">32445384</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Z., Chong J., Zhou G., de Lima Morais D.A., Chang L., Barrette M., Gauthier C., Jacques P.E., Li S., Xia J. MetaboAnalyst 5.0: Narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 2021;49:W388&#x2013;W396. doi: 10.1093/nar/gkab382.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/nar/gkab382</ArticleId><ArticleId IdType=\"pmc\">PMC8265181</ArticleId><ArticleId IdType=\"pubmed\">34019663</ArticleId></ArticleIdList></Reference><Reference><Citation>Durbin B.P., Hardin J.S., Hawkins D.M., Rocke D.M. A variance-stabilizing transformation for gene-expression microarray data. Bioinformatics. 2002;18((Suppl. 1)):S105&#x2013;S110. doi: 10.1093/bioinformatics/18.suppl_1.S105.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/bioinformatics/18.suppl_1.S105</ArticleId><ArticleId IdType=\"pubmed\">12169537</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuznetsova A., Brockhoff P.B., Christensen R.H.B. lmerTest Package: Tests in Linear Mixed Effects Models. J. Stat. Softw. 2017;82:1&#x2013;26. doi: 10.18637/jss.v082.i13.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18637/jss.v082.i13</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenth R. Emmeans: Estimated Marginal Means, aka Least-Squares Means, 1.8.2; R Package. 2022.  [(accessed on 31 January 2022)].  Available online:  https://CRAN.R-project.org/package=emmeans.</Citation></Reference><Reference><Citation>Blighe K., Rana S., Lewis M. EnhancedVolcano: Publication-Ready Volcano Plots with Enhanced Colouring and Labeling, Version 1.16.0; R Package. 2022.  [(accessed on 11 November 2022)].  Available online:  https://bioconductor.org/packages/release/bioc/html/EnhancedVolcano.html.</Citation></Reference><Reference><Citation>Smirnov N.V. On the estimation of the discrepancy between empirical curves of distribution for two independent samples. Bull. Math. Univ. Moscou. 1939;2:3&#x2013;14.</Citation></Reference><Reference><Citation>Kolde R. Pheatmap: Pretty Heatmaps, 1.0.12; R Package. 2019.  [(accessed on 16 February 2022)].  Available online:  https://cran.r-project.org/web/packages/pheatmap/index.html.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">36830795</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Print\">2227-9059</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>18</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">257</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/biomedicines11020257</ELocationID><Abstract><AbstractText>Recent studies provide some evidence for the contribution of antibody-mediated autoimmune mechanisms to the nature of fibromyalgia (FM) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Much attention was paid to the autoantibodies (AAb) targeting G protein-coupled receptors as natural components of the immune system. However, the natural AAb network is much more extensive, and has not been previously investigated in these disorders. The enzyme immunoassays ELI-Viscero-Test and ELI-Neuro-Test were used to determine changes in serum content of 33 natural AAb to neural, organ-specific and non-tissue-specific autoantigens (a) in 11 ME/CFS patients with comorbid FM; (b) in 11 ME/CFS patients without FM; (c) in 11 healthy controls. Individual AAb profiles and their correlation with some clinical symptoms were analyzed. Both patients with ME/CFS(-)FM and ME/CFS(+)FM were characterized by more frequent and pronounced deviations in the immunoreactivity to GABA-receptors than healthy controls. Although the level of other natural AAb did not differ between study groups, AAb correlation signatures were altered in patients compared to healthy controls. Both in patients and healthy controls the level of natural AAb to various neural and tissue-specific antigens correlated with the severity of fatigue, bodily pain, depression, anxiety, physical and mental health-related quality of life. Notably, widely different correlation patterns were observed between study groups. Findings from this pilot study provide some evidence that the homeostasis of autoimmune relationships, which are possibly a physiological part of our immune system, may be altered in FM and ME/CFS. The correlation of disease-induced perturbations in individual AAb profiles with some clinical symptoms may arise from the immune system\\'s ability to reflect qualitative and quantitative changes in antigenic composition of the body.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Ryabkova</LastName><ForeName>Varvara A</ForeName><Initials>VA</Initials><Identifier Source=\"ORCID\">0000-0001-6973-9901</Identifier><AffiliationInfo><Affiliation>Laboratory of the Mosaic of Autoimmunity, Department of Pathology, Saint Petersburg State University, 199034 Saint Petersburg, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Hospital Therapy Named after Academician M.V. Chernorutskii, Research Institute of Rheumatology and Allergology, Pavlov First Saint Petersburg State Medical University, 197022 Saint Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gavrilova</LastName><ForeName>Natalia Y</ForeName><Initials>NY</Initials><AffiliationInfo><Affiliation>Laboratory of the Mosaic of Autoimmunity, Department of Pathology, Saint Petersburg State University, 199034 Saint Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Poletaeva</LastName><ForeName>Alina A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Medical Research Centre \"Immunculus\", 105187 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pukhalenko</LastName><ForeName>Alexander I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Medical Research Centre \"Immunculus\", 105187 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Koshkina</LastName><ForeName>Irina A</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>LLC \"Doctor Koshkina\", 117437 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Churilov</LastName><ForeName>Leonid P</ForeName><Initials>LP</Initials><Identifier Source=\"ORCID\">0000-0001-6359-0026</Identifier><AffiliationInfo><Affiliation>Laboratory of the Mosaic of Autoimmunity, Department of Pathology, Saint Petersburg State University, 199034 Saint Petersburg, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Saint Petersburg Research Institute of Phthisiopulmonology, 191036 Saint Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shoenfeld</LastName><ForeName>Yehuda</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of the Mosaic of Autoimmunity, Department of Pathology, Saint Petersburg State University, 199034 Saint Petersburg, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center Tel-Hashomer, Ramat-Gan 52621, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>22-15-00113</GrantID><Agency>Russian Science Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2023</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">autoantibodies</Keyword><Keyword MajorTopicYN=\"N\">autoimmunity</Keyword><Keyword MajorTopicYN=\"N\">fibromyalgia</Keyword><Keyword MajorTopicYN=\"N\">myalgic encephalomyelitis/chronic fatigue syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2023</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">36830795</ArticleId><ArticleId IdType=\"pmc\">PMC9952981</ArticleId><ArticleId IdType=\"doi\">10.3390/biomedicines11020257</ArticleId><ArticleId IdType=\"pii\">biomedicines11020257</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goebel A., Krock E., Gentry C., Israel M.R., Jurczak A., Urbina C.M., Sandor K., Vastani N., Maurer M., Cuhadar U., et al. Passive transfer of fibromyalgia symptoms from patients to mice. J. Clin. Investig. 2021;131:e144201. doi: 10.1172/JCI144201.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI144201</ArticleId><ArticleId IdType=\"pmc\">PMC8245181</ArticleId><ArticleId IdType=\"pubmed\">34196305</ArticleId></ArticleIdList></Reference><Reference><Citation>Krock E., Morado-Urbina C.E., Menezes J., Hunt M.A., Sandstr&#xf6;m A., Kadetoff D., Tour J., Verma V., Kultima K., Haglund L., et al. Fibromyalgia patients with high levels of anti-satellite glia cell IgG antibodies present with more severe symptoms. BioRxiv. 2022;131:e144201. doi: 10.1101/2022.07.06.498940.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2022.07.06.498940</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera M.C., Mastronardi C., Silva-Aldana C.T., Arcos-Burgos M., Lidbury B.A. Myalgic encephalomyelitis/chronic fatigue syndrome: A comprehensive review. Diagnostics. 2019;9:91. doi: 10.3390/diagnostics9030091.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics9030091</ArticleId><ArticleId IdType=\"pmc\">PMC6787585</ArticleId><ArticleId IdType=\"pubmed\">31394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson B.H. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: Definitions, Similarities, and Differences. Clin. Ther. 2019;41:612&#x2013;618. doi: 10.1016/j.clinthera.2018.12.016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.clinthera.2018.12.016</ArticleId><ArticleId IdType=\"pmc\">PMC6589349</ArticleId><ArticleId IdType=\"pubmed\">30795933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-Morales R., Berm&#xfa;dez-Ben&#xed;tez E., Mart&#xed;nez-Mart&#xed;nez L.A., Mart&#xed;nez-Lav&#xed;n M. Clinical overlap between fibromyalgia and myalgic encephalomyelitis: A systematic review and meta-analysis. Autoimmun. Rev. 2022;21:103129. doi: 10.1016/j.autrev.2022.103129.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2022.103129</ArticleId><ArticleId IdType=\"pubmed\">35690247</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L. Advances in Understanding the Pathophysiology of Chronic Fatigue Syndrome. JAMA. 2019;322:499&#x2013;500. doi: 10.1001/jama.2019.8312.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2019.8312</ArticleId><ArticleId IdType=\"pubmed\">31276153</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D., Annesley S.J., Fisher P.R. Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Diagnostics. 2019;9:80. doi: 10.3390/diagnostics9030080.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics9030080</ArticleId><ArticleId IdType=\"pmc\">PMC6787592</ArticleId><ArticleId IdType=\"pubmed\">31330791</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitag H., Szklarski M., Lorenz S., Sotzny F., Bauer S., Philippe A., Kedor C., Grabowski P., Lange T., Riemekasten G., et al. Autoantibodies to vasoregulative g-protein-coupled receptors correlate with symptom severity, autonomic dysfunction and disability in myalgic encephalomyelitis/chronic fatigue syndrome. J. Clin. Med. 2021;10:3675. doi: 10.3390/jcm10163675.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm10163675</ArticleId><ArticleId IdType=\"pmc\">PMC8397061</ArticleId><ArticleId IdType=\"pubmed\">34441971</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K., Scheibenbogen C.A. Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against &#xdf;2-adrenergic receptors. Autoimmun Rev. 2020;19:102527. doi: 10.1016/j.autrev.2020.102527.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2020.102527</ArticleId><ArticleId IdType=\"pubmed\">32247028</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Marques O., Marques A., Giil L.M., De Vito R., Rademacher J., G&#xfc;nther J., Lange T., Humrich J.Y., Klapa S., Schinke S., et al. GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis. Nat. Commun. 2018;9:5224. doi: 10.1038/s41467-018-07598-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-018-07598-9</ArticleId><ArticleId IdType=\"pmc\">PMC6283882</ArticleId><ArticleId IdType=\"pubmed\">30523250</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Marques O., Halpert G., Schimke L.F., Ostrinski Y., Vojdani A., Baiocchi G.C., Freire P.P., Filgueiras I.S., Zyskind I., Lattin M.T., et al. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nat. Commun. 2022;13:1&#x2013;12. doi: 10.1038/s41467-022-28905-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-28905-5</ArticleId><ArticleId IdType=\"pmc\">PMC8907309</ArticleId><ArticleId IdType=\"pubmed\">35264564</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study. Ann. Intern. Med. 1994;121:953. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType=\"pubmed\">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., Jain A.K., De Meirleir K.L., Peterson D.L., Klimas N.G., Lerner A.M., Bested A.C., Flor-Henry P., Joshi P., Powles A.P., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Chronic Fatigue Syndr. 2003;11:7&#x2013;115. doi: 10.1300/J092v11n01_02.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine . Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. National Academies Press; Washington, DC, USA: 2015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.17226/19012</ArticleId><ArticleId IdType=\"pubmed\">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F., Clauw D.J., Fitzcharles M.A., Goldenberg D.L., H&#xe4;user W., Katz R.L., Mease P.J., Russell A.S., Russell I.J., Walitt B., et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin. Arthritis Rheum. 2016;46:319&#x2013;329. doi: 10.1016/j.semarthrit.2016.08.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.semarthrit.2016.08.012</ArticleId><ArticleId IdType=\"pubmed\">27916278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care. 1992;30:473&#x2013;483. doi: 10.1097/00005650-199206000-00002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00005650-199206000-00002</ArticleId><ArticleId IdType=\"pubmed\">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Smets E.M.A., Garssen B., Bonke B., De Haes J.C.J.M. The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 1995;39:315&#x2013;325. doi: 10.1016/0022-3999(94)00125-O.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0022-3999(94)00125-O</ArticleId><ArticleId IdType=\"pubmed\">7636775</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjelland I., Dahl A.A., Haug T.T., Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: An updated literature review. J. Psychosom. Res. 2002;52:69&#x2013;77. doi: 10.1016/S0022-3999(01)00296-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0022-3999(01)00296-3</ArticleId><ArticleId IdType=\"pubmed\">11832252</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletaev A., Boura P. The immune system, natural autoantibodies and general homeostasis in healthand disease. Hippokratia. 2011;15:295.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3876841</ArticleId><ArticleId IdType=\"pubmed\">24391407</ArticleId></ArticleIdList></Reference><Reference><Citation>Goebel A., Andersson D., Shoenfeld Y. The biology of symptom-based disorders - time to act. Autoimmun Rev. 2023;22:103218. doi: 10.1016/j.autrev.2022.103218.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2022.103218</ArticleId><ArticleId IdType=\"pubmed\">36280093</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A.M., Shoenfeld Y. Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic tachycardia syndrome, autoimmune diseases and autoimmune/inflammatory syndrome induced by adjuvants. Autoimmun. Rev. 2023;22:103230. doi: 10.1016/J.AUTREV.2022.103230.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/J.AUTREV.2022.103230</ArticleId><ArticleId IdType=\"pubmed\">36347462</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier L.A., Binstadt B.A. The Contribution of Autoantibodies to Inflammatory Cardiovascular Pathology. Front. Immunol. 2018;9:911. doi: 10.3389/fimmu.2018.00911.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2018.00911</ArticleId><ArticleId IdType=\"pmc\">PMC5934424</ArticleId><ArticleId IdType=\"pubmed\">29755478</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukushima K., Tsujino K., Futami S., Kida H. Natural Autoantibodies in Chronic Pulmonary Diseases. Int. J. Mol. Sci. 2020;21:1138. doi: 10.3390/ijms21031138.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21031138</ArticleId><ArticleId IdType=\"pmc\">PMC7037933</ArticleId><ArticleId IdType=\"pubmed\">32046322</ArticleId></ArticleIdList></Reference><Reference><Citation>Pashnina I.A., Krivolapova I.M., Fedotkina T.V., Ryabkova V.A., Chereshneva M.V., Churilov L.P., Chereshnev V.A. Antinuclear Autoantibodies in Health: Autoimmunity Is Not a Synonym of Autoimmune Disease. Antibodies. 2021;10:9. doi: 10.3390/antib10010009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antib10010009</ArticleId><ArticleId IdType=\"pmc\">PMC8006153</ArticleId><ArticleId IdType=\"pubmed\">33668697</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen I.R. Biomarkers, self-antigens and the immunological homunculus. J. Autoimmun. 2007;29:246&#x2013;249. doi: 10.1016/j.jaut.2007.07.016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaut.2007.07.016</ArticleId><ArticleId IdType=\"pubmed\">17888625</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletaev A., Osipenko L. General network of natural autoantibodies as immunological homunculus (Immunculus) Autoimmun. Rev. 2003;2:264&#x2013;271. doi: 10.1016/S1568-9972(03)00033-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1568-9972(03)00033-8</ArticleId><ArticleId IdType=\"pubmed\">12965177</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletaev A.B., Churilov L.P., Stroev Y.I., Agapov M.M. Immunophysiology versus immunopathology: Natural autoimmunity in human health and disease. Pathophysiology. 2012;19:221&#x2013;231. doi: 10.1016/j.pathophys.2012.07.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pathophys.2012.07.003</ArticleId><ArticleId IdType=\"pubmed\">22884694</ArticleId></ArticleIdList></Reference><Reference><Citation>Comhaire F., Devriendt G. Chronic Fatigue Syndrome (CFS) or &#x201c;Systemic Immune Disorder&#x201d; (SID)? Intern. Med. Open Access. 2016;6:1000225. doi: 10.4172/2165-8048.1000225.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4172/2165-8048.1000225</ArticleId></ArticleIdList></Reference><Reference><Citation>Laborit H. The major mechanisms of stress. Methods Achiev. Exp. Pathol. 1991;15:1&#x2013;26.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1762547</ArticleId></ArticleIdList></Reference><Reference><Citation>Cope H., Mann A., Pelosi A., David A. Psychosocial risk factors for chronic fatigue and chronic fatigue syndrome following presumed viral illness: A case-control study. Psychol. Med. 1996;26:1197&#x2013;1209. doi: 10.1017/S0033291700035923.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S0033291700035923</ArticleId><ArticleId IdType=\"pubmed\">8931166</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraniuk J.N. Review of the Midbrain Ascending Arousal Network Nuclei and Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Gulf War Illness (GWI) and Postexertional Malaise (PEM) Brain Sci. 2022;12:132. doi: 10.3390/brainsci12020132.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/brainsci12020132</ArticleId><ArticleId IdType=\"pmc\">PMC8870178</ArticleId><ArticleId IdType=\"pubmed\">35203896</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassford J.A.G. The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Front. Physiol. 2017;8:88. doi: 10.3389/fphys.2017.00088.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2017.00088</ArticleId><ArticleId IdType=\"pmc\">PMC5314655</ArticleId><ArticleId IdType=\"pubmed\">28261110</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark A., Lowry P., Smyth D.G. 60 YEARS OF POMC: Lipotropin and beta-endorphin: A perspective. J. Mol. Endocrinol. 2016;56:T13&#x2013;T25. doi: 10.1530/JME-16-0033.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1530/JME-16-0033</ArticleId><ArticleId IdType=\"pubmed\">26903509</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrepf A., Harper D.E., Harte S.E., Wang H., Ichesco E., Hampson J.P., Zubieta J.-K., Clauw D.J., Harris R.E. Endogenous opioidergic dysregulation of pain in fibromyalgia: A PET and fMRI study. Pain. 2016;157:2217&#x2013;2225. doi: 10.1097/j.pain.0000000000000633.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/j.pain.0000000000000633</ArticleId><ArticleId IdType=\"pmc\">PMC5028286</ArticleId><ArticleId IdType=\"pubmed\">27420606</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Wang K.K.W. Glial Fibrillary acidic protein: From intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 2015;38:364. doi: 10.1016/j.tins.2015.04.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tins.2015.04.003</ArticleId><ArticleId IdType=\"pmc\">PMC4559283</ArticleId><ArticleId IdType=\"pubmed\">25975510</ArticleId></ArticleIdList></Reference><Reference><Citation>Danilenko O.V., Gavrilova N.Y., Churilov L.P. Chronic Fatigue Exhibits Heterogeneous Autoimmunity Characteristics Which Reflect Etiology. Pathophysiology. 2022;29:187&#x2013;199. doi: 10.3390/pathophysiology29020016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pathophysiology29020016</ArticleId><ArticleId IdType=\"pmc\">PMC9231045</ArticleId><ArticleId IdType=\"pubmed\">35736644</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg D., Berg L.H., Couvaras J., Harrison H. Chronic fatigue syndrome and/or fibromyalgia as a variation of antiphospholipid antibody syndrome: An explanatory model and approach to laboratory diagnosis. Blood Coagul Fibrinolysis. 1999;10:435&#x2013;438. doi: 10.1097/00001721-199910000-00006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00001721-199910000-00006</ArticleId><ArticleId IdType=\"pubmed\">10695770</ArticleId></ArticleIdList></Reference><Reference><Citation>Eccles J.A., Thompson B., Themelis K., Amato M.L., Stocks R., Pound A., Jones A.M., Cipinova Z., Shah-Goodwin L., Timeyin J., et al. Beyond bones: The relevance of variants of connective tissue (hypermobility) to fibromyalgia, ME/CFS and controversies surrounding diagnostic classification: An observational study. Clin. Med. 2021;21:53&#x2013;58. doi: 10.7861/clinmed.2020-0743.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7861/clinmed.2020-0743</ArticleId><ArticleId IdType=\"pmc\">PMC7850199</ArticleId><ArticleId IdType=\"pubmed\">33479068</ArticleId></ArticleIdList></Reference><Reference><Citation>Babamuradova Z., Shodikulova G. Content of type i collagen antibodies and their association with clinical manifestations of undifferentiated connective tissue dysplasia. Eur. Sci. 2020;2-1:82&#x2013;85.</Citation></Reference><Reference><Citation>Churilov L.P., Stroev Y.I., Serdyuk I.Y., Kaminova-Mudzhikova O.M., Belyaeva I.V., Gvozdetsky A.N., Nitsa N.A., Mikhailova L.R. Autoimmune thyroiditis: Centennial jubilee of a social disease and its comorbidity. Pathophysiology. 2014;21:135&#x2013;145. doi: 10.1016/j.pathophys.2013.11.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pathophys.2013.11.002</ArticleId><ArticleId IdType=\"pubmed\">24274975</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>']\n"
     ]
    }
   ],
   "source": [
    "print(data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "585c357b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n",
      "Completed 0 to 52\n",
      "200\n",
      "Completed 52 to 104\n",
      "200\n",
      "Completed 104 to 156\n",
      "200\n",
      "Completed 156 to 208\n",
      "200\n",
      "Completed 208 to 260\n",
      "200\n",
      "Completed 260 to 312\n",
      "200\n",
      "Completed 312 to 364\n",
      "200\n",
      "Completed 364 to 416\n",
      "200\n",
      "Completed 416 to 468\n",
      "200\n",
      "Completed 468 to 520\n",
      "200\n",
      "Completed 520 to 572\n",
      "200\n",
      "Completed 572 to 624\n",
      "200\n",
      "Completed 624 to 676\n",
      "200\n",
      "Completed 676 to 728\n",
      "200\n",
      "Completed 728 to 780\n",
      "200\n",
      "Completed 780 to 832\n"
     ]
    }
   ],
   "source": [
    "START = 0\n",
    "STOP = 52\n",
    "length = int(len(id_list) / STOP)\n",
    "data = []\n",
    "for i in range(length):\n",
    "    req_data = requests.get(f\"{FETCH_URL}&id={id_list[START:STOP]}&retmode=xml&retstart=0&retmax=52&api_key={KEY}\")\n",
    "    response = req_data.text\n",
    "    data.append(response)\n",
    "    print(req_data.status_code)\n",
    "    print(f\"Completed {START} to {STOP}\")\n",
    "    \n",
    "    START+=52\n",
    "    STOP+=52\n",
    "    \n",
    "    time.sleep(10)\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "id": "158dc2b0",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "abstracts = []\n",
    "\n",
    "for d in data:\n",
    "    \n",
    "    soup = BeautifulSoup(d, \"lxml-xml\")\n",
    "\n",
    "    for art in soup.find_all(\"PubmedArticle\"):\n",
    "        year = art.find(\"DateRevised\")\n",
    "        year = year.find(\"Year\").get_text()\n",
    "\n",
    "        title = art.find(\"ArticleTitle\").get_text()\n",
    "\n",
    "        auth_last = art.find(\"LastName\")\n",
    "        if auth_last:\n",
    "            auth_last = auth_last.get_text()\n",
    "            auth_first = art.find(\"ForeName\").get_text()\n",
    "            auth = f\"{auth_last}, {auth_first}\"\n",
    "\n",
    "        abstract = art.find(\"Abstract\")\n",
    "\n",
    "        if abstract: \n",
    "            abstract = art.find(\"AbstractText\").get_text()\n",
    "\n",
    "        abs_dict = {\"Year\":year, \"Author\":auth, \"Title\":title, \"Abstract\":abstract}\n",
    "\n",
    "        abstracts.append(abs_dict)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "id": "325be34e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "819"
      ]
     },
     "execution_count": 74,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(abstracts)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "09e739b3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'Year': '2006',\n",
       " 'Author': 'Jones, Mark G',\n",
       " 'Title': 'Urinary and plasma organic acids and amino acids in chronic fatigue syndrome.',\n",
       " 'Abstract': \"Previous work by others have suggested the occurrence of one or more chemical or metabolic 'markers' for ME/CFS including specific amino acids and organic acids and a number of unidentified compounds (CFSUM1, CFSUM2). We have shown elsewhere that CFSUM1 is partially derivatised pyroglutamic acid and CFSUM2 partially derivatised serine and have suggested and demonstrated that the analytical methods used were unsuitable to identify or to accurately quantify urinary metabolites. We have now made a detailed analysis of plasma and urinary amino acids and of urinary organic acids from patients with ME/CFS and from three control groups. Fasting blood plasma and timed urine samples were obtained from 31 patients with CFS, 31 age and sex-matched healthy controls, 15 patients with depression and 22 patients with rheumatoid arthritis. Plasma and urinary amino acids and urinary organic acids were determined using established and validated methods and data compared by statistical analysis. None of the previously reported abnormalities in urinary amino acids or of organic acids could be confirmed. Results however provide some evidence in patients with ME/CFS for underlying inflammatory disease and for reduced intramuscular collagen with a lowered threshold for muscle micro-injury. These factors in combination may provide a basis for the fatigue and muscle pain that are the major symptoms in these patients.\"}"
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "abstracts[818]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "8f3fc409",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.DataFrame.from_dict(abstracts)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "df1a063b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Year</th>\n",
       "      <th>Author</th>\n",
       "      <th>Title</th>\n",
       "      <th>Abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2023</td>\n",
       "      <td>Cheng, Yuning</td>\n",
       "      <td>A unique circular RNA expression pattern in th...</td>\n",
       "      <td>Myalgic encephalomyelitis/chronic fatigue synd...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2023</td>\n",
       "      <td>van Campen, C Linda M C</td>\n",
       "      <td>Orthostatic chronotropic incompetence in patie...</td>\n",
       "      <td>Orthostatic intolerance (OI) is a core diagnos...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2023</td>\n",
       "      <td>Ayats-Vidal, Roser</td>\n",
       "      <td>Changes of Erythrocyte Fatty Acids after Suppl...</td>\n",
       "      <td>We characterized the fatty acid profiles in th...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2023</td>\n",
       "      <td>Ghali, Alaa</td>\n",
       "      <td>The relevance of pacing strategies in managing...</td>\n",
       "      <td>Post-COVID-19 syndrome (PCS) shares many featu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2023</td>\n",
       "      <td>van Campen, C Linda M C</td>\n",
       "      <td>Comparison of a 20 degree and 70 degree tilt t...</td>\n",
       "      <td>During a standard 70-degree head-up tilt test,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>814</th>\n",
       "      <td>2019</td>\n",
       "      <td>Jason, Leonard</td>\n",
       "      <td>The Energy Envelope Theory and myalgic encepha...</td>\n",
       "      <td>Individuals with myalgic encephalomyelitis/chr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>815</th>\n",
       "      <td>2022</td>\n",
       "      <td>Jason, Leonard A</td>\n",
       "      <td>The economic impact of ME/CFS: individual and ...</td>\n",
       "      <td>ME/CFS is characterized by debilitating fatigu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>816</th>\n",
       "      <td>2022</td>\n",
       "      <td>Nijs, Jo</td>\n",
       "      <td>Intracellular immune dysfunction in myalgic en...</td>\n",
       "      <td>Evidence in support of intracellular immune dy...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>817</th>\n",
       "      <td>2013</td>\n",
       "      <td>Chalmers, Ronald A</td>\n",
       "      <td>CFSUM1 and CFSUM2 in urine from patients with ...</td>\n",
       "      <td>McGregor et al. reported increased levels of a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>818</th>\n",
       "      <td>2006</td>\n",
       "      <td>Jones, Mark G</td>\n",
       "      <td>Urinary and plasma organic acids and amino aci...</td>\n",
       "      <td>Previous work by others have suggested the occ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>819 rows  4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     Year                   Author  \\\n",
       "0    2023            Cheng, Yuning   \n",
       "1    2023  van Campen, C Linda M C   \n",
       "2    2023       Ayats-Vidal, Roser   \n",
       "3    2023              Ghali, Alaa   \n",
       "4    2023  van Campen, C Linda M C   \n",
       "..    ...                      ...   \n",
       "814  2019           Jason, Leonard   \n",
       "815  2022         Jason, Leonard A   \n",
       "816  2022                 Nijs, Jo   \n",
       "817  2013       Chalmers, Ronald A   \n",
       "818  2006            Jones, Mark G   \n",
       "\n",
       "                                                 Title  \\\n",
       "0    A unique circular RNA expression pattern in th...   \n",
       "1    Orthostatic chronotropic incompetence in patie...   \n",
       "2    Changes of Erythrocyte Fatty Acids after Suppl...   \n",
       "3    The relevance of pacing strategies in managing...   \n",
       "4    Comparison of a 20 degree and 70 degree tilt t...   \n",
       "..                                                 ...   \n",
       "814  The Energy Envelope Theory and myalgic encepha...   \n",
       "815  The economic impact of ME/CFS: individual and ...   \n",
       "816  Intracellular immune dysfunction in myalgic en...   \n",
       "817  CFSUM1 and CFSUM2 in urine from patients with ...   \n",
       "818  Urinary and plasma organic acids and amino aci...   \n",
       "\n",
       "                                              Abstract  \n",
       "0    Myalgic encephalomyelitis/chronic fatigue synd...  \n",
       "1    Orthostatic intolerance (OI) is a core diagnos...  \n",
       "2    We characterized the fatty acid profiles in th...  \n",
       "3    Post-COVID-19 syndrome (PCS) shares many featu...  \n",
       "4    During a standard 70-degree head-up tilt test,...  \n",
       "..                                                 ...  \n",
       "814  Individuals with myalgic encephalomyelitis/chr...  \n",
       "815  ME/CFS is characterized by debilitating fatigu...  \n",
       "816  Evidence in support of intracellular immune dy...  \n",
       "817  McGregor et al. reported increased levels of a...  \n",
       "818  Previous work by others have suggested the occ...  \n",
       "\n",
       "[819 rows x 4 columns]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "c74c3379",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['Header'] = df['Title'] + ':' + df['Abstract']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "ba2ebb26",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Year</th>\n",
       "      <th>Author</th>\n",
       "      <th>Title</th>\n",
       "      <th>Abstract</th>\n",
       "      <th>Header</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2023</td>\n",
       "      <td>Cheng, Yuning</td>\n",
       "      <td>A unique circular RNA expression pattern in th...</td>\n",
       "      <td>Myalgic encephalomyelitis/chronic fatigue synd...</td>\n",
       "      <td>A unique circular RNA expression pattern in th...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2023</td>\n",
       "      <td>van Campen, C Linda M C</td>\n",
       "      <td>Orthostatic chronotropic incompetence in patie...</td>\n",
       "      <td>Orthostatic intolerance (OI) is a core diagnos...</td>\n",
       "      <td>Orthostatic chronotropic incompetence in patie...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2023</td>\n",
       "      <td>Ayats-Vidal, Roser</td>\n",
       "      <td>Changes of Erythrocyte Fatty Acids after Suppl...</td>\n",
       "      <td>We characterized the fatty acid profiles in th...</td>\n",
       "      <td>Changes of Erythrocyte Fatty Acids after Suppl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2023</td>\n",
       "      <td>Ghali, Alaa</td>\n",
       "      <td>The relevance of pacing strategies in managing...</td>\n",
       "      <td>Post-COVID-19 syndrome (PCS) shares many featu...</td>\n",
       "      <td>The relevance of pacing strategies in managing...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2023</td>\n",
       "      <td>van Campen, C Linda M C</td>\n",
       "      <td>Comparison of a 20 degree and 70 degree tilt t...</td>\n",
       "      <td>During a standard 70-degree head-up tilt test,...</td>\n",
       "      <td>Comparison of a 20 degree and 70 degree tilt t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>814</th>\n",
       "      <td>2019</td>\n",
       "      <td>Jason, Leonard</td>\n",
       "      <td>The Energy Envelope Theory and myalgic encepha...</td>\n",
       "      <td>Individuals with myalgic encephalomyelitis/chr...</td>\n",
       "      <td>The Energy Envelope Theory and myalgic encepha...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>815</th>\n",
       "      <td>2022</td>\n",
       "      <td>Jason, Leonard A</td>\n",
       "      <td>The economic impact of ME/CFS: individual and ...</td>\n",
       "      <td>ME/CFS is characterized by debilitating fatigu...</td>\n",
       "      <td>The economic impact of ME/CFS: individual and ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>816</th>\n",
       "      <td>2022</td>\n",
       "      <td>Nijs, Jo</td>\n",
       "      <td>Intracellular immune dysfunction in myalgic en...</td>\n",
       "      <td>Evidence in support of intracellular immune dy...</td>\n",
       "      <td>Intracellular immune dysfunction in myalgic en...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>817</th>\n",
       "      <td>2013</td>\n",
       "      <td>Chalmers, Ronald A</td>\n",
       "      <td>CFSUM1 and CFSUM2 in urine from patients with ...</td>\n",
       "      <td>McGregor et al. reported increased levels of a...</td>\n",
       "      <td>CFSUM1 and CFSUM2 in urine from patients with ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>818</th>\n",
       "      <td>2006</td>\n",
       "      <td>Jones, Mark G</td>\n",
       "      <td>Urinary and plasma organic acids and amino aci...</td>\n",
       "      <td>Previous work by others have suggested the occ...</td>\n",
       "      <td>Urinary and plasma organic acids and amino aci...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>819 rows  5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     Year                   Author  \\\n",
       "0    2023            Cheng, Yuning   \n",
       "1    2023  van Campen, C Linda M C   \n",
       "2    2023       Ayats-Vidal, Roser   \n",
       "3    2023              Ghali, Alaa   \n",
       "4    2023  van Campen, C Linda M C   \n",
       "..    ...                      ...   \n",
       "814  2019           Jason, Leonard   \n",
       "815  2022         Jason, Leonard A   \n",
       "816  2022                 Nijs, Jo   \n",
       "817  2013       Chalmers, Ronald A   \n",
       "818  2006            Jones, Mark G   \n",
       "\n",
       "                                                 Title  \\\n",
       "0    A unique circular RNA expression pattern in th...   \n",
       "1    Orthostatic chronotropic incompetence in patie...   \n",
       "2    Changes of Erythrocyte Fatty Acids after Suppl...   \n",
       "3    The relevance of pacing strategies in managing...   \n",
       "4    Comparison of a 20 degree and 70 degree tilt t...   \n",
       "..                                                 ...   \n",
       "814  The Energy Envelope Theory and myalgic encepha...   \n",
       "815  The economic impact of ME/CFS: individual and ...   \n",
       "816  Intracellular immune dysfunction in myalgic en...   \n",
       "817  CFSUM1 and CFSUM2 in urine from patients with ...   \n",
       "818  Urinary and plasma organic acids and amino aci...   \n",
       "\n",
       "                                              Abstract  \\\n",
       "0    Myalgic encephalomyelitis/chronic fatigue synd...   \n",
       "1    Orthostatic intolerance (OI) is a core diagnos...   \n",
       "2    We characterized the fatty acid profiles in th...   \n",
       "3    Post-COVID-19 syndrome (PCS) shares many featu...   \n",
       "4    During a standard 70-degree head-up tilt test,...   \n",
       "..                                                 ...   \n",
       "814  Individuals with myalgic encephalomyelitis/chr...   \n",
       "815  ME/CFS is characterized by debilitating fatigu...   \n",
       "816  Evidence in support of intracellular immune dy...   \n",
       "817  McGregor et al. reported increased levels of a...   \n",
       "818  Previous work by others have suggested the occ...   \n",
       "\n",
       "                                                Header  \n",
       "0    A unique circular RNA expression pattern in th...  \n",
       "1    Orthostatic chronotropic incompetence in patie...  \n",
       "2    Changes of Erythrocyte Fatty Acids after Suppl...  \n",
       "3    The relevance of pacing strategies in managing...  \n",
       "4    Comparison of a 20 degree and 70 degree tilt t...  \n",
       "..                                                 ...  \n",
       "814  The Energy Envelope Theory and myalgic encepha...  \n",
       "815  The economic impact of ME/CFS: individual and ...  \n",
       "816  Intracellular immune dysfunction in myalgic en...  \n",
       "817  CFSUM1 and CFSUM2 in urine from patients with ...  \n",
       "818  Urinary and plasma organic acids and amino aci...  \n",
       "\n",
       "[819 rows x 5 columns]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "5c256879",
   "metadata": {},
   "outputs": [],
   "source": [
    "import openai as ai"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "9f7becf2",
   "metadata": {},
   "outputs": [],
   "source": [
    "KEY = \"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\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "eba3af8a",
   "metadata": {},
   "outputs": [],
   "source": [
    "ai.api_key = KEY"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "f5e2e219",
   "metadata": {},
   "outputs": [],
   "source": [
    "#function to return the queried response\n",
    "def generate_gpt3_response(text, print_output=False):\n",
    "    \"\"\"\n",
    "    Query OpenAI GPT-3 for the specific key and get back a response\n",
    "    :type user_text: str the user's text to query for\n",
    "    :type print_output: boolean whether or not to print the raw output JSON\n",
    "    \"\"\"\n",
    "    time.sleep(1)\n",
    "    completions = ai.Completion.create(\n",
    "        engine='text-davinci-003',  \n",
    "        temperature=0.9,            \n",
    "        prompt=text,               \n",
    "        max_tokens=500,             \n",
    "        n=1,                       \n",
    "        stop=None,                  \n",
    "    )\n",
    "\n",
    "    if print_output:\n",
    "        print(completions)\n",
    "\n",
    "    return completions.choices[0].text.replace('\\n', '')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "e990df30",
   "metadata": {},
   "outputs": [],
   "source": [
    "text = df['Header'][1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "c3cfa6bd",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Orthostatic chronotropic incompetence in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).:Orthostatic intolerance (OI) is a core diagnostic criterion in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The majority of ME/CFS patients have no evidence of hypotension or postural orthostatic tachycardia syndrome (POTS) during head-up tilt, but do show a significantly larger reduction in stroke volume index (SVI) when upright compared to controls. Theoretically a reduction in SVI should be accompanied by a compensatory increase in heart rate (HR). When there is an incomplete compensatory increase in HR, this is considered chronotropic incompetence. This study explored the relationship between HR and SVI to determine whether chronotropic incompetence was present during tilt testing in ME/CFS patients.'"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 148,
   "id": "a34d4171",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'.Orthostatic Intolerance'"
      ]
     },
     "execution_count": 148,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "generate_gpt3_response(\"I am giving you the title and short description \\\n",
    "                of the article in the format [Title:Description], \\\n",
    "                give me the key word like immune system, chronotropic intolerance, orthostatic intolerance, POTS or the related topic in 1 word for the text '{}', \\\n",
    "                do not include ME/CFS or myalgic encephalomyelitis as a key word\".format(text))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "abe41e70",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'ME/CFS patients have decreased SVI when upright, with poor HR compensation, resulting in chronotropic incompetence.'"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "generate_gpt3_response(\"I am giving you the title and description of the article in the format [Title:Description], \\\n",
    "                give me a 10 word summary for the text '{}' \".format(text))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 126,
   "id": "1db05bdb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'ME/CFS, OI, POTS, SVI, HR, Tilt.'"
      ]
     },
     "execution_count": 126,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "generate_gpt3_response(\"I am giving you the title and short description of the article in the format [Title:Description], give me the key words like immune, RNA, orthostatic intolerance, POTS or the related topics in 6 words for the text '{}' \".format(text))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "d6b8ec68",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Adding the title and description into single column to get more meaningful topics\n",
    "df['Key_Words'] = df['Header'].apply(lambda x:\n",
    "    generate_gpt3_response(\"I am giving you the title and short description of the article in the format [Title:Description], give me the key word like immune system, chronotropic intolerance, orthostatic intolerance, POTS or the related topics in 10 words for the text '{}'\".format(x)))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "5a92f14b",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['Key_Words'] = df['Key_Words'].str.replace('.', '')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "25277e5a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Key_Words\n",
       " Immune System, Chronotropic, Orthostatic, POTS                                                                                                                                                                    2\n",
       " ME/CFS, circRNA, biomarker, expression, exercise, miRNA, physiological, diagnosis, signature, pathway                                                                                                             1\n",
       " miRNomes, Fibromyalgia, ME/CFS, polypharmacy, treatments, pharmacogenomic, personalized medicine, biomarker, differential expression, masking, toxicity                                                           1\n",
       " Nanotechnology, Medicine, Immune Systems                                                                                                                                                                          1\n",
       "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Neuroinflammation, Cytokines, Research Methods, Critical Review, Corrigendum, Immune System, Inflammation, Pro-Inflammatory, Anti-Inflammatory        1\n",
       "                                                                                                                                                                                                                  ..\n",
       "ME/CFS, history, dogma, causation, psychological, scientific, evidence, theorisation, research, treatment, patient                                                                                                 1\n",
       "ME/CFS, Autoantibodies, Vasoregulative, G-Protein-Coupled, Receptors, Symptom Severity, Autonomic Dysfunction, Disability, Beta-Adrenergic, Muscarinic Acetylcholine                                               1\n",
       "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Australian Adolescents, Prognosis, Follow-up Study, Health, Wellbeing, Diagnosis, Symptoms, Criteria, Predictors, Time                                         1\n",
       "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Activin B, ELISA assay, serum biomarkers, clinical symptoms, healthy controls, diagnostic potential, visual analogue scale, gender, age, utility, biomarker    1\n",
       "Chronic fatigue syndrome, ME/CFS, plasma, urinary, amino acids, organic acids, depression, rheumatoid arthritis, inflammatory disease, collagen, micro-injury                                                      1\n",
       "Name: count, Length: 818, dtype: int64"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Key_Words'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "285789d4",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['Summary'] = df['Header'].apply(lambda x: \n",
    "                                   generate_gpt3_response(\"I am giving you the title and short description of the article in the format [Title:Description], give me a 10 word summary for the text '{}' \".format(x)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "a72ddc2c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Summary\n",
       "People experiencing ME/CFS in Sweden face extreme stress due to restrictive workfare policies, resulting in perpetual crisis and lack of identity formation. This in turn affects their health, with some politicising their situation and some avoiding social insurances.                                             1\n",
       " Research focused on severely/very severely ME/CFS patients, who are hard to reach. Reasonable adjustments enabled them to participate via questionnaire. This provided valuable contributions and served as model for future research.                                                                                 1\n",
       "Striking lack of knowledge of ME/CFS symptom burden; 491 patients surveyed with 444 severe, 47 very severe; 45% childhood onset for very severe, disease duration 15+ yrs for 19%; extensive symptom burden; inadequate healthcare and social service support; family carers face large burden with inadequate help.    1\n",
       "IOM proposed replacing ME/CFS with 'systemic exertion intolerance disease', for which new diagnostic criteria were reviewed. The review found flaws in the approach and negative consequences outweighing advantages of the renaming.                                                                                   1\n",
       "Empirically-derived symptoms, such as fatigue and unrefreshing sleep, can improve diagnosis of ME/CFS with good sensitivity and specificity.                                                                                                                                                                            1\n",
       "                                                                                                                                                                                                                                                                                                                       ..\n",
       " ME/CFS is a complex disease characterized by fatigue and reduced metabolism. Its pathogenesis is unknown but mitochondrial dysfunction and hypothamamic inflammation may be involved. Treatment is currently lacking, but could be developed targeting this inflammation.                                              1\n",
       " Study finds abnormalities in ME/CFS patients' metabolism of acyl lipids and steroids.                                                                                                                                                                                                                                  1\n",
       "Autoimmune responses to OSEs associated with better clinical outcome in ME/CFS, but not NO-adducts. IO&NS pathways involved in ME/CFS pathophysiology. Increased IgM and IgA to LPS of gram-negative bacteria.                                                                                                          1\n",
       "Patients with ME/CFS show altered muscle excitability, increased oxidative stress, and muscle dysfunction.                                                                                                                                                                                                              1\n",
       "Examining ME/CFS and ICF patients via two-day CPET reveals differences, with ME/CFS showing reduced oxygen consumption compared to sedentary controls, while ICF patients show no differences.                                                                                                                          1\n",
       "Name: count, Length: 774, dtype: int64"
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.Summary.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "95a73321",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['Summary'] = df['Summary'].str.replace('[Title:Description]:', '')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "c0120662",
   "metadata": {},
   "outputs": [],
   "source": [
    "ME_df = df[df['Key_Words'].str.contains('ME/CFS') | df['Key_Words'].str.contains('Myalgic Encephalomyelitis/Chronic') | df['Key_Words'].str.contains('CFS')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "ceba23ec",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.dropna()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "0dd9b8a4",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.drop([408,540])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "id": "8b6f18a0",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/24/qphg0pgs58s4mjsl71xjqsk00000gn/T/ipykernel_3434/3734492680.py:4: SettingWithCopyWarning:\n",
      "\n",
      "\n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "\n"
     ]
    }
   ],
   "source": [
    "def get_embedding(text, model=\"text-embedding-ada-002\"):\n",
    "    return ai.Embedding.create(input = [text], model=model)['data'][0]['embedding']\n",
    "\n",
    "ME_df['ada_embedding'] = ME_df['Key_Words'].apply(lambda x: get_embedding(x, model='text-embedding-ada-002'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "id": "f118f59c",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/24/qphg0pgs58s4mjsl71xjqsk00000gn/T/ipykernel_3434/1656876064.py:1: SettingWithCopyWarning:\n",
      "\n",
      "\n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "\n"
     ]
    }
   ],
   "source": [
    "ME_df['Key_Words'] = ME_df['Key_Words'].str.replace('()', '')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "15e4f37f",
   "metadata": {},
   "outputs": [],
   "source": [
    "import joblib"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "3a6a479d",
   "metadata": {},
   "outputs": [],
   "source": [
    "ME_df = joblib.load('ME_abstracts.pkl')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "id": "7017e65e",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Year</th>\n",
       "      <th>Author</th>\n",
       "      <th>Title</th>\n",
       "      <th>Abstract</th>\n",
       "      <th>Header</th>\n",
       "      <th>Key_Words</th>\n",
       "      <th>Summary</th>\n",
       "      <th>ada_embedding</th>\n",
       "      <th>Cluster</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2023</td>\n",
       "      <td>Cheng, Yuning</td>\n",
       "      <td>A unique circular RNA expression pattern in th...</td>\n",
       "      <td>Myalgic encephalomyelitis/chronic fatigue synd...</td>\n",
       "      <td>A unique circular RNA expression pattern in th...</td>\n",
       "      <td>circRNA, biomarker, expression, exercise, miR...</td>\n",
       "      <td>ME/CFS is a debilitating disease with potentia...</td>\n",
       "      <td>[-0.027577634900808334, 0.0075575849041342735,...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2023</td>\n",
       "      <td>van Campen, C Linda M C</td>\n",
       "      <td>Orthostatic chronotropic incompetence in patie...</td>\n",
       "      <td>Orthostatic intolerance (OI) is a core diagnos...</td>\n",
       "      <td>Orthostatic chronotropic incompetence in patie...</td>\n",
       "      <td>, Orthostatic Intolerance (OI), Postural Orth...</td>\n",
       "      <td>ME/CFS patients with OI have lower SVI upright...</td>\n",
       "      <td>[-0.022541124373674393, -0.004733376670628786,...</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2023</td>\n",
       "      <td>Ghali, Alaa</td>\n",
       "      <td>The relevance of pacing strategies in managing...</td>\n",
       "      <td>Post-COVID-19 syndrome (PCS) shares many featu...</td>\n",
       "      <td>The relevance of pacing strategies in managing...</td>\n",
       "      <td>Pacing Strategies, Post-COVID-19 Syndrome, Tre...</td>\n",
       "      <td>Pacing strategies shown to be effective in man...</td>\n",
       "      <td>[-0.01052333228290081, 0.00876608956605196, 0....</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2023</td>\n",
       "      <td>van Campen, C Linda M C</td>\n",
       "      <td>Comparison of a 20 degree and 70 degree tilt t...</td>\n",
       "      <td>During a standard 70-degree head-up tilt test,...</td>\n",
       "      <td>Comparison of a 20 degree and 70 degree tilt t...</td>\n",
       "      <td>, tilt test, 20 degrees, 70 degrees, cerebral ...</td>\n",
       "      <td>Reduced cerebral blood flow (CBF) in ME/CFS p...</td>\n",
       "      <td>[-0.008576775901019573, 0.005027199164032936, ...</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>2023</td>\n",
       "      <td>Kimura, Yukio</td>\n",
       "      <td>Free-water-corrected diffusion and adrenergic/...</td>\n",
       "      <td>Free-water-corrected diffusion tensor imaging ...</td>\n",
       "      <td>Free-water-corrected diffusion and adrenergic/...</td>\n",
       "      <td>Free-water-corrected Diffusion, DTI, Autoimmu...</td>\n",
       "      <td>FW-DTI suggests neuroinflammation and neurodeg...</td>\n",
       "      <td>[-0.02878424897789955, 0.015446159057319164, -...</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>814</th>\n",
       "      <td>2019</td>\n",
       "      <td>Jason, Leonard</td>\n",
       "      <td>The Energy Envelope Theory and myalgic encepha...</td>\n",
       "      <td>Individuals with myalgic encephalomyelitis/chr...</td>\n",
       "      <td>The Energy Envelope Theory and myalgic encepha...</td>\n",
       "      <td>Energy Envelope Theory, Fatigue, Symptom Seve...</td>\n",
       "      <td>The Energy Envelope Theory provides useful str...</td>\n",
       "      <td>[-0.020359188318252563, -0.017026275396347046,...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>815</th>\n",
       "      <td>2022</td>\n",
       "      <td>Jason, Leonard A</td>\n",
       "      <td>The economic impact of ME/CFS: individual and ...</td>\n",
       "      <td>ME/CFS is characterized by debilitating fatigu...</td>\n",
       "      <td>The economic impact of ME/CFS: individual and ...</td>\n",
       "      <td>, economic, impact, individual, societal, cost...</td>\n",
       "      <td>ME/CFS affects over 800,000 US adults with dis...</td>\n",
       "      <td>[-0.0038556132931262255, -0.008983579464256763...</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>816</th>\n",
       "      <td>2022</td>\n",
       "      <td>Nijs, Jo</td>\n",
       "      <td>Intracellular immune dysfunction in myalgic en...</td>\n",
       "      <td>Evidence in support of intracellular immune dy...</td>\n",
       "      <td>Intracellular immune dysfunction in myalgic en...</td>\n",
       "      <td>Intracellular Immunity, Evidence, Therapeuti...</td>\n",
       "      <td>Myalgic Encephalomyelitis/Chronic Fatigue Synd...</td>\n",
       "      <td>[-0.0287174079567194, -0.001695576822385192, -...</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>817</th>\n",
       "      <td>2013</td>\n",
       "      <td>Chalmers, Ronald A</td>\n",
       "      <td>CFSUM1 and CFSUM2 in urine from patients with ...</td>\n",
       "      <td>McGregor et al. reported increased levels of a...</td>\n",
       "      <td>CFSUM1 and CFSUM2 in urine from patients with ...</td>\n",
       "      <td>McGregor et al, Urine Samples, Sample Prepara...</td>\n",
       "      <td>CFSUM1 and CFSUM2 artefacts of sample preparat...</td>\n",
       "      <td>[0.009612154215574265, 0.010279664769768715, 0...</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>818</th>\n",
       "      <td>2006</td>\n",
       "      <td>Jones, Mark G</td>\n",
       "      <td>Urinary and plasma organic acids and amino aci...</td>\n",
       "      <td>Previous work by others have suggested the occ...</td>\n",
       "      <td>Urinary and plasma organic acids and amino aci...</td>\n",
       "      <td>Chronic fatigue syndrome, plasma, urinary, ami...</td>\n",
       "      <td>ME/CFS markers including amino acids and organ...</td>\n",
       "      <td>[-0.017055567353963852, -0.0051373750902712345...</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>639 rows  9 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     Year                   Author  \\\n",
       "0    2023            Cheng, Yuning   \n",
       "1    2023  van Campen, C Linda M C   \n",
       "3    2023              Ghali, Alaa   \n",
       "4    2023  van Campen, C Linda M C   \n",
       "5    2023            Kimura, Yukio   \n",
       "..    ...                      ...   \n",
       "814  2019           Jason, Leonard   \n",
       "815  2022         Jason, Leonard A   \n",
       "816  2022                 Nijs, Jo   \n",
       "817  2013       Chalmers, Ronald A   \n",
       "818  2006            Jones, Mark G   \n",
       "\n",
       "                                                 Title  \\\n",
       "0    A unique circular RNA expression pattern in th...   \n",
       "1    Orthostatic chronotropic incompetence in patie...   \n",
       "3    The relevance of pacing strategies in managing...   \n",
       "4    Comparison of a 20 degree and 70 degree tilt t...   \n",
       "5    Free-water-corrected diffusion and adrenergic/...   \n",
       "..                                                 ...   \n",
       "814  The Energy Envelope Theory and myalgic encepha...   \n",
       "815  The economic impact of ME/CFS: individual and ...   \n",
       "816  Intracellular immune dysfunction in myalgic en...   \n",
       "817  CFSUM1 and CFSUM2 in urine from patients with ...   \n",
       "818  Urinary and plasma organic acids and amino aci...   \n",
       "\n",
       "                                              Abstract  \\\n",
       "0    Myalgic encephalomyelitis/chronic fatigue synd...   \n",
       "1    Orthostatic intolerance (OI) is a core diagnos...   \n",
       "3    Post-COVID-19 syndrome (PCS) shares many featu...   \n",
       "4    During a standard 70-degree head-up tilt test,...   \n",
       "5    Free-water-corrected diffusion tensor imaging ...   \n",
       "..                                                 ...   \n",
       "814  Individuals with myalgic encephalomyelitis/chr...   \n",
       "815  ME/CFS is characterized by debilitating fatigu...   \n",
       "816  Evidence in support of intracellular immune dy...   \n",
       "817  McGregor et al. reported increased levels of a...   \n",
       "818  Previous work by others have suggested the occ...   \n",
       "\n",
       "                                                Header  \\\n",
       "0    A unique circular RNA expression pattern in th...   \n",
       "1    Orthostatic chronotropic incompetence in patie...   \n",
       "3    The relevance of pacing strategies in managing...   \n",
       "4    Comparison of a 20 degree and 70 degree tilt t...   \n",
       "5    Free-water-corrected diffusion and adrenergic/...   \n",
       "..                                                 ...   \n",
       "814  The Energy Envelope Theory and myalgic encepha...   \n",
       "815  The economic impact of ME/CFS: individual and ...   \n",
       "816  Intracellular immune dysfunction in myalgic en...   \n",
       "817  CFSUM1 and CFSUM2 in urine from patients with ...   \n",
       "818  Urinary and plasma organic acids and amino aci...   \n",
       "\n",
       "                                             Key_Words  \\\n",
       "0     circRNA, biomarker, expression, exercise, miR...   \n",
       "1     , Orthostatic Intolerance (OI), Postural Orth...   \n",
       "3    Pacing Strategies, Post-COVID-19 Syndrome, Tre...   \n",
       "4    , tilt test, 20 degrees, 70 degrees, cerebral ...   \n",
       "5     Free-water-corrected Diffusion, DTI, Autoimmu...   \n",
       "..                                                 ...   \n",
       "814   Energy Envelope Theory, Fatigue, Symptom Seve...   \n",
       "815  , economic, impact, individual, societal, cost...   \n",
       "816    Intracellular Immunity, Evidence, Therapeuti...   \n",
       "817   McGregor et al, Urine Samples, Sample Prepara...   \n",
       "818  Chronic fatigue syndrome, plasma, urinary, ami...   \n",
       "\n",
       "                                               Summary  \\\n",
       "0    ME/CFS is a debilitating disease with potentia...   \n",
       "1    ME/CFS patients with OI have lower SVI upright...   \n",
       "3    Pacing strategies shown to be effective in man...   \n",
       "4     Reduced cerebral blood flow (CBF) in ME/CFS p...   \n",
       "5    FW-DTI suggests neuroinflammation and neurodeg...   \n",
       "..                                                 ...   \n",
       "814  The Energy Envelope Theory provides useful str...   \n",
       "815  ME/CFS affects over 800,000 US adults with dis...   \n",
       "816  Myalgic Encephalomyelitis/Chronic Fatigue Synd...   \n",
       "817  CFSUM1 and CFSUM2 artefacts of sample preparat...   \n",
       "818  ME/CFS markers including amino acids and organ...   \n",
       "\n",
       "                                         ada_embedding  Cluster  \n",
       "0    [-0.027577634900808334, 0.0075575849041342735,...        6  \n",
       "1    [-0.022541124373674393, -0.004733376670628786,...        8  \n",
       "3    [-0.01052333228290081, 0.00876608956605196, 0....        0  \n",
       "4    [-0.008576775901019573, 0.005027199164032936, ...        8  \n",
       "5    [-0.02878424897789955, 0.015446159057319164, -...        9  \n",
       "..                                                 ...      ...  \n",
       "814  [-0.020359188318252563, -0.017026275396347046,...        1  \n",
       "815  [-0.0038556132931262255, -0.008983579464256763...        7  \n",
       "816  [-0.0287174079567194, -0.001695576822385192, -...        9  \n",
       "817  [0.009612154215574265, 0.010279664769768715, 0...        7  \n",
       "818  [-0.017055567353963852, -0.0051373750902712345...        3  \n",
       "\n",
       "[639 rows x 9 columns]"
      ]
     },
     "execution_count": 98,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ME_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 227,
   "id": "5cfbe539",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/wild/.pyenv/versions/3.11.2/lib/python3.11/site-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
      "  warnings.warn(\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "from sklearn.cluster import KMeans\n",
    "\n",
    "matrix = np.vstack(df2)\n",
    "n_clusters = 10\n",
    "\n",
    "kmeans = KMeans(n_clusters = n_clusters, init='k-means++', random_state=42)\n",
    "kmeans.fit(df2)\n",
    "df['Cluster'] = kmeans.labels_"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 275,
   "id": "11ea2c53",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.sort_values('Cluster')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 574,
   "id": "6a6bebf3",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv('ME_abstract_list.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c624ba20",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
